Structure Search

List Search MOL Search Structure Search

Americas USD

Europe EUR GBP

 EN

English - EN Chinese - ZH

 Cart 0
Chemistry
Life Science
Catalysts Ligands
Materials Science
Catalysts Ligands
Achiral Nitrogen Ligands
Pyridine and Phenanthroline Ligands (274)
Other Achiral Nitrogen Ligands (51)
Achiral Oxygen Ligands
Achiral Oxygen Ligand (54)
Achiral Phosphine Ligands
Alkyl-phosphine Ligands (17)
Aryl-phosphine Ligands (86)
2-(Diphenylphosphaneyl)Benzaldehyde (5)[1,1'-Biphenyl]-2-Yldi-Tert-Butylphosphane (4)Triphenylphosphine Oxide (7)
Bis-phosphine Ligands (88)
Monophosphine Ligands (256)
Multi-phosphine Ligands (5)
Chiral Nitrogen Ligands
Chiral Bis-nitrogen Ligands (94)
Salen Ligands (7)
Other Chiral Nitrogen Ligands (61)
Chiral Oxazoline Ligands
BOX Ligands (526)
Chiral Mono Oxazoline Ligands (410)
Ferrocenyl-oxazoline Ligands (10)
PHOX Ligands (231)
SOX Ligands (34)
TOX Ligands (6)
Other Oxazoline Ligands (14)
Chiral Oxygen Ligands
BINOLs (46)
BIPHENs (2)
Chiral Diphenols (112)
Other Chiral Oxygen Ligands (24)
Chiral Phosphine Ligands
Atropisomeric Bisphosphine Ligands (218)
BIDIME and BIBOP Ligands (86)
BIDIME-BIBOP (7)
2,2',3,3'-Tetrahydro-4,4'-Bibenzo[D][1,3]Oxaphosphole (7)
Chiral Aminophosphine Ligands (48)
Chiral Ferrocenyl Phosphine Ligands (130)
Chiral Phosphoramidite Ligands (190)
Duphos and BPE Ligands (28)
PHOX Ligands (231)
Sadphos Ligands (294)
Other C-Chiral Ligands (76)
Other P-Chiral Ligands (10)
Main-Group Metals
Aluminum (11)
Tin (3)
Metalloids
Metalloid (5)
Photoredox Catalysts
Organic-dye Photoredox Catalysts (86)
Photoredox Acridinium Catalysts (22)
Photoredox Carbazole Catalysts (7)
Photoredox Iridiums Catalysts (100)
Photoredox Rutheniums Catalysts (37)
Other Photoredox Catalysts (13)
Transition Metals
Cadmium (1)
Cobalt (96)
Copper (122)
Gold (105)
Iridium (65)
Iron (113)
Manganese (48)
Molybdenum (17)
Nickel (108)
Osmium (3)
Palladium (318)
Platinum (81)
Rhenium (6)
Rhodium (172)
Ruthenium (219)
Silver (35)
Tantalum (1)
Titanium (12)
Tungsten (6)
Vanadium (7)
Zinc (69)
Other Cheap Metals (6)
Chemistry
Asymmetric Synthesis
Chiral Building Blocks (18446)
Boronic Acids/Esters
1,3,2-Dioxaborinane (394)
Boronic Acids (13208)
MIDA Boronates (363)
Pinacol Boronates (16152)
Pinanediol Boronates (98)
Potassium Organotrifluoroborate Salts (1077)
Other Boronates (132)
Fluorine Chemistry
Aliphatic Fluorinated Building Blocks (727)
Aromatic Fluorinated Building Blocks (9219)
Bis(trifluoromethane)sulfonimides (49)
Difluoromethoxylated Building Blocks (231)
Difluoromethylated Building Blocks (344)
Hexafluorophosphates (62)
Monofluoromethylated Building Blocks (70)
Polyfluoroalkanes (93)
SF5-Containing Building Blocks (72)
Sulfonyl Fluorides (66)
Tetrafluoroborates (139)
Triflates (85)
Trifluoroborates (212)
Trifluoromethoxylated Building Blocks (562)
Trifluoromethylated Building Blocks (4440)
Trifluoromethylthiolated Building Blocks (49)
Heterocyclic Building Blocks
Acridines (641)
1,2,3,4-Tetrahydroacridine (9)9,10-Diphenylacridin-10-Ium (6)Acridine (19)
Aliphatic Heterocycles (105)
(1R,5S)-3-Azabicyclo[3.1.0]Hexane (11)1,2-Dithiolane (7)1,4-Diazepan-2-One (5)1,4-Diazepan-5-One (9)1,4-Dioxane (17)1,4-Oxazepane (8)10,11-Dihydro-5H-Dibenzo[B,F]Azepine (9)11,12-Didehydro-5,6-Dihydrodibenz[B,F]Azocine (14)3-((((9H-Fluoren-9-Yl)Methoxy)Carbonyl)Glycyl)-2,2-Dimethyloxazolidine-4-Carboxylic Acid (9)3H-Diazirine (11)4-Benzyl-1,4-Oxazepane (5)Tetrahydro-2H-Thiopyran 1,1-Dioxide (8)
Aromatic Heterocycles (30)
1,2,4,5-Tetrazine (7)3,4-Dihydronaphthalen-2(1H)-One (23)
Azetidines (2879)
Alcohols (18)Amides (102)Amines (17)Aryls (44)Bromides (7)Carboxylic Acids (17)Chlorides (10)Esters (11)Ethers (18)Fluorinated Building Blocks (20)Ketones (16)Nitriles (5)Sulfamides (5)1-(Azetidin-1-Yl)-2-Bromoethan-1-One (3)1-(Azetidin-3-Yl)-1H-Pyrazole (7)1-(Phenylsulfonyl)Azetidine (7)1-Benzhydrylazetidine (13)1-Benzylazetidine (6)1-Methylazetidine (6)1-Phenylazetidine (8)2,7-Diazaspiro[3.5]Nonane (7)2-Azaspiro[3.3]Heptane (11)2-Imino-N-((6R,7R)-8-Oxo-5-Thia-1-Azabicyclo[4.2.0]Oct-2-En-7-Yl)-2-(Thiazol-4-Yl)Acetamide (3)3-Bromoazetidine (3)3-Methylazetidin-3-Ol (3)3-Methyleneazetidine (8)4-(Azetidin-1-Yl)Piperidine (6)Azetidin-2-One (11)Azetidin-2-Ylmethanol (7)Azetidin-3-Amine (4)Azetidin-3-Ol (11)Azetidin-3-Yl Acetate (3)Azetidin-3-Ylmethanamine (3)Azetidine-2-Carboxylic Acid (6)Azetidine-3-Carboxylic Acid (5)Benzyl Azetidine-1-Carboxylate (9)Methyl Azetidine-2-Carboxylate (3)N-((6R,7R)-8-Oxo-5-Thia-1-Azabicyclo[4.2.0]Oct-2-En-7-Yl)-2-Phenylacetamide (5)Tert-Butyl Azetidine-1-Carboxylate (64)Oxetanes (9)Piperidines (16)Pyridines (4)Pyrimidines (4)Pyrrolidines (12)Spiroes (85)Tetrahydropyrans (6)
Benzimidazoles (4397)
Alcohols (11)Aldehydes (5)Amides (26)Amines (19)Aryls (40)Bromides (8)Carboxylic Acids (6)Chlorides (15)Esters (12)Ethers (17)Fluorinated Building Blocks (14)Sulfides (7)Benzimidazole-Carboxylic Acid (43)(1H-Benzo[D]Imidazol-2-Yl)Methanamine (7)(1H-Benzo[D]Imidazol-2-Yl)Methanol (14)1,2-Diphenyl-1H-Benzo[D]Imidazole (7)1-Benzyl-1H-Benzo[D]Imidazole (6)1-Ethyl-1H-Benzo[D]Imidazole (4)1-Methyl-1H-Benzo[D]Imidazole (47)1-Phenyl-1H-Benzo[D]Imidazole (4)1H-Benzo[D]Imidazol-2-Amine (7)1H-Benzo[D]Imidazol-5-Amine (4)1H-Benzo[D]Imidazol-6-Amine (6)1H-Benzo[D]Imidazole-2-Carbaldehyde (5)1H-Benzo[D]Imidazole-2-Carboxylic Acid (7)1H-Benzo[D]Imidazole-2-Thiol (10)1H-Benzo[D]Imidazole-4-Carboxylic Acid (6)1H-Benzo[D]Imidazole-5-Carboxylic Acid (4)2-((Pyridin-2-Ylmethyl)Thio)-1H-Benzo[D]Imidazole (7)2-(1H-Benzo[D]Imidazol-2-Yl)Ethan-1-Amine (6)2-(Chloromethyl)-1H-Benzo[D]Imidazole (9)2-Benzyl-1H-Benzo[D]Imidazole (7)2-Bromo-1H-Benzo[D]Imidazole (4)2-Chloro-1H-Benzo[D]Imidazole (17)2-Methyl-1H-Benzo[D]Imidazole (20)4-Bromo-1H-Benzo[D]Imidazole (14)4-Methyl-1H-Benzo[D]Imidazole (7)5,6-Dichloro-1H-Benzo[D]Imidazole (4)5-Bromo-1H-Benzo[D]Imidazole (13)5-Chloro-1H-Benzo[D]Imidazole (14)5-Methoxy-1H-Benzo[D]Imidazole (2)5-Methyl-1H-Benzo[D]Imidazole (10)6-Chloro-1H-Benzo[D]Imidazole (25)Methyl (1H-Benzo[D]Imidazol-2-Yl)Carbamate (5)Methyl 1H-Benzo[D]Imidazole-2-Carboxylate (3)Tert-Butyl 1H-Benzo[D]Imidazole-1-Carboxylate (3)Piperidines (18)Pyridines (6)
Benzisoxazoles (508)
Amides (4)Amines (4)Fluorinated Building Blocks (4)3-Chlorobenzo[D]Isoxazole (7)3-Methylbenzo[D]Isoxazole (8)6-Bromobenzo[D]Isoxazole (5)Benzo[C]Isoxazole (5)Benzo[D]Isoxazol-3-Amine (8)Piperidines (4)
Benzodioxans (697)
Alcohols (9)Amines (5)(2,3-Dihydrobenzo[B][1,4]Dioxin-2-Yl)Methanamine (3)2,3-Dihydrobenzo[B][1,4]Dioxine-2-Carboxylic Acid (3)2,3-Dihydrobenzo[B][1,4]Dioxine-6-Carboxylic Acid (3)6-Bromo-2,3-Dihydrobenzo[B][1,4]Dioxine (6)
Benzofurans (3699)
Alcohols (18)Aldehydes (4)Amides (7)Amines (13)Anhydrides (13)Aryls (12)Bromides (18)Carboxylic Acids (9)Chlorides (15)Esters (34)Ethers (2)Fluorinated Building Blocks (11)Iodides (4)Ketones (10)Nitroes (5)Benzofuran-Carboxylic Acid (67)Dimethoxyisobenzofuran (4)Epoxyisobenzofuran (1)Fluorobenzofuran (19)Fluoroisobenzofuran (5)Methoxyisobenzofuran (4)Methylbenzofuran (25)1-(Benzofuran-2-Yl)Ethan-1-One (3)2,2-Dimethyl-2,3-Dihydrobenzofuran (7)2,3-Dihydrobenzofuran-3-Amine (11)2,3-Dihydrobenzofuran-5-Amine (3)2,3-Dihydrobenzofuran-7-Amine (5)2-(Benzofuran-3-Yl)Acetic Acid (3)2-Bromodibenzo[B,D]Furan (6)2-Ethylbenzofuran (3)2-Methylbenzofuran (5)3-Methylbenzofuran (4)4-Bromobenzofuran (3)4-Phenyldibenzo[B,D]Furan (8)5,7,8-Trimethylchromane (3)5-Bromo-2,3-Dihydrobenzofuran (6)5-Chloro-2,3-Dihydrobenzofuran (5)5-Fluoro-2,3-Dihydrobenzofuran (5)5-Methoxyisobenzofuran-1(3H)-One (5)6-Bromo-2,3-Dihydrobenzofuran (7)6-Fluoro-2,3-Dihydrobenzofuran (6)6-Methoxybenzofuran (4)7-Bromo-2,3-Dihydrobenzofuran (6)7-Bromobenzofuran (6)7-Fluoro-2,3-Dihydrobenzofuran (6)Benzofuran-2(3H)-One (7)Benzofuran-2-Carbaldehyde (5)Benzofuran-2-Carboxylic Acid (21)Benzofuran-2-Ylboronic Acid (8)Benzofuran-3(2H)-One (15)Benzofuran-3-Carboxylic Acid (6)Benzofuran-3-Yl(Phenyl)Methanone (11)Methyl Benzofuran-2-Carboxylate (6)Piperidines (5)Spiroes (6)
Benzothiazoles (2441)
Alcohols (6)Aldehydes (5)Amides (23)Amines (30)Aryls (10)Bromides (11)Carboxylic Acids (5)Chlorides (6)Esters (5)Ethers (15)Fluorinated Building Blocks (7)Nitroes (5)Sulfamides (6)Thioesters (12)Benzothiazole-Carboxylic Acid (27)Bromobenzothiazole (7)Dichlorobenzothiazole (10)Methoxybenzothiazole (4)Methylbenzothiazole (7)2-(Methylthio)Benzo[D]Thiazole (6)2-Bromobenzo[D]Thiazole (28)2-Chlorobenzo[D]Thiazole (21)2-Methylbenzo[D]Thiazole (26)4-Bromobenzo[D]Thiazole (9)4-Chlorobenzo[D]Thiazole (7)4-Fluorobenzo[D]Thiazole (6)4-Methylbenzo[D]Thiazole (10)5-Chlorobenzo[D]Thiazole (5)5-Nitrobenzo[D]Thiazole (3)6-Bromobenzo[D]Thiazole (7)6-Chlorobenzo[D]Thiazole (6)6-Fluorobenzo[D]Thiazole (5)6-Methoxybenzo[D]Thiazole (6)6-Methylbenzo[D]Thiazole (6)6-Nitrobenzo[D]Thiazole (3)7-Bromobenzo[D]Thiazole (8)7-Chlorobenzo[D]Thiazole (6)7-Fluorobenzo[D]Thiazole (9)Benzo[D]Thiazol-2-Amine (30)Benzo[D]Thiazol-5-Amine (3)Benzo[D]Thiazol-6-Amine (3)Benzo[D]Thiazol-6-Ol (2)Benzo[D]Thiazole-2-Carbonitrile (11)Benzo[D]Thiazole-2-Thiol (11)Benzo[D]Thiazole-6-Carboxylic Acid (5)Methyl Benzo[D]Thiazole-6-Carboxylate (5)Morpholines (4)
Benzothiophenes (1120)
Amines (6)Aryls (4)Bromides (4)Esters (8)Fluorinated Building Blocks (5)Benzothiophene-Carboxylic Acid (58)2-(Benzo[B]Thiophen-2-Yl)-4,5-Dihydrooxazole (10)2-Methylbenzo[B]Thiophene (4)3-Bromobenzo[B]Thiophene (5)3-Chlorobenzo[B]Thiophene (6)3-Methylbenzo[B]Thiophene (4)4,5,6,7-Tetrahydrobenzo[B]Thiophene (21)5-Bromobenzo[B]Thiophene (3)5-Chlorobenzo[B]Thiophene (4)6-Bromobenzo[B]Thiophene (4)7-Bromobenzo[B]Thiophene (5)Benzo[B]Thiophen-2-Amine (5)Benzo[B]Thiophen-2-Ylboronic Acid (5)Benzo[B]Thiophene-2-Carbaldehyde (7)Benzo[B]Thiophene-2-Carbonitrile (3)Benzo[B]Thiophene-2-Carboxylic Acid (32)Benzo[B]Thiophene-3-Carbaldehyde (6)Ethyl Benzo[B]Thiophene-2-Carboxylate (9)Methyl Benzo[B]Thiophene-2-Carboxylate (27)
Benzoxazoles (2808)
Amides (33)Amines (7)Bromides (10)Carboxylic Acids (4)Chlorides (11)Esters (4)Ethers (6)Fluorinated Building Blocks (5)Nitroes (5)Benzoxazole-Carboxylic Acid (25)2-Chlorobenzo[D]Oxazole (11)2-Methylbenzo[D]Oxazole (26)2-Phenylbenzo[D]Oxazole (22)3-Phenylbenzo[D]Oxazol-3-Ium (8)5-Bromobenzo[D]Oxazole (3)5-Chlorobenzo[D]Oxazole (5)5-Methylbenzo[D]Oxazole (3)6-Chlorobenzo[D]Oxazole (4)Benzo[D]Oxazol-2-Amine (16)Benzo[D]Oxazole-2-Thiol (6)Methyl Benzo[D]Oxazole-2-Carboxylate (3)
Carbazole Series (479)
Carbazolyl-Phenyl-Boronic Acid/Ester (14)1-Methyl-9H-Carbazole (7)2,3,4,9-Tetrahydro-1H-Carbazol-1-One (7)2-Bromo-9H-Carbazole (4)3,9-Diphenyl-9H-Carbazole (7)3-(Tert-Butyl)-9H-Carbazole (3)3-Bromo-9-Phenyl-9H-Carbazole (16)3-Bromo-9H-Carbazole (4)3-Chloro-9H-Carbazole (3)3-Methyl-9H-Carbazole (3)7H-Benzo[C]Carbazole (5)9-([1,1'-Biphenyl]-4-Yl)-9H-Carbazole (9)9-(P-Tolyl)-9H-Carbazole (5)9-Benzyl-9H-Carbazole (7)9-Ethyl-9H-Carbazole (10)
Cinnolines (355)
Cinnoline (12)
Dioxolanes (1576)
Alcohols (4)Amines (4)Aryls (16)Bromides (6)Carboxylic Acids (4)Esters (7)Ketones (5)Sulfonates (4)(3As,6As)-Tetrahydrofuro[3,4-D][1,3]Dioxole (6)1,3-Dioxolan-2-One (11)2,2-Difluorobenzo[D][1,3]Dioxole (23)2,2-Dimethyl-1,3-Dioxolane (29)2,2-Dimethylbenzo[D][1,3]Dioxole (7)2-Phenyl-1,3-Dioxolane (18)4-Bromobenzo[D][1,3]Dioxole (6)4-Methyl-1,3-Dioxolane (5)5,6-Dihydro-[1,3]Dioxolo[4,5-G]Isoquinolino[3,2-A]Isoquinolin-7-Ium (4)5-Bromobenzo[D][1,3]Dioxole (12)5-Chlorobenzo[D][1,3]Dioxole (5)5-Nitrobenzo[D][1,3]Dioxole (4)9-((3As,4R,6Ar)-Tetrahydrofuro[3,4-D][1,3]Dioxol-4-Yl)-9H-Purine (7)Benzo[D][1,3]Dioxol-5-Amine (3)Spiroes (23)
Dioxoles (13)
Epoxides (400)
Aliphatic Chain Hydrocarbons (7)Amides (10)Aryls (25)Esters (9)Ethers (13)Ketones (4)Nitroes (5)Sulfonates (7)Epoxy (5)Oxirane (64)7-Oxabicyclo[4.1.0]Heptane (7)Ethyl Oxirane-2-Carboxylate (4)Oxiran-2-Ylmethanol (3)Spiroes (5)Other Aliphatic Heterocycles (11)
Furans (6925)
Alcohols (8)Aldehydes (15)Alkenyls (9)Amides (30)Amines (22)Aryls (39)Bromides (13)Carboxylic Acids (35)Chlorides (9)Esters (23)Ethers (10)Fluorinated Building Blocks (4)Ketones (10)Nitriles (7)Nitroes (8)Sulfides (6)Aminodihydrofuran (7)Bromofuran (32)Chlorofuran (2)Chlorofuro (11)Cyanofuran (53)Dibromofuran (5)Dihydrofuran (31)Dihydrofuro (15)Dihydroxydihydrofuran (8)Dimethylfuran (10)Formylfuran (10)Hexahydrofuro (6)Hydroxydihydrofuran (31)Methyldihydrofuran (11)Methylfuran (58)Nitrofuran (10)2,3-Dihydrofuran-3-One (9)2-(Bromomethyl)Furan (3)2-(Chloromethyl)Furan (3)2-(Furan-2-Yl)-4,4,5,5-Tetramethyl-1,3,2-Dioxaborolane (6)2-Bromofuran (21)2-Chlorofuran (3)2-Methylfuran (38)2-Nitrofuran (9)3-Bromofuran (13)4-Methylisobenzofuran-1(3H)-One (3)5-Nitro-2,3-Dihydrobenzofuran (3)5-Phenylfuran-2-Carbaldehyde (9)5-Phenylfuran-2-Carboxylic Acid (6)6-Chloro-2,3-Dihydrobenzofuran (3)6-Fluoroisobenzofuran-1(3H)-One (3)7-Chloro-2,3-Dihydrobenzofuran (3)Ethyl Furan-2-Carboxylate (6)Furan-2,5-Dione (8)Furan-2-Carbaldehyde (22)Furan-2-Carbonitrile (8)Furan-2-Carboxylic Acid (32)Furan-2-Ylmethanol (8)Furan-3-Carboxylic Acid (11)Furo[3,2-B]Pyridine (7)Furo[3,2-C]Pyridine (7)Methyl Furan-2-Carboxylate (20)N-(Furan-2-Ylmethyl)Aniline (5)Piperazines (4)Quinolines (3)
Imidazoles (1074)
Alcohols (27)Aldehydes (21)Alkenyls (7)Amides (26)Amines (38)Aryls (50)Bromides (16)Carboxylic Acids (42)Chlorides (15)Esters (34)Ethers (6)Fluorinated Building Blocks (25)Iodides (12)Ketones (7)Nitroes (13)Sulfamides (7)Trifluoromethyls (12)Biimidazole (5)Bromoimidazo (102)Dibromoimidazo (8)Dichloroimidazo (9)Dihydroimidazo (25)Imidazol-Amine (1)Methoxyimidazo (13)Methylimidazo (121)Tetrahydroimidazo (40)Pyridines (4)Pyrrolidines (2)1,1'-Diphenyl-4,4',5,5'-Tetrahydro-1H,1'H-2,2'-Biimidazole (11)1,2-Dimethyl-1H-Imidazole (6)1,3-Diphenyl-1H-Imidazol-3-Ium (14)1,3-Diphenyl-4,5-Dihydro-1H-Imidazol-3-Ium (5)1-(Imidazo[1,2-A]Pyridin-3-Yl)Ethan-1-One (3)1-(Phenylsulfonyl)-1H-Imidazole (5)1-Benzyl-1H-Imidazole (20)1-Decyl-3-Methyl-1H-Imidazol-3-Ium (14)1-Ethyl-1H-Imidazole (3)1-Isopropyl-1H-Imidazole (5)1-Phenyl-1H-Imidazole-4-Carboxylic Acid (5)1-Trityl-1H-Imidazole (15)1H-Imidazo[4,5-B]Pyridine (14)1H-Imidazo[4,5-C]Pyridine (12)1H-Imidazol-2-Amine (6)1H-Imidazole-2-Carboxylic Acid (7)1H-Imidazole-4-Carbonitrile (2)1H-Imidazole-4-Carboxylic Acid (4)2-(Pyridin-2-Yl)-1H-Benzo[D]Imidazole (5)2-Bromo-1H-Imidazole (13)2-Bromoimidazo[1,2-A]Pyridine (5)2-Ethyl-1H-Imidazole (3)2-Methyl-1-Phenyl-1H-Imidazole (11)2-Methylimidazo[1,2-A]Pyridine (8)2-Phenyl-1H-Benzo[D]Imidazole (26)2-Phenyl-1H-Imidazole (26)2-Phenylimidazo[1,2-A]Pyridine (11)2-Propyl-1H-Imidazole (5)3-Bromoimidazo[1,2-A]Pyrazine (6)3-Bromoimidazo[1,2-A]Pyridine (26)3-Bromoimidazo[1,2-A]Pyrimidine (6)3-Iodoimidazo[1,2-A]Pyridine (10)3-Methylimidazo[1,2-A]Pyridine (3)4,5,6,7-Tetrahydro-3H-Imidazo[4,5-C]Pyridine (5)4-(1H-Imidazol-1-Yl)Benzaldehyde (7)4-Bromo-1-Phenyl-1H-Imidazole (9)4-Methyl-1-Phenyl-1H-Imidazole (7)4-Methyl-1H-Imidazole (6)4-Phenyl-1H-Imidazole (8)5,6,7,8-Tetrahydroimidazo[1,2-A]Pyrazine (15)5,6,7,8-Tetrahydroimidazo[1,2-A]Pyridine (12)5,6,7,8-Tetrahydroimidazo[1,5-A]Pyrazine (11)5-Benzyl-1H-Imidazole (1)5-Bromoimidazo[1,2-A]Pyridine (6)5-Chloro-1H-Imidazole (2)5-Fluoro-1H-Benzo[D]Imidazole (12)5-Iodo-1H-Imidazole (4)5-Methylimidazo[1,2-A]Pyridine (4)5-Phenyl-1H-Imidazole (6)6,7-Dihydro-5H-Pyrrolo[1,2-A]Imidazole (9)6-Bromoimidazo[1,2-A]Pyrazine (11)6-Bromoimidazo[1,2-A]Pyridine (14)6-Bromoimidazo[1,2-A]Pyrimidine (5)6-Chloroimidazo[1,2-A]Pyridine (4)6-Chloroimidazo[1,2-B]Pyridazine (30)7-Methylimidazo[1,2-A]Pyridine (3)8-Bromoimidazo[1,2-A]Pyrazine (7)8-Bromoimidazo[1,2-A]Pyridine (15)8-Chloroimidazo[1,2-A]Pyrazine (8)8-Chloroimidazo[1,2-A]Pyridine (7)8-Fluoroimidazo[1,2-A]Pyridine (3)8-Methylimidazo[1,2-A]Pyridine (9)Ethyl 1H-Imidazole-2-Carboxylate (6)Ethyl 2-(Imidazo[1,2-A]Pyridin-3-Yl)Acetate (3)Ethyl Imidazo[1,2-A]Pyridine-2-Carboxylate (25)Ethyl Imidazo[1,2-A]Pyridine-3-Carboxylate (13)Imidazo[1,2-A]Pyridin-3-Amine (7)Imidazo[1,2-A]Pyridin-8-Amine (7)Imidazo[1,2-A]Pyridin-8-Ol (3)Imidazo[1,2-A]Pyridine-2-Carbaldehyde (8)Imidazo[1,2-A]Pyridine-2-Carboxylic Acid (21)Imidazo[1,2-A]Pyridine-3-Carbaldehyde (9)Imidazo[1,2-A]Pyridine-3-Carboxylic Acid (14)Imidazo[1,2-A]Pyridine-7-Carboxylic Acid (5)Imidazo[1,2-A]Pyridine-8-Carboxylic Acid (6)Imidazo[1,2-A]Pyrimidine-3-Carboxylic Acid (5)Imidazo[1,2-C]Pyrimidine (6)Imidazo[1,5-A]Pyrazine (9)Imidazo[2,1-B]Thiazole (14)Methyl 1H-Imidazole-2-Carboxylate (4)Methyl 1H-Imidazole-5-Carboxylate (8)Methyl Imidazo[1,2-A]Pyridine-8-Carboxylate (3)Tert-Butyl 1H-Imidazole-1-Carboxylate (6)
Imidazolidines (1119)
Amides (19)Aryls (10)Carboxylic Acids (3)Methylimidazolidine (3)Oxoimidazolidine (8)Thioxoimidazolidin (9)Spiroes (4)(3Ar,6As)-Tetrahydro-1H-Thieno[3,4-D]Imidazol-2(3H)-One (18)1-Phenylimidazolidin-2-One (8)3-Phenyl-2-Thioxoimidazolidin-4-One (6)3-Phenylimidazolidine-2,4-Dione (4)Imidazolidin-2-One (16)Imidazolidine-2,4-Dione (17)
Imidazolines (681)
Amides (16)Amines (4)Aryls (14)Spiroes (4)
Indazoles (3061)
Alcohols (17)Aldehydes (9)Amides (6)Amines (18)Aryls (8)Bromides (25)Carboxylic Acids (19)Chlorides (10)Esters (15)Ethers (10)Fluorinated Building Blocks (13)Iodides (12)Nitriles (8)Nitroes (7)Indazol-Amide (3)(1H-Indazol-4-Yl)Boronic Acid (3)(1H-Indazol-6-Yl)Boronic Acid (4)1-(1H-Indazol-1-Yl)Ethan-1-One (7)1-(Tetrahydro-2H-Pyran-2-Yl)-1H-Indazole (17)1-Benzyl-1H-Indazole (5)1-Ethyl-1H-Indazole (6)1H-Indazol-3-Amine (23)1H-Indazol-3-Ol (10)1H-Indazol-4-Amine (12)1H-Indazol-4-Ol (4)1H-Indazol-5-Amine (3)1H-Indazol-6-Amine (5)1H-Indazol-6-Ol (6)1H-Indazol-7-Amine (6)1H-Indazole-3-Carbaldehyde (19)1H-Indazole-3-Carbonitrile (9)1H-Indazole-3-Carboxylic Acid (23)1H-Indazole-4-Carboxylic Acid (9)1H-Indazole-5-Carboxylic Acid (4)1H-Indazole-7-Carboxylic Acid (6)2,3-Dimethyl-2H-Indazole (4)2-Methyl-2H-Indazole (34)3-(Piperidin-4-Yl)-1H-Indazole (5)3-Chloro-1H-Indazole (13)4,5,6,7-Tetrahydro-1H-Indazole (12)4-Chloro-1H-Indazole (18)4-Fluoro-1H-Indazole (22)4-Methoxy-1H-Indazole (7)4-Methyl-1H-Indazole (12)4-Nitro-1H-Indazole (10)5-Bromo-1H-Indazole (14)5-Chloro-1H-Indazole (9)5-Methoxy-1H-Indazole (5)5-Nitro-1H-Indazole (5)6-(Trifluoromethyl)-1H-Indazole (6)6-Bromo-1H-Indazole (23)6-Chloro-1H-Indazole (14)6-Fluoro-1H-Indazole (15)6-Methoxy-1H-Indazole (14)6-Methyl-1H-Indazole (9)6-Nitro-1H-Indazole (9)7-Bromo-1H-Indazole (18)7-Chloro-1H-Indazole (7)7-Fluoro-1H-Indazole (12)7-Methoxy-1H-Indazole (5)7-Nitro-1H-Indazole (11)Methyl 1H-Indazole-3-Carboxylate (23)Methyl 1H-Indazole-4-Carboxylate (10)Methyl 1H-Indazole-5-Carboxylate (3)Methyl 1H-Indazole-6-Carboxylate (9)Methyl 1H-Indazole-7-Carboxylate (8)Methyl 2-Methyl-2H-Indazole-3-Carboxylate (3)Tert-Butyl 1H-Indazole-1-Carboxylate (29)
Indoles (7653)
Alcohols (26)Aldehydes (21)Alkenyls (4)Amides (42)Amines (33)Aryls (51)Bromides (36)Carboxylic Acids (52)Chlorides (27)Esters (61)Ethers (54)Fluorinated Building Blocks (39)Iodides (11)Ketones (20)Nitriles (31)Nitroes (10)Sulfamides (6)Trifluoromethyls (7)Azaindole (44)Benzyloxyindole (1)Biindolinylidene (1)Bromo-Indole-Carboxylic Acid (25)Cyanoindole (5)Dihydroindolo (14)Fluoroindole (5)Formylindole (44)Hydroxyindole (7)Hydroxyisoindoline (2)Isoindole (26)Methoxyindole (9)Nitroindole (6)(1-(Tert-Butoxycarbonyl)-1H-Indol-2-Yl)Boronic Acid (17)(1H-Indol-2-Yl)Boronic Acid (3)(1H-Indol-2-Yl)Methanol (8)(3As,7As)-Octahydro-1H-Indole (5)(9H-Fluoren-9-Yl)Methyl (2-(1H-Indol-3-Yl)Ethyl)Carbamate (12)1,2,3,4-Tetrahydrocyclopenta[B]Indole (5)1,2-Dimethyl-1H-Indole (3)1-(1H-Indol-1-Yl)Ethan-1-One (9)1-(1H-Indol-3-Yl)Ethan-1-One (6)1-(Phenylsulfonyl)-1H-Indole (26)1-(Triisopropylsilyl)-1H-Pyrrolo[2,3-B]Pyridine (8)1-Benzyl-1H-Indole (9)1-Ethyl-1H-Indole (7)1-Methyl-1H-Indole (82)1-Methyl-1H-Indole-2-Carboxylic Acid (8)1-Methyl-1H-Indole-3-Carbaldehyde (9)1-Methyl-1H-Pyrrolo[2,3-B]Pyridine (14)1-Phenyl-1H-Indole (5)1H-Indol-3-Ol (5)1H-Indol-3-Yl Acetate (4)1H-Indol-4-Amine (10)1H-Indol-4-Ol (7)1H-Indol-5-Ol (4)1H-Indol-6-Amine (21)1H-Indol-6-Ol (6)1H-Indol-7-Amine (10)1H-Indole-2-Carbaldehyde (20)1H-Indole-2-Carbonitrile (9)1H-Indole-3-Carbonitrile (17)1H-Indole-3-Carboxylic Acid (28)1H-Indole-4-Carboxylic Acid (10)1H-Indole-5-Carbonitrile (5)1H-Indole-5-Carboxylic Acid (4)1H-Indole-6-Carbonitrile (4)1H-Indole-6-Carboxylic Acid (5)1H-Indole-7-Carbonitrile (6)1H-Indole-7-Carboxylic Acid (7)1H-Pyrrolo[2,3-B]Pyridine-3-Carbaldehyde (14)1H-Pyrrolo[2,3-B]Pyridine-5-Carbaldehyde (5)2,3,4,5-Tetrahydro-1H-Pyrido[4,3-B]Indole (12)2,3,4,9-Tetrahydro-1H-Pyrido[3,4-B]Indole (13)2,3-Dimethyl-1H-Indole (9)2-(1,3,2-Dioxaborolan-2-Yl)-1-Methyl-1H-Indole (6)2-(1H-Indol-1-Yl)Acetic Acid (5)2-(1H-Indol-3-Yl)Acetic Acid (28)2-(1H-Indol-3-Yl)Ethan-1-Amine (4)2-(1H-Indol-3-Yl)Ethan-1-Ol (10)2-(2-Methyl-1H-Indol-3-Yl)Acetic Acid (5)2-(4-Fluorophenyl)-1H-Indole (4)2-Methyl-1H-Indole-3-Carbaldehyde (3)2-Methyl-1H-Pyrrolo[2,3-B]Pyridine (12)3-(1-Oxoisoindolin-2-Yl)Piperidine-2,6-Dione (21)3-(1H-Indol-3-Yl)Propanoic Acid (4)3-(Piperidin-4-Yl)-1H-Indole (8)3-Iodo-1H-Pyrrolo[2,3-B]Pyridine (11)3-Methyl-1H-Indole (41)3H-Indole (8)4-Bromo-1H-Indole (25)4-Chloro-1H-Indole (21)4-Fluoro-1H-Indole (24)4-Fluoro-1H-Pyrrolo[2,3-B]Pyridine (6)4-Fluoroindoline-2,3-Dione (3)4-Methoxy-1H-Indole (11)4-Methyl-1H-Indole (23)4-Nitro-1H-Indole (6)5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)-1H-Indole (5)5-(Benzyloxy)-1H-Indole (8)5-Bromo-1-Methyl-1H-Indole (3)5-Chloro-1H-Indole (64)5-Chloro-1H-Indole-2-Carboxylic Acid (6)5-Chloro-1H-Pyrrolo[2,3-B]Pyridine (13)5-Fluoro-1H-Indole (50)5-Fluoro-1H-Pyrrolo[2,3-B]Pyridine (9)5-Fluoroindolin-2-One (4)5-Methoxy-1H-Indole (11)5-Methoxy-2-Methyl-1H-Indole (5)5-Methyl-1H-Indole (33)5-Nitro-1H-Indole (6)6-(Trifluoromethyl)-1H-Indole (5)6-Bromo-1-Methyl-1H-Indole (3)6-Bromo-1H-Indole (15)6-Bromo-1H-Pyrrolo[2,3-B]Pyridine (6)6-Chloro-1H-Indole (19)6-Chloro-1H-Pyrrolo[2,3-B]Pyridine (13)6-Fluoro-1H-Indole (17)6-Methoxy-1H-Indole (12)6-Methyl-1H-Indole (29)6-Methyl-1H-Pyrrolo[2,3-B]Pyridine (8)6-Nitro-1H-Indole (8)7-Bromo-1H-Indole (28)7-Bromoindoline-2,3-Dione (3)7-Chloro-1H-Indole (29)7-Fluoro-1H-Indole (24)7-Fluoro-1H-Indole-2-Carboxylic Acid (5)7-Methoxy-1H-Indole (8)7-Methyl-1H-Indole (34)7-Nitro-1H-Indole (11)9H-Pyrido[3,4-B]Indole (5)Benzo[Cd]Indol-2(1H)-One (5)Ethyl 1H-Indole-3-Carboxylate (6)Ethyl 5-Chloro-1H-Indole-2-Carboxylate (5)Ethyl 5-Fluoro-1H-Indole-2-Carboxylate (5)Ethyl 6-Chloro-1H-Indole-2-Carboxylate (5)Ethyl 7-Chloro-1H-Indole-2-Carboxylate (5)Methyl 1H-Indole-3-Carboxylate (21)Methyl 1H-Indole-4-Carboxylate (9)Methyl 1H-Indole-5-Carboxylate (7)Methyl 1H-Indole-6-Carboxylate (9)Methyl 1H-Indole-7-Carboxylate (7)Methyl 2-(1H-Indol-3-Yl)Acetate (3)N-(2-(1H-Indol-3-Yl)Ethyl)Acetamide (5)Spiro[Indoline-3,4'-Piperidin]-2-One (18)Tert-Butyl 1H-Indole-1-Carboxylate (18)Tert-Butyl 1H-Pyrrolo[2,3-B]Pyridine-1-Carboxylate (9)Tert-Butyl 2-(1,3,2-Dioxaborolan-2-Yl)-1H-Indole-1-Carboxylate (6)Tert-Butyl 3-(Hydroxymethyl)-1H-Indole-1-Carboxylate (10)Tert-Butyl 3-Bromo-1H-Indole-1-Carboxylate (9)Tert-Butyl 3-Iodo-1H-Indole-1-Carboxylate (7)Tert-Butyl 5-Methoxy-1H-Indole-1-Carboxylate (6)Tryptophan (22)Piperazines (5)Piperidines (4)Pyridines (5)Pyrimidines (7)
Indolines (4494)
Alcohols (13)Alkenyls (3)Amides (73)Amines (9)Aryls (20)Bromides (16)Carboxylic Acids (16)Chlorides (14)Esters (9)Ethers (5)Fluorinated Building Blocks (11)Ketones (11)Nitriles (5)Nitroes (9)Aminoindoline (10)Bromoindoline (17)Bromoisoindolin (5)Bromoisoindoline (6)Chloroindolin (4)Chloroisoindoline (3)Dibromoindoline (12)Dichloroindoline (16)Difluoroindoline (1)Dimethylindoline (21)Dioxoindoline (8)Dioxoisoindolin (72)Fluoroindolin (9)Fluoroindoline (9)Fluoroisoindoline (10)Hydroxyindolin (5)Isoindoline (20)Methoxyindoline (12)Methoxyisoindoline (9)Methylindoline (46)Methylisoindoline (18)Nitroindolin (6)Nitroindoline (11)Nitroisoindoline (8)Oxoindoline (32)Oxoisoindoline (16)Spiro-Indoline-Piperidine (34)(E)-[3,3'-Biindolinylidene]-2,2'-Dione (5)(Z)-3-((1H-Pyrrol-2-Yl)Methylene)Indolin-2-One (8)(Z)-3-(Phenyl(Phenylamino)Methylene)Indolin-2-One (5)(Z)-3-Benzylideneindolin-2-One (7)1-(Indolin-1-Yl)Ethan-1-One (9)1-Benzylindoline-2,3-Dione (5)1-Methylindolin-2-One (14)1-Methylindoline (3)1-Methylindoline-2,3-Dione (8)2-(1,3-Dioxoisoindolin-2-Yl)Propanoic Acid (3)2-Methylindoline (7)2-Methylisoindolin-1-One (7)3,3-Dimethylindolin-2-One (5)3,3-Dimethylindoline (7)4-Bromoindoline (4)4-Chloroindoline-2,3-Dione (6)4-Methylindoline (3)5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Indoline (5)5-Bromoindolin-2-One (5)5-Bromoindoline (8)5-Bromoisoindoline-1,3-Dione (3)5-Chloroindolin-2-One (3)5-Fluoroindoline (3)5-Methoxyindoline (4)5-Methylindolin-2-One (3)5-Methylindoline (3)6-Bromoindolin-2-One (8)6-Bromoindoline-2,3-Dione (4)6-Chloroindolin-2-One (5)6-Chloroindoline (3)6-Chloroindoline-2,3-Dione (5)6-Fluoroindolin-2-One (5)6-Fluoroindoline-2,3-Dione (3)7-Bromoindoline (3)7-Fluoroindolin-2-One (3)7-Fluoroindoline-2,3-Dione (6)7-Methylindoline-2,3-Dione (7)Indoline-2-Carboxylic Acid (3)Methyl Indoline-6-Carboxylate (3)Spiro[Cyclopropane-1,3'-Indolin]-2'-One (6)Tert-Butyl Indoline-1-Carboxylate (24)Spiroes (5)
Isoquinolines (2732)
Alcohols (4)Amides (10)Amines (12)Bromides (11)Carboxylic Acids (4)Chlorides (14)Esters (7)Ethers (8)Fluorinated Building Blocks (7)Nitriles (4)Bromoisoquinoline (69)Chloroisoquinoline (101)Dibromoisoquinoline (9)Dichloroisoquinoline (14)Dihydroisoquinoline (107)Fluoroisoquinoline (78)Methoxyisoquinoline (59)Methylisoquinoline (59)Nitroisoquinoline (23)1,3-Dichloroisoquinoline (14)1-Bromoisoquinoline (20)1-Chloroisoquinoline (20)1-Methylisoquinoline (9)1H-Benzo[De]Isoquinoline-1,3(2H)-Dione (14)2-Methyl-3,4-Dihydroisoquinolin-1(2H)-One (6)3-Bromoisoquinoline (10)3-Chloroisoquinoline (20)3-Methylisoquinoline (8)4-Bromoisoquinolin-1(2H)-One (3)4-Bromoisoquinoline (33)4-Chloroisoquinoline (11)4-Fluoroisoquinoline (6)5,6-Dihydro-[1,3]Dioxolo[4,5-G]Isoquinolino[3,2-A]Isoquinolin-7-Ium (4)5-Bromoisoquinoline (17)5-Chloroisoquinoline (6)5-Methoxyisoquinoline (6)5-Nitroisoquinoline (7)6-Bromo-3,4-Dihydroisoquinolin-1(2H)-One (6)6-Bromoisoquinoline (9)6-Methoxy-3,4-Dihydroisoquinolin-1(2H)-One (3)7-Bromo-3,4-Dihydroisoquinolin-1(2H)-One (6)7-Bromoisoquinoline (6)7-Chloroisoquinoline (6)7-Fluoroisoquinoline (3)7-Methoxyisoquinoline (5)8-Bromoisoquinoline (17)8-Chloroisoquinoline (7)8-Fluoroisoquinolin-1(2H)-One (3)8-Fluoroisoquinoline (10)8-Methoxyisoquinoline (7)Isoquinolin-1-Amine (18)Isoquinolin-1-Ol (9)Isoquinolin-3-Amine (13)Isoquinolin-3-Ol (6)Isoquinolin-4-Amine (16)Isoquinolin-4-Ol (9)Isoquinolin-4-Ylboronic Acid (3)Isoquinolin-5-Amine (9)Isoquinolin-5-Ol (7)Isoquinolin-8-Amine (6)Isoquinoline-1-Carbonitrile (7)Isoquinoline-1-Carboxylic Acid (10)Isoquinoline-3-Carboxylic Acid (7)Isoquinoline-4-Carboxylic Acid (12)Isoquinoline-5-Carboxylic Acid (5)Isoquinoline-5-Sulfonyl Chloride (3)Isoquinoline-6-Carboxylic Acid (3)Methyl Isoquinoline-3-Carboxylate (3)Methyl Isoquinoline-4-Carboxylate (6)Tert-Butyl 3,4-Dihydroisoquinoline-2(1H)-Carboxylate (19)
Isothiazoles (345)
Bromides (4)Methylisothiazole (5)Benzo[D]Isothiazol-3(2H)-One 1,1-Dioxide (10)Benzo[D]Isothiazole (12)Isothiazole (25)
Isoxazoles (3406)
Alcohols (8)Aldehydes (9)Amides (16)Amines (25)Aryls (54)Bromides (11)Carboxylic Acids (18)Chlorides (19)Esters (11)Ethers (12)Fluorinated Building Blocks (12)Aminoisoxazole (7)Bromoisoxazole (5)Dihydroisoxazol (2)Dimethylisoxazole (17)Phenylisoxazole (28)(3-Phenylisoxazol-5-Yl)Methanol (7)3-Bromoisoxazole (7)3-Methyl-5-Phenylisoxazole (6)3-Methylisoxazole (30)3-Phenylisoxazol-5-Amine (8)5-(Thiophen-2-Yl)Isoxazole (5)5-Cyclopropylisoxazole (5)5-Methyl-3-Phenylisoxazole (4)5-Methylisoxazole (16)5-Phenylisoxazole-3-Carboxylic Acid (15)Ethyl Isoxazole-3-Carboxylate (8)Ethyl Isoxazole-4-Carboxylate (5)Isoxazol-3-Amine (7)Isoxazol-3-Ylmethanol (3)Isoxazol-5-Amine (15)Isoxazol-5-Ylmethanol (5)Isoxazole-3-Carboxylic Acid (8)Isoxazole-5-Carboxylic Acid (7)Methyl 5-Phenylisoxazole-3-Carboxylate (6)N-((5R,6R)-7-Oxo-4-Thia-1-Azabicyclo[3.2.0]Heptan-6-Yl)-3-Phenylisoxazole-4-Carboxamide (1)
Morpholines (4812)
Alcohols (26)Aldehydes (9)Amides (99)Amines (54)Aryls (137)Bromides (30)Carboxylic Acids (34)Chlorides (24)Esters (32)Ethers (17)Fluorinated Building Blocks (17)Ketones (8)Nitriles (5)Nitroes (12)Phenols (3)Sulfamides (11)Trifluoromethyls (5)Ureas (4)Benzylmorpholine (19)Cyanomorpholine (6)Dimorpholine (3)Ethylmorpholine (9)Isopropylmorpholine (9)Methylmorpholine (68)Morpholinobenzaldehyde (11)Morpholinobenzo (13)Morpholinobenzoic (8)Morpholinoethanone (5)Morpholinoethoxy (1)Morpholinoethyl (5)Morpholinomethyl (16)Morpholinophenyl (14)Morpholinopropoxy (6)Morpholinopyrimidin (6)Morpholinosulfonyl (7)Oxomorpholine (6)(R)-3-Phenylmorpholine (7)(S)-3-Phenylmorpholine (10)2,2-Dimethylmorpholine (5)2,6-Dimethylmorpholine (5)2-(Methoxymethyl)Morpholine (4)2-(Morpholin-2-Yl)Acetic Acid (5)2-Ethylmorpholine (3)2-Isopropylmorpholine (4)2-Methylmorpholine (7)3-(4-Morpholinophenyl)Oxazolidin-2-One (5)3-(Methoxymethyl)Morpholine (4)3-Ethylmorpholine (4)3-Isopropylmorpholine (5)3-Methylmorpholine (13)3-Phenylmorpholine (8)4-(2-Fluorophenyl)Morpholine (8)4-(3-Phenoxypropyl)Morpholine (7)4-(O-Tolyl)Morpholine (6)4-(Pyrazin-2-Yl)Morpholine (5)4-(Pyridin-4-Yl)Morpholine (5)4-(Pyrimidin-2-Yl)Morpholine (9)4-Benzylmorpholin-3-One (6)4-Morpholinoaniline (4)4-Morpholinobenzaldehyde (8)4-Morpholinobenzoic Acid (5)4-Phenylmorpholin-3-One (6)6,6-Dimethylmorpholine-3-Carboxylic Acid (5)Benzyl Morpholine-4-Carboxylate (5)Ethyl Morpholine-2-Carboxylate (4)Methyl 2-(Morpholin-3-Yl)Acetate (3)Methyl Morpholine-2-Carboxylate (4)Methyl Morpholine-3-Carboxylate (10)Morpholin-2-Ylmethanamine (8)Morpholin-2-Ylmethanol (12)Morpholin-3-Ylmethanol (14)Morpholine-2-Carbonitrile (4)Morpholine-2-Carboxylic Acid (12)Morpholine-3-Carboxylic Acid (10)Morpholino(Phenyl)Methanone (11)Tert-Butyl (Morpholin-2-Ylmethyl)Carbamate (3)Tert-Butyl 2-(Bromomethyl)Morpholine-4-Carboxylate (3)Tert-Butyl Morpholine-4-Carboxylate (23)Benzothiazoles (4)Piperidines (30)Pyridazines (4)Pyridines (24)Pyrimidines (4)Spiroes (33)Thiazoles (5)
Naphthyridines (942)
Bromides (4)Carboxylic Acids (3)Fluorinated Building Blocks (4)Ketones (4)1,5-Naphthyridine-3-Carboxylic Acid (6)1,6-Naphthyridine (22)1,7-Naphthyridine (23)2,7-Naphthyridine (5)3-Bromo-1,5-Naphthyridine (8)4-Bromo-1,5-Naphthyridine (5)4-Chloro-1,5-Naphthyridine (6)5,6,7,8-Tetrahydro-1,6-Naphthyridine (22)5,6,7,8-Tetrahydro-1,7-Naphthyridine (6)
Oxadiazoles (3548)
Amides (10)Amines (16)Aryls (12)Bromides (4)Carboxylic Acids (4)1,2,4-Oxadiazole (19)1,2,5-Oxadiazole (12)1,3,4-Oxadiazole (25)2,5-Diphenyl-1,3,4-Oxadiazole (6)2-Phenyl-1,3,4-Oxadiazole (26)3-Phenyl-1,2,4-Oxadiazole (23)Benzo[C][1,2,5]Oxadiazole (17)Piperidines (4)
Oxazines (235)
2,2-Dimethyl-2H-Benzo[B][1,4]Oxazin-3(4H)-One (3)2-Methyl-2H-Benzo[B][1,4]Oxazin-3(4H)-One (3)2H-Pyrido[3,2-B][1,4]Oxazin-3(4H)-One (8)3,4-Dihydro-2H-Pyrido[3,2-B][1,4]Oxazine (5)6-Amino-2H-Benzo[B][1,4]Oxazin-3(4H)-One (3)6-Bromo-2H-Benzo[B][1,4]Oxazin-3(4H)-One (7)6-Bromo-3,4-Dihydro-2H-Benzo[B][1,4]Oxazine (5)6-Chloro-2H-Benzo[B][1,4]Oxazin-3(4H)-One (8)6-Chloro-3,4-Dihydro-2H-Benzo[B][1,4]Oxazine (5)7-Bromo-3,4-Dihydro-2H-Benzo[B][1,4]Oxazine (7)Spiro[Benzo[D][1,3]Oxazine-4,4'-Piperidin]-2(1H)-One (5)
Oxazoles (2023)
Alcohols (9)Amides (10)Amines (16)Aryls (48)Bromides (12)Carboxylic Acids (16)Chlorides (14)Esters (18)Ethers (4)Fluorinated Building Blocks (5)Nitriles (6)Nitroes (4)Bioxazole (12)2-Bromooxazole (7)2-Chlorooxazole (7)2-Methyloxazole (19)2-Phenyloxazole (16)3,4-Diphenylisoxazole (8)4,5-Diphenyloxazole (7)4-(Oxazol-5-Yl)Aniline (3)4-Methyloxazole (9)5-(4-Nitrophenyl)Oxazole (3)5-Methyloxazole (5)6-Bromobenzo[D]Oxazole (3)Ethyl Oxazole-4-Carboxylate (8)Ethyl Oxazole-5-Carboxylate (3)Methyl Oxazole-4-Carboxylate (9)Oxazol-2-Amine (8)Oxazole-4-Carboxylic Acid (4)Oxazolo[4,5-B]Pyridine (7)Oxazolo[5,4-B]Pyridine (5)
Oxazolidines (1192)
Alcohols (6)Amides (50)Amines (4)Anhydrides (5)Aryls (25)Esters (7)Fluorinated Building Blocks (2)Dimethyloxazolidin (3)Dioxooxazolidin (2)Oxazolidinone (2)Phenyloxazolidin (7)Propionyloxazolidin (4)(S)-4-Benzyloxazolidin-2-One (1)3-(4-Morpholinophenyl)Oxazolidin-2-One (5)3-Phenyloxazolidin-2-One (4)4-Isopropyloxazolidine (6)Oxazolidine (21)Oxazolidine-2,5-Dione (9)Spiroes (6)
Oxazolines (1578)
Amides (4)Aryls (8)Esters (6)(3Ar,8As)-2-(Pyridin-2-Yl)-3A,8A-Dihydro-8H-Indeno[1,2-D]Oxazole (6)(3As,8Ar)-2-(Pyridin-2-Yl)-3A,8A-Dihydro-8H-Indeno[1,2-D]Oxazole (7)(4R,5S)-4,5-Diphenyl-2-(Pyridin-2-Yl)-4,5-Dihydrooxazole (5)(R)-4-Benzyl-2-(Pyridin-2-Yl)-4,5-Dihydrooxazole (7)(R)-4-Phenyl-2-(Pyridin-2-Yl)-4,5-Dihydrooxazole (7)(S)-4-Benzyl-2-(Pyridin-2-Yl)-4,5-Dihydrooxazole (8)(S)-4-Phenyl-2-(Pyridin-2-Yl)-4,5-Dihydrooxazole (6)1,3-Bis(4,5-Dihydrooxazol-2-Yl)Benzene (8)2,2'-(1,3-Diphenylpropane-2,2-Diyl)Bis(4,5-Dihydrooxazole) (5)2,2'-(2-Phenylethane-1,1-Diyl)Bis(4,5-Dihydrooxazole) (5)2,3-Dihydropyrazolo[5,1-B]Oxazole (7)2,6-Bis(4,5-Dihydrooxazol-2-Yl)Pyridine (12)2-(6-Benzhydrylpyridin-2-Yl)-4,5-Dihydrooxazole (10)2-(6-Cyclopropylpyridin-2-Yl)-4,5-Dihydrooxazole (10)2-(Benzo[B]Thiophen-2-Yl)-4,5-Dihydrooxazole (10)2-(Pyridin-2-Ylmethyl)-4,5-Dihydrooxazole (14)2-(Quinolin-2-Yl)-4,5-Dihydrooxazole (7)2-Phenyl-4,5-Dihydrooxazole (18)4,4',5,5'-Tetrahydro-2,2'-Bioxazole (10)4-(Tert-Butyl)-2-(Pyridin-2-Yl)-4,5-Dihydrooxazole (16)4-Isopropyl-2-(Pyridin-2-Yl)-4,5-Dihydrooxazole (16)Bis((3Ar,8As)-3A,8A-Dihydro-8H-Indeno[1,2-D]Oxazol-2-Yl)Methane (5)Bis((3As,8Ar)-3A,8A-Dihydro-8H-Indeno[1,2-D]Oxazol-2-Yl)Methane (5)Bis(4,5-Dihydrooxazol-2-Yl)Methane (22)
Oxetanes (772)
Alcohols (24)Alkenyls (4)Amides (14)Amines (29)Aryls (21)Bromides (9)Carboxylic Acids (7)Esters (10)Ethers (6)Fluorinated Building Blocks (5)Iodides (6)Sulfonates (5)Methyloxetane (11)Azetidines (9)Piperidines (8)Pyrrolidines (4)Spiroes (26)
Phthalazines (423)
Amides (8)Dihydrophthalazine (14)Phthalazine (22)
Piperazines (7243)
Alcohols (26)Alkenyls (10)Amides (273)Amines (36)Aryls (139)Bromides (10)Carboxylic Acids (31)Chlorides (22)Esters (38)Ethers (31)Fluorinated Building Blocks (28)Nitriles (17)Nitroes (14)Phenols (7)Sulfamides (12)Sulfones (4)Trifluoromethyls (7)Ureas (6)Isobutylpiperazine (6)Propylpiperazine (10)(9H-Fluoren-9-Yl)Methyl Piperazine-1-Carboxylate (7)1,4-Diphenylpiperazine (7)1-(2-Chlorophenyl)Piperazine (4)1-(2-Fluorophenyl)Piperazine (8)1-(3-Methoxyphenyl)Piperazine (4)1-(4-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Phenyl)Piperazine (10)1-(5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridin-2-Yl)Piperazine (6)1-(Methylsulfonyl)Piperazine (5)1-(Phenylsulfonyl)Piperazine (17)1-(Piperidin-4-Yl)Piperazine (6)1-(Pyridin-3-Yl)Piperazine (13)1-(Pyridin-3-Ylmethyl)Piperazine (6)1-Benzhydryl-4-Benzylpiperazine (1)1-Benzhydrylpiperazine (9)1-Benzyl 4-(Tert-Butyl) Piperazine-1,4-Dicarboxylate (10)1-Benzyl-4-Methylpiperazine (10)1-Ethyl-4-Phenylpiperazine (4)1-Ethylpiperazine (6)1-Isopropylpiperazine (4)1-Methyl-4-(Pyridin-2-Yl)Piperazine (5)1-Methyl-4-Phenylpiperazine (22)1-Methylpiperazin-2-One (6)1-Methylpiperazine (21)10-(3-(Piperazin-1-Yl)Propyl)-10H-Phenothiazine (2)2-(4-(Benzyloxy)Phenyl)-4,4,5,5-Tetramethyl-1,3,2-Dioxaborolane (10)2-(Piperazin-1-Yl)Benzonitrile (6)2-(Piperazin-1-Yl)Ethan-1-Amine (8)2-(Piperazin-1-Yl)Ethan-1-Ol (10)2-(Piperazin-1-Yl)Pyrazine (9)2-(Piperazin-1-Yl)Pyrimidine (11)2-Phenylpiperazine (3)3-(Piperazin-1-Yl)Aniline (3)3-(Piperazin-1-Yl)Benzoic Acid (3)3-(Piperazin-1-Yl)Pyridazine (7)3-Methylpiperazin-2-One (7)4-(Piperazin-1-Yl)Benzaldehyde (5)4-(Piperazin-1-Yl)Pyrimidine (13)Benzyl 2-Methylpiperazine-1-Carboxylate (7)Benzyl 3-(Hydroxymethyl)Piperazine-1-Carboxylate (6)Benzyl 3-Methylpiperazine-1-Carboxylate (5)Phenyl(Piperazin-1-Yl)Methanone (20)Piperazine-2,5-Dione (9)Tert-Butyl 3-Oxopiperazine-1-Carboxylate (7)Tert-Butyl 4-(Pyridin-2-Yl)Piperazine-1-Carboxylate (12)Tert-Butyl 4-Benzylpiperazine-1-Carboxylate (13)Tert-Butyl 4-Phenylpiperazine-1-Carboxylate (23)Tert-Butyl Piperazine-1-Carboxylate (30)Furans (4)Indoles (5)Piperidines (5)Pyridines (16)Pyrimidines (25)Spiroes (14)
Piperidines (21679)
Alcohols (132)Aldehydes (17)Alkenyls (18)Amides (436)Amines (177)Aryls (311)Bromides (31)Carboxylic Acids (91)Chlorides (68)Esters (69)Ethers (82)Fluorinated Building Blocks (95)Iodides (4)Ketones (66)Nitriles (54)Nitroes (13)Oximes (5)Phenols (5)Sulfamides (25)Sulfonates (10)Sulfones (6)Sulfonyl Chlorides (4)Trifluoromethyls (8)Bipiperidine (12)Chloropiperidine (6)Dimethylpiperidine (46)Ethynylpiperidine (5)Fluoropiperidine (33)Formylpiperidine (9)Isopropylpiperidine (11)Piperidine-Carboxylate (3)Piperidineacetic (5)Piperidinecarboxylic (6)Piperidinyl-Phenyl-Boronic Acid/Ester (32)Propylpiperidine (8)Azetidines (16)Benzimidazoles (18)Benzisoxazoles (4)Benzofurans (5)Indoles (4)Morpholines (30)Oxadiazoles (4)Oxetanes (8)Piperazines (5)Pyrazines (8)Pyridines (15)Pyrimidines (4)Pyrrolidines (36)Spiroes (139)Tetrahydrofurans (9)Tetrahydropyrans (5)Thiophenes (9)Other Aromatic Heterocycles (14)(9H-Fluoren-9-Yl)Methyl Piperidine-1-Carboxylate (16)(E)-N-(3-Oxo-1-Phenyl-3-(Piperidin-1-Yl)Prop-1-En-2-Yl)Benzamide (6)(R)-2-Phenylpiperidine (10)(R)-3-Aminopiperidin-2-One (3)(R)-N-(Piperidin-3-Yl)-7H-Pyrrolo[2,3-D]Pyrimidin-4-Amine (5)(S)-2-Phenylpiperidine (11)(S)-N-Phenylpiperidine-2-Carboxamide (1)1,3-Dihydrospiro[Indene-2,4'-Piperidine] (5)1,4'-Bipiperidine (8)1-((Benzyloxy)Carbonyl)Piperidine-2-Carboxylic Acid (5)1-((Benzyloxy)Carbonyl)Piperidine-3-Carboxylic Acid (3)1-(Methylsulfonyl)Piperidine (6)1-(Phenylsulfonyl)Piperidine (23)1-(Piperidin-1-Yl)Ethan-1-One (13)1-(Piperidin-4-Yl)Piperazine (6)1-Benzyl 3-Methyl Piperidine-1,3-Dicarboxylate (3)1-Benzyl-N-Methylpiperidin-3-Amine (6)1-Benzylpiperidin-3-One (5)1-Benzylpiperidin-4-Amine (8)1-Benzylpiperidin-4-One (7)1-Isopropylpiperidine (5)1-Methyl-4-Phenylpiperidine (4)1-Methylpiperidin-2-One (3)1-Oxa-8-Azaspiro[4.5]Decane (5)1-Phenylpiperidin-2-One (8)2,2-Dimethylpiperidin-4-One (6)2,2-Dimethylpiperidine (21)2,7-Diazaspiro[3.5]Nonane (7)2,8-Diazaspiro[4.5]Decan-3-One (6)2,8-Diazaspiro[4.5]Decane (5)2-(Piperidin-1-Yl)Ethan-1-Amine (8)2-(Piperidin-1-Yl)Ethan-1-Ol (10)2-(Piperidin-1-Yl)Pyridine (11)2-(Piperidin-1-Yl)Pyrimidine (16)2-(Piperidin-2-Yl)Ethan-1-Ol (8)2-(Piperidin-4-Yl)Ethan-1-Ol (5)2-(Piperidin-4-Yl)Pyridine (5)2-Methylpiperidin-4-One (6)2-Methylpiperidine (14)2-Phenylpiperidine (14)3,3-Difluoropiperidin-4-One (3)3,3-Difluoropiperidine (29)3,3-Dimethylpiperidin-4-One (3)3,3-Dimethylpiperidine (5)3-(1-Oxoisoindolin-2-Yl)Piperidine-2,6-Dione (21)3-(Piperidin-1-Yl)Pyridine (5)3-(Piperidin-4-Yl)-1H-Indazole (5)3-(Piperidin-4-Yl)-1H-Indole (8)3-(Piperidin-4-Yl)Pyridine (5)3-Fluoropiperidin-4-One (3)3-Fluoropiperidine (26)3-Methoxypiperidine (7)3-Methylpiperidin-4-One (3)3-Methylpiperidine (10)4,4-Difluoropiperidine (5)4-(1H-Pyrazol-1-Yl)Piperidine (11)4-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)-1,2,3,6-Tetrahydropyridine (11)4-(Azetidin-1-Yl)Piperidine (6)4-(Piperidin-1-Yl)Pyrimidine (9)4-(Pyrrolidin-1-Yl)Piperidine (6)4-Benzylpiperidine (18)4-Hydrazineylpiperidine (5)4-Hydroxypiperidin-2-One (3)4-Methyl-1-Phenylpiperidine (6)4-Methylenepiperidine (14)4-Oxopiperidine-2-Carboxylic Acid (3)4-Phenylpiperidin-4-Ol (10)5-Hydroxypiperidin-2-One (3)6-Azaspiro[2.5]Octane (10)6-Oxopiperidine-2-Carboxylic Acid (3)7-Azaspiro[3.5]Nonane (7)Azepane (25)Benzyl 3-Hydroxypiperidine-1-Carboxylate (7)Benzyl 4-Oxopiperidine-1-Carboxylate (12)Benzyl Piperidin-4-Ylcarbamate (7)Benzyl Piperidine-1-Carboxylate (50)Benzyl-3-Aminopiperidine-1-Carboxylate (6)Ethyl Piperidine-1-Carboxylate (5)Ethyl Piperidine-2-Carboxylate (9)Ethyl Piperidine-3-Carboxylate (14)Ethyl Piperidine-4-Carboxylate (10)Methyl 4-Oxopiperidine-2-Carboxylate (3)Methyl Piperidine-2-Carboxylate (12)Methyl Piperidine-3-Carboxylate (19)N-Benzylpiperidin-4-Amine (3)N-Methylpiperidin-3-Amine (5)N-Phenylpiperidine-2-Carboxamide (2)Phenyl(Piperidin-1-Yl)Methanone (21)Phenyl(Piperidin-4-Yl)Methanone (21)Piperidin-2-Ylmethanamine (6)Piperidin-2-Ylmethanol (11)Piperidin-3-Amine (17)Piperidin-3-Ol (27)Piperidin-3-One (13)Piperidin-3-Ylmethanamine (5)Piperidin-3-Ylmethanol (15)Piperidin-4-Amine (14)Piperidin-4-Ol (44)Piperidin-4-Ylmethanamine (7)Piperidin-4-Ylmethanol (11)Piperidine-2,4-Dione (5)Piperidine-2,6-Dione (13)Piperidine-2-Carboxylic Acid (26)Piperidine-3-Carboxamide (5)Piperidine-3-Carboxylic Acid (14)Piperidine-4-Carboxylic Acid (12)Quinuclidine (5)Spiro[Benzo[D][1,3]Oxazine-4,4'-Piperidin]-2(1H)-One (5)Spiro[Chromane-2,4'-Piperidin]-4-One (6)Spiro[Indene-2,4'-Piperidin]-1(3H)-One (5)Spiro[Indoline-3,4'-Piperidin]-2-One (18)Spiro[Indoline-3,4'-Piperidine] (5)Tert-Butyl (2-Oxopiperidin-3-Yl)Carbamate (4)Tert-Butyl (6-Oxopiperidin-3-Yl)Carbamate (3)Tert-Butyl (Piperidin-3-Ylmethyl)Carbamate (5)Tert-Butyl 2-Oxopiperidine-1-Carboxylate (3)Tert-Butyl 3-Bromopiperidine-1-Carboxylate (4)Tert-Butyl 4-Oxopiperidine-1-Carboxylate (16)Tert-Butyl 4-Phenoxypiperidine-1-Carboxylate (12)Tert-Butyl 4-Phenylpiperidine-1-Carboxylate (16)Tert-Butyl Piperidin-3-Ylcarbamate (9)
Purines (2028)
Amides (7)Amines (12)Aryls (4)Chlorides (6)(R)-N-(9-(Tetrahydrofuran-2-Yl)-9H-Purin-6-Yl)Benzamide (5)2-(Acetoxymethyl)-5-(9H-Purin-9-Yl)Tetrahydrofuran-3,4-Diyl Diacetate (6)2-(Hydroxymethyl)-5-(9H-Purin-9-Yl)Tetrahydrofuran-3,4-Diol (28)2-Chloro-7H-Purine (3)2-Chloro-9H-Purine (5)7H-Purin-2-Amine (6)7H-Purin-6-Amine (9)9-((3As,4R,6Ar)-Tetrahydrofuro[3,4-D][1,3]Dioxol-4-Yl)-9H-Purine (7)9-(Tetrahydrofuran-2-Yl)-9H-Purin-6-Amine (30)9-(Tetrahydrofuran-2-Yl)-9H-Purin-6-Ol (6)9-(Tetrahydrofuran-2-Yl)-9H-Purine (2)9H-Purin-6-Amine (3)
Pyrans (1099)
Aryls (3)Carboxylic Acids (2)Esters (5)Ethers (5)Ketones (7)Thioglucopyranoside (4)(S)-2-Phenylchroman-4-One (17)1-(Tetrahydro-2H-Pyran-2-Yl)-1H-Indazole (17)2,2-Dimethylchromane (5)2-(2-Oxo-2H-Chromen-4-Yl)Acetic Acid (4)2-Oxo-2H-Chromene-3-Carbonitrile (4)2-Oxo-2H-Chromene-3-Carboxylic Acid (14)2H-Chromene (16)3,4-Dihydro-2H-Pyran (11)3,6-Dihydro-2H-Pyran (8)3-Acetyl-2H-Chromen-2-One (3)3-Hydroxy-2-Phenyl-4H-Chromen-4-One (21)4-(Trifluoromethyl)-2H-Chromen-2-One (6)4-Hydroxy-2H-Chromen-2-One (10)4-Methyl-2H-Chromen-2-One (27)5-Fluorochroman-4-One (3)5-Fluorochromane (6)5-Hydroxy-2-Phenyl-4H-Chromen-4-One (36)5-Methoxy-2-Phenyl-4H-Chromen-4-One (9)6-Bromochroman-4-One (6)6-Chlorochroman-4-One (6)6-Chlorochromane (6)6-Fluorochroman-4-One (5)6-Fluorochromane (6)6-Methoxychromane (5)7-(Diethylamino)-2H-Chromen-2-One (9)7-Bromochroman-4-One (4)7-Bromochromane (7)7-Chlorochromane (5)7-Fluorochroman-4-One (5)7-Hydroxy-2H-Chromen-2-One (23)7-Methoxy-2H-Chromen-2-One (12)7-Methoxychroman-4-One (3)8-Bromochroman-4-One (4)8-Bromochromane (6)8-Chlorochromane (5)8-Fluorochromane (5)8-Methylchroman-4-One (4)8-Methylchromane (11)Chroman-2-One (5)Chroman-2-Ylmethanamine (3)Chroman-3-Amine (3)Chroman-4-Amine (20)Chroman-4-Ol (4)Chromane-2-Carboxylic Acid (6)Chromane-3-Carboxylic Acid (4)Dihydro-2H-Pyran-2,6(3H)-Dione (5)Ethyl 2-Oxo-2H-Chromene-3-Carboxylate (5)Isochromane (11)Spiro[Chromane-2,4'-Piperidin]-4-One (6)Tetrahydro-2H-Pyran-2-One (15)Tetrahydro-2H-Thiopyran (10)Tetrahydro-4H-Pyran-4-One (12)Thiochroman-4-One (10)
Pyrazines (3356)
Alcohols (6)Aldehydes (4)Alkynyls (6)Amides (17)Amines (19)Aryls (13)Bromides (9)Carboxylic Acids (12)Chlorides (31)Esters (9)Ethers (19)Fluorinated Building Blocks (8)Trifluoromethyls (5)Dibromopyrazine (7)Dichloropyrazine (21)Dihydropyrazine (6)Dimethylpyrazine (30)Ethoxypyrazine (5)Ethylpyrazine (7)Fluoropyrazine (6)Hydroxypyrazine (4)Iodopyrazine (17)Methoxypyrazine (36)Phenylpyrazin (5)Pyrazino (5)Pyrazino-Nitrile (50)Piperidines (8)1,2,3,4-Tetrahydropyrido[2,3-B]Pyrazine (5)1-(Pyrazin-2-Yl)Ethan-1-One (5)1H-Pyrazolo[3,4-B]Pyrazine (5)2,3-Diphenylpyrazine (5)2,5-Dibromopyrazine (4)2,5-Dichloropyrazine (4)2,6-Dibromopyrazine (9)2,6-Dichloropyrazine (14)2-(Piperazin-1-Yl)Pyrazine (9)2-(Trifluoromethyl)Pyrazine (6)2-Bromo-3-Methoxypyrazine (5)2-Bromo-3-Methylpyrazine (5)2-Bromo-5-Chloropyrazine (6)2-Bromo-6-Chloropyrazine (5)2-Bromo-6-Methylpyrazine (5)2-Bromopyrazine (15)2-Chloro-3-Methylpyrazine (7)2-Chloro-6-Methylpyrazine (12)2-Chloropyrazine (24)2-Ethoxypyrazine (3)2-Ethylpyrazine (9)2-Fluoropyrazine (7)2-Iodopyrazine (25)2-Methoxypyrazine (45)2-Methylpyrazine (16)2-Phenylpyrazine (12)3-Chloropyrazin-2-Amine (6)3-Chloropyrazine-2-Carbonitrile (6)4,5,6,7-Tetrahydropyrazolo[1,5-A]Pyrazine (7)4-(Pyrazin-2-Yl)Morpholine (5)5,6,7,8-Tetrahydro-[1,2,4]Triazolo[4,3-A]Pyrazine (11)5,6,7,8-Tetrahydroimidazo[1,2-A]Pyrazine (15)5,6,7,8-Tetrahydroimidazo[1,5-A]Pyrazine (11)5-Bromopyrazin-2-Amine (13)5-Bromopyrazin-2-Ol (5)5-Chloropyrazin-2-Amine (9)5H-Pyrrolo[2,3-B]Pyrazine (14)6-Bromopyrazin-2-Amine (5)6-Chloropyrazin-2-Amine (11)[1,2,4]Triazolo[1,5-A]Pyrazine (9)[1,2,4]Triazolo[4,3-A]Pyrazine (11)Ethyl Pyrazine-2-Carboxylate (10)Imidazo[1,5-A]Pyrazine (9)Methyl 3-Bromopyrazine-2-Carboxylate (5)Methyl 6-Bromopyrazine-2-Carboxylate (7)Methyl 6-Chloropyrazine-2-Carboxylate (5)Methyl Pyrazine-2-Carboxylate (19)Pyrazin-2-Amine (22)Pyrazin-2-Ol (7)Pyrazin-2-Ylmethanamine (12)Pyrazine-2-Carbaldehyde (17)Pyrazine-2-Carbohydrazide (3)Pyrazine-2-Carbonitrile (15)Pyrazine-2-Carboxamide (10)Pyrazine-2-Carboxylic Acid (34)Pyrazolo[1,5-A]Pyrazine (5)Pyrido[2,3-B]Pyrazine (12)Pyrido[3,4-B]Pyrazine (11)Tert-Butyl Pyrazin-2-Ylcarbamate (8)
Pyrazoles (16147)
Alcohols (42)Aldehydes (41)Amides (46)Amines (159)Aryls (122)Bromides (38)Carboxylic Acids (71)Chlorides (27)Difluoromethyls (11)Esters (33)Ethers (39)Fluorinated Building Blocks (53)Iodides (18)Ketones (14)Nitriles (39)Nitroes (28)Sulfamides (4)Sulfonyl Chlorides (4)Trifluoromethyls (27)Bipyrazole (5)Chloropyrazolo (33)Dichloropyrazolo (11)Dihydropyrazolo (28)Dimethylpyrazolo (6)Ethylpyrazole (7)Fluoropyrazolo (9)Hydroxypyrazolo (10)Methoxypyrazolo (16)Methyl-Pyrazole-Carboxylic Acid (147)Methyl-Pyrazolone (87)Methylpyrazolo (32)Pyrazolopyridine-Carboxylic Acid (48)Tetrahydropyrazolo (23)(1-Methyl-1H-Pyrazol-3-Yl)Methanol (7)(1-Phenyl-1H-Pyrazol-4-Yl)Boronic Acid (4)1,3-Dimethyl-1H-Pyrazole (28)1,3-Diphenyl-1H-Pyrazole (6)1,4,5,6-Tetrahydropyrrolo[3,4-C]Pyrazole (6)1,5-Diphenyl-1H-Pyrazole (13)1-(2-Chlorophenyl)-1H-Pyrazole (3)1-(3-Chlorophenyl)-1H-Pyrazole (3)1-(4-Methoxybenzyl)-1H-Pyrazole (5)1-(Azetidin-3-Yl)-1H-Pyrazole (7)1-(Tetrahydro-2H-Pyran-2-Yl)-1H-Pyrazole (9)1-(Tetrahydro-2H-Pyran-4-Yl)-1H-Pyrazole (6)1-Benzyl-1H-Pyrazolo[3,4-B]Pyridine (9)1-Benzyl-4-Bromo-1H-Pyrazole (5)1-Benzyl-4-Iodo-1H-Pyrazole (5)1-Cyclopentyl-1H-Pyrazole (5)1-Cyclopropyl-1H-Pyrazole (9)1-Methyl-1H-Pyrazol-3-Amine (14)1-Methyl-3-Phenyl-1H-Pyrazole (21)1-Methyl-4-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)-1H-Pyrazole (6)1-Methyl-5-Phenyl-1H-Pyrazole (7)1-Phenyl-1H-Pyrazol-3-Amine (3)1-Phenyl-1H-Pyrazol-3-Ol (3)1-Phenyl-1H-Pyrazol-5-Amine (4)1-Phenyl-1H-Pyrazole-3-Carboxylic Acid (10)1-Phenyl-1H-Pyrazole-4-Carbaldehyde (8)1-Phenyl-1H-Pyrazole-4-Carbonitrile (17)1-Phenyl-1H-Pyrazole-4-Carboxylic Acid (19)1-Phenyl-1H-Pyrazole-5-Carboxylic Acid (3)1-Phenyl-3-(Trifluoromethyl)-1H-Pyrazole (5)1-Trityl-1H-Pyrazole (5)1H-Pyrazol-4-Amine (6)1H-Pyrazol-4-Ol (3)1H-Pyrazol-5-Amine (19)1H-Pyrazole-4-Carbaldehyde (30)1H-Pyrazole-4-Carbonitrile (5)1H-Pyrazole-4-Carboxylic Acid (9)1H-Pyrazole-4-Sulfonyl Chloride (8)1H-Pyrazole-5-Carboxamide (3)1H-Pyrazole-5-Carboxylic Acid (10)1H-Pyrazolo[3,4-B]Pyrazine (5)1H-Pyrazolo[3,4-B]Pyridin-5-Amine (3)1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (5)1H-Pyrazolo[4,3-D]Pyrimidine (5)2,3-Dihydropyrazolo[5,1-B]Oxazole (7)2,4-Dihydro-3H-Pyrazol-3-One (10)2,6-Di(1H-Pyrazol-1-Yl)Pyridine (5)2-(1H-Pyrazol-1-Yl)Pyridine (16)2-(1H-Pyrazol-1-Yl)Pyrimidine (6)2-(1H-Pyrazol-3-Yl)Pyridine (5)2-Phenyl-2,4-Dihydro-3H-Pyrazol-3-One (24)3-(Tert-Butyl)-1-Phenyl-1H-Pyrazole (4)3-Bromo-1-Methyl-1H-Pyrazole (16)3-Bromopyrazolo[1,5-A]Pyridine (6)3-Bromopyrazolo[1,5-A]Pyrimidine (11)3-Chloro-1-Methyl-1H-Pyrazole (7)3-Cyclopropyl-1H-Pyrazole (5)3-Iodo-1-Methyl-1H-Pyrazole (6)3-Iodo-1H-Pyrazolo[3,4-B]Pyridine (4)3-Methyl-1-Phenyl-1H-Pyrazole (23)3-Phenyl-1H-Pyrazol-5-Amine (11)4,5,6,7-Tetrahydro-1H-Pyrazolo[3,4-C]Pyridine (7)4,5,6,7-Tetrahydro-1H-Pyrazolo[4,3-C]Pyridine (14)4,5,6,7-Tetrahydropyrazolo[1,5-A]Pyrazine (7)4,5,6,7-Tetrahydropyrazolo[1,5-A]Pyridine (6)4-(1H-Pyrazol-1-Yl)Benzoic Acid (3)4-(1H-Pyrazol-1-Yl)Piperidine (11)4-Bromo-1-Methyl-1H-Pyrazole (14)4-Bromo-1-Phenyl-1H-Pyrazole (11)4-Bromo-1H-Pyrazolo[3,4-B]Pyridine (4)4-Bromopyrazolo[1,5-A]Pyridine (8)4-Chloro-1H-Pyrazole (10)4-Chloro-1H-Pyrazolo[3,4-B]Pyridine (5)4-Chloro-1H-Pyrazolo[3,4-D]Pyrimidine (5)4-Iodo-1H-Pyrazole (9)4-Methyl-1-Phenyl-1H-Pyrazole (6)4-Methyl-1H-Pyrazole (11)4-Nitro-1H-Pyrazole (8)4-Phenyl-1H-Pyrazole (18)5,6-Dihydro-4H-Pyrrolo[1,2-B]Pyrazole (8)5-(Difluoromethyl)-1H-Pyrazole (6)5-Bromo-1H-Pyrazole (11)5-Bromo-1H-Pyrazolo[3,4-B]Pyridine (11)5-Bromo-1H-Pyrazolo[3,4-C]Pyridine (5)5-Chloro-1H-Pyrazole (8)5-Chloro-1H-Pyrazolo[3,4-B]Pyridine (3)5-Chloropyrazolo[1,5-A]Pyrimidine (24)5-Cyclopropyl-1H-Pyrazole (6)5-Iodo-1H-Pyrazole (4)5-Nitro-1H-Pyrazole (9)5-Nitro-1H-Pyrazolo[3,4-B]Pyridine (3)5-Phenyl-1H-Pyrazole-3-Carboxylic Acid (15)6,7-Dihydro-5H-Pyrazolo[5,1-B][1,3]Oxazine (13)6-Bromopyrazolo[1,5-A]Pyridine (8)6-Bromopyrazolo[1,5-A]Pyrimidine (7)6-Chloro-1H-Pyrazolo[3,4-D]Pyrimidine (12)7-Chloropyrazolo[1,5-A]Pyrimidine (8)Ethyl 1-Phenyl-1H-Pyrazole-3-Carboxylate (4)Ethyl 1-Phenyl-1H-Pyrazole-4-Carboxylate (13)Ethyl 1H-Pyrazole-4-Carboxylate (11)Ethyl Pyrazolo[1,5-A]Pyridine-3-Carboxylate (11)Ethyl Pyrazolo[1,5-A]Pyrimidine-3-Carboxylate (6)Methyl 1H-Pyrazole-4-Carboxylate (10)Methyl 1H-Pyrazolo[3,4-B]Pyridine-5-Carboxylate (3)Methyl Pyrazolo[1,5-A]Pyridine-3-Carboxylate (16)Pyrazolo[1,5-A]Pyrazine (5)Pyrazolo[1,5-A]Pyridine-2-Carboxylic Acid (5)Pyrazolo[1,5-A]Pyridine-3-Carboxylic Acid (13)Pyrazolo[1,5-A]Pyrimidine-3-Carboxylic Acid (7)Tert-Butyl 1H-Pyrazolo[3,4-B]Pyridine-1-Carboxylate (7)Tert-Butyl 4-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)-1H-Pyrazole-1-Carboxylate (3)Tetrahydropyrans (4)Thiophenes (12)
Pyridazines (2753)
Alcohols (8)Amides (20)Amines (10)Aryls (15)Bromides (10)Carboxylic Acids (10)Chlorides (32)Esters (11)Ethers (7)Fluorinated Building Blocks (4)Ketones (4)Nitriles (5)Aminopyridazine (12)Dihydropyridazine (26)Dimethylpyridazine (9)Hexahydropyridazines (9)2-Methylpyridazin-3(2H)-One (7)3,6-Dichloropyridazine (20)3-(Piperazin-1-Yl)Pyridazine (7)3-(Trifluoromethyl)Pyridazine (3)3-Bromopyridazine (25)3-Chloro-4-Methylpyridazine (7)3-Chloropyridazine (44)3-Iodopyridazine (5)3-Methoxypyridazine (17)3-Methylpyridazine (6)3-Phenylpyridazine (8)4-Aminopyridazin-3(2H)-One (4)4-Bromopyridazin-3(2H)-One (3)4-Bromopyridazine (5)4-Chloropyridazin-3(2H)-One (4)4-Chloropyridazine (16)4-Methoxypyridazine (8)4-Methylpyridazine (3)6-Chloropyridazin-3(2H)-One (5)6-Chloropyridazin-3-Amine (5)[1,2,4]Triazolo[4,3-B]Pyridazine (10)Ethyl Pyridazine-3-Carboxylate (6)Methyl Pyridazine-3-Carboxylate (7)Pyridazin-3-Amine (18)Pyridazin-3-Ol (3)Pyridazin-4-Amine (10)Pyridazine-3-Carboxylic Acid (7)Morpholines (4)
Pyridines (70646)
Acyl Chlorides (13)Alcohols (160)Aldehydes (54)Alkenyls (36)Alkynyls (17)Amides (267)Amidines (13)Amines (394)Aryls (178)Bromides (398)Carboxylic Acids (172)Chlorides (372)Difluoromethyls (56)Esters (230)Ethers (239)Fluorinated Building Blocks (296)Hydrazides (17)Hydrazines (27)Iodides (78)Ketones (98)Nitriles (126)Nitroes (61)Oximes (11)Phenols (4)Sulfamides (19)Sulfides (18)Sulfones (14)Sulfonyl Chlorides (5)Thioureas (4)Trifluoromethyls (39)Acetylpyridin (5)Aminopicolinate (8)Benzyloxypyridine (36)Bipyridine (200)Bromopicolinate (19)Bromopicolinic (4)Bromopicolinic Acid (5)Bromopicolinonitrile (6)Bromopyrido (13)Butylpyridine (5)Chloroisonicotinic Acid (5)Chloronicotinaldehyde (23)Chloronicotinamide (11)Chloronicotinate (45)Chloronicotinic (41)Cyanopicolinate (7)Cyanopicolinic (6)Cyanopyridine (34)Cyclopropoxypyridine (6)Cyclopropylpyridine (30)Dibromopicolinate (4)Dibromopicolinic Acid (3)Dibromopyridine (36)Dichloropicolinate (9)Dichloropicolinonitrile (4)Dichloropyridine (120)Difluoropicolinic Acid (3)Difluoropyridine (58)Dihydropyrido (27)Diiodopyridine (13)Dimethoxypicolinic Acid (5)Dimethoxypyridine (33)Dimethylpyridine (143)Diphenylpyridine (6)Dipyridine (26)Ethoxypicolinic Acid (3)Ethoxypyridine (35)Ethylpyridine (36)Ethynylpicolinate (3)Fluoro-Pyridine--Boronate (79)Fluoropicolinaldehyde (8)Fluoropicolinamide (8)Fluoropicolinate (22)Fluoropyridine (287)Fluoropyrido (3)Formylpyridine (23)Hexahydropyrido (7)Hydrazinylpyridine (22)Hydroxymethylpyridine (26)Hydroxypicolinate (13)Hydroxypicolinic (9)Hydroxypicolinonitrile (7)Iodopicolinate (5)Iodopicolinic Acid (4)Iodopyridine (167)Isopropoxypyridine (20)Isopropylpyridine (32)Methoxyisonicotinaldehyde (10)Methoxynicotinaldehyde (18)Methoxypicolinaldehyde (13)Methoxypicolinamide (13)Methoxypicolinate (21)Methoxypicolinic (18)Methoxypicolinic Acid (16)Methoxypicolinimidamide (5)Methoxypicolinonitrile (13)Methoxypyridine (341)Methylisonicotinamide (8)Methylnicotinaldehyde (30)Methylnicotinamide (13)Methylpicolinaldehyde (16)Methylpicolinamide (15)Methylpicolinate (27)Methylpicolinic (23)Methylpicolinonitrile (28)Methylpyrido (13)Nitropyridine (392)Oxopyridin (2)Picolinate (41)Pyridinecarbonitrile (50)Pyridyl-Benzene-Boronic Acid/Ester (16)Pyridyl-Phenyl-Boronate (2)Pyridylmethyl (6)Terpyridine (32)Tetrachloropyridine (5)Tetrafluoropyridine (21)Tetrahydropyridine (49)Tetrahydropyrido (32)Tribromopyridine (9)Trichloropyridine (17)Trifluoropyridine (8)Trimethylpyridine (5)Azetidines (4)Benzimidazoles (6)Imidazoles (4)Indoles (5)Morpholines (24)Piperazines (16)Piperidines (15)Pyrroles (7)Pyrrolidines (2)Thiadiazoles (7)Thiophenes (17)Thiophenols (6)Triazoles (13)Other Aromatic Heterocycles (2)(2-Chloropyridin-4-Yl)Boronic Acid (6)(3-Bromopyridin-2-Yl)Methanol (7)(3-Chloropyridin-2-Yl)Methanamine (6)(3-Fluoropyridin-2-Yl)Methanamine (5)(3-Methylpyridin-2-Yl)Methanamine (5)(3-Methylpyridin-2-Yl)Methanol (10)(3Ar,8As)-2-(Pyridin-2-Yl)-3A,8A-Dihydro-8H-Indeno[1,2-D]Oxazole (6)(3As,8Ar)-2-(Pyridin-2-Yl)-3A,8A-Dihydro-8H-Indeno[1,2-D]Oxazole (7)(4R,5S)-4,5-Diphenyl-2-(Pyridin-2-Yl)-4,5-Dihydrooxazole (5)(5-(Trifluoromethyl)Pyridin-3-Yl)Boronic Acid (4)(5-Bromopyridin-2-Yl)Methanamine (5)(5-Bromopyridin-2-Yl)Methanol (5)(5-Chloropyridin-2-Yl)Methanamine (5)(6-Methylpyridin-2-Yl)Methanamine (6)(6-Methylpyridin-2-Yl)Methanol (5)(6-Phenoxypyridin-3-Yl)Boronic Acid (5)(R)-3-(Pyrrolidin-2-Yl)Pyridine (9)(R)-4-Benzyl-2-(Pyridin-2-Yl)-4,5-Dihydrooxazole (7)(R)-4-Phenyl-2-(Pyridin-2-Yl)-4,5-Dihydrooxazole (7)(S)-4-Benzyl-2-(Pyridin-2-Yl)-4,5-Dihydrooxazole (8)(S)-4-Phenyl-2-(Pyridin-2-Yl)-4,5-Dihydrooxazole (6)1,1'-Diphenyl-[4,4'-Bipyridine]-1,1'-Diium (7)1,10-Phenanthrolin-4-Ol (3)1,2,3,4-Tetrahydropyrido[2,3-B]Pyrazine (5)1,2,3,6-Tetrahydropyridine (22)1,3-Dihydro-2H-Pyrrolo[2,3-B]Pyridin-2-One (19)1,3-Dihydro-2H-Pyrrolo[2,3-C]Pyridin-2-One (5)1,3-Dihydro-2H-Pyrrolo[3,2-B]Pyridin-2-One (11)1,4-Di(Pyridin-4-Yl)Benzene (5)1-(5-Bromopyridin-2-Yl)Piperazine (6)1-(Phenylsulfonyl)-1H-Pyrrolo[2,3-B]Pyridine (30)1-(Pyridin-2-Yl)Ethan-1-Amine (15)1-(Pyridin-2-Yl)Ethan-1-One (36)1-(Pyridin-2-Yl-L2-Azaneyl)Ethan-1-One (12)1-(Pyridin-3-Yl)Ethan-1-Amine (17)1-(Pyridin-3-Yl)Ethan-1-One (29)1-(Pyridin-3-Yl)Piperazine (13)1-(Pyridin-3-Ylmethyl)Piperazine (6)1-(Pyridin-4-Yl)Ethan-1-Amine (23)1-(Pyridin-4-Yl)Ethan-1-One (14)1-Benzyl-1,2,3,6-Tetrahydropyridine (9)1-Benzyl-1H-Pyrazolo[3,4-B]Pyridine (9)1-Methyl-4-(Pyridin-2-Yl)Piperazine (5)1-Methylpyridin-1-Ium Iodide (5)1-Phenyl-3-(4-(Pyridin-4-Yloxy)Phenyl)Urea (8)1H-Imidazo[4,5-B]Pyridine (14)1H-Imidazo[4,5-C]Pyridine (12)1H-Pyrazolo[3,4-B]Pyridin-5-Amine (3)1H-Pyrrolo[2,3-C]Pyridin-7-Ol (3)1H-Pyrrolo[2,3-C]Pyridine-2-Carboxylic Acid (4)1H-Pyrrolo[3,2-B]Pyridine-3-Carboxylic Acid (6)2,2':6',2''-Terpyridine (15)2,2-Dimethyl-1-(Pyridin-2-Yl-L2-Azaneyl)Propan-1-One (7)2,3'-Bipyridine (11)2,3,4,5-Tetrahydro-1H-Pyrido[4,3-B]Indole (12)2,3,4,9-Tetrahydro-1H-Pyrido[3,4-B]Indole (13)2,3,5-Trichloropyridine (13)2,3,6-Trichloropyridine (16)2,3-Dibromopyridine (21)2,3-Dichloropyridine (38)2,3-Difluoropyridine (13)2,3-Dihydro-1H-Pyrrolo[2,3-B]Pyridine (10)2,3-Dihydro-1H-Pyrrolo[2,3-C]Pyridine (5)2,3-Dihydro-1H-Pyrrolo[3,2-C]Pyridine (7)2,3-Dihydro-1H-Pyrrolo[3,4-C]Pyridine (6)2,3-Dihydro-[1,4]Dioxino[2,3-B]Pyridine (5)2,3-Dihydropyridin-2-One (5)2,3-Dimethoxypyridine (7)2,3-Dimethylpyridine (8)2,4,6-Trichloropyridine (5)2,4,6-Triphenylpyridine (7)2,4-Dibromopyridine (5)2,4-Dichloro-6-Methylpyridine (8)2,4-Dichloropyridine (50)2,4-Dimethylpyridine (5)2,5-Dibromopyridine (26)2,5-Dichloropyridine (32)2,5-Difluoropyridine (8)2,6-Bis(4,5-Dihydrooxazol-2-Yl)Pyridine (12)2,6-Di(1H-Pyrazol-1-Yl)Pyridine (5)2,6-Dibromo-3-Fluoropyridine (3)2,6-Dibromopyridin-4-Amine (3)2,6-Dibromopyridine (28)2,6-Dichloro-3-Fluoropyridine (10)2,6-Dichloro-3-Methylpyridine (5)2,6-Dichloro-3-Nitropyridine (6)2,6-Dichloro-4-Iodopyridine (4)2,6-Dichloro-4-Methylpyridine (5)2,6-Dichloronicotinonitrile (8)2,6-Dichloropyridin-3-Amine (11)2,6-Dichloropyridine (49)2,6-Difluoropyridine (29)2,6-Dimethoxypyridine (11)2,6-Dimethylpyridin-4-Ol (4)2,6-Dimethylpyridine (26)2-(1H-Pyrazol-1-Yl)Pyridine (16)2-(1H-Pyrazol-3-Yl)Pyridine (5)2-(2,2,2-Trifluoroethoxy)Pyridine (8)2-(2-Chlorophenyl)Pyridine (3)2-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (6)2-(4-Fluorophenyl)Pyridine (11)2-(6-Benzhydrylpyridin-2-Yl)-4,5-Dihydrooxazole (10)2-(6-Cyclopropylpyridin-2-Yl)-4,5-Dihydrooxazole (10)2-(Benzyloxy)Pyridine (18)2-(Bromomethyl)Pyridine (27)2-(Chloromethyl)-3-Methylpyridine (12)2-(Chloromethyl)Pyridine (12)2-(Chloromethyl)Pyridine 1-Oxide (4)2-(Difluoromethyl)Pyridine (21)2-(Methylsulfonyl)Pyridine (11)2-(Methylthio)Pyridine (5)2-(P-Tolyl)Pyridine (6)2-(Phenoxymethyl)Pyridine (5)2-(Piperidin-1-Yl)Pyridine (11)2-(Piperidin-4-Yl)Pyridine (5)2-(Pyridin-2-Yl)-1H-Benzo[D]Imidazole (5)2-(Pyridin-2-Yl)Acetonitrile (8)2-(Pyridin-2-Yl)Pyrimidine (8)2-(Pyridin-2-Ylmethyl)-4,5-Dihydrooxazole (14)2-(Pyridin-3-Yl)Acetic Acid (14)2-(Pyridin-3-Yl)Acetonitrile (6)2-(Pyrrolidin-2-Yl)Pyridine (5)2-(Thiophen-2-Yl)Pyridine (5)2-(Trifluoromethoxy)Pyridine (6)2-(Trifluoromethyl)Pyridine (6)2-Aminonicotinonitrile (6)2-Benzylpyridine (12)2-Bromo-3-(Trifluoromethyl)Pyridine (4)2-Bromo-3-Chloropyridine (25)2-Bromo-3-Fluoropyridine (26)2-Bromo-3-Iodopyridine (6)2-Bromo-3-Methoxypyridine (7)2-Bromo-3-Methylpyridine (25)2-Bromo-3-Nitropyridine (5)2-Bromo-4-Chloropyridine (7)2-Bromo-4-Methylpyridine (6)2-Bromo-5-(Trifluoromethyl)Pyridine (6)2-Bromo-5-Chloropyridine (22)2-Bromo-5-Fluoropyridine (33)2-Bromo-5-Methoxypyridine (11)2-Bromo-5-Methylpyridine (19)2-Bromo-5-Nitropyridine (11)2-Bromo-6-(Trifluoromethyl)Pyridine (6)2-Bromo-6-Chloropyridine (23)2-Bromo-6-Fluoropyridine (21)2-Bromo-6-Iodopyridine (5)2-Bromo-6-Methoxypyridine (15)2-Bromo-6-Methylpyridine (17)2-Bromo-6-Phenylpyridine (4)2-Bromonicotinic Acid (5)2-Bromopyridin-3-Amine (10)2-Bromopyridin-3-Ol (7)2-Bromopyridine (10)2-Bromopyridine 1-Oxide (6)2-Chloro-3,6-Dimethylpyridine (4)2-Chloro-3-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (4)2-Chloro-3-(Trifluoromethyl)Pyridine (12)2-Chloro-3-Fluoropyridin-4-Amine (3)2-Chloro-3-Fluoropyridine (20)2-Chloro-3-Iodopyridin-4-Amine (3)2-Chloro-3-Iodopyridine (13)2-Chloro-3-Methoxypyridine (12)2-Chloro-3-Methylpyridine (17)2-Chloro-3-Nitropyridine (10)2-Chloro-4,6-Dimethylpyridine (7)2-Chloro-4-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (14)2-Chloro-4-(Trifluoromethyl)Pyridine (9)2-Chloro-4-Ethoxypyridine (5)2-Chloro-4-Fluoropyridine (10)2-Chloro-4-Iodopyridine (19)2-Chloro-4-Methoxypyridine (22)2-Chloro-4-Methylpyridine (31)2-Chloro-5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (6)2-Chloro-5-(Trifluoromethyl)Pyridine (4)2-Chloro-5-Fluoropyridin-4-Amine (3)2-Chloro-5-Fluoropyridine (16)2-Chloro-5-Iodopyridine (18)2-Chloro-5-Methylpyridine (11)2-Chloro-5-Nitropyridine (8)2-Chloro-6-(Trifluoromethyl)Pyridine (16)2-Chloro-6-Fluoropyridine (14)2-Chloro-6-Iodopyridine (9)2-Chloro-6-Methoxypyridine (24)2-Chloro-6-Methyl-3-Nitropyridine (4)2-Chloro-6-Methylnicotinonitrile (10)2-Chloro-6-Methylpyridine (49)2-Chloroisonicotinaldehyde (19)2-Chloroisonicotinic Acid (17)2-Chloroisonicotinonitrile (7)2-Chloronicotinic Acid (7)2-Chloronicotinonitrile (9)2-Chloropyridin-3-Amine (11)2-Chloropyridin-3-Ol (9)2-Chloropyridin-4-Amine (28)2-Chloropyridine 1-Oxide (10)2-Cyclopropyl-4-Phenylquinoline (12)2-Cyclopropylpyridine (20)2-Ethoxypyridine (20)2-Ethylpyridine (9)2-Ethynylpyridine (31)2-Fluoro-3-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (7)2-Fluoro-3-Iodopyridine (8)2-Fluoro-3-Methylpyridine (14)2-Fluoro-4-Methylpyridine (6)2-Fluoro-5-Methoxypyridine (4)2-Fluoro-5-Methylpyridine (6)2-Fluoro-6-Methoxypyridine (6)2-Fluoro-6-Methylpyridine (20)2-Fluoropyridine (15)2-Hydrazineylpyridine (32)2-Iodo-6-Methylpyridine (5)2-Iodopyridine (27)2-Isopropoxypyridine (16)2-Isopropylpyridine (14)2-Methoxy-3-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (7)2-Methoxy-3-(Trifluoromethyl)Pyridine (6)2-Methoxy-4-Methylpyridine (5)2-Methoxy-5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (5)2-Methoxy-5-(Trifluoromethyl)Pyridine (4)2-Methoxy-5-Methylpyridine (5)2-Methoxy-5-Nitropyridine (8)2-Methoxy-6-Methylpyridine (14)2-Methoxyisonicotinic Acid (13)2-Methoxypyridin-3-Amine (6)2-Methoxypyridine (434)2-Methyl-1,10-Phenanthroline (3)2-Methyl-3-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (5)2-Methyl-3-Nitropyridine (9)2-Methyl-5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (3)2-Methylimidazo[1,2-A]Pyridine (8)2-Methylpyridin-3-Ol (9)2-Methylpyridin-4-Amine (7)2-Methylpyridine 1-Oxide (9)2-Nitropyridine (40)2-Phenoxy-5-(Trifluoromethyl)Pyridine (7)2-Phenylimidazo[1,2-A]Pyridine (11)2-Propoxypyridine (9)2H-Pyrido[3,2-B][1,4]Oxazin-3(4H)-One (8)3,3'-Bipyridine (7)3,4-Dihydro-2H-Pyrido[3,2-B][1,4]Oxazine (5)3,5-Dibromopyridine (12)3,5-Dichloropyridine (16)3,5-Difluoropyridine (12)3,5-Dimethoxypyridine (4)3,5-Dimethylpyridine (8)3,5-Diphenylpyridine (5)3-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)-5-(Trifluoromethyl)Pyridine (3)3-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (74)3-(Benzyloxy)Pyridine (19)3-(Bromomethyl)Pyridine (18)3-(Chloromethyl)Pyridine (22)3-(Cyclopropylmethyl)Pyridine (6)3-(Difluoromethyl)Pyridine (5)3-(Methylsulfonyl)Pyridine (5)3-(Piperidin-1-Yl)Pyridine (5)3-(Piperidin-4-Yl)Pyridine (5)3-(Pyrrolidin-2-Yl)Pyridine (6)3-(Tert-Butyl)Pyridine (5)3-(Trifluoromethyl)-1H-Pyrrolo[2,3-B]Pyridine (3)3-(Trifluoromethyl)Pyridin-2-Ol (5)3-(Trifluoromethyl)Pyridine (51)3-Bromo-1H-Pyrrolo[3,2-B]Pyridine (6)3-Bromo-2-Chloropyridin-4-Amine (3)3-Bromo-2-Chloropyridine (20)3-Bromo-2-Fluoropyridine (21)3-Bromo-2-Methoxypyridine (20)3-Bromo-2-Methylpyridine (27)3-Bromo-4-Methylpyridine (13)3-Bromo-5-Chloropyridine (14)3-Bromo-5-Fluoropyridine (18)3-Bromo-5-Methylpyridine (14)3-Bromo-5-Nitropyridine (10)3-Bromopicolinic Acid (9)3-Bromopicolinonitrile (13)3-Bromopyrazolo[1,5-A]Pyridine (6)3-Bromopyridin-2-Amine (30)3-Bromopyridin-2-Ol (17)3-Bromopyridine 1-Oxide (8)3-Chloro-2-Fluoropyridine (13)3-Chloro-2-Methoxypyridine (16)3-Chloro-2-Methylpyridine (4)3-Chloro-5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (5)3-Chloro-5-Fluoropyridine (10)3-Chloro-5-Methylpyridine (7)3-Chloro-5-Nitropyridine (5)3-Chloroimidazo[1,2-A]Pyridine (3)3-Chloropicolinic Acid (9)3-Chloropicolinonitrile (6)3-Chloropyridin-2-Amine (17)3-Chloropyridin-2-Ol (10)3-Cyclopropylpyridine (28)3-Ethoxypyridine (12)3-Ethylpyridine (11)3-Ethynylpyridine (22)3-Fluoro-2-Methoxypyridine (14)3-Fluoro-2-Methylpyridine (15)3-Fluoro-5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (7)3-Fluoropicolinic Acid (6)3-Fluoropicolinonitrile (5)3-Fluoropyridin-2-Amine (12)3-Fluoropyridin-4-Amine (4)3-Hydrazineylpyridine (8)3-Iodo-1H-Pyrazolo[3,4-B]Pyridine (4)3-Iodo-1H-Pyrrolo[3,2-B]Pyridine (6)3-Iodo-1H-Pyrrolo[3,2-C]Pyridine (4)3-Iodopyridin-2-Amine (12)3-Iodopyridin-2-Ol (4)3-Iodopyridin-4-Amine (6)3-Iodopyridin-4-Ol (4)3-Iodopyridine (37)3-Methoxypyridin-2-Amine (5)3-Methoxypyridine (51)3-Methyl-1H-Pyrrolo[2,3-B]Pyridine (5)3-Methyl-2-Phenylpyridine (3)3-Methyl-5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (6)3-Methyl-5-Nitropyridine (4)3-Methylimidazo[1,2-A]Pyridine (3)3-Methylpicolinic Acid (13)3-Methylpyridin-2-Amine (7)3-Methylpyridine (49)3-Methylpyridine 1-Oxide (7)3-Nitropyridin-2-Ol (11)3-Nitropyridin-4-Amine (5)3-Nitropyridine (54)3-Phenoxypyridine (12)4'-Phenyl-2,2':6',2''-Terpyridine (13)4,4'-Bipyridine (10)4,5,6,7-Tetrahydro-1H-Pyrazolo[3,4-C]Pyridine (7)4,5,6,7-Tetrahydro-1H-Pyrazolo[4,3-C]Pyridine (14)4,5,6,7-Tetrahydro-3H-Imidazo[4,5-C]Pyridine (5)4,5,6,7-Tetrahydrothiazolo[5,4-C]Pyridine (10)4,5,6,7-Tetrahydrothieno[2,3-C]Pyridine (10)4,5,6,7-Tetrahydrothieno[3,2-C]Pyridine (9)4,6-Dichloropyridin-2-Amine (6)4,6-Dichloropyridin-3-Amine (4)4,7-Diphenyl-1,10-Phenanthroline (3)4-(2,4-Diphenyl-1H-Imidazol-5-Yl)Pyridine (5)4-(Benzyloxy)Pyridine (8)4-(Bromomethyl)Pyridine (8)4-(Pyridin-2-Yl)Morpholine (21)4-(Pyridin-3-Yl)Pyrimidine (5)4-(Pyridin-4-Yl)Morpholine (5)4-(Tert-Butyl)-2-(Pyridin-2-Yl)-4,5-Dihydrooxazole (16)4-(Tert-Butyl)Pyridine (5)4-(Trifluoromethyl)Nicotinic Acid (3)4-(Trifluoromethyl)Pyridine (14)4-Bromo-2-Chloropyridine (29)4-Bromo-2-Fluoropyridine (4)4-Bromo-2-Methoxypyridine (4)4-Bromo-3-Methylpyridine (5)4-Bromopyrazolo[1,5-A]Pyridine (8)4-Bromopyridine (31)4-Chloro-1H-Pyrazolo[4,3-C]Pyridine (7)4-Chloro-1H-Pyrrolo[2,3-B]Pyridine (13)4-Chloro-1H-Pyrrolo[3,2-C]Pyridine (10)4-Chloro-2,6-Dimethylpyridine (4)4-Chloro-2-Methoxypyridine (6)4-Chloro-3-Methylpyridine (7)4-Chloronicotinic Acid (4)4-Chloropyridin-2-Amine (6)4-Chloropyridine (31)4-Cyclopropylpyridine (7)4-Ethoxypyridine (7)4-Ethynylpyridine (10)4-Iodopyridine (17)4-Isopropyl-2-(Pyridin-2-Yl)-4,5-Dihydrooxazole (16)4-Methoxypyridine (136)4-Methyl-2,2'-Bipyridine (8)4-Methyl-2-Phenylpyridine (3)4-Methyl-3-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (5)4-Methyl-3-Nitropyridine (8)4-Methylnicotinic Acid (5)4-Methylpyridine (24)4-Nitropyridine (11)4-Phenoxypyridine (7)4-Phenyl-1,2,3,6-Tetrahydropyridine (7)4-Phenyl-1,4-Dihydropyridine (10)5,6,7,8-Tetrahydroimidazo[1,2-A]Pyridine (12)5,6,7,8-Tetrahydropyrido[3,4-D]Pyrimidine (7)5,6,7,8-Tetrahydropyrido[4,3-D]Pyrimidine (17)5,6-Dichloropyridin-2-Amine (4)5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Nicotinonitrile (4)5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridin-2-Amine (9)5-(Trifluoromethyl)Pyridin-2-Amine (5)5-(Trifluoromethyl)Pyridin-2-Ol (8)5-Benzyl-4,5,6,7-Tetrahydrothieno[3,2-C]Pyridine (7)5-Bromo-2-Chloro-4-Methylpyridine (5)5-Bromo-2-Chloropyridine (40)5-Bromo-2-Fluoropyridine (22)5-Bromo-2-Iodopyridine (5)5-Bromo-2-Methoxypyridine (29)5-Bromo-2-Methylpyridine (23)5-Bromo-2-Phenylpyridine (3)5-Bromo-4-Methylpyridin-2-Amine (5)5-Bromo-6-Chloropyridin-2-Amine (3)5-Bromonicotinaldehyde (12)5-Bromonicotinic Acid (6)5-Bromonicotinonitrile (6)5-Bromopicolinic Acid (11)5-Bromopicolinonitrile (13)5-Bromopyridin-2-Amine (35)5-Bromopyridin-2-Ol (18)5-Bromopyridin-3-Amine (10)5-Bromopyridin-3-Ol (6)5-Chloro-1H-Pyrazolo[3,4-B]Pyridine (3)5-Chloro-1H-Pyrazolo[4,3-B]Pyridine (6)5-Chloro-1H-Pyrrolo[2,3-C]Pyridine (5)5-Chloro-1H-Pyrrolo[3,2-B]Pyridine (6)5-Chloro-2-Fluoropyridine (13)5-Chloro-2-Methoxypyridine (10)5-Chloro-2-Methylpyridine (10)5-Chloroimidazo[1,2-A]Pyridine (3)5-Chloropicolinic Acid (7)5-Chloropicolinonitrile (6)5-Chloropyridin-2-Amine (26)5-Chloropyridin-2-Ol (15)5-Chloropyridin-3-Amine (7)5-Fluoro-2-Methoxypyridine (15)5-Fluoro-2-Methylpyridine (8)5-Fluoropicolinonitrile (5)5-Fluoropyridin-2-Amine (15)5-Iodopyridin-2-Amine (17)5-Iodopyridin-2-Ol (8)5-Methoxy-1H-Pyrrolo[2,3-C]Pyridine (4)5-Methoxypyridin-3-Amine (4)5-Methylimidazo[1,2-A]Pyridine (4)5-Methylpyridin-2-Amine (7)5-Methylpyridin-3-Amine (4)5-Nitronicotinic Acid (5)5-Nitropyridin-2-Amine (6)5-Phenylpicolinic Acid (4)6,7-Dihydro-5H-Cyclopenta[B]Pyridine (18)6,7-Dihydro-5H-Cyclopenta[C]Pyridine (7)6,7-Dihydro-5H-Pyrrolo[3,4-B]Pyridine (5)6-(Trifluoromethyl)Pyridin-2-Amine (11)6-(Trifluoromethyl)Pyridin-3-Amine (5)6-Bromo-1H-Pyrazolo[4,3-B]Pyridine (4)6-Bromo-1H-Pyrrolo[3,2-B]Pyridine (7)6-Bromo-1H-Pyrrolo[3,2-C]Pyridine (5)6-Bromoimidazo[1,2-A]Pyridine (14)6-Bromonicotinaldehyde (10)6-Bromonicotinic Acid (9)6-Bromonicotinonitrile (7)6-Bromopicolinic Acid (5)6-Bromopyrazolo[1,5-A]Pyridine (8)6-Bromopyridin-2-Amine (8)6-Bromopyridin-3-Amine (12)6-Bromopyridin-3-Ol (13)6-Chloro-1H-Pyrazolo[4,3-C]Pyridine (8)6-Chloro-1H-Pyrrolo[3,2-C]Pyridine (13)6-Chloro-3-Nitropyridin-2-Amine (4)6-Chloro-5-(Trifluoromethyl)Pyridin-2-Amine (3)6-Chloro-5-Iodopyridin-2-Amine (3)6-Chloroimidazo[1,2-A]Pyridine (4)6-Chloronicotinaldehyde (24)6-Chloronicotinic Acid (4)6-Chloropicolinic Acid (12)6-Chloropicolinonitrile (9)6-Chloropyridin-2-Amine (21)6-Chloropyridin-2-Ol (9)6-Chloropyridin-3-Amine (4)6-Chloropyridine-3-Sulfonyl Chloride (5)6-Fluoro-1H-Pyrrolo[2,3-B]Pyridine (3)6-Fluoropyridin-2-Amine (8)6-Fluoropyridin-3-Amine (4)6-Methoxy-1H-Pyrrolo[2,3-B]Pyridine (3)6-Methoxynicotinaldehyde (4)6-Methoxypicolinic Acid (9)6-Methoxypyridin-2-Amine (14)6-Methoxypyridin-3-Amine (8)6-Methylnicotinic Acid (6)6-Methylnicotinonitrile (7)6-Methylpicolinic Acid (12)6-Methylpicolinonitrile (10)6-Methylpyridin-2-Amine (46)6-Methylpyridin-2-Ol (23)6-Methylpyridin-3-Amine (5)6-Methylpyridin-3-Ol (7)6-Phenoxypyridin-3-Amine (5)6-Phenylnicotinic Acid (8)6-Phenylpicolinic Acid (3)7-Bromo-1H-Pyrrolo[2,3-C]Pyridine (4)7-Chloro-1H-Pyrrolo[2,3-C]Pyridine (5)7-Methoxy-1H-Pyrrolo[2,3-C]Pyridine (5)7-Methylimidazo[1,2-A]Pyridine (3)9H-Pyrido[3,4-B]Indole (5)Bis(Pyridin-2-Ylmethyl)Amine (6)Dimethyl Pyridine-2,6-Dicarboxylate (7)Dimethyl(Pyridin-2-Yl)Phosphine Oxide (8)Dimethyl(Pyridin-3-Yl)Phosphine Oxide (7)Ethyl 2-(Pyridin-2-Yl)Acetate (15)Ethyl 2-Methylnicotinate (6)Ethyl 4,6-Dichloronicotinate (4)Ethyl 6-Chloropicolinate (7)Ethyl Isonicotinate (12)Ethyl Nicotinate (25)Ethyl Picolinate (41)Ethyl Pyrazolo[1,5-A]Pyridine-3-Carboxylate (11)Furo[3,2-B]Pyridine (7)Furo[3,2-C]Pyridine (7)Imidazo[1,2-A]Pyridin-2-Ylmethanol (4)Imidazo[1,2-A]Pyridine-5-Carboxylic Acid (3)Imidazo[1,2-A]Pyridine-6-Carbonitrile (3)Isonicotinaldehyde (68)Isonicotinamide (12)Isonicotinic Acid (23)Isonicotinohydrazide (6)Isonicotinonitrile (16)Methyl 1H-Pyrazolo[3,4-B]Pyridine-5-Carboxylate (3)Methyl 1H-Pyrrolo[2,3-B]Pyridine-2-Carboxylate (3)Methyl 2-(Pyridin-2-Yl)Acetate (9)Methyl 2-Chloroisonicotinate (11)Methyl 2-Chloronicotinate (6)Methyl 3-Bromopicolinate (9)Methyl 3-Chloropicolinate (9)Methyl 5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Nicotinate (4)Methyl 5-Hydroxypicolinate (5)Methyl 6-Bromonicotinate (6)Methyl 6-Chloropicolinate (11)Methyl 6-Fluoronicotinate (4)Methyl 6-Methoxynicotinate (4)Methyl Isonicotinate (16)Methyl Nicotinate (52)Methyl Pyrazolo[1,5-A]Pyridine-3-Carboxylate (16)N,N-Dimethylpyridin-2-Amine (10)N,N-Dimethylpyridin-4-Amine (6)N-(Pyridin-2-Yl)Benzamide (9)N-Benzylpyridin-2-Amine (9)N-Methylpicolinamide (10)N-Methylpyridin-2-Amine (47)N-Methylpyridin-3-Amine (15)N-Phenyl-4-(Pyridin-3-Yl)Pyrimidin-2-Amine (5)N-Phenylpicolinamide (8)N-Phenylpyridin-2-Amine (9)Nicotinaldehyde (152)Nicotinamide (64)Nicotinic Acid (53)Nicotinonitrile (82)Oxazolo[4,5-B]Pyridine (7)Oxazolo[5,4-B]Pyridine (5)Phenyl(Pyridin-2-Yl)Methanone (10)Phenyl(Pyridin-3-Yl)Methanone (9)Picolinaldehyde (98)Picolinamide (26)Picolinic Acid (22)Picolinimidamide (11)Picolinohydrazide (5)Pyrazolo[1,5-A]Pyridine-2-Carboxylic Acid (5)Pyrazolo[1,5-A]Pyridine-3-Carboxylic Acid (13)Pyridin-2-Amine (29)Pyridin-2-Ol (170)Pyridin-2-Ylboronic Acid (9)Pyridin-2-Ylmethanamine (38)Pyridin-2-Ylmethanol (65)Pyridin-3-Amine (21)Pyridin-3-Ol (13)Pyridin-3-Ylboronic Acid (49)Pyridin-3-Ylmethanamine (29)Pyridin-3-Ylmethanol (39)Pyridin-4-Amine (22)Pyridin-4-Ol (16)Pyridin-4-Ylboronic Acid (21)Pyridin-4-Ylmethanamine (12)Pyridin-4-Ylmethanol (16)Pyridine 1-Oxide (33)Pyridine-2,3-Diamine (5)Pyridine-2,6-Diamine (12)Pyridine-2,6-Dicarboxylic Acid (9)Pyridine-2,6-Diol (6)Pyridine-2-Sulfonamide (6)Pyridine-2-Sulfonyl Chloride (9)Pyridine-2-Thiol (8)Pyridine-3-Sulfonic Acid (6)Pyridine-3-Sulfonyl Chloride (25)Pyrido[2,3-B]Pyrazine (12)Pyrido[2,3-D]Pyrimidine (8)Pyrido[3,2-D]Pyrimidine (14)Pyrido[3,4-B]Pyrazine (11)Pyrido[3,4-D]Pyrimidine (10)Tert-Butyl (2-Chloropyridin-4-Yl)Carbamate (4)Tert-Butyl 1H-Pyrazolo[3,4-B]Pyridine-1-Carboxylate (7)Tert-Butyl 4-(Pyridin-2-Yl)Piperazine-1-Carboxylate (12)Tert-Butyl Pyridin-2-Ylcarbamate (37)Tert-Butyl Pyridin-3-Ylcarbamate (16)Tert-Butyl Pyridin-4-Ylcarbamate (6)Thiazolo[4,5-B]Pyridine (12)Thiazolo[5,4-B]Pyridine (13)Thiazolo[5,4-C]Pyridine (5)Thieno[2,3-B]Pyridine (22)Thieno[2,3-C]Pyridine (14)Thieno[3,2-B]Pyridine (18)Thieno[3,2-C]Pyridine (13)
Pyrimidines (14593)
Alcohols (63)Aldehydes (11)Alkenyls (10)Alkynyls (7)Amides (120)Amidines (4)Amines (191)Aryls (79)Bromides (71)Carboxylic Acids (46)Chlorides (209)Difluoromethyls (9)Esters (63)Ethers (113)Fluorinated Building Blocks (38)Hydrazines (8)Iodides (15)Ketones (8)Nitriles (15)Nitroes (13)Sulfamides (1)Sulfides (53)Sulfones (7)Trifluoromethyls (6)Bipyrimidine (4)Dibromopyrimidine (15)Methoxypyrimidine (107)Pyrimidinone (3)Tetraoxatetradecan (10)Trichloropyrimidine (11)Azetidines (4)Indoles (7)Morpholines (4)Piperazines (25)Piperidines (4)Pyrrolidines (31)Thiophenols (4)(R)-7-(Tetrahydrofuran-2-Yl)-7H-Pyrrolo[2,3-D]Pyrimidine (8)(R)-N-(Piperidin-3-Yl)-7H-Pyrrolo[2,3-D]Pyrimidin-4-Amine (5)1,4,5,6-Tetrahydropyrimidine (4)1-(3-Fluorotetrahydrofuran-2-Yl)Pyrimidin-2(1H)-One (10)1-(5-(Hydroxymethyl)Tetrahydrofuran-2-Yl)Pyrimidine-2,4(1H,3H)-Dione (31)1-(Pyrimidin-2-Yl)Ethan-1-One (5)1-(Pyrimidin-4-Yl)Ethan-1-One (6)1-(Tetrahydrofuran-2-Yl)Pyrimidin-2(1H)-One (50)1H-Pyrazolo[3,4-D]Pyrimidin-4-Amine (5)1H-Pyrazolo[4,3-D]Pyrimidine (5)2,4,5-Trichloropyrimidine (6)2,4,6-Trichloropyrimidine (14)2,4,6-Triphenylpyrimidine (9)2,4-Dichloro-6-Methylpyrimidine (7)2,4-Dichloropyrimidin-5-Amine (6)2,4-Dimethoxypyrimidine (13)2,4-Dimethylpyrimidine (7)2-(1H-Pyrazol-1-Yl)Pyrimidine (6)2-(Chloromethyl)Pyrimidine (5)2-(Methylsulfonyl)Pyrimidine (25)2-(Methylthio)Pyrimidin-4-Amine (10)2-(Methylthio)Pyrimidine (19)2-(Piperazin-1-Yl)Pyrimidine (11)2-(Piperidin-1-Yl)Pyrimidine (16)2-(Propylthio)Pyrimidine (5)2-(Pyridin-2-Yl)Pyrimidine (8)2-(Pyrrolidin-1-Yl)Pyrimidine (8)2-(Trifluoromethyl)Pyrimidine (27)2-Aminopyrimidin-4(3H)-One (11)2-Bromopyrimidine (22)2-Chloro-4-(Trifluoromethyl)Pyrimidine (6)2-Chloro-4-Methoxypyrimidine (14)2-Chloro-4-Methylpyrimidine (16)2-Chloro-4-Phenylpyrimidine (7)2-Chloro-5-Fluoropyrimidine (6)2-Chloro-5-Methylpyrimidine (5)2-Chloro-5-Nitropyrimidine (5)2-Chloro-7H-Pyrrolo[2,3-D]Pyrimidine (13)2-Chloropyrimidin-4-Amine (22)2-Cyclopropylpyrimidine (10)2-Ethoxypyrimidine (7)2-Ethylpyrimidine (6)2-Fluoropyrimidine (9)2-Hydrazineylpyrimidine (6)2-Iodopyrimidine (8)2-Methoxypyrimidin-4-Amine (6)2-Methoxypyrimidine (59)2-Methylpyrimidin-4-Amine (22)2-Methylpyrimidin-4-Ol (11)2-Phenoxypyrimidine (8)2-Phenylpyrimidin-5-Amine (5)3-Methylpyrimidin-4(3H)-One (6)4,5-Dichloropyrimidine (7)4,6-Dichloro-2-(Methylthio)Pyrimidine (9)4,6-Dichloro-2-Methylpyrimidine (7)4,6-Dichloropyrimidin-2-Amine (9)4,6-Dichloropyrimidine (14)4,6-Diphenylpyrimidine (7)4-(Dimethoxymethyl)Pyrimidine (5)4-(Piperazin-1-Yl)Pyrimidine (13)4-(Piperidin-1-Yl)Pyrimidine (9)4-(Pyridin-3-Yl)Pyrimidine (5)4-(Pyrimidin-2-Yl)Morpholine (9)4-(Pyrimidin-4-Yl)Morpholine (13)4-(Trifluoromethyl)Pyrimidin-2-Amine (6)4-(Trifluoromethyl)Pyrimidine (12)4-Amino-1-(Tetrahydrofuran-2-Yl)Pyrimidin-2(1H)-One (22)4-Bromopyrimidine (24)4-Chloro-2-(Methylthio)Pyrimidine (29)4-Chloro-2-Methoxypyrimidine (12)4-Chloro-2-Phenylpyrimidine (5)4-Chloro-5-Fluoro-2-Methylpyrimidine (5)4-Chloro-5-Iodopyrimidine (6)4-Chloro-5-Methoxypyrimidine (7)4-Chloro-5-Methylpyrimidine (8)4-Chloro-6-Methoxypyrimidine (5)4-Chloropyrimidin-2-Amine (23)4-Chloropyrimidin-5-Amine (7)4-Chloropyrimidine-5-Carbonitrile (6)4-Ethoxypyrimidine (6)4-Fluoropyrimidine (8)4-Iodopyrimidine (9)4-Methoxy-2-Methylpyrimidine (8)4-Methoxypyrimidin-2-Amine (6)4-Methoxypyrimidine (102)4-Methyl-2-(Methylthio)Pyrimidine (7)4-Methylpyrimidin-2-Amine (9)4-Methylpyrimidine (22)4-Phenoxypyrimidine (5)4-Phenylpyrimidin-2-Amine (15)5,6,7,8-Tetrahydropyrido[3,4-D]Pyrimidine (7)5,6,7,8-Tetrahydropyrido[4,3-D]Pyrimidine (17)5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyrimidine (27)5-(Benzyloxy)Pyrimidine (5)5-Benzylpyrimidine (7)5-Bromo-1-(Tetrahydrofuran-2-Yl)Pyrimidine-2,4(1H,3H)-Dione (4)5-Bromo-2-(Methylthio)Pyrimidine (6)5-Bromo-2-Chloropyrimidine (6)5-Bromo-2-Methylpyrimidine (5)5-Bromo-4-Chloropyrimidine (4)5-Bromo-7H-Pyrrolo[2,3-D]Pyrimidine (3)5-Bromopyrimidin-4(3H)-One (3)5-Chloropyrimidin-4(3H)-One (4)5-Chloropyrimidine (8)5-Chloropyrimidine-2,4(1H,3H)-Dione (3)5-Ethylpyrimidine (5)5-Fluoro-1-(Tetrahydrofuran-2-Yl)Pyrimidin-2(1H)-One (7)5-Fluoro-1-(Tetrahydrofuran-2-Yl)Pyrimidine-2,4(1H,3H)-Dione (3)5-Fluoropyrimidin-4(3H)-One (3)5-Fluoropyrimidine (11)5-Fluoropyrimidine-2,4(1H,3H)-Dione (3)5-Iodo-7H-Pyrrolo[2,3-D]Pyrimidine (4)5-Iodopyrimidine (5)5-Methylpyrimidine (3)5-Phenylpyrimidine (16)5H-Pyrrolo[3,2-D]Pyrimidine (16)6,7-Dihydro-5H-Cyclopenta[D]Pyrimidine (5)6,7-Dihydro-5H-Pyrrolo[3,4-D]Pyrimidine (8)6-Chloro-1H-Pyrazolo[3,4-D]Pyrimidine (12)6-Chloropyrimidin-4-Amine (8)7-(Phenylsulfonyl)-7H-Pyrrolo[2,3-D]Pyrimidine (7)7H-Pyrrolo[2,3-D]Pyrimidin-2-Amine (5)7H-Pyrrolo[2,3-D]Pyrimidin-4-Amine (3)[1,2,4]Triazolo[1,5-A]Pyrimidine (14)Ethyl 4-Chloropyrimidine-5-Carboxylate (5)Ethyl Pyrazolo[1,5-A]Pyrimidine-3-Carboxylate (6)Ethyl Pyrimidine-4-Carboxylate (7)Ethyl Pyrimidine-5-Carboxylate (5)Imidazo[1,2-C]Pyrimidine (6)Methyl Pyrimidine-2-Carboxylate (10)Methyl Pyrimidine-4-Carboxylate (11)Methyl Pyrimidine-5-Carboxylate (5)N,N-Dimethylpyrimidin-2-Amine (10)N-(9-((2R,5S)-5-((Trityloxy)Methyl)Tetrahydrofuran-2-Yl)-9H-Purin-6-Yl)Benzamide (5)N-Benzyl-9H-Purin-6-Amine (6)N-Cyclopropylpyrimidin-2-Amine (5)N-Methyl-N-(4-Phenylpyrimidin-2-Yl)Methanesulfonamide (7)N-Methylpyrimidin-2-Amine (10)N-Methylpyrimidin-4-Amine (10)N-Phenyl-4-(Pyridin-3-Yl)Pyrimidin-2-Amine (5)N-Phenylpyrimidin-2-Amine (5)N-Phenylpyrimidin-4-Amine (7)N2,N4-Diphenylpyrimidine-2,4-Diamine (5)Pyrido[2,3-D]Pyrimidine (8)Pyrido[3,2-D]Pyrimidine (14)Pyrido[3,4-D]Pyrimidine (10)Pyrimidin-2-Ol (21)Pyrimidin-2-Ylmethanamine (7)Pyrimidin-2-Ylmethanol (5)Pyrimidin-4-Amine (29)Pyrimidin-4-Ol (25)Pyrimidin-5-Amine (6)Pyrimidin-5-Ol (5)Pyrimidin-5-Ylboronic Acid (9)Pyrimidine-2,4-Diamine (14)Pyrimidine-2-Carbonitrile (14)Pyrimidine-2-Carboxylic Acid (11)Pyrimidine-2-Thiol (6)Pyrimidine-4,6(1H,5H)-Dione (3)Pyrimidine-4-Carbonitrile (9)Pyrimidine-4-Carboxylic Acid (17)Pyrimidine-5-Carbaldehyde (38)Pyrimidine-5-Carbonitrile (6)Pyrimidine-5-Carboxylic Acid (7)Tetrahydropyrimidin-2(1H)-One (6)Thiazolo[5,4-D]Pyrimidine (5)Thieno[2,3-D]Pyrimidine (30)Thieno[3,2-D]Pyrimidine (24)
Pyrroles (4887)
Alcohols (2)Aldehydes (12)Amides (15)Amines (10)Aryls (30)Bromides (5)Carboxylic Acids (28)Chlorides (13)Esters (21)Fluorinated Building Blocks (8)Ketones (16)Nitriles (6)Nitroes (8)Trifluoromethyls (4)Bromopyrrolo (8)Chloropyrrolo (10)Dihydropyrrolo (15)Octahydropyrrolo (6)Pyrrolopyridine-Methylamine (6)(9H-Fluoren-9-Yl)Methyl Pyrrolidine-1-Carboxylate (26)(Z)-3-((1H-Pyrrol-2-Yl)Methylene)Indolin-2-One (8)1,3-Dihydro-2H-Pyrrolo[2,3-B]Pyridin-2-One (19)1,3-Dihydro-2H-Pyrrolo[3,2-B]Pyridin-2-One (11)1,4,5,6-Tetrahydropyrrolo[3,4-C]Pyrazole (6)1-(1H-Pyrrolo[2,3-B]Pyridin-3-Yl)Ethan-1-One (4)1-(Phenylsulfonyl)-1H-Pyrrole (24)1-(Phenylsulfonyl)-1H-Pyrrolo[2,3-B]Pyridine (30)1-Benzylpyrrolidin-2-One (18)1-Methyl-1H-Pyrrole (43)1H-Pyrrol-1-Amine (7)1H-Pyrrole-2-Carbaldehyde (21)1H-Pyrrole-2-Carbonitrile (7)1H-Pyrrole-2-Carboxylic Acid (30)1H-Pyrrole-3-Carbaldehyde (9)1H-Pyrrole-3-Carbonitrile (9)1H-Pyrrolo[2,3-B]Pyridin-6-Amine (4)1H-Pyrrolo[2,3-B]Pyridine-3-Carboxylic Acid (5)1H-Pyrrolo[2,3-C]Pyridin-7-Ol (3)2,3-Dihydro-1H-Pyrrolo[2,3-B]Pyridine (10)2,3-Dihydro-1H-Pyrrolo[3,4-C]Pyridine (6)2-Bromo-1H-Pyrrole (11)2-Methyl-1H-Pyrrole (49)2-Nitro-1H-Pyrrole (5)2-Phenyl-1H-Pyrrole (24)3,6-Di(Thiophen-2-Yl)-2,5-Dihydropyrrolo[3,4-C]Pyrrole-1,4-Dione (17)3-Bromo-1H-Pyrrole (16)3-Bromo-1H-Pyrrolo[2,3-B]Pyridine (7)3-Iodo-1H-Pyrrolo[3,2-C]Pyridine (4)3-Methyl-1H-Pyrrolo[2,3-B]Pyridine (5)3-Phenyl-1H-Pyrrole (4)4-Bromo-1H-Pyrrolo[2,3-B]Pyridine (9)4-Chloro-1H-Pyrrolo[2,3-B]Pyridine (13)4H-Thieno[3,2-B]Pyrrole (6)5-Bromo-1H-Pyrrolo[2,3-B]Pyridine (13)5-Chloro-1H-Pyrrolo[2,3-C]Pyridine (5)5-Methoxy-1H-Pyrrolo[2,3-C]Pyridine (4)5H-Pyrrolo[2,3-B]Pyrazine (14)5H-Pyrrolo[3,2-D]Pyrimidine (16)7-(Phenylsulfonyl)-7H-Pyrrolo[2,3-D]Pyrimidine (7)7-Methoxy-1H-Pyrrolo[2,3-C]Pyridine (5)Ethyl 1H-Pyrrole-2-Carboxylate (24)Ethyl 1H-Pyrrole-3-Carboxylate (8)Methyl 1H-Pyrrole-2-Carboxylate (30)Methyl 1H-Pyrrole-3-Carboxylate (5)Methyl 1H-Pyrrolo[2,3-B]Pyridine-3-Carboxylate (4)Methyl 1H-Pyrrolo[2,3-B]Pyridine-6-Carboxylate (3)Pyrrolo[2,1-F][1,2,4]Triazine (14)Tert-Butyl 1H-Pyrrole-1-Carboxylate (8)Tert-Butyl 1H-Pyrrole-2-Carboxylate (3)Pyridines (7)Thiophenes (5)
Pyrrolidines (14354)
Alcohols (82)Alkenyls (14)Alkynyls (8)Amides (307)Amines (81)Aryls (142)Bromides (25)Carboxylic Acids (26)Chlorides (49)Esters (32)Ethers (56)Fluorinated Building Blocks (38)Hydrazines (3)Ketones (23)Nitriles (11)Nitroes (12)Sulfamides (10)Sulfides (7)Sulfonates (4)Trifluoromethyls (4)Ureas (2)Acetylpyrrolidine (9)Benzylpyrrolidine (31)Bipyrrolidine (8)Bromopyrrolidine (7)Carbamoylpyrrolidine (5)Difluoropyrrolidine (16)Dimethylpyrrolidine (31)Dioxopyrrolidin (131)Ethylpyrrolidine (9)Fluoropyrrolidine (26)Formylpyrrolidine (10)Mercaptopyrrolidine (4)Methoxypyrrolidine (19)Methylenepyrrolidine (2)Methylpyrrolidine (128)Phenoxypyrrolidine (3)Pyrrolidine-Benzene-Boronic Acid/Ester (20)(3Ar,6As)-Octahydrocyclopenta[C]Pyrrole (5)(9H-Fluoren-9-Yl)Methyl Pyrrolidine-1-Carboxylate (26)(R)-3-(Pyrrolidin-2-Yl)Pyridine (9)(R)-3-Benzylpyrrolidine (6)(S)-N-(((S)-Tetrahydro-2H-Pyran-2-Yl)Methyl)Pyrrolidine-2-Carboxamide (4)(S)-N-(4-(Thiazol-5-Yl)Benzyl)Pyrrolidine-2-Carboxamide (7)(S)-N-Phenethyl-3-(Pyrrolidin-2-Yl)Propanamide (5)1-((Benzyloxy)Carbonyl)Pyrrolidine-3-Carboxylic Acid (6)1-(3-Chlorophenyl)Pyrrolidine (3)1-(Phenylsulfonyl)Pyrrolidine (15)1-(Pyrrolidin-1-Yl)Ethan-1-One (9)1-Benzyl 2-Methyl Pyrrolidine-1,2-Dicarboxylate (7)1-Benzylpyrrolidin-2-One (18)1-Benzylpyrrolidine (26)1-Methylpyrrolidin-2-One (13)1-Phenylpyrrolidin-2-One (18)2,2-Dimethylpyrrolidine (4)2,5-Dioxopyrrolidin-1-Yl ((Benzyloxy)Carbonyl)Glycinate (8)2,5-Dioxopyrrolidin-1-Yl Benzoate (8)2,8-Diazaspiro[4.5]Decan-3-One (6)2-((3-Phenylpropyl)Amino)-1-(Pyrrolidin-1-Yl)Ethan-1-One (2)2-(2-Chlorophenyl)Pyrrolidine (17)2-(2-Fluorophenyl)Pyrrolidine (16)2-(3-Fluorophenyl)Pyrrolidine (5)2-(Methoxymethyl)Pyrrolidine (6)2-(Pyrrolidin-1-Yl)Benzoic Acid (3)2-(Pyrrolidin-1-Yl)Pyridine (11)2-(Pyrrolidin-1-Yl)Pyrimidine (8)2-(Pyrrolidin-2-Yl)Acetic Acid (8)2-(Pyrrolidin-2-Yl)Pyridine (5)2-(Pyrrolidin-3-Yl)Acetic Acid (6)2-Amino-1-(Pyrrolidin-1-Yl)Ethan-1-One (5)2-Azabicyclo[2.2.1]Heptane (6)2-Methyl-1-Phenyl-1H-Pyrrole (8)2-Methylpyrrolidine (21)3,3-Difluoropyrrolidine (29)3-(Pyrrolidin-2-Yl)Pyridine (6)3-Aminopyrrolidin-2-One (5)3-Bromopyrrolidine (6)3-Hydroxypyrrolidin-2-One (4)3-Phenoxypyrrolidine (5)3-Phenyl-1-(Pyrrolidin-1-Yl)Propan-1-One (1)4-(Hydroxymethyl)Pyrrolidin-2-One (4)4-(Pyrrolidin-1-Yl)Aniline (3)4-(Pyrrolidin-1-Yl)Piperidine (6)4-Hydroxypyrrolidin-2-One (7)4H-Thieno[3,4-C]Pyrrole-4,6(5H)-Dione (7)5-(Aminomethyl)Pyrrolidin-2-One (3)5-(Hydroxymethyl)Pyrrolidin-2-One (7)5-Azaspiro[2.4]Heptane (13)5-Oxopyrrolidine-2-Carboxylic Acid (4)6-Azaspiro[3.4]Octane (4)Benzyl (S)-Pyrrolidin-3-Ylcarbamate (7)Benzyl 3-Hydroxypyrrolidine-1-Carboxylate (5)Benzyl-2-(Hydroxymethyl)Pyrrolidine-1-Carboxylate (9)Benzyl-3-Aminopyrrolidine-1-Carboxylate (7)Ethyl 5-Oxopyrrolidine-2-Carboxylate (3)Hexahydro-1H-Pyrrolizine (12)Methyl 5-Oxopyrrolidine-2-Carboxylate (3)Methyl Prolinate (43)Methyl Pyrrolidine-3-Carboxylate (9)N,N-Dimethylpyrrolidin-3-Amine (7)N-Methylpyrrolidin-3-Amine (6)Octahydrocyclopenta[C]Pyrrole (6)Phenyl(Pyrrolidin-1-Yl)Methanone (12)Proline (13)Pyrrolidin-2-Ylmethanamine (12)Pyrrolidin-2-Ylmethanol (26)Pyrrolidin-3-Ol (59)Pyrrolidin-3-Ylmethanamine (6)Pyrrolidin-3-Ylmethanol (13)Pyrrolidine-2-Carbonitrile (9)Pyrrolidine-2-Carboxamide (12)Pyrrolidine-3-Carbonitrile (6)Pyrrolidine-3-Carboxylic Acid (14)Tert-Butyl (2-Oxopyrrolidin-3-Yl)Carbamate (3)Tert-Butyl (5-Oxopyrrolidin-3-Yl)Carbamate (3)Tert-Butyl 2-Oxopyrrolidine-1-Carboxylate (15)Tert-Butyl 3-((Methylsulfonyl)Oxy)Pyrrolidine-1-Carboxylate (5)Tert-Butyl 3-Hydroxypyrrolidine-1-Carboxylate (20)Tert-Butyl 3-Methoxypyrrolidine-1-Carboxylate (6)Tert-Butyl Pyrrolidin-3-Ylcarbamate (12)Tert-Butyl Pyrrolidine-1-Carboxylate (21)Azetidines (12)Imidazoles (2)Oxetanes (4)Piperidines (36)Pyridines (2)Pyrimidines (31)Spiroes (86)Tetrahydropyrans (6)
Pyrrolines (1759)
Amides (24)Aryls (14)Bromides (6)Esters (2)1,3-Dihydro-2H-Pyrrolo[2,3-C]Pyridin-2-One (5)1-Phenyl-1H-Pyrrole-2,5-Dione (12)2,3-Dihydro-1H-Pyrrolo[2,3-C]Pyridine (5)2,3-Dihydro-1H-Pyrrolo[3,2-C]Pyridine (7)2,5-Dihydro-1H-Pyrrol-2-One (5)2,5-Dihydro-1H-Pyrrole (13)2-Phenyl-2,5,6,7-Tetrahydropyrrolo[2,1-C][1,2,4]Triazol-4-Ium (6)3,4-Dihydro-2H-Pyrrole (5)3-Bromo-1H-Pyrrole-2,5-Dione (3)5,6-Dihydro-4H-Pyrrolo[1,2-B]Pyrazole (8)6,7-Dihydro-5H-Pyrrolo[1,2-A]Imidazole (9)6,7-Dihydro-5H-Pyrrolo[3,4-B]Pyridine (5)6,7-Dihydro-5H-Pyrrolo[3,4-D]Pyrimidine (8)
Quinazolines (3145)
Alcohols (12)Amides (42)Amines (9)Aryls (7)Bromides (13)Carboxylic Acids (4)Chlorides (20)Esters (5)Ethers (17)Fluorinated Building Blocks (5)Nitroes (4)Dichloroquinazoline (14)Iodoquinazoline (10)Methylquinazoline (46)Nitroquinazoline (20)Trichloroquinazoline (5)2,4-Dichloroquinazoline (19)2-(Trifluoromethyl)Quinazoline (4)2-Bromoquinazoline (4)2-Chloroquinazolin-4(3H)-One (4)2-Cyclopropylquinazoline (5)2-Mercaptoquinazolin-4(3H)-One (3)2-Methylquinazoline (20)4-Chloroquinazoline (39)4-Methylquinazoline (4)5,6,7,8-Tetrahydroquinazoline (8)5-Chloroquinazoline (4)6-Bromoquinazoline (7)7-Bromoquinazolin-4(3H)-One (4)7-Fluoroquinazolin-4(3H)-One (4)7-Methoxy-N-Phenylquinazolin-4-Amine (12)8-Bromoquinazoline (8)8-Chloroquinazoline (5)8-Fluoroquinazoline (4)8-Methoxyquinazoline (3)8-Methylquinazoline (3)Ethyl Quinazoline-2-Carboxylate (4)N-(3-Chlorophenyl)Quinazolin-4-Amine (10)Quinazolin-2-Amine (13)Quinazolin-2-Ol (7)Quinazolin-4-Amine (8)Quinazolin-4-Ol (10)
Quinolines (11915)
Alcohols (79)Aldehydes (23)Alkenyls (10)Amides (33)Amines (79)Aryls (24)Bromides (106)Carboxylic Acids (90)Chlorides (110)Esters (74)Ethers (82)Fluorinated Building Blocks (50)Hydrazines (4)Iodides (12)Ketones (50)Nitriles (19)Nitroes (19)Sulfonyl Chlorides (6)Trifluoromethyls (7)Iodoquinoline (32)Furans (3)Quinuclidines (8)1,2-Dihydroquinoline (5)1-Cyclopropyl-3-(4-(Quinolin-4-Yloxy)Phenyl)Urea (6)2,2'-Biquinoline (3)2,3,6,7-Tetrahydro-1H,5H-Pyrido[3,2,1-Ij]Quinoline (7)2-(Quinolin-2-Yl)-4,5-Dihydrooxazole (7)2-Hydroxyquinolin-4(1H)-One (3)2-Phenylquinoline (19)3,4-Dihydroisoquinoline (11)4-Oxo-1,4-Dihydroquinoline-3-Carboxylic Acid (3)4-Phenoxyquinoline (5)4-Phenylquinoline (9)6-Bromo-3,4-Dihydroquinolin-2(1H)-One (4)7,8-Dihydroquinolin-5(6H)-One (5)7-(Benzyloxy)Quinoline (6)7-Methoxy-3,4-Dihydroquinolin-2(1H)-One (3)N-Phenyl-N-(4-(Quinolin-4-Yloxy)Phenyl)Cyclopropane-1,1-Dicarboxamide (5)N-Phenylquinolin-4-Amine (11)
Quinoxalines (1405)
Alcohols (6)Amides (15)Amines (7)Bromides (9)Carboxylic Acids (5)Chlorides (9)Fluorinated Building Blocks (5)Nitroes (7)Dichloroquinoxaline (8)Dihydroquinoxalin (7)1,2,3,4-Tetrahydroquinoxaline (6)2-Chloroquinoxaline (39)2-Methylquinoxaline (5)2-Phenylquinoxaline (5)3,4-Dihydroquinoxalin-2(1H)-One (7)5-Bromoquinoxaline (6)6-Bromoquinoxaline (9)6-Chloroquinoxaline (3)6-Methoxyquinoxaline (6)Quinoxalin-2-Amine (3)Quinoxalin-2-Ol (4)
Quinuclidines (202)
Alcohols (5)Alkenyls (6)Amines (5)Aryls (2)Esters (3)Ethers (2)Quinolines (8)
Spiroes (4761)
Alcohols (15)Aliphatic Cyclic Hydrocarbons (19)Alkenyls (4)Amides (190)Amines (14)Aryls (36)Bromides (11)Carboxylic Acids (20)Chlorides (4)Esters (19)Fluorinated Building Blocks (9)Ketones (47)Nitriles (2)Aminospiro (4)Azaspiro (246)Bromospiro (11)Diazaspiro (182)Dihydrospiro (18)Dioxaspiro (39)Fluorospiro (4)Oxospiro (22)Triazaspiro (13)1,3-Dihydrospiro[Indene-2,4'-Piperidine] (5)1,4-Dioxaspiro[4.5]Decane (17)2,8-Diazaspiro[4.5]Decane (5)2-Oxa-8-Azaspiro[4.5]Decane (5)3-Phenyloxetane (11)6-Azaspiro[3.4]Octane (4)7-Azaspiro[3.5]Nonane (7)9,9'-Spirobi[Fluorene] (19)Spiro[Cyclopropane-1,3'-Indolin]-2'-One (6)Spiro[Indene-2,4'-Piperidin]-1(3H)-One (5)Spiro[Indoline-3,4'-Piperidine] (5)Azetidines (85)Benzofurans (6)Dioxolanes (23)Epoxides (5)Imidazolidines (4)Imidazolines (4)Indolines (5)Morpholines (33)Oxazolidines (6)Oxetanes (26)Piperazines (14)Piperidines (139)Pyrrolidines (86)Tetrahydrofurans (18)Tetrahydropyrans (24)Other Aliphatic Heterocycles (14)Other Aromatic Heterocycles (12)
Tetrahydrofurans (2277)
Alcohols (11)Amides (19)Amines (8)Anhydrides (3)Aryls (12)Bromides (4)Carboxylic Acids (7)Chlorides (3)Esters (22)Ethers (1)Ketones (6)Hydroxytetrahydrofuran (16)Iodotetrahydrofuran (3)Methoxytetrahydrofuran (11)Oxotetrahydrofuran (26)(2R,3S)-2-((Benzoyloxy)Methyl)Tetrahydrofuran-3-Yl Benzoate (8)(3Ar,6Ar)-Hexahydrofuro[3,2-B]Furan (5)(3As,6As)-Tetrahydrofuro[3,4-D][1,3]Dioxole (6)(R)-7-(Tetrahydrofuran-2-Yl)-7H-Pyrrolo[2,3-D]Pyrimidine (8)(R)-N-(9-(Tetrahydrofuran-2-Yl)-9H-Purin-6-Yl)Benzamide (5)(Tetrahydrofuran-2-Yl)Methanamine (4)(Tetrahydrofuran-2-Yl)Methanol (6)(Tetrahydrofuran-3-Yl)Methanamine (3)1,3-Dihydrobenzo[C][1,2]Oxaborole (20)1-(3-Fluorotetrahydrofuran-2-Yl)Pyrimidin-2(1H)-One (10)1-(5-(Hydroxymethyl)Tetrahydrofuran-2-Yl)Pyrimidine-2,4(1H,3H)-Dione (31)1-(Tetrahydrofuran-2-Yl)Pyrimidin-2(1H)-One (50)1-Oxa-8-Azaspiro[4.5]Decane (5)2-(Acetoxymethyl)-5-(9H-Purin-9-Yl)Tetrahydrofuran-3,4-Diyl Diacetate (6)2-(Hydroxymethyl)-5-(9H-Purin-9-Yl)Tetrahydrofuran-3,4-Diol (28)2-Oxa-8-Azaspiro[4.5]Decane (5)2-Oxabicyclo[2.1.1]Hexane (6)3-Aminodihydrofuran-2(3H)-One (4)3-Iodotetrahydrofuran (3)4-Amino-1-(Tetrahydrofuran-2-Yl)Pyrimidin-2(1H)-One (22)4-Fluoro-2-(Hydroxymethyl)-5-(9H-Purin-9-Yl)Tetrahydrofuran-3-Ol (4)4-Hydroxydihydrofuran-2(3H)-One (14)5-(Hydroxymethyl)Dihydrofuran-2(3H)-One (7)5-Bromo-1-(Tetrahydrofuran-2-Yl)Pyrimidine-2,4(1H,3H)-Dione (4)5-Fluoro-1-(Tetrahydrofuran-2-Yl)Pyrimidin-2(1H)-One (7)5-Fluoro-1-(Tetrahydrofuran-2-Yl)Pyrimidine-2,4(1H,3H)-Dione (3)5-Oxotetrahydrofuran-2-Carboxylic Acid (4)9-(Tetrahydrofuran-2-Yl)-9H-Purin-6-Amine (30)9-(Tetrahydrofuran-2-Yl)-9H-Purin-6-Ol (6)9-(Tetrahydrofuran-2-Yl)-9H-Purine (2)Dihydrofuran-3(2H)-One (8)Tert-Butyl (Tetrahydrofuran-3-Yl)Carbamate (4)Tetrahydrofuran-2-Carboxylic Acid (4)Tetrahydrofuran-3-Amine (6)Tetrahydrofuran-3-Carboxylic Acid (4)Tetrahydrofuran-3-Ol (6)Piperidines (9)Spiroes (18)
Tetrahydroisoquinolines (1289)
Amides (7)Amines (3)Aryls (3)Chlorides (4)Tetrahydroisoquinoline-Carboxylic Acid (48)(9H-Fluoren-9-Yl)Methyl 3,4-Dihydroisoquinoline-2(1H)-Carboxylate (7)1,2,3,4-Tetrahydroisoquinolin-5-Amine (4)1,2,3,4-Tetrahydroisoquinolin-5-Ol (3)1,2,3,4-Tetrahydroisoquinolin-6-Amine (3)1,2,3,4-Tetrahydroisoquinolin-6-Ol (6)1,2,3,4-Tetrahydroisoquinolin-7-Amine (3)1,2,3,4-Tetrahydroisoquinoline-1-Carboxylic Acid (19)1,2,3,4-Tetrahydroisoquinoline-3-Carboxylic Acid (12)1,4-Dihydroisoquinolin-3(2H)-One (5)1-Methyl-1,2,3,4-Tetrahydroisoquinoline (4)2-Methyl-1,2,3,4-Tetrahydroisoquinoline (13)4,4-Dimethyl-1,2,3,4-Tetrahydroisoquinoline (3)5,6,7,8-Tetrahydroisoquinoline (5)5-Bromo-1,2,3,4-Tetrahydroisoquinoline (4)5-Chloro-1,2,3,4-Tetrahydroisoquinoline (3)5-Fluoro-1,2,3,4-Tetrahydroisoquinoline (3)5-Methyl-1,2,3,4-Tetrahydroisoquinoline (4)6-Bromo-1,2,3,4-Tetrahydroisoquinoline (4)6-Chloro-1,2,3,4-Tetrahydroisoquinoline (3)6-Fluoro-1,2,3,4-Tetrahydroisoquinoline (3)6-Methoxy-1,2,3,4-Tetrahydroisoquinoline (3)6-Nitro-1,2,3,4-Tetrahydroisoquinoline (3)7-Bromo-1,2,3,4-Tetrahydroisoquinoline (4)7-Chloro-1,2,3,4-Tetrahydroisoquinoline (5)7-Fluoro-1,2,3,4-Tetrahydroisoquinoline (3)7-Methoxy-1,2,3,4-Tetrahydroisoquinoline (6)7-Nitro-1,2,3,4-Tetrahydroisoquinoline (3)Isoquinoline-1,3(2H,4H)-Dione (7)
Tetrahydropyrans (3363)
Alcohols (36)Aldehydes (6)Alkenyls (7)Amides (15)Amines (3)Aryls (28)Bromides (6)Carboxylic Acids (12)Chlorides (5)Esters (25)Ethers (24)Fluorinated Building Blocks (8)Hydrazines (4)Iodides (4)Ketones (7)Nitriles (9)Sulfides (3)Difluorochroman (16)(1S,4Ar,7Ar)-1-(((S)-Tetrahydro-2H-Pyran-2-Yl)Oxy)-1,4A,5,7A-Tetrahydrocyclopenta[C]Pyran (4)(6-Phenoxytetrahydro-2H-Pyran-2-Yl)Methanol (18)(R)-2-Phenoxytetrahydro-2H-Pyran (7)(S)-2-(Phenylthio)Tetrahydro-2H-Pyran (5)(S)-7-(((S)-Tetrahydro-2H-Pyran-2-Yl)Oxy)-7,8,9,10-Tetrahydrotetracene-5,12-Dione (5)(S)-N-(((S)-Tetrahydro-2H-Pyran-2-Yl)Methyl)Pyrrolidine-2-Carboxamide (4)1-(Tetrahydro-2H-Pyran-4-Yl)-1H-Pyrazole (6)2-(Phenoxymethyl)Tetrahydro-2H-Pyran (5)2-Phenoxytetrahydro-2H-Pyran (6)2-Phenoxytetrahydro-2H-Pyran-4-Yl Acetate (6)4-Phenoxytetrahydro-2H-Pyran (5)9-Bromoanthracene (5)Azetidines (6)Piperidines (5)Pyrazoles (4)Pyrrolidines (6)Spiroes (24)
Tetrahydroquinolines (1465)
Amides (14)Amines (5)Bromides (6)Fluorinated Building Blocks (6)Tetrahydroquinoline-Carboxylic Acid (18)1-Ethyl-1,2,3,4-Tetrahydroquinoline (6)1-Methyl-1,2,3,4-Tetrahydroquinoline (6)2,3-Dihydroquinolin-4(1H)-One (19)2-Methyl-1,2,3,4-Tetrahydroquinoline (3)4,4-Dimethyl-1,2,3,4-Tetrahydroquinoline (3)4-Methyl-1,2,3,4-Tetrahydroquinoline (2)5,6,7,8-Tetrahydroquinoline (17)6-Bromo-1,2,3,4-Tetrahydroquinoline (6)6-Chloro-1,2,3,4-Tetrahydroquinoline (3)6-Fluoro-1,2,3,4-Tetrahydroquinoline (3)7-Fluoro-1,2,3,4-Tetrahydroquinoline (3)Tert-Butyl 3,4-Dihydroquinoline-1(2H)-Carboxylate (11)
Tetrazoles (136)
Aryls (5)Esters (5)1-Phenyl-1H-Tetrazole (6)5-Phenyl-1H-Tetrazole (23)5-Phenyl-2H-Tetrazole (9)
Thiadiazoles (2120)
Amides (11)Amines (24)Aryls (17)Chlorides (4)Esters (4)Ethers (7)Sulfamides (4)Sulfides (7)1,2,3-Thiadiazole (8)1,2,4-Thiadiazole (16)1,2,5-Thiadiazole (6)1,3,4-Thiadiazol-2-Amine (9)2-Bromo-1,3,4-Thiadiazole (11)2-Methyl-1,3,4-Thiadiazole (12)2-Phenyl-1,3,4-Thiadiazole (19)4,7-Diphenylbenzo[C][1,2,5]Thiadiazole (6)4-Bromobenzo[C][1,2,5]Thiadiazole (14)Benzo[D][1,2,3]Thiadiazole (7)Pyridines (7)Thiophenols (6)
Thiazines (61)
Thiazoles (6687)
Alcohols (32)Aldehydes (15)Amides (40)Amines (102)Aryls (97)Bromides (70)Carboxylic Acids (62)Chlorides (29)Esters (70)Ethers (16)Fluorinated Building Blocks (9)Iodides (4)Ketones (19)Nitriles (7)Nitroes (8)Sulfides (8)Acetylthiazole (7)Bromothiazolo (9)Chlorothiazole (32)Chlorothiazolo (18)Cyanothiazole (7)Cyclopropylthiazole (11)Dibromothiazole (7)Dichlorothiazole (8)Dihydrothiazole (16)Dihydrothiazolo (14)Dimethylthiazole (22)Ethylthiazole (8)Formylthiazole (7)Methylthiazole (109)Nitrothiazol (8)Tetrahydrothiazolo (8)1-(Thiazol-2-Yl)Ethan-1-One (9)2,4-Dibromothiazole (5)2,4-Dichlorothiazole (4)2,4-Dimethylthiazole (7)2,5-Dibromothiazole (5)2,5-Dimethylthiazole (4)2-(Chloromethyl)Thiazole (5)2-(Methylthio)Thiazole (5)2-(Thiazol-4-Yl)Acetic Acid (9)2-(Trifluoromethyl)Thiazole (11)2-Bromo-4-Methylthiazole (7)2-Bromo-5-Methylthiazole (7)2-Chloro-4-Methylthiazole (5)2-Chloro-5-Methylthiazole (5)2-Chlorothiazole (32)2-Imino-N-((6R,7R)-8-Oxo-5-Thia-1-Azabicyclo[4.2.0]Oct-2-En-7-Yl)-2-(Thiazol-4-Yl)Acetamide (3)2-Isopropylthiazole (11)2-Methyl-4-Phenylthiazole (6)2-Phenoxythiazole (5)2-Phenylbenzo[D]Thiazole (16)2-Phenylthiazole-4-Carbaldehyde (9)4,5,6,7-Tetrahydrobenzo[D]Thiazole (14)4,5,6,7-Tetrahydrothiazolo[5,4-C]Pyridine (10)4,5-Dihydrothiazole (8)4-(4-Fluorophenyl)Thiazole (9)4-(Trifluoromethyl)Thiazole (7)4-Bromothiazole (10)4-Cyclopropylthiazole (6)4-Methyl-2-Phenylthiazole (6)4-Methylthiazol-2-Amine (7)4-Methylthiazole (5)4-Phenylthiazol-2-Amine (37)5,6-Dihydrobenzo[D]Thiazol-7(4H)-One (5)5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Thiazole (7)5-Bromothiazol-2-Amine (6)5-Bromothiazole (8)5-Methyl-4-Phenylthiazole (5)5-Methylthiazol-2-Amine (6)5-Phenylthiazole (20)Ethyl 2-Aminothiazole-4-Carboxylate (6)Ethyl 2-Aminothiazole-5-Carboxylate (5)Ethyl 2-Phenylthiazole-4-Carboxylate (12)Ethyl 2-Phenylthiazole-5-Carboxylate (9)Ethyl Thiazole-2-Carboxylate (7)Ethyl Thiazole-4-Carboxylate (7)Ethyl Thiazole-5-Carboxylate (7)Methyl 2-Aminothiazole-4-Carboxylate (6)Methyl Thiazole-2-Carboxylate (6)Methyl Thiazole-4-Carboxylate (6)N-(Thiazol-2-Yl)Acetamide (9)N-(Thiazol-2-Yl)Benzamide (9)N-Phenylthiazol-2-Amine (9)Tert-Butyl Thiazol-2-Ylcarbamate (22)Thiazol-2-Ylmethanamine (5)Thiazol-2-Ylmethanol (9)Thiazol-5-Amine (6)Thiazole-2-Carbaldehyde (9)Thiazole-2-Carboxylic Acid (9)Thiazole-4-Carboxylic Acid (5)Thiazole-5-Carbaldehyde (19)Thiazole-5-Carbonitrile (7)Thiazole-5-Carboxylic Acid (10)Thiazolo[4,5-B]Pyridine (12)Thiazolo[5,4-B]Pyridine (13)Thiazolo[5,4-C]Pyridine (5)Thiazolo[5,4-D]Pyrimidine (5)Morpholines (5)Thiophenols (4)
Thiazolidines (1284)
Amides (16)Aryls (8)Carboxylic Acids (10)Thioesters (8)Thioxothiazolidin (21)(E)-5-Benzylidenethiazolidine-2,4-Dione (6)1,2,3-Oxathiazolidine 2,2-Dioxide (14)2-Thioxothiazolidin-4-One (6)Thiazolidine (19)
Thiomorpholines (442)
Sulfones (8)Thiomorpholine (10)Thiomorpholine 1,1-Dioxide (6)
Thiophenes (1233)
Acetylthiophene (5)Aminothiophene (23)Bromothieno (29)Chlorothieno (41)Chlorothiophene (61)Cyanothiophene (5)Dibromothieno (5)Dibromothiophene (17)Dichlorothieno (10)Dichlorothiophene (13)Dihydrothieno (24)Dihydrothiophene (1)Dihydroxythiophene (7)Dimethylthieno (10)Dimethylthiophene (21)Dithiophene (40)Fluorothiophene (18)Formylthiophene (16)Hydroxythiophene (7)Iodothieno (6)Iodothiophene (13)Methylthieno (27)Nitrothiophene (27)Terthiophene (10)Tetrahydrothieno (17)Thiophenecarboxaldehyde (10)Thiphen-Amine-Hydrochloride (53)Trithiophene (5)(9H-Fluoren-9-Yl)Methyl (2-(Thiophen-2-Yl)Ethyl)Carbamate (5)1-(Thiophen-2-Yl)Ethan-1-One (17)2,2'-Bithiophene (25)2,2':5',2''-Terthiophene (9)2,3-Dihydrothieno[3,4-B][1,4]Dioxine (9)2,5-Dibromothiophene (18)2,5-Diphenylthiophene (5)2-(Thiophen-2-Yl)Pyridine (5)2-(Trifluoromethyl)Thiophene (10)2-Chlorothiophene (20)2-Ethynylthiophene (8)2-Iodothiophene (14)2-Methoxythiophene (7)2-Nitrothiophene (20)3-Bromothiophene (6)3-Chlorothiophene (17)3-Fluorothiophene (6)3-Methoxythiophene (9)3-Methylthiophene (14)3-Nitrothiophene (6)3-Phenylthiophene (13)4,4,5,5-Tetramethyl-2-(Thiophen-2-Yl)-1,3,2-Dioxaborolane (23)4,4,5,5-Tetramethyl-2-(Thiophen-3-Yl)-1,3,2-Dioxaborolane (10)4,5,6,7-Tetrahydrothieno[2,3-C]Pyridine (10)4,5,6,7-Tetrahydrothieno[3,2-C]Pyridine (9)4,7-Di(Thiophen-2-Yl)Benzo[C][1,2,5]Thiadiazole (9)4,8-Di(Thiophen-2-Yl)Benzo[1,2-B:4,5-B']Dithiophene (8)4-Phenyl-6H-Thieno[3,2-F][1,2,4]Triazolo[4,3-A][1,4]Diazepine (5)4H-Cyclopenta[2,1-B:3,4-B']Dithiophene (9)4H-Thieno[3,2-B]Pyrrole (6)4H-Thieno[3,4-C]Pyrrole-4,6(5H)-Dione (7)5,6-Dihydro-4H-Cyclopenta[B]Thiophene (7)5-(Thiophen-2-Yl)Isoxazole (5)5-Benzyl-4,5,6,7-Tetrahydrothieno[3,2-C]Pyridine (7)5-Phenylthiophen-2-Amine (5)Benzo[1,2-B:4,5-B']Dithiophene (7)Dibenzo[B,D]Thiophene (22)Dihydrothiophen-3(2H)-One (4)Dithieno[3,2-B:2',3'-D]Thiophene (5)Ethyl Thiophene-2-Carboxylate (19)Ethyl Thiophene-3-Carboxylate (11)Methyl Thiophene-3-Carboxylate (34)N,N-Diphenyl-4-(Thiophen-2-Yl)Aniline (5)Phenyl(Thiophen-2-Yl)Methanone (6)Thieno[2,3-B]Pyridine (22)Thieno[2,3-C]Pyridine (14)Thieno[2,3-D]Pyrimidine (30)Thieno[3,2-B]Pyridine (18)Thieno[3,2-B]Thiophene (19)Thieno[3,2-C]Pyridine (13)Thieno[3,2-D]Pyrimidine (24)Thieno[3,4-B]Thiophene (5)Thiophen-2-Ylboronic Acid (20)Thiophen-2-Ylmethanol (11)Thiophen-3-Amine (18)Thiophen-3-Ol (6)Thiophene-2-Carbaldehyde (43)Thiophene-2-Carbonitrile (23)Thiophene-3-Carbaldehyde (17)Thiophene-3-Carbonitrile (13)Thiophene-3-Carboxamide (5)Thiophene-3-Carboxylic Acid (8)
Triazines (1388)
Amides (11)Amines (14)Aryls (12)Chlorides (13)1,2,4-Triazine (10)1,3,5-Triazin-2-Amine (3)2,4,6-Triphenoxy-1,3,5-Triazine (4)2,4,6-Triphenyl-1,3,5-Triazine (24)2,4-Diphenyl-1,3,5-Triazine (6)2-Chloro-1,3,5-Triazine (10)2-Methoxy-1,3,5-Triazine (10)2-Phenyl-1,3,5-Triazine (6)N2,N4,N6-Triphenyl-1,3,5-Triazine-2,4,6-Triamine (4)Pyrrolo[2,1-F][1,2,4]Triazine (14)
Triazoles (7725)
Amides (8)Amines (21)Aryls (24)Carboxylic Acids (10)Esters (9)Ethers (5)Hydrazines (3)Sulfides (3)(5As,10Br)-2-Phenyl-2,5A,6,10B-Tetrahydro-4H-Indeno[2,1-B][1,2,4]Triazolo[4,3-D][1,4]Oxazin-11-Ium (6)1-(Phenylsulfonyl)-1H-1,2,4-Triazole (6)1-Benzyl-1H-1,2,3-Triazole (8)1-Benzyl-1H-1,2,4-Triazole (6)1-Methyl-1H-1,2,3-Triazole (9)1-Methyl-1H-1,2,4-Triazole (17)1-Methyl-1H-Benzo[D][1,2,3]Triazole (10)1-Phenyl-1H-1,2,3-Triazole (7)1-Phenyl-1H-1,2,4-Triazole (20)1H-1,2,4-Triazol-3-Amine (7)1H-1,2,4-Triazol-5-Amine (6)2-Bromo-[1,2,4]Triazolo[1,5-A]Pyridine (6)2-Phenyl-2,5,6,7-Tetrahydropyrrolo[2,1-C][1,2,4]Triazol-4-Ium (6)2-Phenyl-2H-1,2,3-Triazole (7)2-Phenyl-2H-Benzo[D][1,2,3]Triazole (8)2H-1,2,3-Triazole (7)4-(4-Cyclopropylnaphthalen-1-Yl)-4H-1,2,4-Triazole (7)4-Phenyl-4H-1,2,4-Triazole (6)4-Phenyl-6H-Thieno[3,2-F][1,2,4]Triazolo[4,3-A][1,4]Diazepine (5)4H-1,2,4-Triazole (13)5-Bromo-1H-1,2,4-Triazole (6)5-Bromo-1H-Benzo[D][1,2,3]Triazole (5)5-Fluoro-1H-Benzo[D][1,2,3]Triazole (4)6-Bromo-[1,2,4]Triazolo[1,5-A]Pyridine (12)6-Bromo-[1,2,4]Triazolo[4,3-A]Pyridine (8)8-Bromo-[1,2,4]Triazolo[1,5-A]Pyridine (6)[1,2,4]Triazolo[1,5-A]Pyrazine (9)[1,2,4]Triazolo[1,5-A]Pyridin-2-Amine (17)[1,2,4]Triazolo[4,3-A]Pyridin-3-Ylmethanamine (5)Ethyl 1H-1,2,4-Triazole-3-Carboxylate (3)Pyridines (13)Thiophenols (8)
Other Aliphatic Heterocycles (6214)
Alcohols (39)Alkenyls (19)Amides (103)Amines (17)Anhydrides (10)Aryls (55)Carboxylic Acids (12)Chlorides (3)Esters (69)Ethers (5)Fluorinated Building Blocks (5)Ketones (59)Sulfamides (11)Sulfides (8)Sulfones (9)1,3-Dioxane (20)1,4-Diazepane (12)3-Azabicyclo[3.1.0]Hexane (14)Epoxides (11)Spiroes (14)
Other Aromatic Heterocycles (37790)
Alcohols (110)Aldehydes (40)Alkenyls (5)Amides (181)Amines (134)Anhydrides (33)Aryls (110)Bromides (92)Carboxylic Acids (65)Chlorides (149)Esters (146)Ethers (48)Fluorinated Building Blocks (47)Iodides (28)Ketones (131)Nitriles (31)Nitroes (22)Sulfamides (17)Sulfides (8)Sulfones (5)Trifluoromethyls (19)Indolizine (15)Phenazine (8)Piperidines (14)Pyridines (2)Spiroes (12)
NHCs
Achiral NHCs Catalysts (35)
Achiral NHCs Ligands (110)
Chiral NHCs Catalysts (138)
Chiral NHCs Ligands (84)
Organic Building Blocks
Acyl Chlorides (3027)
Aliphatic Chain Hydrocarbons (24)Aliphatic Cyclic Hydrocarbons (10)Alkenyls (7)Amides (13)Aryls (28)Bromides (5)Chlorides (88)Esters (22)Pyridines (13)2-Chlorobenzoyl Chloride (13)2-Phenoxyacetyl Chloride (3)2-Phenylacetyl Chloride (9)
Alcohols (45612)
Aldehydes (19)Aliphatic Chain Hydrocarbons (404)Aliphatic Cyclic Hydrocarbons (117)Alkenyls (101)Alkynyls (34)Amides (371)Amines (287)Aryls (633)Azetidines (18)Benzimidazoles (11)Benzodioxans (9)Benzofurans (18)Benzothiazoles (6)Bromides (147)Carboxylic Acid Salts (22)Carboxylic Acids (171)Chlorides (157)Difluoromethyls (10)Dioxolanes (4)Esters (239)Ethers (224)Fluorinated Building Blocks (169)Furans (8)Hydrazides (5)Hydrazines (5)Imidazoles (27)Indazoles (17)Indoles (26)Indolines (13)Iodides (16)Isoquinolines (4)Isoxazoles (8)Ketones (64)Morpholines (26)Nitriles (45)Nitroes (42)Oxazoles (9)Oxazolidines (6)Oxetanes (24)Phenols (15)Piperazines (26)Piperidines (132)Pyrazines (6)Pyrazoles (42)Pyridazines (8)Pyridines (160)Pyrimidines (63)Pyrroles (2)Pyrrolidines (82)Quinazolines (12)Quinolines (79)Quinoxalines (6)Quinuclidines (5)Spiroes (15)Sulfamides (28)Sulfides (26)Sulfones (7)Tetrahydrofurans (11)Tetrahydropyrans (36)Thiazoles (32)Thiols (5)Thiophenes (23)Trifluoromethyls (71)Ureas (5)Other Aliphatic Heterocycles (39)Other Aromatic Heterocycles (110)Amino-Propanol (6)Cyclopropylethanol (6)Diethanol (23)Diethanol (23)Dihydroxybenzylidene (4)Dihydroxynaphthalene (7)Dihydroxypropanoate (7)Dihydroxyterephthalic Acid (3)Hydroxyacetamide (1)Hydroxyacetimidamide (3)Hydroxyadamantan (4)Hydroxyadamantan (4)Hydroxyazetidine (7)Hydroxybenzyl (17)Hydroxybenzylidene (5)Hydroxybicyclo (7)Hydroxybutan (4)Hydroxybutan (4)Hydroxybutanoate (36)Hydroxybutanoic (33)Hydroxycarbamimidoyl (2)Hydroxycinnamic Acid (2)Hydroxycyclobutyl (3)Hydroxycyclohexyl (7)Hydroxycyclopentyl (1)Hydroxydiphenylmethyl (2)Hydroxyethoxy (22)Hydroxyethoxy (22)Hydroxyhexanoate (8)Hydroxyhexanoic (6)Hydroxyimino (11)Hydroxyisonicotinaldehyde (7)Hydroxyisonicotinate (5)Hydroxyisonicotinic (5)Hydroxyisonicotinic (5)Hydroxyisonicotinic Acid (4)Hydroxymethyl-Phenyl-Boronic-Acid (32)Hydroxynaphthalene (27)Hydroxynicotinaldehyde (7)Hydroxynicotinate (13)Hydroxynicotinonitrile (6)Hydroxyoctadec (1)Hydroxyoctadec (1)Hydroxyoctadecanoic (7)Hydroxypentanoate (6)Hydroxypropanoic (35)Pentahydroxyhexanal (9)Phenyl-Methanol (1)Propanediol (9)Propanediol (9)Tetrahydroxy (25)Tetrahydroxy (25)Tetrahydroxyhexanal (9)Tetrahydroxypentanal (5)Trihydroxy (246)Trihydroxy (246)(1-Methyl-1H-Pyrazol-3-Yl)Methanol (7)(1-Phenylcyclopropyl)Methanol (3)(1H-Benzo[D]Imidazol-2-Yl)Methanol (14)(1H-Indol-2-Yl)Methanol (8)(2-(Trifluoromethyl)Phenyl)Methanol (10)(2-Bromo-6-Fluorophenyl)Methanol (4)(2-Bromophenyl)Methanol (39)(2-Chlorophenyl)Methanol (40)(2-Fluorophenyl)Methanol (60)(2-Iodophenyl)Methanol (12)(2-Nitrophenyl)Methanol (29)(3-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Phenyl)Methanol (7)(3-(Trifluoromethoxy)Phenyl)Methanol (4)(3-(Trifluoromethyl)Phenyl)Methanol (22)(3-Chlorophenyl)Methanol (38)(3-Fluorophenyl)Methanol (58)(3-Iodophenyl)Methanol (13)(3-Methylpyridin-2-Yl)Methanol (10)(3-Nitrophenyl)Methanol (31)(3-Phenoxyphenyl)Methanol (3)(3-Phenylisoxazol-5-Yl)Methanol (7)(4-Fluorophenyl)Methanol (29)(4-Nitrophenyl)Methanol (17)(6-Methylpyridin-2-Yl)Methanol (5)(Tetrahydrofuran-2-Yl)Methanol (6)1,2-Diphenylethan-1-Ol (8)1-Phenyl-1H-Pyrazol-3-Ol (3)1-Phenylethan-1-Ol (103)2,2,2-Trifluoro-1-Phenylethan-1-Ol (27)2-(1H-Indol-3-Yl)Ethan-1-Ol (10)2-(2-Chlorophenyl)Ethan-1-Ol (8)2-(Piperazin-1-Yl)Ethan-1-Ol (10)2-(Piperidin-1-Yl)Ethan-1-Ol (10)2-(Piperidin-2-Yl)Ethan-1-Ol (8)2-(Piperidin-4-Yl)Ethan-1-Ol (5)2-Amino-2-(2-Fluorophenyl)Ethan-1-Ol (7)2-Amino-2-(Anthracen-9-Yl)Ethan-1-Ol (4)2-Amino-2-Phenylethan-1-Ol (196)2-Hydroxy-1,2-Diphenylethan-1-One (3)2-Hydroxy-1-Phenylethan-1-One (8)2-Hydroxyethyl Benzoate (3)2-Phenoxyethan-1-Ol (14)2-Phenylethan-1-Ol (78)2-Phenylpropan-2-Ol (21)3-Phenylpropan-1-Ol (24)4-Fluoro-2-(Hydroxymethyl)-5-(9H-Purin-9-Yl)Tetrahydrofuran-3-Ol (4)4-Phenylpiperidin-4-Ol (10)Azetidin-2-Ylmethanol (7)Azetidin-3-Ol (11)Benzyl 3-(Hydroxymethyl)Piperazine-1-Carboxylate (6)Benzyl-2-(Hydroxymethyl)Pyrrolidine-1-Carboxylate (9)Bicyclo[1.1.1]Pentan-1-Ylmethanol (3)Cyclobutanol (46)Cyclobutylmethanol (15)Cyclohexanol (71)Cyclohexylmethanol (31)Cyclopentanol (51)Diphenylmethanol (20)Isoxazol-3-Ylmethanol (3)Isoxazol-5-Ylmethanol (5)M-Tolylmethanol (34)Morpholin-2-Ylmethanol (12)Morpholin-3-Ylmethanol (14)Naphthalen-1-Ylmethanol (8)O-Tolylmethanol (35)Oxiran-2-Ylmethanol (3)Piperidin-2-Ylmethanol (11)Piperidin-3-Ol (27)Piperidin-3-Ylmethanol (15)Piperidin-4-Ylmethanol (11)Pyridin-2-Ylmethanol (65)Pyridin-3-Ylmethanol (39)Pyridin-4-Ylmethanol (16)Pyrimidin-2-Ylmethanol (5)Pyrrolidin-2-Ylmethanol (26)Pyrrolidin-3-Ylmethanol (13)Quinazolin-2-Ol (7)Tert-Butyl 3-(Hydroxymethyl)-1H-Indole-1-Carboxylate (10)Thiazol-2-Ylmethanol (9)Thiophen-2-Ylmethanol (11)Triphenylmethanol (13)
Aldehydes (18934)
Alcohols (19)Aliphatic Chain Hydrocarbons (55)Aliphatic Cyclic Hydrocarbons (12)Alkenyls (29)Alkynyls (6)Amides (56)Amines (29)Aryls (346)Benzimidazoles (5)Benzofurans (4)Benzothiazoles (5)Bromides (78)Carboxylic Acids (18)Chlorides (88)Esters (47)Ethers (130)Fluorinated Building Blocks (79)Furans (15)Imidazoles (21)Indazoles (9)Indoles (21)Isoxazoles (9)Ketones (19)Morpholines (9)Nitriles (12)Nitroes (22)Phenols (13)Piperidines (17)Pyrazines (4)Pyrazoles (41)Pyridines (54)Pyrimidines (11)Pyrroles (12)Quinolines (23)Sulfamides (6)Sulfides (8)Tetrahydropyrans (6)Thiazoles (15)Thiophenes (13)Trifluoromethyls (10)Other Aromatic Heterocycles (40)Aminonicotinaldehyde (5)Aminonicotinaldehyde (5)Carboxyaldehyde (1093)Dicarbaldehyde (37)Dicarbaldehyde (37)Formylisonicotinate (7)Tetracarbaldehyde (8)Tetracarbaldehyde (8)Tricarbaldehyde (10)1-Methyl-1H-Indole-3-Carbaldehyde (9)1-Naphthaldehyde (23)1-Phenyl-1H-Pyrazole-4-Carbaldehyde (8)1H-Benzo[D]Imidazole-2-Carbaldehyde (5)1H-Indazole-3-Carbaldehyde (19)1H-Indole-2-Carbaldehyde (20)1H-Pyrazole-4-Carbaldehyde (30)1H-Pyrrole-2-Carbaldehyde (21)1H-Pyrrole-3-Carbaldehyde (9)1H-Pyrrolo[2,3-B]Pyridine-3-Carbaldehyde (14)1H-Pyrrolo[2,3-B]Pyridine-5-Carbaldehyde (5)2,3-Dichlorobenzaldehyde (7)2,3-Difluorobenzaldehyde (18)2,4-Dichlorobenzaldehyde (8)2,4-Difluorobenzaldehyde (19)2,6-Dibromobenzaldehyde (4)2,6-Difluorobenzaldehyde (25)2-(Benzyloxy)Benzaldehyde (13)2-(Phenylethynyl)Benzaldehyde (9)2-(Trifluoromethoxy)Benzaldehyde (7)2-(Trifluoromethyl)Benzaldehyde (27)2-Bromo-3-Hydroxybenzaldehyde (4)2-Bromo-3-Methoxybenzaldehyde (4)2-Bromo-6-Fluorobenzaldehyde (15)2-Chloro-3-Hydroxybenzaldehyde (4)2-Chloro-3-Methoxybenzaldehyde (7)2-Chloro-4-Fluorobenzaldehyde (10)2-Fluoro-3-Methylbenzaldehyde (8)2-Fluorobenzaldehyde (175)2-Hydroxy-3-Iodobenzaldehyde (3)2-Iodobenzaldehyde (17)2-Methyl-1H-Indole-3-Carbaldehyde (3)2-Naphthaldehyde (12)2-Nitrobenzaldehyde (53)2-Oxo-2-Phenylacetaldehyde (12)2-Phenylacetaldehyde (20)3-(Benzyloxy)Benzaldehyde (13)3-(Trifluoromethoxy)Benzaldehyde (10)3-(Trifluoromethyl)Benzaldehyde (31)3-Bromo-2-Chlorobenzaldehyde (4)3-Bromo-2-Fluorobenzaldehyde (9)3-Bromo-2-Hydroxybenzaldehyde (10)3-Bromo-4-Fluorobenzaldehyde (7)3-Bromo-4-Hydroxybenzaldehyde (9)3-Bromo-4-Methoxybenzaldehyde (9)3-Chloro-2-Fluorobenzaldehyde (9)3-Chloro-2-Hydroxybenzaldehyde (5)3-Chloro-4-Methoxybenzaldehyde (7)3-Chlorobenzaldehyde (106)3-Fluorobenzaldehyde (137)3-Iodobenzaldehyde (28)3-Methoxy-2-Nitrobenzaldehyde (3)3-Nitrobenzaldehyde (49)3-Phenoxybenzaldehyde (7)4-(1H-Imidazol-1-Yl)Benzaldehyde (7)4-(Benzyloxy)Benzaldehyde (23)4-(Piperazin-1-Yl)Benzaldehyde (5)4-Fluorobenzaldehyde (78)4-Hydroxy-3-Nitrobenzaldehyde (5)4-Morpholinobenzaldehyde (8)4-Nitrobenzaldehyde (18)4-Phenoxybenzaldehyde (12)5-Phenylfuran-2-Carbaldehyde (9)6-Methoxynicotinaldehyde (4)[1,1'-Biphenyl]-3-Carbaldehyde (20)[1,1'-Biphenyl]-4-Carbaldehyde (31)Benzo[B]Thiophene-2-Carbaldehyde (7)Benzo[B]Thiophene-3-Carbaldehyde (6)Benzo[D][1,3]Dioxole-5-Carbaldehyde (6)Benzofuran-2-Carbaldehyde (5)Furan-2-Carbaldehyde (22)Imidazo[1,2-A]Pyridine-2-Carbaldehyde (8)Imidazo[1,2-A]Pyridine-3-Carbaldehyde (9)Isonicotinaldehyde (68)Methyl 3-Formylbenzoate (23)Nicotinaldehyde (152)Picolinaldehyde (98)Pyrazine-2-Carbaldehyde (17)Pyrimidine-5-Carbaldehyde (38)Thiazole-2-Carbaldehyde (9)Thiazole-5-Carbaldehyde (19)Thiophene-2-Carbaldehyde (43)Thiophene-3-Carbaldehyde (17)
Aliphatic Chain Hydrocarbons (12641)
Acyl Chlorides (24)Alcohols (404)Aldehydes (55)Alkenyls (383)Alkynyls (23)Amides (456)Amidines (21)Amines (304)Anhydrides (11)Bromides (148)Carboxylic Acid Salts (64)Carboxylic Acids (159)Chlorides (143)Difluoromethyls (13)Epoxides (7)Esters (450)Ethers (199)Fluorinated Building Blocks (169)Guanidines (18)Hydrazides (48)Hydrazines (61)Hydroxylamines (11)Iodides (38)Ketones (182)Nitriles (92)Nitroes (7)Sulfamides (37)Sulfides (27)Sulfonates (4)Sulfones (19)Sulfonyl Chlorides (19)Thioesters (4)Thiols (27)Thioureas (19)Trifluoromethyls (68)Ureas (28)Acetylthio (7)Acetylthio (7)Azanonadecan (7)Azanylylidene (1)Azapentadecan (10)Azapentadecan (10)Azatridecan (4)Butyloctyl (4)Butyloctyl (4)Carbonylbis (1)Carbonylbis (1)Diazirine (13)Diazirine (13)Didodecyl (7)Didodecyl (7)Diethyl (73)Diethyl (73)Dihydroxypropan (6)Diisobutyl (2)Diisopropyl (27)Diisopropyl (27)Dimethoxy (305)Dimethyladamantane (14)Dimethyladamantane (14)Dimethylalkanes (7)Dioctyl (1)Dioxide (445)Dioxide (445)Ethoxy (708)Ethoxyethoxy (5)Ethoxyethoxy (5)Ethoxyethyl (15)Ethoxyethyl (15)Ethoxymethyl (11)Ethoxymethylene (1)Ethoxymethylene (1)Isopropylidenebis (2)Isopropylsulfonyl (10)Isopropylsulfonyl (10)Methoxybut (2)Methoxybut (2)Methoxyethoxy (67)Methoxyethoxy (67)Methoxyethyl (66)Methoxyisonicotinic (11)Methoxyisonicotinic (11)Methoxymethoxy (23)Methoxymethoxy (23)Methoxymethyl (117)Methoxynicotinic (26)Methoxynicotinic (26)Methoxynicotinic Acid (20)Methoxypropan (24)Methoxypropan (24)Methoxypropoxy (8)Methoxypropoxy (8)Methoxypropyl (10)Methoxytetrahydro (14)Methoxytetrahydro (14)Methyladamantan (4)Methylisonicotinic (13)Oxoethoxy (1)Oxopropane (10)Oxopropyl (32)Oxopropyl (32)Pentyloxy (7)Tetramethoxy (6)Trimethoxy (15)Trimethoxy (15)Yldisulfanyl (7)
Aliphatic Cyclic Hydrocarbons (11010)
Acyl Chlorides (10)Alcohols (117)Aldehydes (12)Alkenyls (57)Amides (132)Amines (135)Aryls (10)Bromides (31)Carboxylic Acids (65)Chlorides (19)Esters (109)Ethers (32)Fluorinated Building Blocks (56)Hydrazides (5)Hydrazines (11)Iodides (10)Ketones (156)Nitriles (29)Spiroes (19)Sulfamides (8)Sulfonic Acids (4)Sulfonyl Chlorides (8)Trifluoromethyls (19)Ureas (6)(1-Phenylcyclobutyl)Methanamine (9)(1-Phenylcyclopropyl)Methanamine (12)(1-Phenylcyclopropyl)Methanol (3)(3Ar,E)-4-((Z)-2-(2-Methylenecyclohexylidene)Ethylidene)Octahydro-1H-Indene (7)(4-Cyclohexylphenyl)Boronic Acid (7)(4-Pentylcyclohexyl)Benzene (5)(4-Propylcyclohexyl)Benzene (5)(9H-Fluoren-2-Yl)Boronic Acid (6)(9H-Fluoren-9-Yl)Methyl (4-Methoxybenzyl)Carbamate (7)(Cyclopropylmethoxy)Benzene (18)1,1-Difluorocyclobutane (14)1,1-Difluorocyclohexane (18)1,1-Difluorocyclopentane (5)1-Bromo-2-Cyclopropylbenzene (3)1-Bromo-3-Cyclopropylbenzene (6)1-Chloro-2-Cyclopropylbenzene (7)1-Cyclohexyl-2-Fluorobenzene (4)1-Cyclopropyl-3-Methylbenzene (3)1-Methylcyclohex-1-Ene (26)1-Phenylcyclobutan-1-Amine (5)1-Phenylcyclobutane-1-Carbonitrile (7)1-Phenylcyclobutane-1-Carboxylic Acid (16)1-Phenylcyclohexane-1-Carboxylic Acid (6)1-Phenylcyclopropan-1-Amine (26)1-Phenylcyclopropane-1-Carbonitrile (19)1-Phenylcyclopropane-1-Carboxylic Acid (23)2-((((9H-Fluoren-9-Yl)Methoxy)Carbonyl)Amino)-2-Phenylacetic Acid (5)2-Bromo-9,9-Diphenyl-9H-Fluorene (5)2-Bromo-9H-Fluorene (15)2-Cyclohexylacetic Acid (14)2-Cyclopropyl-4-Phenylquinoline (12)2-Cyclopropylpyridine (20)2-Cyclopropylpyrimidine (10)2-Iodo-9H-Fluorene (8)2-Methylcyclohexan-1-One (3)2-Phenylcyclopropan-1-Amine (20)3,3-Dimethylcyclohexan-1-One (4)3-Cyclopropylpyridine (28)3-Methylcyclohexan-1-One (9)4-Cyclohexylbenzoic Acid (6)4-Cyclohexylbenzonitrile (10)4-Cyclohexylphenol (7)5-Azaspiro[2.4]Heptane (13)6-Azaspiro[2.5]Octane (10)9,9-Dimethyl-9H-Fluorene (16)Bicyclo[1.1.1]Pentan-1-Ylmethanol (3)Bicyclo[1.1.1]Pentane-1-Carboxylic Acid (6)Bicyclo[2.2.1]Hept-2-Ene (18)Bicyclo[2.2.1]Heptane (15)Bromocyclohexane (7)Cyclobutanamine (90)Cyclobutanecarboxylic Acid (23)Cyclobutanol (46)Cyclobutylmethanol (15)Cycloheptane (12)Cyclohex-3-Ene-1-Carboxylic Acid (7)Cyclohexanamine (59)Cyclohexanecarboxylic Acid (83)Cyclohexanol (71)Cyclohexylmethanol (31)Cyclopentanamine (5)Cyclopentanecarboxylic Acid (26)Cyclopentanol (51)Cyclopropoxybenzene (13)Ethyl 1-Phenylcyclopropane-1-Carboxylate (4)Ethyl 2-Phenylcyclopropane-1-Carboxylate (5)Ethyl Cyclohexanecarboxylate (33)Isopropylcyclohexane (19)Methoxycyclohexane (7)Methyl 1-Phenylcyclopropane-1-Carboxylate (10)Methyl 4-Oxocyclohexane-1-Carboxylate (5)Methyl Bicyclo[1.1.1]Pentane-1-Carboxylate (10)Methyl Cyclobutanecarboxylate (24)Methyl Cyclohexanecarboxylate (45)Methyl Cyclopentanecarboxylate (18)N-Methylcyclohexanamine (7)Naphthalene-1,4-Dione (23)Spiro[3.3]Heptane (11)Tert-Butyl (1-Phenylcyclopropyl)Carbamate (6)Tert-Butyl (2-Phenylcyclopropyl)Carbamate (3)Tert-Butyl Bicyclo[1.1.1]Pentan-1-Ylcarbamate (5)Tert-Butyl Cyclobutylcarbamate (17)Tert-Butyl Cyclohexylcarbamate (9)Tert-Butyl Cyclopentylcarbamate (28)Aminobicyclo (24)Aminocyclobutanol (5)Aminocyclobutyl (5)Aminocyclohexane (55)Aminocyclohexanol (21)Aminocyclopentanol (17)Aminocyclopentyl (6)Aminocyclopropyl (4)Azabicyclo (290)Azabicyclo (290)Azatricyclo (5)Azatricyclo (5)Azetidine (177)Azetidine (177)Benzylazetidin (9)Bicyclo (61)Bicyclohexyl (6)Bromobicyclo (9)Butylcyclohexyl (9)Butylsulfonyl (6)Chlorocyclopropyl (2)Cyanoazetidine (5)Cyanocyclopropyl (4)Cyclobutanecarbonitrile (2)Cyclobutylacetic (4)Cyclobutylmethyl (4)Cyclobutylmethyl (4)Cyclohexa (168)Cyclohexa (168)Cyclohexane (126)Cyclohexane (126)Cyclohexanecarboxylic (19)Cyclohexanediamine (8)Cyclohexanone (93)Cyclohexylacetic (2)Cyclohexylamino (9)Cyclohexylbutanoic (4)Cyclohexylcarbamoyl (5)Cyclohexylethanamine (11)Cyclohexylmethoxy (4)Cyclohexylmethoxy (4)Cyclohexylmethyl (7)Cyclohexylmethyl (7)Cyclohexyloxy (10)Cyclohexylpropan (75)Cyclohexylpropanoic (3)Cyclopentadienyl (2)Cyclopentane (169)Cyclopentane (169)Cyclopentanecarboxylic (7)Cyclopentyl (56)Cyclopentyl (56)Cyclopentylacetic (3)Cyclopentylamino (1)Cyclopentylmethyl (4)Cyclopentyloxy (15)Cyclopentyloxy (15)Cyclopropanamine (32)Cyclopropanamine (32)Cyclopropanecarbonitrile (14)Cyclopropanecarbonyl (6)Cyclopropanecarbonyl (6)Cyclopropanecarboxamide (14)Cyclopropanol (4)Cyclopropoxyphenyl (7)Cyclopropyl (356)Cyclopropyl (356)Cyclopropylacetate (6)Cyclopropylacetic (3)Cyclopropylamino (24)Cyclopropylcarbamoyl (5)Cyclopropylethan (5)Cyclopropylethan (5)Cyclopropylethynyl (1)Cyclopropylmethoxy (32)Cyclopropylmethoxy (32)Cyclopropylmethyl (21)Cyclopropylmethyl (21)Cyclopropylpropanoic (5)Cyclopropylsulfonyl (6)Cyclopropylsulfonyl (6)Diazabicyclo (77)Diazabicyclo (77)Dicyclohexyl (6)Dicyclohexyl (6)Dicyclohexylphosphino (18)Dicyclohexylphosphino (18)Difluorocyclobutyl (6)Difluorocyclohexyl (6)Dihydroinden (8)Dihydroindeno (5)Dihydroindeno (5)Dihydropteridin (6)Dimethylbicyclo (5)Dimethylbicyclo (5)Dimethylcyclohex (5)Dimethylcyclohexane (16)Dimethylcyclohexanone (7)Dioxathiolane (1)Dioxathiolane (1)Dioxol (174)Dithiolan (1)Dithiolan (1)Ethylcyclohexyl (4)Ethylcyclohexyl (4)Ethylsulfonyl (42)Fluoroazetidine (1)Fluorobicyclo (4)Hexahydrocyclohepta (6)Hexahydrocyclohepta (6)Hexahydrocyclopenta (4)Hydroxycyclobutanecarboxylic (4)Hydroxycyclohexanecarboxylic (6)Methanesulfonyl (314)Methanesulfonyl (314)Methoxycyclohexanamine (6)Methylazetidine (30)Methylbicyclo (6)Methylbicyclo (6)Methylcyclobutanamine (5)Methylcyclobutanecarboxylic (5)Methylcyclohexanamine (11)Methylcyclohexane (8)Methylcyclohexane (8)Methylcyclohexanecarboxylic (5)Methylcyclohexanecarboxylic Acid (4)Methylcyclohexanol (21)Methylcyclohexanone (5)Methylcyclohexyl (33)Methylcyclopentane (2)Methylcyclopropanamine (4)Methylcyclopropanamine (4)Methylcyclopropane (16)Methylsulfinyl (24)Methylsulfonimidoyl (6)Methylsulfonimidoyl (6)Methylsulphonyl (10)Octahydrocyclopenta (14)Oxabicyclo (40)Oxabicyclo (40)Oxazepane (13)Oxetanes (228)Oxoazetidine (8)Oxoazetidine (8)Oxobicyclo (11)Oxobicyclo (11)Oxocyclobutyl (2)Oxocyclohex (3)Oxocyclohexane (4)Oxocyclohexane (4)Oxocyclohexanecarboxylic (6)Oxocyclohexyl (3)Oxocyclohexyl (3)Oxocyclopentane (2)Oxocyclopentyl (5)Pentamethylcyclopentadienyl (11)Pentylcyclohexyl (10)Pentylcyclohexyl (10)Phenylcyclopropanamine (8)Propylcyclohexyl (15)Propylcyclohexyl (15)Tetraazacyclododecane (13)Tetraazacyclododecane (13)Tetraazacyclotetradecane (7)Tetraazacyclotetradecane (7)Tetramethylcyclohexane (4)Tetraoxatridecan (3)Tetraoxatridecan (3)Thiazepine (2)Tricyclohexylphosphine (9)Trimethylbicyclo (21)Trimethylcyclohex (20)
Alkenyls (16087)
Acyl Chlorides (7)Alcohols (101)Aldehydes (29)Aliphatic Chain Hydrocarbons (383)Aliphatic Cyclic Hydrocarbons (57)Amides (98)Amines (112)Anhydrides (4)Aryls (281)Benzyl Chlorides (1)Bromides (45)Carboxylic Acid Salts (9)Carboxylic Acids (129)Chlorides (57)Esters (245)Ethers (79)Fluorinated Building Blocks (42)Furans (9)Imidazoles (7)Indoles (4)Indolines (3)Iodides (6)Ketones (85)Nitriles (62)Nitroes (21)Oxetanes (4)Phenols (13)Piperazines (10)Piperidines (18)Pyridines (36)Pyrimidines (10)Pyrrolidines (14)Quinolines (10)Quinuclidines (6)Spiroes (4)Sulfamides (12)Sulfones (12)Tetrahydropyrans (7)Thiophenes (15)Trifluoromethyls (5)Other Aliphatic Heterocycles (19)Other Aromatic Heterocycles (5)(1E,4E)-1,5-Diphenylpenta-1,4-Dien-3-One (7)(1E,6E)-1,7-Diphenylhepta-1,6-Diene-3,5-Dione (7)(2,2-Dibromovinyl)Benzene (6)(2-(4-Bromophenyl)Ethene-1,1,2-Triyl)Tribenzene (11)(2-Nitrovinyl)Benzene (28)(Allyloxy)Benzene (17)(E)-5-Benzylidenethiazolidine-2,4-Dione (6)(E)-[3,3'-Biindolinylidene]-2,2'-Dione (5)(E)-N-(3-Oxo-1-Phenyl-3-(Piperidin-1-Yl)Prop-1-En-2-Yl)Benzamide (6)(Z)-3-(Phenyl(Phenylamino)Methylene)Indolin-2-One (5)(Z)-3-Benzylideneindolin-2-One (7)1,2-Diphenylethene (5)1,3,3-Trimethylcyclohex-1-Ene (12)1-Bromo-4-Styrylbenzene (5)1-Methylcyclohex-1-Ene (26)2-Benzalacetophenone (36)2-Methoxycyclohexa-2,5-Diene-1,4-Dione (7)2-Methylcyclohexa-2,5-Diene-1,4-Dione (5)3-(2-Fluorophenyl)Acrylic Acid (17)3-(3-Chlorophenyl)Acrylic Acid (10)3-Methylene-2,3-Dihydro-1H-Inden-1-One (5)3-Methyleneazetidine (8)3-Phenylacrylaldehyde (29)3-Styrylphenol (11)4-(1,2,2-Triphenylvinyl)Benzaldehyde (5)4-(Prop-1-En-2-Yl)Cyclohex-1-Ene (5)5H-Dibenzo[B,F]Azepine (5)Allyl Benzoate (5)Cyclohex-1-En-1-Yl Trifluoromethanesulfonate (3)Cyclohex-1-En-1-Ylboronic Acid (4)Cyclohex-1-Ene-1-Carboxylic Acid (4)Cyclohexa-1,3-Diene (5)Cyclopent-2-En-1-Amine (4)Ethyl Cyclohex-1-Ene-1-Carboxylate (5)Methyl Cinnamate (37)Methyl Cyclohex-3-Ene-1-Carboxylate (3)Methylenecyclobutane (8)Methylenecyclohexane (8)N-Phenylacrylamide (7)Styrene (78)Tert-Butyl-Cyclopent-2-En-1-Ylcarbamate (6)Vinylcyclopropane (8)Acrylaldehyde (11)Acryloyl (8)Acryloyl (8)Annulene (2)Cyclohexene (89)Cyclooctene (9)Cyclopentene (3)Diacrylamide (6)Diallyl (5)Diazene (21)Divinyl (1)Divinyl (1)Enamide (6)Enamide (6)Enecarbaldehyde (2)Enoyl (7)Methacrylamide (3)Methacrylamide (3)Methoxycinnamaldehyde (3)Nitroethylene (37)Tetrahydrocyclopenta (19)
Alkyls (193)
Isopropyl-Phenyl-Boronic Acid/Ester (26)Methylpentan (7)
Alkynyls (2695)
Alcohols (34)Aldehydes (6)Aliphatic Chain Hydrocarbons (23)Amides (30)Amines (19)Aryls (116)Bromides (11)Carboxylic Acids (13)Chlorides (18)Esters (19)Ethers (29)Fluorinated Building Blocks (6)Ketones (8)Pyrazines (6)Pyridines (17)Pyrimidines (7)Pyrrolidines (8)(Bromoethynyl)Benzene (5)(Prop-2-Yn-1-Yloxy)Benzene (12)1,3,5-Tris(Phenylethynyl)Benzene (6)1,4-Bis(Phenylethynyl)Benzene (7)1,4-Diphenylbuta-1,3-Diyne (9)1-Ethynyl-2-Fluorobenzene (10)1-Methyl-4-(Phenylethynyl)Benzene (7)2-(Phenylethynyl)Benzaldehyde (9)2-Ethynylpyridine (31)2-Ethynylthiophene (8)3-Ethynylpyridine (22)4-(Phenylethynyl)-1,1'-Biphenyl (5)4-(Phenylethynyl)Phenol (7)4-Ethynylpyridine (10)9,10-Bis(Phenylethynyl)Anthracene (5)Ethynylbenzene (145)Trimethyl(Phenylethynyl)Silane (23)
Amides (89669)
Acyl Chlorides (13)Alcohols (371)Aldehydes (56)Aliphatic Chain Hydrocarbons (456)Aliphatic Cyclic Hydrocarbons (132)Alkenyls (98)Alkynyls (30)Amidines (8)Amines (614)Anhydrides (33)Aryls (1193)Azetidines (102)Benzimidazoles (26)Benzisoxazoles (4)Benzofurans (7)Benzothiazoles (23)Benzoxazoles (33)Benzyl Bromides (6)Benzyl Chlorides (8)Bromides (311)Carboxylic Acid Salts (6)Carboxylic Acids (226)Chlorides (372)Epoxides (10)Esters (300)Ethers (254)Fluorinated Building Blocks (240)Furans (30)Guanidines (12)Hydrazides (169)Hydrazines (176)Hydrazones (9)Hydroxylamines (12)Imidazoles (26)Imidazolidines (19)Imidazolines (16)Indazoles (6)Indoles (42)Indolines (73)Iodides (36)Isoquinolines (10)Isoxazoles (16)Ketones (185)Morpholines (99)Nitriles (92)Oxadiazoles (10)Oxazoles (10)Oxazolidines (50)Oxazolines (4)Oxetanes (14)Phenols (44)Phthalazines (8)Piperazines (273)Piperidines (436)Purines (7)Pyrazines (17)Pyrazoles (46)Pyridazines (20)Pyridines (267)Pyrimidines (120)Pyrroles (15)Pyrrolidines (307)Pyrrolines (24)Quinazolines (42)Quinolines (33)Quinoxalines (15)Spiroes (190)Sulfamides (43)Sulfides (40)Sulfonates (15)Sulfones (13)Tetrahydrofurans (19)Tetrahydroisoquinolines (7)Tetrahydropyrans (15)Tetrahydroquinolines (14)Thiadiazoles (11)Thiazoles (40)Thiazolidines (16)Thioesters (25)Thiols (4)Thiophenes (44)Thiophenols (6)Thioureas (61)Triazines (11)Triazoles (8)Trifluoromethyls (74)Ureas (82)Other Aliphatic Heterocycles (103)Other Aromatic Heterocycles (181)(3-(Phenylcarbamoyl)Phenyl)Boronic Acid (3)(4-(Phenylcarbamoyl)Phenyl)Boronic Acid (11)(9H-Fluoren-9-Yl)Methyl (3-Phenylpropyl)Carbamate (24)(S)-N-Phenethyl-3-(Pyrrolidin-2-Yl)Propanamide (5)(S)-N-Phenylpiperidine-2-Carboxamide (1)1-(Pyridin-2-Yl-L2-Azaneyl)Ethan-1-One (12)1-Methylindoline-2,3-Dione (8)1-Phenylurea (11)1H-Pyrazole-5-Carboxamide (3)2,2-Dimethyl-1-(Pyridin-2-Yl-L2-Azaneyl)Propan-1-One (7)2-((Tert-Butoxycarbonyl)Amino)Benzoic Acid (11)2-(Trifluoromethyl)Benzamide (6)2-Amino-N-Phenylbenzamide (21)2-Aminobenzamide (30)2-Bromo-N-Phenylacetamide (5)2-Chloro-N-Phenylacetamide (26)2-Chloro-N-Phenylbenzamide (4)2-Chlorobenzamide (16)2-Fluoro-N-Methylbenzamide (12)2-Fluorobenzamide (32)2-Hydroxy-N-Phenylbenzamide (3)2-Hydroxybenzamide (14)2-Iodobenzamide (4)2-Methoxybenzamide (9)3-Benzamidopropanoic Acid (3)3-Bromo-4-Fluorobenzamide (3)3-Fluorobenzamide (26)3-Nitrobenzamide (17)3-Oxo-N-Phenylbutanamide (10)4-Amino-N-Phenylbenzamide (7)4-Benzamidobenzoic Acid (3)4-Fluorobenzamide (19)4-Oxo-4-(Phenylamino)Butanoic Acid (7)Benzoylglycine (15)Benzyl Benzylcarbamate (14)Benzyl Cyclohexylcarbamate (9)Benzyl Phenylcarbamate (15)Ethyl 2-Oxo-2-(Phenylamino)Acetate (8)Isonicotinamide (12)N,N-Diethylbenzamide (17)N,N-Dimethylbenzamide (34)N-((5R,6R)-7-Oxo-4-Thia-1-Azabicyclo[3.2.0]Heptan-6-Yl)-3-Phenylisoxazole-4-Carboxamide (1)N-((6R,7R)-8-Oxo-5-Thia-1-Azabicyclo[4.2.0]Oct-2-En-7-Yl)-2-Phenylacetamide (5)N-(2-(1H-Indol-3-Yl)Ethyl)Acetamide (5)N-(2-Benzoylphenyl)-2-Bromoacetamide (3)N-(2-Chlorophenyl)Acetamide (16)N-(2-Iodophenyl)Acetamide (8)N-(2-Nitrophenyl)Acetamide (11)N-(3-Fluorophenyl)Acetamide (14)N-(4-Aminophenyl)Benzamide (2)N-(4-Chlorophenyl)Acetamide (9)N-(4-Chlorophenyl)Benzamide (6)N-(4-Fluorophenyl)Benzamide (3)N-(4-Phenoxyphenyl)Acetamide (4)N-(O-Tolyl)Benzamide (9)N-(P-Tolyl)Benzamide (6)N-(Thiazol-2-Yl)Acetamide (9)N-Isopropylbenzamide (16)N-Methoxy-N-Methylbenzamide (24)N-Methylbenzamide (58)N-Methylpicolinamide (10)N-Phenylacrylamide (7)N-Phenylpivalamide (11)Nicotinamide (64)Phenyl Dimethylcarbamate (5)Phenyl Ethyl(Methyl)Carbamate (5)Picolinamide (26)Piperidine-3-Carboxamide (5)Pyrazine-2-Carboxamide (10)Pyrrolidine-2-Carboxamide (12)Tert-Butyl (1-Phenylethyl)Carbamate (19)Tert-Butyl (4-Fluorophenyl)Carbamate (9)Tert-Butyl Benzylcarbamate (52)Tert-Butyl Methyl(Phenyl)Carbamate (9)Tert-Butyl O-Tolylcarbamate (11)Tert-Butyl Phenethylcarbamate (1)Tert-Butyl-Cyclopent-2-En-1-Ylcarbamate (6)Thiophene-3-Carboxamide (5)Acetamide (645)Acetamide (645)Acetamido (150)Carboxamide (919)Carboxamide (919)Diacetamide (3)Dicarboxamide (19)Diethylacetamide (4)Diethylacetamide (4)Dimethylacetamide (9)Dimethylnicotinamide (7)Dimethylnicotinamide (7)Formamidophenylboronic Acid/Ester (11)Isobutyramide (7)Oxobutanamide (10)Oxobutanamide (10)Pentanamide (18)Pentanamide (18)Propanamide (1)Propanamido (5)Propanamido (5)
Amidines (1564)
Aliphatic Chain Hydrocarbons (21)Amides (8)Amines (6)Aryls (20)Chlorides (9)Ethers (4)Fluorinated Building Blocks (7)Hydrazines (2)Oximes (24)Pyridines (13)Pyrimidines (4)Trifluoromethyls (3)Carbamimidoyl (15)Benzimidamide (50)N'-Hydroxybenzimidamide (13)Picolinimidamide (11)
Amines (139022)
Alcohols (287)Aldehydes (29)Aliphatic Chain Hydrocarbons (304)Aliphatic Cyclic Hydrocarbons (135)Alkenyls (112)Alkynyls (19)Amides (614)Amidines (6)Aryls (1269)Azetidines (17)Benzimidazoles (19)Benzisoxazoles (4)Benzodioxans (5)Benzofurans (13)Benzothiazoles (30)Benzothiophenes (6)Benzoxazoles (7)Bromides (216)Carboxylic Acid Salts (6)Carboxylic Acids (178)Chlorides (309)Difluoromethyls (19)Dioxolanes (4)Esters (302)Ethers (403)Fluorinated Building Blocks (284)Furans (22)Hydrazides (8)Hydrazines (26)Hydroxylamines (14)Imidazoles (38)Imidazolines (4)Indazoles (18)Indoles (33)Indolines (9)Iodides (36)Isoquinolines (12)Isoxazoles (25)Ketones (88)Morpholines (54)Nitriles (142)Nitroes (114)Oxadiazoles (16)Oxazoles (16)Oxazolidines (4)Oxetanes (29)Oximes (5)Phenols (26)Piperazines (36)Piperidines (177)Purines (12)Pyrazines (19)Pyrazoles (159)Pyridazines (10)Pyridines (394)Pyrimidines (191)Pyrroles (10)Pyrrolidines (81)Quinazolines (9)Quinolines (79)Quinoxalines (7)Quinuclidines (5)Spiroes (14)Sulfamides (50)Sulfides (42)Sulfonates (6)Sulfones (20)Sulfonic Acids (12)Tetrahydrofurans (8)Tetrahydroisoquinolines (3)Tetrahydropyrans (3)Tetrahydroquinolines (5)Thiadiazoles (24)Thiazoles (102)Thioesters (5)Thiophenes (54)Thiophenols (5)Triazines (14)Triazoles (21)Trifluoromethyls (95)Ureas (6)Other Aliphatic Heterocycles (17)Other Aromatic Heterocycles (134)(1-Phenylcyclobutyl)Methanamine (9)(1-Phenylcyclopropyl)Methanamine (12)(1H-Benzo[D]Imidazol-2-Yl)Methanamine (7)(2,3-Dihydrobenzo[B][1,4]Dioxin-2-Yl)Methanamine (3)(2-Aminophenyl)(Phenyl)Methanone (30)(2-Bromophenyl)Methanamine (12)(2-Chlorophenyl)Methanamine (28)(2-Fluorophenyl)Methanamine (49)(3-Chlorophenyl)Methanamine (19)(3-Fluoropyridin-2-Yl)Methanamine (5)(3-Methylpyridin-2-Yl)Methanamine (5)(4-Aminophenyl)(Phenyl)Methanone (4)(4-Fluorophenyl)Methanamine (27)(6-Methylpyridin-2-Yl)Methanamine (6)(Tetrahydrofuran-2-Yl)Methanamine (4)(Tetrahydrofuran-3-Yl)Methanamine (3)1,2,3,4-Tetrahydroisoquinolin-5-Amine (4)1,2,3,4-Tetrahydroisoquinolin-6-Amine (3)1,2,3,4-Tetrahydroisoquinolin-7-Amine (3)1,3,4-Thiadiazol-2-Amine (9)1,3,5-Triazin-2-Amine (3)1-(2,3-Dihydro-1H-Inden-5-Yl)Ethan-1-Amine (3)1-(2-Aminophenyl)Ethan-1-One (29)1-(2-Bromophenyl)Ethan-1-Amine (10)1-(2-Chlorophenyl)-1H-Pyrazole (3)1-(2-Fluorophenyl)Ethan-1-Amine (80)1-(2-Fluorophenyl)Propan-1-Amine (8)1-(3-(Trifluoromethoxy)Phenyl)Ethan-1-Amine (6)1-(3-(Trifluoromethyl)Phenyl)Ethan-1-Amine (25)1-(3-Aminophenyl)Ethan-1-One (18)1-(3-Chlorophenyl)-N-Methylmethanamine (8)1-(4-(Trifluoromethoxy)Phenyl)Ethan-1-Amine (6)1-(Anthracen-9-Yl)Ethan-1-Amine (3)1-(Pyridin-2-Yl)Ethan-1-Amine (15)1-(Pyridin-3-Yl)Ethan-1-Amine (17)1-(Pyridin-4-Yl)Ethan-1-Amine (23)1-Aminoanthracene-9,10-Dione (8)1-Benzyl-N-Methylpiperidin-3-Amine (6)1-Benzylpiperidin-4-Amine (8)1-Methyl-1H-Pyrazol-3-Amine (14)1-Phenyl-1H-Pyrazol-3-Amine (3)1-Phenyl-1H-Pyrazol-5-Amine (4)1-Phenylcyclobutan-1-Amine (5)1-Phenylcyclopropan-1-Amine (26)1-Phenylethan-1-Amine (436)1H-1,2,4-Triazol-3-Amine (7)1H-1,2,4-Triazol-5-Amine (6)1H-Benzo[D]Imidazol-2-Amine (7)1H-Benzo[D]Imidazol-5-Amine (4)1H-Benzo[D]Imidazol-6-Amine (6)1H-Imidazol-2-Amine (6)1H-Indazol-3-Amine (23)1H-Indazol-4-Amine (12)1H-Indazol-5-Amine (3)1H-Indazol-6-Amine (5)1H-Indazol-7-Amine (6)1H-Indol-4-Amine (10)1H-Indol-6-Amine (21)1H-Indol-7-Amine (10)1H-Pyrazol-4-Amine (6)1H-Pyrazol-5-Amine (19)1H-Pyrrol-1-Amine (7)1H-Pyrrolo[2,3-B]Pyridin-6-Amine (4)2,2,2-Trifluoro-1-Phenylethan-1-Amine (48)2,3-Dichloroaniline (18)2,3-Difluoroaniline (34)2,3-Dihydrobenzofuran-3-Amine (11)2,3-Dihydrobenzofuran-5-Amine (3)2,4-Dibromoaniline (18)2,4-Dichloropyrimidin-5-Amine (6)2,4-Difluoroaniline (44)2,5-Difluoroaniline (34)2,6-Dibromoaniline (17)2,6-Dichloroaniline (27)2,6-Difluoroaniline (23)2,6-Diiodoaniline (8)2-((2-Nitrophenyl)Amino)Ethan-1-Ol (5)2-((3-Phenylpropyl)Amino)-1-(Pyrrolidin-1-Yl)Ethan-1-One (2)2-(1H-Benzo[D]Imidazol-2-Yl)Ethan-1-Amine (6)2-(1H-Indol-3-Yl)Ethan-1-Amine (4)2-(Diethylamino)Ethyl Benzoate (3)2-(Methylsulfonyl)Aniline (3)2-(Phenylamino)Benzoic Acid (11)2-(Piperazin-1-Yl)Ethan-1-Amine (8)2-(Piperidin-1-Yl)Ethan-1-Amine (8)2-(Trifluoromethoxy)Aniline (18)2-(Trifluoromethyl)Aniline (58)2-Amino-2-(2-Fluorophenyl)Ethan-1-Ol (7)2-Amino-2-Phenylethan-1-Ol (196)2-Amino-3-Chlorophenol (4)2-Amino-3-Fluorobenzoic Acid (11)2-Amino-6-Bromophenol (3)2-Amino-6-Chlorobenzoic Acid (5)2-Amino-6-Chlorobenzonitrile (3)2-Amino-6-Chlorophenol (5)2-Aminobenzamide (30)2-Aminobenzenesulfonic Acid (9)2-Aminophenol (107)2-Aminopyrimidin-4(3H)-One (11)2-Bromo-3-Chloroaniline (4)2-Bromo-3-Fluoroaniline (13)2-Bromo-3-Methylaniline (6)2-Bromo-4-Methylaniline (14)2-Bromo-6-Methylaniline (11)2-Bromo-N,N-Dimethylaniline (5)2-Bromo-N-Methylaniline (8)2-Chloro-3-Methylaniline (4)2-Chloro-4-Methylaniline (7)2-Chloro-6-Methylaniline (11)2-Chloro-N-Methylaniline (4)2-Chloro-N-Phenylaniline (8)2-Chloroaniline (214)2-Chlorobenzene-1,3-Diamine (3)2-Chlorobenzene-1,4-Diamine (6)2-Chloropyrimidin-4-Amine (22)2-Fluoro-6-Iodoaniline (7)2-Fluoro-N-Phenylaniline (4)2-Fluoroaniline (262)2-Iodo-4-Methylaniline (5)2-Iodo-N,N-Dimethylaniline (3)2-Iodoaniline (87)2-Methoxypyridin-3-Amine (6)2-Methyl-6-Nitroaniline (10)2-Methyl-N-Phenylaniline (7)2-Methylpyridin-4-Amine (7)2-Methylpyrimidin-4-Amine (22)2-Nitro-N-Phenylaniline (3)2-Phenoxyaniline (4)2-Phenylcyclopropan-1-Amine (20)2-Phenylpyrimidin-5-Amine (5)3,4-Dibromoaniline (4)3,4-Dichloroaniline (21)3,4-Difluoroaniline (44)3-(1,3,2-Dioxaborinan-2-Yl)Aniline (3)3-(Benzyloxy)Aniline (12)3-(Methylsulfonyl)Aniline (7)3-(Piperazin-1-Yl)Aniline (3)3-(Trifluoromethoxy)Aniline (22)3-(Trifluoromethyl)Aniline (102)3-Aminobenzenesulfonic Acid (6)3-Aminodihydrofuran-2(3H)-One (4)3-Bromo-2-Fluoroaniline (15)3-Bromo-4-Chloroaniline (13)3-Bromo-4-Fluoroaniline (22)3-Bromo-4-Methoxyaniline (7)3-Bromo-4-Methylaniline (14)3-Bromoaniline (187)3-Bromobenzene-1,2-Diamine (11)3-Chloro-2-Iodoaniline (3)3-Chloro-2-Methylaniline (11)3-Chloro-4-Fluoroaniline (18)3-Chloro-4-Iodoaniline (3)3-Chloro-4-Methoxyaniline (6)3-Chloro-4-Methylaniline (12)3-Chlorobenzene-1,2-Diamine (6)3-Chloropyrazin-2-Amine (6)3-Fluoro-2-Methylaniline (9)3-Fluoroaniline (288)3-Iodo-2-Methylaniline (4)3-Iodoaniline (32)3-Methoxypyridin-2-Amine (5)3-Methyl-N-Phenylaniline (4)3-Methylpyridin-2-Amine (7)3-Nitroaniline (98)3-Phenoxyaniline (2)3-Phenyl-1H-Pyrazol-5-Amine (11)3-Phenylisoxazol-5-Amine (8)4,6-Dichloropyrimidin-2-Amine (9)4-(Benzyloxy)Aniline (8)4-(Oxazol-5-Yl)Aniline (3)4-(Pyrrolidin-1-Yl)Aniline (3)4-(Trifluoromethoxy)Aniline (26)4-Amino-2-Chlorobenzonitrile (8)4-Amino-2-Fluorophenol (9)4-Amino-3-Chlorobenzoic Acid (6)4-Amino-3-Chlorophenol (5)4-Amino-N-Phenylbenzenesulfonamide (3)4-Aminopyridazin-3(2H)-One (4)4-Benzylaniline (7)4-Bromo-3-Chloroaniline (21)4-Bromo-3-Fluoroaniline (29)4-Bromo-3-Methylaniline (19)4-Bromo-3-Nitroaniline (8)4-Bromo-N,N-Diphenylaniline (10)4-Bromo-N-Phenylaniline (6)4-Chloro-2-Iodoaniline (9)4-Chloro-3-Fluoroaniline (17)4-Chloro-3-Iodoaniline (3)4-Chloro-3-Methylaniline (11)4-Chloro-N-Phenylaniline (6)4-Chloropyrimidin-2-Amine (23)4-Chloropyrimidin-5-Amine (7)4-Fluoro-N-Phenylaniline (4)4-Fluoroaniline (225)4-Iodo-N,N-Diphenylaniline (3)4-Methoxy-N-Phenylaniline (5)4-Methyl-3-Nitroaniline (8)4-Methylpyrimidin-2-Amine (9)4-Methylthiazol-2-Amine (7)4-Morpholinoaniline (4)4-Nitroaniline (65)4-Phenoxyaniline (6)4-Phenylpyrimidin-2-Amine (15)4-Phenylthiazol-2-Amine (37)5-Bromopyrazin-2-Amine (13)5-Bromothiazol-2-Amine (6)5-Chloropyrazin-2-Amine (9)5-Methoxypyridin-3-Amine (4)5-Methyl-2-Nitroaniline (6)5-Methylpyridin-2-Amine (7)5-Methylpyridin-3-Amine (4)5-Methylthiazol-2-Amine (6)5-Phenylthiophen-2-Amine (5)5H-Dibenzo[B,F]Azepine (5)6-Amino-2H-Benzo[B][1,4]Oxazin-3(4H)-One (3)6-Bromopyrazin-2-Amine (5)6-Chloropyrazin-2-Amine (11)6-Chloropyridazin-3-Amine (5)6-Chloropyrimidin-4-Amine (8)6-Methoxypyridin-2-Amine (14)6-Methoxypyridin-3-Amine (8)6-Methylpyridin-2-Amine (46)6-Methylpyridin-3-Amine (5)6-Phenoxypyridin-3-Amine (5)7-Methoxy-N-Phenylquinazolin-4-Amine (12)7H-Purin-2-Amine (6)7H-Purin-6-Amine (9)7H-Pyrrolo[2,3-D]Pyrimidin-2-Amine (5)7H-Pyrrolo[2,3-D]Pyrimidin-4-Amine (3)9H-Purin-6-Amine (3)[1,1'-Biphenyl]-2-Amine (8)[1,1'-Biphenyl]-3-Amine (11)[1,2,4]Triazolo[1,5-A]Pyridin-2-Amine (17)[1,2,4]Triazolo[4,3-A]Pyridin-3-Ylmethanamine (5)Azetidin-3-Amine (4)Azetidin-3-Ylmethanamine (3)Aziridine (9)Benzo[B]Thiophen-2-Amine (5)Benzo[D]Oxazol-2-Amine (16)Benzo[D]Thiazol-2-Amine (30)Benzo[D]Thiazol-5-Amine (3)Benzo[D]Thiazol-6-Amine (3)Benzyl-3-Aminopiperidine-1-Carboxylate (6)Benzyl-3-Aminopyrrolidine-1-Carboxylate (7)Bis(Pyridin-2-Ylmethyl)Amine (6)Chroman-2-Ylmethanamine (3)Chroman-3-Amine (3)Chroman-4-Amine (20)Cyclobutanamine (90)Cyclohexanamine (59)Cyclopent-2-En-1-Amine (4)Cyclopentanamine (5)Cyclopropyl(Phenyl)Methanamine (22)Diphenylmethanamine (26)Ethyl 2-Aminobenzoate (23)Ethyl 3-Aminobenzoate (19)Ethyl 4-Aminobenzoate (23)Imidazo[1,2-A]Pyridin-3-Amine (7)Imidazo[1,2-A]Pyridin-8-Amine (7)Isoquinolin-1-Amine (18)Isoquinolin-3-Amine (13)Isoquinolin-4-Amine (16)Isoquinolin-5-Amine (9)Isoquinolin-8-Amine (6)Isoxazol-5-Amine (15)Methyl 2-Amino-2-Phenylacetate (38)Methyl 2-Aminobenzoate (95)Methyl 3-Amino-3-Phenylpropanoate (27)Methyl 3-Aminobenzoate (88)Methyl 4-Aminobenzoate (71)Morpholin-2-Ylmethanamine (8)N,N-Diethylaniline (18)N,N-Dimethyl-2-Phenoxyethan-1-Amine (16)N,N-Dimethylaniline (117)N,N-Dimethylnaphthalen-1-Amine (4)N,N-Dimethylpyridin-2-Amine (10)N,N-Dimethylpyridin-4-Amine (6)N,N-Dimethylpyrimidin-2-Amine (10)N,N-Dimethylpyrrolidin-3-Amine (7)N,N-Diphenyl-4-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Aniline (6)N,N-Diphenyl-[1,1'-Biphenyl]-4-Amine (8)N-(4-Aminophenyl)Benzamide (2)N-(Furan-2-Ylmethyl)Aniline (5)N-(Prop-2-Yn-1-Yl)-2,3-Dihydro-1H-Inden-1-Amine (3)N-Benzyl-1-Phenylethan-1-Amine (7)N-Benzyl-2-Phenylethan-1-Amine (1)N-Benzylpiperidin-4-Amine (3)N-Cyclopropylpyrimidin-2-Amine (5)N-Methyl-1-Phenylmethanamine (65)N-Methyl-2-Nitroaniline (20)N-Methyl-4-Nitroaniline (6)N-Methylaniline (140)N-Methylcyclohexanamine (7)N-Methylpiperidin-3-Amine (5)N-Methylpyridin-2-Amine (47)N-Methylpyridin-3-Amine (15)N-Methylpyrimidin-2-Amine (10)N-Methylpyrimidin-4-Amine (10)N-Methylpyrrolidin-3-Amine (6)N-Phenyl-3-(Trifluoromethyl)Aniline (3)N-Phenyl-4-(Trifluoromethyl)Aniline (3)N-Phenylnaphthalen-1-Amine (5)N-Phenylpyridin-2-Amine (9)N-Phenylpyrimidin-2-Amine (5)N-Phenylpyrimidin-4-Amine (7)N1,N1-Diphenylbenzene-1,4-Diamine (2)N1-Phenylbenzene-1,4-Diamine (3)N2,N4,N6-Triphenyl-1,3,5-Triazine-2,4,6-Triamine (4)N2,N4-Diphenylpyrimidine-2,4-Diamine (5)Naphthalen-2-Amine (12)O-Benzylhydroxylamine (16)Oxazol-2-Amine (8)Phenylmethanamine (315)Piperidin-2-Ylmethanamine (6)Piperidin-3-Amine (17)Piperidin-3-Ylmethanamine (5)Piperidin-4-Amine (14)Piperidin-4-Ylmethanamine (7)Pyrazin-2-Amine (22)Pyrazin-2-Ylmethanamine (12)Pyridazin-3-Amine (18)Pyridazin-4-Amine (10)Pyridin-2-Amine (29)Pyridin-2-Ylmethanamine (38)Pyridin-3-Amine (21)Pyridin-3-Ylmethanamine (29)Pyridin-4-Amine (22)Pyridin-4-Ylmethanamine (12)Pyridine-2,3-Diamine (5)Pyridine-2,6-Diamine (12)Pyrimidin-2-Ylmethanamine (7)Pyrimidin-4-Amine (29)Pyrimidin-5-Amine (6)Pyrimidine-2,4-Diamine (14)Pyrrolidin-2-Ylmethanamine (12)Pyrrolidin-3-Ylmethanamine (6)Quinazolin-2-Amine (13)Quinazolin-4-Amine (8)Quinoxalin-2-Amine (3)Tetrahydrofuran-3-Amine (6)Thiazol-2-Ylmethanamine (5)Thiazol-5-Amine (6)Thiophen-3-Amine (18)Tri([1,1'-Biphenyl]-4-Yl)Amine (9)Amino-Propanol (6)Aminoacetamido (4)Aminoacetyl (2)Aminoadamantan (5)Aminoadamantan (5)Aminoazepane (10)Aminobutane (23)Aminobutane (23)Aminobutyl (15)Aminobutyl (15)Aminoethoxy (18)Aminoethoxy (18)Aminoethyl (152)Aminoethyl (152)Aminohexan (6)Aminohexyl (3)Aminohexyl (3)Aminoisonicotinic Acid (12)Aminomethyl (402)Aminomethyl (402)Aminooxy (6)Aminopentyl (10)Aminopentyl (10)Aminopropanamido (1)Aminopropane (20)Aminopropane (20)Aminopropoxy (2)Aminopropoxy (2)Aminotetrahydro (12)Aminotetrahydro (12)Benzylazetidine (4)Bromobenzylamine (6)Bromobenzylcarbamate (28)Butoxycarbonylamino (7)Butylcarbamoyl (5)Carbamothioyl (2)Carbamoyl (114)Chlorobenzylamine (4)Diamino (88)Diamino (88)Diaminopteridin (3)Diaminopteridin (3)Dibutylamino (6)Dibutylamino (6)Dichlorobenzylamine (5)Diethylamino (91)Diethylamino (91)Diisopropylamino (1)Dimethyl-Ethylamine (2)Dimethylamino (484)Dimethylamino (484)Dimethylcarbamoyl (14)Dimethylmethanamine (16)Dipropylamino (1)Dipropylamino (1)Ethylamino (37)Ethylamino (37)Fluindamine (32)Hydroxyamino (2)Hydroxyamino (2)Imidazol-Amine (1)Methoxyimino (2)Methylamino (236)Methylamino (236)Methylcarbamoyl (18)Methylcarbamoyl (18)Propanediamine (6)Propylamino (5)Propylamino (5)Pyrrolopyridine-Methylamine (6)Silanamine (3)Triamine (25)Triamine (25)
Anhydrides (655)
Aliphatic Chain Hydrocarbons (11)Alkenyls (4)Amides (33)Aryls (14)Benzofurans (13)Bromides (5)Chlorides (8)Esters (81)Ethers (8)Fluorinated Building Blocks (8)Nitroes (5)Oxazolidines (5)Tetrahydrofurans (3)Other Aliphatic Heterocycles (10)Other Aromatic Heterocycles (33)Dianhydride (3)1H,3H-Benzo[De]Isochromene-1,3-Dione (8)Furan-2,5-Dione (8)
Aryls (186252)
Acyl Chlorides (28)Alcohols (633)Aldehydes (346)Aliphatic Cyclic Hydrocarbons (10)Alkenyls (281)Alkynyls (116)Amides (1193)Amidines (20)Amines (1269)Anhydrides (14)Azetidines (44)Azoes (12)Benzimidazoles (40)Benzofurans (12)Benzothiazoles (10)Benzothiophenes (4)Benzyl Bromides (82)Benzyl Chlorides (53)Bromides (936)Carboxylic Acid Salts (16)Carboxylic Acids (849)Chlorides (1047)Difluoromethyls (43)Dioxolanes (16)Epoxides (25)Esters (893)Ethers (1461)Fluorinated Building Blocks (868)Furans (39)Guanidines (13)Hydrazides (84)Hydrazines (121)Hydrazones (10)Hydroxylamines (8)Imidazoles (50)Imidazolidines (10)Imidazolines (14)Indazoles (8)Indoles (51)Indolines (20)Iodides (87)Isocyanates and Isothiocyanates (8)Isocyanides (2)Isoxazoles (54)Ketones (582)Morpholines (137)Nitriles (353)Nitroes (356)Oxadiazoles (12)Oxazoles (48)Oxazolidines (25)Oxazolines (8)Oxetanes (21)Oximes (24)Phenols (289)Phosphoruses (10)Piperazines (139)Piperidines (311)Purines (4)Pyrans (3)Pyrazines (13)Pyrazoles (122)Pyridazines (15)Pyridines (178)Pyrimidines (79)Pyrroles (30)Pyrrolidines (142)Pyrrolines (14)Quinazolines (7)Quinolines (24)Quinuclidines (2)Spiroes (36)Sulfamides (218)Sulfides (143)Sulfonates (83)Sulfones (121)Sulfonic Acids (23)Sulfonyl Chlorides (57)Sulfoxides (19)Tetrahydrofurans (12)Tetrahydroisoquinolines (3)Tetrahydropyrans (28)Tetrazoles (5)Thiadiazoles (17)Thiazoles (97)Thiazolidines (8)Thioesters (9)Thiols (8)Thiophenes (46)Thiophenols (29)Thioureas (28)Triazines (12)Triazoles (24)Trifluoromethyls (260)Ureas (30)Other Aliphatic Heterocycles (55)Other Aromatic Heterocycles (110)(6-Phenoxytetrahydro-2H-Pyran-2-Yl)Methanol (18)(8S,9S,14R)-1,2,6,7,8,9,10,11,12,13,14,15,16,17-Tetradecahydro-3H-Cyclopenta[A]Phenanthren-3-One (1)(9H-Fluoren-9-Yl)Methyl (2-(Tritylthio)Ethyl)Carbamate (9)(9H-Fluoren-9-Yl)Methyl Cyclohexylcarbamate (8)(Benzylsulfonyl)Benzene (11)(Cyclopentyloxy)Benzene (12)1,1-Dimethylcyclopropane (5)1,3,4,5-Tetrahydro-2H-Benzo[B]Azepin-2-One (15)1,3-Diphenylurea (24)1-(2-Hydroxyphenyl)-2-Phenylethan-1-One (6)1-(2-Hydroxyphenyl)-3-Phenylprop-2-En-1-One (11)1-([1,1'-Biphenyl]-4-Yl)Ethan-1-One (5)1-(Naphthalen-2-Yl)Ethan-1-One (3)1-Benzyl-4-Chlorobenzene (6)1-Benzyl-4-Fluorobenzene (2)1-Bromonaphthalene (4)1-Chloronaphthalene (24)1-Fluoronaphthalene (23)1-Methoxynaphthalene (18)1-Methyl-4-(Phenylethynyl)Benzene (7)1-Methylnaphthalene (10)1-Naphthaldehyde (23)1-Naphthoic Acid (23)1-Nitronaphthalene (3)10H-Phenothiazine (20)2,2',3,3',5,5',6,6'-Octafluoro-1,1'-Biphenyl (4)2,5-Diphenylthiophene (5)2-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Phenol (7)2-(Trifluoromethyl)-1,1'-Biphenyl (8)2-Benzylaniline (5)2-Bromo-1,1'-Biphenyl (12)2-Bromonaphthalene (4)2-Chloro-1,1'-Biphenyl (8)2-Chloronaphthalene (6)2-Ethoxynaphthalene (4)2-Fluorocyclopropane-1-Carboxylic Acid (7)2-Hydroxycyclohexa-2,5-Diene-1,4-Dione (3)2-Iodonaphthalene (5)2-Methoxy-1,1'-Biphenyl (7)2-Methoxynaphthalene (22)2-Methoxytetrahydro-2H-Pyran (9)2-Methyl-1,1'-Biphenyl (26)2-Methylnaphthalene (13)2-Naphthaldehyde (12)2-Naphthoic Acid (14)2-Naphthonitrile (15)2-Nitronaphthalene (4)2-Phenoxytetrahydro-2H-Pyran-4-Yl Acetate (6)2-Phenylnaphthalene (12)3,3'-Diphenyl-5,5',6,6',7,7',8,8'-Octahydro-1,1'-Binaphthalene (13)3,3-Diphenyl-3H-Benzo[C][1,2]Oxathiole 1,1-Dioxide (19)3-Bromo-1,1'-Biphenyl (12)3-Chloro-1,1'-Biphenyl (12)3-Fluoro-1,1'-Biphenyl (16)3-Methyl-1,1'-Biphenyl (10)3-Methyl-1,1':4',1''-Terphenyl (3)3-Phenethylphenol (5)3-Phenyl-1,2,4,5-Tetrazine (9)3-Styrylphenol (11)4-(Bromomethyl)-1,1'-Biphenyl (13)4-(Phenyldiazenyl)Benzoic Acid (4)4-(Phenylsulfonyl)Morpholine (14)4-(Tert-Butyl)-1,1'-Biphenyl (5)4-Cyclohexylphenol (7)4-Iodo-1,1'-Biphenyl (9)4-Methoxy-1,1'-Biphenyl (4)9H-Xanthene (7)[1,1'-Biphenyl]-2-Amine (8)[1,1'-Biphenyl]-2-Carbonitrile (12)[1,1'-Biphenyl]-2-Carboxylic Acid (24)[1,1'-Biphenyl]-2-Ol (16)[1,1'-Biphenyl]-3-Amine (11)[1,1'-Biphenyl]-3-Carbaldehyde (20)[1,1'-Biphenyl]-3-Carboxylic Acid (40)[1,1'-Biphenyl]-3-Ol (9)[1,1'-Biphenyl]-4-Carbaldehyde (31)[1,1'-Biphenyl]-4-Carbonitrile (27)[1,1'-Biphenyl]-4-Ol (29)[1,1'-Biphenyl]-4-Ylboronic Acid (29)Benzyltriphenylphosphonium (14)Cyclopentylbenzene (28)Cyclopropanecarboxylic Acid (11)Cyclopropyl(Phenyl)Methanamine (22)Cyclopropyl(Phenyl)Methanone (13)Diphenyl Phosphonate (11)Diphenylphosphane (25)Diphenylphosphine Oxide (27)Ethane-1,1-Diyldibenzene (3)Ethene-1,1,2-Triyltribenzene (14)Ethyl Cyclopropanecarboxylate (8)Methyl 1-Naphthoate (7)Methyl 2-Naphthoate (11)Methyl [1,1'-Biphenyl]-4-Carboxylate (8)Methyl Cyclopropanecarboxylate (8)N,1-Diphenylmethanimine (15)N,N-Dimethylnaphthalen-1-Amine (4)N-((5R,6R)-7-Oxo-4-Thia-1-Azabicyclo[3.2.0]Heptan-6-Yl)-2-Phenylacetamide (5)N-Benzylbenzamide (21)N-Benzylbenzenesulfonamide (18)N-Cyclopropylbenzamide (14)N-Cyclopropylbenzenesulfonamide (10)N-Phenethylbenzamide (9)N-Phenyl-2-Naphthamide (11)Naphthalen-1-Ol (28)Naphthalen-1-Ylboronic Acid (4)Naphthalen-1-Ylmethanol (8)Naphthalen-2-Amine (12)Naphthalen-2-Ol (25)Naphthalen-2-Ylboronic Acid (8)Naphthalene-1,4-Diol (3)Naphthalene-2-Sulfonic Acid (4)Propane-2,2-Diyldibenzene (17)Tert-Butyl Cyclopropylcarbamate (7)Tetrahydro-2H-Pyran-2-Ol (12)Tetrahydro-2H-Pyran-2-Yl Acetate (12)Tetraphenylmethane (16)Triphenylene (12)Vinylcyclopropane (8)Acetylbenzonitrile (3)Aminobenzyl (6)Benzylamine (21)Benzylamino (47)Benzylhydroxylamine (25)Benzylidene (16)Benzylidene (16)Benzyloxy (1053)Benzylthio (16)Benzylthio (16)Cyanobenzyl (12)Dibenzyl (15)Dibenzylamino (7)Dichlorobenzylidene (8)Difluorobenzyl (17)Dimethoxybenzyl (20)Dimethoxybenzyl (20)Dimethylbenzonitrile (25)Dimethylbenzyl (6)Dimethylbenzyl (6)Dimethylbenzylamine (6)Ethoxybenzyl (8)Ethoxybenzyl (8)Fluorobenzyl (131)Fluorobenzylidene (2)Formylbenzonitrile (35)Iodobenzyl (9)Isopropylbenzonitrile (4)Methoxybenzyl (175)Methoxybenzylamine (7)Methoxybenzylidene (6)Methylbenzonitrile (104)Methylbenzyl (73)Methylbenzyl (73)Methylbenzylamine (8)Methylbenzylidene (1)Methylbenzylidene (1)Nitrobenzyl (31)Nitrobenzylidene (2)Phenoxybenzonitrile (5)Trifluorobenzyl (2)
Azides (43)
Azoes (119)
Aryls (12)(E)-1-(Naphthalen-1-Yl)-2-Phenyldiazene (7)1,2-Diphenyldiazene (7)3-(Phenyldiazenyl)Benzoic Acid (7)
Benzene Compounds (18446)
Acetamidophenoxy (1)Acetamidophenyl (5)Acetylbenzoate (7)Acetylphenyl (11)Acetylphenyl (11)Acetylphenylboronic (3)Aminobenzoyl (4)Aminobiphenyl (4)Aminonaphthalene (14)Aminophenoxy (19)Aminophenyl (233)Anisole (4)Anthracenes (143)Benzaldehyde (1587)Benzamidophenyl (1)Benzenedimethanol (4)Benzenethiol (8)Benzhydrylazetidine (10)Benzhydrylazetidine (10)Benzhydryloxy (4)Benzhydryloxy (4)Benziodoxol (2)Benzodioxole (5)Benzoquinone (6)Benzoquinone (6)Benzoylbenzoate (4)Benzoylphenyl (4)Binaphthalene (123)Binaphthalene (123)Biphenyl (1369)Boronophenyl (1)Boronophenyl (1)Bromobenzo (104)Bromobenzoyl (6)Bromodibenzo (9)Bromophenoxy (34)Bromophenyl (957)Butoxyphenyl (8)Butylaniline (7)Butylbenzene (16)Butyldiphenylsilyl (7)Butylphenol (20)Butylphenyl (32)Butylphenyl (32)Carbamoylphenoxy (12)Carbamoylphenyl (8)Carboxyphenyl (17)Carboxyphenyl (17)Chlorobenzenesulfonyl (23)Chlorobenzoyl (9)Chlorodibenzo (18)Chloronaphthalene (36)Chlorophenethyl (7)Chlorophenoxy (43)Chlorophenylacetate (4)Chlorophenylacetate Acid (9)Chlorophenylboronic (5)Cyclopropylaniline (6)Cyclopropylbenzoate (5)Cyclopropylnaphthalen (10)Cyclopropylnaphthalen (10)Cyclopropylphenyl (12)Cyclopropylphenyl (12)Diaminobenzene (7)Dibenzaldehyde (19)Dibenzene (7)Dibenzimidamide (5)Dibenzo (108)Dibenzo (108)Dibenzoate (9)Dibenzonitrile (11)Dibromobenzene (45)Dibromobenzo (14)Dibromodibenzo (8)Dibromonaphthalene (15)Dibromophenanthrene (3)Dibromophenoxy (2)Dibromophenylboronic (2)Dichlorobenzene (38)Dichlorobenzoyl (4)Dichlorophenoxy (16)Dichlorophenyl (328)Dichlorophenylboronic (5)Didehydrodibenz (2)Didehydrodibenz (2)Diethoxyphenyl (10)Diethylaniline (6)Diethylbenzamide (7)Diethylbenzene (6)Diethylbenzene (6)Difluorobenzene (57)Difluorobenzo (12)Difluorobenzoyl (9)Difluorophenoxy (9)Difluorophenyl (384)Difluorophenylboronic (11)Dihydroanthracene (1)Dihydroanthracene (1)Dihydrobenzo (188)Dihydrobenzo (188)Dihydrodibenzo (7)Dihydronaphthalene (104)Dihydronaphthalene (104)Diiodobenzene (12)Diisopropylaniline (5)Diisopropylbenzamide (8)Diisopropylphenyl (40)Diisopropylphenyl (40)Dimesityl (12)Dimesityl (12)Dimethoxyacetophenone (5)Dimethoxyaniline (20)Dimethoxybenzaldehyde (40)Dimethoxybenzamide (6)Dimethoxybenzene (47)Dimethoxybenzo (4)Dimethoxybenzo (4)Dimethoxybenzoate (20)Dimethoxybenzohydrazide (3)Dimethoxybenzonitrile (11)Dimethoxybenzoyl (4)Dimethoxybiphenyl (3)Dimethoxybiphenyl (3)Dimethoxynaphthalene (10)Dimethoxynaphthalene (10)Dimethoxyphenol (22)Dimethoxyphenyl (255)Dimethoxyphenylboronic (17)Dimethoxyphenylboronic (17)Dimethoxystyryl (4)Dimethylaminophenyl (4)Dimethylanthracene (4)Dimethylbenzaldehyde (27)Dimethylbenzamide (37)Dimethylbenzene (334)Dimethylbenzene (334)Dimethylbenzenesulfonamide (16)Dimethylbenzo (21)Dimethylbenzo (21)Dimethylbenzoate (27)Dimethylbenzoyl (3)Dimethylbenzoyl (3)Dimethylnaphthalene (6)Dimethylphenol (36)Dimethylphenoxy (13)Dimethylphenoxy (13)Dimethylphenylboronic (6)Dimethylphenylboronic (6)Dimethylphenylhydrazine (3)Dimethylphenylisothiocyanate (4)Dinaphtho (5)Dinitrobenzene (20)Diphenol (30)Diphenylamino (26)Diphenylaniline (9)Diphenylethane (10)Diphenylethanone (5)Diphenylethene (6)Diphenylethyl (4)Diphenylethyl (4)Diphenylmethyl (8)Diphenylmethyl (8)Diphenylmethylene (6)Diphenylphosphine (203)Diphenylphosphine (203)Diphenylpropane (18)Diphenylsilane (2)Diphenylurea (4)Diphenylurea (4)Ethoxyaniline (10)Ethoxybenzaldehyde (9)Ethoxybenzoate (12)Ethoxybenzonitrile (6)Ethoxyphenoxy (7)Ethoxyphenoxy (7)Ethoxyphenyl (45)Ethoxyphenyl (45)Ethoxyphenylboronic (7)Ethylaniline (8)Ethylaniline (8)Ethylbenzenesulfonamide (323)Ethylbenzo (7)Ethylbenzo (7)Ethylbenzoate (9)Ethylphenol (12)Ethylphenyl (39)Ethylphenyl (39)Ethynylaniline (7)Ethynylbenzaldehyde (17)Ethynylphenyl (35)Fluorobenzeneboronic (24)Fluoronaphthalene (34)Fluorophenoxy (46)Formylbenzoate (39)Formylphenoxy (4)Formylphenoxy (4)Formylphenyl (43)Formylphenyl (43)Formylphenylboronic (9)Formylphenylboronic (9)Hexahydrobenzo (3)Hexahydrobenzo (3)Hexylphenyl (3)Hexylphenyl (3)Homophenylalanine (16)Hydroxybenzenesulfonate (5)Hydroxybenzimidamide (11)Hydroxyisophthalaldehyde (6)Hydroxyphenethyl (2)Hydroxyphenethyl (2)Hydroxyphenyl (440)Hydroxyphenyl (440)Iodobenzo (15)Iodobenzoic (54)Iodobenzoyl (7)Iodobiphenyl (24)Iododibenzo (7)Iodonaphthalene (9)Iodophenoxy (5)Isobutoxyphenyl (15)Isobutoxyphenyl (15)Isobutylbenzene (5)Isobutylbenzene (5)Isobutylphenyl (9)Isophthalate (8)Isophthalonitrile (4)Isopropoxyaniline (10)Isopropoxyaniline (10)Isopropoxybenzaldehyde (7)Isopropoxybenzoate (7)Isopropoxyphenyl (40)Isopropoxyphenyl (40)Isopropylaniline (18)Isopropylbenzaldehyde (6)Isopropylbenzamide (9)Isopropylbenzenesulfonamide (19)Isopropylbenzoate (8)Isopropylphenyl (58)Mercaptobenzo (21)Methanobenzo (15)Methanobenzo (15)Methoxyacetophenone (12)Methoxyaniline (74)Methoxybenzaldehyde (104)Methoxybenzene (1710)Methoxybenzene (1710)Methoxybenzenesulfonamide (6)Methoxybenzenesulfonic (3)Methoxybenzenesulfonyl (13)Methoxybenzenesulfonyl (13)Methoxybenzimidamide (5)Methoxybenzo (52)Methoxybenzo (52)Methoxybenzoate (115)Methoxybenzonitrile (67)Methoxybenzoyl (12)Methoxybenzoyl (12)Methoxycarbonylphenylboronic (5)Methoxynaphthalene (54)Methoxynaphthalene (54)Methoxyphenol (72)Methoxyphenoxy (41)Methoxyphenoxy (41)Methoxyphenylacetate (4)Methoxyphenylboronic (24)Methoxyphenylboronic (24)Methoxyphenylhydrazine (4)Methoxystyryl (13)Methylacetophenone (6)Methylaniline (183)Methylanisole (3)Methylanthracene (5)Methylbenzaldehyde (101)Methylbenzamide (90)Methylbenzamido (3)Methylbenzenesulfinamide (4)Methylbenzenesulfonamide (79)Methylbenzenesulfonic (9)Methylbenzenesulfonyl (4)Methylbenzenesulfonyl (4)Methylbenzimidamide (6)Methylbenzoate (193)Methylbenzohydrazide (6)Methylbenzothioamide (6)Methylbenzothioamide (6)Methylbenzotrifluoride (5)Methylbenzoyl (24)Methylbenzoyl (24)Methylnaphthalene (34)Methylnaphthalene (34)Methylphenol (107)Methylphenoxy (18)Methylphenoxy (18)Methylphenyl (525)Methylphenylacetonitrile (45)Methylphenylboronic (24)Methylphenylhydrazine (10)Methylpropiophenone (5)Methylpropiophenone (5)Naphthaldehyde (28)Naphthalene (447)Naphthalene (447)Naphthaleneboronic (15)Naphthalenesulfonic (7)Naphthamide (15)Naphthonitrile (18)Nitrobenzenesulfonyl (8)Nitrobenzo (54)Nitrobenzoyl (13)Nitronaphthalene (24)Nitrophenoxy (43)Nitrophenyl (717)Nitrophenylboronic (14)Nitrotoluene (27)Octylbenzene (11)Octylbenzene (11)Paracyclophane (2)Paracyclophane (2)Pentafluorobenzene (13)Pentylbenzene (5)Pentylbenzene (5)Pentylbenzoate (2)Pentylphenol (4)Pentylphenyl (5)Pentylphenyl (5)Perfluorophenoxy (5)Perfluorophenyl (31)Phenoxyacetate (5)Phenoxyaniline (8)Phenoxybenzaldehyde (5)Phenoxybenzoate (5)Phenoxyethyl (6)Phenoxyethyl (6)Phenoxymethyl (7)Phenoxymethyl (7)Phenoxyphenyl (61)Phenoxyphenyl (61)Phenoxypropan (4)Phenylacetamide (34)Phenylacetonitrile (8)Phenylacetyl (1)Phenylacetyl (1)Phenylacrylamide (3)Phenylalaninol (2)Phenylamino (31)Phenylaniline (19)Phenylanthracene (16)Phenylbenzamide (23)Phenylbenzenesulfonamide (3)Phenylbutanoate (10)Phenylbutoxy (2)Phenylbutoxy (2)Phenylcarbamoyl (5)Phenylcyclohexanone (6)Phenylcyclopropanecarboxylic (6)Phenylcyclopropyl (7)Phenylcyclopropyl (7)Phenyldiazenyl (4)Phenylene (167)Phenylene (167)Phenylenediamine (13)Phenylenedimethanamine (5)Phenylethanamine (12)Phenylethane (9)Phenylethane (9)Phenylethanol (10)Phenylethanone (19)Phenylethoxy (2)Phenylethyl (66)Phenylethyl (66)Phenylethylisocyanate (2)Phenylhex (3)Phenylimino (1)Phenylisocyanate (9)Phenylisoserine (4)Phenylmethanesulfonyl (2)Phenylmethanesulfonyl (2)Phenylmethoxy (4)Phenylmethoxy (4)Phenylmethyl (8)Phenylmethyl (8)Phenylnaphthalene (6)Phenylpentan (11)Phenylpentan (11)Phenylpropanamide (11)Phenylpropyl (20)Phenylpyrazolo (8)Phenylsulfinyl (3)Phenylsulfinyl (3)Phenylsulfonyl (88)Phenylsulfonyl (88)Phenylthio (24)Phenylthio (24)Phenylthiophene (23)Phenylthiophene (23)Phenylthiourea (6)Phenylurea (3)Phenylurea (3)Phenylvinyl (9)Phthalate (23)Phthalimide (12)Phthalonitrile (8)Propoxybenzaldehyde (4)Propoxyphenyl (29)Propoxyphenyl (29)Propoxyphenylboronic (79)Propylphenyl (26)Propylphenyl (26)Pyrenes (52)Quaternaphthalene (6)Quaterphenyl (15)Quaterphenyl (15)Styryl (12)Sulfamoylphenyl (3)Sulfophenyl (4)Sulfophenyl (4)Terephthalaldehyde (11)Terephthalate (13)Terphenyl (236)Terphenyl (236)Tetraaniline (6)Tetrabenzaldehyde (7)Tetrafluorobenzene (17)Tetrahydrobenzo (70)Tetrahydrobenzo (70)Tetrahydronaphthalene (149)Tetrahydronaphthalene (149)Tetralone (12)Tetramethylbenzene (9)Tetramethylbenzene (9)Tetramethylbiphenyl (57)Tetramethylbiphenyl (57)Tetraphenyl (11)Tetraphenyl (11)Toluenesulfonyl (68)Tolyl (403)Tolyl (403)Tolylamino (3)Tolylazanediyl (4)Tolylazanediyl (4)Tolylethynyl (3)Tolyloxy (18)Tolyloxy (18)Tolylphosphine (8)Tolylphosphine (8)Tolylthio (3)Tolylthio (3)Trianiline (7)Tribenzaldehyde (5)Tribromobenzene (7)Trichlorobenzene (19)Trichlorophenoxy (3)Trichlorophenylboronic (6)Triethylbenzene (5)Trifluorophenyl (52)Trifluorophenylboronic (154)Triiodobenzene (5)Triisopropylbenzene (9)Triisopropylphenyl (6)Triisopropylphenyl (6)Trimethoxybenzene (43)Trimethoxystyryl (5)Trimethylaniline (18)Trimethylbenzene (28)Trimethylphenol (6)Trimethylphenyl (20)Trimethylphenyl (20)Trimethylpropiophenone (4)Triphenylphosphoranylidene (9)Triphenylphosphoranylidene (9)Triphenylvinyl (11)Trityl (19)Trityl (19)Tritylamino (2)Trityloxy (2)Tritylthio (3)Tritylthio (3)(((9H-Fluoren-9-Yl)Methoxy)Carbonyl)Amino)-3-(4-Fluorophenyl)Propanoic Acid (3)(10Ar)-1,2,3,4,4A,9,10,10A-Octahydrophenanthrene (3)(1E,1'E)-N,N'-(Ethane-1,2-Diyl)Bis(1-Phenylmethanimine) (5)(1R,4R)-4-Phenyl-1,1'-Bi(Cyclohexane) (24)(9H-Fluoren-9-Yl)Methyl Benzylcarbamate (22)(9H-Fluoren-9-Yl)Methyl Piperazine-1-Carboxylate (7)(Cyclopentylmethyl)Benzene (5)(R)-3-Benzylpyrrolidine (6)(R)-3-Phenylmorpholine (7)(R)-N-(1,2-Diphenylethyl)Benzenesulfonamide (1)(S)-N-(1,2-Diphenylethyl)Benzenesulfonamide (1)1,1':2',1''-Terphenyl (4)1,1':3',1''-Terphenyl (28)1,1':4',1'':4'',1'''-Quaterphenyl (7)1,1,2,2-Tetra([1,1'-Biphenyl]-4-Yl)Ethene (10)1,1-Dimethyl-1,2,3,4-Tetrahydronaphthalene (10)1,2,3,4-Tetrahydronaphthalen-1-Amine (36)1,2,3,4-Tetrahydronaphthalen-1-Ol (5)1,2,3,4-Tetrahydronaphthalene-1-Carboxylic Acid (3)1,2,3,5,6,7-Hexahydro-S-Indacene (23)1,2,4-Trimethylbenzene (41)1,2-Dihydroacenaphthylene (6)1,2-Dinitrobenzene (6)1,3,5-Tris(Phenylethynyl)Benzene (6)1,3,6,8-Tetraphenylpyrene (10)1,3-Bis(Benzyloxy)Benzene (8)1,3-Dihydro-2H-Inden-2-One (6)1,3-Diphenoxypropane (6)1,3-Diphenyl-1H-Pyrazole (6)1,3-Diphenylpropane (6)1,3-Diphenylpropane-1,3-Dione (4)1,4-Bis(Phenylethynyl)Benzene (7)1,4-Diphenylbuta-1,3-Diyne (9)1-(2,3-Dihydro-1H-Inden-5-Yl)Ethan-1-Amine (3)1-(Anthracen-9-Yl)Ethan-1-Amine (3)1-Benzylazetidine (6)1-Bromopyrene (4)1-Cyclohexyl-4-(Phenylethynyl)Benzene (10)1-Cyclopropylnaphthalene (6)1-Phenyl-1H-Tetrazole (6)1-Phenylnaphthalene (12)1-Trityl-1H-Pyrazole (5)1H-Indene (18)1H-Indene-1,3(2H)-Dione (5)2,2 ', 3,3' - Tetrahydro-1,1 '- Spiro [Indene] (5)2,3,4,5-Tetrahydro-1H-Benzo[C]Azepine (7)2,3-Dihydro-1H-Inden-1-Amine (52)2,3-Dihydro-1H-Inden-1-Ol (13)2,3-Dihydro-1H-Inden-4-Amine (6)2,3-Dihydro-1H-Inden-4-Ol (6)2,3-Dihydro-1H-Indene-1-Carboxylic Acid (5)2,3-Dihydro-1H-Indene-4-Carbonitrile (4)2,4-Diphenyl-1,3,5-Triazine (6)2,5-Diphenyl-1,3,4-Oxadiazole (6)2,7-Bis(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)-9H-Fluorene (7)2-(2-Chlorophenyl)-4,4,5,5-Tetramethyl-1,3,2-Dioxaborolane (24)2-(2-Fluorophenyl)-4,4,5,5-Tetramethyl-1,3,2-Dioxaborolane (21)2-(2-Methoxyphenyl)-4,4,5,5-Tetramethyl-1,3,2-Dioxaborolane (29)2-(3-Bromophenyl)-4,4,5,5-Tetramethyl-1,3,2-Dioxaborolane (14)2-(3-Fluorophenyl)-4,4,5,5-Tetramethyl-1,3,2-Dioxaborolane (19)2-(3-Methoxyphenyl)-4,4,5,5-Tetramethyl-1,3,2-Dioxaborolane (30)2-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Aniline (17)2-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Benzaldehyde (20)2-(4-Chlorophenyl)-4,4,5,5-Tetramethyl-1,3,2-Dioxaborolane (15)2-(4-Fluorophenyl)-4,4,5,5-Tetramethyl-1,3,2-Dioxaborolane (16)2-Amino-2-(Anthracen-9-Yl)Ethan-1-Ol (4)2-Methyl-2,3-Dihydro-1H-Inden-1-One (9)2-Phenyl-1,3,5-Triazine (6)2-Phenyl-1,3-Dioxane (7)2-Phenyl-2H-1,2,3-Triazole (7)2-Phenylisoindoline-1,3-Dione (7)2H-Benzo[B][1,4]Thiazin-3(4H)-One (6)3,3-Dimethyl-2,3-Dihydro-1H-Inden-1-One (5)3,4-Dihydro-2H-Benzo[B][1,4]Dioxepine (7)3,5,6,7-Tetrahydro-S-Indacen-1(2H)-One (5)3-((((9H-Fluoren-9-Yl)Methoxy)Carbonyl)Amino)-3-(2-Bromophenyl)Propanoic Acid (3)3-((((9H-Fluoren-9-Yl)Methoxy)Carbonyl)Amino)-3-(2-Chlorophenyl)Propanoic Acid (3)3-((((9H-Fluoren-9-Yl)Methoxy)Carbonyl)Amino)-3-(3-(Trifluoromethyl)Phenyl)Propanoic Acid (3)3-((((9H-Fluoren-9-Yl)Methoxy)Carbonyl)Amino)-3-(3-Fluorophenyl)Propanoic Acid (3)3-((((9H-Fluoren-9-Yl)Methoxy)Carbonyl)Amino)-3-(3-Methoxyphenyl)Propanoic Acid (4)3-((((9H-Fluoren-9-Yl)Methoxy)Carbonyl)Amino)-3-(3-Nitrophenyl)Propanoic Acid (3)3-((((9H-Fluoren-9-Yl)Methoxy)Carbonyl)Amino)-3-(4-Bromophenyl)Propanoic Acid (3)3-((((9H-Fluoren-9-Yl)Methoxy)Carbonyl)Amino)-3-(4-Nitrophenyl)Propanoic Acid (3)3-((((9H-Fluoren-9-Yl)Methoxy)Carbonyl)Amino)-3-(O-Tolyl)Propanoic Acid (3)3-((((9H-Fluoren-9-Yl)Methoxy)Carbonyl)Amino)-3-(P-Tolyl)Propanoic Acid (3)3-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Aniline (25)3-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Benzaldehyde (19)3-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Benzoic Acid (12)3-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Phenol (13)3-Methyl-2,3-Dihydro-1H-Inden-1-One (4)3-Phenyl-1H-Pyrrole (4)3-Phenyloxazolidin-2-One (4)4',5'-Diphenyl-1,1':2',1''-Terphenyl (7)4,4,5,5-Tetramethyl-2-(3-(Trifluoromethyl)Phenyl)-1,3,2-Dioxaborolane (19)4,4,5,5-Tetramethyl-2-(3-Nitrophenyl)-1,3,2-Dioxaborolane (24)4,4,5,5-Tetramethyl-2-(M-Tolyl)-1,3,2-Dioxaborolane (21)4,4,5,5-Tetramethyl-2-(O-Tolyl)-1,3,2-Dioxaborolane (24)4,5-Diphenyloxazole (7)4,7-Diphenylbenzo[C][1,2,5]Thiadiazole (6)4-(4-Cyclopropylnaphthalen-1-Yl)-4H-1,2,4-Triazole (7)4-(Phenylethynyl)-1,1'-Biphenyl (5)4-Bromo-2,3-Dihydro-1H-Inden-1-One (5)4-Bromo-2,3-Dihydro-1H-Indene (10)4-Chloro-2,3-Dihydro-1H-Inden-1-One (8)4-Chloro-2,3-Dihydro-1H-Indene (5)4-Cyclohexyl-1,1'-Biphenyl (18)4-Fluoro-2,3-Dihydro-1H-Inden-1-One (6)4-Fluoro-2,3-Dihydro-1H-Indene (14)4-Methoxy-2,3-Dihydro-1H-Inden-1-One (6)4-Methyl-2,3-Dihydro-1H-Inden-1-One (8)4-Methyl-2,3-Dihydro-1H-Indene (3)4-Phenyl-1,1'-Bi(Cyclohexane) (8)4-Phenyl-4H-1,2,4-Triazole (6)5''-([1,1'-Biphenyl]-4-Yl)-1,1':4',1'':3'',1''':4''',1''''-Quinquephenyl (5)5',5''-Diphenyl-1,1':3',1'':3'',1'''-Quaterphenyl (8)5,5',6,6',7,7',8,8'-Octahydro-1,1'-Binaphthalene (6)5,6,7,8-Tetrahydronaphthalen-2-Ol (5)5-Bromo-1,2,3,4-Tetrahydronaphthalene (6)5-Bromo-2,3-Dihydro-1H-Indene (8)5-Fluoro-2,3-Dihydro-1H-Indene (3)5-Methoxy-1,2,3,4-Tetrahydronaphthalene (3)5-Methoxy-2,3-Dihydro-1H-Indene (2)5-Methyl-3,4-Dihydronaphthalen-1(2H)-One (6)5-Phenyl-1H-Imidazole (6)5-Phenylcyclohexane-1,3-Dione (6)6,7,8,9-Tetrahydro-5H-Benzo[7]Annulen-5-One (6)6-Bromo-1,2,3,4-Tetrahydronaphthalene (9)6-Bromo-2,3-Dihydro-1H-Inden-1-One (8)6-Bromo-3,4-Dihydronaphthalen-1(2H)-One (3)6-Chloro-1,2,3,4-Tetrahydronaphthalene (3)6-Chloro-2,3-Dihydro-1H-Inden-1-One (5)6-Fluoro-1,2,3,4-Tetrahydronaphthalene (6)6-Fluoro-2,3-Dihydro-1H-Inden-1-One (4)6-Methoxy-2,3-Dihydro-1H-Inden-1-One (6)6-Methoxy-3,4-Dihydronaphthalen-1(2H)-One (5)6-Methyl-1,2,3,4-Tetrahydronaphthalene (5)6-Methyl-2,3-Dihydro-1H-Inden-1-One (3)6-Methyl-3,4-Dihydronaphthalen-1(2H)-One (2)7-Bromo-2,3-Dihydro-1H-Inden-1-One (13)7-Chloro-2,3-Dihydro-1H-Inden-1-One (9)7-Fluoro-2,3-Dihydro-1H-Inden-1-One (8)7-Hydroxy-2,3-Dihydro-1H-Inden-1-One (6)7-Methoxy-2,3-Dihydro-1H-Inden-1-One (6)7-Methoxy-3,4-Dihydronaphthalen-1(2H)-One (6)7-Methyl-2,3-Dihydro-1H-Inden-1-One (7)9,10-Bis(Phenylethynyl)Anthracene (5)9,10-Diphenylanthracene (16)9-Methylanthracene (4)9-Phenylxanthylium (7)9H-Fluoren-9-One (17)[1,1'-Binaphthalen]-2-Amine (3)[1,1':4',1''-Terphenyl]-4,4''-Dicarbaldehyde (9)Benzenesulfinic Acid (6)Benzil (17)Benzo-18-Crown-6 (7)Benzo[Lmn][3,8]Phenanthroline-1,3,6,8(2H,7H)-Tetraone (10)Benzyl ((Benzyloxy)Carbonyl)Glycinate (8)Benzyl (4-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Phenyl)Carbamate (5)Benzyl (S)-Pyrrolidin-3-Ylcarbamate (7)Benzyl 3-Phenylpropanoate (1)Benzyl Piperidin-4-Ylcarbamate (7)Bicyclo[4.2.0]Octa-1,3,5-Triene (13)Cumene (181)Dibenzyl Phosphonate (6)Diphenylmethanimine (9)Ethane-1,1,2-Triyltribenzene (4)Ethylbenzene (197)Mesitylene (71)Methyl 2-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Benzoate (14)Methyl 3-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Benzoate (11)N,2-Diphenylacetamide (7)N,N,N-Trimethyl-1-Phenylmethanaminium (6)N,N-Diphenyl-[1,1'-Biphenyl]-4-Amine (8)N-Benzyl-2-Phenylethan-1-Amine (1)N-Benzylcyclopropanamine (6)N-Phenylcinnamamide (16)N1,N1,N4,N4-Tetraphenylbenzene-1,4-Diamine (6)N4,N4,N4',N4'-Tetraphenyl-[1,1'-Biphenyl]-4,4'-Diamine (7)Phenanthrene (23)Phenanthrene-9,10-Dione (8)Phenethyldiphenylphosphane (6)Phenothiazin-5-Ium (6)Phenyl (1R,4R)-[1,1'-Bi(Cyclohexane)]-4-Carboxylate (6)Phenyl 4-Cyclohexylbenzoate (8)Tert-Butyl (2,3-Dihydro-1H-Inden-1-Yl)Carbamate (3)Tert-Butylbenzene (245)Triphenyl Phosphate (6)
Benzyl Bromides (1074)
Amides (6)Aryls (82)Bromides (81)Chlorides (6)Esters (14)Ethers (6)Fluorinated Building Blocks (2)Nitriles (5)Sulfamides (3)1-(Bromomethyl)-2-(Trifluoromethyl)Benzene (13)1-(Bromomethyl)-2-Chlorobenzene (28)1-(Bromomethyl)-2-Fluorobenzene (50)1-(Bromomethyl)-3-(Trifluoromethyl)Benzene (17)1-(Bromomethyl)-3-Chlorobenzene (27)1-(Bromomethyl)-3-Fluorobenzene (47)1-(Bromomethyl)-3-Methoxybenzene (19)1-Bromo-2-(Bromomethyl)Benzene (34)2-(2-(Bromomethyl)Phenyl)-4,4,5,5-Tetramethyl-1,3,2-Dioxaborolane (9)2-(Bromomethyl)-1,3-Difluorobenzene (12)2-(Bromomethyl)Benzonitrile (15)Methyl 2-(Bromomethyl)Benzoate (33)
Benzyl Chlorides (658)
Alkenyls (1)Amides (8)Aryls (53)Bromides (5)Chlorides (49)Esters (10)Ethers (7)Fluorinated Building Blocks (2)Dichlorobenzyl (39)1-(Chloromethyl)-2-Fluorobenzene (8)1-(Chloromethyl)-3-Fluorobenzene (11)
Bromides (52776)
Acyl Chlorides (5)Alcohols (147)Aldehydes (78)Aliphatic Chain Hydrocarbons (148)Aliphatic Cyclic Hydrocarbons (31)Alkenyls (45)Alkynyls (11)Amides (311)Amines (216)Anhydrides (5)Aryls (936)Azetidines (7)Benzimidazoles (8)Benzofurans (18)Benzothiazoles (11)Benzothiophenes (4)Benzoxazoles (10)Benzyl Bromides (81)Benzyl Chlorides (5)Carboxylic Acids (176)Chlorides (241)Difluoromethyls (36)Dioxolanes (6)Esters (314)Ethers (328)Fluorinated Building Blocks (305)Furans (13)Imidazoles (16)Indazoles (25)Indoles (36)Indolines (16)Iodides (54)Isoquinolines (11)Isothiazoles (4)Isoxazoles (11)Ketones (169)Morpholines (30)Naphthyridines (4)Nitriles (82)Nitroes (62)Oxadiazoles (4)Oxazoles (12)Oxetanes (9)Phenols (34)Piperazines (10)Piperidines (31)Pyrazines (9)Pyrazoles (38)Pyridazines (10)Pyridines (398)Pyrimidines (71)Pyrroles (5)Pyrrolidines (25)Pyrrolines (6)Quinazolines (13)Quinolines (106)Quinoxalines (9)Spiroes (11)Sulfamides (35)Sulfides (18)Sulfones (31)Sulfonyl Chlorides (17)Tetrahydrofurans (4)Tetrahydropyrans (6)Tetrahydroquinolines (6)Thiazoles (70)Thiophenes (66)Thiophenols (4)Trifluoromethyls (95)Other Aromatic Heterocycles (92)Bromoacetyl (14)Bromoaniline (2)Bromoanthracene (5)Bromoanthracene (5)Bromobenzaldehyde (15)Bromobenzamide (7)Bromobenzimidamide (6)Bromobenzyl (33)Bromobut (2)Bromobut (2)Bromobutoxy (4)Bromobutoxy (4)Bromobutyl (6)Bromobutyl (6)Bromochroman (26)Bromochroman (26)Bromoethoxy (22)Bromoethoxy (22)Bromoethyl (86)Bromoethyl (86)Bromoethynyl (6)Bromohexyl (11)Bromohexyl (11)Bromomethyl (759)Bromonicotinaldehyde (5)Bromonicotinamide (5)Bromooctyl (3)Bromopentyl (8)Bromopentyl (8)Bromopropane (10)Bromopropane (10)Bromopropoxy (6)Bromopropoxy (6)Bromopropyl (25)Bromopropyl (25)Bromothiochroman (4)Bromothiochroman (4)Bromovinyl (2)Dibromo (696)Dibromo (696)Dibromoanthracene (3)Dibromoanthracene (3)Dibromobenzaldehyde (8)Dibromobenzonitrile (8)Dibromomethyl (6)Dibromomethyl (6)Tetrabromo (10)Tetrabromo (10)Tribromo (9)Tribromo (9)(1-Bromoethyl)Benzene (11)(2,2-Dibromovinyl)Benzene (6)(2-(4-Bromophenyl)Ethene-1,1,2-Triyl)Tribenzene (11)(2-Bromo-6-Fluorophenyl)Methanol (4)(2-Bromoethyl)Benzene (33)(2-Bromophenyl)(Phenyl)Methanone (3)(2-Bromophenyl)Boronic Acid (39)(2-Bromophenyl)Hydrazine (8)(2-Bromophenyl)Methanamine (12)(2-Bromophenyl)Methanol (39)(3-Bromo-2-Fluorophenyl)Boronic Acid (7)(3-Bromo-2-Methoxyphenyl)Boronic Acid (6)(3-Bromophenyl)Boronic Acid (65)(3-Bromopropyl)Benzene (10)(3-Bromopyridin-2-Yl)Methanol (7)(4-Bromophenyl)(Phenyl)Methanone (9)(5-Bromopyridin-2-Yl)Methanamine (5)(5-Bromopyridin-2-Yl)Methanol (5)(Bromoethynyl)Benzene (5)(Dibromomethyl)Benzene (6)1,2,3-Tribromobenzene (5)1,2,4-Tribromobenzene (13)1,2-Dibromo-3-Chlorobenzene (3)1,2-Dibromo-3-Fluorobenzene (9)1,2-Dibromo-3-Methylbenzene (9)1,2-Dibromo-4-Fluorobenzene (11)1,2-Dibromobenzene (64)1,3-Dibromo-2,4-Difluorobenzene (5)1,3-Dibromo-2,4-Dimethylbenzene (3)1,3-Dibromo-2-Chlorobenzene (8)1,3-Dibromo-2-Fluorobenzene (15)1,3-Dibromo-2-Iodobenzene (4)1,3-Dibromo-2-Methoxybenzene (11)1,3-Dibromo-2-Methylbenzene (14)1,3-Dibromo-2-Nitrobenzene (4)1,4-Dibromo-2-Iodobenzene (3)1-(2-Bromophenyl)Ethan-1-Amine (10)1-(2-Bromophenyl)Ethan-1-One (27)1-(5-Bromopyridin-2-Yl)Piperazine (6)1-(Azetidin-1-Yl)-2-Bromoethan-1-One (3)1-(Benzyloxy)-2-Bromobenzene (12)1-(Benzyloxy)-3-Bromobenzene (12)1-(Benzyloxy)-4-Bromobenzene (8)1-(Bromomethyl)-2-Iodobenzene (9)1-(Bromomethyl)-2-Methoxybenzene (14)1-(Bromomethyl)-2-Methylbenzene (14)1-(Bromomethyl)-2-Nitrobenzene (23)1-(Bromomethyl)-3-Methylbenzene (11)1-Benzyl-3-Bromobenzene (7)1-Benzyl-4-Bromo-1H-Pyrazole (5)1-Bromo-2,3-Dichlorobenzene (18)1-Bromo-2,3-Difluorobenzene (67)1-Bromo-2,3-Dimethoxybenzene (8)1-Bromo-2,3-Dimethylbenzene (23)1-Bromo-2,4-Difluorobenzene (59)1-Bromo-2-(Bromomethyl)Benzene (34)1-Bromo-2-(Difluoromethyl)Benzene (5)1-Bromo-2-(Methylsulfonyl)Benzene (4)1-Bromo-2-(Tert-Butyl)Benzene (7)1-Bromo-2-(Trifluoromethoxy)Benzene (22)1-Bromo-2-Chloro-3-Fluorobenzene (20)1-Bromo-2-Chloro-3-Methoxybenzene (6)1-Bromo-2-Chloro-3-Methylbenzene (9)1-Bromo-2-Chloro-4-Nitrobenzene (5)1-Bromo-2-Cyclopropylbenzene (3)1-Bromo-2-Ethoxybenzene (16)1-Bromo-2-Ethylbenzene (13)1-Bromo-2-Fluoro-3-(Trifluoromethyl)Benzene (4)1-Bromo-2-Fluoro-3-Methoxybenzene (7)1-Bromo-2-Fluoro-3-Methylbenzene (11)1-Bromo-2-Fluoro-3-Nitrobenzene (11)1-Bromo-2-Fluoro-4-Nitrobenzene (13)1-Bromo-2-Iodobenzene (65)1-Bromo-2-Isopropylbenzene (10)1-Bromo-2-Phenoxybenzene (3)1-Bromo-3-(Trifluoromethyl)Benzene (100)1-Bromo-3-Chloro-2-Fluorobenzene (9)1-Bromo-3-Chloro-2-Methylbenzene (6)1-Bromo-3-Cyclopropylbenzene (6)1-Bromo-3-Fluoro-2-Iodobenzene (4)1-Bromo-3-Fluoro-2-Methoxybenzene (12)1-Bromo-3-Fluoro-2-Methylbenzene (17)1-Bromo-3-Fluoro-2-Nitrobenzene (10)1-Bromo-3-Iodobenzene (70)1-Bromo-3-Methoxybenzene (187)1-Bromo-3-Methyl-2-Nitrobenzene (3)1-Bromo-3-Nitrobenzene (235)1-Bromo-3-Phenoxybenzene (8)1-Bromo-4-(Phenylsulfonyl)Benzene (7)1-Bromo-4-Chloro-2-Fluorobenzene (22)1-Bromo-4-Fluoro-2-Methoxybenzene (11)1-Bromo-4-Fluoro-2-Methylbenzene (18)1-Bromo-4-Iodobenzene (67)1-Bromo-4-Phenoxybenzene (8)1-Bromo-4-Styrylbenzene (5)1-Bromobicyclo[1.1.1]Pentane (3)1-Bromoisoquinoline (20)1-Bromonaphthalene (4)2,3-Dibromopyridine (21)2,4-Dibromo-1-Chlorobenzene (8)2,4-Dibromo-1-Fluorobenzene (18)2,4-Dibromo-1-Methoxybenzene (6)2,4-Dibromoaniline (18)2,4-Dibromophenol (16)2,4-Dibromopyridine (5)2,4-Dibromothiazole (5)2,5-Dibromopyrazine (4)2,5-Dibromopyridine (26)2,5-Dibromothiazole (5)2,5-Dibromothiophene (18)2,6-Dibromo-3-Fluoropyridine (3)2,6-Dibromoaniline (17)2,6-Dibromobenzaldehyde (4)2,6-Dibromobenzonitrile (4)2,6-Dibromophenol (20)2,6-Dibromopyrazine (9)2,6-Dibromopyridin-4-Amine (3)2,6-Dibromopyridine (28)2-(2-Bromophenyl)-4,4,5,5-Tetramethyl-1,3,2-Dioxaborolane (5)2-(2-Bromophenyl)Acetic Acid (23)2-(2-Bromophenyl)Acetonitrile (10)2-(4-Bromophenyl)-4,4,5,5-Tetramethyl-1,3,2-Dioxaborolane (8)2-(Bromomethyl)Furan (3)2-(Bromomethyl)Pyridine (27)2-Amino-3-Bromobenzoic Acid (8)2-Amino-3-Bromobenzonitrile (7)2-Amino-3-Bromophenol (3)2-Amino-6-Bromophenol (3)2-Bromo-1,1'-Biphenyl (12)2-Bromo-1,3,4-Thiadiazole (11)2-Bromo-1,3,4-Trifluorobenzene (16)2-Bromo-1,3,4-Trimethylbenzene (4)2-Bromo-1,3-Dichlorobenzene (12)2-Bromo-1,3-Difluorobenzene (43)2-Bromo-1,3-Dimethoxybenzene (7)2-Bromo-1,3-Dimethylbenzene (35)2-Bromo-1,4-Dichlorobenzene (12)2-Bromo-1,4-Difluorobenzene (64)2-Bromo-1,4-Dimethoxybenzene (11)2-Bromo-1,4-Dimethylbenzene (22)2-Bromo-1-Chloro-3-Fluorobenzene (9)2-Bromo-1-Chloro-4-Fluorobenzene (20)2-Bromo-1-Chloro-4-Methylbenzene (6)2-Bromo-1-Chloro-4-Nitrobenzene (9)2-Bromo-1-Fluoro-3-Nitrobenzene (9)2-Bromo-1-Fluoro-4-(Trifluoromethyl)Benzene (4)2-Bromo-1-Fluoro-4-Methoxybenzene (12)2-Bromo-1-Fluoro-4-Methylbenzene (17)2-Bromo-1-Fluoro-4-Nitrobenzene (23)2-Bromo-1-Methoxy-3-Methylbenzene (3)2-Bromo-1-Methoxy-4-Methylbenzene (7)2-Bromo-1-Methyl-4-Nitrobenzene (12)2-Bromo-1H-Benzo[D]Imidazole (4)2-Bromo-1H-Imidazole (13)2-Bromo-1H-Pyrrole (11)2-Bromo-3-(Trifluoromethyl)Pyridine (4)2-Bromo-3-Chloroaniline (4)2-Bromo-3-Chloropyridine (25)2-Bromo-3-Fluoroaniline (13)2-Bromo-3-Fluoropyridine (26)2-Bromo-3-Hydroxybenzaldehyde (4)2-Bromo-3-Methoxybenzaldehyde (4)2-Bromo-3-Methoxypyridine (7)2-Bromo-3-Methylaniline (6)2-Bromo-3-Methylphenol (4)2-Bromo-3-Methylpyrazine (5)2-Bromo-3-Methylpyridine (25)2-Bromo-3-Nitrobenzoic Acid (4)2-Bromo-3-Nitropyridine (5)2-Bromo-4-(Trifluoromethyl)Aniline (9)2-Bromo-4-Chloro-1-Fluorobenzene (16)2-Bromo-4-Chloro-1-Methoxybenzene (7)2-Bromo-4-Chloro-1-Methylbenzene (11)2-Bromo-4-Chloro-1-Nitrobenzene (5)2-Bromo-4-Chloroaniline (15)2-Bromo-4-Chlorophenol (11)2-Bromo-4-Chloropyridine (7)2-Bromo-4-Fluoro-1-Methoxybenzene (12)2-Bromo-4-Fluoro-1-Methylbenzene (21)2-Bromo-4-Fluoro-1-Nitrobenzene (23)2-Bromo-4-Fluoroaniline (28)2-Bromo-4-Fluorobenzaldehyde (7)2-Bromo-4-Fluorobenzoic Acid (8)2-Bromo-4-Fluorobenzonitrile (7)2-Bromo-4-Fluorophenol (10)2-Bromo-4-Methoxy-1-Nitrobenzene (6)2-Bromo-4-Methoxyaniline (6)2-Bromo-4-Methoxybenzaldehyde (8)2-Bromo-4-Methoxybenzoic Acid (4)2-Bromo-4-Methylaniline (14)2-Bromo-4-Methylbenzoic Acid (5)2-Bromo-4-Methylpyridine (6)2-Bromo-4-Methylthiazole (7)2-Bromo-4-Nitroaniline (12)2-Bromo-5-(Trifluoromethyl)Pyridine (6)2-Bromo-5-Chloropyrazine (6)2-Bromo-5-Chloropyridine (22)2-Bromo-5-Fluoroaniline (18)2-Bromo-5-Fluorobenzaldehyde (7)2-Bromo-5-Fluorobenzoic Acid (11)2-Bromo-5-Fluoropyridine (33)2-Bromo-5-Methoxybenzaldehyde (6)2-Bromo-5-Methoxypyridine (11)2-Bromo-5-Methylpyridine (19)2-Bromo-5-Methylthiazole (7)2-Bromo-5-Nitropyridine (11)2-Bromo-6-(Trifluoromethyl)Aniline (5)2-Bromo-6-(Trifluoromethyl)Pyridine (6)2-Bromo-6-Chloroaniline (10)2-Bromo-6-Chlorophenol (5)2-Bromo-6-Chloropyrazine (5)2-Bromo-6-Chloropyridine (23)2-Bromo-6-Fluoroaniline (14)2-Bromo-6-Fluorobenzaldehyde (15)2-Bromo-6-Fluorobenzoic Acid (11)2-Bromo-6-Fluorobenzonitrile (7)2-Bromo-6-Fluorophenol (9)2-Bromo-6-Fluoropyridine (21)2-Bromo-6-Iodoaniline (4)2-Bromo-6-Methoxyaniline (5)2-Bromo-6-Methoxyphenol (5)2-Bromo-6-Methoxypyridine (15)2-Bromo-6-Methylaniline (11)2-Bromo-6-Methylbenzoic Acid (5)2-Bromo-6-Methylphenol (7)2-Bromo-6-Methylpyrazine (5)2-Bromo-6-Methylpyridine (17)2-Bromo-6-Nitroaniline (14)2-Bromo-6-Nitrophenol (9)2-Bromo-6-Phenylpyridine (4)2-Bromo-9,9-Diphenyl-9H-Fluorene (5)2-Bromo-9H-Fluorene (15)2-Bromo-[1,2,4]Triazolo[1,5-A]Pyridine (6)2-Bromo-N,N-Dimethylaniline (5)2-Bromo-N-Methylaniline (8)2-Bromo-N-Phenylacetamide (5)2-Bromobenzene-1,3-Diol (7)2-Bromobenzene-1,4-Diol (4)2-Bromobenzenesulfonyl Chloride (8)2-Bromobenzo[D]Thiazole (28)2-Bromodibenzo[B,D]Furan (6)2-Bromofuran (21)2-Bromoimidazo[1,2-A]Pyridine (5)2-Bromonaphthalene (4)2-Bromonicotinic Acid (5)2-Bromooxazole (7)2-Bromopyrazine (15)2-Bromopyridin-3-Amine (10)2-Bromopyridin-3-Ol (7)2-Bromopyridine (10)2-Bromopyridine 1-Oxide (6)2-Bromopyrimidine (22)2-Bromoquinazoline (4)3,4-Dibromoaniline (4)3,4-Dibromophenol (3)3,5-Dibromopyridine (12)3-(Bromomethyl)Pyridine (18)3-Bromo-1,1'-Biphenyl (12)3-Bromo-1,5-Naphthyridine (8)3-Bromo-1-Methyl-1H-Pyrazole (16)3-Bromo-1H-Pyrrole (16)3-Bromo-1H-Pyrrolo[2,3-B]Pyridine (7)3-Bromo-1H-Pyrrolo[3,2-B]Pyridine (6)3-Bromo-2-Chlorobenzaldehyde (4)3-Bromo-2-Chlorobenzoic Acid (7)3-Bromo-2-Chloropyridin-4-Amine (3)3-Bromo-2-Chloropyridine (20)3-Bromo-2-Fluoroaniline (15)3-Bromo-2-Fluorobenzaldehyde (9)3-Bromo-2-Fluorobenzoic Acid (10)3-Bromo-2-Fluorobenzonitrile (10)3-Bromo-2-Fluorophenol (5)3-Bromo-2-Fluoropyridine (21)3-Bromo-2-Hydroxybenzaldehyde (10)3-Bromo-2-Hydroxybenzoic Acid (4)3-Bromo-2-Hydroxybenzonitrile (3)3-Bromo-2-Methoxypyridine (20)3-Bromo-2-Methylpyridine (27)3-Bromo-4-Chloroaniline (13)3-Bromo-4-Chlorobenzoic Acid (6)3-Bromo-4-Chlorophenol (5)3-Bromo-4-Fluoroaniline (22)3-Bromo-4-Fluorobenzaldehyde (7)3-Bromo-4-Fluorobenzamide (3)3-Bromo-4-Fluorobenzoic Acid (10)3-Bromo-4-Fluorophenol (11)3-Bromo-4-Hydroxybenzaldehyde (9)3-Bromo-4-Hydroxybenzoic Acid (3)3-Bromo-4-Methoxyaniline (7)3-Bromo-4-Methoxybenzaldehyde (9)3-Bromo-4-Methoxybenzoic Acid (7)3-Bromo-4-Methylaniline (14)3-Bromo-4-Methylbenzoic Acid (9)3-Bromo-4-Methylpyridine (13)3-Bromo-5'-Phenyl-1,1':3',1''-Terphenyl (4)3-Bromo-5-Chloropyridine (14)3-Bromo-5-Fluoropyridine (18)3-Bromo-5-Methylpyridine (14)3-Bromo-5-Nitropyridine (10)3-Bromoaniline (187)3-Bromoazetidine (3)3-Bromobenzene-1,2-Diamine (11)3-Bromobenzene-1,2-Diol (8)3-Bromobenzo[B]Thiophene (5)3-Bromobenzoic Acid (159)3-Bromobenzonitrile (110)3-Bromofuran (13)3-Bromoimidazo[1,2-A]Pyridine (26)3-Bromoimidazo[1,2-A]Pyrimidine (6)3-Bromoisoquinoline (10)3-Bromoisoxazole (7)3-Bromopicolinic Acid (9)3-Bromopicolinonitrile (13)3-Bromopyrazolo[1,5-A]Pyrimidine (11)3-Bromopyridazine (25)3-Bromopyridin-2-Amine (30)3-Bromopyridin-2-Ol (17)3-Bromopyridine 1-Oxide (8)3-Bromopyrrolidine (6)3-Bromothiophene (6)4-(Bromomethyl)-1,1'-Biphenyl (13)4-(Bromomethyl)Pyridine (8)4-Bromo-1,5-Naphthyridine (5)4-Bromo-1-Methyl-1H-Pyrazole (14)4-Bromo-1-Phenyl-1H-Imidazole (9)4-Bromo-1-Phenyl-1H-Pyrazole (11)4-Bromo-1H-Benzo[D]Imidazole (14)4-Bromo-1H-Indole (25)4-Bromo-1H-Pyrazolo[3,4-B]Pyridine (4)4-Bromo-1H-Pyrrolo[2,3-B]Pyridine (9)4-Bromo-2-Chloro-1-Iodobenzene (4)4-Bromo-2-Chloropyridine (29)4-Bromo-2-Fluoro-1-Iodobenzene (8)4-Bromo-2-Fluoropyridine (4)4-Bromo-2-Iodoaniline (8)4-Bromo-2-Methoxypyridine (4)4-Bromo-3-(Trifluoromethyl)Aniline (7)4-Bromo-3-Chloroaniline (21)4-Bromo-3-Fluoroaniline (29)4-Bromo-3-Methylaniline (19)4-Bromo-3-Methylpyridine (5)4-Bromo-3-Nitroaniline (8)4-Bromo-N,N-Diphenylaniline (10)4-Bromo-N-Phenylaniline (6)4-Bromo-N-Phenylbenzenesulfonamide (23)4-Bromobenzo[C][1,2,5]Thiadiazole (14)4-Bromobenzo[D][1,3]Dioxole (6)4-Bromobenzo[D]Thiazole (9)4-Bromobenzofuran (3)4-Bromoindoline (4)4-Bromoisoindolin-1-One (3)4-Bromoisoquinolin-1(2H)-One (3)4-Bromoisoquinoline (33)4-Bromopyridazine (5)4-Bromopyridine (31)4-Bromopyrimidine (24)4-Bromothiazole (10)5-Bromo-1,2,3,4-Tetrahydroisoquinoline (4)5-Bromo-1-Methyl-1H-Indole (3)5-Bromo-1H-1,2,4-Triazole (6)5-Bromo-1H-Benzo[D][1,2,3]Triazole (5)5-Bromo-1H-Benzo[D]Imidazole (13)5-Bromo-1H-Indazole (14)5-Bromo-1H-Pyrazole (11)5-Bromo-1H-Pyrazolo[3,4-B]Pyridine (11)5-Bromo-1H-Pyrazolo[3,4-C]Pyridine (5)5-Bromo-1H-Pyrrolo[2,3-B]Pyridine (13)5-Bromo-2,3-Dihydro-1H-Indene (8)5-Bromo-2,3-Dihydrobenzofuran (6)5-Bromo-2-Chloro-4-Methylpyridine (5)5-Bromo-2-Chloropyridine (40)5-Bromo-2-Chloropyrimidine (6)5-Bromo-2-Fluoropyridine (22)5-Bromo-2-Methoxypyridine (29)5-Bromo-2-Methylpyridine (23)5-Bromo-2-Methylpyrimidine (5)5-Bromo-2-Phenylpyridine (3)5-Bromo-4-Methylpyridin-2-Amine (5)5-Bromo-6-Chloropyridin-2-Amine (3)5-Bromo-7H-Pyrrolo[2,3-D]Pyrimidine (3)5-Bromobenzo[B]Thiophene (3)5-Bromobenzo[D][1,3]Dioxole (12)5-Bromobenzo[D]Oxazole (3)5-Bromoimidazo[1,2-A]Pyridine (6)5-Bromoindoline (8)5-Bromoisoindolin-1-One (8)5-Bromoisoquinoline (17)5-Bromonicotinaldehyde (12)5-Bromonicotinic Acid (6)5-Bromonicotinonitrile (6)5-Bromopicolinic Acid (11)5-Bromopicolinonitrile (13)5-Bromopyrazin-2-Ol (5)5-Bromopyridin-2-Amine (35)5-Bromopyridin-2-Ol (18)5-Bromopyridin-3-Amine (10)5-Bromopyridin-3-Ol (6)5-Bromoquinoxaline (6)5-Bromothiazole (8)6-Bromo-1,2,3,4-Tetrahydroisoquinoline (4)6-Bromo-1,2,3,4-Tetrahydroquinoline (6)6-Bromo-1-Methyl-1H-Indole (3)6-Bromo-1H-Indazole (23)6-Bromo-1H-Indole (15)6-Bromo-1H-Pyrazolo[4,3-B]Pyridine (4)6-Bromo-1H-Pyrrolo[2,3-B]Pyridine (6)6-Bromo-1H-Pyrrolo[3,2-B]Pyridine (7)6-Bromo-1H-Pyrrolo[3,2-C]Pyridine (5)6-Bromo-3,4-Dihydro-2H-Benzo[B][1,4]Oxazine (5)6-Bromo-3,4-Dihydroisoquinolin-1(2H)-One (6)6-Bromo-3,4-Dihydroquinolin-2(1H)-One (4)6-Bromo-[1,2,4]Triazolo[1,5-A]Pyridine (12)6-Bromo-[1,2,4]Triazolo[4,3-A]Pyridine (8)6-Bromobenzo[B]Thiophene (4)6-Bromobenzo[D]Oxazole (3)6-Bromobenzo[D]Thiazole (7)6-Bromochroman-4-One (6)6-Bromoimidazo[1,2-A]Pyrimidine (5)6-Bromoindoline-2,3-Dione (4)6-Bromoisoindolin-1-One (4)6-Bromoisoquinoline (9)6-Bromonicotinaldehyde (10)6-Bromonicotinic Acid (9)6-Bromonicotinonitrile (7)6-Bromopicolinic Acid (5)6-Bromopyrazolo[1,5-A]Pyrimidine (7)6-Bromopyridin-2-Amine (8)6-Bromopyridin-3-Amine (12)6-Bromopyridin-3-Ol (13)6-Bromoquinazoline (7)6-Bromoquinoxaline (9)7-Bromo-1,2,3,4-Tetrahydroisoquinoline (4)7-Bromo-1H-Indazole (18)7-Bromo-1H-Indole (28)7-Bromo-1H-Pyrrolo[2,3-C]Pyridine (4)7-Bromo-2,3-Dihydrobenzofuran (6)7-Bromo-3,4-Dihydro-2H-Benzo[B][1,4]Oxazine (7)7-Bromo-3,4-Dihydroisoquinolin-1(2H)-One (6)7-Bromo-3,4-Dihydronaphthalen-1(2H)-One (8)7-Bromobenzo[B]Thiophene (5)7-Bromobenzo[D]Thiazole (8)7-Bromobenzofuran (6)7-Bromochromane (7)7-Bromoindoline (3)7-Bromoisoquinoline (6)8-Bromo-[1,2,4]Triazolo[1,5-A]Pyridine (6)8-Bromochromane (6)8-Bromoimidazo[1,2-A]Pyridine (15)8-Bromoisoquinoline (17)8-Bromoquinazoline (8)9-Bromoanthracene (5)Bromocyclohexane (7)Ethyl 2-Bromo-2-Phenylacetate (6)Methyl 2-(2-Bromophenyl)Acetate (8)Methyl 2-Bromo-2-Phenylacetate (7)Methyl 2-Bromo-3-Nitrobenzoate (3)Methyl 2-Bromo-5-Fluorobenzoate (8)Methyl 2-Bromo-6-Fluorobenzoate (7)Methyl 2-Bromo-6-Methylbenzoate (8)Methyl 2-Bromobenzoate (69)Methyl 3-(Bromomethyl)Benzoate (16)Methyl 3-Bromo-4-Chlorobenzoate (6)Methyl 3-Bromo-4-Fluorobenzoate (7)Methyl 3-Bromo-4-Methoxybenzoate (10)Methyl 3-Bromo-4-Methylbenzoate (9)Methyl 3-Bromobenzoate (153)Methyl 3-Bromopicolinate (9)Methyl 4-Amino-3-Bromobenzoate (8)Methyl 5-Amino-2-Bromobenzoate (6)Methyl 6-Bromonicotinate (6)N-(2-Benzoylphenyl)-2-Bromoacetamide (3)Tert-Butyl 2-(Bromomethyl)Morpholine-4-Carboxylate (3)Tert-Butyl 3-Bromo-1H-Indole-1-Carboxylate (9)Tert-Butyl 3-Bromopiperidine-1-Carboxylate (4)
Carbamates (7546)
Carboxylic Acid Salts (671)
Alcohols (22)Aliphatic Chain Hydrocarbons (64)Alkenyls (9)Amides (6)Amines (6)Aryls (16)Carboxylic Acids (5)Esters (3)Ethers (5)Ketones (4)
Carboxylic Acids (58085)
Alcohols (171)Aldehydes (18)Aliphatic Chain Hydrocarbons (159)Aliphatic Cyclic Hydrocarbons (65)Alkenyls (129)Alkynyls (13)Amides (226)Amines (178)Aryls (849)Azetidines (17)Benzimidazoles (6)Benzofurans (9)Benzothiazoles (5)Benzoxazoles (4)Bromides (176)Carboxylic Acid Salts (5)Chlorides (174)Difluoromethyls (19)Dioxolanes (4)Esters (73)Ethers (291)Fluorinated Building Blocks (237)Furans (35)Imidazoles (42)Imidazolidines (3)Indazoles (19)Indoles (52)Indolines (16)Iodides (24)Isoquinolines (4)Isoxazoles (18)Ketones (138)Morpholines (34)Naphthyridines (3)Nitriles (45)Nitroes (44)Oxadiazoles (4)Oxazoles (16)Oxetanes (7)Phenols (21)Piperazines (31)Piperidines (91)Pyrans (2)Pyrazines (12)Pyrazoles (71)Pyridazines (10)Pyridines (172)Pyrimidines (46)Pyrroles (28)Pyrrolidines (26)Quinazolines (4)Quinolines (90)Quinoxalines (5)Spiroes (20)Sulfamides (28)Sulfides (57)Sulfones (15)Tetrahydrofurans (7)Tetrahydropyrans (12)Thiazoles (62)Thiazolidines (10)Thioesters (7)Thiophenes (66)Triazoles (10)Trifluoromethyls (71)Ureas (4)Other Aliphatic Heterocycles (12)Other Aromatic Heterocycles (65)Aceticacid (1245)Acetylbenzoic Acid (3)Acrylic (95)Aminobenzoic (7)Aminobutanoic (8)Aminoheptanoic (6)Aminohexanoic (10)Aminonicotinic Acid (4)Aminopentanoic (8)Aminophenylacetic Acid (22)Aminopropanoic (8)Aminoundecanoic Acid (4)Benzenedicarboxylic (6)Benzenedicarboxylic Acid (6)Benzylpropanoic Acid (71)Benzylsuccinic Acid (6)Boronobenzoic (4)Bromobutanoic (5)Bromododecanoate (3)Bromoisonicotinic Acid (4)Bromonicotinic (8)Bromonicotinic Acid (9)Bromophenylacetic Acid (15)Bromovalerate (4)Butanoic (115)Chlorobenzoic (35)Chloromandelic Acid (3)Cyanonicotinic (5)Cyanonicotinic Acid (3)Diacetic (19)Diacetic (19)Diaminobenzoic (7)Diaminobutanoic (5)Diaminohexanoic (4)Dibenzoic (40)Dibromobenzoic (10)Dibromobenzoic Acid (10)Dibromonicotinic Acid (7)Dicarboxylic (183)Dicarboxylic (183)Dichlorobenzoic (21)Dichlorobenzoic Acid (22)Dichloroisonicotinic (6)Dichloroisonicotinic Acid (6)Dichlorophenylacetic Acid (4)Dienoate (14)Dienoic (10)Difluorobenzoic (54)Difluorobutanoic (3)Difluoroisonicotinic Acid (7)Difluorophenylacetic (7)Difluorophenylacetic Acid (7)Diiodobenzoic (5)Diisophthalic (17)Diisophthalic Acid (9)Diisopropylbenzoic Acid (4)Dimethoxybenzoic (33)Dimethoxyphenylacetic Acid (3)Dimethylbenzoic (32)Dimethylbutanoic (13)Dimethylbutanoic (13)Dimethylpropanoic (5)Diphenylpropanoic (4)Diyldimethanol (17)Enedioic (8)Enoic (127)Ethoxybenzoic (9)Ethylbenzoic (11)Ethylbenzoic Acid (12)Ethynylbenzoic (6)Ethynylbenzoic Acid (5)Fluoroisophthalic Acid (4)Fluorophenylacetic (10)Fluorophenylacetic Acid (11)Fluorophthalic (5)Fluorophthalic Acid (3)Fluoropicolinic (12)Formylbenzoic (22)Formylbenzoic Acid (19)Guanidinopentanoic (8)Heptanoic (6)Heptanoic (6)Hexacarboxylic Acid (5)Hexanoic (25)Hexanoic (25)Hydrazinylbenzoic (6)Hydrazinylbenzoic Acid (5)Hydroxynicotinic (15)Isophthalic (29)Isophthalic Acid (15)Isopropoxybenzoic (8)Isopropoxybenzoic Acid (7)Isopropylbenzoic (13)Isopropylnicotinic Acid (4)Malonate (39)Mercaptobenzoic (6)Mercaptobenzoic Acid (4)Mercaptopropanoic (11)Methoxybenzoic (142)Methoxybutanoic (4)Methoxybutanoic (4)Methoxyisophthalic Acid (5)Methoxyphenylacetic (10)Methoxyphenylacetic Acid (12)Methoxypropanoic (7)Methoxypropanoic (7)Methylbenzoic (174)Methylbutanoic (32)Methylbutanoic (32)Methylcinnamic Acid (9)Methylhexanoic (8)Methylhexanoic (8)Methylisophthalic Acid (17)Methylnicotinic (46)Methyloctanoic (6)Methylpentanoic (103)Methylpentanoic (103)Methylpropanoic (57)Naphthoic (64)Nitrobenzoic (161)Nitroisonicotinic Acid (5)Nitroisophthalic Acid (3)Nitronicotinic (10)Nitropicolinic (11)Octanoic (6)Octanoic (6)Oxoacetic (22)Oxobutanoic (54)Oxobutanoic (54)Oxodecanoic (5)Oxodecanoic (5)Oxododecanoic (9)Oxododecanoic (9)Oxoheptanoic (5)Oxoheptanoic (5)Oxoheptanoic Acid (4)Oxohexadecanoic (13)Oxohexadecanoic (13)Oxohexanoic (10)Oxohexanoic (10)Oxooctadecanoic (7)Oxooctadecanoic (7)Oxopentanoic (37)Oxopentanoic (37)Oxopropanoic (8)Pentanedioic (17)Pentanedioic (17)Pentanoic (27)Phenoxybenzoic (5)Phenylacetic (35)Phenylbutanoic (41)Phenylpentanoic (11)Phenylpropanoic (26)Propanoic (996)Propenoic (6)Succinic (13)Sulfamoylbenzoic (15)Sulfobenzoic (5)Terephthalic (7)Tetraacetic (5)Tetrabenzoic (13)Tetrabenzoic Acid (14)Tetracarboxylic (13)Tribenzoic (15)Tribenzoic Acid (14)Tricarboxylic (18)Trichlorobenzoic (5)Trichlorobenzoic Acid (4)Trifluorobenzoic (12)Trifluorobenzoic Acid (11)Trifluorobutanoic (3)Trifluoromethylbenzoic (5)Trifluoromethylbenzoic Acid (4)Trifluoropentanoic (4)Trifluorophenylacetic Acid (16)Trifluoropropanoic (4)Triiodobenzoic (4)Trimethylbenzoic Acid (4)1,2,3,4-Tetrahydroisoquinoline-1-Carboxylic Acid (19)1,2,3,4-Tetrahydroisoquinoline-3-Carboxylic Acid (12)1,5-Naphthyridine-3-Carboxylic Acid (6)1-((Benzyloxy)Carbonyl)Piperidine-2-Carboxylic Acid (5)1-((Benzyloxy)Carbonyl)Piperidine-3-Carboxylic Acid (3)1-((Benzyloxy)Carbonyl)Pyrrolidine-3-Carboxylic Acid (6)1-Methyl-1H-Indole-2-Carboxylic Acid (8)1-Naphthoic Acid (23)1-Phenyl-1H-Imidazole-4-Carboxylic Acid (5)1-Phenyl-1H-Pyrazole-3-Carboxylic Acid (10)1-Phenyl-1H-Pyrazole-4-Carboxylic Acid (19)1-Phenyl-1H-Pyrazole-5-Carboxylic Acid (3)1-Phenylcyclobutane-1-Carboxylic Acid (16)1-Phenylcyclohexane-1-Carboxylic Acid (6)1-Phenylcyclopropane-1-Carboxylic Acid (23)1H-Benzo[D]Imidazole-2-Carboxylic Acid (7)1H-Benzo[D]Imidazole-4-Carboxylic Acid (6)1H-Benzo[D]Imidazole-5-Carboxylic Acid (4)1H-Imidazole-2-Carboxylic Acid (7)1H-Imidazole-4-Carboxylic Acid (4)1H-Indazole-3-Carboxylic Acid (23)1H-Indazole-4-Carboxylic Acid (9)1H-Indazole-5-Carboxylic Acid (4)1H-Indazole-7-Carboxylic Acid (6)1H-Indole-3-Carboxylic Acid (28)1H-Indole-4-Carboxylic Acid (10)1H-Indole-5-Carboxylic Acid (4)1H-Indole-6-Carboxylic Acid (5)1H-Indole-7-Carboxylic Acid (7)1H-Pyrazole-4-Carboxylic Acid (9)1H-Pyrazole-5-Carboxylic Acid (10)1H-Pyrrole-2-Carboxylic Acid (30)1H-Pyrrolo[2,3-B]Pyridine-3-Carboxylic Acid (5)1H-Pyrrolo[2,3-C]Pyridine-2-Carboxylic Acid (4)1H-Pyrrolo[3,2-B]Pyridine-3-Carboxylic Acid (6)2,3-Difluorobenzoic Acid (35)2,3-Dihydrobenzo[B][1,4]Dioxine-2-Carboxylic Acid (3)2,3-Dihydrobenzo[B][1,4]Dioxine-6-Carboxylic Acid (3)2,4-Difluorobenzoic Acid (29)2,5-Dichlorobenzoic Acid (13)2,5-Difluorobenzoic Acid (32)2,6-Dichlorobenzoic Acid (13)2,6-Difluorobenzoic Acid (33)2-(1,3-Dioxoisoindolin-2-Yl)Propanoic Acid (3)2-(1H-Indol-1-Yl)Acetic Acid (5)2-(1H-Indol-3-Yl)Acetic Acid (28)2-(2-Bromophenyl)Acetic Acid (23)2-(2-Chlorophenyl)Acetic Acid (24)2-(2-Fluorophenyl)Acetic Acid (43)2-(2-Hydroxyphenyl)Acetic Acid (8)2-(2-Methoxyphenyl)Acetic Acid (16)2-(2-Methyl-1H-Indol-3-Yl)Acetic Acid (5)2-(2-Nitrophenyl)Acetic Acid (20)2-(2-Oxo-2H-Chromen-4-Yl)Acetic Acid (4)2-(3-Fluorophenyl)Acetic Acid (50)2-(3-Hydroxyphenyl)Acetic Acid (8)2-(3-Methoxyphenyl)Acetic Acid (23)2-(4-Chlorophenoxy)Acetic Acid (3)2-(4-Fluorophenyl)Acetic Acid (30)2-(4-Methoxyphenyl)Acetic Acid (21)2-(4-Nitrophenyl)Acetic Acid (9)2-(Benzofuran-3-Yl)Acetic Acid (3)2-(M-Tolyl)Acetic Acid (16)2-(Morpholin-2-Yl)Acetic Acid (5)2-(O-Tolyl)Acetic Acid (17)2-(P-Tolyl)Acetic Acid (9)2-(Phenylamino)Benzoic Acid (11)2-(Pyridin-3-Yl)Acetic Acid (14)2-(Pyrrolidin-1-Yl)Benzoic Acid (3)2-(Pyrrolidin-2-Yl)Acetic Acid (8)2-(Pyrrolidin-3-Yl)Acetic Acid (6)2-(Thiazol-4-Yl)Acetic Acid (9)2-(Trifluoromethoxy)Benzoic Acid (8)2-(Trifluoromethyl)Benzoic Acid (33)2-Amino-2-(2-Fluorophenyl)Acetic Acid (11)2-Amino-3-Bromobenzoic Acid (8)2-Amino-3-Chlorobenzoic Acid (7)2-Amino-6-Chlorobenzoic Acid (5)2-Benzoylbenzoic Acid (10)2-Bromo-4-Fluorobenzoic Acid (8)2-Bromo-4-Methylbenzoic Acid (5)2-Bromo-6-Fluorobenzoic Acid (11)2-Bromo-6-Methylbenzoic Acid (5)2-Chloro-3-Methoxybenzoic Acid (6)2-Chloro-3-Methylbenzoic Acid (4)2-Chloro-3-Nitrobenzoic Acid (4)2-Chloro-4-Fluorobenzoic Acid (9)2-Chloro-4-Methylbenzoic Acid (3)2-Chloro-6-Fluorobenzoic Acid (8)2-Chlorobenzoic Acid (130)2-Cyclohexylacetic Acid (14)2-Fluoro-4-Methylbenzoic Acid (7)2-Fluoro-5-Methoxybenzoic Acid (9)2-Fluorobenzoic Acid (220)2-Fluorocyclopropane-1-Carboxylic Acid (7)2-Iodobenzoic Acid (47)2-Methoxyisonicotinic Acid (13)2-Methyl-2-Phenylpropanoic Acid (20)2-Methyl-3-Nitrobenzoic Acid (7)2-Naphthoic Acid (14)2-Nitrobenzoic Acid (65)2-Oxo-2-Phenylacetic Acid (17)2-Oxo-2H-Chromene-3-Carboxylic Acid (14)2-Phenoxypropanoic Acid (13)3-(1H-Indol-3-Yl)Propanoic Acid (4)3-(2-Fluorophenyl)Acrylic Acid (17)3-(3-Chlorophenyl)Acrylic Acid (10)3-(3-Chlorophenyl)Propanoic Acid (11)3-(3-Methoxyphenyl)Propanoic Acid (9)3-(Benzyloxy)Benzoic Acid (5)3-(Chlorosulfonyl)Benzoic Acid (15)3-(Methylsulfonyl)Benzoic Acid (6)3-(Phenyldiazenyl)Benzoic Acid (7)3-(Piperazin-1-Yl)Benzoic Acid (3)3-(Trifluoromethoxy)Benzoic Acid (19)3-(Trifluoromethyl)Benzoic Acid (52)3-Benzamidopropanoic Acid (3)3-Bromo-2-Chlorobenzoic Acid (7)3-Bromo-2-Fluorobenzoic Acid (10)3-Bromo-2-Hydroxybenzoic Acid (4)3-Bromo-4-Chlorobenzoic Acid (6)3-Bromo-4-Fluorobenzoic Acid (10)3-Bromo-4-Hydroxybenzoic Acid (3)3-Bromo-4-Methoxybenzoic Acid (7)3-Bromo-4-Methylbenzoic Acid (9)3-Bromobenzoic Acid (159)3-Chloro-2-Fluorobenzoic Acid (9)3-Chloro-2-Methoxybenzoic Acid (4)3-Chloro-4-Fluorobenzoic Acid (8)3-Chloro-4-Methoxybenzoic Acid (5)3-Chlorobenzoic Acid (144)3-Fluoro-4-Methoxybenzoic Acid (6)3-Fluorobenzoic Acid (206)3-Fluoropicolinic Acid (6)3-Iodobenzoic Acid (55)3-Methoxy-4-Nitrobenzoic Acid (4)3-Methylpicolinic Acid (13)3-Nitrobenzoic Acid (109)3-Phenoxybenzoic Acid (6)3-Phenoxypropanoic Acid (14)4-(1H-Pyrazol-1-Yl)Benzoic Acid (3)4-(Benzyloxy)Benzoic Acid (5)4-(Phenyldiazenyl)Benzoic Acid (4)4-(Trifluoromethyl)Nicotinic Acid (3)4-Amino-3-Chlorobenzoic Acid (6)4-Benzamidobenzoic Acid (3)4-Cyclohexylbenzoic Acid (6)4-Fluoro-3-Iodobenzoic Acid (5)4-Fluorobenzoic Acid (114)4-Methylnicotinic Acid (5)4-Morpholinobenzoic Acid (5)4-Nitrobenzoic Acid (35)4-Oxo-1,4-Dihydroquinoline-3-Carboxylic Acid (3)4-Oxo-4-(Phenylamino)Butanoic Acid (7)4-Oxo-4-Phenylbutanoic Acid (16)4-Oxopiperidine-2-Carboxylic Acid (3)4-Phenoxybenzoic Acid (4)4-Phenylbutanoic Acid (19)5'-(4-Carboxyphenyl)-[1,1':3',1''-Terphenyl]-4,4''-Dicarboxylic Acid (7)5-Oxotetrahydrofuran-2-Carboxylic Acid (4)5-Phenyl-1H-Pyrazole-3-Carboxylic Acid (15)5-Phenylfuran-2-Carboxylic Acid (6)5-Phenylisoxazole-3-Carboxylic Acid (15)6,6-Dimethylmorpholine-3-Carboxylic Acid (5)6-Methoxypicolinic Acid (9)6-Methylnicotinic Acid (6)6-Methylpicolinic Acid (12)6-Oxopiperidine-2-Carboxylic Acid (3)6-Phenylpicolinic Acid (3)7-Fluoro-1H-Indole-2-Carboxylic Acid (5)[1,1'-Biphenyl]-2-Carboxylic Acid (24)[1,1'-Biphenyl]-3-Carboxylic Acid (40)Azetidine-2-Carboxylic Acid (6)Benzo[B]Thiophene-2-Carboxylic Acid (32)Benzo[D]Thiazole-6-Carboxylic Acid (5)Benzofuran-2-Carboxylic Acid (21)Benzofuran-3-Carboxylic Acid (6)Benzoic Acid (3487)Benzoylglycine (15)Bicyclo[1.1.1]Pentane-1-Carboxylic Acid (6)Chromane-2-Carboxylic Acid (6)Chromane-3-Carboxylic Acid (4)Cyclobutanecarboxylic Acid (23)Cyclohex-1-Ene-1-Carboxylic Acid (4)Cyclohex-3-Ene-1-Carboxylic Acid (7)Cyclohexanecarboxylic Acid (83)Cyclopentanecarboxylic Acid (26)Cyclopropanecarboxylic Acid (11)Ethyl 5-Oxopyrrolidine-2-Carboxylate (3)Furan-2-Carboxylic Acid (32)Furan-3-Carboxylic Acid (11)Imidazo[1,2-A]Pyridine-2-Carboxylic Acid (21)Imidazo[1,2-A]Pyridine-3-Carboxylic Acid (14)Imidazo[1,2-A]Pyridine-5-Carboxylic Acid (3)Imidazo[1,2-A]Pyridine-7-Carboxylic Acid (5)Imidazo[1,2-A]Pyridine-8-Carboxylic Acid (6)Imidazo[1,2-A]Pyrimidine-3-Carboxylic Acid (5)Indoline-2-Carboxylic Acid (3)Isonicotinic Acid (23)Isoquinoline-1-Carboxylic Acid (10)Isoquinoline-3-Carboxylic Acid (7)Isoquinoline-4-Carboxylic Acid (12)Isoquinoline-5-Carboxylic Acid (5)Isoquinoline-6-Carboxylic Acid (3)Isoxazole-3-Carboxylic Acid (8)Isoxazole-5-Carboxylic Acid (7)Methyl Benzofuran-2-Carboxylate (6)Methyl Isoquinoline-3-Carboxylate (3)Morpholine-2-Carboxylic Acid (12)Morpholine-3-Carboxylic Acid (10)Nicotinic Acid (53)Oxazole-4-Carboxylic Acid (4)Picolinic Acid (22)Piperidine-2-Carboxylic Acid (26)Piperidine-3-Carboxylic Acid (14)Piperidine-4-Carboxylic Acid (12)Proline (13)Pyrazine-2-Carboxylic Acid (34)Pyrazolo[1,5-A]Pyrimidine-3-Carboxylic Acid (7)Pyridazine-3-Carboxylic Acid (7)Pyridine-2,6-Dicarboxylic Acid (9)Pyrimidine-2-Carboxylic Acid (11)Pyrimidine-4-Carboxylic Acid (17)Pyrimidine-5-Carboxylic Acid (7)Pyrrolidine-3-Carboxylic Acid (14)Tetrahydrofuran-2-Carboxylic Acid (4)Tetrahydrofuran-3-Carboxylic Acid (4)Thiazole-2-Carboxylic Acid (9)Thiazole-4-Carboxylic Acid (5)Thiazole-5-Carboxylic Acid (10)Thiophene-3-Carboxylic Acid (8)Tryptophan (22)
Chlorides (77789)
Acyl Chlorides (88)Alcohols (157)Aldehydes (88)Aliphatic Chain Hydrocarbons (143)Aliphatic Cyclic Hydrocarbons (19)Alkenyls (57)Alkynyls (18)Amides (372)Amidines (9)Amines (309)Anhydrides (8)Aryls (1047)Azetidines (10)Benzimidazoles (15)Benzofurans (15)Benzothiazoles (6)Benzoxazoles (11)Benzyl Bromides (6)Benzyl Chlorides (49)Bromides (241)Carboxylic Acids (174)Difluoromethyls (22)Esters (298)Ethers (285)Fluorinated Building Blocks (224)Furans (9)Hydrazides (15)Hydrazines (26)Hydrazones (4)Imidazoles (15)Indazoles (10)Indoles (27)Indolines (14)Iodides (51)Isoquinolines (14)Isoxazoles (19)Ketones (139)Morpholines (24)Nitriles (97)Nitroes (81)Oxazoles (14)Oximes (7)Phenols (26)Piperazines (22)Piperidines (68)Purines (6)Pyrazines (31)Pyrazoles (27)Pyridazines (32)Pyridines (372)Pyrimidines (209)Pyrroles (13)Pyrrolidines (49)Quinazolines (20)Quinolines (110)Quinoxalines (9)Spiroes (4)Sulfamides (51)Sulfides (50)Sulfones (29)Sulfoxides (7)Tetrahydrofurans (3)Tetrahydroisoquinolines (4)Tetrahydropyrans (5)Thiadiazoles (4)Thiazoles (29)Thiophenes (49)Triazines (13)Trifluoromethyls (61)Ureas (7)Other Aliphatic Heterocycles (3)Other Aromatic Heterocycles (149)Chloroacetamide (17)Chloroacetyl (10)Chloroaniline (18)Chlorobenzaldehyde (18)Chlorobenzamide (12)Chlorobutyl (6)Chlorobutyl (6)Chlorocarbonyl (7)Chloroethoxy (10)Chloroethoxy (10)Chloroethyl (89)Chloromethyl (478)Chloropicolinaldehyde (8)Chloropicolinamide (5)Chloropropane (18)Chloropropane (18)Chloropropoxy (2)Chloropropoxy (2)Chloropropyl (23)Dichloride (28)Dichloroaniline (9)Dichloroanthracene (3)Dichlorobenzaldehyde (13)Dichlorobenzamide (8)Dichloroisonicotinaldehyde (4)Dichloromethyl (3)Dichloromethyl (3)Dichloronicotinaldehyde (6)Dichloronicotinic (6)Dichloronicotinic (6)Dichloronicotinic Acid (5)Dichloropalladium (4)Dichloropalladium (4)Tetrachloro (2)Tetrachloro (2)Trichloro (36)Trichloro (36)Trichloroacetimidate (5)Trichloroaniline (6)Trichlorobenzaldehyde (4)Trichloromethyl (11)Trichloromethyl (11)(2,3-Dichlorophenyl)Boronic Acid (11)(2,6-Dichlorophenyl)Boronic Acid (6)(2-Chloroethoxy)Benzene (5)(2-Chlorophenyl)(Phenyl)Methanone (19)(2-Chlorophenyl)Hydrazine (16)(2-Chlorophenyl)Methanamine (28)(2-Chlorophenyl)Methanol (40)(2-Chloropyridin-4-Yl)Boronic Acid (6)(3,4-Dichlorophenyl)Boronic Acid (10)(3-Chloro-4-Fluorophenyl)Boronic Acid (8)(3-Chlorophenyl)(Phenyl)Methanone (19)(3-Chlorophenyl)Boronic Acid (121)(3-Chlorophenyl)Hydrazine (12)(3-Chlorophenyl)Methanamine (19)(3-Chlorophenyl)Methanol (38)(3-Chloropyridin-2-Yl)Methanamine (6)(4-Chlorophenyl)(Phenyl)Methanone (11)(5-Chloropyridin-2-Yl)Methanamine (5)(Chloromethanetriyl)Tribenzene (7)(Chloromethylene)Dibenzene (5)1,2,3,4-Tetrachlorobenzene (8)1,2,4-Trichlorobenzene (26)1,2-Dibromo-3-Chlorobenzene (3)1,2-Dichloro-3-Fluorobenzene (13)1,2-Dichloro-3-Methoxybenzene (7)1,2-Dichloro-3-Methylbenzene (8)1,2-Dichloro-4-Fluorobenzene (15)1,2-Dichloro-4-Methoxybenzene (11)1,2-Dichloro-4-Nitrobenzene (16)1,3-Dibromo-2-Chlorobenzene (8)1,3-Dichloro-2-Fluorobenzene (23)1,3-Dichloro-2-Iodobenzene (5)1,3-Dichloro-2-Methoxybenzene (9)1,3-Dichloro-2-Nitrobenzene (5)1,3-Dichloroisoquinoline (14)1,4-Dichloro-2-Fluorobenzene (11)1,4-Dichloro-2-Methoxybenzene (8)1-(2-Chlorophenyl)Ethan-1-One (40)1-(2-Chlorophenyl)Piperazine (4)1-(3-Chlorophenyl)-1H-Pyrazole (3)1-(3-Chlorophenyl)-N-Methylmethanamine (8)1-(3-Chlorophenyl)Ethan-1-One (38)1-(3-Chlorophenyl)Pyrrolidine (3)1-(Benzyloxy)-2-Chlorobenzene (16)1-(Benzyloxy)-3-Chlorobenzene (6)1-(Bromomethyl)-2-Chlorobenzene (28)1-(Bromomethyl)-3-Chlorobenzene (27)1-(Chloromethyl)-2-Methylbenzene (7)1-Benzyl-2-Chlorobenzene (9)1-Benzyl-3-Chlorobenzene (3)1-Benzyl-4-Chlorobenzene (6)1-Bromo-2,3-Dichlorobenzene (18)1-Bromo-2-Chloro-3-Methylbenzene (9)1-Bromo-3-Chloro-2-Fluorobenzene (9)1-Bromo-3-Chloro-2-Methylbenzene (6)1-Bromo-4-Chloro-2-Fluorobenzene (22)1-Chloro-2,3-Difluorobenzene (27)1-Chloro-2,4-Difluorobenzene (35)1-Chloro-2,4-Dimethoxybenzene (7)1-Chloro-2-(Chloromethyl)Benzene (12)1-Chloro-2-(Trifluoromethoxy)Benzene (20)1-Chloro-2-(Trifluoromethyl)Benzene (81)1-Chloro-2-Cyclopropylbenzene (7)1-Chloro-2-Ethoxybenzene (14)1-Chloro-2-Fluoro-3-Iodobenzene (5)1-Chloro-2-Fluoro-4-Nitrobenzene (9)1-Chloro-2-Iodobenzene (65)1-Chloro-2-Isocyanatobenzene (6)1-Chloro-2-Isothiocyanatobenzene (7)1-Chloro-2-Methyl-3-Nitrobenzene (6)1-Chloro-2-Nitrobenzene (138)1-Chloro-2-Phenoxybenzene (10)1-Chloro-2-Propoxybenzene (5)1-Chloro-3,5-Dimethylbenzene (8)1-Chloro-3-(Chloromethyl)Benzene (7)1-Chloro-3-(Trifluoromethoxy)Benzene (18)1-Chloro-3-(Trifluoromethyl)Benzene (101)1-Chloro-3-Fluoro-2-Methylbenzene (10)1-Chloro-3-Fluoro-2-Nitrobenzene (6)1-Chloro-3-Iodo-2-Methylbenzene (3)1-Chloro-3-Iodobenzene (78)1-Chloro-3-Methoxybenzene (125)1-Chloro-3-Nitrobenzene (161)1-Chloro-3-Phenoxybenzene (5)1-Chloro-4-(Trifluoromethoxy)Benzene (8)1-Chloro-4-Iodobenzene (49)1-Chloro-4-Methoxybenzene (98)1-Chloro-4-Phenoxybenzene (13)1-Chloroanthracene-9,10-Dione (6)1-Chloroisoquinoline (20)1-Chloronaphthalene (24)2,3,5-Trichloropyridine (13)2,3,6-Trichloropyridine (16)2,3-Dichloroaniline (18)2,3-Dichlorobenzaldehyde (7)2,3-Dichlorophenol (9)2,3-Dichloropyridine (38)2,4,5-Trichloropyrimidine (6)2,4,6-Trichloropyridine (5)2,4,6-Trichloropyrimidine (14)2,4-Dibromo-1-Chlorobenzene (8)2,4-Dichloro-1-Fluorobenzene (27)2,4-Dichloro-1-Methoxybenzene (18)2,4-Dichloro-1-Nitrobenzene (19)2,4-Dichloro-6-Methylpyridine (8)2,4-Dichloro-6-Methylpyrimidine (7)2,4-Dichlorobenzaldehyde (8)2,4-Dichlorobenzonitrile (4)2,4-Dichloropyridine (50)2,4-Dichloroquinazoline (19)2,4-Dichlorothiazole (4)2,5-Dichlorophenol (7)2,5-Dichloropyrazine (4)2,5-Dichloropyridine (32)2,6-Dichloro-3-Fluoropyridine (10)2,6-Dichloro-3-Methylpyridine (5)2,6-Dichloro-3-Nitropyridine (6)2,6-Dichloro-4-Methylpyridine (5)2,6-Dichloroaniline (27)2,6-Dichlorobenzoic Acid (13)2,6-Dichlorobenzonitrile (8)2,6-Dichloronicotinonitrile (8)2,6-Dichlorophenol (16)2,6-Dichloropyrazine (14)2,6-Dichloropyridin-3-Amine (11)2,6-Dichloropyridine (49)2-(2-Chlorophenyl)Acetic Acid (24)2-(2-Chlorophenyl)Acetonitrile (16)2-(2-Chlorophenyl)Ethan-1-Ol (8)2-(2-Chlorophenyl)Pyridine (3)2-(2-Chlorophenyl)Pyrrolidine (17)2-(3-Chlorophenyl)-4,4,5,5-Tetramethyl-1,3,2-Dioxaborolane (8)2-(3-Chlorophenyl)Acetonitrile (16)2-(4-Chlorophenoxy)Acetic Acid (3)2-(Chloromethyl)-1H-Benzo[D]Imidazole (9)2-(Chloromethyl)-3-Methylpyridine (12)2-(Chloromethyl)Furan (3)2-(Chloromethyl)Pyridine (12)2-(Chloromethyl)Pyridine 1-Oxide (4)2-(Chloromethyl)Pyrimidine (5)2-(Chloromethyl)Thiazole (5)2-Amino-3-Chlorobenzoic Acid (7)2-Amino-3-Chlorobenzonitrile (3)2-Amino-6-Chlorophenol (5)2-Bromo-1,3-Dichlorobenzene (12)2-Bromo-1,4-Dichlorobenzene (12)2-Bromo-1-Chloro-4-Methylbenzene (6)2-Bromo-4-Chloro-1-Iodobenzene (6)2-Bromo-4-Chloro-1-Methoxybenzene (7)2-Bromo-4-Chloro-1-Methylbenzene (11)2-Bromo-4-Chloroaniline (15)2-Bromo-4-Chlorophenol (11)2-Bromo-6-Chloroaniline (10)2-Bromo-6-Chlorophenol (5)2-Chloro-1,1'-Biphenyl (8)2-Chloro-1,3,5-Triazine (10)2-Chloro-1,3-Difluorobenzene (27)2-Chloro-1,3-Dimethoxybenzene (3)2-Chloro-1,3-Dinitrobenzene (2)2-Chloro-1,4-Difluorobenzene (25)2-Chloro-1,4-Dimethoxybenzene (4)2-Chloro-1-Fluoro-4-Nitrobenzene (16)2-Chloro-1-Methyl-3-Nitrobenzene (4)2-Chloro-1-Phenylethan-1-One (20)2-Chloro-1H-Benzo[D]Imidazole (17)2-Chloro-3,6-Dimethylpyridine (4)2-Chloro-3-(Trifluoromethyl)Aniline (3)2-Chloro-3-(Trifluoromethyl)Pyridine (12)2-Chloro-3-Fluoropyridin-4-Amine (3)2-Chloro-3-Hydroxybenzaldehyde (4)2-Chloro-3-Methoxypyridine (12)2-Chloro-3-Methylaniline (4)2-Chloro-3-Methylbenzoic Acid (4)2-Chloro-3-Methylbenzonitrile (5)2-Chloro-3-Methylpyrazine (7)2-Chloro-3-Methylpyridine (17)2-Chloro-3-Nitropyridine (10)2-Chloro-4,6-Dimethylpyridine (7)2-Chloro-4-(Trifluoromethyl)Pyridine (9)2-Chloro-4-Ethoxypyridine (5)2-Chloro-4-Fluoro-1-Nitrobenzene (13)2-Chloro-4-Fluoroaniline (19)2-Chloro-4-Fluoropyridine (10)2-Chloro-4-Methoxypyridine (22)2-Chloro-4-Methyl-1-Nitrobenzene (6)2-Chloro-4-Methylaniline (7)2-Chloro-4-Methylbenzoic Acid (3)2-Chloro-4-Methylpyridine (31)2-Chloro-4-Methylpyrimidine (16)2-Chloro-4-Methylthiazole (5)2-Chloro-4-Phenylpyrimidine (7)2-Chloro-5-(Trifluoromethyl)Pyridine (4)2-Chloro-5-Fluoropyridin-4-Amine (3)2-Chloro-5-Fluoropyridine (16)2-Chloro-5-Methoxyaniline (8)2-Chloro-5-Methylpyridine (11)2-Chloro-5-Methylpyrimidine (5)2-Chloro-5-Methylthiazole (5)2-Chloro-5-Nitropyridine (8)2-Chloro-6-(Trifluoromethyl)Aniline (4)2-Chloro-6-(Trifluoromethyl)Pyridine (16)2-Chloro-6-Fluoroaniline (8)2-Chloro-6-Fluorophenol (5)2-Chloro-6-Fluoropyridine (14)2-Chloro-6-Iodophenol (3)2-Chloro-6-Methoxyaniline (3)2-Chloro-6-Methoxyphenol (4)2-Chloro-6-Methoxypyridine (24)2-Chloro-6-Methyl-3-Nitropyridine (4)2-Chloro-6-Methylaniline (11)2-Chloro-6-Methylnicotinonitrile (10)2-Chloro-6-Methylphenol (5)2-Chloro-6-Methylpyrazine (12)2-Chloro-6-Methylpyridine (49)2-Chloro-6-Nitroaniline (11)2-Chloro-7H-Purine (3)2-Chloro-7H-Pyrrolo[2,3-D]Pyrimidine (13)2-Chloro-9H-Purine (5)2-Chloro-N-Phenylacetamide (26)2-Chloro-N-Phenylaniline (8)2-Chloroaniline (214)2-Chlorobenzamide (16)2-Chlorobenzene-1,3-Diamine (3)2-Chlorobenzene-1,3-Diol (4)2-Chlorobenzene-1,4-Diamine (6)2-Chlorobenzenesulfonyl Chloride (24)2-Chlorobenzenethiol (7)2-Chlorobenzo[D]Oxazole (11)2-Chlorobenzo[D]Thiazole (21)2-Chlorobenzoic Acid (130)2-Chlorobenzonitrile (99)2-Chlorobenzoyl Chloride (13)2-Chlorocyclohexa-2,5-Diene-1,4-Dione (4)2-Chlorofuran (3)2-Chloroisonicotinaldehyde (19)2-Chloroisonicotinic Acid (17)2-Chloroisonicotinonitrile (7)2-Chloronaphthalene (6)2-Chloronicotinic Acid (7)2-Chloronicotinonitrile (9)2-Chlorooxazole (7)2-Chlorophenol (163)2-Chloropyrazine (24)2-Chloropyridin-3-Amine (11)2-Chloropyridin-3-Ol (9)2-Chloropyridin-4-Amine (28)2-Chloropyridine 1-Oxide (10)2-Chloroquinoxaline (39)2-Chlorothiazole (32)2-Chlorothiophene (20)3,4-Dichloroaniline (21)3,5-Dichloropyridine (16)3,6-Dichloropyridazine (20)3-(3-Chlorophenyl)Propanoic Acid (11)3-(Chloromethyl)Pyridine (22)3-Chloro-1,1'-Biphenyl (12)3-Chloro-1-Methyl-1H-Pyrazole (7)3-Chloro-1-Phenylpropan-1-One (10)3-Chloro-1H-Indazole (13)3-Chloro-2-Fluoroaniline (9)3-Chloro-2-Fluorobenzaldehyde (9)3-Chloro-2-Fluorobenzoic Acid (9)3-Chloro-2-Fluorobenzonitrile (7)3-Chloro-2-Fluoropyridine (13)3-Chloro-2-Hydroxybenzaldehyde (5)3-Chloro-2-Methoxypyridine (16)3-Chloro-2-Methylaniline (11)3-Chloro-2-Methylpyridine (4)3-Chloro-2-Nitroaniline (5)3-Chloro-4-(Trifluoromethyl)Aniline (5)3-Chloro-4-Fluoroaniline (18)3-Chloro-4-Fluorobenzoic Acid (8)3-Chloro-4-Hydroxybenzaldehyde (7)3-Chloro-4-Methylaniline (12)3-Chloro-4-Methylpyridazine (7)3-Chloro-4-Nitroaniline (5)3-Chloro-5-Fluoropyridine (10)3-Chloro-5-Methylpyridine (7)3-Chloro-5-Nitropyridine (5)3-Chloro-9H-Carbazole (3)3-Chlorobenzaldehyde (106)3-Chlorobenzene-1,2-Diamine (6)3-Chlorobenzene-1,2-Diol (6)3-Chlorobenzenesulfonyl Chloride (21)3-Chlorobenzo[B]Thiophene (6)3-Chlorobenzoic Acid (144)3-Chlorobenzonitrile (100)3-Chloroimidazo[1,2-A]Pyridine (3)3-Chloroisoquinoline (20)3-Chlorophenol (112)3-Chloropicolinic Acid (9)3-Chloropicolinonitrile (6)3-Chloropyridazine (44)3-Chloropyridin-2-Amine (17)3-Chloropyridin-2-Ol (10)3-Chlorothiophene (17)4,5-Dichloropyrimidine (7)4,6-Dichloro-2-Methylpyrimidine (7)4,6-Dichloropyridin-2-Amine (6)4,6-Dichloropyridin-3-Amine (4)4,6-Dichloropyrimidine (14)4-Chloro-1,5-Naphthyridine (6)4-Chloro-1-Phenylbutan-1-One (8)4-Chloro-1H-Indazole (18)4-Chloro-1H-Indole (21)4-Chloro-1H-Pyrazole (10)4-Chloro-1H-Pyrazolo[3,4-B]Pyridine (5)4-Chloro-1H-Pyrazolo[3,4-D]Pyrimidine (5)4-Chloro-1H-Pyrazolo[4,3-C]Pyridine (7)4-Chloro-1H-Pyrrolo[3,2-C]Pyridine (10)4-Chloro-2,6-Dimethylpyridine (4)4-Chloro-2-Methoxypyridine (6)4-Chloro-2-Phenylpyrimidine (5)4-Chloro-3-Fluoroaniline (17)4-Chloro-3-Methylaniline (11)4-Chloro-3-Methylpyridine (7)4-Chloro-5-Methylpyrimidine (8)4-Chloro-N-Phenylaniline (6)4-Chlorobenzene-1,3-Diol (6)4-Chlorobenzenesulfonic Acid (4)4-Chlorobenzenesulfonyl Chloride (12)4-Chlorobenzo[D]Thiazole (7)4-Chloroindoline-2,3-Dione (6)4-Chloroisoquinoline (11)4-Chloronicotinic Acid (4)4-Chloropyridazine (16)4-Chloropyridin-2-Amine (6)4-Chloropyridine (31)4-Chloroquinazoline (39)5,6-Dichloro-1H-Benzo[D]Imidazole (4)5,6-Dichloropyridin-2-Amine (4)5-Bromo-4-Chloropyrimidine (4)5-Chloro-1,2,3,4-Tetrahydroisoquinoline (3)5-Chloro-1H-Imidazole (2)5-Chloro-1H-Indazole (9)5-Chloro-1H-Indole (64)5-Chloro-1H-Indole-2-Carboxylic Acid (6)5-Chloro-1H-Pyrazole (8)5-Chloro-1H-Pyrazolo[4,3-B]Pyridine (6)5-Chloro-1H-Pyrrolo[2,3-B]Pyridine (13)5-Chloro-1H-Pyrrolo[3,2-B]Pyridine (6)5-Chloro-2,3-Dihydrobenzofuran (5)5-Chloro-2-Fluoropyridine (13)5-Chloro-2-Methoxypyridine (10)5-Chloro-2-Methylpyridine (10)5-Chlorobenzo[B]Thiophene (4)5-Chlorobenzo[D]Oxazole (5)5-Chlorobenzo[D]Thiazole (5)5-Chloroimidazo[1,2-A]Pyridine (3)5-Chloroindolin-2-One (3)5-Chloroisoquinoline (6)5-Chloropicolinic Acid (7)5-Chloropicolinonitrile (6)5-Chloropyrazolo[1,5-A]Pyrimidine (24)5-Chloropyridin-2-Amine (26)5-Chloropyridin-2-Ol (15)5-Chloropyridin-3-Amine (7)5-Chloropyrimidine (8)5-Chloroquinazoline (4)6-Chloro-1,2,3,4-Tetrahydroisoquinoline (3)6-Chloro-1,2,3,4-Tetrahydroquinoline (3)6-Chloro-1H-Benzo[D]Imidazole (25)6-Chloro-1H-Indazole (14)6-Chloro-1H-Indole (19)6-Chloro-1H-Pyrazolo[4,3-C]Pyridine (8)6-Chloro-1H-Pyrrolo[2,3-B]Pyridine (13)6-Chloro-1H-Pyrrolo[3,2-C]Pyridine (13)6-Chloro-2,3-Dihydrobenzofuran (3)6-Chloro-3,4-Dihydro-2H-Benzo[B][1,4]Oxazine (5)6-Chloro-3-Nitropyridin-2-Amine (4)6-Chloro-5-(Trifluoromethyl)Pyridin-2-Amine (3)6-Chlorobenzo[D]Oxazole (4)6-Chlorobenzo[D]Thiazole (6)6-Chlorochroman-4-One (6)6-Chlorochromane (6)6-Chloroindoline (3)6-Chloroindoline-2,3-Dione (5)6-Chloronicotinaldehyde (24)6-Chloronicotinic Acid (4)6-Chloropicolinic Acid (12)6-Chloropicolinonitrile (9)6-Chloropyridazin-3(2H)-One (5)6-Chloropyridin-2-Amine (21)6-Chloropyridin-2-Ol (9)6-Chloropyridin-3-Amine (4)6-Chloropyridine-3-Sulfonyl Chloride (5)6-Chloroquinoxaline (3)7-Chloro-1,2,3,4-Tetrahydroisoquinoline (5)7-Chloro-1H-Indazole (7)7-Chloro-1H-Indole (29)7-Chloro-1H-Pyrrolo[2,3-C]Pyridine (5)7-Chloro-2,3-Dihydrobenzofuran (3)7-Chloro-3,4-Dihydronaphthalen-1(2H)-One (6)7-Chlorobenzo[D]Thiazole (6)7-Chlorochromane (5)7-Chloroisoquinoline (6)7-Chloropyrazolo[1,5-A]Pyrimidine (8)8-Chlorochromane (5)8-Chloroimidazo[1,2-A]Pyridine (7)8-Chloroisoquinoline (7)8-Chloroquinazoline (5)Ethyl 4,6-Dichloronicotinate (4)Ethyl 5-Chloro-1H-Indole-2-Carboxylate (5)Ethyl 6-Chloropicolinate (7)Ethyl 7-Chloro-1H-Indole-2-Carboxylate (5)Methyl 2,6-Dichlorobenzoate (7)Methyl 2-Chloro-4-Fluorobenzoate (5)Methyl 2-Chloro-6-Fluorobenzoate (7)Methyl 2-Chlorobenzoate (79)Methyl 2-Chloroisonicotinate (11)Methyl 2-Chloronicotinate (6)Methyl 3-Chlorobenzoate (88)Methyl 3-Chloropicolinate (9)Methyl 6-Chloropicolinate (11)N-(2-Chlorophenyl)Acetamide (16)N-(3-Chlorophenyl)Benzenesulfonamide (6)N-(3-Chlorophenyl)Quinazolin-4-Amine (10)N-(4-Chlorophenyl)Acetamide (9)Phenyl Carbonochloridate (5)Pyridine-2-Sulfonyl Chloride (9)Pyridine-3-Sulfonyl Chloride (25)Tert-Butyl (2-Chloropyridin-4-Yl)Carbamate (4)
Diazoes (3)
Difluoromethyls (32970)
Alcohols (10)Aliphatic Chain Hydrocarbons (13)Amines (19)Aryls (43)Bromides (36)Carboxylic Acids (19)Chlorides (22)Esters (6)Ethers (64)Fluorinated Building Blocks (124)Ketones (1)Pyrazoles (11)Pyridines (56)Pyrimidines (9)(Difluoromethyl)Benzene (62)1-(Difluoromethoxy)-2-Fluorobenzene (11)1-(Difluoromethyl)-2-Fluorobenzene (13)1-Bromo-2-(Difluoromethyl)Benzene (5)2-(Difluoromethoxy)Phenol (5)2-(Difluoromethyl)Pyridine (21)3-(Difluoromethyl)Pyridine (5)4-(Difluoromethoxy)Aniline (6)5-(Difluoromethyl)-1H-Pyrazole (6)
Esters (50749)
Acyl Chlorides (22)Alcohols (239)Aldehydes (47)Aliphatic Chain Hydrocarbons (450)Aliphatic Cyclic Hydrocarbons (109)Alkenyls (245)Alkynyls (19)Amides (300)Amines (302)Anhydrides (81)Aryls (893)Azetidines (11)Benzimidazoles (12)Benzofurans (34)Benzothiazoles (5)Benzothiophenes (8)Benzoxazoles (4)Benzyl Bromides (14)Benzyl Chlorides (10)Bromides (314)Carboxylic Acid Salts (3)Carboxylic Acids (73)Chlorides (298)Difluoromethyls (6)Dioxolanes (7)Epoxides (9)Ethers (268)Fluorinated Building Blocks (194)Furans (23)Hydrazines (7)Imidazoles (34)Indazoles (15)Indoles (61)Indolines (9)Iodides (31)Isoquinolines (7)Isoxazoles (11)Ketones (319)Morpholines (32)Nitriles (102)Nitroes (72)Oxazoles (18)Oxazolidines (7)Oxazolines (6)Oxetanes (10)Oximes (5)Phenols (30)Phosphoruses (6)Piperazines (38)Piperidines (69)Pyrans (5)Pyrazines (9)Pyrazoles (33)Pyridazines (11)Pyridines (230)Pyrimidines (63)Pyrroles (21)Pyrrolidines (32)Pyrrolines (2)Quinazolines (5)Quinolines (74)Quinuclidines (3)Spiroes (19)Sulfamides (23)Sulfides (27)Sulfones (16)Tetrahydrofurans (22)Tetrahydropyrans (25)Tetrazoles (5)Thiadiazoles (4)Thiazoles (70)Thiols (9)Thiophenes (70)Triazoles (9)Trifluoromethyls (72)Other Aliphatic Heterocycles (69)Other Aromatic Heterocycles (146)Acetoxymethyl (85)Acetoxyphenyl (1)Acetyloxy (54)Acrylate (118)Acryloyloxy (3)Adipate (17)Adipate (17)Aminobenzoate (18)Aminobenzylcarbamate (8)Aminobutanoate (14)Aminocyclobutanecarboxylic Acid (4)Aminocyclohexanecarboxylic (16)Aminocyclohexanecarboxylic Acid (11)Aminocyclopentanecarboxylic (13)Aminoheptanoate (9)Aminohexanoate (6)Aminoisonicotinate (4)Aminoisophthalate (5)Aminonicotinate (7)Aminopentanedioate (15)Aminopentanoate (7)Aminopropanoate (16)Benzoyloxy (14)Benzylcarbamate (8)Bromobenzoate (26)Bromobutanoate (9)Bromodecanoate (20)Bromoisonicotinate (8)Bromoisophthalate (3)Bromonicotinate (13)Bromopropanoate (9)Bromoundecanoate (3)Butoxycarbonyl (1449)Butoxycarbonyl (1449)Carbamate (1496)Chlorobenzoate (49)Chloroformate (4)Chloropicolinate (30)Chloropropanoate (5)Cyanoacrylate (5)Decanedioate (9)Decanedioate (9)Decanoate (7)Decanoate (7)Diacetate (55)Diacetoxy (1)Diacrylate (15)Diaminobenzoate (7)Dibromobenzoate (4)Dicarbamate (14)Dichlorobenzoate (24)Dichloroisonicotinate (9)Dimethacrylate (1)Dimethylbutanoate (14)Dimethylcarbamate (3)Dimethylnicotinate (10)Dimethylnicotinate (10)Dipropanoate (6)Dipropanoate (6)Diyldicarbamate (5)Dodecanoate (11)Enecarboxylate (9)Enoate (116)Ethoxycarbonyl (69)Ethylbutanoate (6)Ethynylbenzoate (7)Ethynylbenzylcarbamate (3)Glutarate (3)Glutarate (3)Hexanoate (14)Hexanoate (14)Iodoacrylate (6)Iodobutanoate (4)Iodopropanoate (1)Isobutyrate (18)Isobutyrate (18)Methacrylate (87)Methacryloyloxy (7)Methoxycarbonyl (168)Methoxycarbonyl (168)Methoxyisonicotinate (11)Methoxyisonicotinate (11)Methoxynicotinate (24)Methoxynicotinate (24)Methoxypropanoate (5)Methoxypropanoate (5)Methylacrylate (13)Methylbutanoate (38)Methylmalonate (6)Methylnicotinate (57)Methylpentanoate (17)Methylpropanoate (47)Nitropicolinate (13)Nonanedioate (4)Nonanedioate (4)Oxoacetate (21)Oxoacetate (21)Oxobutanoate (56)Oxobutanoate (56)Oxoheptanoate (8)Oxoheptanoate (8)Oxohexanoate (14)Oxohexanoate (14)Oxopentanoate (31)Oxopropanoate (39)Oxopropanoate (39)Pentanoate (13)Pentanoate (13)Phenylacrylate (5)Phenylpropanoate (30)Propanoate (266)Propylpentanoate (5)Propylpentanoate (5)Succinate (23)Succinate (23)Sulfamoylbenzoate (6)Tetraacetate (7)Tetraacetate (7)Tetradecanoate (10)Tetradecanoate (10)Tosylcarbamate (4)Tosyloxy (12)Triacetate (12)Triacetate (12)Vinylbenzoate (3)Vinylcyclopropanecarboxylic Acid (3)(2R,3S)-2-((Benzoyloxy)Methyl)Tetrahydrofuran-3-Yl Benzoate (8)(9H-Fluoren-9-Yl)Methyl (3-Phenylpropyl)Carbamate (24)1,3-Dioxoisoindolin-2-Yl 2-Phenylacetate (5)1-Benzyl 2-Methyl Pyrrolidine-1,2-Dicarboxylate (7)1-Benzyl 3-Methyl Piperidine-1,3-Dicarboxylate (3)1-Benzyl 4-(Tert-Butyl) Piperazine-1,4-Dicarboxylate (10)1H-Indol-3-Yl Acetate (4)2,5-Dioxopyrrolidin-1-Yl Benzoate (8)2-((Tert-Butoxycarbonyl)Amino)Benzoic Acid (11)2-(Diethylamino)Ethyl Benzoate (3)2-Ethylhexyl Benzoate (13)2-Hydroxyethyl Benzoate (3)2-Phenoxyacetyl Chloride (3)4-Cyanophenyl Benzoate (11)Allyl Benzoate (5)Azetidin-3-Yl Acetate (3)Benzoic Anhydride (6)Benzyl Acetate (11)Benzyl Benzoate (12)Benzyl Benzylcarbamate (14)Benzyl Cyclohexylcarbamate (9)Benzyl Morpholine-4-Carboxylate (5)Benzyl Phenylcarbamate (15)Benzyl Piperidine-1-Carboxylate (50)Butyl Benzoate (10)Dimethyl Isophthalate (32)Dimethyl Phthalate (14)Dimethyl Pyridine-2,6-Dicarboxylate (7)Ethane-1,2-Diyl Dibenzoate (11)Ethyl 1-Phenyl-1H-Pyrazole-3-Carboxylate (4)Ethyl 1-Phenyl-1H-Pyrazole-4-Carboxylate (13)Ethyl 1-Phenylcyclopropane-1-Carboxylate (4)Ethyl 1H-1,2,4-Triazole-3-Carboxylate (3)Ethyl 1H-Imidazole-2-Carboxylate (6)Ethyl 1H-Indole-3-Carboxylate (6)Ethyl 1H-Pyrazole-4-Carboxylate (11)Ethyl 1H-Pyrrole-2-Carboxylate (24)Ethyl 1H-Pyrrole-3-Carboxylate (8)Ethyl 2-(Imidazo[1,2-A]Pyridin-3-Yl)Acetate (3)Ethyl 2-(Pyridin-2-Yl)Acetate (15)Ethyl 2-Aminobenzoate (23)Ethyl 2-Aminothiazole-4-Carboxylate (6)Ethyl 2-Aminothiazole-5-Carboxylate (5)Ethyl 2-Bromo-2-Phenylacetate (6)Ethyl 2-Fluorobenzoate (37)Ethyl 2-Hydroxybenzoate (18)Ethyl 2-Iodobenzoate (4)Ethyl 2-Methylbenzoate (26)Ethyl 2-Methylnicotinate (6)Ethyl 2-Nitrobenzoate (9)Ethyl 2-Oxo-2-(Phenylamino)Acetate (8)Ethyl 2-Oxo-2-Phenylacetate (18)Ethyl 2-Oxo-2H-Chromene-3-Carboxylate (5)Ethyl 2-Phenoxyacetate (10)Ethyl 2-Phenylacetate (60)Ethyl 2-Phenylcyclopropane-1-Carboxylate (5)Ethyl 3-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Benzoate (6)Ethyl 3-Aminobenzoate (19)Ethyl 3-Fluorobenzoate (34)Ethyl 3-Hydroxybenzoate (12)Ethyl 3-Iodobenzoate (11)Ethyl 3-Nitrobenzoate (22)Ethyl 3-Oxo-3-Phenylpropanoate (41)Ethyl 3-Phenylpropanoate (17)Ethyl 4-Aminobenzoate (23)Ethyl 4-Chloropyrimidine-5-Carboxylate (5)Ethyl 5-Fluoro-1H-Indole-2-Carboxylate (5)Ethyl 6-Chloro-1H-Indole-2-Carboxylate (5)Ethyl Benzo[B]Thiophene-2-Carboxylate (9)Ethyl Cinnamate (26)Ethyl Cyclohex-1-Ene-1-Carboxylate (5)Ethyl Cyclohexanecarboxylate (33)Ethyl Cyclopropanecarboxylate (8)Ethyl Furan-2-Carboxylate (6)Ethyl Imidazo[1,2-A]Pyridine-2-Carboxylate (25)Ethyl Imidazo[1,2-A]Pyridine-3-Carboxylate (13)Ethyl Isonicotinate (12)Ethyl Isoxazole-3-Carboxylate (8)Ethyl Isoxazole-4-Carboxylate (5)Ethyl Morpholine-2-Carboxylate (4)Ethyl Nicotinate (25)Ethyl Oxazole-4-Carboxylate (8)Ethyl Oxazole-5-Carboxylate (3)Ethyl Oxirane-2-Carboxylate (4)Ethyl Picolinate (41)Ethyl Piperidine-2-Carboxylate (9)Ethyl Piperidine-3-Carboxylate (14)Ethyl Piperidine-4-Carboxylate (10)Ethyl Pyrazine-2-Carboxylate (10)Ethyl Pyridazine-3-Carboxylate (6)Ethyl Pyrimidine-4-Carboxylate (7)Ethyl Pyrimidine-5-Carboxylate (5)Ethyl Quinazoline-2-Carboxylate (4)Ethyl Thiazole-2-Carboxylate (7)Ethyl Thiazole-4-Carboxylate (7)Ethyl Thiazole-5-Carboxylate (7)Ethyl Thiophene-2-Carboxylate (19)Ethyl Thiophene-3-Carboxylate (11)Hexyl Benzoate (5)Isobutyl Benzoate (10)Isopropyl Benzoate (10)Methyl 1-Naphthoate (7)Methyl 1H-Benzo[D]Imidazole-2-Carboxylate (3)Methyl 1H-Imidazole-2-Carboxylate (4)Methyl 1H-Imidazole-5-Carboxylate (8)Methyl 1H-Indazole-3-Carboxylate (23)Methyl 1H-Indazole-4-Carboxylate (10)Methyl 1H-Indazole-5-Carboxylate (3)Methyl 1H-Indazole-6-Carboxylate (9)Methyl 1H-Indazole-7-Carboxylate (8)Methyl 1H-Indole-3-Carboxylate (21)Methyl 1H-Indole-4-Carboxylate (9)Methyl 1H-Indole-5-Carboxylate (7)Methyl 1H-Indole-6-Carboxylate (9)Methyl 1H-Indole-7-Carboxylate (7)Methyl 1H-Pyrazole-4-Carboxylate (10)Methyl 1H-Pyrrole-2-Carboxylate (30)Methyl 1H-Pyrrole-3-Carboxylate (5)Methyl 1H-Pyrrolo[2,3-B]Pyridine-2-Carboxylate (3)Methyl 1H-Pyrrolo[2,3-B]Pyridine-3-Carboxylate (4)Methyl 1H-Pyrrolo[2,3-B]Pyridine-6-Carboxylate (3)Methyl 2,6-Dichlorobenzoate (7)Methyl 2,6-Difluorobenzoate (17)Methyl 2-(1H-Indol-3-Yl)Acetate (3)Methyl 2-(2-Bromophenyl)Acetate (8)Methyl 2-(4-Hydroxyphenyl)Acetate (10)Methyl 2-(Bromomethyl)Benzoate (33)Methyl 2-(Chlorosulfonyl)Benzoate (7)Methyl 2-(Morpholin-3-Yl)Acetate (3)Methyl 2-(Pyridin-2-Yl)Acetate (9)Methyl 2-(Trifluoromethyl)Benzoate (14)Methyl 2-Amino-2-Phenylacetate (38)Methyl 2-Aminobenzoate (95)Methyl 2-Aminothiazole-4-Carboxylate (6)Methyl 2-Bromo-2-Phenylacetate (7)Methyl 2-Bromo-3-Nitrobenzoate (3)Methyl 2-Bromo-5-Fluorobenzoate (8)Methyl 2-Bromo-6-Fluorobenzoate (7)Methyl 2-Bromo-6-Methylbenzoate (8)Methyl 2-Bromobenzoate (69)Methyl 2-Chloro-4-Fluorobenzoate (5)Methyl 2-Chloro-6-Fluorobenzoate (7)Methyl 2-Chlorobenzoate (79)Methyl 2-Cyanobenzoate (22)Methyl 2-Fluorobenzoate (132)Methyl 2-Hydroxybenzoate (74)Methyl 2-Iodobenzoate (28)Methyl 2-Methoxybenzoate (70)Methyl 2-Methyl-2H-Indazole-3-Carboxylate (3)Methyl 2-Methylbenzoate (101)Methyl 2-Naphthoate (11)Methyl 2-Nitrobenzoate (54)Methyl 2-Phenoxyacetate (12)Methyl 2-Phenoxybenzoate (4)Methyl 2-Phenylacetate (114)Methyl 3-(Benzyloxy)Benzoate (5)Methyl 3-(Bromomethyl)Benzoate (16)Methyl 3-(Trifluoromethyl)Benzoate (22)Methyl 3-Amino-3-Phenylpropanoate (27)Methyl 3-Aminobenzoate (88)Methyl 3-Bromo-4-Chlorobenzoate (6)Methyl 3-Bromo-4-Fluorobenzoate (7)Methyl 3-Bromo-4-Methoxybenzoate (10)Methyl 3-Bromo-4-Methylbenzoate (9)Methyl 3-Bromobenzoate (153)Methyl 3-Bromopyrazine-2-Carboxylate (5)Methyl 3-Chlorobenzoate (88)Methyl 3-Cyanobenzoate (29)Methyl 3-Fluorobenzoate (136)Methyl 3-Formylbenzoate (23)Methyl 3-Hydroxybenzoate (58)Methyl 3-Iodo-4-Methylbenzoate (6)Methyl 3-Iodobenzoate (47)Methyl 3-Methoxybenzoate (72)Methyl 3-Methylbenzoate (75)Methyl 3-Nitrobenzoate (109)Methyl 3-Oxo-3-Phenylpropanoate (16)Methyl 3-Phenylpropanoate (28)Methyl 4-Amino-3-Bromobenzoate (8)Methyl 4-Amino-3-Iodobenzoate (7)Methyl 4-Amino-3-Nitrobenzoate (9)Methyl 4-Aminobenzoate (71)Methyl 4-Fluorobenzoate (75)Methyl 4-Nitrobenzoate (29)Methyl 4-Oxocyclohexane-1-Carboxylate (5)Methyl 4-Oxopiperidine-2-Carboxylate (3)Methyl 4-Phenoxybenzoate (3)Methyl 5-Amino-2-Bromobenzoate (6)Methyl 5-Hydroxypicolinate (5)Methyl 5-Oxopyrrolidine-2-Carboxylate (3)Methyl 5-Phenylisoxazole-3-Carboxylate (6)Methyl 6-Bromopyrazine-2-Carboxylate (7)Methyl 6-Chloropyrazine-2-Carboxylate (5)Methyl 6-Methoxynicotinate (4)Methyl [1,1'-Biphenyl]-4-Carboxylate (8)Methyl Azetidine-2-Carboxylate (3)Methyl Benzo[B]Thiophene-2-Carboxylate (27)Methyl Benzo[D]Oxazole-2-Carboxylate (3)Methyl Benzo[D]Thiazole-6-Carboxylate (5)Methyl Bicyclo[1.1.1]Pentane-1-Carboxylate (10)Methyl Cinnamate (37)Methyl Cyclobutanecarboxylate (24)Methyl Cyclohex-3-Ene-1-Carboxylate (3)Methyl Cyclohexanecarboxylate (45)Methyl Cyclopentanecarboxylate (18)Methyl Cyclopropanecarboxylate (8)Methyl Furan-2-Carboxylate (20)Methyl Imidazo[1,2-A]Pyridine-8-Carboxylate (3)Methyl Indoline-6-Carboxylate (3)Methyl Isonicotinate (16)Methyl Isoquinoline-4-Carboxylate (6)Methyl Morpholine-2-Carboxylate (4)Methyl Morpholine-3-Carboxylate (10)Methyl Nicotinate (52)Methyl Oxazole-4-Carboxylate (9)Methyl Piperidine-2-Carboxylate (12)Methyl Piperidine-3-Carboxylate (19)Methyl Prolinate (43)Methyl Pyrazine-2-Carboxylate (19)Methyl Pyridazine-3-Carboxylate (7)Methyl Pyrimidine-2-Carboxylate (10)Methyl Pyrimidine-4-Carboxylate (11)Methyl Pyrimidine-5-Carboxylate (5)Methyl Pyrrolidine-3-Carboxylate (9)Methyl Thiazole-2-Carboxylate (6)Methyl Thiazole-4-Carboxylate (6)Methyl Thiophene-3-Carboxylate (34)Phenyl (1R,4R)-[1,1'-Bi(Cyclohexane)]-4-Carboxylate (6)Phenyl Dimethylcarbamate (5)Phenyl Ethyl(Methyl)Carbamate (5)Propyl Benzoate (11)Tert-Butyl (1-Phenylethyl)Carbamate (19)Tert-Butyl (2,3-Dihydro-1H-Inden-1-Yl)Carbamate (3)Tert-Butyl (2-Phenylcyclopropyl)Carbamate (3)Tert-Butyl (3-Oxocyclohexyl)Carbamate (3)Tert-Butyl (Morpholin-2-Ylmethyl)Carbamate (3)Tert-Butyl (Tetrahydrofuran-3-Yl)Carbamate (4)Tert-Butyl 1H-Benzo[D]Imidazole-1-Carboxylate (3)Tert-Butyl 1H-Imidazole-1-Carboxylate (6)Tert-Butyl 1H-Indazole-1-Carboxylate (29)Tert-Butyl 1H-Indole-1-Carboxylate (18)Tert-Butyl 1H-Pyrrole-1-Carboxylate (8)Tert-Butyl 1H-Pyrrole-2-Carboxylate (3)Tert-Butyl 1H-Pyrrolo[2,3-B]Pyridine-1-Carboxylate (9)Tert-Butyl 3,4-Dihydroisoquinoline-2(1H)-Carboxylate (19)Tert-Butyl 3-((Methylsulfonyl)Oxy)Pyrrolidine-1-Carboxylate (5)Tert-Butyl 3-Oxopiperazine-1-Carboxylate (7)Tert-Butyl 4-Phenylpiperazine-1-Carboxylate (23)Tert-Butyl 4-Phenylpiperidine-1-Carboxylate (16)Tert-Butyl Azetidine-1-Carboxylate (64)Tert-Butyl Benzoate (66)Tert-Butyl Benzylcarbamate (52)Tert-Butyl Bicyclo[1.1.1]Pentan-1-Ylcarbamate (5)Tert-Butyl Cyclopentylcarbamate (28)Tert-Butyl Isoindoline-2-Carboxylate (13)Tert-Butyl Methyl(Phenyl)Carbamate (9)Tert-Butyl Morpholine-4-Carboxylate (23)Tert-Butyl O-Tolylcarbamate (11)Tert-Butyl Phenethylcarbamate (1)Tert-Butyl Piperazine-1-Carboxylate (30)Tert-Butyl Pyrrolidine-1-Carboxylate (21)
Ethers (82449)
Alcohols (224)Aldehydes (130)Aliphatic Chain Hydrocarbons (199)Aliphatic Cyclic Hydrocarbons (32)Alkenyls (79)Alkynyls (29)Amides (254)Amidines (4)Amines (403)Anhydrides (8)Aryls (1461)Azetidines (18)Benzimidazoles (17)Benzofurans (2)Benzothiazoles (15)Benzoxazoles (6)Benzyl Bromides (6)Benzyl Chlorides (7)Bromides (328)Carboxylic Acid Salts (5)Carboxylic Acids (291)Chlorides (285)Difluoromethyls (64)Epoxides (13)Esters (268)Fluorinated Building Blocks (235)Furans (10)Hydrazides (23)Hydrazines (40)Imidazoles (6)Indazoles (10)Indoles (54)Indolines (5)Iodides (32)Isoquinolines (8)Isoxazoles (12)Ketones (160)Morpholines (17)Nitriles (103)Nitroes (84)Oxazoles (4)Oxetanes (6)Phenols (44)Piperazines (31)Piperidines (82)Pyrans (5)Pyrazines (19)Pyrazoles (39)Pyridazines (7)Pyridines (239)Pyrimidines (113)Pyrrolidines (56)Quinazolines (17)Quinolines (82)Quinuclidines (2)Sulfamides (23)Sulfides (29)Sulfonates (4)Sulfones (12)Sulfonyl Chlorides (19)Sulfoxides (5)Tetrahydrofurans (1)Tetrahydropyrans (24)Thiadiazoles (7)Thiazoles (16)Thiophenes (5)Thiophenols (7)Triazoles (5)Trifluoromethyls (108)Other Aliphatic Heterocycles (5)Other Aromatic Heterocycles (48)(1S,4Ar,7Ar)-1-(((S)-Tetrahydro-2H-Pyran-2-Yl)Oxy)-1,4A,5,7A-Tetrahydrocyclopenta[C]Pyran (4)(2,2,2-Trifluoroethoxy)Benzene (18)(2-(Benzyloxy)Phenyl)Boronic Acid (23)(2-(Phenoxymethyl)Phenyl)Boronic Acid (3)(2-Chloro-3-Methoxyphenyl)Boronic Acid (5)(2-Chloroethoxy)Benzene (5)(2-Methoxyethoxy)Benzene (32)(3-(Benzyloxy)Phenyl)Boronic Acid (9)(3-(Phenoxymethyl)Phenyl)Boronic Acid (3)(3-Chloro-2-Methoxyphenyl)Boronic Acid (4)(3-Phenoxyphenyl)Methanol (3)(4-(Benzyloxy)Phenyl)Boronic Acid (26)(4-(Phenoxymethyl)Phenyl)Boronic Acid (6)(4-Methoxyphenyl)(Phenyl)Methanone (7)(9H-Fluoren-9-Yl)Methyl (2-(Benzyloxy)Ethyl)Carbamate (6)(9H-Fluoren-9-Yl)Methyl (4-Methoxybenzyl)Carbamate (7)(Allyloxy)Benzene (17)(Ethoxymethyl)Benzene (7)(Hexyloxy)Benzene (7)(Methoxymethyl)Benzene (30)(Prop-2-Yn-1-Yloxy)Benzene (12)(R)-2-Phenoxytetrahydro-2H-Pyran (7)(S)-7-(((S)-Tetrahydro-2H-Pyran-2-Yl)Oxy)-7,8,9,10-Tetrahydrotetracene-5,12-Dione (5)1,2-Bis(Benzyloxy)Benzene (11)1,2-Dichloro-3-Methoxybenzene (7)1,2-Dichloro-4-Methoxybenzene (11)1,2-Difluoro-3-Methoxybenzene (28)1,2-Difluoro-4-Methoxybenzene (19)1,2-Dimethoxybenzene (224)1,2-Diphenoxyethane (11)1,3-Bis(Benzyloxy)Benzene (8)1,3-Dibromo-2-Methoxybenzene (11)1,3-Dichloro-2-Methoxybenzene (9)1,3-Diiodo-2-Phenoxybenzene (1)1,3-Dimethoxybenzene (239)1,3-Diphenoxybenzene (8)1,4-Dichloro-2-Methoxybenzene (8)1,4-Dimethoxybenzene (66)1-(2-Methoxyphenyl)Ethan-1-One (34)1-(3-(Benzyloxy)Phenyl)Ethan-1-One (3)1-(3-Methoxyphenyl)Ethan-1-One (38)1-(3-Methoxyphenyl)Piperazine (4)1-(4-(Benzyloxy)Phenyl)Ethan-1-One (4)1-(4-Methoxybenzyl)-1H-Pyrazole (5)1-(Benzyloxy)-2-Bromobenzene (12)1-(Benzyloxy)-2-Chlorobenzene (16)1-(Benzyloxy)-2-Fluorobenzene (10)1-(Benzyloxy)-2-Methoxybenzene (19)1-(Benzyloxy)-2-Methylbenzene (12)1-(Benzyloxy)-2-Nitrobenzene (3)1-(Benzyloxy)-3-Bromobenzene (12)1-(Benzyloxy)-3-Chlorobenzene (6)1-(Benzyloxy)-3-Fluorobenzene (14)1-(Benzyloxy)-3-Methylbenzene (8)1-(Benzyloxy)-3-Nitrobenzene (10)1-(Benzyloxy)-4-Bromobenzene (8)1-(Benzyloxy)-4-Iodobenzene (3)1-(Bromomethyl)-2-Methoxybenzene (14)1-(Bromomethyl)-3-Methoxybenzene (19)1-(Difluoromethoxy)-2-Fluorobenzene (11)1-Benzyl-4-Methoxybenzene (6)1-Bromo-2,3-Dimethoxybenzene (8)1-Bromo-2-Chloro-3-Methoxybenzene (6)1-Bromo-2-Ethoxybenzene (16)1-Bromo-2-Fluoro-3-Methoxybenzene (7)1-Bromo-2-Phenoxybenzene (3)1-Bromo-3-Methoxybenzene (187)1-Bromo-3-Phenoxybenzene (8)1-Bromo-4-Phenoxybenzene (8)1-Chloro-2,4-Dimethoxybenzene (7)1-Chloro-2-Ethoxybenzene (14)1-Chloro-2-Phenoxybenzene (10)1-Chloro-2-Propoxybenzene (5)1-Chloro-3-Fluoro-2-Methoxybenzene (4)1-Chloro-3-Methoxybenzene (125)1-Chloro-3-Phenoxybenzene (5)1-Chloro-4-Methoxybenzene (98)1-Chloro-4-Phenoxybenzene (13)1-Cyclopropyl-3-(4-(Quinolin-4-Yloxy)Phenyl)Urea (6)1-Ethoxy-2,3-Difluorobenzene (9)1-Ethoxy-2-Fluorobenzene (37)1-Ethoxy-3-Nitrobenzene (7)1-Fluoro-2-(Trifluoromethoxy)Benzene (20)1-Fluoro-2-Isopropoxybenzene (18)1-Fluoro-2-Phenoxybenzene (11)1-Fluoro-3-Methoxybenzene (213)1-Fluoro-3-Phenoxybenzene (8)1-Fluoro-4-(Trifluoromethoxy)Benzene (14)1-Fluoro-4-Methoxybenzene (125)1-Fluoro-4-Phenoxybenzene (8)1-Iodo-2-Methoxybenzene (50)1-Iodo-3-Methoxybenzene (48)1-Iodo-4-Methoxybenzene (34)1-Iodo-4-Phenoxybenzene (4)1-Methoxy-2-(Trifluoromethyl)Benzene (21)1-Methoxy-3-(Trifluoromethoxy)Benzene (9)1-Methoxy-3-(Trifluoromethyl)Benzene (40)1-Methoxy-3-Nitrobenzene (108)1-Methoxy-4-(Phenoxymethyl)Benzene (3)1-Methoxy-4-(Trifluoromethyl)Benzene (18)1-Methoxy-4-Nitrobenzene (90)1-Methoxynaphthalene (18)1-Methyl-3-Phenoxybenzene (9)1-Nitro-2-Phenoxybenzene (4)1-Nitro-4-Phenoxybenzene (5)1-Phenoxy-3-(Trifluoromethyl)Benzene (2)1-Phenoxy-4-(Trifluoromethyl)Benzene (2)1-Phenyl-3-(4-(Pyridin-4-Yloxy)Phenyl)Urea (8)2,3,5,6,8,9,11,12-Octahydrobenzo[B][1,4,7,10,13]Pentaoxacyclopentadecine (8)2,3-Dimethoxypyridine (7)2,4,6-Triphenoxy-1,3,5-Triazine (4)2,4-Dibromo-1-Methoxybenzene (6)2,4-Dichloro-1-Methoxybenzene (18)2,4-Difluoro-1-Methoxybenzene (25)2,4-Dimethoxy-1-Nitrobenzene (5)2,4-Dimethoxypyrimidine (13)2,6-Dimethoxypyridine (11)2-(2-Methoxyphenyl)Acetic Acid (16)2-(3-Isopropoxyphenyl)-4,4,5,5-Tetramethyl-1,3,2-Dioxaborolane (5)2-(3-Methoxyphenyl)Acetic Acid (23)2-(4-(Benzyloxy)Phenyl)Acetonitrile (3)2-(4-Methoxyphenyl)Acetic Acid (21)2-(Benzyloxy)Benzaldehyde (13)2-(Benzyloxy)Naphthalene (5)2-(Benzyloxy)Phenol (5)2-(Methoxymethyl)Morpholine (4)2-(Methoxymethyl)Pyrrolidine (6)2-(Phenoxymethyl)Oxirane (13)2-(Phenoxymethyl)Pyridine (5)2-(Phenoxymethyl)Tetrahydro-2H-Pyran (5)2-Bromo-1,3-Dimethoxybenzene (7)2-Bromo-1,4-Dimethoxybenzene (11)2-Bromo-1-Fluoro-4-Methoxybenzene (12)2-Bromo-1-Methoxy-3-Methylbenzene (3)2-Bromo-1-Methoxy-4-Methylbenzene (7)2-Bromo-3-Methoxypyrazine (5)2-Bromo-4-Methoxy-1-Nitrobenzene (6)2-Bromo-4-Methoxyaniline (6)2-Bromo-4-Methoxybenzaldehyde (8)2-Bromo-4-Methoxybenzoic Acid (4)2-Bromo-5-Methoxybenzaldehyde (6)2-Bromo-6-Methoxyaniline (5)2-Bromo-6-Methoxyphenol (5)2-Chloro-1,3-Dimethoxybenzene (3)2-Chloro-1,4-Dimethoxybenzene (4)2-Chloro-3-Methoxybenzaldehyde (7)2-Chloro-3-Methoxybenzoic Acid (6)2-Chloro-4-Fluoro-1-Methoxybenzene (10)2-Chloro-4-Methoxypyrimidine (14)2-Chloro-5-Methoxyaniline (8)2-Chloro-6-Methoxyaniline (3)2-Chloro-6-Methoxyphenol (4)2-Ethoxynaphthalene (4)2-Ethoxypyridine (20)2-Ethoxypyrimidine (7)2-Fluoro-1,3-Dimethoxybenzene (8)2-Fluoro-1-Methoxy-4-Nitrobenzene (8)2-Fluoro-4-Methoxyaniline (6)2-Fluoro-5-Methoxybenzoic Acid (9)2-Fluoro-5-Methoxypyridine (4)2-Fluoro-6-Methoxypyridine (6)2-Isopropoxypyridine (16)2-Methoxy-1,1'-Biphenyl (7)2-Methoxy-1,3,5-Triazine (10)2-Methoxy-4-Methylpyridine (5)2-Methoxy-5-Methylpyridine (5)2-Methoxy-6-Methylpyridine (14)2-Methoxy-6-Nitrophenol (5)2-Methoxybenzamide (9)2-Methoxybenzenesulfonyl Chloride (15)2-Methoxynaphthalene (22)2-Methoxyphenol (201)2-Methoxypyrazine (45)2-Methoxypyridine (434)2-Methoxypyrimidin-4-Amine (6)2-Methoxypyrimidine (59)2-Methoxythiophene (7)2-Methyl-N-Phenylaniline (7)2-Phenoxyacetonitrile (11)2-Phenoxyaniline (4)2-Phenoxybenzonitrile (5)2-Phenoxyethan-1-Ol (14)2-Phenoxypropanoic Acid (13)2-Phenoxypyrimidine (8)2-Phenoxytetrahydro-2H-Pyran (6)2-Phenoxythiazole (5)2-Propoxypyridine (9)3,5-Dimethoxypyridine (4)3-(3-Methoxyphenyl)Propanoic Acid (9)3-(Benzyloxy)Aniline (12)3-(Benzyloxy)Benzaldehyde (13)3-(Benzyloxy)Benzoic Acid (5)3-(Benzyloxy)Phenol (5)3-(Methoxymethyl)Morpholine (4)3-Chloro-2-Methoxybenzoic Acid (4)3-Chloro-4-Methoxyaniline (6)3-Chloro-4-Methoxybenzaldehyde (7)3-Chloro-4-Methoxybenzoic Acid (5)3-Ethoxypyridine (12)3-Fluoro-2-Methoxypyridine (14)3-Fluoro-4-Methoxybenzoic Acid (6)3-Methoxypiperidine (7)3-Methoxypyridazine (17)3-Methoxypyridine (51)3-Methoxythiophene (9)3-Phenoxyaniline (2)3-Phenoxybenzaldehyde (7)3-Phenoxybenzoic Acid (6)3-Phenoxybenzonitrile (5)3-Phenoxypropanoic Acid (14)3-Phenoxypyrrolidine (5)4-(3-Phenoxypropyl)Morpholine (7)4-(Benzyloxy)Aniline (8)4-(Benzyloxy)Benzaldehyde (23)4-(Benzyloxy)Benzoic Acid (5)4-(Benzyloxy)Phenol (2)4-(Difluoromethoxy)Aniline (6)4-(Dimethoxymethyl)Pyrimidine (5)4-(Phenylethynyl)Phenol (7)4-Chloro-2-Methoxypyrimidine (12)4-Chloro-5-Methoxypyrimidine (7)4-Chloro-6-Methoxypyrimidine (5)4-Ethoxypyridine (7)4-Ethoxypyrimidine (6)4-Methoxy-1,1'-Biphenyl (4)4-Methoxy-1H-Indazole (7)4-Methoxy-1H-Indole (11)4-Methoxy-2-Methylpyrimidine (8)4-Methoxy-N-Phenylaniline (5)4-Methoxy-N-Phenylbenzenesulfonamide (3)4-Methoxybenzenesulfonamide (5)4-Methoxypyridazine (8)4-Methoxypyridine (136)4-Methoxypyrimidin-2-Amine (6)4-Methoxypyrimidine (102)4-Phenoxyaniline (6)4-Phenoxybenzaldehyde (12)4-Phenoxybenzoic Acid (4)4-Phenoxypyridine (7)4-Phenoxypyrimidine (5)4-Phenoxyquinoline (5)4-Phenoxytetrahydro-2H-Pyran (5)5-(Benzyloxy)Pyrimidine (5)5-Fluoro-2-Methoxypyridine (15)5-Methoxy-1H-Benzo[D]Imidazole (2)5-Methoxy-1H-Indazole (5)5-Methoxy-1H-Indole (11)5-Methoxy-2-Methyl-1H-Indole (5)5-Methoxy-2-Nitroaniline (7)5-Methoxyindoline (4)5-Methoxyisobenzofuran-1(3H)-One (5)5-Methoxyisoquinoline (6)6-Methoxy-1,2,3,4-Tetrahydroisoquinoline (3)6-Methoxy-1H-Indazole (14)6-Methoxy-1H-Indole (12)6-Methoxy-1H-Pyrrolo[2,3-B]Pyridine (3)6-Methoxy-3,4-Dihydroisoquinolin-1(2H)-One (3)6-Methoxybenzo[D]Thiazole (6)6-Methoxybenzofuran (4)6-Methoxychromane (5)6-Methoxyisoindolin-1-One (3)6-Methoxyquinoxaline (6)7-(Benzyloxy)Quinoline (6)7-Methoxy-1,2,3,4-Tetrahydroisoquinoline (6)7-Methoxy-1H-Indazole (5)7-Methoxy-1H-Indole (8)7-Methoxy-3,4-Dihydroquinolin-2(1H)-One (3)7-Methoxyisoquinoline (5)8-Methoxyisoquinoline (7)8-Methoxyquinazoline (3)Butoxybenzene (51)Ethoxybenzene (283)Ethyl 2-Phenoxyacetate (10)Isobutoxybenzene (22)Isopropoxybenzene (84)Methoxycyclohexane (7)Methyl 2-Methoxybenzoate (70)Methyl 2-Phenoxyacetate (12)Methyl 2-Phenoxybenzoate (4)Methyl 3-(Benzyloxy)Benzoate (5)Methyl 3-Methoxybenzoate (72)Methyl 4-Phenoxybenzoate (3)N,N-Dimethyl-2-Phenoxyethan-1-Amine (16)N-(2-Phenoxyphenyl)Methanesulfonamide (3)N-(4-Phenoxyphenyl)Acetamide (4)N-Phenyl-N-(4-(Quinolin-4-Yloxy)Phenyl)Cyclopropane-1,1-Dicarboxamide (5)Phenethoxybenzene (23)Propoxybenzene (63)Tert-Butoxybenzene (12)Tert-Butyl 3-Methoxypyrrolidine-1-Carboxylate (6)Tert-Butyl 4-Phenoxypiperidine-1-Carboxylate (12)Tert-Butyl 5-Methoxy-1H-Indole-1-Carboxylate (6)Butoxy-Phenyl-Boronic Acid/Ester (76)Diethoxy (14)Diethoxy (14)Diethoxyethyl (9)Diethoxyethyl (9)Diethoxymethyl (8)Diethoxymethyl (8)Dimethoxyethyl (8)Dimethoxypropane (11)Dimethoxypropane (11)Dioxane (153)Dioxepine (7)Dioxepine (7)Disulfide (38)Methoxyphenylboronic-Acid (32)
Fluorinated Building Blocks (99019)
Alcohols (169)Aldehydes (79)Aliphatic Chain Hydrocarbons (169)Aliphatic Cyclic Hydrocarbons (56)Alkenyls (42)Alkynyls (6)Amides (240)Amidines (7)Amines (284)Anhydrides (8)Aryls (868)Azetidines (20)Benzimidazoles (14)Benzisoxazoles (4)Benzofurans (11)Benzothiazoles (7)Benzothiophenes (5)Benzoxazoles (5)Benzyl Bromides (2)Benzyl Chlorides (2)Bromides (305)Carboxylic Acids (237)Chlorides (224)Difluoromethyls (124)Esters (194)Ethers (235)Furans (4)Hydrazides (6)Hydrazines (12)Imidazoles (25)Indazoles (13)Indoles (39)Indolines (11)Iodides (54)Isoquinolines (7)Isoxazoles (12)Ketones (150)Morpholines (17)Naphthyridines (4)Nitriles (76)Nitroes (75)Oxazoles (5)Oxazolidines (2)Oxetanes (5)Phenols (28)Phosphoruses (5)Piperazines (28)Piperidines (95)Pyrazines (8)Pyrazoles (53)Pyridazines (4)Pyridines (296)Pyrimidines (38)Pyrroles (8)Pyrrolidines (38)Quinazolines (5)Quinolines (50)Quinoxalines (5)Spiroes (9)Sulfamides (26)Sulfides (21)Sulfonates (23)Sulfones (14)Tetrahydropyrans (8)Tetrahydroquinolines (6)Thiazoles (9)Thioesters (4)Thiophenes (18)Thiophenols (4)Trifluoromethyls (502)Other Aliphatic Heterocycles (5)Other Aromatic Heterocycles (47)Dichlorofluorobenzene (22)Difluoro (897)Difluoroaniline (37)Difluorobenzaldehyde (33)Difluorobenzamide (6)Difluorobenzenesulfonamide (5)Difluorobenzoate (59)Difluoroethyl (26)Difluoroethyl (26)Difluoromethoxy (196)Difluoromethoxy (196)Difluoropropan (7)Difluoropropan (7)Fluindamine (32)Fluoroacetanilide (5)Fluoroacetophenone (8)Fluoroaniline (65)Fluoroanisole (9)Fluorobenzaldehyde (69)Fluorobenzamide (28)Fluorobenzenesulfonamide (7)Fluorobenzenethiol (6)Fluorobenzylamine (10)Fluorobromobenzene (3)Fluorocinnamic (10)Fluorocinnamic (10)Fluorocinnamic Acid (9)Fluorocyclopropanecarboxylic (9)Fluoroethoxy (4)Fluoroethyl (8)Fluoroethyl (8)Fluoroindan (3)Fluoroindan (3)Fluoroisonicotinaldehyde (7)Fluoroisonicotinate (8)Fluoroisonicotinic (13)Fluoroisonicotinic Acid (13)Fluoromethyl (15)Fluoromethyl (15)Fluoronicotinaldehyde (20)Fluoronicotinamide (3)Fluoronicotinic (19)Fluoronicotinic (19)Fluoronicotinic Acid (14)Fluorophenylisocyanate (3)Fluoropropan (15)Fluoropropan (15)Fluorostyryl (7)Fluorosulfonyl (12)Fluorosulfonyl (12)Hexafluoro (9)Hexafluoro (9)Hexafluoropropan (4)Hexafluoropropan (4)Nonafluoro (2)Nonafluoro (2)Octafluoro (2)Octafluoro (2)Pentafluoro (4)Pentafluorobenzoate (4)Tetrafluoro (12)Tetrafluoro (12)Tetrafluoroaniline (7)Tetrafluoroethoxy (3)Tetrafluoroethoxy (3)Trifluoro (270)Trifluoro (270)Trifluoroacetamide (8)Trifluoroacetyl (13)Trifluoroaniline (11)Trifluorobenzaldehyde (9)Trifluorobenzoate (14)Trifluorobut (36)Trifluorobut (36)Trifluoroethan (2)Trifluoroethan (2)Trifluoroethanamine (23)Trifluoroethanol (6)Trifluoroethoxy (60)Trifluoroethoxy (60)Trifluoroethyl (62)Trifluoromethanesulfonyl (22)Trifluoromethoxy (477)Trifluoromethoxy (477)Trifluoromethylthio (5)Trifluoromethylthio (5)Trifluoropropane (36)Trifluoropropanoate (5)Trifluoropropyl (9)(2,3-Difluorophenyl)Boronic Acid (33)(2,6-Difluorophenyl)Boronic Acid (28)(2-Chloro-6-Fluorophenyl)Boronic Acid (9)(2-Fluorobenzyl)Hydrazine (6)(2-Fluorophenyl)(Phenyl)Methanone (15)(2-Fluorophenyl)Boronic Acid (229)(2-Fluorophenyl)Hydrazine (22)(2-Fluorophenyl)Methanamine (49)(2-Fluorophenyl)Methanol (60)(3-Fluorophenyl)(Phenyl)Methanone (5)(3-Fluorophenyl)Boronic Acid (169)(3-Fluorophenyl)Methanol (58)(4-Fluorophenyl)(Phenyl)Methanone (8)(4-Fluorophenyl)Boronic Acid (93)(4-Fluorophenyl)Methanamine (27)(4-Fluorophenyl)Methanol (29)1,1-Difluorocyclobutane (14)1,1-Difluorocyclohexane (18)1,2,3,4,5-Pentafluorobenzene (45)1,2,3,4-Tetrafluorobenzene (68)1,2,3-Trifluorobenzene (144)1,2,4-Trifluorobenzene (197)1,2-Dibromo-3-Fluorobenzene (9)1,2-Dibromo-4-Fluorobenzene (11)1,2-Dichloro-3-Fluorobenzene (13)1,2-Dichloro-4-Fluorobenzene (15)1,2-Difluoro-3-Iodobenzene (13)1,2-Difluoro-3-Methoxybenzene (28)1,2-Difluoro-3-Methylbenzene (23)1,2-Difluoro-3-Nitrobenzene (23)1,2-Difluoro-4-Methoxybenzene (19)1,2-Difluoro-4-Nitrobenzene (43)1,2-Difluorobenzene (631)1,3-Dibromo-2,4-Difluorobenzene (5)1,3-Dibromo-2-Fluorobenzene (15)1,3-Dichloro-2-Fluorobenzene (23)1,3-Difluoro-2-Iodobenzene (12)1,3-Difluoro-2-Methylbenzene (18)1,3-Difluoro-2-Nitrobenzene (16)1,4-Dichloro-2-Fluorobenzene (11)1,4-Difluoro-2-Iodobenzene (8)1,4-Difluoro-2-Nitrobenzene (28)1,4-Difluorobenzene (343)1-(2-Fluorophenyl)Ethan-1-Amine (80)1-(2-Fluorophenyl)Ethan-1-One (58)1-(2-Fluorophenyl)Piperazine (8)1-(2-Fluorophenyl)Propan-1-Amine (8)1-(3-Fluorophenyl)Ethan-1-One (63)1-(4-Fluorophenyl)Ethan-1-One (36)1-(Benzyloxy)-2-Fluorobenzene (10)1-(Benzyloxy)-3-Fluorobenzene (14)1-(Bromomethyl)-2-Fluorobenzene (50)1-(Bromomethyl)-3-Fluorobenzene (47)1-(Chloromethyl)-2-Fluorobenzene (8)1-(Chloromethyl)-3-Fluorobenzene (11)1-Benzyl-4-Fluorobenzene (2)1-Bromo-2,3-Difluorobenzene (67)1-Bromo-2,4-Difluorobenzene (59)1-Bromo-2-Chloro-3-Fluorobenzene (20)1-Bromo-2-Fluoro-3-Methylbenzene (11)1-Bromo-3-Fluoro-2-Methoxybenzene (12)1-Bromo-3-Fluoro-2-Methylbenzene (17)1-Bromo-3-Fluoro-2-Nitrobenzene (10)1-Bromo-4-Fluoro-2-Methoxybenzene (11)1-Bromo-4-Fluoro-2-Methylbenzene (18)1-Chloro-2,3-Difluorobenzene (27)1-Chloro-2,4-Difluorobenzene (35)1-Chloro-3-Fluoro-2-Methoxybenzene (4)1-Chloro-3-Fluoro-2-Methylbenzene (10)1-Cyclohexyl-2-Fluorobenzene (4)1-Ethoxy-2,3-Difluorobenzene (9)1-Ethoxy-2-Fluorobenzene (37)1-Ethynyl-2-Fluorobenzene (10)1-Fluoro-2,3-Dimethylbenzene (8)1-Fluoro-2-(Methylsulfonyl)Benzene (5)1-Fluoro-2-Iodo-4-Methylbenzene (3)1-Fluoro-2-Iodobenzene (102)1-Fluoro-2-Isopropoxybenzene (18)1-Fluoro-2-Methylbenzene (255)1-Fluoro-2-Phenoxybenzene (11)1-Fluoro-3,5-Dimethylbenzene (12)1-Fluoro-3-(Methylsulfonyl)Benzene (10)1-Fluoro-3-Iodo-2-Methylbenzene (3)1-Fluoro-3-Iodobenzene (94)1-Fluoro-3-Methoxybenzene (213)1-Fluoro-3-Methylbenzene (254)1-Fluoro-3-Nitrobenzene (216)1-Fluoro-3-Phenoxybenzene (8)1-Fluoro-4-Iodobenzene (65)1-Fluoro-4-Methoxybenzene (125)1-Fluoro-4-Methylbenzene (140)1-Fluoro-4-Phenoxybenzene (8)1-Fluorobicyclo[1.1.1]Pentane (4)1-Fluoronaphthalene (23)2'-Fluoro-1,1':4',1''-Terphenyl (6)2,2',3,3',5,5',6,6'-Octafluoro-1,1'-Biphenyl (4)2,3-Difluoroaniline (34)2,3-Difluorobenzaldehyde (18)2,3-Difluorobenzoic Acid (35)2,3-Difluorobenzonitrile (29)2,3-Difluorophenol (36)2,3-Difluoropyridine (13)2,4-Dibromo-1-Fluorobenzene (18)2,4-Dichloro-1-Fluorobenzene (27)2,4-Difluoro-1-Iodobenzene (14)2,4-Difluoro-1-Methoxybenzene (25)2,4-Difluoro-1-Nitrobenzene (46)2,4-Difluoroaniline (44)2,4-Difluorobenzaldehyde (19)2,4-Difluorobenzoic Acid (29)2,4-Difluorobenzonitrile (21)2,4-Difluorophenol (21)2,5-Difluoroaniline (34)2,5-Difluorobenzoic Acid (32)2,5-Difluoropyridine (8)2,6-Difluoroaniline (23)2,6-Difluorobenzaldehyde (25)2,6-Difluorobenzoic Acid (33)2,6-Difluorobenzonitrile (28)2,6-Difluorophenol (23)2,6-Difluoropyridine (29)2-(2-Fluorophenyl)Acetic Acid (43)2-(2-Fluorophenyl)Acetonitrile (30)2-(2-Fluorophenyl)Pyrrolidine (16)2-(3-Fluorophenyl)Acetic Acid (50)2-(3-Fluorophenyl)Pyrrolidine (5)2-(4-Fluorophenyl)-1H-Indole (4)2-(4-Fluorophenyl)Acetic Acid (30)2-(Bromomethyl)-1,3-Difluorobenzene (12)2-Amino-2-(2-Fluorophenyl)Acetic Acid (11)2-Amino-3-Fluorobenzoic Acid (11)2-Bromo-1,3,4-Trifluorobenzene (16)2-Bromo-1,3-Difluorobenzene (43)2-Bromo-1,4-Difluorobenzene (64)2-Bromo-1-Chloro-3-Fluorobenzene (9)2-Bromo-1-Chloro-4-Fluorobenzene (20)2-Bromo-1-Fluoro-4-Methylbenzene (17)2-Bromo-4-Chloro-1-Fluorobenzene (16)2-Bromo-4-Fluoro-1-Methoxybenzene (12)2-Bromo-4-Fluoro-1-Methylbenzene (21)2-Bromo-4-Fluoroaniline (28)2-Bromo-4-Fluorobenzaldehyde (7)2-Bromo-4-Fluorobenzonitrile (7)2-Bromo-4-Fluorophenol (10)2-Bromo-5-Fluoroaniline (18)2-Bromo-5-Fluorobenzaldehyde (7)2-Bromo-5-Fluorobenzoic Acid (11)2-Bromo-6-Fluoroaniline (14)2-Bromo-6-Fluorophenol (9)2-Chloro-1,3-Difluorobenzene (27)2-Chloro-1,4-Difluorobenzene (25)2-Chloro-3-Fluoropyridine (20)2-Chloro-4-Fluoro-1-Methoxybenzene (10)2-Chloro-4-Fluoroaniline (19)2-Chloro-4-Fluorobenzaldehyde (10)2-Chloro-4-Fluorobenzoic Acid (9)2-Chloro-4-Fluorobenzonitrile (9)2-Chloro-4-Fluorophenol (9)2-Chloro-5-Fluoropyrimidine (6)2-Chloro-6-Fluoroaniline (8)2-Chloro-6-Fluorobenzoic Acid (8)2-Chloro-6-Fluorobenzonitrile (5)2-Chloro-6-Fluorophenol (5)2-Fluoro-1,3-Dimethoxybenzene (8)2-Fluoro-1,3-Dimethylbenzene (14)2-Fluoro-1-Iodo-4-Methylbenzene (5)2-Fluoro-3-Methylbenzaldehyde (8)2-Fluoro-3-Methylpyridine (14)2-Fluoro-4-Methoxyaniline (6)2-Fluoro-4-Methyl-1-Nitrobenzene (13)2-Fluoro-4-Methylbenzoic Acid (7)2-Fluoro-4-Methylpyridine (6)2-Fluoro-5-Methylpyridine (6)2-Fluoro-6-Methylpyridine (20)2-Fluoro-N-Methylbenzamide (12)2-Fluoro-N-Phenylaniline (4)2-Fluoro-N-Phenylbenzenesulfonamide (6)2-Fluoroaniline (262)2-Fluorobenzaldehyde (175)2-Fluorobenzamide (32)2-Fluorobenzenesulfonamide (12)2-Fluorobenzenesulfonyl Chloride (31)2-Fluorobenzoic Acid (220)2-Fluoropyridine (15)2-Fluoropyrimidine (9)3,3-Difluoropiperidine (29)3,3-Difluoropyrrolidine (29)3,4-Difluoroaniline (44)3,4-Difluorophenol (19)3,5-Difluoropyridine (12)3-Chloro-2-Fluoroaniline (9)3-Fluoro-1,1'-Biphenyl (16)3-Fluoro-2-Iodoaniline (8)3-Fluoro-2-Methylaniline (9)3-Fluoro-2-Methylpyridine (15)3-Fluoro-4-Nitroaniline (7)3-Fluoroaniline (288)3-Fluorobenzaldehyde (137)3-Fluorobenzamide (26)3-Fluorobenzenesulfonyl Chloride (22)3-Fluorobenzoic Acid (206)3-Fluorophenol (177)3-Fluoropiperidine (26)3-Fluoropyridin-2-Amine (12)3-Fluoropyridin-4-Amine (4)3-Fluorothiophene (6)4,4-Difluoropiperidine (5)4-(2-Fluorophenyl)Morpholine (8)4-(4-Fluorophenyl)Thiazole (9)4-Chloro-5-Fluoro-2-Methylpyrimidine (5)4-Fluoro-1-Methyl-2-Nitrobenzene (12)4-Fluoro-1H-Indazole (22)4-Fluoro-1H-Indole (24)4-Fluoro-1H-Pyrrolo[2,3-B]Pyridine (6)4-Fluoro-2-Iodoaniline (7)4-Fluoro-2-Nitroaniline (14)4-Fluoroaniline (225)4-Fluorobenzaldehyde (78)4-Fluorobenzamide (19)4-Fluorobenzenesulfonyl Chloride (26)4-Fluorobenzo[D]Thiazole (6)4-Fluorobenzoic Acid (114)4-Fluorobenzonitrile (89)4-Fluoroisoquinoline (6)4-Fluorophenol (111)4-Fluoropyrimidine (8)5-Fluoro-1,2,3,4-Tetrahydroisoquinoline (3)5-Fluoro-1H-Benzo[D][1,2,3]Triazole (4)5-Fluoro-1H-Benzo[D]Imidazole (12)5-Fluoro-1H-Indole (50)5-Fluoro-1H-Pyrrolo[2,3-B]Pyridine (9)5-Fluoro-2,3-Dihydro-1H-Indene (3)5-Fluoro-2,3-Dihydrobenzofuran (5)5-Fluoro-2-Methylpyridine (8)5-Fluoro-3,4-Dihydronaphthalen-1(2H)-One (5)5-Fluorochromane (6)5-Fluoroindoline (3)5-Fluoroisoindolin-1-One (3)5-Fluoropyridin-2-Amine (15)5-Fluoropyrimidine (11)6-Fluoro-1,2,3,4-Tetrahydroisoquinoline (3)6-Fluoro-1,2,3,4-Tetrahydroquinoline (3)6-Fluoro-1H-Indazole (15)6-Fluoro-1H-Indole (17)6-Fluoro-1H-Pyrrolo[2,3-B]Pyridine (3)6-Fluorobenzo[D]Thiazole (5)6-Fluorochromane (6)6-Fluoropyridin-2-Amine (8)6-Fluoropyridin-3-Amine (4)7-Fluoro-1,2,3,4-Tetrahydroisoquinoline (3)7-Fluoro-1,2,3,4-Tetrahydroquinoline (3)7-Fluoro-1H-Indazole (12)7-Fluoro-1H-Indole (24)7-Fluorobenzo[D]Thiazole (9)7-Fluoroindoline-2,3-Dione (6)7-Fluoroisoquinoline (3)8-Fluoro-3,4-Dihydronaphthalen-1(2H)-One (5)8-Fluorochromane (5)8-Fluoroimidazo[1,2-A]Pyridine (3)8-Fluoroisoquinoline (10)8-Fluoroquinazoline (4)Benzenesulfonyl Fluoride (50)Ethyl 2-Fluorobenzoate (37)Ethyl 3-Fluorobenzoate (34)Fluorobenzene (9797)Methyl 2,6-Difluorobenzoate (17)Methyl 2-Fluorobenzoate (132)Methyl 3-Fluorobenzoate (136)Methyl 4-Fluorobenzoate (75)Methyl 6-Fluoronicotinate (4)N-(3-Fluorophenyl)Acetamide (14)N-(4-Fluorophenyl)Benzamide (3)Pentafluoro(Phenyl)-L6-Sulfane (19)Phenyl Trifluoromethanesulfonate (27)Tert-Butyl (4-Fluorophenyl)Carbamate (9)Trifluoro(Phenyl)Borate (80)
Guanidines (769)
Aliphatic Chain Hydrocarbons (18)Amides (12)Aryls (13)Nitriles (4)Biguanide (2)Biguanide (2)
Hydrazides (3096)
Alcohols (5)Aliphatic Chain Hydrocarbons (48)Aliphatic Cyclic Hydrocarbons (5)Amides (169)Amines (8)Aryls (84)Chlorides (15)Ethers (23)Fluorinated Building Blocks (6)Hydrazines (121)Phenols (6)Pyridines (17)Thioureas (11)Ureas (7)Acetohydrazide (17)Acetohydrazide (17)Chlorobenzhydrazide (3)Dihydrazide (5)Dihydrazide (5)Fluorobenzohydrazide (6)Pyrazine-2-Carbohydrazide (3)
Hydrazines (6273)
Alcohols (5)Aliphatic Chain Hydrocarbons (61)Aliphatic Cyclic Hydrocarbons (11)Amides (176)Amidines (2)Amines (26)Aryls (121)Chlorides (26)Esters (7)Ethers (40)Fluorinated Building Blocks (12)Hydrazides (121)Nitriles (5)Phenols (2)Pyridines (27)Pyrimidines (8)Pyrrolidines (3)Quinolines (4)Sulfamides (4)Tetrahydropyrans (4)Thioureas (8)Triazoles (3)Trifluoromethyls (4)Ureas (4)Dichlorophenylhydrazine (3)Hydrazinecarbothioamide (1)Hydrazinecarboxamide (1)Hydrazinylbenzoate (6)(2-Bromophenyl)Hydrazine (8)(2-Chlorophenyl)Hydrazine (16)(2-Fluorobenzyl)Hydrazine (6)(2-Fluorophenyl)Hydrazine (22)(3-Chlorophenyl)Hydrazine (12)2-Hydrazineylpyridine (32)2-Hydrazineylpyrimidine (6)3-Hydrazineylpyridine (8)4-Hydrazineylpiperidine (5)Isonicotinohydrazide (6)Phenylhydrazine (153)Picolinohydrazide (5)
Hydrazones (2064)
Amides (9)Aryls (10)Chlorides (4)1-Benzylidene-2-Phenylhydrazine (4)
Hydroxylamines (630)
Aliphatic Chain Hydrocarbons (11)Amides (12)Amines (14)Aryls (8)N-Hydroxybenzamide (8)
Iodides (14105)
Alcohols (16)Aliphatic Chain Hydrocarbons (38)Aliphatic Cyclic Hydrocarbons (10)Alkenyls (6)Amides (36)Amines (36)Aryls (87)Benzofurans (4)Bromides (54)Carboxylic Acids (24)Chlorides (51)Esters (31)Ethers (32)Fluorinated Building Blocks (54)Imidazoles (12)Indazoles (12)Indoles (11)Ketones (10)Nitriles (10)Nitroes (6)Oxetanes (6)Phenols (9)Piperidines (4)Pyrazoles (18)Pyridines (78)Pyrimidines (15)Quinolines (12)Tetrahydropyrans (4)Thiazoles (4)Thiophenes (3)Trifluoromethyls (15)Other Aromatic Heterocycles (28)Diiodo (18)Diiodobenzoate (5)Iodoaniline (60)Iodoanisole (5)Iodobenzaldehyde (38)Iodobenzamide (6)Iodobutane (1)Iodobutane (1)Iodoethoxy (6)Iodoethoxy (6)Iodoethyl (5)Iodoethyl (5)Iodomethyl (26)Iodomethyl (26)Iodonicotinaldehyde (6)Iodonicotinic (14)Iodonicotinic (14)Iodopropyl (4)Iodopropyl (4)(2-Iodophenyl)(Phenyl)Methanone (4)(2-Iodophenyl)Methanol (12)(3-Iodophenyl)Boronic Acid (5)(3-Iodophenyl)Methanol (13)1,2-Benziodoxol-3-(1H)-One (6)1,2-Difluoro-3-Iodobenzene (13)1,2-Diiodobenzene (10)1,3-Dibromo-2-Iodobenzene (4)1,3-Dichloro-2-Iodobenzene (5)1,3-Difluoro-2-Iodobenzene (12)1,3-Diiodo-2-Phenoxybenzene (1)1,3-Diiodobenzene (52)1,4-Dibromo-2-Iodobenzene (3)1,4-Difluoro-2-Iodobenzene (8)1-(2-Iodophenyl)Ethan-1-One (4)1-(3-Iodophenyl)Ethan-1-One (7)1-(Benzyloxy)-4-Iodobenzene (3)1-(Bromomethyl)-2-Iodobenzene (9)1-Benzyl-4-Iodo-1H-Pyrazole (5)1-Bromo-2-Iodobenzene (65)1-Bromo-3-Fluoro-2-Iodobenzene (4)1-Bromo-3-Iodobenzene (70)1-Bromo-4-Iodobenzene (67)1-Chloro-2-Fluoro-3-Iodobenzene (5)1-Chloro-2-Iodobenzene (65)1-Chloro-3-Iodo-2-Methylbenzene (3)1-Chloro-3-Iodobenzene (78)1-Chloro-4-Iodobenzene (49)1-Ethyl-2-Iodobenzene (6)1-Fluoro-2-Iodo-4-Methylbenzene (3)1-Fluoro-2-Iodobenzene (102)1-Fluoro-3-Iodo-2-Methylbenzene (3)1-Fluoro-3-Iodobenzene (94)1-Fluoro-4-Iodobenzene (65)1-Iodo-2,3-Dimethylbenzene (8)1-Iodo-2,4-Dimethylbenzene (9)1-Iodo-2-(Trifluoromethoxy)Benzene (6)1-Iodo-2-(Trifluoromethyl)Benzene (13)1-Iodo-2-Isopropylbenzene (4)1-Iodo-2-Methoxybenzene (50)1-Iodo-2-Methylbenzene (91)1-Iodo-2-Nitrobenzene (36)1-Iodo-3-(Trifluoromethoxy)Benzene (6)1-Iodo-3-(Trifluoromethyl)Benzene (30)1-Iodo-3-Methoxybenzene (48)1-Iodo-3-Methylbenzene (60)1-Iodo-3-Nitrobenzene (45)1-Iodo-4-Methoxybenzene (34)1-Iodo-4-Phenoxybenzene (4)2,4-Difluoro-1-Iodobenzene (14)2,6-Dichloro-4-Iodopyridine (4)2,6-Diiodoaniline (8)2,6-Diiodophenol (9)2-Bromo-3-Iodopyridine (6)2-Bromo-4-Chloro-1-Iodobenzene (6)2-Bromo-6-Iodoaniline (4)2-Bromo-6-Iodopyridine (5)2-Chloro-3-Iodopyridin-4-Amine (3)2-Chloro-3-Iodopyridine (13)2-Chloro-4-Iodopyridine (19)2-Chloro-5-Iodopyridine (18)2-Chloro-6-Iodophenol (3)2-Chloro-6-Iodopyridine (9)2-Fluoro-1-Iodo-4-Methylbenzene (5)2-Fluoro-3-Iodopyridine (8)2-Fluoro-6-Iodoaniline (7)2-Hydroxy-3-Iodobenzaldehyde (3)2-Iodo-1,3-Dimethylbenzene (15)2-Iodo-1,4-Dimethylbenzene (5)2-Iodo-1-Methyl-4-Nitrobenzene (3)2-Iodo-4-Methylaniline (5)2-Iodo-6-Methylpyridine (5)2-Iodo-6-Nitroaniline (3)2-Iodo-9H-Fluorene (8)2-Iodo-N,N-Dimethylaniline (3)2-Iodoaniline (87)2-Iodobenzaldehyde (17)2-Iodobenzamide (4)2-Iodobenzene-1,3-Diol (3)2-Iodobenzoic Acid (47)2-Iodobenzonitrile (26)2-Iodonaphthalene (5)2-Iodophenol (54)2-Iodopyrazine (25)2-Iodopyridine (27)2-Iodopyrimidine (8)2-Iodothiophene (14)3-Chloro-2-Iodoaniline (3)3-Chloro-4-Iodoaniline (3)3-Fluoro-2-Iodoaniline (8)3-Iodo-1-Methyl-1H-Pyrazole (6)3-Iodo-1H-Pyrrolo[2,3-B]Pyridine (11)3-Iodo-1H-Pyrrolo[3,2-B]Pyridine (6)3-Iodo-2-Methylaniline (4)3-Iodoaniline (32)3-Iodobenzaldehyde (28)3-Iodobenzoic Acid (55)3-Iodobenzonitrile (27)3-Iodoimidazo[1,2-A]Pyridine (10)3-Iodophenol (21)3-Iodopyridazine (5)3-Iodopyridin-2-Amine (12)3-Iodopyridin-2-Ol (4)3-Iodopyridin-4-Amine (6)3-Iodopyridin-4-Ol (4)3-Iodopyridine (37)3-Iodotetrahydrofuran (3)4-Bromo-2-Chloro-1-Iodobenzene (4)4-Bromo-2-Fluoro-1-Iodobenzene (8)4-Bromo-2-Iodoaniline (8)4-Chloro-2-Iodoaniline (9)4-Chloro-3-Iodoaniline (3)4-Chloro-5-Iodopyrimidine (6)4-Fluoro-2-Iodoaniline (7)4-Fluoro-3-Iodobenzoic Acid (5)4-Iodo-1,1'-Biphenyl (9)4-Iodo-1H-Pyrazole (9)4-Iodo-N,N-Diphenylaniline (3)4-Iodopyridine (17)4-Iodopyrimidine (9)5-Bromo-2-Iodopyridine (5)5-Iodo-1H-Imidazole (4)5-Iodo-1H-Pyrazole (4)5-Iodo-7H-Pyrrolo[2,3-D]Pyrimidine (4)5-Iodopyridin-2-Amine (17)5-Iodopyridin-2-Ol (8)5-Iodopyrimidine (5)6-Chloro-5-Iodopyridin-2-Amine (3)Ethyl 2-Iodobenzoate (4)Ethyl 3-Iodobenzoate (11)Methyl 2-Iodobenzoate (28)Methyl 3-Iodo-4-Methylbenzoate (6)Methyl 3-Iodobenzoate (47)Methyl 4-Amino-3-Iodobenzoate (7)N-(2-Iodophenyl)Acetamide (8)Phenyl(O-Tolyl)Iodonium (14)Tert-Butyl 3-Iodo-1H-Indole-1-Carboxylate (7)
Isocyanates and Isothiocyanates (240)
Aryls (8)Isocyanate (12)Isocyanate (12)(Isothiocyanatomethyl)Benzene (6)1-Chloro-2-Isocyanatobenzene (6)1-Chloro-2-Isothiocyanatobenzene (7)Isocyanatobenzene (47)Isothiocyanatobenzene (39)
Isocyanides (67)
Aryls (2)Isocyanato (7)Isocyanide (1)Isothiocyanato (5)Isothiocyanato (5)
Ketones (39956)
Alcohols (64)Aldehydes (19)Aliphatic Chain Hydrocarbons (182)Aliphatic Cyclic Hydrocarbons (156)Alkenyls (85)Alkynyls (8)Amides (185)Amines (88)Aryls (582)Azetidines (16)Benzofurans (10)Bromides (169)Carboxylic Acid Salts (4)Carboxylic Acids (138)Chlorides (139)Difluoromethyls (1)Dioxolanes (5)Epoxides (4)Esters (319)Ethers (160)Fluorinated Building Blocks (150)Furans (10)Imidazoles (7)Indoles (20)Indolines (11)Iodides (10)Morpholines (8)Naphthyridines (4)Nitriles (57)Nitroes (28)Phenols (33)Piperidines (66)Pyrans (7)Pyrazoles (14)Pyridazines (4)Pyridines (98)Pyrimidines (8)Pyrroles (16)Pyrrolidines (23)Quinolines (50)Spiroes (47)Sulfamides (4)Sulfides (18)Sulfones (9)Sulfonic Acids (4)Tetrahydrofurans (6)Tetrahydropyrans (7)Thiazoles (19)Thiophenes (42)Trifluoromethyls (42)Other Aliphatic Heterocycles (59)Other Aromatic Heterocycles (131)Acetylacetonate (26)Bromoethanone (4)Butanedione (6)Butanedione (6)Butanone (10)Butanone (10)Carbonyl-Phenyl-Boronic Acid/Ester (184)Chloroethanone (2)Dicarbonyl (2)Dicarbonyl (2)Dichloroacetophenone (5)Dienone (2)Diethanone (5)Diethanone (5)Dione (1784)Dioxobutanoate (2)Enone (21)Ethanone (1016)Heptanedionato (7)Heptanedionato (7)Hydroxyethanone (3)Methyl-Pyrazolone (87)Oxoacetaldehyde (4)Oxoazepane (3)Oxoazepane (3)Oxochroman (5)Oxotetrahydro (11)Pyrimidinone (3)Tetraone (45)Tetraone (45)Trifluoroacetophenone (9)Trifluoroethanone (15)(1E,4E)-1,5-Diphenylpenta-1,4-Dien-3-One (7)(1E,6E)-1,7-Diphenylhepta-1,6-Diene-3,5-Dione (7)(2-Aminophenyl)(Phenyl)Methanone (30)(2-Bromophenyl)(Phenyl)Methanone (3)(2-Chlorophenyl)(Phenyl)Methanone (19)(2-Fluorophenyl)(Phenyl)Methanone (15)(2-Hydroxyphenyl)(Phenyl)Methanone (24)(2-Iodophenyl)(Phenyl)Methanone (4)(3-Chlorophenyl)(Phenyl)Methanone (19)(3-Fluorophenyl)(Phenyl)Methanone (5)(3-Nitrophenyl)(Phenyl)Methanone (5)(4-Aminophenyl)(Phenyl)Methanone (4)(4-Bromophenyl)(Phenyl)Methanone (9)(4-Chlorophenyl)(Phenyl)Methanone (11)(4-Fluorophenyl)(Phenyl)Methanone (8)(4-Hydroxyphenyl)(Phenyl)Methanone (3)(4-Methoxyphenyl)(Phenyl)Methanone (7)(4-Nitrophenyl)(Phenyl)Methanone (3)(R)-5-Thia-1-Azabicyclo[4.2.0]Oct-2-En-8-One (8)1,3-Dioxoisoindolin-2-Yl 2-Phenylacetate (5)1,3-Diphenylpropan-1-One (9)1,4-Diazepan-5-One (9)1,4-Dihydroisoquinolin-3(2H)-One (5)1-(1H-Indazol-1-Yl)Ethan-1-One (7)1-(1H-Indol-1-Yl)Ethan-1-One (9)1-(1H-Indol-3-Yl)Ethan-1-One (6)1-(1H-Pyrrolo[2,3-B]Pyridin-3-Yl)Ethan-1-One (4)1-(2-(Trifluoromethyl)Phenyl)Ethan-1-One (9)1-(2-Aminophenyl)Ethan-1-One (29)1-(2-Bromophenyl)Ethan-1-One (27)1-(2-Chlorophenyl)Ethan-1-One (40)1-(2-Fluorophenyl)Ethan-1-One (58)1-(2-Hydroxyphenyl)-2-Phenylethan-1-One (6)1-(2-Hydroxyphenyl)-3-Phenylprop-2-En-1-One (11)1-(2-Hydroxyphenyl)Ethan-1-One (74)1-(2-Iodophenyl)Ethan-1-One (4)1-(2-Methoxyphenyl)Ethan-1-One (34)1-(2-Nitrophenyl)Ethan-1-One (24)1-(3-(Benzyloxy)Phenyl)Ethan-1-One (3)1-(3-Aminophenyl)Ethan-1-One (18)1-(3-Chlorophenyl)Ethan-1-One (38)1-(3-Fluorophenyl)Ethan-1-One (63)1-(3-Hydroxyphenyl)Ethan-1-One (20)1-(3-Iodophenyl)Ethan-1-One (7)1-(3-Methoxy-2-Nitrophenyl)Ethan-1-One (4)1-(3-Methoxyphenyl)Ethan-1-One (38)1-(3-Nitrophenyl)Ethan-1-One (25)1-(3-Nitrophenyl)Propan-1-One (4)1-(4-(Benzyloxy)Phenyl)Ethan-1-One (4)1-(4-Fluorophenyl)Ethan-1-One (36)1-([1,1'-Biphenyl]-4-Yl)Ethan-1-One (5)1-(Benzofuran-2-Yl)Ethan-1-One (3)1-(Imidazo[1,2-A]Pyridin-3-Yl)Ethan-1-One (3)1-(M-Tolyl)Ethan-1-One (37)1-(Naphthalen-2-Yl)Ethan-1-One (3)1-(O-Tolyl)Ethan-1-One (26)1-(Piperidin-1-Yl)Ethan-1-One (13)1-(Pyrazin-2-Yl)Ethan-1-One (5)1-(Pyridin-2-Yl)Ethan-1-One (36)1-(Pyridin-3-Yl)Ethan-1-One (29)1-(Pyridin-4-Yl)Ethan-1-One (14)1-(Pyrimidin-2-Yl)Ethan-1-One (5)1-(Pyrimidin-4-Yl)Ethan-1-One (6)1-(Pyrrolidin-1-Yl)Ethan-1-One (9)1-(Thiazol-2-Yl)Ethan-1-One (9)1-(Thiophen-2-Yl)Ethan-1-One (17)1-Aminoanthracene-9,10-Dione (8)1-Benzylindoline-2,3-Dione (5)1-Benzylpiperidin-3-One (5)1-Chloroanthracene-9,10-Dione (6)1-Hydroxyanthracene-9,10-Dione (13)1-Methylpiperazin-2-One (6)1-Methylpyrrolidin-2-One (13)1-Phenylbutan-1-One (13)1-Phenylpentan-1-One (12)1-Phenylpiperidin-2-One (8)1-Phenylpropan-2-One (36)2,2,2-Trifluoro-1-Phenylethan-1-One (51)2,2-Dimethyl-1-Phenylpropan-1-One (8)2,2-Dimethyl-2H-Benzo[B][1,4]Oxazin-3(4H)-One (3)2,3,4,9-Tetrahydro-1H-Carbazol-1-One (7)2,3-Dihydrofuran-3-One (9)2,3-Dihydropyridin-2-One (5)2,5-Dichlorobenzoic Acid (13)2-Amino-1-(Pyrrolidin-1-Yl)Ethan-1-One (5)2-Benzalacetophenone (36)2-Benzoylbenzoic Acid (10)2-Chloro-1-Phenylethan-1-One (20)2-Chlorocyclohexa-2,5-Diene-1,4-Dione (4)2-Chloroquinazolin-4(3H)-One (4)2-Hydroxy-1,2-Diphenylethan-1-One (3)2-Hydroxy-1-Phenylethan-1-One (8)2-Hydroxycyclohexa-2,5-Diene-1,4-Dione (3)2-Hydroxyquinolin-4(1H)-One (3)2-Methoxycyclohexa-2,5-Diene-1,4-Dione (7)2-Methyl-1-Phenylpropan-1-One (20)2-Methyl-2H-Benzo[B][1,4]Oxazin-3(4H)-One (3)2-Methyl-3,4-Dihydroisoquinolin-1(2H)-One (6)2-Methylcyclohexa-2,5-Diene-1,4-Dione (5)2-Methylcyclohexan-1-One (3)2-Methylisoindolin-1-One (7)2-Methylisoindoline-1,3-Dione (5)2-Methylpyridazin-3(2H)-One (7)2-Oxo-2-Phenylacetaldehyde (12)2-Oxo-2-Phenylacetic Acid (17)3,3-Difluoropiperidin-4-One (3)3,3-Dimethylcyclohexan-1-One (4)3,3-Dimethylpiperidin-4-One (3)3,4-Dihydroquinoxalin-2(1H)-One (7)3-Acetyl-2H-Chromen-2-One (3)3-Aminopyrrolidin-2-One (5)3-Bromo-1H-Pyrrole-2,5-Dione (3)3-Chloro-1-Phenylpropan-1-One (10)3-Fluoropiperidin-4-One (3)3-Hydroxy-2-Phenyl-4H-Chromen-4-One (21)3-Hydroxypyrrolidin-2-One (4)3-Methylcyclohexan-1-One (9)3-Methylene-2,3-Dihydro-1H-Inden-1-One (5)3-Methylpiperazin-2-One (7)3-Methylpyrimidin-4(3H)-One (6)3-Oxo-3-Phenylpropanenitrile (21)3-Oxo-N-Phenylbutanamide (10)3-Phenyl-1-(Pyrrolidin-1-Yl)Propan-1-One (1)3-Phenyl-2-Thioxoimidazolidin-4-One (6)3-Phenylacrylaldehyde (29)3-Phenylimidazolidine-2,4-Dione (4)4,4,4-Trifluoro-1-Phenylbutane-1,3-Dione (10)4-(1,2,2-Triphenylvinyl)Benzaldehyde (5)4-(Hydroxymethyl)Pyrrolidin-2-One (4)4-Benzylmorpholin-3-One (6)4-Bromoisoindolin-1-One (3)4-Bromopyridazin-3(2H)-One (3)4-Chloro-1-Phenylbutan-1-One (8)4-Chloropyridazin-3(2H)-One (4)4-Fluoroindoline-2,3-Dione (3)4-Hydroxy-2H-Chromen-2-One (10)4-Hydroxydihydrofuran-2(3H)-One (14)4-Hydroxypiperidin-2-One (3)4-Hydroxypyrrolidin-2-One (7)4-Methyl-2H-Chromen-2-One (27)4-Methylisobenzofuran-1(3H)-One (3)4-Oxo-4-Phenylbutanoic Acid (16)4-Phenylbutan-2-One (15)4-Phenylcyclohexan-1-One (11)4-Phenylmorpholin-3-One (6)5,6-Dihydrobenzo[D]Thiazol-7(4H)-One (5)5-(Aminomethyl)Pyrrolidin-2-One (3)5-(Hydroxymethyl)Pyrrolidin-2-One (7)5-Bromoisoindolin-1-One (8)5-Bromoisoindoline-1,3-Dione (3)5-Bromopyrimidin-4(3H)-One (3)5-Chloroisoindoline-1,3-Dione (3)5-Chloropyrimidin-4(3H)-One (4)5-Chloropyrimidine-2,4(1H,3H)-Dione (3)5-Fluoro-3,4-Dihydronaphthalen-1(2H)-One (5)5-Fluorochroman-4-One (3)5-Fluoroindolin-2-One (4)5-Fluoroisoindolin-1-One (3)5-Fluoropyrimidin-4(3H)-One (3)5-Fluoropyrimidine-2,4(1H,3H)-Dione (3)5-Hydroxy-2-Phenyl-4H-Chromen-4-One (36)5-Hydroxypiperidin-2-One (3)5-Methoxy-2-Phenyl-4H-Chromen-4-One (9)5-Methyl-3,4-Dihydronaphthalen-1(2H)-One (6)5-Methylindolin-2-One (3)5-Oxopyrrolidine-2-Carboxylic Acid (4)6-Bromoisoindolin-1-One (4)6-Fluorochroman-4-One (5)6-Fluoroindoline-2,3-Dione (3)6-Fluoroisobenzofuran-1(3H)-One (3)6-Hydroxy-2,3-Dihydro-1H-Inden-1-One (3)6-Methoxy-2,3-Dihydro-1H-Inden-1-One (6)6-Methoxy-3,4-Dihydronaphthalen-1(2H)-One (5)6-Methoxyisoindolin-1-One (3)6-Methyl-2,3-Dihydro-1H-Inden-1-One (3)7,8-Dihydroquinolin-5(6H)-One (5)7-(Diethylamino)-2H-Chromen-2-One (9)7-Bromo-3,4-Dihydronaphthalen-1(2H)-One (8)7-Bromochroman-4-One (4)7-Bromoindoline-2,3-Dione (3)7-Bromoquinazolin-4(3H)-One (4)7-Chloro-3,4-Dihydronaphthalen-1(2H)-One (6)7-Fluorochroman-4-One (5)7-Fluoroindolin-2-One (3)7-Fluoroquinazolin-4(3H)-One (4)7-Hydroxy-2H-Chromen-2-One (23)7-Methoxy-2H-Chromen-2-One (12)7-Methoxy-3,4-Dihydronaphthalen-1(2H)-One (6)7-Methoxychroman-4-One (3)7-Methylindoline-2,3-Dione (7)8-Bromochroman-4-One (4)8-Fluoro-3,4-Dihydronaphthalen-1(2H)-One (5)8-Fluoroisoquinolin-1(2H)-One (3)8-Methylchroman-4-One (4)Acetophenone (1114)Azepan-2-One (18)Benzo[Cd]Indol-2(1H)-One (5)Benzofuran-2(3H)-One (7)Chroman-2-One (5)Cyclobutanone (24)Cyclohex-2-En-1-One (27)Cyclohexane-1,3-Dione (12)Cyclopent-2-En-1-One (21)Cyclopentane-1,3-Dione (6)Dihydro-2H-Pyran-2,6(3H)-Dione (5)Dihydrofuran-2,5-Dione (12)Dihydrofuran-3(2H)-One (8)Dihydrothiophen-3(2H)-One (4)Ethene-1,1-Diyldibenzene (10)Ethyl 2-Oxo-2-Phenylacetate (18)Ethyl 3-Oxo-3-Phenylpropanoate (41)Furan-2(5H)-One (26)Isoquinolin-1-Ol (9)Methyl 3-Oxo-3-Phenylpropanoate (16)Morpholin-3-One (11)Phenyl(3-(Trifluoromethyl)Phenyl)Methanone (3)Phenyl(M-Tolyl)Methanone (3)Phenyl(P-Tolyl)Methanone (4)Phenyl(Pyridin-3-Yl)Methanone (9)Phenyl(Thiophen-2-Yl)Methanone (6)Piperidine-2,4-Dione (5)Propiophenone (59)Pyrimidine-4,6(1H,5H)-Dione (3)Tert-Butyl (2-Oxopiperidin-3-Yl)Carbamate (4)Tert-Butyl (2-Oxopyrrolidin-3-Yl)Carbamate (3)Tert-Butyl (3-Oxocyclohexyl)Carbamate (3)Tert-Butyl (5-Oxopyrrolidin-3-Yl)Carbamate (3)Tert-Butyl (6-Oxopiperidin-3-Yl)Carbamate (3)Tert-Butyl 2-Oxopiperidine-1-Carboxylate (3)Tert-Butyl 2-Oxopyrrolidine-1-Carboxylate (15)Tert-Butyl 4-Oxopiperidine-1-Carboxylate (16)Tetrahydropyrimidin-2(1H)-One (6)
Mercaptos (10)
Mercaptopropanoate (10)
Nitrates and Nitrites (1)
Nitriles (28592)
Alcohols (45)Aldehydes (12)Aliphatic Chain Hydrocarbons (92)Aliphatic Cyclic Hydrocarbons (29)Alkenyls (62)Amides (92)Amines (142)Aryls (353)Azetidines (5)Benzyl Bromides (5)Bromides (82)Carboxylic Acids (45)Chlorides (97)Esters (102)Ethers (103)Fluorinated Building Blocks (76)Furans (7)Guanidines (4)Hydrazines (5)Indazoles (8)Indoles (31)Indolines (5)Iodides (10)Isoquinolines (4)Ketones (57)Morpholines (5)Nitroes (26)Oxazoles (6)Phenols (5)Piperazines (17)Piperidines (54)Pyrazoles (39)Pyridazines (5)Pyridines (126)Pyrimidines (15)Pyrroles (6)Pyrrolidines (11)Quinolines (19)Spiroes (2)Sulfamides (4)Sulfides (13)Sulfones (9)Sulfonyl Chlorides (5)Tetrahydropyrans (9)Thiazoles (7)Thiophenes (15)Trifluoromethyls (13)Other Aromatic Heterocycles (31)1-Phenyl-1H-Pyrazole-4-Carbonitrile (17)1-Phenylcyclobutane-1-Carbonitrile (7)1-Phenylcyclopropane-1-Carbonitrile (19)1H-Imidazole-4-Carbonitrile (2)1H-Indazole-3-Carbonitrile (9)1H-Indole-2-Carbonitrile (9)1H-Indole-3-Carbonitrile (17)1H-Indole-5-Carbonitrile (5)1H-Indole-6-Carbonitrile (4)1H-Indole-7-Carbonitrile (6)1H-Pyrazole-4-Carbonitrile (5)1H-Pyrrole-2-Carbonitrile (7)1H-Pyrrole-3-Carbonitrile (9)2,3-Difluorobenzonitrile (29)2,4-Dichlorobenzonitrile (4)2,4-Difluorobenzonitrile (21)2,6-Dibromobenzonitrile (4)2,6-Dichlorobenzonitrile (8)2,6-Difluorobenzonitrile (28)2-(1,3,2-Dioxaborinan-2-Yl)Benzonitrile (4)2-(2-Bromophenyl)Acetonitrile (10)2-(2-Chlorophenyl)Acetonitrile (16)2-(2-Fluorophenyl)Acetonitrile (30)2-(3-Chlorophenyl)Acetonitrile (16)2-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Benzonitrile (14)2-(4-(Benzyloxy)Phenyl)Acetonitrile (3)2-(Bromomethyl)Benzonitrile (15)2-(Piperazin-1-Yl)Benzonitrile (6)2-(Pyridin-2-Yl)Acetonitrile (8)2-(Pyridin-3-Yl)Acetonitrile (6)2-(Trifluoromethoxy)Benzonitrile (7)2-(Trifluoromethyl)Benzonitrile (35)2-Amino-3-Bromobenzonitrile (7)2-Amino-3-Chlorobenzonitrile (3)2-Amino-6-Chlorobenzonitrile (3)2-Aminonicotinonitrile (6)2-Bromo-6-Fluorobenzonitrile (7)2-Chloro-3-Methylbenzonitrile (5)2-Chloro-4-Fluorobenzonitrile (9)2-Chloro-6-Fluorobenzonitrile (5)2-Chloro-N-Methylaniline (4)2-Chlorobenzonitrile (99)2-Hydroxybenzonitrile (45)2-Iodobenzonitrile (26)2-Naphthonitrile (15)2-Nitrobenzonitrile (37)2-Oxo-2H-Chromene-3-Carbonitrile (4)2-Phenoxyacetonitrile (11)2-Phenoxybenzonitrile (5)2-Phenylacetonitrile (172)3-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Benzonitrile (25)3-(Trifluoromethoxy)Benzonitrile (11)3-(Trifluoromethyl)Benzonitrile (47)3-Bromo-2-Fluorobenzonitrile (10)3-Bromo-2-Hydroxybenzonitrile (3)3-Bromobenzonitrile (110)3-Chloro-2-Fluorobenzonitrile (7)3-Chlorobenzonitrile (100)3-Chloropyrazine-2-Carbonitrile (6)3-Fluoropicolinonitrile (5)3-Hydroxybenzonitrile (40)3-Iodobenzonitrile (27)3-Nitrobenzonitrile (59)3-Oxo-3-Phenylpropanenitrile (21)3-Phenoxybenzonitrile (5)4-Amino-2-Chlorobenzonitrile (8)4-Chloropyrimidine-5-Carbonitrile (6)4-Cyanophenyl Benzoate (11)4-Cyclohexylbenzonitrile (10)4-Fluorobenzonitrile (89)4-Nitrobenzonitrile (25)5-Fluoropicolinonitrile (5)6-Methylnicotinonitrile (7)6-Methylpicolinonitrile (10)[1,1'-Biphenyl]-2-Carbonitrile (12)[1,1'-Biphenyl]-4-Carbonitrile (27)Benzo[B]Thiophene-2-Carbonitrile (3)Benzo[D]Thiazole-2-Carbonitrile (11)Benzonitrile (1335)Furan-2-Carbonitrile (8)Imidazo[1,2-A]Pyridine-6-Carbonitrile (3)Isonicotinonitrile (16)Isoquinoline-1-Carbonitrile (7)Methyl 2-Cyanobenzoate (22)Methyl 3-Cyanobenzoate (29)Morpholine-2-Carbonitrile (4)Nicotinonitrile (82)Pyrazine-2-Carbonitrile (15)Pyrimidine-2-Carbonitrile (14)Pyrimidine-4-Carbonitrile (9)Pyrimidine-5-Carbonitrile (6)Pyrrolidine-2-Carbonitrile (9)Pyrrolidine-3-Carbonitrile (6)Thiazole-5-Carbonitrile (7)Thiophene-2-Carbonitrile (23)Thiophene-3-Carbonitrile (13)Acetonitrile (255)Acrylonitrile (8)Aminobutanenitrile (5)Aminocyclohexanecarbonitrile (6)Bromobenzonitrile (15)Bromonicotinonitrile (9)Bromophenylacetonitrile (2)Butanenitrile (2)Butanenitrile (2)Chlorobenzonitrile (27)Chloroisonicotinonitrile (4)Chloronicotinonitrile (40)Cyanide (432)Cyanide (432)Cyanoacetamide (4)Cyanoacetate (14)Cyanobenzaldehyde (4)Cyanobenzoate (27)Cyanobenzoic (20)Cyanoethyl (15)Cyanoethyl (15)Cyanoisonicotinate (4)Cyanomethyl (42)Cyanomethyl (42)Cyanonicotinate (8)Cyanophenoxy (8)Cyanophenyl (63)Cyanophenylboronic (5)Cyanopropan (4)Cyanopropan (4)Diacetonitrile (1)Diaminobenzonitrile (8)Dibromoisonicotinonitrile (3)Dicarbonitrile (45)Dicarbonitrile (45)Dichlorobenzonitrile (12)Dichloroisonicotinonitrile (4)Difluorobenzonitrile (41)Fluorobenzonitrile (85)Fluoroisonicotinonitrile (5)Fluoronicotinonitrile (14)Fluorophenylacetonitrile (8)Fluoropicolinonitrile (13)Formylnicotinonitrile (5)Formylnicotinonitrile (5)Hydrazinylbenzonitrile (6)Iodobenzonitrile (44)Iodonicotinonitrile (8)Malononitrile (43)Malononitrile (43)Methoxyisonicotinonitrile (7)Methoxyisonicotinonitrile (7)Methoxynicotinonitrile (18)Methoxynicotinonitrile (18)Methylnicotinonitrile (57)Methylnicotinonitrile (57)Methylpropanenitrile (9)Methylpropanenitrile (9)Nitropicolinonitrile (10)Oxopropanenitrile (8)Phenylacrylonitrile (21)Propanenitrile (41)Propanenitrile (41)Pyrazino-Nitrile (50)Tetrafluorobenzonitrile (5)Thiocyanatoaniline (3)Tricarbonitrile (5)Tricarbonitrile (5)Trifluorobenzonitrile (7)Trifluoromethylbenzonitrile (5)
Nitroes (24098)
Alcohols (42)Aldehydes (22)Aliphatic Chain Hydrocarbons (7)Alkenyls (21)Amines (114)Anhydrides (5)Aryls (356)Benzofurans (5)Benzothiazoles (5)Benzoxazoles (5)Bromides (62)Carboxylic Acids (44)Chlorides (81)Epoxides (5)Esters (72)Ethers (84)Fluorinated Building Blocks (75)Furans (8)Imidazoles (13)Indazoles (7)Indoles (10)Indolines (9)Iodides (6)Ketones (28)Morpholines (12)Nitriles (26)Oxazoles (4)Phenols (12)Piperazines (14)Piperidines (13)Pyrazoles (28)Pyridines (61)Pyrimidines (13)Pyrroles (8)Pyrrolidines (12)Quinazolines (4)Quinolines (19)Quinoxalines (7)Sulfamides (7)Sulfides (12)Sulfonates (6)Thiazoles (8)Thiophenes (7)Trifluoromethyls (5)Other Aromatic Heterocycles (22)Difluoronitrobenzene (9)Dinitro (7)Dinitroaniline (5)Nitroacetophenone (7)Nitroaniline (211)Nitrobenzaldehyde (100)Nitrobenzamide (35)Nitrobenzenesulfonamide (26)Nitrobenzonitrile (106)Nitrobenzotrifluoride (16)Nitroisophthalate (4)(2-Nitrophenyl)Boronic Acid (13)(2-Nitrophenyl)Methanol (29)(2-Nitrovinyl)Benzene (28)(3-Nitrophenyl)(Phenyl)Methanone (5)(3-Nitrophenyl)Boronic Acid (32)(3-Nitrophenyl)Methanol (31)(4-Nitrophenyl)(Phenyl)Methanone (3)(4-Nitrophenyl)Methanol (17)1,2-Dichloro-4-Nitrobenzene (16)1,2-Difluoro-3-Nitrobenzene (23)1,2-Difluoro-4-Nitrobenzene (43)1,2-Dimethyl-3-Nitrobenzene (6)1,2-Dinitrobenzene (6)1,3-Dibromo-2-Nitrobenzene (4)1,3-Dichloro-2-Nitrobenzene (5)1,3-Difluoro-2-Nitrobenzene (16)1,3-Dimethyl-2-Nitrobenzene (9)1,3-Dinitrobenzene (31)1,4-Difluoro-2-Nitrobenzene (28)1,4-Dimethyl-2-Nitrobenzene (10)1-(2-Nitrophenyl)Ethan-1-One (24)1-(3-Methoxy-2-Nitrophenyl)Ethan-1-One (4)1-(3-Nitrophenyl)Ethan-1-One (25)1-(3-Nitrophenyl)Propan-1-One (4)1-(Benzyloxy)-2-Nitrobenzene (3)1-(Benzyloxy)-3-Nitrobenzene (10)1-(Bromomethyl)-2-Nitrobenzene (23)1-(Methylsulfonyl)-3-Nitrobenzene (7)1-(Tert-Butyl)-2-Nitrobenzene (4)1-(Tert-Butyl)-3-Nitrobenzene (7)1-Bromo-2-Chloro-4-Nitrobenzene (5)1-Bromo-2-Fluoro-3-Nitrobenzene (11)1-Bromo-2-Fluoro-4-Nitrobenzene (13)1-Bromo-3-Methyl-2-Nitrobenzene (3)1-Bromo-3-Nitrobenzene (235)1-Chloro-2-Fluoro-4-Nitrobenzene (9)1-Chloro-2-Methyl-3-Nitrobenzene (6)1-Chloro-2-Nitrobenzene (138)1-Chloro-3-Fluoro-2-Nitrobenzene (6)1-Chloro-3-Nitrobenzene (161)1-Ethoxy-3-Nitrobenzene (7)1-Fluoro-3-Nitrobenzene (216)1-Iodo-2-Nitrobenzene (36)1-Iodo-3-Nitrobenzene (45)1-Methoxy-3-Nitrobenzene (108)1-Methoxy-4-Nitrobenzene (90)1-Methyl-2-Nitrobenzene (176)1-Methyl-3-Nitrobenzene (147)1-Methyl-4-Nitrobenzene (82)1-Nitro-2-(Trifluoromethoxy)Benzene (8)1-Nitro-2-(Trifluoromethyl)Benzene (32)1-Nitro-2-Phenoxybenzene (4)1-Nitro-3-(Trifluoromethoxy)Benzene (9)1-Nitro-3-(Trifluoromethyl)Benzene (82)1-Nitro-4-Phenoxybenzene (5)1-Nitronaphthalene (3)2,4-Dichloro-1-Nitrobenzene (19)2,4-Difluoro-1-Nitrobenzene (46)2,4-Dimethoxy-1-Nitrobenzene (5)2,4-Dimethyl-1-Nitrobenzene (15)2-((2-Nitrophenyl)Amino)Ethan-1-Ol (5)2-(2-Nitrophenyl)Acetic Acid (20)2-(4-Nitrophenyl)Acetic Acid (9)2-Bromo-1-Chloro-4-Nitrobenzene (9)2-Bromo-1-Fluoro-3-Nitrobenzene (9)2-Bromo-1-Fluoro-4-Nitrobenzene (23)2-Bromo-1-Methyl-4-Nitrobenzene (12)2-Bromo-3-Nitrobenzoic Acid (4)2-Bromo-4-Chloro-1-Nitrobenzene (5)2-Bromo-4-Fluoro-1-Nitrobenzene (23)2-Bromo-4-Nitroaniline (12)2-Bromo-6-Nitroaniline (14)2-Bromo-6-Nitrophenol (9)2-Chloro-1,3-Dinitrobenzene (2)2-Chloro-1-Fluoro-4-Nitrobenzene (16)2-Chloro-1-Methyl-3-Nitrobenzene (4)2-Chloro-3-Nitrobenzoic Acid (4)2-Chloro-4-Fluoro-1-Nitrobenzene (13)2-Chloro-4-Methyl-1-Nitrobenzene (6)2-Chloro-4-Nitrophenol (5)2-Chloro-5-Nitropyrimidine (5)2-Chloro-6-Nitroaniline (11)2-Chloro-6-Nitrophenol (7)2-Fluoro-1-Methoxy-4-Nitrobenzene (8)2-Fluoro-4-Methyl-1-Nitrobenzene (13)2-Iodo-1-Methyl-4-Nitrobenzene (3)2-Iodo-6-Nitroaniline (3)2-Methoxy-5-Nitropyridine (8)2-Methoxy-6-Nitrophenol (5)2-Methyl-3-Nitrobenzoic Acid (7)2-Methyl-3-Nitropyridine (9)2-Methyl-6-Nitroaniline (10)2-Nitro-1H-Pyrrole (5)2-Nitro-N-Phenylaniline (3)2-Nitrobenzaldehyde (53)2-Nitrobenzoic Acid (65)2-Nitrobenzonitrile (37)2-Nitrofuran (9)2-Nitronaphthalene (4)2-Nitropyridine (40)2-Nitrothiophene (20)3-Chloro-2-Nitroaniline (5)3-Chloro-4-Nitroaniline (5)3-Fluoro-4-Nitroaniline (7)3-Methoxy-2-Nitrobenzaldehyde (3)3-Methoxy-4-Nitrobenzoic Acid (4)3-Methyl-5-Nitropyridine (4)3-Nitroaniline (98)3-Nitrobenzaldehyde (49)3-Nitrobenzamide (17)3-Nitrobenzene-1,2-Diol (6)3-Nitrobenzenesulfonamide (8)3-Nitrobenzoic Acid (109)3-Nitrobenzonitrile (59)3-Nitrophenol (72)3-Nitropyridin-2-Ol (11)3-Nitropyridin-4-Amine (5)3-Nitropyridine (54)3-Nitrothiophene (6)4,4,5,5-Tetramethyl-2-(2-Nitrophenyl)-1,3,2-Dioxaborolane (5)4-Fluoro-1-Methyl-2-Nitrobenzene (12)4-Fluoro-2-Nitroaniline (14)4-Hydroxy-3-Nitrobenzaldehyde (5)4-Methyl-3-Nitroaniline (8)4-Methyl-3-Nitropyridine (8)4-Nitro-1H-Indazole (10)4-Nitro-1H-Indole (6)4-Nitro-1H-Pyrazole (8)4-Nitroaniline (65)4-Nitrobenzaldehyde (18)4-Nitrobenzene-1,3-Diol (5)4-Nitrobenzoic Acid (35)4-Nitrobenzonitrile (25)4-Nitrophenol (67)4-Nitropyridine (11)5-(4-Nitrophenyl)Oxazole (3)5-Methoxy-2-Nitroaniline (7)5-Methyl-2-Nitroaniline (6)5-Nitro-1H-Indazole (5)5-Nitro-1H-Indole (6)5-Nitro-1H-Pyrazole (9)5-Nitro-1H-Pyrazolo[3,4-B]Pyridine (3)5-Nitro-2,3-Dihydrobenzofuran (3)5-Nitrobenzo[D][1,3]Dioxole (4)5-Nitrobenzo[D]Thiazole (3)5-Nitroisoquinoline (7)5-Nitronicotinic Acid (5)5-Nitropyridin-2-Amine (6)6-Nitro-1,2,3,4-Tetrahydroisoquinoline (3)6-Nitro-1H-Indazole (9)6-Nitro-1H-Indole (8)6-Nitrobenzo[D]Thiazole (3)7-Nitro-1,2,3,4-Tetrahydroisoquinoline (3)7-Nitro-1H-Indazole (11)7-Nitro-1H-Indole (11)Ethyl 2-Nitrobenzoate (9)Ethyl 3-Nitrobenzoate (22)Ethyl Cinnamate (26)Methyl 2-Nitrobenzoate (54)Methyl 3-Nitrobenzoate (109)Methyl 4-Amino-3-Nitrobenzoate (9)Methyl 4-Nitrobenzoate (29)N-(2-Nitrophenyl)Acetamide (11)N-Methyl-2-Nitroaniline (20)N-Methyl-4-Nitroaniline (6)Nitrobenzene (2277)
Oximes (855)
Amidines (24)Amines (5)Aryls (24)Chlorides (7)Esters (5)Piperidines (5)Pyridines (11)
Phenols (1870)
Aminophenol (9)Bromophenol (13)Chlorophenol (28)Dibromophenol (9)Dichlorophenol (17)Difluorophenol (36)Dihydroxybenzaldehyde (16)Dihydroxybenzamide (6)Dihydroxybenzoate (15)Dihydroxybenzoic (17)Dihydroxybenzonitrile (6)Dihydroxyphenyl (93)Dihydroxystyryl (4)Diiodophenol (6)Fluorophenol (73)Hydroxyacetophenone (16)Hydroxybenzaldehyde (88)Hydroxybenzamide (24)Hydroxybenzenesulfonic (4)Hydroxybenzenesulfonic Acid (3)Hydroxybenzoate (113)Hydroxybenzohydrazide (4)Hydroxybenzoic (89)Hydroxybenzonitrile (60)Hydroxybenzoyl (1)Hydroxyphenoxy (7)Hydroxyphenylacetic (7)Hydroxyphenylacetic Acid (7)Hydroxyphenylboronic (8)Hydroxypropiophenone (3)Iodophenol (41)Nitrophenol (134)Tetrafluorophenol (9)Trifluorophenol (5)Trihydroxybenzaldehyde (5)Trihydroxybenzoate (12)Trihydroxybenzoic (5)Trihydroxybenzoic Acid (4)Trihydroxyphenyl (10)1,2,3,4-Tetrahydroisoquinolin-5-Ol (3)1,2,3,4-Tetrahydroisoquinolin-6-Ol (6)1-(2-Hydroxyphenyl)Ethan-1-One (74)1-(3-Hydroxyphenyl)Ethan-1-One (20)1-Hydroxyanthracene-9,10-Dione (13)2,3-Dichlorophenol (9)2,3-Difluorophenol (36)2,4-Dibromophenol (16)2,4-Difluorophenol (21)2,5-Dichlorophenol (7)2,6-Dibromophenol (20)2,6-Dichlorophenol (16)2,6-Difluorophenol (23)2,6-Diiodophenol (9)2,6-Dimethylphenol (19)2-(2-Hydroxyphenyl)Acetic Acid (8)2-(3-Hydroxyphenyl)Acetic Acid (8)2-(Benzyloxy)Phenol (5)2-(Difluoromethoxy)Phenol (5)2-(Tert-Butyl)Phenol (56)2-(Trifluoromethoxy)Phenol (8)2-(Trifluoromethyl)Phenol (23)2-Amino-3-Bromophenol (3)2-Amino-3-Chlorophenol (4)2-Aminophenol (107)2-Benzylphenol (8)2-Bromo-3-Methylphenol (4)2-Bromo-6-Methylphenol (7)2-Bromobenzene-1,3-Diol (7)2-Bromobenzene-1,4-Diol (4)2-Chloro-4-Fluorophenol (9)2-Chloro-4-Nitrophenol (5)2-Chloro-6-Methylphenol (5)2-Chloro-6-Nitrophenol (7)2-Chlorobenzene-1,3-Diol (4)2-Chlorophenol (163)2-Ethylphenol (10)2-Hydroxy-N-Phenylbenzamide (3)2-Hydroxybenzamide (14)2-Hydroxybenzonitrile (45)2-Iodobenzene-1,3-Diol (3)2-Iodophenol (54)2-Isopropylphenol (28)2-Methoxyphenol (201)3,4-Dibromophenol (3)3,4-Difluorophenol (19)3-(Benzyloxy)Phenol (5)3-(Trifluoromethoxy)Phenol (12)3-(Trifluoromethyl)Phenol (43)3-Bromo-2-Fluorophenol (5)3-Bromo-4-Chlorophenol (5)3-Bromo-4-Fluorophenol (11)3-Bromobenzene-1,2-Diol (8)3-Chloro-4-Hydroxybenzaldehyde (7)3-Chlorobenzene-1,2-Diol (6)3-Chlorophenol (112)3-Fluorophenol (177)3-Hydroxybenzonitrile (40)3-Iodophenol (21)3-Nitrobenzene-1,2-Diol (6)3-Nitrophenol (72)4-(Benzyloxy)Phenol (2)4-(Trifluoromethyl)Phenol (18)4-Amino-2-Fluorophenol (9)4-Amino-3-Chlorophenol (5)4-Benzylphenol (14)4-Chlorobenzene-1,3-Diol (6)4-Fluorophenol (111)4-Hydroxybenzenesulfonic Acid (5)4-Nitrobenzene-1,3-Diol (5)4-Nitrophenol (67)6-Hydroxy-2,3-Dihydro-1H-Inden-1-One (3)Ethyl 2-Hydroxybenzoate (18)Ethyl 3-Hydroxybenzoate (12)M-Cresol (145)Methyl 2-(4-Hydroxyphenyl)Acetate (10)Methyl 2-Hydroxybenzoate (74)Methyl 3-Hydroxybenzoate (58)O-Cresol (164)P-Cresol (71)Pyrocatechol (128)Resorcinol (147)
Phosphoruses (831)
Aryls (10)Esters (6)Fluorinated Building Blocks (5)1,1,1-Trifluoro-N-(4-Oxido-2,6-Diphenyldinaphtho[2,1-D:1',2'-F][1,3,2]Dioxaphosphepin-4-Yl)Methanesulfonamide (16)Diethyl Benzylphosphonate (17)Dimethyl(Phenyl)Phosphine Oxide (20)Ethyltriphenylphosphonium (2)Methyltriphenylphosphonium (3)Phenyl Phosphate (3)Phenylphosphonic Acid (6)Diethoxyphosphoryl (5)Diisopropylphosphoramidite (4)Dimethoxyphosphoryl (4)Dimethoxyphosphoryl (4)Dimethylphosphine (28)Dioxaphosphepine (146)Diphosphonic (9)Phosphorothioate (1)
Polycyclic Aromatic Hydrocarbons (3)
Protective Groups (23)
Saturated Aliphatic Fused Rings (3)
(8Ar,12Br,14Br)-1,2,3,4,4A,5,6,6A,6B,7,8,8A,9,10,11,12,12A,12B,13,14B-Icosahydropicene (3)
Silicon Compounds (450)
Butyldimethylsilyl (94)Butyldimethylsilyl (94)Butyldimethylsilyloxy (8)Dimethylsilane (16)Dimethylsilane (16)Dimethylsilyl (4)Tetramethyldisiloxane (3)Tetramethyldisiloxane (3)Triethoxysilyl (13)Triethoxysilyl (13)Triisopropylsilyl (22)Triisopropylsilyl (22)Trimethoxysilane (19)Trimethoxysilane (19)Trimethylsilane (155)1-(Triisopropylsilyl)-1H-Pyrrolo[2,3-B]Pyridine (8)Tert-Butyldimethyl(Phenoxy)Silane (17)Tetraphenylsilane (7)Trimethoxy(Phenyl)Silane (6)Trimethyl(Phenyl)Silane (22)Trimethyl(Phenylethynyl)Silane (23)
Sulfamides (10221)
Alcohols (28)Aldehydes (6)Aliphatic Chain Hydrocarbons (37)Aliphatic Cyclic Hydrocarbons (8)Alkenyls (12)Amides (43)Amines (50)Aryls (218)Azetidines (5)Benzothiazoles (6)Benzyl Bromides (3)Bromides (35)Carboxylic Acids (28)Chlorides (51)Esters (23)Ethers (23)Fluorinated Building Blocks (26)Hydrazines (4)Imidazoles (7)Indoles (6)Ketones (4)Morpholines (11)Nitriles (4)Nitroes (7)Piperazines (12)Piperidines (25)Pyrazoles (4)Pyridines (19)Pyrimidines (1)Pyrrolidines (10)Sulfonates (6)Thiadiazoles (4)Thiophenes (16)Trifluoromethyls (5)Ureas (3)Other Aliphatic Heterocycles (11)Other Aromatic Heterocycles (17)Dimethylsulfamoyl (5)Dimethylsulfamoyl (5)Methanesulfonamide (49)Methanesulfonamide (49)Methylmethanesulfonamide (3)Methylmethanesulfonamide (3)Methylsulfonamido (4)Methylsulfonamido (4)Sulfinamide (55)Sulfinamide (55)2-Fluoro-N-Phenylbenzenesulfonamide (6)2-Fluorobenzenesulfonamide (12)2-Methylbenzenesulfonamide (8)3-Nitrobenzenesulfonamide (8)4-Amino-N-Phenylbenzenesulfonamide (3)4-Bromo-N-Phenylbenzenesulfonamide (23)4-Chloro-N-Phenylbenzenesulfonamide (4)4-Methoxy-N-Phenylbenzenesulfonamide (3)4-Methoxybenzenesulfonamide (5)4-Methyl-N-Phenylbenzenesulfonamide (13)N,N-Diethylbenzenesulfonamide (8)N,N-Dimethylbenzenesulfonamide (23)N-(2-Phenoxyphenyl)Methanesulfonamide (3)N-(3-Chlorophenyl)Benzenesulfonamide (6)N-(O-Tolyl)Benzenesulfonamide (4)N-(Tert-Butyl)Benzenesulfonamide (14)N-Ethylbenzenesulfonamide (8)N-Isopropylbenzenesulfonamide (8)N-Methyl-N-(4-Phenylpyrimidin-2-Yl)Methanesulfonamide (7)N-Methylbenzenesulfonamide (15)N-Phenylbenzenesulfonamide (81)N-Phenylmethanesulfonamide (37)Phenylmethanesulfonamide (13)Pyridine-2-Sulfonamide (6)
Sulfides (10154)
Alcohols (26)Aldehydes (8)Aliphatic Chain Hydrocarbons (27)Amides (40)Amines (42)Aryls (143)Benzimidazoles (7)Bromides (18)Carboxylic Acids (57)Chlorides (50)Esters (27)Ethers (29)Fluorinated Building Blocks (21)Furans (6)Ketones (18)Nitriles (13)Nitroes (12)Phenols (3)Pyridines (18)Pyrimidines (53)Pyrrolidines (7)Tetrahydropyrans (3)Thiadiazoles (7)Thiazoles (8)Thiophenes (4)Triazoles (3)Other Aliphatic Heterocycles (8)Other Aromatic Heterocycles (8)Methylthio (429)(S)-2-(Phenylthio)Tetrahydro-2H-Pyran (5)1,2-Diphenyldisulfane (19)2-((Pyridin-2-Ylmethyl)Thio)-1H-Benzo[D]Imidazole (7)2-(Methylthio)Benzo[D]Thiazole (6)2-(Methylthio)Pyridine (5)2-(Methylthio)Pyrimidin-4-Amine (10)2-(Methylthio)Pyrimidine (19)2-(Methylthio)Thiazole (5)2-(Propylthio)Pyrimidine (5)4,6-Dichloro-2-(Methylthio)Pyrimidine (9)4-Chloro-2-(Methylthio)Pyrimidine (29)4-Methyl-2-(Methylthio)Pyrimidine (7)5-Bromo-2-(Methylthio)Pyrimidine (6)Benzyl(Phenyl)Sulfane (5)Ethyl(Phenyl)Sulfane (8)Pentafluoro(Phenyl)-L6-Sulfane (19)Phenyl(Trifluoromethyl)Sulfane (23)
Sulfonates (1156)
Aliphatic Chain Hydrocarbons (4)Amides (15)Amines (6)Aryls (83)Dioxolanes (4)Epoxides (7)Ethers (4)Fluorinated Building Blocks (23)Nitroes (6)Oxetanes (5)Piperidines (10)Pyrrolidines (4)Sulfamides (6)Trifluoromethyls (14)4-Methylbenzenesulfonate (9)
Sulfones (3921)
Alcohols (7)Aliphatic Chain Hydrocarbons (19)Alkenyls (12)Amides (13)Amines (20)Aryls (121)Bromides (31)Carboxylic Acids (15)Chlorides (29)Esters (16)Ethers (12)Fluorinated Building Blocks (14)Ketones (9)Nitriles (9)Phenols (5)Piperazines (4)Piperidines (6)Pyridines (14)Pyrimidines (7)Thiomorpholines (8)Thiophenes (4)Other Aliphatic Heterocycles (9)Other Aromatic Heterocycles (5)(4-(Methylsulfonyl)Phenyl)Boronic Acid (6)(Ethylsulfonyl)Benzene (8)1-(Methylsulfonyl)-3-Nitrobenzene (7)1-(Methylsulfonyl)Piperazine (5)1-(Methylsulfonyl)Piperidine (6)1-(Phenylsulfonyl)-1H-1,2,4-Triazole (6)1-(Phenylsulfonyl)-1H-Imidazole (5)1-(Phenylsulfonyl)Azetidine (7)1-Bromo-2-(Methylsulfonyl)Benzene (4)1-Bromo-4-(Phenylsulfonyl)Benzene (7)1-Fluoro-2-(Methylsulfonyl)Benzene (5)1-Fluoro-3-(Methylsulfonyl)Benzene (10)1-Methyl-3-(Methylsulfonyl)Benzene (5)2-(Methylsulfonyl)Aniline (3)2-(Methylsulfonyl)Pyridine (11)2-(Methylsulfonyl)Pyrimidine (25)3-(Methylsulfonyl)Aniline (7)3-(Methylsulfonyl)Benzoic Acid (6)3-(Methylsulfonyl)Pyridine (5)Benzenesulfonyl Fluoride (50)Tetrahydro-2H-Thiopyran 1,1-Dioxide (8)Tetrahydrothiophene 1,1-Dioxide (13)
Sulfonic Acids (1258)
Aliphatic Cyclic Hydrocarbons (4)Amines (12)Aryls (23)Ketones (4)Aminobenzenesulfonic (4)Bromobenzenesulfonic Acid (4)Disulfonic (9)Disulfonic (9)Ethanesulfonic (3)Methanesulfonic (2)Methanesulfonic (2)Methylbenzenesulfonate (143)Propanesulfonic Acid (2)Trifluoromethanesulfonic (3)2-Aminobenzenesulfonic Acid (9)2-Methylbenzenesulfonic Acid (8)3-Aminobenzenesulfonic Acid (6)4-Chlorobenzenesulfonic Acid (4)4-Hydroxybenzenesulfonic Acid (5)Naphthalene-2-Sulfonic Acid (4)Pyridine-3-Sulfonic Acid (6)
Sulfonyl Chlorides (4011)
Aliphatic Chain Hydrocarbons (19)Aliphatic Cyclic Hydrocarbons (8)Aryls (57)Bromides (17)Ethers (19)Nitriles (5)Piperidines (4)Pyrazoles (4)Pyridines (5)Quinolines (6)Thiophenes (5)Fluorobenzenesulfonyl (12)1H-Pyrazole-4-Sulfonyl Chloride (8)2-Bromobenzenesulfonyl Chloride (8)2-Chlorobenzenesulfonyl Chloride (24)2-Fluorobenzenesulfonyl Chloride (31)2-Methoxybenzenesulfonyl Chloride (15)2-Methylbenzenesulfonyl Chloride (22)3-(Chlorosulfonyl)Benzoic Acid (15)3-(Trifluoromethyl)Benzenesulfonyl Chloride (13)3-Chlorobenzenesulfonyl Chloride (21)3-Fluorobenzenesulfonyl Chloride (22)4-Chlorobenzenesulfonyl Chloride (12)4-Fluorobenzenesulfonyl Chloride (26)Isoquinoline-5-Sulfonyl Chloride (3)Methyl 2-(Chlorosulfonyl)Benzoate (7)Phenylmethanesulfonyl Chloride (20)
Sulfonyl Hydrazides (25)
Benzenesulfonohydrazide (12)
Sulfoxides (336)
Aryls (19)Chlorides (7)Ethers (5)(Methylsulfinyl)Benzene (7)
Thioesters (624)
Aliphatic Chain Hydrocarbons (4)Amides (25)Amines (5)Aryls (9)Benzothiazoles (12)Carboxylic Acids (7)Fluorinated Building Blocks (4)Thiazolidines (8)
Thiols (472)
Alcohols (5)Aliphatic Chain Hydrocarbons (27)Amides (4)Aryls (8)Esters (9)Dithiole (9)Dithiole (9)Ethanethioate (9)Ethanethioate (9)Methanethiol (6)1H-Benzo[D]Imidazole-2-Thiol (10)2-Chlorobenzenethiol (7)2-Mercaptoquinazolin-4(3H)-One (3)Benzo[D]Oxazole-2-Thiol (6)Benzo[D]Thiazole-2-Thiol (11)Phenylmethanethiol (16)Pyridine-2-Thiol (8)Pyrimidine-2-Thiol (6)
Thiophenols (3049)
Amides (6)Amines (5)Aryls (29)Bromides (4)Ethers (7)Fluorinated Building Blocks (4)Pyridines (6)Pyrimidines (4)Thiadiazoles (6)Thiazoles (4)Triazoles (8)
Thioureas (1119)
Aliphatic Chain Hydrocarbons (19)Amides (61)Aryls (28)Hydrazides (11)Hydrazines (8)Pyridines (4)Carbamimidothioate (4)1,3-Diphenylthiourea (8)1-Phenylthiourea (33)
Trifluoromethyls (28935)
Alcohols (71)Aldehydes (10)Aliphatic Chain Hydrocarbons (68)Aliphatic Cyclic Hydrocarbons (19)Alkenyls (5)Amides (74)Amidines (3)Amines (95)Aryls (260)Bromides (95)Carboxylic Acids (71)Chlorides (61)Esters (72)Ethers (108)Fluorinated Building Blocks (502)Hydrazines (4)Imidazoles (12)Indoles (7)Iodides (15)Ketones (42)Morpholines (5)Nitriles (13)Nitroes (5)Phenols (2)Piperazines (7)Piperidines (8)Pyrazines (5)Pyrazoles (27)Pyridines (39)Pyrimidines (6)Pyrroles (4)Pyrrolidines (4)Quinolines (7)Sulfamides (5)Sulfonates (14)Thiophenes (1)Other Aromatic Heterocycles (19)Trifluoromethyl-Picolinamide (7)Trifluoromethylaniline (3)(2,2,2-Trifluoroethoxy)Benzene (18)(2-(Trifluoromethoxy)Phenyl)Boronic Acid (5)(2-(Trifluoromethyl)Phenyl)Boronic Acid (20)(2-(Trifluoromethyl)Phenyl)Methanol (10)(2-Fluoro-3-(Trifluoromethyl)Phenyl)Boronic Acid (6)(3-(Trifluoromethoxy)Phenyl)Boronic Acid (9)(3-(Trifluoromethoxy)Phenyl)Methanol (4)(3-(Trifluoromethyl)Phenyl)Boronic Acid (41)(3-(Trifluoromethyl)Phenyl)Methanol (22)(4-(Trifluoromethyl)Phenyl)Boronic Acid (23)(Perfluoropropane-2,2-Diyl)Dibenzene (7)(Trifluoromethyl)Benzene (1314)1,3-Bis(Trifluoromethyl)Benzene (70)1-(2-(Trifluoromethyl)Phenyl)Ethan-1-One (9)1-(3-(Trifluoromethoxy)Phenyl)Ethan-1-Amine (6)1-(3-(Trifluoromethyl)Phenyl)Ethan-1-Amine (25)1-(4-(Trifluoromethoxy)Phenyl)Ethan-1-Amine (6)1-(Bromomethyl)-2-(Trifluoromethyl)Benzene (13)1-(Bromomethyl)-3-(Trifluoromethyl)Benzene (17)1-Bromo-2-(Trifluoromethoxy)Benzene (22)1-Bromo-2-Fluoro-3-(Trifluoromethyl)Benzene (4)1-Bromo-3-(Trifluoromethyl)Benzene (100)1-Chloro-2-(Trifluoromethoxy)Benzene (20)1-Chloro-2-(Trifluoromethyl)Benzene (81)1-Chloro-3-(Trifluoromethoxy)Benzene (18)1-Chloro-3-(Trifluoromethyl)Benzene (101)1-Chloro-4-(Trifluoromethoxy)Benzene (8)1-Fluoro-2-(Trifluoromethoxy)Benzene (20)1-Fluoro-2-(Trifluoromethyl)Benzene (125)1-Fluoro-3-(Trifluoromethyl)Benzene (98)1-Fluoro-4-(Trifluoromethoxy)Benzene (14)1-Fluoro-4-(Trifluoromethyl)Benzene (53)1-Iodo-2-(Trifluoromethyl)Benzene (13)1-Iodo-3-(Trifluoromethyl)Benzene (30)1-Methoxy-2-(Trifluoromethyl)Benzene (21)1-Methoxy-3-(Trifluoromethoxy)Benzene (9)1-Methoxy-3-(Trifluoromethyl)Benzene (40)1-Methoxy-4-(Trifluoromethyl)Benzene (18)1-Methyl-2-(Trifluoromethoxy)Benzene (5)1-Methyl-2-(Trifluoromethyl)Benzene (43)1-Methyl-3-(Trifluoromethyl)Benzene (22)1-Nitro-2-(Trifluoromethoxy)Benzene (8)1-Nitro-2-(Trifluoromethyl)Benzene (32)1-Nitro-3-(Trifluoromethoxy)Benzene (9)1-Nitro-3-(Trifluoromethyl)Benzene (82)1-Phenoxy-3-(Trifluoromethyl)Benzene (2)1-Phenoxy-4-(Trifluoromethyl)Benzene (2)1-Phenyl-3-(Trifluoromethyl)-1H-Pyrazole (5)2,2,2-Trifluoro-1-Phenylethan-1-Amine (48)2,2,2-Trifluoro-1-Phenylethan-1-Ol (27)2,2,2-Trifluoro-1-Phenylethan-1-One (51)2-(2,2,2-Trifluoroethoxy)Pyridine (8)2-(Trifluoromethoxy)Aniline (18)2-(Trifluoromethoxy)Benzaldehyde (7)2-(Trifluoromethoxy)Benzoic Acid (8)2-(Trifluoromethoxy)Benzonitrile (7)2-(Trifluoromethoxy)Phenol (8)2-(Trifluoromethoxy)Pyridine (6)2-(Trifluoromethyl)-1,1'-Biphenyl (8)2-(Trifluoromethyl)Aniline (58)2-(Trifluoromethyl)Benzaldehyde (27)2-(Trifluoromethyl)Benzamide (6)2-(Trifluoromethyl)Benzoic Acid (33)2-(Trifluoromethyl)Benzonitrile (35)2-(Trifluoromethyl)Phenol (23)2-(Trifluoromethyl)Pyrazine (6)2-(Trifluoromethyl)Pyridine (6)2-(Trifluoromethyl)Pyrimidine (27)2-(Trifluoromethyl)Quinazoline (4)2-(Trifluoromethyl)Thiazole (11)2-(Trifluoromethyl)Thiophene (10)2-Bromo-1-Fluoro-4-(Trifluoromethyl)Benzene (4)2-Bromo-4-(Trifluoromethyl)Aniline (9)2-Bromo-6-(Trifluoromethyl)Aniline (5)2-Chloro-3-(Trifluoromethyl)Aniline (3)2-Chloro-4-(Trifluoromethyl)Pyrimidine (6)2-Chloro-6-(Trifluoromethyl)Aniline (4)2-Methoxy-3-(Trifluoromethyl)Pyridine (6)2-Methoxy-5-(Trifluoromethyl)Pyridine (4)2-Phenoxy-5-(Trifluoromethyl)Pyridine (7)3-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)-5-(Trifluoromethyl)Pyridine (3)3-(Trifluoromethoxy)Aniline (22)3-(Trifluoromethoxy)Benzaldehyde (10)3-(Trifluoromethoxy)Benzoic Acid (19)3-(Trifluoromethoxy)Benzonitrile (11)3-(Trifluoromethoxy)Phenol (12)3-(Trifluoromethyl)-1H-Pyrrolo[2,3-B]Pyridine (3)3-(Trifluoromethyl)Aniline (102)3-(Trifluoromethyl)Benzaldehyde (31)3-(Trifluoromethyl)Benzenesulfonyl Chloride (13)3-(Trifluoromethyl)Benzoic Acid (52)3-(Trifluoromethyl)Benzonitrile (47)3-(Trifluoromethyl)Phenol (43)3-(Trifluoromethyl)Pyridazine (3)3-(Trifluoromethyl)Pyridin-2-Ol (5)3-(Trifluoromethyl)Pyridine (51)3-Chloro-4-(Trifluoromethyl)Aniline (5)4,4,4-Trifluoro-1-Phenylbutane-1,3-Dione (10)4,4,5,5-Tetramethyl-2-(2-(Trifluoromethyl)Phenyl)-1,3,2-Dioxaborolane (5)4,4,5,5-Tetramethyl-2-(3-(Trifluoromethoxy)Phenyl)-1,3,2-Dioxaborolane (5)4-(Trifluoromethoxy)Aniline (26)4-(Trifluoromethyl)-2H-Chromen-2-One (6)4-(Trifluoromethyl)Phenol (18)4-(Trifluoromethyl)Pyridine (14)4-(Trifluoromethyl)Pyrimidin-2-Amine (6)4-(Trifluoromethyl)Pyrimidine (12)4-(Trifluoromethyl)Thiazole (7)4-Bromo-3-(Trifluoromethyl)Aniline (7)5-(Trifluoromethyl)Pyridin-2-Amine (5)5-(Trifluoromethyl)Pyridin-2-Ol (8)6-(Trifluoromethyl)-1H-Indazole (6)6-(Trifluoromethyl)-1H-Indole (5)6-(Trifluoromethyl)Pyridin-2-Amine (11)6-(Trifluoromethyl)Pyridin-3-Amine (5)Methyl 2-(Trifluoromethyl)Benzoate (14)Methyl 3-(Trifluoromethyl)Benzoate (22)N-Phenyl-4-(Trifluoromethyl)Aniline (3)Phenyl(3-(Trifluoromethyl)Phenyl)Methanone (3)Phenyl(Trifluoromethyl)Sulfane (23)
Ureas (1850)
Alcohols (5)Aliphatic Chain Hydrocarbons (28)Aliphatic Cyclic Hydrocarbons (6)Amides (82)Amines (6)Aryls (30)Carboxylic Acids (4)Chlorides (7)Hydrazides (7)Hydrazines (4)Morpholines (4)Piperazines (6)Pyrrolidines (2)Sulfamides (3)
Other Function Groups (2)
Organocatalysts
Chiral Hydrogen-Bonding Organocatalysts (76)
Chiral Phosphoric Acids (190)
4-Hydroxy-2,6-Diphenyldinaphtho[2,1-D:1',2'-F][1,3,2]Dioxaphosphepine 4-Oxide (20)
Cinchona Alkaloids (32)
MacMillan Imidazolidinone Organocatalysts (11)
NHTf (59)
Proline-Based Organocatalysts (51)
Other Organocatalysts (45)
Organometallic Reagents
Organoborons (34751)
Fluorene-Phenyl-Boronic Acid/Ester (4)Hydroxymethyl-Phenyl-Boronic-Acid (32)Methoxyphenylboronic-Acid (32)Phenyl-Naphthalene-Boronic Acid/Ester (9)(1-(Tert-Butoxycarbonyl)-1H-Indol-2-Yl)Boronic Acid (17)(1-Phenyl-1H-Pyrazol-4-Yl)Boronic Acid (4)(1H-Indazol-4-Yl)Boronic Acid (3)(1H-Indazol-6-Yl)Boronic Acid (4)(1H-Indol-2-Yl)Boronic Acid (3)(2,3-Dichlorophenyl)Boronic Acid (11)(2,3-Difluorophenyl)Boronic Acid (33)(2,6-Dichlorophenyl)Boronic Acid (6)(2,6-Difluorophenyl)Boronic Acid (28)(2-(Phenoxymethyl)Phenyl)Boronic Acid (3)(2-(Trifluoromethoxy)Phenyl)Boronic Acid (5)(2-(Trifluoromethyl)Phenyl)Boronic Acid (20)(2-Bromophenyl)Boronic Acid (39)(2-Chloro-3-Methoxyphenyl)Boronic Acid (5)(2-Chloro-6-Fluorophenyl)Boronic Acid (9)(2-Fluoro-3-(Trifluoromethyl)Phenyl)Boronic Acid (6)(2-Fluorophenyl)Boronic Acid (229)(2-Nitrophenyl)Boronic Acid (13)(3,4-Dichlorophenyl)Boronic Acid (10)(3-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Phenyl)Methanol (7)(3-(Benzyloxy)Phenyl)Boronic Acid (9)(3-(Phenoxymethyl)Phenyl)Boronic Acid (3)(3-(Phenylcarbamoyl)Phenyl)Boronic Acid (3)(3-(Trifluoromethoxy)Phenyl)Boronic Acid (9)(3-(Trifluoromethyl)Phenyl)Boronic Acid (41)(3-Bromo-2-Fluorophenyl)Boronic Acid (7)(3-Bromo-2-Methoxyphenyl)Boronic Acid (6)(3-Bromophenyl)Boronic Acid (65)(3-Chloro-2-Methoxyphenyl)Boronic Acid (4)(3-Chloro-4-Fluorophenyl)Boronic Acid (8)(3-Chlorophenyl)Boronic Acid (121)(3-Fluorophenyl)Boronic Acid (169)(3-Iodophenyl)Boronic Acid (5)(3-Nitrophenyl)Boronic Acid (32)(4-(Benzyloxy)Phenyl)Boronic Acid (26)(4-(Methylsulfonyl)Phenyl)Boronic Acid (6)(4-(Phenoxymethyl)Phenyl)Boronic Acid (6)(4-(Phenylcarbamoyl)Phenyl)Boronic Acid (11)(4-(Trifluoromethyl)Phenyl)Boronic Acid (23)(4-Cyclohexylphenyl)Boronic Acid (7)(4-Fluorophenyl)Boronic Acid (93)(5-(Trifluoromethyl)Pyridin-3-Yl)Boronic Acid (4)(6-Phenoxypyridin-3-Yl)Boronic Acid (5)(9H-Fluoren-2-Yl)Boronic Acid (6)(E)-4,4,5,5-Tetramethyl-2-Styryl-1,3,2-Dioxaborolane (16)1,3,2-Dioxaborinane (6)1-(4-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Benzyl)Piperazine (5)1-(4-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Phenyl)Piperazine (10)1-(5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridin-2-Yl)Piperazine (6)1-Methyl-4-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)-1H-Pyrazole (6)2,7-Bis(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)-9H-Fluorene (7)2-(1,3,2-Dioxaborinan-2-Yl)Benzonitrile (4)2-(1,3,2-Dioxaborolan-2-Yl)-1-Methyl-1H-Indole (6)2-(2-(Bromomethyl)Phenyl)-4,4,5,5-Tetramethyl-1,3,2-Dioxaborolane (9)2-(2-Bromophenyl)-4,4,5,5-Tetramethyl-1,3,2-Dioxaborolane (5)2-(3-Chlorophenyl)-4,4,5,5-Tetramethyl-1,3,2-Dioxaborolane (8)2-(3-Cyclopropylphenyl)-1,3,2-Dioxaborolane (5)2-(3-Isopropoxyphenyl)-4,4,5,5-Tetramethyl-1,3,2-Dioxaborolane (5)2-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Benzonitrile (14)2-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Phenol (7)2-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (6)2-(4-(Benzyloxy)Phenyl)-4,4,5,5-Tetramethyl-1,3,2-Dioxaborolane (10)2-(4-Bromophenyl)-4,4,5,5-Tetramethyl-1,3,2-Dioxaborolane (8)2-(4-Cyclopropylphenyl)-1,3,2-Dioxaborolane (8)2-(4-Fluorophenyl)-1,3,2-Dioxaborinane (5)2-([1,1'-Biphenyl]-4-Yl)-4,4,5,5-Tetramethyl-1,3,2-Dioxaborolane (10)2-(Cyclohex-1-En-1-Yl)-4,4,5,5-Tetramethyl-1,3,2-Dioxaborolane (16)2-(Furan-2-Yl)-4,4,5,5-Tetramethyl-1,3,2-Dioxaborolane (6)2-(M-Tolyl)-1,3,2-Dioxaborinane (4)2-Benzyl-4,4,5,5-Tetramethyl-1,3,2-Dioxaborolane (12)2-Chloro-3-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (4)2-Chloro-4-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (14)2-Chloro-5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (6)2-Fluoro-3-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (7)2-Methoxy-3-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (7)2-Methoxy-5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (5)2-Methyl-3-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (5)2-Methyl-5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (3)3-(1,3,2-Dioxaborinan-2-Yl)Aniline (3)3-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Benzonitrile (25)3-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (74)3-Chloro-5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (5)3-Fluoro-5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (7)3-Methyl-5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (6)4,4,5,5-Tetramethyl-2-(2-(Trifluoromethyl)Phenyl)-1,3,2-Dioxaborolane (5)4,4,5,5-Tetramethyl-2-(2-Nitrophenyl)-1,3,2-Dioxaborolane (5)4,4,5,5-Tetramethyl-2-(3-(Trifluoromethoxy)Phenyl)-1,3,2-Dioxaborolane (5)4,4,5,5-Tetramethyl-2-(Naphthalen-1-Yl)-1,3,2-Dioxaborolane (19)4,4,5,5-Tetramethyl-2-(Naphthalen-2-Yl)-1,3,2-Dioxaborolane (12)4,4,5,5-Tetramethyl-2-(Thiophen-2-Yl)-1,3,2-Dioxaborolane (23)4,4,5,5-Tetramethyl-2-(Thiophen-3-Yl)-1,3,2-Dioxaborolane (10)4-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)-1,2,3,6-Tetrahydropyridine (11)4-Methyl-3-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridine (5)5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)-1H-Indole (5)5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Indoline (5)5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Nicotinonitrile (4)5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyridin-2-Amine (9)5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Pyrimidine (27)5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Thiazole (7)[1,1'-Biphenyl]-4-Ylboronic Acid (29)Benzo[B]Thiophen-2-Ylboronic Acid (5)Benzofuran-2-Ylboronic Acid (8)Benzyl (4-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Phenyl)Carbamate (5)Cyclohex-1-En-1-Ylboronic Acid (4)Ethyl 3-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Benzoate (6)Isoquinolin-4-Ylboronic Acid (3)Methyl 5-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Nicotinate (4)N,N-Diphenyl-4-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)Aniline (6)Naphthalen-1-Ylboronic Acid (4)Naphthalen-2-Ylboronic Acid (8)Phenylboronic Acid (1287)Pyridin-2-Ylboronic Acid (9)Pyridin-3-Ylboronic Acid (49)Pyridin-4-Ylboronic Acid (21)Pyrimidin-5-Ylboronic Acid (9)Tert-Butyl 2-(1,3,2-Dioxaborolan-2-Yl)-1H-Indole-1-Carboxylate (6)Tert-Butyl 4-(4,4,5,5-Tetramethyl-1,3,2-Dioxaborolan-2-Yl)-1H-Pyrazole-1-Carboxylate (3)Tetraphenylborate (8)Thiophen-2-Ylboronic Acid (20)
Organosilicons (72)
Organotins (5)
Phase-Transfer Catalysts
Achiral Phase-Transfer Catalysts (62)
Chiral Phase-Transfer Catalysts (25)
Specialty Synthesis
Ionic Liquids (629)
Ammonium (66)Imidazolium (246)Other Organic Salts (17)Phosphonium (30)Piperidinium (11)Pyridinium (58)Pyrrolidinium (26)Raw Materials (13)Alkenyl (29)Benzyl (12)Carboxyl (5)Ether (9)Hydroxyl (8)Other Functional Groups (12)Sulfonic Acid (17)
Synthetic Reagents
C-C Bond Formation (62)
Condensation Agents (74)
Fluorination Reagents (20)
Halogenation Reagents (20)
Inorganic Salts (24996)
Phase Transfer Catalysts (42)
Other Synthetic Reagents (99)
Materials Science
Electronic Materials
Contact Printing & Self-Assembly Materials (80)
Disulfides (6)Phosphonic Acids (40)Thiols (27)
Liquid Crystal (LC) Materials (580)
Chiral Liquid Crystals (87)Cholesteric Liquid Crystals (7)Negative Dielectric Anisotropy Liquid Crystals (19)Nematic & Smectic Liquid Crystals (349)Alkenes & Alkynes (35)Biphenyls & Cyclohexanes (125)Cholesteryl Compounds (7)Esters (79)
Molecular Conductors (82)
Acceptor Molecules (24)Donor Molecules (17)Electrocrystallization Supporting Electrolytes (12)Tetrathiafulvalene (TTF) Precursors (18)
Organic Field-Effect Transistor (OFET) Materials (103)
Other Structures (7)Polycyclic Aromatic Hydrocarbons & Biphenyls (17)Thiophenes (29)Liquid Crystalline Semiconductors (12)n-Type Organic Semiconductors (13)p-Type Organic Semiconductors (37)
Organic Light-Emitting Diode (OLED) Materials (2219)
Biphenyls & Aromatic Amines (245)Boric Acids & Organoborons (376)Carbazoles & Fluorenes (278)Halogenated Benzenes & Phenols (150)Other Structures (58)Polycyclic Aromatic Hydrocarbons (214)Polymers (10)Six-Membered Heterocycles (Nitrogen) (223)Thiophenes & Furans (147)4-(Diphenylamino)Benzaldehyde (8)4-Bromo-N,N-Bis(4-Methoxyphenyl)Aniline (3)4-Methoxy-N,N-Diphenylaniline (5)4-Methyl-N,N-Diphenylaniline (6)Electron Injection Layers (EIL) (5)Electron Transport Materials (ETM) (54)Guest Materials (75)Hole Injection Layers (HIL) (27)Hole Transport Materials (113)Host Materials (230)Other Materials (4)Blue Emitters (95)Fluorescence Materials (60)Green Emitters (75)Phosphorescence Materials (119)Red Emitters (63)Thermally Activated Delayed Fluorescence Materials (TADF) (184)Yellow Emitters (13)
Photoresist Materials (267)
Acrylic Monomers (90)Adamantane Monomers (20)Other Monomers (87)Photo-Acid Generators (50)
Silane Coupling Agents (297)
Alkyl & Alkoxy Silanes (51)Aminoalkyl Silanes (38)Glycidyloxyalkyl Silanes (9)Halogen-Containing Silanes (19)Isocyanate Silanes & Silicate Esters (6)Olefinyl & Aryl Silanes (48)Other Silanes (6)Sulfur-Containing Silanes (6)
Energy and Battery Materials
Battery Additives (89)
Carbonate & Other Esters (18)Other Structures (14)Phosphate Esters & Phosphazenes (17)Salts (12)Sulfate & Sulphonate Esters (13)Conductive Additives (15)Film-Forming Additives (23)Flame Retardant Additives (30)
Battery Electrolytes Materials (16)
Li (9)
Battery Solvent Materials (26)
Carbonate Esters (12)Sulfonyls and Related Compounds (7)
Electrode Active Materials (4)
Ionic Liquids (629)
Ammonium (66)Imidazolium (246)Other Organic Salts (17)Phosphonium (30)Piperidinium (11)Pyridinium (58)Pyrrolidinium (26)Raw Materials (13)Alkenyl (29)Benzyl (12)Carboxyl (5)Ether (9)Hydroxyl (8)Other Functional Groups (12)Sulfonic Acid (17)
Organic Redox Flow Battery Materials (27)
Organic Radicals (13)Other Organic Active Materials (6)Quinones and Analogues (8)
Solution & Vapor Deposition Precursors (33)
Acetylacetone Type Salts (13)Metal Carbonyl Complexes (6)Metal Cyclopentenyl Complexes (7)Co (9)
Material Building Blocks
Alkyl Chain Building Blocks (98)
Branched Alkyl Sources (28)Fluorinated Alkyl Sources (12)Linear Alkyl Sources (49)C11-C15 (22)C16-C20 (21)C4-C10 (32)≥ C21 (15)Amino Groups (17)Carboxylic Acid Groups (7)Halogen Groups (30)Hydroxyl & Sulfhydryl Groups (34)
Ligands for Functional Metal Complexes (224)
Bipyridine Ligands (66)Other Ligands (39)Phenanthroline Ligands (26)Phenylpyridine Ligands (43)Porphyrin & Phthalocyanine Ligands (20)Quinolinol Ligands (7)Redox Active Ligands (17)
Liquid Crystal (LC) Building Blocks (387)
Acetophenones & Benzaldehydes (27)Aromatic Amines & Benzonitriles (25)Benzeneboronic Acids (24)Benzoic Acids (24)Benzoyl Chlorides (9)Bromobenzenes & Iodobenzenes (37)Chiral Compounds (20)Cyclohexanes (48)Ethynylbenzenes (21)Phenols (27)Polycyclic Aromatic Hydrocarbons & Biphenyls (45)
Phthalocyanine Building Blocks (39)
Dicyanopyrazines and Analogues (9)Naphthalonitriles and Analogues (7)Phthalonitriles and Analogues (22)
Small Molecule Semiconductor Building Blocks (1183)
Anthracenes & Anthraquinones (83)Aromatic Amines (123)Benzo Heterocyclic Compounds (135)Biphenyls (68)Carbazoles & Carbolines (186)Fluorenes & Fluorenones (117)Other Structures (43)Polycyclic Aromatic Hydrocarbons (110)Six-Membered Nitrogen Heterocycles (96)Tetraphenylethylenes (97)Thiophenes (102)
Organic Frameworks and Supramolecular Materials
Covalent Organic Framework (COF) Linkers (1096)
2 Reaction Sites (31)3 Reaction Sites (14)Multiple Reaction Sites (11)2 Reaction Sites (89)3 Reaction Sites (23)Multiple Reaction Sites (24)2 Reaction Sites (70)3 Reaction Sites (25)Carboxylic Anhydride Linkers (10)Halogen Linkers (133)Hydroxyl & Quinone Linkers (26)Multiple Reaction Sites (70)Other Linkers (5)2 Reaction Sites (201)3 Reaction Sites (56)4 Reaction Sites (66)Multiple Reaction Sites (16)2 Reaction Sites (210)3 Reaction Sites (58)4 Reaction Sites (72)Multiple Reaction Sites (21)2 Reaction Sites (38)3 Reaction Sites (8)Multiple Reaction Sites (16)
Metal Organic Framework (MOF) Linkers (1701)
2 Reaction Sites (261)3 Reaction Sites (97)Multiple Reaction Sites (87)2D MOF Linkers (18)2 Reaction Sites (27)3 Reaction Sites (9)Multiple Reaction Sites (12)Other Linkers (8)Phosphoric & Sulfonic Acid Linkers (38)2 Reaction Sites (439)3 Reaction Sites (145)4 Reaction Sites (219)Multiple Reaction Sites (67)2 Reaction Sites (70)3 Reaction Sites (77)Multiple Reaction Sites (65)Porphyrins and Derivatives Linkers (77)
Metal Organic Frameworks (MOFs) (59)
Industrial Gas Separation (8)Al-MOFs (10)Cu-MOFs (13)Fe-MOFs (9)Other Metal Element MOFs (11)Zn-MOFs (10)IR (10)MIL (16)Others MOFs (11)
Organic Framework Building Blocks (218)
Bipyridines (35)Other Structures (115)TPE-Based (65)
Supramolecular Host Materials (133)
Calixarenes (8)Crown Ethers and Analogues (55)Cucurbiturils (7)Cyclodextrins (29)Cycloparaphenylenes and Analogues (7)Cyclophanes & Parylenes (10)
Polymer Additives
Antioxidants (120)
Amine Antioxidants (14)Hindered Phenol Antioxidants (48)Phosphorus Antioxidants (18)Sulfur Antioxidants (11)
Crosslinking Agents (105)
Maleimides (5)Other Structures (11)Alcohols (6)
Flame Retardants (53)
Brominated Flame Retardants (15)Other Organic Compounds (5)Phosphorus Flame Retardants (31)
Light Stabilizers (90)
Benzophenones-Type UV Absorbents (15)Benzotriazole-Type UV Absorbents (14)Cinnamate-Type UV Absorbents (7)Hindered Amine Light Stabilizers (HALS) (18)Other UV Absorbents (13)Triazine-Type UV Absorbents (17)
Plasticizers (92)
Alcohols & Ethers (5)Amides (7)Benzoate Esters (12)Carboxylate Esters (44)
Polymerization Catalysts (170)
Cross-Coupling Polymerization Catalysts (72)Epoxy Polymerization Catalysts (4)Olefin Copolymerization Catalysts (45)Olefin Metathesis Catalysts (10)Polyurethane Catalysts (15)
Polymerization Initiators (164)
Photo-Anionic Polymerization Initiators (10)Photo-Cationic Polymerization Initiators (59)Photo-Radical Polymerization Initiators (78)Cationic Polymerization Initiators (5)Thermal-Anionic Polymerization Initiators (8)
Polymerization Reagents (287)
Iodine Transfer Radical Polymerization Reagents (6)Nitroxide-Mediated Radical Polymerization (NMP) Reagents (7)Reversible Addition Fragmentation Chain Transfer (RAFT) Polymerization Reagents (73)Initiators (19)Ligands (19)Transition Metal Catalysts (7)Group Transfer Polymerization (GTP) Reagents (13)
Surfactants (365)
Nonionic Surfactants (77)Carboxylates (15)Sulfates (5)Sulfonates (25)Alkylamine Salts & Quarternary Alkylammonium Salts (85)Aromatic Quaternary Ammonium Salts (26)Heterocyclic Quarternary Ammonium Salts (10)Zwitterionic Surfactants (42)
Other Additives (49)
Chain Extenders (12)Fluorescent Brightening Agents (10)Polymerization Inhibitors (9)Vulcanization Agents (7)
Polymer Reagents
Dendrimer Materials (57)
Building Blocks (52)
Ion Exchange Resins (7)
Monomers (1688)
Acrylamide Monomers (39)Acrylate Monomers (112)Acrylic & Methacrylic Monomers (14)Methacrylamide Monomers (25)Methacrylate Monomers (127)Alcohol Monomers (175)Ester Monomers (22)Isocyanate & Isothiocyanate Monomers (5)Thiol Monomers (21)Anhydride Monomers (41)Carboxylic Acid Monomers (110)Tetracarboxylic Dianhydride Monomers (37)Acyl Chloride Monomers (11)Amine & Amide Monomers (203)Maleimide Monomers (126)Sulfonyl Chloride Monomers (8)Epoxide Monomers (82)Other Monomers (64)Oxazoline Monomers (52)Cyclic Olefin Monomers (35)Linear Olefin Monomers (125)Styrene Monomers (76)
Photopolymer Monomers (187)
Acrylic Monomers (90)Adamantane Monomers (20)Other Monomers (87)
Polybenzoxazole and Polyimide Raw Materials (242)
Bis(2-aminophenol)s (6)Dicarbonyl Chlorides and Dicarboxylic Acids (7)Acid Anhydrides (61)Amines (153)Other Structures (16)
Polymer Semiconductor Monomers (272)
Donor-Acceptor (DA) Type Monomers (10)Carbazoles (40)Fluorenes (26)Organotin Compounds (12)Thiophene Donors (64)Carbaldehyde Monomers (10)Dibromo Monomers (34)Other Monomers (27)Diazosulfide and Analogues (14)Other Acceptor Monomers (25)Thiophene Acceptors (7)
Polymers (931)
Other Polymers (21)Polyethylene Glycols (201)Polyolefins (31)Polysaccharides (19)Polystyrenes (8)Copolymers (19)Homopolymers and Polycondensates (51)Natural Polymers (19)
Quantum Dots and Micro/Nano Materials
Nanocarbon Materials (48)
Nanocarbon Unit Structures (40)
Quantum Dot (QD) Capping Agents (231)
Amines Capping Agents (33)Ammonium Salt Capping Agents (49)Carboxylic Acid Capping Agents (77)Composite Capping Agents (19)Phosphorus (21)Thiol Capping Agents (21)
Quantum Dot (QD) Synthetic Reagents (14)
Organic Reagents (9)
Solar Cells and Photonic Materials
Donor Intermediates & Acceptor Intermediates (1038)
Benzodiazole Derivatives (109)Isoindigo Derivatives (7)Other Structures (47)Perylenes and Analogues (13)Polycyclic Aromatic Hydrocarbons (23)Pyridines & Thiazoles (29)Pyrroles & Pyrrolidinediones (70)Thiophenes & Furans (44)Triazoles (18)Aromatic Amines (54)Benzenes & Polycyclic Aromatic Hydrocarbons (122)Fluorenes and Analogues (48)Heterocycles (Nitrogen) (72)Thiophenes & Selenophens (319)TPE Derivatives (43)
Dye-Sensitized Solar Cell (DSSC) Materials (96)
Dye Sensitizers (15)Electrolytes (25)Hole Transport Materials (12)Ligands (13)
Dyes and Pigments (450)
Anthracene Dyes (5)Azobenzene Dyes (4)Diarylethene Dyes (5)Spiropyran Dyes (7)Acid Dyes (19)Direct Dyes (14)Disperse Dyes (8)Heat Sensitive & Pressure Sensitive Dyes (9)NIR Dyes (15)Other Dyes and Pigments (25)Solvent Dyes (7)Vat Dyes (6)Coumarin Dyes (38)Cyanine & Squarylium Dyes (26)Dipyrromethene Dyes (21)Other Functional Dyes (16)Perylene Dyes (23)Phthalocyanine & Porphyrin Dyes (160)Xanthene Dyes (37)
Organic Non-Linear Optical (NLO) Materials (23)
Organic Photo-Voltaics (OPVs) Materials (229)
Polymer Acceptors (2)Small Molecular Acceptors (46)Interfacial Layer Materials (19)Polymer Materials (36)Self-Assembled Monolayers Materials (16)Small Molecular Materials (52)Polymer Donors (24)Small Molecular Donors (19)
Perovskite Solar Cell (PSC) Materials (241)
Heterocycles (Nitrogen) (9)Phosphonic Acids (14)Polycyclic Aromatic Hydrocarbons & Aromatic Amines (14)Polymers (8)Bromides (47)Chlorides (39)Organometallic Salts (7)Other Onium Salts (35)Additives & Dopants (30)Electron Transport Materials (ETM) (8)Hole Transport Materials (48)Interfacial Layer Materials (9)Self-Assembled Monolayers Materials (17)Surface Passivation Reagents (10)
Visible Light Photoredox Catalysts (27)
Iridium Catalysts (5)Organic Catalysts (15)
Other Functional Materials
Aggregation-Induced Emission Materials (129)
Alcohols (12)Aldehydes (9)Alkenes & Alkynes (6)Amines (11)Boronic Acids & Esters (9)Carboxylic Acids (10)Ethers (14)Halides (22)Heterocycles (6)Nitriles (6)Other Structures (9)Other Organic Compounds (13)
Inorganic Compounds and Ceramic Materials (35)
Mg (5)Oxides (25)
Magnetic Materials (49)
Co (8)Cu (4)Ni (10)Dithiolene Complexes (10)Organic Radicals (14)Phthalocyanine & Porphyrin Complexes (5)β-Diketonato Complexes (12)
Life Science
Inhibitors/Agonists
ADC (369)
ADC Linker (369)
Angiogenesis (1704)
ALK (84)Bcr-Abl (105)BTK (149)EGFR (401)FAK (56)FGFR (136)FLT3 (134)HER2 (29)HIF (111)JAK (244)PDGFR (127)Src (110)Syk (40)VDA (1)VEGFR (268)
Anti-Infection (4704)
3CLpro (42)Antibacterial (2072)Antifungal (500)Antiparasitic (639)Antiprotozoal (3)Antiviral (49)Arenavirus (5)BVDV (3)CMV (28)Dengue Virus (36)EBV (15)Enterovirus (35)FCoV (3)Filovirus (13)Flavivirus (63)GraR (1)HBV (154)HCV (220)HHV (1)HIV (442)HIV Integrase (38)HIV Protease (70)HPV (10)HRV (3)HSV (76)Influenza Virus (250)LpxC (2)M2 proton channel (2)MERS-CoV (1)Neuraminidase (4)NNRTI (12)NRTI (22)Orthopoxvirus (24)Penicillin-Binding Protein (7)PLP (13)Prion (1)Protein Synthesis (3)Reverse Transcriptase (99)RSV (43)SAMHD1 (1)SARS-CoV (297)SQLE (6)TMV (11)Viral MTase (3)Virus Protease (60)VSV (2)β-lactamase (51)
Antibody-Drug Conjugate/ADC Related (645)
ADC Linker (369)ADC Toxins (122)Payload-Linker Conjugate (166)
Apoptosis (2429)
Apoptosis (2132)Apoptosis Inducer (1403)Bcl-2 (194)Bcl-6 (6)BRK (3)c-Myc (47)c-RET (64)C/EBP (2)Caspase (170)DAPK (12)Ferroptosis (111)FKBP (15)GDNF Receptor (2)IAP (47)IDO (69)MDM2 (142)MRCK (2)Necroptosis (33)p32 (1)p53 (41)PERK (35)PKD (10)Pyroptosis (12)RIP Kinase (82)Survivin (12)Thymidylate Synthase (24)TNF (22)TNF Receptor (112)TNF-alpha (28)
Autophagy (725)
ATG4B (4)ATTECs (3)AUTACs (7)Autophagy (710)Beclin1 (1)FKBP (15)LC3 (1)LRRK2 (32)Lysosome (1)mitoNEET (1)Mitophagy (3)PPT (1)SPHK (24)TFEB (1)ULK (17)
Cell Cycle (4584)
Antifolate (31)APC (6)Aurora Kinase (86)BUB (3)Casein Kinase (101)CDK (475)Chk (46)CRISPR/Cas9 (7)CRM1 (17)DHFR (55)DNA polymerase θ (2)DNA/RNA Synthesis (620)DOCK (3)DYRK (60)E2F (2)eIF (43)Endonuclease (3)FOXM1 (3)G-quadruplex (6)Haspin Kinase (8)HDAC (334)HGF (1)HSF (4)HSP (160)IRE1 (28)Kinesin (35)Lats kinase (1)LIMK (17)Mad2 (1)Microtubule/Tubulin (302)MKLP (2)Mps1 (21)MTH2 (1)Nucleoside Antimetabolite/Analog (1442)p21 (1)PAK (29)PDI (1)PKMYT1 (2)PLK (50)PPAR (190)PTEN (5)RAD51 (17)Rho (14)RNA polymerase 2 (1)RNA polymerase 1 (2)ROCK (87)Separase (1)Sirtuin (127)SRPK (51)STK33 (2)TACC (3)Telomerase (20)TOPK (1)Topoisomerase (271)Wee1 (16)YB-1 (5)
Cytoskeleton (722)
Actin (1)Arp2/3 Complex (6)CYTH (1)Cytoplasmic dynein (1)Dynamin (15)FAK (56)Filamin-A (1)Gap Junction (11)Integrin (134)Kinesin (35)MARK (1)Microtubule/Tubulin (302)MLCK (5)Mps1 (21)Myosin (25)PAK (29)ROCK (87)Spastin (1)
DNA Damage (3015)
ADAR (1)AP endonuclease (1)ATAD5 (1)ATM/ATR (67)Aurora Kinase (86)Casein Kinase (101)ClpP (5)CRISPR/Cas9 (7)DNA Alkylator/Crosslinker (76)DNA-PK (39)DNA/RNA Synthesis (620)HDR (1)HSP (160)MRE11 (1)MTH1 (8)Nucleoside Antimetabolite/Analog (1442)OGG (3)p97 (15)PARP (168)RAD51 (17)RAD52 (2)Telomerase (20)Topoisomerase (271)WRN (5)YB-1 (5)
Endocrinology/Hormones (801)
5 Alpha Reductase (2)ACE (73)Adrenergic Receptor (180)Androgen Receptor (96)Aromatase (8)ERR (213)GHSR (21)Glucocorticoid Receptor (44)GNRH Receptor (19)Mineralocorticoid Receptor (12)Opioid Receptor (47)Progesterone Receptor (9)PTHR (1)Renin (17)Sepiapterin reductase (2)SSTR (28)Taste receptor (3)Thyroid Hormone Receptor (3)TPO (4)TRHR (1)TSH Receptor (16)TTR (7)
Endoplasmic Reticulum Stress (545)
Antioxidant (20)IRE1 (28)JNK (79)PDI (1)PERK (35)ROS (388)
Epigenetics (2336)
AMPK (103)Aurora Kinase (86)DNA Methyltransferase (41)Epigenetic Reader Domain (391)FTO (15)HDAC (334)HIF (111)Histone Acetyltransferase (92)Histone Demethylase (146)Histone Methyltransferase (277)JAK (244)MBD-containing protein (1)METTL3 (10)MicroRNA (16)PAD (24)PARP (168)Pim (58)PKC (157)PRMT (16)SF3B1 (3)Sirtuin (127)TET (4)
Ferroptosis Signaling Pathway (78)
ABC Transporter (2)ACC (22)GPx (24)GTPCH (1)SCD (18)SLC (6)VDAC (6)
GPCR/G Protein (3432)
5-HT Receptor (392)Adenosine Receptor (169)Adenylyl Cyclase (1)Adiponectin Receptor (2)Adrenergic Receptor (180)Amylin receptor (1)Angiotensin Receptor (76)Apelin Receptor (21)Bombesin Receptor (7)Bradykinin Receptor (17)cAMP (35)Cannabinoid Receptor (62)CaSR (23)CCR (88)CGRP Receptor (12)Chemerin Receptor (2)Cholecystokinin Receptor (32)CRF Receptor (19)CXCR (112)Dopamine Receptor (166)Endothelin Receptor (48)Epac (9)G protein (2)GHSR (21)GLP Receptor (24)Glucagon Receptor (50)GNRH Receptor (19)GPCR (198)GPCR19 (2)GPR109A (1)GPR119 (2)GPR139 (3)GPR24 (1)GPR35 (1)GPR40 (7)GPR52 (4)GPR6 (3)GPR68 (2)GPR84 (1)GPR88 (8)Guanylate Cyclase (30)HCAR (2)Histamine Receptor (234)ICMT (61)Kisspeptin Receptor (2)LHCGR (39)LPA Receptor (11)LPL Receptor (113)Melanocortin Receptor (26)mGluR (228)Motilin Receptor (1)MRGPR (13)Neuropeptide Y receptor (8)Neurotensin Receptor (13)NMUR (2)NPFF receptor (3)Opioid Receptor (47)OXTR (10)P2Y Receptor (76)PACAP Receptor (3)PAFR (38)PAR (54)Prostaglandin Receptor (217)Ras (275)RGS (6)RXFP Receptor (14)S1P Receptor (5)Sigma Receptor (48)SOS (7)SRPK (51)SSTR (28)SUCNR1 (5)TAAR (7)TSH Receptor (16)Urotensin Receptor (7)Vasopressin Receptor (23)β-arrestin (17)
Hedgehog (Hh) (831)
BMI-1 (3)c-Myc (47)Casein Kinase (101)CDK (475)Cytoplasmic dynein (1)Gli (6)GSK-3 (125)PKA (59)Smo (36)ULK (17)
Hippo (80)
Lats kinase (1)MAP4K (47)MST (2)TEAD (10)YAP (28)
Immunology/Inflammation (2659)
AIM2 (5)AP-1 (16)Arginase (14)Calcineurin (8)CCR (88)CD22 (1)CD28 (2)CD28-B7 (1)CD3 (2)CD38 (9)CD47 (5)CD73 (25)CD80 (1)cGAS (8)COX (344)CRTH2 (9)CTLA-4 (1)CXCR (112)Cyclophilin (7)FAP (17)FKBP (15)FLAP (17)FPR (17)Galectin (3)Glucocorticoid Receptor (44)Glycoprotein VI (3)GM-CSF (2)Histamine Receptor (234)HMGB (1)IFNAR (22)IL (161)IL Receptor (9)Immunology & Inflammation Related (76)IRAK (71)IRF3 (1)LanC-like protein (1)Legumain (1)LTA4H (3)LTR (73)MALT1 (24)MIF (17)MyD88 (6)NADPH Oxidase (32)NFAT (11)NLR (73)NO Synthesis (6)NOS (185)NOT (1)Nrf2 (99)PD-1/PD-L1 (76)PG Synthase (31)PSMA (13)Pyroptosis (12)ROS (388)Ros1 (18)S100A9 (1)Scavenger receptor (1)SIK (15)SOD (4)SPHK (24)STING (99)TENT (1)Thrombopoietin Receptor (11)Tim3 (3)TLR (166)TSPO (2)VISTA (1)XBP1 (1)
JAK-STAT-Signaling (833)
EGFR (401)JAK (244)Pim (58)STAT (159)
MAPK/ERK Pathway (712)
AP-1 (16)ERK (167)HPK1 (2)JNK (79)KLF (5)MAP3K (24)MAP3K12 (1)MAP4K (47)MAP4K4 (5)MAP4K6 (1)MEK (100)MK2 (11)MLK (14)MNK (11)p38 MAPK (161)Raf (105)RSK (32)TAOK (1)
Membrane Transporter/Ion Channel (1691)
ABC Transporter (2)AKK1 (3)ANT (1)AQP (5)AQP3 (1)ARF (2)ATP synthase (19)ATPase (42)BCRP (23)Calcium Channel (267)CFTR (61)Chloride Channel (28)CRAC Channel (13)CRM1 (17)EAAT (3)Efflux pump (1)ENT (2)Ferroportin (2)GABA Receptor (182)GLUT (32)Glutamate transporter (21)Glycine transporter (21)HCN Channel (2)IBAT (10)ITPKA (2)MAT (24)MCT (17)Na+/Ca2+ Exchanger (14)Na+/K+ ATPase (14)Na/HCO3 cotransporter (1)NKCC (1)Oct (10)OCTN (1)Organic Anion Transporter (1)P-gp (55)P2X Receptor (79)Piezo (4)Potassium Channel (281)Proton Pump (54)SEO1 (1)SGLT (44)SLC (6)Sodium Channel (194)SV2 (2)TRP Channel (179)UCP (1)URAT1 (18)Urea Transporter (2)VDAC (6)VRAC (1)
Metabolic Enzyme (3461)
15-PGDH (2)2OG Oxygenase (1)3-PGDH (2)3MST (1)6PGD (3)ACAT (37)ACC (22)ACMSD (2)Aconitate hydratase (1)ACS (3)Adenosine Deaminase (12)Adenosylhomocysteinase (8)ADP-ribosyltransferase (1)AhR (50)AKR (15)ALDH (31)Aldose Reductase (53)Aminopeptidase (25)Antifolate (31)AO (2)ApoE (1)Arginase (14)Asparagine synthetase (1)ATF/CREB proteins (2)ATP Citrate Lyase (6)ATP synthase (19)BDK (1)Beta-glucuronidase (3)Carbonic Anhydrase (123)Carboxylesterase (23)Carboxypeptidase (7)Cardiolipin Peroxidase (1)Cathepsin (93)Ceramidase (4)CETP (14)Cholesterol Transporter (1)CPA (5)CPSI (2)Creatine kinase (1)Cryptochrome (5)CSE (2)CYP51 (1)D-amino acid oxidase (3)D6D (1)DAPA synthase (1)Decarboxylase (8)Dehydrogenase (156)DGAT (62)DGK (20)Dopamine β-hydroxylase (8)E-NTPDase (1)Elastase (32)Enolase (7)Enteropeptidase (5)ERAP (3)FABP (6)Factor Xa (45)Farnesyl Transferase (4)FAS (34)FBPase (4)Ferroptosis (111)FOXO (3)FPR (17)FTO (15)Fumarate hydratase (2)FVII (2)FXR (74)G0/G1 switch protein 2 (2)Galactosidases (5)GCN (1)GCS (3)GGTase (6)Glucokinase (25)Glucosidase (133)GLUT (32)Glutaminase C (2)Glutathione Reductase (1)Glyoxalase (14)GOAT (1)GPx (24)GSNOR (3)GST (16)Heme Oxygenase (HO) (7)Hexokinase (7)HMGCR (45)HPSE (2)Hydrolase (12)Hydroxylase (20)IDH (37)IDO (69)Ketohexokinase (5)LDL (11)LDLR (1)Lipase (93)Lipoxygenase (111)LOX (4)LRH-1 (4)LXR (27)MAGL (2)MASTL (1)MDH (3)MetAP (10)MGAT (7)Mineralocorticoid Receptor (12)Mitochondrial Electron Transport Chain (3)Mitochondrial Metabolism (92)MPC (3)NAMPT (33)Neprilysin (15)NNMT (8)NPP (2)NPR (15)NQO (2)OGT (2)OPA1 (1)P448 (1)P450 (254)PAI-1 (24)PARG (12)PDE (358)PDHK (12)PEPCK (2)PGAM1 (1)PGC-1α (4)PHGDH (5)Phospholipase (108)Phosphorylase (10)PI5P4K (11)PKM1 (2)PKM2 (6)Procollagen C Proteinase (1)Proprotein convertases (5)Pyruvate Kinase (28)QR (2)RAR/RXR (87)RBP (3)REV-ERB (4)ROR (67)SCD (18)sEH (33)SGK (15)SHMT (7)Sialyltransferase (1)Sphingosine acyltransferase (2)SQOR (2)Srx (1)Steroid Sulfatase (8)TDO (3)TGH (1)Thioredoxin (12)Thrombin (41)Thymidylate Synthase (24)Transferase (79)Transketolase (7)TrxR (11)Trypanothione reductase (1)UGT (3)VD/VDR (47)Xanthine Oxidase (49)αKGD (2)
Neuronal Signaling (3786)
5-HT Receptor (392)AAK1 (17)AChE (44)AChR (346)Adenosine Kinase (6)Adrenergic Receptor (180)AMPAR (53)Amylin receptor (1)Amyloid-β (169)Calcium Channel (267)CaMK (54)Cannabinoid Receptor (62)CGRP Receptor (12)Cholecystokinin Receptor (32)Cholinesterase (235)CHT (1)COMT (17)DAT (21)Dopamine Receptor (166)Endorphin (1)Enkephalinase (3)FAAH (44)GABA Receptor (182)Glucosylceramide Synthase (13)GluR (206)GPR119 (2)GPR139 (3)GPR24 (1)Histamine Receptor (234)Huntingtin (3)Imidazoline Receptor (14)Kainate receptor (5)MAO (194)Melanocortin Receptor (26)mGluR (228)MT Receptor (11)NET (3)Neuropeptide Y receptor (8)Neurotensin Receptor (13)NGF (3)NK Receptor (56)NMDA (1)NMDAR (50)Notch (26)Nurr1 (7)OLIG2 (1)Opioid Receptor (47)OX Receptor (46)P2X Receptor (79)Proprotein convertases (5)QC (3)RAGE (3)REST (1)Ryanodine Receptor-1 (1)S100β (1)Secretase (110)SERT (28)Sigma Receptor (48)SMS (4)SSRIs (5)Substance P (2)TAAR (7)Tau Protein (28)TLX (1)Trk Receptor (80)TRP Channel (179)TTR (7)α-synuclein (1)
NF-κB Signaling Pathway (539)
IKK (75)MALT1 (24)NF-κB (417)Nrf2 (99)Pirin (3)RANKL/RANK (3)RIP Kinase (82)TAK1 (3)
Notch Signaling Pathway (733)
ERK (167)Gli (6)MRCK (2)Notch (26)p53 (41)ROCK (87)TGF-beta/Smad (351)β-catenin (72)
PI3K/AKT/mTOR (1039)
Akt (208)AMPK (103)ATM/ATR (67)DNA-PK (39)FOXO (3)GSK-3 (125)MELK (9)mTOR (188)PDK (22)PDK-1 (3)PI3K (337)PI4K (28)PIKfyve (9)PIN1 (10)PTEN (5)RSK (32)
PPAR Signaling Pathway (2097)
ACS (3)Akt (208)AMPK (103)AQP (5)Bcl-6 (6)FABP (6)FATP (3)IL (161)LXR (27)MMP (176)NF-κB (417)NLR (73)OxPhos (4)PDK-1 (3)PEPCK (2)PPAR (190)RAR/RXR (87)RGS (6)ROS (388)SCD (18)SGK (15)Sirtuin (127)STAT (159)TNF-alpha (28)
Protease (693)
ADAMTS (5)Aspartic Protease (2)Cysteine Protease (23)Dipeptidase 1 (2)DPP (39)DPP2 (2)DPP4 (35)Glutaminase (26)MMP (176)NEP (3)PE (2)Proteasome (123)Ser/Thr Protease (157)Serine Protease (5)SPP (1)Tyrosinase (102)
Protein Tyrosine Kinase/RTK (2730)
Ack1 (5)ALK (84)Bcr-Abl (105)BMX Kinase (3)BRK (3)BTK (149)c-FMS (60)c-Kit (87)c-Met/HGFR (131)c-RET (64)DDR1/DDR2 Receptor (22)DYRK (60)EGFR (401)Ephrin Receptor (16)ErbB (6)FAK (56)FGF (2)FGFR (136)FLT3 (134)GAK (623)HER2 (29)IGF-1R (27)Insulin Receptor (26)ITK (18)JAK (244)MRCK (2)PDGFR (127)PTK (7)Pyk2 (4)Ros1 (18)SHP2 (48)Src (110)Syk (40)TAM Receptor (50)Tie-2 (16)Trk Receptor (80)VEGFR (268)
Pyroptosis (977)
Caspase (170)Cathepsin (93)IL (161)MyD88 (6)NF-κB (417)TLR (166)
Stem Cells (1494)
BMI-1 (3)Casein Kinase (101)CREB (5)ERK (167)Frizzled (2)Gli (6)GSK-3 (125)Hedgehog (31)JAK (244)LIN28 (4)MST (2)Notch (26)Notum (2)PKA (59)PORCN (10)ROCK (87)sFRP-1 (1)Smo (36)SOD1 (2)STAT (159)TGF-beta/Smad (351)Wnt (104)YAP (28)β-catenin (72)
TGF-beta/Smad (426)
Bcr-Abl (105)PKC (157)ROCK (87)TGF-beta/Smad (351)
Toll-Like Receptor (TLR) (565)
CREB (5)IKK (75)IRAK (71)IRF3 (1)JNK (79)MyD88 (6)p38 MAPK (161)TAK1 (3)TLR (166)
Ubiquitin (367)
DUB (82)E1/E2/E3 Enzyme (140)FBXO (2)NAE (7)p97 (15)Proteasome (123)SUMO (4)
Vitamin D Related/Nuclear Receptor (581)
Androgen Receptor (96)Glucocorticoid Receptor (44)LXR (27)Mineralocorticoid Receptor (12)PPAR (190)Progesterone Receptor (9)RAR/RXR (87)REV-ERB (4)ROR (67)Thyroid Hormone Receptor (3)VD/VDR (47)
Wnt Signaling Pathway (2356)
AP-1 (16)APC (6)ATF/CREB proteins (2)c-Myc (47)Calcineurin (8)CaMK (54)Casein Kinase (101)CDK (475)CREB (5)Frizzled (2)GSK-3 (125)JNK (79)MMP (176)NF-κB (417)NFAT (11)p300/CBP/PROTAC (2)PDE (358)Phospholipase (108)PKC (157)PKG (10)Rho (14)ROCK (87)ROR (67)Wnt (104)β-catenin (72)
Other Inhibitors/Agonists (3145)
20-HETE (2)AIMP2-DX2 (2)Amino Acids and Amino Acid Derivatives (109)Aminoacyl-tRNA Synthetase (18)Anesthetic (3)Anti-inflammation (32)Anti-Thyroid Agent (1)Anti-tumor (7)Anti-ulcer (1)Antioxidant (20)Antispasmodic Agent (2)ASGPR (11)Bcat (11)c-RET (64)Cancer Stem Cells (2)CAR (5)Cardiac transcription factor (2)CBFβ-SMMHC (1)CD73 (25)CerK (1)Chelating Agent (15)Choleretic (1)Choline Kinase (3)CNT (1)CRTH2 (9)CSE (2)DCLK (1)DcpS (1)Decarboxylase (8)Dehydrogenase (156)Diabetes (2)Diuretic (1)Drug Metabolite (283)DUE-B (1)E2F (2)ECE (2)Endogenous Metabolite (1190)ERO1 (2)FAP (17)FATP (3)Fer/FerT (1)FPP synthase (1)Fucosyltransferase (4)Fungicide (61)G protein (2)Galectin (3)Galectin-3 (12)GBF1 (1)GCase (4)Glucocorticoid Receptor (44)GRK (21)GTPCH (1)Herbicide (17)HIPK2 (3)Histidine kinase (1)HNF4α (1)HPPD (3)HRGP (1)Hydroxylase (20)IMP1 (1)Importin β (1)Insecticide (26)ITPKA (2)LAT1 (3)LDL (11)Lipase (93)Lipocalin-2 (1)LYTACs (8)MALAT1 (1)MITF (1)MLKL (4)Molecular Glues (41)MPO (6)MTTP (8)Muscle Relaxant (1)MYOF (1)NAADP (1)Neuroprotection/neurogenic Agent (4)NMD (1)NT (2)Nur77 (8)O-GlcNAcase (9)O-glycosylation (1)OSBP (1)OSBPL (1)OSC (2)Osteoclasts/Bone/Osteogenesis (16)OxPhos (4)PAM complex (1)PANK (2)PAX2 (1)PBR (4)PCA1 (1)PCSK9 (5)PDX1 (1)PEPT (1)PFKFB3 (7)Phosphatase (250)Phosphorylase (10)Photosensitizer (6)PIN1 (10)PKG (10)Platelet (5)PME-1 (2)PMO/MNA (4)PNP (1)PREP (20)Protein Synthesis (3)PXR (3)Quorum Sensing (57)RasGAP (2)Rev-ErbA (3)RUNX (7)SAP (1)SMARC (6)SQS (4)SREBP (5)SRPK (51)Sweetener (3)Tgase (2)Thioredoxin (12)TIR1 (1)TNIK (8)TNK (4)TNNI3K (1)UGT1A1 (1)Urease (5)vanin (4)VDA (1)Vitamin (64)VPS (3)XOR (1)α-amylase (16)Others (2543)
Inhibitory Monoclonal Antibody
Human Inhibitory Monoclonal Antibody (549)
ADAM9/monoclonal antibody (1)Adrenomedullin/monoclonal antibody (1)ALK/monoclonal antibody (1)AMHRII/monoclonal antibody (1)Amyloid Alpha/monoclonal antibody (1)Amyloid-β/monoclonal antibody (6)Ang2/monoclonal antibody (1)ANGPTL3/monoclonal antibody (1)Antifolate/monoclonal antibody (1)APRIL/monoclonal antibody (1)ASCT2/monoclonal antibody (1)AXL/monoclonal antibody (2)B7-H4/monoclonal antibody (1)BST2/monoclonal antibody (1)BTLA/monoclonal antibody (1)BTN1A1/monoclonal antibody (1)c-FMS/monoclonal antibody (6)c-Kit/monoclonal antibody (1)c-Met/HGFR/monoclonal antibody (3)C1q/monoclonal antibody (1)C1s/monoclonal antibody (1)C5AR/monoclonal antibody (1)CA Ⅸ/monoclonal antibody (1)CA-125/monoclonal antibody (1)CCL2/monoclonal antibody (1)CCL20/monoclonal antibody (1)CCL5/monoclonal antibody (1)CCR/monoclonal antibody (3)CD105/monoclonal antibody (1)CD11/monoclonal antibody (2)CD123/monoclonal antibody (2)CD137/monoclonal antibody (1)CD138/monoclonal antibody (1)CD14/monoclonal antibody (1)CD163/monoclonal antibody (1)CD166/monoclonal antibody (1)CD19/monoclonal antibody (5)CD2/monoclonal antibody (1)CD20/monoclonal antibody (7)CD22/monoclonal antibody (3)CD23/monoclonal antibody (1)CD248/monoclonal antibody (1)CD25/monoclonal antibody (3)CD276/B7-H3/monoclonal antibody (4)CD27L/monoclonal antibody (1)CD28/monoclonal antibody (3)CD3/monoclonal antibody (3)CD33/monoclonal antibody (2)CD37/monoclonal antibody (3)CD38/monoclonal antibody (3)CD39/monoclonal antibody (1)CD4/monoclonal antibody (5)CD40/monoclonal antibody (8)CD40L/monoclonal antibody (4)CD44v6/monoclonal antibody (1)CD45/monoclonal antibody (1)CD46/monoclonal antibody (1)CD47/monoclonal antibody (5)CD52/monoclonal antibody (2)CD56/monoclonal antibody (1)CD6/monoclonal antibody (1)CD62p/monoclonal antibody (2)CD7/monoclonal antibody (1)CD70/monoclonal antibody (1)CD73/monoclonal antibody (2)CD74/monoclonal antibody (1)CD79b/monoclonal antibody (2)CD80/monoclonal antibody (1)CD98/monoclonal antibody (2)CDH6/monoclonal antibody (1)Cdiff Toxin A/monoclonal antibody (1)CEA/monoclonal antibody (1)CEACAM1/monoclonal antibody (1)CEACAM5 /monoclonal antibody (1)CEACAM6/monoclonal antibody (1)CGRP Receptor/monoclonal antibody (4)CLDN18.2/monoclonal antibody (1)CLDN6/monoclonal antibody (2)CLEC4C/monoclonal antibody (1)clusterin/monoclonal antibody (1)Complement C3/monoclonal antibody (1)Complement System/monoclonal antibody (8)CTGF/monoclonal antibody (1)CTLA-4/monoclonal antibody (5)CX3CL1/monoclonal antibody (1)CXCL10/monoclonal antibody (1)CXCR/monoclonal antibody (2)DKK1/monoclonal antibody (2)DLL3/monoclonal antibody (1)DLL4/monoclonal antibody (1)DPEP3/monoclonal antibody (1)DPP4/monoclonal antibody (1)EGFR/monoclonal antibody (9)EpCAM/monoclonal antibody (2)EphA3/monoclonal antibody (1)ErbB/monoclonal antibody (4)Factor XI/monoclonal antibody (2)Factor XII/monoclonal antibody (1)FAP/monoclonal antibody (1)FcRn/monoclonal antibody (3)FGF23/monoclonal antibody (1)FGFR/monoclonal antibody (4)Filovirus/monoclonal antibody (7)FLT3/monoclonal antibody (1)FRα/monoclonal antibody (1)FZD/monoclonal antibody (1)FZD10/monoclonal antibody (1)GCGR/monoclonal antibody (2)GD2/monoclonal antibody (2)GD3/monoclonal antibody (1)GDF-15/monoclonal antibody (2)GFRA3/monoclonal antibody (1)GFRAL/monoclonal antibody (1)glycoprotein (GP) IIb/IIIa/monoclonal antibody (1)Glycoprotein VI/monoclonal antibody (1)GM-CSF/monoclonal antibody (3)GPA33/monoclonal antibody (1)GPC3/monoclonal antibody (1)GPNMB/monoclonal antibody (1)GPRC5D/monoclonal antibody (1)Gremlin-1/monoclonal antibody (1)GUCY2C/monoclonal antibody (1)HBEGF/monoclonal antibody (1)Hepcidin/monoclonal antibody (1)HER2/monoclonal antibody (5)HFE2/monoclonal antibody (1)HGF/monoclonal antibody (2)Histone H1/monoclonal antibody (1)HTRA1/monoclonal antibody (1)ICAM-1/monoclonal antibody (1)ICOS/monoclonal antibody (4)ICOSL/monoclonal antibody (1)IFNAR/monoclonal antibody (5)IgE/monoclonal antibody (3)IGF-1R/monoclonal antibody (5)IL-12/monoclonal antibody (1)IL-13/monoclonal antibody (5)IL-13Ra1/monoclonal antibody (1)IL-15/monoclonal antibody (1)IL-17a/monoclonal antibody (5)IL-17c/monoclonal antibody (1)IL-17R/monoclonal antibody (1)IL-18/monoclonal antibody (1)IL-1a/monoclonal antibody (1)IL-1R1/monoclonal antibody (1)IL-1RL1/monoclonal antibody (2)IL-1β/monoclonal antibody (2)IL-20/monoclonal antibody (1)IL-21/monoclonal antibody (1)IL-22/monoclonal antibody (1)IL-22Ra/monoclonal antibody (1)IL-23/monoclonal antibody (5)IL-31Ra/monoclonal antibody (1)IL-33/monoclonal antibody (2)IL-36R/monoclonal antibody (1)IL-3Rβ/monoclonal antibody (1)IL-4/monoclonal antibody (1)IL-4Ra/monoclonal antibody (3)IL-5/monoclonal antibody (2)IL-5Rα/monoclonal antibody (1)IL-6/monoclonal antibody (7)IL-6R/monoclonal antibody (1)IL-6Ra/monoclonal antibody (1)IL-7Ra/monoclonal antibody (1)IL-8/monoclonal antibody (1)IL-9/monoclonal antibody (1)IL1RAP/monoclonal antibody (1)IL22RA1 /monoclonal antibody (1)ILDR2/monoclonal antibody (1)ILT7/monoclonal antibody (1)Influenza Virus/monoclonal antibody (1)Integrin/monoclonal antibody (9)KIR/monoclonal antibody (1)KIR3DL2 /monoclonal antibody (1)Klotho β/monoclonal antibody (1)L-selectin/monoclonal antibody (1)LAG-3/monoclonal antibody (3)LDLR/monoclonal antibody (1)LEPR/monoclonal antibody (1)LIF/monoclonal antibody (1)LILRB2/monoclonal antibody (1)LINGO-1/monoclonal antibody (1)LIV-1/monoclonal antibody (1)LOXL2/monoclonal antibody (1)LRRC15/monoclonal antibody (1)LT α/monoclonal antibody (1)LYPD3/monoclonal antibody (1)MAdCAM-1/monoclonal antibody (1)MASP-2/monoclonal antibody (1)MCAM/monoclonal antibody (1)Mesothelin/monoclonal antibody (2)MIF/monoclonal antibody (1)MMP/monoclonal antibody (1)MUC16/monoclonal antibody (1)MUC5AC/monoclonal antibody (1)Mucin/monoclonal antibody (2)NaPi2b /monoclonal antibody (2)Nectin-4/monoclonal antibody (1)NeuGcGM3/monoclonal antibody (1)Neuropilin-1/monoclonal antibody (1)Neurotensin Receptor/monoclonal antibody (1)NGF/monoclonal antibody (4)NKG2A/monoclonal antibody (1)NKG2D /monoclonal antibody (1)Notch/monoclonal antibody (1)NOTCH3/monoclonal antibody (1)OSMR/monoclonal antibody (1)Osteopontin/monoclonal antibody (1)OX40/monoclonal antibody (5)OX40L /monoclonal antibody (2)P-cadherin/monoclonal antibody (1)PAC1/monoclonal antibody (1)PAR/monoclonal antibody (1)PCSK9/monoclonal antibody (4)PD-1/PD-L1/monoclonal antibody (31)PDGFR/monoclonal antibody (3)Phosphatidylserine/monoclonal antibody (1)Phosphorylcholine/monoclonal antibody (1)PRLR/monoclonal antibody (1)Prolactin Receptor/monoclonal antibody (1)Protective antigen/monoclonal antibody (1)PSMA/monoclonal antibody (1)PTK/monoclonal antibody (1)PVR/monoclonal antibody (1)PVRIG/monoclonal antibody (1)Rabies virus/monoclonal antibody (2)RAGE/monoclonal antibody (1)RANKL /monoclonal antibody (1)RG1/monoclonal antibody (1)RGMα/monoclonal antibody (1)RHD/monoclonal antibody (2)RON/monoclonal antibody (1)ROR/monoclonal antibody (1)ROR2/monoclonal antibody (1)RSPO3/monoclonal antibody (1)RSV/monoclonal antibody (4)RTN4/monoclonal antibody (1)SAA1/monoclonal antibody (1)SAP/monoclonal antibody (1)SARS-CoV/monoclonal antibody (11)Sclerostin/monoclonal antibody (2)SEMA4D/monoclonal antibody (1)Sialyl-Lewis A/monoclonal antibody (1)Siglec-15/monoclonal antibody (1)Siglec-4a/monoclonal antibody (1)SIRPα/monoclonal antibody (1)SLAMF7/monoclonal antibody (1)SLC40A1/monoclonal antibody (1)SLITRK6/monoclonal antibody (1)SpA/monoclonal antibody (1)sphingosine-1-phosphate/monoclonal antibody (1)STAB1/monoclonal antibody (1)STEAP1/monoclonal antibody (1)TAG-72/monoclonal antibody (1)Tau Protein/monoclonal antibody (2)TBFbR2/monoclonal antibody (1)TCR/monoclonal antibody (1)Tenascin-C/monoclonal antibody (1)TFPI/monoclonal antibody (1)TGF-beta/monoclonal antibody (3)TGM2/monoclonal antibody (1)Tie-2/monoclonal antibody (1)TIGIT/monoclonal antibody (5)Tim3/monoclonal antibody (3)Tissue Factor/monoclonal antibody (1)TLR/monoclonal antibody (2)TNF Receptor/monoclonal antibody (15)TNF-alpha/monoclonal antibody (5)TNF/monoclonal antibody (1)TREM2/monoclonal antibody (2)TROP2/monoclonal antibody (2)TSHR/monoclonal antibody (1)TSLP/monoclonal antibody (1)TWEAK/monoclonal antibody (1)TYRP1/monoclonal antibody (1)uPAR/monoclonal antibody (1)VAP-1/monoclonal antibody (1)VEGF/monoclonal antibody (1)VEGFC/monoclonal antibody (1)VEGFR/monoclonal antibody (5)VEGI/monoclonal antibody (2)Vimentin/monoclonal antibody (2)VISTA/monoclonal antibody (1)α-Synuclein/monoclonal antibody (2)α-toxin /monoclonal antibody (2)
Recombinant Protein
Bacterial Proteins (7)
Antimicrobial Peptides (1)Bacterial Cell Wall & Envelope (1)Bacterial Toxins (1)Flagellar Proteins (3)Virulence Factors (1)
CAR-T related Proteins (141)
B Cell Maturation Antigen (BCMA) (10)B7-H3 (7)c-Met/HGFR/Recombinant Protein (4)CA-125 (3)Carbonic Anhydrase Proteins (2)CD138/Syndecan-1 (3)CD19 Proteins (2)CD20 Proteins (3)CD27 Ligand/CD70 (4)CD30 Proteins (5)CD314/NKG2D (6)CD319/SLAMF7 (5)CD38 Proteins (6)CD4 Proteins (2)CD7 Proteins (5)EGFR/Recombinant Protein (5)Epithelial Cell Adhesion Molecule (EpCAM) (5)ErbB2/HER2 (6)ErbB3/HER3 (5)FLK-1/VEGFR-2 (3)Folate Receptor alpha (FR-alpha) (6)GPC-3 (5)MUC-1/CD227 (5)Nectin-4/Recombinant Protein (9)ROR1/Recombinant Protein (7)Siglec-2/CD22 (5)Siglec-3/CD33 (6)TROP-2/Recombinant Protein (7)
CD Antigens (646)
B Cell CD Proteins (138)Dendritic Cell CD Proteins (226)Endothelial cell CD Proteins (179)Epithelial cell CD Proteins (216)Erythrocyte CD Proteins (45)Macrophage CD Proteins (318)Monocyte CD Proteins (134)NK Cell CD Proteins (176)Platelet CD Proteins (90)Stem Cell CD Proteins (165)T Cell CD Proteins (160)
Complement System (24)
Complement Component 1 (1)Complement Component 3 (2)Complement Component 5 (2)Complement Component 8 (1)Complement Receptor/Recombinant Protein (3)Complement Regulatory Proteins (13)Mannose-binding Protein (2)
Cytokines and Growth Factors (662)
Angiopoietins (14)Chemokine & Receptors (54)CSF & Receptors (35)EGF Superfamily (25)Ephrin/Eph Family (24)FGF Family (10)HGF & Receptors (4)IGF family (13)Interferon & Receptors (24)Interleukin & Receptors (208)Neurotrophic Factors (52)PDGFs & PDGFRs (4)Peptide Hormone & Neuropeptides (29)TGF-beta Superfamily (57)TNF Superfamily (146)VEGF & VEGFR (3)
Enzymes & Regulators (244)
Carbonic Anhydrase Proteins (2)Carboxypeptidase Proteins (5)Caspase Proteins (1)Cathepsin Proteins (5)Cyclin-Dependent Kinase Inhibitor Proteins (2)Cystatin Family (12)Hydrolases (EC 3) (50)Isomerases (EC 5) (4)Lyases (EC 4) (9)Matrix Metalloproteinases (3)Oxidoreductases (EC 1) (18)Phosphatase/Recombinant Protein (6)Protease Inhibitors (42)Protein Tyrosine Kinases (79)Serine/Threonine Kinase Proteins (17)Transferases (EC 2) (15)
Fc Receptors (33)
Fc alpha RI/CD89 (1)Fc Receptor-like Proteins (2)Fc-epsilon Receptor (1)Fc-gamma Receptor (8)FcRn (5)Immunoglobulin Fc Region (16)
Immune Checkpoint Proteins (276)
Butyrophilins (24)Inhibitory Checkpoint Molecules (167)Stimulatory Immune Checkpoint Molecules (120)
Receptor Proteins (383)
Cell Adhesion Molecules (CAMs) (114)Cytokine Receptors (51)G-Protein-Coupled Receptors (GPCRs) (32)Killer-Cell Immunoglobulin-like Receptors (4)Leukocyte Immunoglobin-like Receptors (23)Notch family (6)Nuclear Receptor Superfamily (1)Pattern Recognition Receptors (18)Receptor Serine/Threonine Kinases (16)Receptor Tyrosine Kinases (81)Receptor Tyrosine Phosphatase (2)Siglec/Recombinant Protein (36)
Ubiquitin Related Proteins (3)
Ubiquitin Enzymes/Recombinant Protein (2)Ubiquitin/UBLs (1)
Viral Proteins (1)
HIV Proteins (1)
Animal Modeling Reagents
Circulatory System Disease Models (11)
Cardiomyopathy Model (1)Heart Disease Correlation Model (2)Heart Failure Model (1)Hyperlipidemia Model (1)Hypertension Model (3)Thrombolysis Model (2)Vascular Inflammation Model (1)
Digestive System Disease Models (17)
Gallstone Model (1)Gastrointestinal Disease Model (8)Liver Disease Model (5)Pancreatic Disease Model (3)
Endocrine System Disease Models (12)
Aging Model (1)Diabetes Model (4)Hyperuricemia Model (8)
Immune and Inflammatory Disease Models (29)
Arthritis Model (1)Cystitis Model (1)Dermatitis Model (1)Ear Edema Model (1)Encephalomyelitis Model (2)Foot Edema Model (2)Gastrointestinal Inflammation and Ulcer Model (8)Gouty Arthritis Model (1)Liver Inflammation Model (2)Myocarditis Model (2)Nephritis Model (1)Pancreatitis Model (5)Psoriasis Model (3)Systemic Lupus Erythematosus Model (2)
Nervous System Disease Models (10)
Alzheimers Disease Model (3)Epilepsy Model (3)Neuropathic Pain Model (1)Parkinsons Disease Model (3)Schizophrenia Model (1)
Otorhinolaryngological Disease Models (4)
Cataract Model (1)Gingival Hyperplasia Model (2)Optic Neuropathy Model (1)Other Otorhinolaryngological Disease Model (1)
Respiratory System Disease Models (2)
Acute Lung Injury Model (1)Pulmonary Fibrosis Model (1)
Skin Disease Models (2)
Acne Animal Model (1)Atopic Dermatitis Model (1)
Tumor Models (9)
Breast Tumor Model (2)Colon Tumor Model (1)Esophageal Tumor Model (1)Kidney Tumor Model (1)Liver Tumor Model (1)Lung Tumor Model (2)Skin Tumor Model (2)Uterine Fibroid Model (1)
Urinary System Disease Models (19)
Aging Model (1)Chronic Kidney Disease Model (2)Diabetes Model (4)Hyperuricemia Model (8)Kidney Stone Model (1)Nephrotoxicity Model (1)Renal Injury Model (5)Other Urinary System Disease Model (3)
Antibiotic and Antivirus
Function (144)
Anti-bacterial Antibiotic (2)Anti-fungal Antibiotic (7)Antivirus (66)Cell Culture Antibiotic (4)Insect Repellent (44)Plant Tissue Culture Antibiotic (7)Preservative and Disinfectant (20)
Structure (8699)
Amino Acid Derivative (1)Aminoglycoside (9)Ansamycin (3)Cephalosporin (7)Imidazole (6042)Macrolide (8)Nucleoside (8)Penicillin (3)Pyridine / Pyrimidine (6)Quinolone (20)Sulfonamide (18)Tetracycline (6)β-Lactam (4)Other Antibiotics (37)Others (2543)
Biochemical Reagents
Amino Acids (742)
Amino Acid Amide (16)Biologically Modified Amino Acid (27)C-protective Amino Acid (182)N-protective Amino Acid (407)Non-protein Amino Acid (101)Protein Amino Acid (58)Side Chain Protected Amino Acid (22)
Biological Buffers (2576)
Good's Buffer (20)Other Buffers (13)Others (2543)
Cross-Linking Agents (34)
Amino-amino Crosslinker (8)Amino-sulfhydryl Crosslinker (15)Photoreactive Crosslinker (3)Sulfhydryl-carbonyl Crosslinker (1)Sulfhydryl-sulfhydryl Crosslinker (4)Other Reactive Crosslinkers (3)
Denaturants (2)
Surface Active Agent (2)
Detergents (16)
Amphoteric Surfactant (4)Anionic Surfactant (3)Cationic Surfactant (1)Nonionic Surfactant (5)Sulfonated Betaine (3)
Lipids (221)
Aliphatic Acyl (211)Glycerol Lipid (8)Sphingolipid (2)
Polypeptides (33)
Dipeptide and Tripeptide (30)Oligopeptide (3)
Steroids (2606)
Bile Acid (49)Cholestane (3)Estrogen (1)Plant Sterol (10)Steroidal Glycoside (2)Other Steroids (2)Others (2543)
Sugar and Derivatives (152)
Sugar (136)Sugar Alcohol (17)
Sweeteners (For Research Experiments) (18)
Artificial sweetener (6)Natural sweetener (12)
Cancer
Cancer Stem Cells (2416)
Cathepsin (93)CXCR (112)Hedgehog (31)IL (161)IL Receptor (9)Integrin (134)MIF (17)MMP (176)NF-κB (417)NOS (185)Notch (26)PDGFR (127)PPAR (190)STAT (159)TGF-beta/Smad (351)VEGFR (268)Wnt (104)YAP (28)
Tumor Development and Microenvironment Evolution (1801)
ALK (84)AP-1 (16)CAR (5)CCR (88)COX (344)DDR1/DDR2 Receptor (22)ErbB (6)GABA Receptor (182)GSK-3 (125)IFNAR (22)IRAK (71)JAK (244)NLR (73)Nrf2 (99)PD-1/PD-L1 (76)STING (99)Syk (40)TLR (166)TNF-alpha (28)TNK (4)
Tumor Epigenetics and Gene Regulation (2822)
Aminoacyl-tRNA Synthetase (18)ATM/ATR (67)DNA Methyltransferase (41)DNA/RNA Synthesis (620)Epigenetic Reader Domain (391)HDAC (334)HIF (111)Histone Acetyltransferase (92)Histone Demethylase (146)Histone Methyltransferase (277)METTL3 (10)MicroRNA (16)PAD (24)PARP (168)Pim (58)PKC (157)RNA polymerase 1 (2)Sirtuin (127)TET (4)Topoisomerase (271)
Tumor Growth, Proliferation and Apoptosis (2205)
Akt (208)Aurora Kinase (86)Bcl-2 (194)c-Met/HGFR (131)c-Myc (47)EGFR (401)ERK (167)HER2 (29)MEK (100)MLKL (4)mTOR (188)p53 (41)PI3K (337)PTEN (5)Raf (105)Ras (275)ROR (67)Telomerase (20)
Tumor Metabolism (1255)
ACC (22)ALDH (31)AMPK (103)Arginase (14)ATP Citrate Lyase (6)Dehydrogenase (156)FBPase (4)FTO (15)GLUT (32)Glutaminase (26)Hexokinase (7)IDH (37)IDO (69)MCT (17)MDH (3)NADPH Oxidase (32)OGT (2)P450 (254)PDHK (12)PHGDH (5)PKM2 (6)ROS (388)SHMT (7)SLC (6)SOD (4)SREBP (5)
Cell Biology
Cell Analysis (2)
Cell Proliferation and Cytotoxicity (2)
Cell Apoptosis/Death Detection (1415)
Apoptosis Inducer (1403)Apoptosis Inhibitor (2)Iron death Inhibitor (10)
Cell Culture (321)
Additive and Auxiliary Reagent (127)Cell Assay Reagents (9)Cell Staining (2)Organoid Culture Additive (83)Stem Cell Induction (119)
Enzymology
Enzyme Inhibitors (210)
Acetaldehyde Dehydrogenase Inhibitor (2)Acyltransferase Inhibitor (4)Alkaline Phosphatase Inhibitor (2)Angiotensin Converting Enzyme Inhibitor (4)ATP Enzyme Inhibitor (8)Calcineurin Inhibitor (1)Carbonic Acid Dehydratase Inhibitor (2)Caspase Inhibitor (2)Cyclooxygenase (COX) Inhibitor (54)DNA Topoisomerase II Inhibitor (11)Hypoxia Inducible Factor (HIF) Inhibitor (3)Inosine Monophosphate (IMP) Dehydrogenase Inhibitor (10)Leukotriene A4 Hydrolase Inhibitor (3)Lipoxygenase Inhibitor (11)Monoamine Oxidase Inhibitor (4)NADH Peroxidase Inhibitor (2)Pancreatic Lipase Inhibitor (2)Phosphodiesterase Inhibitor (19)Protease Inhibitor (15)Reverse Transcriptase Inhibitor (16)Starch Glucosidase Inhibitor (3)Thromboxane Synthase Inhibitor (3)Topoisomerase I Inhibitor (8)Tyrosine / EGF Receptor Protein Kinase Inhibitor (33)
Enzyme Preparation (69)
Cyclooxygenase (COX) (53)E3 Ubiquitin Ligase (1)Hydrolase (12)Nitric Oxide Metabolism (3)
Enzyme Substrates (5)
Peroxidase Substrate (2)β-Galactosidase Substrate (1)β-Glucuronidase Substrate (2)
Fluorescent Probe / Staining
Cell Biology Fluorescent Dyes (98)
Apoptosis Dyes (5)BODIPY (21)Cytoplasm Dyes (5)Cytotoxicity Analysis Dyes (11)Endocytosis and pinocytosis Dyes (5)Endoplasmic Reticulum Dyes (1)Exosome Dyes (4)Lipid Droplet Dyes (3)Lysosome Dyes (4)Membrane Dyes (5)Mitochondrial Dyes (5)NOS Dyes (8)Nucleic Acid Dyes (1)Nucleus Dyes (10)PH Indicators (19)ROS Dyes (27)
Fluorescence Labeling Reagents (2782)
Anthocyanine (1)Boron Dipyrrole Methylene  (2)Coumarin (8)Danacyl (2)Fluoressin (8)Nitrobenzoxadiazole (NBD) (2)Pyrene (6)Other Fluorescence Labeling Reagents (214)Others (2543)
Fluorescent Dyes (2697)
Acridine Dye (9)Cancer Analysis Dyes (9)Coumarine Dye (57)Cyanine Dye (25)Neuroscience Analysis Dyes (33)Protein (3)Other Fluorescent Dyes (8)Others (2543)
Molecular Biology
Extraction and Analysis Of Nucleic Acid (5)
Hybridization Reagent (3)Probe (2)
Gene Cloning (19)
Buffer (19)
Nucleic Acid Electrophoresis (4)
Electrophoretic Buffer (3)Gelatin (1)
Natural Products
Acanthaceae (20)
Adhatoda (4)Andrographis (9)Justicia (4)Phlogacanthus (2)Strobilanthes (1)
Aceraceae (2)
Acer (2)
Adiantaceae (2)
Adiantum (2)
Alariaceae (77)
Acanthopanax (5)Aralia (8)Diplopanax (3)Eleutherococcus (3)Hedera (4)Oplopanax (1)Panax (53)
Alismataceae (3)
Alisma (3)
Amaranthaceae (6)
Achyranthes (3)Celosia (2)Cyathula (1)
Amaryllidaceae (23)
Agave (4)Allium (5)Curculigo (10)Lycoris (3)Narcissus (1)
Anacardiaceae (15)
Lannea (1)lodes (1)Mangifera (6)Rhus (4)Toxicodendron (3)
Annonaceae (19)
Annona (2)Fissistigma (6)Goniothalamus (4)Guatteria (1)Miliusa (1)Orophea (2)Polyalthia (2)Uvaria (1)
Apocynaceae (45)
Alstonia (3)Apocynum (1)Aspidosperma (1)Catharanthus (5)Cerbera (5)Kopsia (1)Nerium (10)Plumeria (2)Rauvolfia (9)Thevetia (3)Trachelospermum (4)Voacanga (1)
Aquifoliaceae (3)
Ilex (3)
Araceae (14)
Acorus (10)Eminium (2)Pinellia (2)
Aristolochiaceae (16)
Aristolochia (12)Asarum (3)Holostylis (1)
Asclepiadaceae (20)
Cryptolepis (3)Cynanchum (7)Marsdenia (5)Periploca (5)
Asparagaceae (11)
Eucomis (2)Muscari (1)Scilla (8)
Asteraceae (228)
Achillea (3)Ageratum (1)Ambrosia (2)Arctium (2)Arnica (1)Artemisia (24)Aster (2)Atractylodes (10)Aucklandia (5)Bellis (1)Blumea (4)Cacalia (1)Carpesium (1)Carthamus (7)Centaurea (5)Centipeda (4)Chrysactinia (4)Chrysanthemum (6)Cichorium (2)Cirsium (2)Conyza (1)Coreopsis (1)Cosmos (1)Crepis (3)Cynara (1)Dahlia (2)Dittrichia (1)Doronicum (1)Echinacea (2)Eclipta (6)Elephantopus (1)Erigeron (3)Eupatorium (20)Gnaphalium (1)Gynura (2)Helianthus (4)Heterotheca (1)Inula (8)Kalimeris (1)Laggera (13)Laurentia (1)Ligularia (4)Matricaria (2)Petasites (2)Pulicaria (4)Saussurea (3)Scorzonera (2)Senecio (9)Siegesbeckia (2)Silybum (5)Smallanthus (1)Stevia (10)Tagetes (4)Telekia (1)Tessaria (1)Tussilago (2)Verbesina (1)Vernonia (5)Wedelia (2)Xanthium (6)Zinnia (1)
Athyriaceae (1)
Cystopteris (1)
Balsaminaceae (5)
Impatiens (5)
Berberidaceae (36)
Berberis (3)Bongardia (1)Caulophyllum (2)Dysosma (3)Epimedium (25)Sinopodophyllum (2)
Betulaceae (11)
Alnus (6)Betula (1)Carpinus (1)Corylus (3)
Bignoniaceae (16)
Catalpa (8)Crescentia (2)Incarvillea (1)Kigelia (1)Macfadyena (1)Markhamia (1)Oroxylum (2)
Blechnaceae (1)
Woodwardia (1)
Boraginaceae (18)
Arnebia (2)Echium (1)Ehretia (1)Lithospermum (13)Tournefortia (1)
Burseraceae (13)
Boswellia (5)Canarium (5)Commiphora (3)
Buxaceae (3)
Buxus (3)
By Structure (5522)
Alkaloids (148)Coumarins (21)Lignans (39)Phenols (1870)Phenylpropanane (56)Quinones (34)Natural Products-Other Structure (3379)
Calophyllaceae (8)
Pseudostellaria (2)Stellaria (1)Vaccaria (5)
Campanulaceae (14)
Codonopsis (1)Lobelia (2)Platycodon (10)Sphenoclea (1)
Cannabaceae (16)
Cannabis (3)Humulus (8)
Caprifoliaceae (23)
Lonicera (20)Sambucus (1)Viburnum (2)
Celastraceae (16)
Celastrus (3)Euonymus (1)Maytenus (1)Tripterygium (11)
Cephalotaxaceae (10)
Cephalotaxus (10)
Chenopodiaceae (3)
Kochia (1)Spinacia (1)Suaeda (1)
Chloranthaceae (11)
Chloranthus (10)Sarcandra (1)
Clusiaceae (96)
Alliaria (1)Brassica (8)Calophyllum (6)Cratoxylum (2)Descurainia (1)Eruca (1)Garcinia (47)Hypericum (15)Isatis (2)Lepidium (4)Mammea (1)Mesua (1)Raphanus (3)Sinapis (3)Symphonia (1)
Combretaceae (6)
Calycopteris (1)Combretum (2)Terminalia (3)
Convolvulaceae (2)
Erycibe (1)Ipomoea (1)
Coriariaceae (2)
Coriaria (2)
Cornaceae (3)
Cornus (3)
Crassulaceae (12)
Rhodiola (7)Sedum (5)
Cucurbitaceae (45)
Bolbostemma (1)Bryonia (1)Cucumis (1)Cucurbita (1)Echinocystis (1)Gynostemma (4)Hemsleya (3)Herpetospermum (1)Lagenaria (3)Luffa (1)Momordica (9)Siraitia (17)Trichosanthes (2)
Cupressaceae (12)
Chamaecyparis (2)Juniperus (5)Platycladus (4)
Cyperaceae (5)
Carex (2)Cyperus (3)
Daphniphyllaceae (36)
Aquilaria (10)daphne (3)Daphniphyllum (1)Edgeworthia (1)Excoecaria (1)Pieris (2)Stellera (10)Wikstroemia (8)
Dennstaedtiaceae (1)
Dennstaedtia (1)
Dicksoniaceae (4)
Cibotium (4)
Dioscoreaceae (11)
Dioscorea (11)
Dipsacaceae (3)
Dipsacus (3)
Dryopteridaceae (4)
Dryopteris (4)
Elaeagnaceae (7)
Elaeagnus (2)Hippophae (5)
Equisetaceae (3)
Equisetum (3)
Erythroxylaceae (1)
Erythroxylum (1)
Eucommiaceae (12)
Eucommia (12)
Euphorbiaceae (47)
Breynia (1)Croton (7)Endospermum (1)Euphorbia (11)Excoecaria (1)Flueggea (1)Hevea (3)Jatropha (5)Macaranga (1)Mallotus (1)Phyllanthus (11)Suregada (2)Trigonostemon (2)
Fabaceae (347)
Abrus (1)Acacia (9)Adenanthera (1)Albizia (1)Ammothamnus (1)Antheroporum (1)Astragalus (23)Butea (1)Caesalpinia (18)Cajanus (3)Campylotropis (1)Cassia (27)Cicer (1)Crotalaria (5)Cytisus (3)Dalbergia (10)Derris (13)Desmodium (3)Erythrina (13)Flemingia (3)Genista (1)Glycine (21)Glycyrrhiza (42)Griffonia (1)Hedysarum (1)Lespedeza (5)Leucaena (3)Lotus (5)Lupinus (7)Maackia (4)Medicago (1)Millettia (6)Mimosa (1)Mucuna (2)Ononis (2)Parochetus (2)Phyllodium (1)Pisum (1)Pongamia (1)Prosopis (2)Psoralea (18)Pterocarpus (1)Pueraria (25)Robinia (2)Saraca (1)Senna (1)Sophora (36)Spartium (1)Spatholobus (2)Styphnolobium (1)Trifolium (6)Trigonella (2)Vicia (2)Wisteria (2)
Fagaceae (2)
Castanea (1)Lithocarpus (1)
Gentianaceae (28)
Anthocleista (1)Canscora (1)Gentiana (16)Gentianella (1)Halenia (1)Swertia (8)
Geraniaceae (3)
Geranium (2)Pelargonium (1)
Gesneriaceae (1)
Lysionotus (1)
Ginkgoaceae (10)
Ginkgo (10)
Gnetaceae (4)
Gnetum (4)
Hamamelidaceae (2)
Hamamelis (1)Loropetalum (1)
Hernandiaceae (127)
Ammi (2)Angelica (32)Bupleurum (13)Centella (3)Cnidium (9)Ferula (3)Heracleum (13)Hernandia (2)Ledebouriella (1)Ligusticopsis (1)Ligusticum (9)Notopterygium (7)Oenanthe (1)Petroselinum (2)Peucedanum (20)Pimpinella (1)Saposhnikovia (7)Seseli (1)
Hippocastanaceae (5)
Aesculus (5)
Illiciaceae (6)
Illicium (6)
Iridaceae (19)
Belamcanda (8)Crocus (6)Eleutherine (3)Iris (2)
Juglandaceae (6)
Diospyros (2)Engelhardtia (1)Juglans (1)Sesamum (2)
Juncaceae (5)
Juncus (5)
Lamiaceae (142)
Ajuga (2)Ballota (1)Clinopodium (3)Coleus (2)Dracocephalum (3)Elsholtzia (1)Isodon (5)Lamiophlomis (1)Leonurus (9)Marrubium (2)Mentha (4)Mosla (2)Perilla (4)Phlomis (1)Plectranthus (1)Pogostemon (1)Rosmarinus (7)Salvia (45)Scutellaria (40)Stachys (2)Tectona (1)Thymus (5)
Lauraceae (23)
Cinnamomum (7)Cryptocarya (3)Endlicheria (1)Laurus (1)Lindera (4)Litsea (1)Nectandra (2)Ocotea (4)
Lepidoziaceae (1)
Lepidozia (1)
Lichenes (1)
Usnea (1)
Liliaceae (80)
Aloe (5)Anemarrhena (8)Asparagus (1)Dracaena (11)Fritillaria (3)Hosta (1)Lilium (4)Liriope (3)Ophiopogon (28)Paris (9)Polygonatum (3)Smilax (1)Trillium (1)Tupistra (1)Veratrum (1)
Linaceae (2)
Linum (2)
Loganiaceae (5)
Buddleja (2)Gelsemium (1)Strychnos (2)
Loranthaceae (1)
Taxillus (1)
Lycopodiaceae (3)
Lycopodium (3)
Lygodiaceae (1)
Lygodium (1)
Lythraceae (11)
Lawsonia (4)Punica (7)
Magnoliaceae (24)
Liriodendron (4)Magnolia (19)Michelia (1)
Malvaceae (5)
Abelmoschus (1)Gossypium (1)Guazuma (2)Hibiscus (1)
Meliaceae (24)
Aglaia (12)Amoora (2)Aphanamixis (3)Melia (4)Walsura (3)
Menispermaceae (13)
Cocculus (2)Diploclisia (1)Menispermum (1)Stephania (5)Tinospora (3)Triclisia (1)
Moraceae (69)
Artocarpus (2)Broussonetia (13)Cudrania (16)Morus (37)Trilepisium (1)
Moringaceae (7)
Moringa (7)
Musaceae (13)
Musa (10)Musella (3)
Myricaceae (7)
Morella (7)
Myristicaceae (7)
Myristica (7)
Myrsinaceae (2)
Ardisia (2)
Myrtaceae (28)
allspice (1)Eucalyptus (16)Psidium (6)Rhodomyrtus (1)Syzygium (4)
Nartheciaceae (4)
Narthecium (1)Philydrum (1)Xanthorrhoea (2)
Nelumbonaceae (3)
Nelumbo (3)
Nyctaginaceae (34)
Atropa (1)Boerhavia (3)Capsicum (5)Datura (7)Lycium (3)Mirabilis (1)Nicotiana (2)Physalis (4)Scopolia (1)Solanum (6)Withania (1)
Nyssaceae (50)
Camptotheca (6)Gaultheria (1)Pyrola (2)Rhododendron (4)Vaccinium (37)
Oleaceae (36)
Abeliophyllum (1)Forsythia (12)Fraxinus (4)Jasminum (6)Ligustrum (11)Osmanthus (1)Syringa (1)
Orchidaceae (28)
Anoectochilus (1)Bletilla (2)Cremastra (2)Dendrobium (7)Gastrodia (3)Gymnadenia (8)Pholidota (3)Vanda (1)Vanilla (1)
Orobanchaceae (10)
Cistanche (10)
Paeoniaceae (6)
Paeonia (6)
Palmae (6)
Areca (4)Euterpe (1)Trachycarpus (1)
Pandanaceae (3)
Pandanus (3)
Papaveraceae (26)
Chelidonium (10)Corydalis (8)Glaucium (1)Hylomecon (1)Hypecoum (1)Macleaya (2)Papaver (1)Sanguinaria (2)
Parmeliaceae (4)
Parmelia (4)
Passifloraceae (2)
Passiflora (2)
Pentaphylacaceae (1)
Adinandra (1)
Phyllanthaceae (4)
Securinega (3)Uapaca (1)
Phytolaccaceae (6)
Microtea (1)Phytolacca (5)
Pinaceae (35)
Abies (2)Cedrus (4)Larix (1)Pinus (18)Pseudolarix (9)Tsuga (1)
Piperaceae (28)
Piper (28)
Pittosporaceae (2)
Pittosporum (2)
Plantaginaceae (3)
Picrorhiza (2)Plantago (1)
Plumbaginaceae (2)
Limoniastrum (1)Plumbago (1)
Poaceae (13)
Avena (2)Coix (1)Hordeum (2)Leptochloa (1)Oryza (1)Phyllostachys (1)Poa (2)Saccharum (1)Secale (1)Zea (1)
Podocarpaceae (8)
Podocarpus (8)
Polygalaceae (32)
Polygala (31)Securidaca (1)
Polygonaceae (40)
Atraphaxis (2)Fallopia (3)Polygonum (9)Rheum (22)Rumex (4)
Polypodiaceae (2)
Phymatopteris (2)
Polyporaceae (8)
Ganoderma (4)Polyporus (1)Wolfiporia (3)
Pontederiaceae (1)
Monochoria (1)
Portulacaceae (1)
Talinum (1)
Primulaceae (4)
Lysimachia (3)Primula (1)
Proteaceae (4)
Grevillea (1)Helicia (3)
Ranunculaceae (48)
Aconitum (2)Anemone (6)Cimicifuga (11)Clematis (3)Coptis (6)Delphinium (2)Hydrastis (2)Pulsatilla (11)Semiaquilegia (1)Thalictrum (3)Trollius (1)
Resedaceae (1)
Reseda (1)
Rhamnaceae (16)
Hovenia (1)Rhamnus (11)Ziziphus (4)
Rhizophoraceae (3)
Cassipourea (1)Kandelia (2)
Rosaceae (32)
Agrimonia (4)Crataegus (4)Exochorda (5)Filipendula (2)Malus (1)Photinia (1)Potentilla (2)Pourthiaea (1)Prunus (3)Rosa (3)Rubus (2)Sanguisorba (2)Sorbus (1)Spiraea (1)
Rubiaceae (66)
Borreria (1)Cinchona (2)Coffea (3)Emmenopterys (1)Galium (5)Gardenia (10)Hedyotis (8)Knoxia (3)Mitragyna (1)Morinda (4)Mussaenda (1)Nauclea (2)Paederia (5)Pausinystalia (2)Pentas (1)Rubia (11)Uncaria (6)
Rutaceae (161)
Aegle (1)Boenninghausenia (2)Cedrelopsis (1)Citrus (38)Clausena (7)Dictamnus (8)Euodia (1)Evodia (13)Flindersia (1)Fortunella (1)Glycosmis (3)Haplophyllum (3)Melicope (1)Micromelum (11)Murraya (21)Phebalium (2)Phellodendron (8)Ptaeroxylon (1)Ruta (3)Skimmia (1)Tetradium (1)Toddalia (14)Zanthoxylum (19)
Salicaceae (2)
Populus (2)
Santalaceae (3)
Thesium (3)
Sapindaceae (10)
Dodonaea (10)
Saururaceae (6)
Houttuynia (1)Saururus (5)
Saxifragaceae (32)
Astilbe (1)Bergenia (1)Dichroa (3)Hydrangea (6)Penthorum (1)
Schisandraceae (21)
Kadsura (6)Schisandra (15)
Scrophulariaceae (35)
Bacopa (6)Euphrasia (1)Limnophila (1)Linaria (2)Melampyrum (1)Paulownia (1)Pedicularis (2)Picria (3)Rehmannia (13)Scrophularia (5)
Selaginellaceae (3)
Selaginella (3)
Simaroubaceae (32)
Ailanthus (8)Brucea (8)Eurycoma (1)Picrasma (14)Quassia (1)
Sinopteridaceae (17)
Onychium (4)Pteridium (3)Pteris (10)
Stemonaceae (1)
Stemona (1)
Sterculiaceae (4)
Casearia (1)Gynocardia (2)Hydnocarpus (1)
Styracaceae (3)
Styrax (3)
Tamaricaceae (1)
Tamarix (1)
Taxaceae (8)
Taxus (7)Torreya (1)
Taxodiaceae (5)
Cryptomeria (2)Sequoia (3)
Theaceae (9)
Camellia (9)
Tiliaceae (2)
Microcos (1)Tilia (1)
Toricelliaceae (3)
Toricellia (3)
Tropaeolaceae (1)
Tropaeolum (1)
Typhaceae (4)
Typha (4)
Ulmaceae (1)
Ulmus (1)
Valerianaceae (18)
Nardostachys (4)Patrinia (4)Valeriana (10)
Verbenaceae (40)
Callicarpa (11)Clerodendrum (7)Duranta (1)Gmelina (1)Lippia (1)Stachytarpheta (1)Verbena (2)Vitex (16)
Violaceae (7)
Viola (7)
Viscaceae (2)
Viscum (2)
Vitaceae (18)
Ampelopsis (4)Turpinia (2)Vitis (12)
Winteraceae (4)
Drimys (4)
Zingiberaceae (81)
Aframomum (1)Alpinia (25)Amomum (1)Boesenbergia (2)Curcuma (35)Kaempferia (1)Zingiber (16)
Zygophyllaceae (6)
Peganum (4)Tribulus (2)
Pharmaceutical Research
Animal Modeling Agents (46)
Cardio-cerebrovascular Disease Model (2)Diabete Model (1)Inflammation Model (21)Lifestyle-related Disease Model (10)Nervous System Model (5)Pain and Pruritus Model (8)Tumor Model (6)Other Modeling Agents (6)
Classical Positive Drugs (57)
Cardiovascular System (21)Diabete (24)Digestive System (12)
Drug Analysis (674)
Drug Standard (216)Plant Standard (460)
Drug Delivery (370)
Cationic Lipids (119)Cholesterol (12)Fluorescent Lipids (1)Pegylated Lipids (12)Phospholipids (174)
Pharmacy Related (27)
Biomaterial (2)Classical Raw Material Drug (2)Cosolvents (11)Medicinal Excipient (14)
Small Molecule Positive Drugs (2781)
Anti-allergy (5)Anti-inflammation (32)Anti-osteoporosis (2)Anti-rheumatoid Arthritis (6)Anti-tumor (7)Antivirus (66)Depressurization (18)Diabete (24)Neurotransmitter (34)Reduce Blood Lipid (7)Other Compounds (70)Others (2543)
PROTACS
E3 Ligand-Linker Conjugate (167)
CRBN Ligand-Linkers (117)VHL Ligand-Linkers (50)
E3 Ligands (71)
CRBN Inactive Ligand (4)CRBN Ligand (56)IAP Ligand (1)MDM2 Ligand (2)VHL Ligand (8)
Molecular Glue (31)
Bcl-6/PROTAC (3)Casein Kinase 1α/PROTAC (2)Cyclin K/PROTAC (5)GSPT1/PROTAC (5)IKZF1/3/PROTAC (7)mHTT/PROTAC (2)PDE6D/PROTAC (2)RBM39/PROTAC (4)β-catenin/PROTAC (1)
Warhead (1)
Bcr-Abl/Warhead Ligand (1)
Vesicle
Exosome (2549)
ApoE (1)ARF (2)Calcium Channel (267)Ceramidase (4)FGF (2)HBV (154)HIV (442)HSP (160)HSV (76)ICAM-1/monoclonal antibody (1)Integrin (134)LPL Receptor (113)MicroRNA (16)mTOR (188)Neurotransmitter (34)p53 (41)PD-1/PD-L1 (76)Phospholipase (108)Ras (275)STAT (159)TGF-beta/Smad (351)
Parkinson'S Disease and Alzheimer'S Disease (5745)
Akt (208)AMPAR (53)Apoptosis (2132)Caspase (170)CDK (475)CREB (5)Dopamine Receptor (166)Dopamine β-hydroxylase (8)ERK (167)Glucagon Receptor (50)GPCR (198)GSK-3 (125)IL (161)JAK (244)JNK (79)LRRK2 (32)MyD88 (6)NF-κB (417)Notch (26)p53 (41)PI3K (337)PKA (59)PTEN (5)RAGE (3)Ras (275)Rho (14)ROCK (87)ROS (388)Secretase (110)STAT (159)STING (99)Tau Protein (28)TLR (166)TNF (22)Tyrosinase (102)Tyrosine / EGF Receptor Protein Kinase Inhibitor (33)Wnt (104)α-synuclein (1)β-catenin (72)
Zoology and Botany
Pesticide Composition (103)
Fungicide (61)Herbicide (17)Insecticide (26)
Home Cart Sign in  
/
Inhibitors/Agonists
/
Cell Cycle
/
DNA/RNA Synthesis
/
Fludarabine
/
Inhibitors/Agonists
/
Cell Cycle
DNA Damage
/
DNA/RNA Synthesis
Nucleoside Antimetabolite/Analog
/
Chemical Structure| 21679-14-1 Chemical Structure| 21679-14-1

Structure of Fludarabine
CAS No.: 21679-14-1

Chemical Structure| 21679-14-1

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Fludarabine (NSC 118218) is a DNA synthesis inhibitor and fluorinated purine analogue with antineoplastic activity in lymphoproliferative malignancies. It inhibits the cytokine-induced activation of STAT1 and STAT1-dependent gene transcription in normal resting or activated lymphocytes.

Synonyms: F-ara-A; NSC 118218; HSDB 6964

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

DE Stock

US Stock

Asia Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

Quality Control of Fludarabine Purity: 98% SDS Specification
COA

Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.

 NMR

Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.

 CNMR

Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.

 HPLC

Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.

 LC-MS

Search for reports by entering the product batch number.
Batch number can be found on the product's label following the word 'Batch'.
  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Product Citations      Show More

Lei, Daoyun ; Liu, Li ; Xie, Songhui ; Ji, Haiyan ; Guo, Yanxing ; Ma, Tieliang , et al.

DOI: PubMed ID:

Abstract: Dexmedetomidine is an α2 adrenergic receptor agonist that has been reported to modulate the polarization of CD4+ T cells. However, the underlying mechanisms by which dexmedetomidine induces T-helper 1 (Th1) cell differentiation remain poorly understood. The aim of this study was to explore the potential mechanisms through which dexmedetomidine can induce Th1 cell differentiation. Purified CD4+ T cells were stimulated with anti-CD3/anti-CD28 and then treated with dexmedetomidine. Flow cytometry analysis was adopted to measure the concentration of Th1 cells. Enzyme-linked immunosorbent assay (ELISA) and real-time quantitative polymerase chain reaction (qPCR) were performed to detect protein levels and mRNA expression, respectively, of IFN-γ and IL-4. Western blotting was used to determine the phosphorylation of signal transducer and activator of transcription 1 (STAT1) and T-bet expression. The Th1 cell subset and IFN-γ levels were elevated in the dexmedetomidine-induced CD4+ T cells. Dexmedetomidine enhanced the phosphorylation of STAT1 and the expression of T-bet in the CD4+ T cells. Atipamezole (an α2 adrenergic antagonist) and fludarabine (a STAT1 inhibitor) reversed the dexmedetomidine-induced Th1 cell differentiation. These results suggested that dexmedetomidine induced Th1 cell differentiation via the STAT1-T-bet signaling pathway.

Purchased from AmBeed: ;

Huangfu, Ning ; Zheng, Wenyuan ; Xu, Zhenyu ; Wang, Shenghuang ; Wang, Yong ; Cheng, Jingsong , et al.

DOI: PubMed ID:

Abstract: M1/M2 macrophages polarization play important roles in regulating tissue homeostasis. Recently, RNA-binding motif 4 (RBM4) has been reported to modulate the proliferation and expression of inflammatory factors in HeLa cells. However, whether RBM4 is involved in regulating macrophage polarization and inflammatory factor expression are still unknown. In this study, RAW264.7, a mouse macrophage cell line, were stimulated with interferon γ (IFN-γ) or interleukin‐4 (IL‐4) to induce M1/M2 macrophages polarization. We found that IFN-γ, but not IL-4, stimulation decreased RBM4 expression in macrophages, and RBM4 overexpression inhibits IFN-γ-induced M1 macrophage polarization. Furthermore, RNA-Sequencing, protein immunoprecipitation accompanied with mass spectrometry, and extracellular acidification rate analysis showed that RBM4 suppresses IFN-γ-induced M1 macrophage polarization though inhibiting glycolysis. Moreover, RBM4 knockdown promoted IFN-γ-induced signal transducer and activator of transcription 1 (STAT1) activation via increasing STAT1 mRNA stability, leading to the increase of glycolysis-related gene transcripts regulated by STAT1. Finally, we find that RBM4 interacts with YTH N6-methyladenosine RNA binding protein 2 (YTHDF2) to degrade m6A modified STAT1 mRNA, thereby regulating glycolysis and M1 macrophage polarization. Collectively, the current study firstly reports that RBM4 regulates M1 macrophages polarization through targeting STAT1-mediated glycolysis and shows that RBM4 is a possible candidate for regulating macrophage M1 polarization and inflammatory responses.

Keywords: Macrophages polarization ; Interferon γ ; RNA-binding motif 4 ; Signal transducer and activator of transcription 1 ; Glycolysis

Purchased from AmBeed:

Alternative Products

Product Details of Fludarabine

CAS No. :21679-14-1
Formula : C10H12FN5O4
M.W : 285.23
SMILES Code : [C@@H]3([N]1C2=C(N=C1)C(=NC(=N2)F)N)O[C@H](CO)[C@H]([C@@H]3O)O
Synonyms :
F-ara-A; NSC 118218; HSDB 6964
MDL No. :MFCD00132942

Safety of Fludarabine

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H332-H335
Precautionary Statements:P280-P305+P351+P338-P310

Related Pathways of Fludarabine

DNA

Isoform Comparison

Biological Activity

Target

  • STAT1

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT00006251 Acute Undifferentiated Leukemi... More >>a Adult Nasal Type Extranodal NK/T-cell Lymphoma Anaplastic Large Cell Lymphoma Angioimmunoblastic T-cell Lymphoma Childhood Burkitt Lymphoma Childhood Diffuse Large Cell Lymphoma Childhood Grade III Lymphomatoid Granulomatosis Childhood Immunoblastic Large Cell Lymphoma Childhood Myelodysplastic Syndromes Childhood Nasal Type Extranodal NK/T-cell Lymphoma Chronic Myelomonocytic Leukemia Cutaneous B-cell Non-Hodgkin Lymphoma de Novo Myelodysplastic Syndromes Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue Hepatosplenic T-cell Lymphoma Intraocular Lymphoma Juvenile Myelomonocytic Leukemia Mast Cell Leukemia Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable Myeloid/NK-cell Acute Leukemia Nodal Marginal Zone B-cell Lymphoma Noncutaneous Extranodal Lymphoma Peripheral T-cell Lymphoma Post-transplant Lymphoproliferative Disorder Previously Treated Myelodysplastic Syndromes Primary Systemic Amyloidosis Recurrent Adult Acute Lymphoblastic Leukemia Recurrent Adult Acute Myeloid Leukemia Recurrent Adult Burkitt Lymphoma Recurrent Adult Diffuse Large Cell Lymphoma Recurrent Adult Diffuse Mixed Cell Lymphoma Recurrent Adult Diffuse Small Cleaved Cell Lymphoma Recurrent Adult Grade III Lymphomatoid Granulomatosis Recurrent Adult Hodgkin Lymphoma Recurrent Adult Immunoblastic Large Cell Lymphoma Recurrent Adult Lymphoblastic Lymphoma Recurrent Adult T-cell Leukemia/Lymphoma Recurrent Childhood Acute Lymphoblastic Leukemia Recurrent Childhood Acute Myeloid Leukemia Recurrent Childhood Anaplastic Large Cell Lymphoma Recurrent Childhood Grade III Lymphomatoid Granulomatosis Recurrent Childhood Large Cell Lymphoma Recurrent Childhood Lymphoblastic Lymphoma Recurrent Childhood Small Noncleaved Cell Lymphoma Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma Recurrent Grade 1 Follicular Lymphoma Recurrent Grade 2 Follicular Lymphoma Recurrent Grade 3 Follicular Lymphoma Recurrent Mantle Cell Lymphoma Recurrent Marginal Zone Lymphoma Recurrent Mycosis Fungoides/Sezary Syndrome Recurrent Renal Cell Cancer Recurrent Small Lymphocytic Lymphoma Recurrent/Refractory Childhood Hodgkin Lymphoma Refractory Chronic Lymphocytic Leukemia Refractory Hairy Cell Leukemia Refractory Multiple Myeloma Small Intestine Lymphoma Splenic Marginal Zone Lymphoma Stage II Multiple Myeloma Stage III Multiple Myeloma T-cell Large Granular Lymphocyte Leukemia Testicular Lymphoma Waldenstr?m Macroglobulinemia Less << Phase 1 Phase 2 Active, not recruiting - United States, Washington ... More >> Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 Italy University of Torino Torino, Italy, 10126 Less <<
NCT01723839 Chronic Lymphocytic Leukemia (... More >>CLL) Less << Phase 2 Active, not recruiting August 2018 United States, New Jersey ... More >> John Theurer Cancer Center at HackensackUMC Hackensack, New Jersey, United States, 07601 Less <<
NCT00544466 Leukemia Myel... More >>odysplastic Syndromes Less << Phase 1 Phase 2 Active, not recruiting July 2019 United States, California ... More >> City of Hope Medical Center Duarte, California, United States, 91010-3000 Less <<
NCT02328950 - Unknown December 2017 China, Fujian ... More >> Union Hospital,Fujian Medical University Recruiting Fuzhou, Fujian, China, 350001 Contact: Ting Yang, Prof.    +86-591-83357896 ext 8041    yang.hopeting@gmail.com    Contact: Jianda Hu, Prof.    +86-591-83357896 ext 8041    jdhu@medmail.com.cn    Principal Investigator: Jianda Hu, Dr.          Sub-Investigator: Ting Yang, Dr. Less <<
NCT01703364 CLL Chronic L... More >>ymphocytic Leukemia Less << Phase 1 Phase 2 Completed - Austria ... More >> Universitätsklinik für Innere Medizin Innsbruck, Klinische Abteilung für Hämatologie und Onkologie Innsbruck, Tirol, Austria, 6020 Universitätsklinik der PMU Salzburg, Univ-Klinik für Innere Medizin III Salzburg, Austria, 5020 Less <<
NCT00688883 Lymphoma Phase 2 Completed - Japan ... More >> Nagoya-shi, Aichi, Japan, 464-8681 Nagoya-shi, Aichi, Japan, 466-8560 Kashiwa-shi, Chiba, Japan, 277-8577 Fukuoka-shi, Fukuoka, Japan, 812-0033 Fukuoka-shi, Fukuoka, Japan, 812-8582 Sapporo-shi, Hokkaido, Japan, 003-0006 Akashi-shi, Hyogo, Japan, 673-8558 Kagoshima-shi, Kagoshima, Japan, 890-0064 Isehara-shi, Kanagawa, Japan, 259-1193 Kyoto-shi, Kyoto, Japan, 602-0841 Sendai-shi, Miyagi, Japan, 980-0872 Nagasaki-shi, Nagasaki, Japan, 852-8523 Okayama-shi, Okayama, Japan, 700-8558 Moriguchi-shi, Osaka, Japan, 570-8540 Hamamatsu-shi, Shizuoka, Japan, 431-3192 Chuo-ku, Tokyo, Japan, 104-0045 Shinjuku-ku, Tokyo, Japan, 160-8582 Less <<
NCT00475020 Myelofibrosis Phase 2 Completed - United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00860457 Chronic Lymphocytic Leukemia Phase 2 Completed - United States, District of Col... More >>umbia Lombardi Cancer Center at Georgetown University Medical Center Washington, District of Columbia, United States, 20007 Less <<
NCT01088724 Post-transplant Lymphoprolifer... More >>ative Disease (PTLD) Non Burkitt Less << Phase 4 Completed - Italy ... More >> Ospedali Riuniti di Bergamo Bergamo, BG, Italy, 24121 Less <<
NCT00860457 - Completed - -
NCT00641095 Lymphoma Phase 2 Phase 3 Completed - -
NCT00824265 Leukaemia, Lymphocytic, Chroni... More >>c Less << Phase 3 Completed - -
NCT00475020 - Completed - -
NCT00824265 - Completed - -
NCT00068315 Extranodal Marginal Zone B-cel... More >>l Lymphoma of Mucosa-associated Lymphoid Tissue Hematopoietic/Lymphoid Cancer Nodal Marginal Zone B-cell Lymphoma Recurrent Adult Diffuse Small Cleaved Cell Lymphoma Recurrent Grade 1 Follicular Lymphoma Recurrent Grade 2 Follicular Lymphoma Recurrent Mantle Cell Lymphoma Recurrent Marginal Zone Lymphoma Recurrent Small Lymphocytic Lymphoma Refractory Chronic Lymphocytic Leukemia Splenic Marginal Zone Lymphoma Waldenstr?m Macroglobulinemia Less << Phase 1 Completed - United States, Ohio ... More >> Mercy Medical Center Canton, Ohio, United States, 44708 Case Western Reserve University Cleveland, Ohio, United States, 44106 Seidman Cancer Center at University Hospitals Case Medical Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States, 44106 Southwest General Health Center Ireland Cancer Center Middleburg Heights, Ohio, United States, 44130 UHHS-Chagrin Highlands Medical Center Orange Village, Ohio, United States, 44122 University Suburban Medical Center South Euclid, Ohio, United States, 44121 UHHS-Westlake Medical Center Westlake, Ohio, United States, 44145 Less <<
NCT02083250 Acute Lymphoblastic Leukemia i... More >>n Remission Acute Myeloid Leukemia in Remission Allogeneic Hematopoietic Stem Cell Transplantation Recipient Myelodysplastic Syndrome Previously Treated Myelodysplastic Syndrome Recurrent Acute Lymphoblastic Leukemia Recurrent Acute Myeloid Leukemia Less << Phase 1 Active, not recruiting March 30, 2021 United States, Texas ... More >> M D Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT01316549 Hematologic Malignancies|Nonma... More >>lignant Diseases|Immunodeficiencies|Hemoglobinopathies|Genetic Inborn Errors of Metabolism|Fanconi Anemia|Thalassemia|Sickle Cell Disease Less << COMPLETED 2016-04-30 University of California, San ... More >>Francisco, San Francisco, California, 94143, United States Less <<
NCT00281892 Chronic Lymphocytic Leukemia ... More >> Anemia Less << Phase 3 Completed - Germany ... More >> Hamatologische/Onkologische Gemeinschaftspraxis - Augsburg Augsburg, Germany, 86150 Onkologische Schwerpunktpraxis und Tagesklinik Dres Bad Soden, Germany, 65812 Internistische Gemeinschaftspraxis - Berlin Berlin, Germany, 13347 Charite - Campus Charite Mitte Berlin, Germany, D-10117 Augusta-Kranken-Anstalt gGmbH Bochum, Germany, D-44791 Medizinische Universitaetsklinik I at the University of Cologne Cologne, Germany, D-50924 Internistische Praxis - Dusseldorf Dusseldorf, Germany, 40211 Hans - Susemihl - Krankenhaus Emden, Germany, D-26721 Universitaetsklinikum Essen Essen, Germany, D-45122 Klinikum Frankfurt (Oder) GmbH Frankfurt (Oder), Germany, D-15236 Internistische Praxis - Gerlingen Gerlingen, Germany, 70839 Internistische Praxisgemeinschaft Germering, Germany, 82110 Universitaetsklinikum Göttingen Göttingen, Germany, 37075 Internistische Gemeinschaftspraxis - Halle Halle, Germany, 06110 University Medical Center Hamburg - Eppendorf Hamburg, Germany, D-20246 Clinic for Bone Marrow Transplantation and Hematology and Oncology Idar-Oberstein, Germany, D-55743 Westpfalz-Klinikum GmbH Kaiserslautern, Germany, D-67653 Staedtisches Klinikum Karlsruhe gGmbH Karlsruhe, Germany, 76133 Klinikum Kempten Oberallgaeu Kempten, Germany, D-87439 Internistische Onkologische Praxis - Kronach Kronach, Germany, 96317 Internistische Praxis - Landshut Landshut, Germany, 84028 Caritas - Krakenhaus Lebach Lebach, Germany, 66822 Onkologische Schwerpunktpraxis - Leer Leer, Germany, D-26789 Staedtisches Klinikum Magdeburg Magdeburg, Germany, D-39130 Hospital Maria-Hilf II Monchengladbach, Germany, D-41063 Hamatologie/Onkologie Praxisgemeinschaft - Muenchen Munchen, Germany, 81245 Munich Oncologic Practice at Elisenhof Munich, Germany, D-80335 I. Frauenklinik und Hebammenschule der Ludwig-Maximillians Universitaet Muenchen Munich, Germany, D-81377 Klinikum der Universitaet Muenchen - Grosshadern Campus Munich, Germany, D-81377 Haematologische Schwerpunktpraxis Munich, Germany, D-81679 Klinikum Schwaebisch Gmuend Stauferklinik Mutlangen, Germany, D-73557 Haematologische-onkologische GemeinschaftspraxisSchick - Schick - Schmidt - Wiesmeier München, Germany, D-81241 Onkologische Schwerpunktpraxis Dr. Schmidt Neunkirchen, Germany, D-66538 Praxis fuer Haematologie und Interne Onkologie Norderstedt, Germany, 22844 Internistische Gemeinschaftspraxis - Oldenburg Oldenburg, Germany, D-26121 Pforzheim, Germany, 75179 Scherpunktpraxis fur Hematologie und Onkologie Regensburg, Germany, 93053 Krankenhaus Barmherzige Brueder Regensburg Regensburg, Germany, D-93049 Schwerpunktpraxis fuer Haematologie und Onkologie Saarbruecken, Germany, 66113 St. Marien - Krankenhaus Siegen GMBH Siegen, Germany, D-57072 Southwest German Cancer Center at Eberhard-Karls-University Tuebingen, Germany, D-72076 Comprehensive Cancer Center Ulm at Universitaetsklinikum Ulm Ulm, Germany, D-89081 St. Marienhospital - Vechta Vechta, Germany, D-49377 Haematologische Praxis Weiden, Germany, D-92637 Helios Kliniken Wuppertal University Hospital Wuppertal, Germany, D-42283 Hamatologisch - Onkologische Praxis Wurzburg Wurzburg, Germany, 97070 Less <<
NCT01423032 Chronic Lymphocytic Leukemia Phase 2 Phase 3 Completed - Germany ... More >> Prof. Dr. Norbert Niederle Leverkusen, NRW, Germany, D-51375 Less <<
NCT00002779 Lymphoma Phase 2 Completed - United States, Arizona ... More >> CCOP - Scottsdale Oncology Program Scottsdale, Arizona, United States, 85259-5404 United States, Illinois CCOP - Illinois Oncology Research Association Peoria, Illinois, United States, 61602 CCOP - Carle Cancer Center Urbana, Illinois, United States, 61801 United States, Iowa CCOP - Cedar Rapids Oncology Project Cedar Rapids, Iowa, United States, 52403-1206 CCOP - Iowa Oncology Research Association Des Moines, Iowa, United States, 10309-1016 Siouxland Hematology-Oncology Sioux City, Iowa, United States, 51101-1733 United States, Kansas CCOP - Wichita Wichita, Kansas, United States, 67214-3882 United States, Louisiana CCOP - Ochsner New Orleans, Louisiana, United States, 70121 United States, Minnesota CCOP - Duluth Duluth, Minnesota, United States, 55805 Mayo Clinic Cancer Center Rochester, Minnesota, United States, 55905 CCOP - Metro-Minnesota Saint Louis Park, Minnesota, United States, 55416 United States, Nebraska CCOP - Missouri Valley Cancer Consortium Omaha, Nebraska, United States, 68131 United States, North Dakota Quain & Ramstad Clinic, P.C. Bismarck, North Dakota, United States, 58501 CCOP - Merit Care Hospital Fargo, North Dakota, United States, 58122 Altru Health Systems Grand Forks, North Dakota, United States, 58201 United States, Ohio CCOP - Toledo Community Hospital Oncology Program Toledo, Ohio, United States, 43623-3456 United States, Pennsylvania CCOP - Geisinger Clinical and Medical Center Danville, Pennsylvania, United States, 17822-2001 United States, South Dakota Rapid City Regional Hospital Rapid City, South Dakota, United States, 57709 CCOP - Sioux Community Cancer Consortium Sioux Falls, South Dakota, United States, 57105-1080 Canada, Saskatchewan Saskatchewan Cancer Agency Regina, Saskatchewan, Canada, S4S 6X3 Less <<
NCT00004857 Leukemia Phase 2 Completed - -
NCT01263704 Lymphocytic Leukemia, Chronic Phase 2 Completed - Israel ... More >> Haemek Medical Center; Hematology Department Afula, Israel, 18101 Soroka Medical Center; Hematology Deptartment Beer Sheva, Israel, 8410101 Rambam Medical Center; Heamatology & Bone Marrow Transplantation Haifa, Israel, 3109601 Bnei-Zion Medical Center; Hematology Dept Haifa, Israel, 3339419 Shaare Zedek Medical Center; Hematology Dept. Jerusalem, Israel, 9103102 Hadassah Ein Karem Hospital; Haematology Jerusalem, Israel, 9112001 Meir Medical Center; Internal Dept A Kfar Saba, Israel, 44281 Western Galilee Hospital - Nahariya Nahariya, Israel, 22100 Beilinson Medical Center; Haematology Petach Tikva, Israel, 49100 Kaplan Medical Center Rehovot, Israel, 7661041 ASSAF Harofe; Department of Hematology Rishon Lezion, Israel, 70300 Ichilov Sourasky Medical Center; Heamatology Tel Aviv, Israel, 6423906 Less <<
NCT01263704 - Completed - -
NCT00943319 Leukemia Lymp... More >>homa Myeloma Less << Phase 1 Phase 2 Active, not recruiting December 2018 United States, Illinois ... More >> The University of Chicago Chicago, Illinois, United States, 60637 Less <<
NCT00262795 Chronic Lymphocytic Leukemia Phase 3 Completed - -
NCT01173679 Chronic Lymphocytic Leukemia ... More >> Small Lymphocytic Lymphoma Less << Phase 2 Terminated(Slow accrual) - United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02115 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 Less <<
NCT00727415 Chronic Lymphocytic Leukemia Phase 1 Phase 2 Completed - Italy ... More >> Unità Operativa Ematologia 1 - Università degli Studi di Bari Bari, Italy, 70010 Istituto di Ematologia e Oncologia Medica "Lorenzo e A. Seragnoli" - Università degli Studi di Bologna - Policlinico S. Orsola - Malpighi Bologna, Italy Azienda Ospedaliera Pugliese Ciaccio Catanzaro, Italy, 88100 Sez.Ematologia e Dip. scienze Biomediche Arcispedale S. Anna Ferrara, Italy, 44100 Clinica Ematologica - Università degli Studi Genova, Italy Divisione di Ematologia Ospedale "Santa Maria Goretti" Latina, Italy Istituto Scientifico Romagnoli per lo Studio e la Cura dei Tumori- IRST Meldola, Italy Divisione di Ematologia - Azienda Ospedaliera Ospedali Riuniti "Papardo Piemonte" Messina, Italy UO Centro Trapianti di Midollo - IRCCS Ospedale Maggiore Policlinico Milano, Italy (SA) U.O. di Oncoematologia di Nocera Inferiore-plesso ospedaliero "A. Tortora" di Pagani del DEA Nocera-Pagani Nocera Inferiore, Italy Università degli Studi di Padova - Ematologia ed Immunologia Clinica Padova, Italy U.O. Ematologia Clinica - Azienda USL di Pescara Pescara, Italy Unità Operativa Ematologia e Centro Trapianti - Dipartimento di Oncologia ed Ematologia - AUSL Ospedale di Piacenza Piacenza, Italy Ospedale S. M. delle Croci Ravenna, Italy, I-48100 Azienda Ospedaliera Bianchi Melacrino Morelli Reggio Calabria, Italy, 89100 Ospedale "Infermi" Rimini, Italy Università degli Studi "Sapienza" - Dip Biotecnologie Cellulari ed Ematologia - Divisione di Ematologia Roma, Italy Universita Degli Studi "La Sapeinza" Rome, Italy, 00161 Policlinico A. Gemelli - Universita Cattolica del Sacro Cuore Rome, Italy, 00168 U.O.C. Ematologia - Ospedale S.Eugenio Rome, Italy U.O. Ematologia, Azienda Ospedaliera Universitaria Senese Siena, Italy, 53100 SS.C. di Oncoematologia - Dipartimento di Medicina Clinica e Sperimentale - Azienda Ospedaliera - S. Maria Di Terni Terni, Italy Clinica Ematologica - Policlinico Universitario Udine, Italy Less <<
NCT03121014 Acute Myeloid Leukemia ... More >> Myelodysplastic Syndromes Less << Phase 2 Recruiting April 24, 2024 United States, Illinois ... More >> University of Illinois at Chicago Recruiting Chicago, Illinois, United States, 60612 Contact: Damiano Rondelli, MD    312-413-3547    drond@uic.edu Less <<
NCT00612612 B-cell Chronic Lymphocytic Leu... More >>kemia Leukemia Prolymphocytic Leukemia Refractory Chronic Lymphocytic Leukemia Stage I Chronic Lymphocytic Leukemia Stage II Chronic Lymphocytic Leukemia Stage III Chronic Lymphocytic Leukemia Stage IV Chronic Lymphocytic Leukemia Less << Phase 1 Terminated - United States, Massachusetts ... More >> Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 Less <<
NCT00794820 Chronic Lymphocytic Leukemia Phase 2 Completed - United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00774280 Leukemia Myel... More >>odysplastic Syndrome Less << Phase 3 Completed - Korea, Republic of ... More >> Asan Medical Center Seoul, Korea, Republic of, 138-736 Less <<
NCT00794820 - Completed - -
NCT02319135 Acute Myeloid Leukemia Phase 3 Active, not recruiting October 2019 Spain ... More >> Hospital Universitari i Politècnic La Fe Valencia, Spain, 46026 Less <<
NCT00474747 Aplastic Anemia Phase 1 Phase 2 Completed - United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT03609814 - Recruiting April 2019 United States, California ... More >> University of California, San Francisco Recruiting San Francisco, California, United States, 94143 Contact: Danna D Chan, Pharm.D.    415-596-4594    danna.chan@ucsf.edu    Contact: Janel R Long-Boyle, PharmD, PhD    415-514-2746    long-boylej@pharmacy.ucsf.edu Less <<
NCT00738829 Leukemia, Lymphocytic, Chronic... More >>, B-Cell Less << Phase 1 Phase 2 Completed - Austria ... More >> Medizinische Universitaet Innsbruck, Abtlg. f. Haematologie und Onkologie Innsbruck, Tirol, Austria, A-6020 Landeskrankenhaus Feldkirch Feldkirch, Austria, A-6806 Krankenhaus d. Barmherzigen Schwestern Linz Linz, Austria, A-4010 Krankenhaus der Elisabethinen Linz GmbH Linz, Austria, A-4010 Krankenhaus der Stadt Linz Linz, Austria, A-4020 Universitaetsklinik f. Innere Medizin III Salzburg, Austria, A-5020 Klinikum Wels-Grieskirchen GmbH Wels, Austria, A-4600 Less <<
NCT01173679 - Terminated(Slow accrual) - -
NCT00452374 Leukemia Phase 1 Phase 2 Completed - United States, California ... More >> University of California-San Diego La Jolla, California, United States, 92093 United States, Massachusetts Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 Less <<
NCT00469014 Acute Myeloid Leukemia ... More >> Myelodysplastic Syndrome Chronic Myeloid Leukemia Less << Phase 2 Completed - United States, Texas ... More >> UT MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00452374 - Completed - -
NCT00009984 Recurrent Small Lymphocytic Ly... More >>mphoma Refractory Chronic Lymphocytic Leukemia Less << Phase 2 Terminated - United States, New York ... More >> Montefiore Medical Center Bronx, New York, United States, 10467-2490 Less <<
NCT03494569 Acute Lymphoblastic Leukemia ... More >> Acute Lymphoblastic Leukemia in Remission Acute Myeloid Leukemia Acute Myeloid Leukemia in Remission Hematopoietic Cell Transplantation Recipient Minimal Residual Disease Myelodysplastic Syndrome Secondary Acute Myeloid Leukemia Less << Phase 1 Recruiting July 2020 United States, California ... More >> City of Hope Medical Center Recruiting Duarte, California, United States, 91010 Contact: Monzr M. Al Malki    626-301-4673    malmalki@coh.org    Principal Investigator: Monzr M. Al Malki Less <<
NCT00850499 Follicular Lymphoma Phase 2 Terminated - -
NCT00143065 Lymphoma, Small Lymphocytic ... More >> Lymphocytic Leukemia, Chronic Less << Phase 2 Completed - United States, Ohio ... More >> Ohio State University Columbus, Ohio, United States, 43210 Less <<
NCT00472329 Graft Failure Phase 2 Recruiting December 2020 United States, Colorado ... More >> Rocky Mountain Blood and Marrow Transplant Program Recruiting Denver, Colorado, United States, 80218 Contact: Juli Murphy    303-285-5087    Juli.Murphy@usoncology.com    Contact: Nicole Stephens    303-336-2183    Nicole.Stephens@usoncology.com    Principal Investigator: Mark W Brunvand, MD          Sub-Investigator: Robert M Rifkin, MD          Sub-Investigator: Jeffrey V Matous, MD          Sub-Investigator: Peter A McSweeney, MD          Sub-Investigator: Scott I Bearman, MD          Sub-Investigator: Michael B Maris, MD Less <<
NCT00850499 - Terminated - -
NCT01991457 Adult Lymphoblastic Lymphoma Phase 2 Recruiting June 2019 United States, Alabama ... More >> UAB Bone Marrow Transplantation and Cellular Therapy Program Recruiting Birmingham, Alabama, United States, 35249 Contact: Tiffany D Hill, RN    205-996-8023    tiffanydhill@uabmc.edu    Contact: Lindsey M Stephens, RN    205-975-2713    lmeggs@uabmc.edu    Principal Investigator: Ayman A Saad, MD          Sub-Investigator: Shin Mineishi, MD          Sub-Investigator: Donna Salzman, MD          Sub-Investigator: Racquel D Innis-Shelton, MD          Sub-Investigator: Ruby Meredith, MD, PhD          Sub-Investigator: Lawrence S Lamb, PhD          Sub-Investigator: Antonio Di Stasi, MD          Sub-Investigator: Luciano Costa, MD Less <<
NCT01271010 Lymphocytic Leukemia, Chronic Phase 4 Terminated - Russian Federation ... More >> The order of Honour pin Irkutsk regional clinical hospital; Hematology Department Irkutsk, Russian Federation, 664079 Kemerovo Regional Clinical Hospital Kemerovo, Russian Federation, 650066 Regional Clinical Oncology Despensary #1; Hematology Department Krasnodar, Russian Federation, 350040 N.N.Blokhin Russian Cancer Research Center; Dept. of Chemotherapy & Hemoblastosis Moscow, Russian Federation, 115478 City Clinical Hospital After Botkin; Hematology Moscow, Russian Federation, 125101 City Clinical Hospital #15; Hematology department Saint-Petersburg, Russian Federation, 198205 Leningrad Regional Clinical Hospital; Hematology #1 St Petersburg, Russian Federation Saint-Petersburg SHI City Clinical Hospital #31 St. Petersburg, Russian Federation, 197110 GUZ Tula Regioanal Clinical Hospital; Hematology Tula, Russian Federation, 300053 Republican clinical hospital named after G.G. Kuvatov UFA, Russian Federation, 450005 Less <<
NCT00230282 Leukemia B-ce... More >>ll Leukemia Chronic Leukemia Chronic Lymphocytic Leukemia (CLL) Less << Phase 2 Completed - United States, California ... More >> Stanford University School of Medicine Stanford, California, United States, 94305 Less <<
NCT01131169 Multiple Myeloma Phase 2 Active, not recruiting May 2019 United States, New York ... More >> Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 Less <<
NCT01271010 - Terminated - -
NCT02928991 Bone Marrow Failure Syndromes Early Phase 1 Recruiting April 2020 United States, Pennsylvania ... More >> Children's Hospital of Philadelphia Recruiting Philadelphia, Pennsylvania, United States, 19104 Contact: Timothy Olson, MD, PhD       OLSONT@email.chop.edu    Contact: Barbara McGlynn, RN, BSN       MCGLYNN@email.chop.edu    Principal Investigator: Timothy Olson, MD Less <<
NCT00536341 - Completed - -
NCT00230282 - Completed - -
NCT01572662 Leukemia Acut... More >>e Myeloid Leukemia Acute Lymphocytic Leukemia Chronic Myeloid Leukemia Chronic Lymphocytic Leukemia Myeloproliferative Diseases Non-Hodgkins Lymphoma Hodgkins Lymphoma Multiple Myeloma Myelodysplastic Syndrome Less << Phase 2 Active, not recruiting April 2019 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT01883323 Metastatic, Stage III or Stage... More >> IV, Melanoma Less << Phase 2 Completed - Canada, Ontario ... More >> Princess Margaret Cancer Centre Toronto, Ontario, Canada, M5G 2M9 Less <<
NCT00918723 Chronic Lymphocytic Leukemia ... More >> Stage I Chronic Lymphocytic Leukemia Stage I Small Lymphocytic Lymphoma Stage II Chronic Lymphocytic Leukemia Stage II Small Lymphocytic Lymphoma Stage III Chronic Lymphocytic Leukemia Stage III Small Lymphocytic Lymphoma Stage IV Chronic Lymphocytic Leukemia Stage IV Small Lymphocytic Lymphoma Less << Phase 1 Phase 2 Active, not recruiting October 2019 United States, Washington ... More >> Swedish Cancer Institute-Breast Center at First Hill Campus Seattle, Washington, United States, 98104 Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 Less <<
NCT00566332 Waldenstr?m Macroglobulinemia ... More >> Lymphoplasmacytic Lymphoma Splenic Marginal Zone Lymphoma Less << Phase 3 Completed - France ... More >> Hôpital La Pitié-Salpêtrière. 47-83 Bd de l'hôpital Paris, France, 75013 Less <<
NCT00918723 - Active, not recruiting - -
NCT00480987 Myelodysplastic Syndromes ... More >> Acute Myeloid Leukemia Leukemia Less << Phase 1 Phase 2 Terminated(Lack of support.) - United States, Texas ... More >> UT MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00840385 T-Cell Lymphomas ... More >> Chemotherapy Less << Phase 2 Unknown November 2010 China, Shanghai ... More >> Cancer Hospital, Fudan University Recruiting Shanghai, Shanghai, China, 200032 Contact: Xiaojian Liu, PhD    8613816983809 ext 1107    Xiaojian_liu068@hotmail.com Less <<
NCT00480987 - Terminated(Lack of support.) - -
NCT03071276 Acute Myeloid Leukemia (AML) Phase 2 Recruiting September 2019 United States, Arizona ... More >> Phoenix Children's Hospital Recruiting Phoenix, Arizona, United States, 85016 Contact: Jessica Boklan, MD    602-933-0920    jboklan@phoenixchildrens.com    Principal Investigator: Jessica Boklan, MD          United States, California Lucile Packard Children's Hospital Stanford University Recruiting Palo Alto, California, United States, 94304 Contact: Norman J. Lacayo, MD    650-497-8953    lacayon@stanford.edu    Principal Investigator: Normal J. Lacayo, MD          United States, Illinois University of Chicago Recruiting Chicago, Illinois, United States, 60637 Contact: Jennifer McNeer, MD    773-834-7424    jmcneer@peds.uchicago.edu    Principal Investigator: Jennifer McNeer, MD          United States, Michigan Children's Hospital of Michigan Recruiting Detroit, Michigan, United States, 48201 Contact: Jeffrey W. Taub, MD    313-745-5515    jtaub@med.wayne.edu    Principal Investigator: Jeffrey W. Taub, MD          United States, North Carolina Duke University Medical Center Completed Durham, North Carolina, United States, 27710 United States, Tennessee St. Jude Children's Research Hospital Recruiting Memphis, Tennessee, United States, 38105 Contact: Jeffrey E. Rubnitz, MD, PhD    866-278-5833    referralinfo@stjude.org    Principal Investigator: Jeffrey E. Rubnitz, MD, PhD          United States, Texas Cook Children's Medical Center Recruiting Fort Worth, Texas, United States, 76104 Contact: Kenneth M. Heym, MD    682-885-4007    kenneth.heym@cookchildrens.org    Principal Investigator: Kenneth M. Heym, MD Less <<
NCT01499147 - Completed - -
NCT01499147 Acute Myeloid Leukemia ... More >> Acute Leukemia Chronic Myelogenous Leukemia Malignant Lymphoma Hodgkin's Disease Multiple Myeloma Lymphocytic Leukemia Myeloproliferative Disorder Polycythemia Vera Myelofibrosis Aplastic Anemia Less << Not Applicable Completed - United States, Illinois ... More >> University of Illinois at Chicago Medical Center Chicago, Illinois, United States, 60612 Less <<
NCT00117156 - Completed - -
NCT00543114 Chronic Lymphocytic Leukemia ... More >> Small Lymphocytic Leukemia Less << Phase 1 Terminated(lack of efficacy an... More >>d tolerability) Less << - United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 Less <<
NCT00117156 Lymphoma, Non-Hodgkin ... More >> MALT Lymphoma Less << Phase 2 Completed - United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02115 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 United States, New York University of Rochester Cancer Center Rochester, New York, United States, 14627 Less <<
NCT00536341 Chronic Lymphocytic Leukemia Phase 1 Phase 2 Completed - United States, Florida ... More >> Florida Cancer Specialists Fort Myers, Florida, United States, 33901 Florida Hospital Cancer Institute Orlando, Florida, United States, 32804 United States, Maryland Center for Cancer and Blood Disorders Bethesda, Maryland, United States, 20817 National Capital Clinical Research Consortium Bethesda, Maryland, United States, 20817 United States, South Carolina South Carolina Oncology Associates, PA Columbia, South Carolina, United States, 29210 United States, Tennessee Tennessee Oncology, PLLC Nashville, Tennessee, United States, 37023 Less <<
NCT02250937 Acute Myeloid Leukemia ... More >> Myelodysplastic Syndrome Less << Phase 2 Recruiting October 2020 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Less <<
NCT00276848 Chronic Lymphocytic Leukemia Phase 3 Completed - -
NCT01772953 Acute Myeloid Leukemia (AML) ... More >> Myelodysplastic Syndrome (MDS) Less << Phase 2 Completed - -
NCT00800839 Hematologic Diseases ... More >> Leukemia Lymphoma Myeloma Less << Phase 2 Completed - United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT01322776 Mantle Cell Lymphoma Recurrent Phase 1 Phase 2 Unknown October 2013 China, Guang Dong ... More >> SunYat-sen University Cancer Centre Recruiting Guang Zhou, Guang Dong, China Contact: Huiqiang Huang       huanghq@sysucc.org.cn    Principal Investigator: Huiqiang Huang          Sub-Investigator: Xiaoxiao Wang Less <<
NCT00800839 - Completed - -
NCT00577161 Non-Hodgkin's Lymphoma Phase 3 Terminated(closed to enrollmen... More >>t) Less << July 2012 United States, Alabama ... More >> Northwest Alabama Cancer Center Muscle Shoals, Alabama, United States, 35661 United States, California Ventura County Hematology Oncology Specialist Oxnard, California, United States, 93030 United States, Missouri Capitol Comprehensive Cancer Care Jefferson City, Missouri, United States, 65109 Heartland Hematology Oncology Associates Kansas City, Missouri, United States, 64118 United States, New York Cancer Care Center New Albany, New York, United States, 47150 Interlakes Foundation, Inc. Rochester, New York, United States, 14623 United States, Ohio Hematology Oncology Consultants Columbus, Ohio, United States, 43235 United States, Utah Utah Hematology Oncology, P.C. Ogden, Utah, United States, 84403 Less <<
NCT00772811 Chronic Lymphocytic Leukemia ... More >> Lymphoma Multiple Myeloma Less << Phase 2 Completed - Korea, Republic of ... More >> Asan Medical Center Seoul, Korea, Republic of, 138-736 Less <<
NCT00206726 Leukemia, Lymphocytic, Chronic... More >>, B-Cell Less << Phase 2 Completed - -
NCT00382694 Multiple Myeloma PHASE2 UNKNOWN 2025-12-06 Department of Haematology B, A... More >>alborg Hospital, University of Aarhus, Aalborg, 9000, Denmark|Department of Haematology, Herlev University Hospital, Herlev, 2730, Denmark|Department of Haematology, Rigshospitalet, K?benhavn ?, 2100, Denmark|Department of Haematology X, Odense University Hospital, Odense, 5000, Denmark|Department of Haematology, Vejle Hospital, Vejle, 7100, Denmark|Dept. of Haematology, ?rhus University Hospital, ?rhus, 8000, Denmark Less <<
NCT01658319 Adult Nasal Type Extranodal NK... More >>/T-cell Lymphoma Anaplastic Large Cell Lymphoma Angioimmunoblastic T-cell Lymphoma Cutaneous B-cell Non-Hodgkin Lymphoma Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue Hepatosplenic T-cell Lymphoma Intraocular Lymphoma Nodal Marginal Zone B-cell Lymphoma Peripheral T-cell Lymphoma Recurrent Adult Burkitt Lymphoma Recurrent Adult Diffuse Large Cell Lymphoma Recurrent Adult Diffuse Mixed Cell Lymphoma Recurrent Adult Diffuse Small Cleaved Cell Lymphoma Recurrent Adult Grade III Lymphomatoid Granulomatosis Recurrent Adult Hodgkin Lymphoma Recurrent Adult Immunoblastic Large Cell Lymphoma Recurrent Adult Lymphoblastic Lymphoma Recurrent Adult T-cell Leukemia/Lymphoma Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma Recurrent Grade 1 Follicular Lymphoma Recurrent Grade 2 Follicular Lymphoma Recurrent Grade 3 Follicular Lymphoma Recurrent Mantle Cell Lymphoma Recurrent Marginal Zone Lymphoma Recurrent Mycosis Fungoides/Sezary Syndrome Recurrent Small Lymphocytic Lymphoma Refractory Chronic Lymphocytic Leukemia Refractory Multiple Myeloma Relapsing Chronic Myelogenous Leukemia Small Intestine Lymphoma Splenic Marginal Zone Lymphoma Stage III Chronic Lymphocytic Leukemia Testicular Lymphoma Waldenstr?m Macroglobulinemia Less << Phase 1 Completed - United States, Ohio ... More >> Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States, 44106 Less <<
NCT00925873 Acute Myeloid Leukemia Phase 3 Completed - France ... More >> GOELAMS Tours, France, 37000 Less <<
NCT00881933 Aplastic Anemia Phase 1 Phase 2 Unknown September 2012 Korea, Republic of ... More >> Seoul National University Hospital Recruiting Seoul, Korea, Republic of, 110-744 Contact: Hyo Seop Ahn, M.D, Ph.D    82 2 2072 3625    hsahn@snu.ac.kr Less <<
NCT00924170 Adult T-Cell Leukemia (ATL) Phase 1 Phase 2 Active, not recruiting January 1, 2019 United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT03613532 Acute Myeloid Leukemia (AML) ... More >> Myelodysplastic Syndrome (MDS) Chronic Myelomonocytic Leukemia (CMML) MDS/Myeloproliferative Neoplasm-unclassifiable (MDS/MPN-unclassifiable) Hematopoietic Stem Cell Transplant Less << Phase 1 Recruiting February 1, 2021 United States, Massachusetts ... More >> Dana-Farber Cancer Institute Recruiting Boston, Massachusetts, United States, 02215 Contact: Jacqueline S Garcia, MD    617-632-1906    jacqueline_garcia@dfci.harvard.edu    Principal Investigator: Jacqueline S Garcia, MD Less <<
NCT00206726 - Completed - -
NCT00098670 B-cell Chronic Lymphocytic Leu... More >>kemia Stage I Chronic Lymphocytic Leukemia Stage II Chronic Lymphocytic Leukemia Stage III Chronic Lymphocytic Leukemia Stage IV Chronic Lymphocytic Leukemia Less << Phase 2 Completed - United States, Illinois ... More >> Cancer and Leukemia Group B Chicago, Illinois, United States, 60606 United States, Ohio Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University Medical Center Columbus, Ohio, United States, 43210 Less <<
NCT00472849 Richter's Transformation ... More >> Leukemia Less << Phase 1 Phase 2 Completed - United States, Texas ... More >> UT MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00086580 B-Cell Chronic Lymphocytic Leu... More >>kemia Less << Phase 3 Completed - -
NCT00924170 - Active, not recruiting - -
NCT03335241 Ovarian Cancer Phase 2 Recruiting December 2022 China, Guangdong ... More >> Sun Yat-sen University Cancer Recruiting Guangzhou, Guangdong, China, 510060 Contact: Jundong Li    +86-20-87343104    lijd@sysucc.org.cn    Contact: Yin Wang    +86-20-87343104    wangyin@sysucc.org.cn Less <<
NCT00098670 - Completed - -
NCT00572897 - Completed - -
NCT00572897 Myelofibrosis Phase 2 Completed - United States, Illinois ... More >> University of Illinois at Chicago Chicago, Illinois, United States, 60612 United States, Maryland Johns Hopkins Baltimore, Maryland, United States, 21205 United States, New York Roswell Park Cancer Institute Buffalo, New York, United States, 14263 Icahn School of Medicine at Mount Sinai New York, New York, United States, 10029 Weill Cornell Medical College New York, New York, United States, 10065 United States, Ohio Ohio State Univesity Columbus, Ohio, United States, 43210 United States, Utah University of Utah Salt Lake City, Utah, United States, 84132 Canada, Ontario Princess Margaret Hospital Toronto, Ontario, Canada, M5G2M9 Italy University of Florence Florence, IL, Italy, 60302 Ospedali Riuniti di Bergamo Bergamo, Italy, 24128 University of San Martino San Martino, Italy Sweden Regionala etikprovningsnamnden Goteborg Goteborg, Sweden, 60302 Less <<
NCT00472849 - Completed - -
NCT00625430 Prostate Cancer Phase 1 Unknown December 2012 Australia, New South Wales ... More >> St Vincent's Hospital, Sydney Recruiting Darlinghurst, New South Wales, Australia, 2010 Less <<
NCT01366612 Myeloid Malignancies ... More >> Acute Myelogenous Leukemia Chronic Myelogenous Leukemia Myeloproliferative Disorders Myelodysplastic Syndrome Less << Phase 3 Recruiting November 2018 United States, New Jersey ... More >> John Theurer Cancer Center at Hackensack University Medical Center Recruiting Hackensack, New Jersey, United States, 07601 Contact: Mariefel Vendivil, RN    551-996-5828    Mariefel.Vendivil@HackensackMeridian.org    Contact: Andrea Ortega, RN    551-996-3923    Andrea.Ortega@HackensackMeridian.org    Principal Investigator: Michele Donato, MD          Sub-Investigator: Melissa Baker, APN          Sub-Investigator: Michele Boonstra, APN          Sub-Investigator: Phyllis McKiernan, APN          Sub-Investigator: Scott Rowley, MD          Sub-Investigator: Alan Skarbnik, MD          Sub-Investigator: David Vesole, MD, PhD Less <<
NCT02212561 Acute Myeloid Leukemia (AML) ... More >> Acute Lymphoblastic Leukemia (ALL) Myelodysplastic Syndrome (MDS) Mixed Phenotype Acute Leukemia (MPAL) Less << Phase 1 Completed - United States, Arizona ... More >> Phoenix Children's Hospital Phoenix, Arizona, United States, 85016 United States, California Lucile Packard Children's Hospital Stanford University Palo Alto, California, United States, 94304 United States, Illinois University of Chicago Chicago, Illinois, United States, 60637 United States, North Carolina Duke University Medical Center Durham, North Carolina, United States, 27710 United States, Tennessee St. Jude Children's Research Hospital Memphis, Tennessee, United States, 38105 United States, Texas Cook Children's Medical Center Fort Worth, Texas, United States, 76104 Less <<
NCT03247088 Acute Myeloid Leukemia Phase 1 Phase 2 Recruiting July 2022 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact: Clinical Research Operations       CR_Study_Registration@mdanderson.org Less <<
NCT00506857 - Completed - -
NCT00004246 Head and Neck Cancer Phase 1 Completed - United States, Texas ... More >> University of Texas - MD Anderson Cancer Center Houston, Texas, United States, 77030-4009 Less <<
NCT00086580 - Completed - -
NCT01814475 Myelofibrosis Phase 2 Completed - Italy ... More >> Azienda Ospedaliera SS Antonio e Biagio Alessandria, Italy Clinica di Ematologia - Ospedali Riuniti di Ancona Ancona, Italy Divisione di Ematologia - Ospedali Papa Giovanni XXIII Bergamo, Italy AO Spedali Civili di Brescia- USD - TMO Adulti Brescia, Italy Ospedale Ferrarotto - Ematologia Catania, Italy Cattedra di Ematologia - Azienda Ospedaliera di Careggi Firenze, Italy AOU IRCCS San Martino - IST Genova, Italy Ospedale Panico Lecce, Italy Divisione di Ematologia - Istituto Nazionale dei Tumori Milano, Italy Divisione Ematologia - Azienda Ospedaliera Universitaria - Policlinico - Modena, Italy AO Ospedali Riuniti Villa Sofia - Cervello Palermo, Italy Dipartimento Oncologico La Maddalena Palermo, Italy Fondazione IRCCS San Matteo Pavia, Italy, 27100 Dip. di Ematologia - Unità di Terapia Intensiva Ematologica per il Trapianto Emopoietico - Ospedale Civile di Pescara Pescara, Italy Centro Unico Regionale Trapianti di Midollo Osseo - Ospedale Bianchi-Melacino-Morelli Reggio Calabria, Italy Arciospedale S. M. Novella Reggio Emilia, Italy Cattedra di Ematologia - Università La Sapienza Roma, Italy Ematologia e Centro Trapianti Midollo Osseo - Ospedale IRCCS Casa Sollievo della Sofferenza S. Giovanni Rotondo (FG), Italy Ospedale San Giuseppe Moscato Taranto, Italy Ematologia 2 - ASO San Giovanni Battista Torino, Italy A.O. Santa Maria della Misericordia Udine, Italy Less <<
NCT03016988 Mantle Cell Lymphoma Phase 2 Not yet recruiting December 2020 -
NCT00815568 AML MDS ... More >> ALL CML Lymphoma Less << Phase 2 Unknown December 2012 Korea, Republic of ... More >> Dong Hwan Kim Recruiting Seoul, Korea, Republic of, 135-710 Less <<
NCT00502905 Leukemia Phase 2 Completed - United States, Texas ... More >> U.T.M.D. Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00502905 - Completed - -
NCT00506857 Hematologic Malignancies Phase 1 Phase 2 Completed - United States, Texas ... More >> UT MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT01019317 Leukemia AML ... More >> MDS CML Less << Phase 2 Completed - United States, Texas ... More >> UT MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT01019317 - Completed - -
NCT01186458 Lymphoma, Non-Hodgkin Phase 2 Terminated(Slow accrual) - United States, Indiana ... More >> Cancer Care Center of Southern Indiana Bloomington, Indiana, United States, 47403 Fort Wayne Oncology & Hematology, Inc Fort Wayne, Indiana, United States, 46815 Indiana University Melvin and Bren Simon Cancer Center Indianapolis, Indiana, United States, 46202 Community Regional Cancer Center Indianapolis, Indiana, United States, 46256 Arnett Cancer Care Lafayette, Indiana, United States, 47904 United States, New Jersey Virtua Health Cancer Program Mount Holly, New Jersey, United States, 08060 South Jersey Health Care Vineland, New Jersey, United States, 08360 United States, New York University of Rochester Medical Center Rochester, New York, United States, 14642 United States, Ohio Case Comprehensive Cancer Center - University Hospitals Case Medical Center Cleveland, Ohio, United States, 44106 Seidman Cancer Center Cleveland, Ohio, United States, 44106 United States, Pennsylvania Reading Hospital Regional Cancer Center W. Reading, Pennsylvania, United States, 19611 Less <<
NCT00208975 Lymphoma Phase 2 Terminated(slow accrual) - United States, Georgia ... More >> Emory University Winship Cancer Institute Atlanta, Georgia, United States, 30322 Less <<
NCT02514083 CLL (Chronic Lymphocytic Leuke... More >>mia) SLL (Small Lymphocytic Lymphoma) Less << Phase 2 Recruiting July 1, 2020 United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact Office of Patient Recruitment (OPR)    800-411-1222 ext TTY8664111010    prpl@cc.nih.gov Less <<
NCT00208975 - Terminated(slow accrual) - -
NCT03342196 Leukemia Phase 2 Recruiting June 2022 United States, Ohio ... More >> University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center Recruiting Cleveland, Ohio, United States, 44106-5065 Contact: Leland Metheny, MD    216-983-4946    Leland.Metheny@uhhospitals.org    Principal Investigator: Leland Metheny Less <<
NCT01186458 - Terminated(Slow accrual) - -
NCT00278265 T-Cell Large Granular Lymphocy... More >>tic Leukemia Less << Phase 2 Terminated(slow recruitment) - Germany ... More >> Robert Roessle Comprehensive Cancer Center - Charite Campus Buch Berlin, Germany, D-13125 University Hospital Schleswig-Holstein - Kiel Campus Kiel, Germany, D-24105 I. Frauenklinik und Hebammenschule der Ludwig-Maximillians Universitaet Muenchen Munich, Germany, D-80337 Klinikum Schwaebisch Gmuend Stauferklinik Mutlangen, Germany, D-73557 Praxis fuer Haematologie und Interne Onkologie Norderstedt, Germany, 22844 St. Marien - Krankenhaus Siegen GMBH Siegen, Germany, D-57072 Comprehensive Cancer Center Ulm at Universitaetsklinikum Ulm Ulm, Germany, D-89081 Less <<
NCT02024308 Acute Myeloid Leukemia ... More >> AML1-ETO Fusion Protein Expression Less << Phase 4 Unknown December 2016 China ... More >> Department of Hematology, Changhai Hospital Recruiting Shanghai, China, 200433 Contact: Xianmin Song    86-21-31161285    shongxm@gmail.com    Principal Investigator: Xianmin Song Less <<
NCT01310179 Head and Neck Cancer Phase 1 Completed - United States, Alabama ... More >> University of Alabama at Birmingham Birmingham, Alabama, United States, 35233 United States, Tennessee Vanderbilt-Ingram Cancer Center Nashville, Tennessee, United States, 37212 Less <<
NCT00882323 Aplastic Anemia Phase 2 Unknown October 2012 Korea, Republic of ... More >> Seoul National University Hospital Recruiting Seoul, Korea, Republic of, 110-744 Contact: Hyo Seop Ahn, M.D, Ph.D    82 2 2072 3625    hsahn@snu.ac.kr Less <<
NCT01310179 - Completed - -
NCT02128945 Untreated B-Chronic Lymphocyti... More >>c Leukemia or Diffuse Large B Cells Lymphoma Patients Less << Phase 1 Completed - France ... More >> University Hospital Caen, France, 14000 Less <<
NCT02926586 Acute Myeloid Leukemia ... More >> Core-Binding Factor Less << Phase 4 Recruiting July 2020 China, Shanghai ... More >> Xianmin Song Recruiting Shanghai, Shanghai, China, 200080 Contact: Xianmin Song, Doctor    86-21-63240090-3932    shongxm@sjtu.edu.cn Less <<
NCT03696537 Acute Myeloid Leukemia ... More >> Chronic Myeloid Leukemia Acute Lymphatic Leukemia Myelodysplastic Syndromes Less << Phase 1 Phase 2 Recruiting March 31, 2024 United States, Indiana ... More >> Indiana University Melvin & Bren Simon Cancer Center Recruiting Indianapolis, Indiana, United States, 46202 Contact: Carol Huntley, RN    317-274-3782    chuntley@iu.edu Less <<
NCT02718755 Hematologic Malignancy Phase 2 Withdrawn(Problem with drug su... More >>pply) Less << May 2022 -
NCT01472055 Acute Leukemia|Chronic Leukemi... More >>a|Severe Aplastic Anemia Less << PHASE2 UNKNOWN 2025-09-14 Seoul National University Hosp... More >>ital, Seoul, Daehangno, Jongno-gu, Korea, Republic of Less <<
NCT02649764 Leukemia Phase 1 Active, not recruiting May 2022 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT03754933 Recurrent Head and Neck Cancer Phase 1 Phase 2 Not yet recruiting August 2021 United States, California ... More >> Stanford University Not yet recruiting Stanford, California, United States, 94305 Contact: Stefania U Chirita    650-723-1423    schirita@stanford.edu    Contact: A Dimitrios Colevas, MD    650-724-9707    colevas@stanford.edu Less <<
NCT01096992 Leukemia Phase 1 Phase 2 Completed - United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00044954 Leukemia Lymp... More >>homa Multiple Myeloma and Plasma Cell Neoplasm Myelodysplastic Syndromes Myelodysplastic/Myeloproliferative Diseases Less << Phase 2 Unknown - United States, Colorado ... More >> Rocky Mountain Cancer Centers - Denver Midtown Denver, Colorado, United States, 80218 United States, Florida Florida Hospital Cancer Institute Orlando, Florida, United States, 32804 United States, Georgia Blood and Marrow Transplant Group of Georgia Atlanta, Georgia, United States, 30342-4777 United States, Iowa Holden Comprehensive Cancer Center at University of Iowa Iowa City, Iowa, United States, 52242-1009 United States, Missouri Kansas City Cancer Centers - Central Kansas City, Missouri, United States, 64111 United States, New Jersey Cancer Center at Hackensack University Medical Center Hackensack, New Jersey, United States, 07601 St. Joseph's Hospital and Medical Center Paterson, New Jersey, United States, 07503 United States, New York James P. Wilmot Cancer Center at University of Rochester Medical Center Rochester, New York, United States, 14642 United States, Oregon Cancer Institute at Oregon Health and Science University Portland, Oregon, United States, 97239-3098 United States, Tennessee Vanderbilt-Ingram Cancer Center at Vanderbilt Medical Center Nashville, Tennessee, United States, 37212 United States, Texas Simmons Cancer Center at University of Texas Southwestern Medical Center - Dallas Dallas, Texas, United States, 75235-8590 Texas Transplant Institute San Antonio, Texas, United States, 78229 United States, Virginia Massey Cancer Center at Virginia Commonwealth University Richmond, Virginia, United States, 23298-0037 United States, Wisconsin University of Wisconsin Comprehensive Cancer Center Madison, Wisconsin, United States, 53792 Less <<
NCT03524235 Multiple Myeloma ... More >> CLL Chronic Lymphocytic Leukemia Lymphoma Less << Phase 1 Recruiting May 2023 United States, California ... More >> Cedars Sinai Medical Center Recruiting Los Angeles, California, United States, 90048 Contact: Hannah Coleman    310-967-4376    hannah.coleman@cshs.org Less <<
NCT00450983 Graft Versus Host Disease ... More >> Leukemia Myelodysplastic Syndromes Less << Phase 2 Terminated - United States, Washington ... More >> Seattle Cancer Care Alliance Seattle, Washington, United States, 98109-1023 Fred Hutchinson Cancer Research Center Seattle, Washington, United States, 98109-1024 Less <<
NCT00450983 - Terminated - -
NCT00732316 Leukemia Myel... More >>odysplastic Syndromes Less << Phase 2 Completed - Korea, Republic of ... More >> Asan Medical Center - University of Ulsan College of Medicine Seoul, Korea, Republic of, 138-736 Less <<
NCT00093743 Adult Acute Myeloid Leukemia i... More >>n Remission Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities Adult Acute Myeloid Leukemia With Del(5q) Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) Adult Acute Myeloid Leukemia With t(15;17)(q22;q12) Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) Adult Acute Myeloid Leukemia With t(8;21)(q22;q22) Childhood Acute Myeloid Leukemia in Remission Childhood Myelodysplastic Syndromes Fanconi Anemia Previously Treated Myelodysplastic Syndromes Less << Phase 1 Completed - United States, Illinois ... More >> Robert H. Lurie Comprehensive Cancer Center Chicago, Illinois, United States, 60611 United States, Indiana Riley Hospital for Children Indianapolis, Indiana, United States, 46202 United States, Tennessee Vanderbilt-Ingram Cancer Center Nashville, Tennessee, United States, 37232 United States, Utah Huntsman Cancer Institute/University of Utah Salt Lake City, Utah, United States, 84112 United States, Washington Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 Less <<
NCT01824693 Juvenile Myelomonocytic Leukem... More >>ia Less << Phase 2 Completed - -
NCT01824693 - Completed - -
NCT00281983 Chronic Lymphocytic Leukemia Phase 1 Phase 2 Completed - Canada, Quebec ... More >> Maisonneuve-Rosemont Hospital Montreal, Quebec, Canada, H1T 2M4 Germany Charite - Universitaetsmedizin Berlin - Campus Benjamin Franklin Berlin, Germany, 12200 Universitaetsklinikum Essen Essen, Germany, 45122 Universitaetsklinikum Goettingen Goettingen, Germany, 37075 Asklepios Klinik St. Georg Hamburg, Germany, D-20099 Medizinische Hochschule Hannover Hannover, Germany, 30625 Universitaets-Kinderklinik Heidelberg Heidelberg, Germany, D-69120 Universitaetsklinikum des Saarlandes Homburg, Germany, 66421 Clinic for Bone Marrow Transplantation and Hematology and Oncology Idar-Oberstein, Germany, D-55743 University Hospital Schleswig-Holstein - Kiel Campus Kiel, Germany, 24116 University Hospital of Leipzig Leipzig, Germany, 04103 Klinikum der Universitaet Regensburg Regensburg, Germany, 93053 Comprehensive Cancer Center Ulm at Universitaetsklinikum Ulm Ulm, Germany, 89081 Less <<
NCT00226512 Acute Myeloid Leukemia ... More >> Myelodysplastic Syndrome Less << Phase 3 Withdrawn(the PI is no longer ... More >>work at Hadassah) Less << - Israel ... More >> Hadassah Medical Organization Jerusalem, Israel, 91120 Less <<
NCT02916979 Leukemia, Lymphoid ... More >> Leukemia, Myeloid Myelodysplastic Syndromes Myelofibrosis Lymphoma, Malignant Multiple Myeloma Waldenstrom Macroglobulinemia Less << Phase 1 Recruiting December 2019 United States, New Hampshire ... More >> Dartmouth-Hitchcock Medical Center Recruiting Lebanon, New Hampshire, United States, 03756 Contact: Research Nurse    800-639-6918    cancer.research.nurse@dartmouth.edu    Principal Investigator: Kenneth Meehan, MD Less <<
NCT00311129 Lymphoma, Low-Grade Phase 2 Completed - Japan ... More >> Nagoya-shi, Aichi, Japan, 464-8681 Nagoya-shi, Aichi, Japan, 466-0814 Kashiwa-shi, Chiba, Japan, 277-8577 Isehara-shi, Kanagawa, Japan, 259-1193 Kyoto-shi, Kyoto, Japan, 602-0841 Sendai-shi, Miyagi, Japan, 980-0872 Hamamatsu-shi, Shizuoka, Japan, 431-3192 Chuo-ku, Tokyo, Japan, 104-0045 Less <<
NCT01509300 Acute Leukemia ... More >> Myelodysplastic Syndrome Solid Tumors Less << Phase 1 Phase 2 Unknown March 2014 Korea, Republic of ... More >> Asan Medical Center Recruiting Seoul, Korea, Republic of, 138-736 Contact: Ho Joon Im, MD & PhD    82-2-3010-3371    hojim@amc.seoul.kr    Principal Investigator: Ho Joon Im, MD & PhD Less <<
NCT00488709 Acute Myeloid Leukemia Phase 4 Completed - Spain ... More >> Hospital Juan Canalejo A Coruña, Spain Hospital Ntra. Sra. de Sonsoles Avila, Spain Hospital germans Trias i Pujol Badalona, Spain Centro Médico Teknon Barcelona, Spain Hospital Sant Pau Barcelona, Spain Hospital Vall d'Hebron Barcelona, Spain Hospital General Yagüe Burgos, Spain Hospital de Jerez Cadiz, Spain Complejo hospitalario Xeral-Calde Lugo, Spain Hospital Clínico Universitario San Carlos Madrid, Spain Hospital Ramón y Cajal Madrid, Spain Hospital Virgen de la Victoria Málaga, Spain Hosptal Joan XXIII Tarragona, Spain Hospital Verge de la Cinta Tortosa, Spain Hospital Rio Hortega Valladolid, Spain Hospital Clinico Lozano Blesa Zaragoza, Spain Less <<
NCT00119392 B-cell Chronic Lymphocytic Leu... More >>kemia Nodal Marginal Zone B-cell Lymphoma Recurrent Adult Burkitt Lymphoma Recurrent Adult Diffuse Large Cell Lymphoma Recurrent Adult Diffuse Mixed Cell Lymphoma Recurrent Adult Diffuse Small Cleaved Cell Lymphoma Recurrent Adult Grade III Lymphomatoid Granulomatosis Recurrent Adult Immunoblastic Large Cell Lymphoma Recurrent Adult Lymphoblastic Lymphoma Recurrent Grade 1 Follicular Lymphoma Recurrent Grade 2 Follicular Lymphoma Recurrent Grade 3 Follicular Lymphoma Recurrent Mantle Cell Lymphoma Recurrent Marginal Zone Lymphoma Recurrent Small Lymphocytic Lymphoma Splenic Marginal Zone Lymphoma Waldenstr?m Macroglobulinemia Less << Phase 2 Completed - United States, Washington ... More >> Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 Less <<
NCT01336712 - Completed - -
NCT00208923 Hematologic Malignancies Phase 2 Completed - United States, Georgia ... More >> Emory Universtiy Winship Cancer Institute Atlanta, Georgia, United States, 30322 Less <<
NCT00354822 Lymphoma, Non-Hodgkin Phase 2 Terminated(Inability to recrui... More >>t in time a sufficient number of patients) Less << - Italy ... More >> USC Ematologia Ospedali Riuniti di Bergamo Bergamo, BG, Italy, 24128 U.O. Ematologia Ospedali Civili Brescia Brescia, BS, Italy Medicina Nucleare ed Oncologia Medica AOU Policlinico Universitario di Messina Messina, ME, Italy, 98125 Istituto per la Ricerca e la Cura del Cancro IRCC Candiolo, TO, Italy, 10060 SC Ematologia 2 ASO S. Giovanni Battista Torino, TO, Italy U.O. Ematologia Ospedale Cà Foncello Treviso, TV, Italy, 31100 Less <<
NCT00003635 Leukemia Phase 2 Completed - -
NCT00119392 - Completed - -
NCT01983761 Blood And Marrow Transplantati... More >>on Leukemia Lymphoma Transplantation Infection Myelodysplastic Syndrome (MDS) Non-Hodgkin's Lymphoma (NHL) Hodgkin's Lymphoma Less << Phase 1 Phase 2 Unknown - United States, California ... More >> Scripps Green Hospital La Jolla, California, United States, 92037 United States, Ohio University Hospitals of Cleveland Cleveland, Ohio, United States, 44106 United States, Texas M.D. Anderson Cancer Center Houston, Texas, United States, 77030 Texas Transplant Institute San Antonio, Texas, United States, 78229 Less <<
NCT00349349 Leukaemia, Lymphocytic, Chroni... More >>c Less << Phase 2 Completed - -
NCT00358657 Immunodeficiency Syndrome ... More >> Non-Cancer Diagnosis Severe Aplastic Anemia Less << Phase 2 Recruiting - United States, Tennessee ... More >> The Children's Hospital at TriStar Centennial Recruiting Nashville, Tennessee, United States, 37203 Contact: Haydar A. Frangoul    615-329-7339    Haydar.Frangoul@hcahealthcare.com    Principal Investigator: Haydar A. Frangoul          Vanderbilt University/Ingram Cancer Center Recruiting Nashville, Tennessee, United States, 37232 Contact: James Connelly    615-936-1762    james.a.connelly@vanderbilt.edu    Principal Investigator: James Connelly          United States, Washington Fred Hutch/University of Washington Cancer Consortium Recruiting Seattle, Washington, United States, 98109 Contact: Lauri M. Burroughs    206-667-2396    lburroug@fredhutch.org    Principal Investigator: Lauri M. Burroughs Less <<
NCT01336712 Chronic Leukemia ... More >> Acute Leukemia Hodgkin's Disease Non-Hodgkin's Lymphoma Myelodysplastic Syndrome Less << Phase 2 Completed - United States, Georgia ... More >> Northside Hospital Atlanta, Georgia, United States, 30342 Less <<
NCT00349349 - Completed - -
NCT00274976 Leukemia Phase 2 Completed - Austria ... More >> Allgemeines Krankenhaus der Stadt Wien Vienna, Austria, A-1090 Germany Gemeinschaftspraxis Fuer Innere Medizin, Haematologie Und Internistische Onkologie Ansbach, Germany, 91522 Specialist Practice for Oncology Aschaffenburg, Germany, 63739 Humaine - Clinic Bad Saarow, Germany, 15526 Haematolo-Onkologische Schwerpunktpraxis - Berlin Berlin, Germany, 13357 Robert Roessle Comprehensive Cancer Center at University of Berlin - Charite Campus Buch Berlin, Germany, D-13122 Hospital Kuchwald Chemnitz Chemnitz, Germany, 09113 Universitaetsklinikum Essen Essen, Germany, D-45122 Staedtische Kliniken Esslingen Esslingen, Germany, 73730 Krankenhaus Nordwest Frankfurt, Germany, D-60488 Universitaetsklinikum Freiburg Freiburg, Germany, D-79106 Universitaetsklinikum Goettingen Goettingen, Germany, D-37075 Klinik Fuer Innere Medizin, Hematology/Oncology, Ernst Moritz Armdt Universitaet Greifswald, Germany, D-17487 St. Marien Hospital - Katholisches Krankenhaus Hagen gGmbH Hagen, Germany, 58095 Internistische Gemeinschaftspraxis - Halle Halle, Germany, 06110 Praxis fur Innere Medizin - Hamburg Hamburg, Germany, 22457 Asklepios Klinik St. Georg Hamburg, Germany, D-20099 Evangelische Krankenhaus Hamm Hamm, Germany, DOH-59063 Medizinische Hochschule Hannover Hannover, Germany, D-30625 Universitaets-Kinderklinik Heidelberg Heidelberg, Germany, D-69120 Marienhospital at Ruhr University Bochum Herne, Germany, D-44625 Universitaetsklinikum des Saarlandes Homburg, Germany, D-66421 Clinic for Bone Marrow Transplantation and Hematology and Oncology Idar-Oberstein, Germany, D-55743 Internistische Gemeinschaftspraxis - Kassel Kassel, Germany, 34117 University Hospital Schleswig-Holstein - Kiel Campus Kiel, Germany, D-24105 Internistische Praxis - Landshut Landshut, Germany, 84028 Klinikum Lippe - Lemgo Lemgo, Germany, D-32657 III Medizinische Klinik Mannheim Mannheim, Germany, D-68305 Klinikum Rechts Der Isar - Technische Universitaet Muenchen Munich, Germany, D-81675 Klinikum Oldenburg Oldenburg, Germany, D-26133 St. Marien - Krankenhaus Siegen GMBH Siegen, Germany, D-57072 Southwest German Cancer Center at Eberhard-Karls-University Tuebingen, Germany, D-72076 Universitaetsklinikum Ulm Ulm, Germany, D-89081 Medizinische Klinik und Poliklinik II - Universitaetsklinikum Wuerzburg Wuerzburg, Germany, D- Hamatologisch - Onkologische Praxis Wurzburg Wurzburg, Germany, 97070 Less <<
NCT00800150 Chronic Myeloproliferative Dis... More >>orders Leukemia Lymphoma Multiple Myeloma and Plasma Cell Neoplasm Myelodysplastic Syndromes Myelodysplastic/Myeloproliferative Neoplasms Less << Phase 1 Terminated(Protocol objective ... More >>could not be met. A new study with amended eligibility criteria will be developed.) Less << - United States, California ... More >> City of Hope Comprehensive Cancer Center Duarte, California, United States, 91010-3000 Less <<
NCT00070135 - Completed - -
NCT02178683 Graft Versus Host Disease Phase 3 Unknown December 2018 United States, Colorado ... More >> Colorado Blood Cancer Institute Recruiting Denver, Colorado, United States, 80218 Contact: Juli B Murphy    720-754-4890    Juli.Murphy@healthonecares.com    Contact: Mark Brunvand, MD    720-754-4800    Mark.Brunvand@healthonecares.com    Principal Investigator: Mark Brunvand, MD          Sub-Investigator: Peter McSweeney, MD          Sub-Investigator: Michael Maris, MD          Sub-Investigator: Jeff Matous, MD          Sub-Investigator: Scott Bearman, MD          Sub-Investigator: Tara Gregory, MD          Sub-Investigator: Richard Nash, MD Less <<
NCT00290511 Lymphoma Phase 2 Active, not recruiting August 24, 2019 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00070135 Adult Acute Myeloid Leukemia i... More >>n Remission Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome Less << Phase 2 Completed - United States, California ... More >> UCSF Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States, 94115 United States, Delaware Tunnell Cancer Center at Beebe Medical Center Lewes, Delaware, United States, 19958 CCOP - Christiana Care Health Services Newark, Delaware, United States, 19713 United States, Maryland Greenebaum Cancer Center at University of Maryland Medical Center Baltimore, Maryland, United States, 21201 Union Hospital of Cecil County Elkton, Maryland, United States, 21921 United States, Massachusetts Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Dana-Farber/Brigham and Women's Cancer Center Boston, Massachusetts, United States, 02115 Dana-Farber/Harvard Cancer Center at Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02215 United States, Minnesota Masonic Cancer Center at University of Minnesota Minneapolis, Minnesota, United States, 55455 United States, Missouri Siteman Cancer Center at Barnes-Jewish Hospital - Saint Louis Saint Louis, Missouri, United States, 63110 United States, New Jersey Cancer Institute of New Jersey at Cooper - Voorhees Voorhees, New Jersey, United States, 08043 United States, New York Roswell Park Cancer Institute Buffalo, New York, United States, 14263-0001 Monter Cancer Center of the North Shore-LIJ Health System Lake Success, New York, United States, 11042 CCOP - North Shore University Hospital Manhasset, New York, United States, 11030 Don Monti Comprehensive Cancer Center at North Shore University Hospital Manhasset, New York, United States, 11030 Long Island Jewish Medical Center New Hyde Park, New York, United States, 11040 New York Weill Cornell Cancer Center at Cornell University New York, New York, United States, 10021 Mount Sinai Medical Center New York, New York, United States, 10029 United States, North Carolina Wake Forest University Comprehensive Cancer Center Winston-Salem, North Carolina, United States, 27157-1096 United States, Ohio Arthur G. James Cancer Hospital and Richard J. Solove Research Institute at Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States, 43210-1240 Less <<
NCT00525603 Leukemia Chro... More >>nic Lymphocytic Leukemia Less << Phase 2 Completed - United States, Texas ... More >> The University of Texas M.D. Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00069992 Chronic Myeloproliferative Dis... More >>orders Leukemia Myelodysplastic Syndromes Less << Phase 2 Terminated(Closed due to compe... More >>ting protocols) Less << - United States, Texas ... More >> Texas Children's Hospital Houston, Texas, United States, 77030 The Methodist Hospital Houston, Texas, United States, 77030 Less <<
NCT00038831 Acute Myelogenous Leukemia ... More >> Myelodysplastic Syndrome Chronic Lymphocytic Leukemia Less << Phase 1 Phase 2 Completed - United States, Texas ... More >> MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00110058 Leukemia Phase 2 Completed - United States, California ... More >> City of Hope Comprehensive Cancer Center Duarte, California, United States, 91010-3000 United States, Washington Seattle Cancer Care Alliance Seattle, Washington, United States, 98109-1023 Fred Hutchinson Cancer Research Center Seattle, Washington, United States, 98109-1024 Less <<
NCT01560117 Follicular T-NHL Lymphoma ... More >> Rituximab Maintenance Less << Phase 2 Completed - -
NCT00525603 - Completed - -
NCT01392079 Chronic Lymphocytic Leukemia Phase 2 Unknown December 2016 Austria ... More >> Hanuschkrankenhaus Wien Wien, Austria University Hospital Wien, Austria France Centre Hospitalier de la Côte Basque Bayonne, France Hopital Avicenne Bobigny Cedex, France, 93009 CHU Estaing Clermont-Ferrand, France Hôpital Henri Mondor, Creteil -APHP CRETEIL Cedex, France CHU de Grenoble Grenoble, France CHU Claude Huriez Lille, France Hôpital Edouard Herriot Lyon Lyon, France CHU de Nancy NANCY Cedex, France CHU Nantes Nantes, France Hôpital Pitié Salpêtrière Paris-APHP Paris, France Hôpital Saint-Louis Paris -APHP Paris, France Centre Hospitalier Marechal Joffre Hôpital Saint-Jean Perpignan PERPIGNAN Cedex, France CHU de Poitiers POITIERS Cedex, France CHU Robert-Debre Reims, France, 51092 CHU de Tours Tours, France Germany Charité CBF Berlin Berlin, Germany University of Cologne Cologne, Germany Dresden Universtiy Hospital Dresden, Germany Essen University Essen, Germany Freiburg University Freiburg, Germany Goettingen University Goettingen, Germany LMU Munich Grosshadern, Germany AK St. Georg Hamburg Hamburg, Germany Hannover medical school (MHH) Hannover, Germany Heidelberg University Heidelberg, Germany Homburg/Saar University Homburg/Saar, Germany Dr. Soeling Kassel Kassel, Germany Kiel University Kiel, Germany Mainz University Mainz, Germany TU Munich Munich, Germany Nuernberg University Hospital Nuernberg, Germany OncoProGbR Regensburg Regensburg, Germany Universtiy of Tuebingen Tuebingen, Germany University of ulm Ulm, Germany, 89081 Dr. Schlag Wuerzburg Wuerzburg, Germany University Hospital Wuerzburg Wuerzburg, Germany Less <<
NCT01313689 Leukaemia Phase 3 Completed - -
NCT03455504 Acute Myeloid Leukemia Phase 2 Not yet recruiting September 2020 Italy ... More >> Ematologia - ASST Papa Giovanni XXIII Not yet recruiting Bergamo, Italy Contact: Alessandro Rambaldi          Principal Investigator: Alessandro Rambaldi          Spedali Civili - Azienda Ospedaliera U.O. Ematologia Not yet recruiting Brescia, Italy Contact: Giuseppe Rossi          Principal Investigator: Giuseppe Rossi          Università di Catania - Cattedra di Ematologia - Ospedale "Ferrarotto" Not yet recruiting Catania, Italy Contact: Francesco Di Raimondo          Principal Investigator: Francesco Di Raimondo          A.O.U. Careggi - Ematologia Not yet recruiting Firenze, Italy Contact: Alberto Bosi          Principal Investigator: Alberto Bosi          Istituto Scientifico Romagnoli per lo Studio e la Cura dei Tumori IRST Not yet recruiting Meldola, Italy Contact: Giovanni Martinelli          Principal Investigator: Giovanni Martinelli          Ospedale Niguarda "Ca Granda" SC Ematologia Not yet recruiting Milano, Italy Contact: Roberto Cairoli          Principal Investigator: Roberto Cairoli          U.O. Ematologia e Trapianto di Midollo Ist. Scientifico Ospedale San Raffaele Not yet recruiting Milano, Italy Contact: Fabio Ciceri          Principal Investigator: Fabio Ciceri          U.O.C. Ematologia e CTMO Az Ospedaliero Universitaria Not yet recruiting Parma, Italy Contact: Giovanni Roti          Principal Investigator: Giovanni Roti          Dipartimento Oncologico - Ospedale S. Maria delle Croci Not yet recruiting Ravenna, Italy Contact: Francesco Lanza          Principal Investigator: Francesco Lanza          Università degli Studi "Sapienza" Dip. Biotecnologie Cellulari ed Ematologia Not yet recruiting Roma, Italy Contact: Roberto Foà          Principal Investigator: Roberto Foà          Dipartimento di Oncologia ed Ematologia S.C. -Città della Scienza di Torino San Giovanni Battista Not yet recruiting Torino, Italy Contact: Ernesta Audisio          Principal Investigator: Ernesta Audisio Less <<
NCT01683123 - Unknown October 2012 -
NCT02251548 Chronic Lymphocytic Leukemia ... More >> Leukemia Less << Phase 2 Active, not recruiting January 2022 United States, Florida ... More >> University of Miami Sylvester Comprehensive Cancer Center Coral Gables, Florida, United States, 33146 University of Miami Sylvester Comprehensive Cancer Center Deerfield Beach, Florida, United States, 33442 Unversity of Miami Sylvester Comprehensve Cancer Center Miami, Florida, United States, 33136 United States, Kansas University of Kansas Cancer Center Westwood, Kansas, United States, 66205 United States, Massachusetts Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02215 Dana Farber Cancer Institute Boston, Massachusetts, United States, 02215 United States, Michigan West Michigan Cancer Center Kalamazoo, Michigan, United States, 49007 United States, North Carolina Duke University Medical Center Durham, North Carolina, United States, 27710 Less <<
NCT00719888 Acute Biphenotypic Leukemia ... More >> Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome Acute Myeloid Leukemia in Remission Adult Acute Lymphoblastic Leukemia in Complete Remission Aggressive Non-Hodgkin Lymphoma Beta-2-Microglobulin Greater Than 3 g/mL Blasts Under 5 Percent of Bone Marrow Nucleated Cells Burkitt Lymphoma Childhood Acute Lymphoblastic Leukemia in Complete Remission Chromosome 13 Abnormality Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive Lymphoblastic Lymphoma Mantle Cell Lymphoma Myelodysplastic Syndrome With Excess Blasts Myelofibrosis Pancytopenia Plasma Cell Myeloma Prolymphocytic Leukemia Recurrent Childhood Acute Myeloid Leukemia Recurrent Chronic Lymphocytic Leukemia Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive Recurrent Follicular Lymphoma Recurrent Lymphoplasmacytic Lymphoma Recurrent Marginal Zone Lymphoma Recurrent Small Lymphocytic Lymphoma Recurrent Non-Hodgkin Lymphoma Less << Phase 2 Recruiting - United States, Colorado ... More >> University of Colorado Hospital Completed Aurora, Colorado, United States, 80045 United States, Washington VA Puget Sound Health Care System Recruiting Seattle, Washington, United States, 98101 Contact: Thomas R. Chauncey    206-764-2199    tchaunce@u.washington.edu    Principal Investigator: Thomas R. Chauncey          Fred Hutch/University of Washington Cancer Consortium Recruiting Seattle, Washington, United States, 98109 Contact: Ann E. Dahlberg    206-667-1959    adahlber@fredhutch.org    Principal Investigator: Ann E. Dahlberg Less <<
NCT00381004 - Completed - -
NCT00346359 Chronic Myeloproliferative Dis... More >>orders Graft Versus Host Disease Leukemia Myelodysplastic Syndromes Myelodysplastic/Myeloproliferative Diseases Less << Phase 2 Completed - United States, Washington ... More >> Fred Hutchinson Cancer Research Center Seattle, Washington, United States, 98109-1024 Less <<
NCT00381004 Chronic Lymphocytic Leukemia Phase 2 Completed - United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT02047578 Acute Lymphoblastic Leukemia Phase 2 Recruiting December 2018 Korea, Republic of ... More >> Seoul National University Hospital Recruiting Seoul, Daehangno, Jongno-gu, Korea, Republic of Contact: Hyoung Jin Kang, MD, PhD    82 2 2072 3304    kanghj@snu.ac.kr    Contact: Ji Won Lee, MD    82 2 2072 4192    agnesjw@hanmail.net Less <<
NCT00772486 Chronic Lymphocytic Leukemia Phase 1 Unknown - United States, California ... More >> University of California, San Diego Moores Cancer Center San Diego, California, United States, 92093 Less <<
NCT00301912 Anemia Chroni... More >>c Myeloproliferative Disorders Leukemia Lymphoma Multiple Myeloma and Plasma Cell Neoplasm Myelodysplastic Syndromes Myelodysplastic/Myeloproliferative Diseases Less << Phase 2 Withdrawn(Withdrawn because st... More >>udy never opened to accrual) Less << - United States, California ... More >> UCSF Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States, 94115 Less <<
NCT00027820 Adult Acute Myeloid Leukemia i... More >>n Remission Childhood Acute Lymphoblastic Leukemia in Remission Childhood Acute Myeloid Leukemia in Remission Childhood Myelodysplastic Syndrome Childhood Renal Cell Carcinoma Chronic Myelomonocytic Leukemia Clear Cell Renal Cell Carcinoma de Novo Myelodysplastic Syndrome Metastatic Renal Cell Cancer Previously Treated Myelodysplastic Syndrome Progression of Multiple Myeloma or Plasma Cell Leukemia Recurrent Adult Acute Lymphoblastic Leukemia Recurrent Adult Acute Myeloid Leukemia Recurrent Adult Hodgkin Lymphoma Recurrent Adult Lymphoblastic Lymphoma Recurrent Adult Non-Hodgkin Lymphoma Recurrent Childhood Acute Lymphoblastic Leukemia Recurrent Childhood Acute Myeloid Leukemia Recurrent Childhood Lymphoblastic Lymphoma Recurrent Childhood Non-Hodgkin Lymphoma Refractory Anemia Refractory Anemia With Ringed Sideroblasts Refractory Childhood Hodgkin Lymphoma Refractory Chronic Lymphocytic Leukemia Renal Medullary Carcinoma Type 1 Papillary Renal Cell Carcinoma Type 2 Papillary Renal Cell Carcinoma Untreated Adult Acute Lymphoblastic Leukemia Untreated Adult Acute Myeloid Leukemia Untreated Childhood Acute Lymphoblastic Leukemia Less << Phase 1 Phase 2 Active, not recruiting - United States, Arizona ... More >> University of Arizona Health Sciences Center Tucson, Arizona, United States, 85724 United States, California Stanford University Hospitals and Clinics Stanford, California, United States, 94305 United States, Georgia Emory University/Winship Cancer Institute Atlanta, Georgia, United States, 30322 United States, Oregon OHSU Knight Cancer Institute Portland, Oregon, United States, 97239 United States, Texas Baylor Medical Center at Garland Garland, Texas, United States, 75042 United States, Utah Huntsman Cancer Institute/University of Utah Salt Lake City, Utah, United States, 84112 United States, Washington Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 United States, Wisconsin Froedtert and the Medical College of Wisconsin Milwaukee, Wisconsin, United States, 53226 Germany Universitaet Leipzig Leipzig, Germany, D-04103 Italy University of Torino Torino, Italy, 10126 Less <<
NCT00529880 Acute Myeloid Leukemia Phase 2 Unknown October 2007 Korea, Republic of ... More >> Asan Medical Center Recruiting Songpa-gu, Seoul, Korea, Republic of, 138-833 Contact: Keun-Hee Kim, nurse    82-2-3010-7290    kuny9847@naver.com Less <<
NCT03235973 Leukemia, Myeloid, Acute ... More >> Leukemia, Lymphoblastic, Acute Less << Phase 1 Recruiting April 2021 France ... More >> Institut Paoli-Calmettes Recruiting Marseille, Bouches-du-Rhône, France, 13009 Contact: Dominique Genre, MD    +33491223778    drci.up@ipc.unicancer.fr    Principal Investigator: Raynier Devillier, MD,PhD Less <<
NCT00119340 Leukemia Phase 1 Phase 2 Completed - United States, Washington ... More >> Veterans Affairs Medical Center - Seattle Seattle, Washington, United States, 98108 Seattle Cancer Care Alliance Seattle, Washington, United States, 98109-1023 Fred Hutchinson Cancer Research Center Seattle, Washington, United States, 98109-1024 Less <<
NCT00868413 Chronic Lymphocytic Leukemia Phase 1 Completed - United States, California ... More >> Site Reference ID/Investigator# 17841 La Jolla, California, United States, 92093 Site Reference ID/Investigator# 25899 Stanford, California, United States, 94305-5821 United States, Maryland Site Reference ID/Investigator# 21622 Baltimore, Maryland, United States, 21231-1000 United States, Ohio Site Reference ID/Investigator# 21621 Columbus, Ohio, United States, 43210 United States, Pennsylvania Site Reference ID/Investigator# 39613 Philadelphia, Pennsylvania, United States, 19111 United States, Texas Site Reference ID/Investigator# 17943 Houston, Texas, United States, 77030-4009 Less <<
NCT01145469 - Completed - -
NCT00027560 - Completed - -
NCT00027560 Leukemia Lymp... More >>homa Multiple Myeloma and Plasma Cell Neoplasm Myelodysplastic Syndromes Myelodysplastic/Myeloproliferative Neoplasms Less << Phase 2 Completed - United States, New York ... More >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10021 Less <<
NCT01861002 Lymphoblastic Leukemia, Acute,... More >> Childhood Myelogenous Leukemia, Acute, Childhood Less << Phase 1 Completed - -
NCT02158091 Chronic Lymphocytic Leukemia Phase 1 Phase 2 Active, not recruiting July 2021 United States, Massachusetts ... More >> Beth Isreal Deaconess Medical Center Boston, Massachusetts, United States, 02115 Dana Farber Cancer Institute Boston, Massachusetts, United States, 02115 Less <<
NCT00280241 Chronic Lymphocytic Leukemia Phase 2 Completed - United States, Pennsylvania ... More >> Hillman Cancer Center Pittsburgh, Pennsylvania, United States, 15232 Less <<
NCT00968162 Bone Marrow Transplantation ... More >> Sickle Cell Disease Less << Phase 1 Completed - United States, Alabama ... More >> University of Alabama-Birmingham Birmingham, Alabama, United States United States, District of Columbia Children's National Medical Center Washington, D.C., District of Columbia, United States United States, Florida All Children's Research Institute Inc. Saint Petersburg, Florida, United States, 33701 United States, Georgia Children's Healthcare of Atlanta Atlanta, Georgia, United States, 30322 United States, Louisiana Tulane University New Orleans, Louisiana, United States, 70112 United States, Michigan Wayne State University Detroit, Michigan, United States, 48202 United States, Mississippi University of Mississippi Medical Center Jackson, Mississippi, United States United States, New York Montefiore Medical Center The Bronx, New York, United States United States, North Carolina University of North Carolina at Chapel Hill Chapel Hill, North Carolina, United States, 27516 United States, Texas University of Texas Southwestern Dallas, Texas, United States Less <<
NCT00280241 - Completed - -
NCT01313689 - Completed - -
NCT00513747 Leukemia Phase 3 Terminated(Insufficient accrua... More >>l) Less << - -
NCT00396968 Acute Myelogenous Leukemia ... More >> Myelodysplastic Syndromes Less << Phase 1 Phase 2 Withdrawn - -
NCT00397800 Lymphoma Phase 1 Phase 2 Unknown May 2013 Germany ... More >> Medizinische Klinik, Klinikum Augsburg Augsburg, Germany, D-86156 Medizinische Klinik III - Universitaetsklinikum Erlangen Erlangen, Germany, D-91054 Universitaetsklinikum Goettingen Goettingen, Germany, D-37075 Universitaetsklinikum Schleswig-Holstein - Campus Luebeck Luebeck, Germany, D-23538 Universitaetsklinkum Magdeburg der Otto-von-Guericke-Universitaet Magdeburg Magdeburg, Germany, D-39120 Universitatsklinik Mainz Mainz, Germany, D-55101 LMU-Klinikum Grosshadern Munich, Germany, D-81366 Klinikum Rechts Der Isar - Technische Universitaet Muenchen Munich, Germany, D-81675 Klinikum der Universitaet Regensburg Regensburg, Germany, D-93042 Universitaetsklinikum Tuebingen Tuebingen, Germany, D-72076 Comprehensive Cancer Center Ulm at Universitaetsklinikum Ulm Ulm, Germany, D-89081 Medizinische Klinik und Poliklinik II - Universitaetsklinikum Wuerzburg Wuerzburg, Germany, D-97080 Less <<
NCT02034630 Genetic Rare Disease Phase 1 Phase 2 Recruiting December 2018 Korea, Republic of ... More >> Seoul National University Hospital Recruiting Seoul, Daehangno, Jongno-gu, Korea, Republic of Contact: Hyoung Jin Kang, MD, PhD    82 2 2072 3304    kanghj@snu.ac.kr    Contact: Ji Won Lee, MD    82 2 2072 3452    agnesjw@hanmail.net Less <<
NCT02158091 - Active, not recruiting - -
NCT00565981 B-cell Chronic Lymphocytic Leu... More >>kemia Less << Phase 2 Completed - Austria ... More >> Landeskrankenhaus Feldkirch Feldkirch, Austria, A-6806 A.ö. Landeskrankenhaus Fürstenfeld Fürstenfeld, Austria, A-8280 Universitätsklinik Innsbruck/ Klinik für Innere Medizin Innsbruck, Austria, A-6020 A.ö. Landeskrankenhaus Leoben Leoben, Austria, A-8700 Krankenhaus der Stadt Linz Linz, Austria, A-4020 St. Johanns LK Salzburg, Austria, A-5020 A.ö. Krankenhaus der Landeshauptstadt St. Pölten St. Poelten, Austria, A-3100 Klinikum Kreuzschwestern Wels GmbH Wels, Austria, A-4600 Less <<
NCT00024440 Leukemia Phase 3 Completed - United States, New Jersey ... More >> Genta Incorporated Berkeley Heights, New Jersey, United States, 07922 Less <<
NCT00112567 Leukemia Myel... More >>odysplastic Syndromes Less << Phase 1 Phase 2 Completed - United States, Washington ... More >> Fred Hutchinson Cancer Research Center Seattle, Washington, United States, 98104 Seattle Cancer Care Alliance Seattle, Washington, United States, 98109-1023 Less <<
NCT00393107 Follicular Lymphoma Phase 2 Completed - Italy ... More >> Ospedale di Arezzo Arezzo, Italy, 52100 Ospedale Maggiore di Milano Milano, Italy, 20100 Ospedale Monteluce Perugia, Italy, 06110 Ospedale di Pescara Pescara, Italy, 89100 Ospedale di Piacenza Piacenza, Italy, 29100 Ospedale di Pisa Pisa, Italy, 56100 Ospedale di Reggio Calabria Reggio Calabria, Italy, 89100 Ospedale S. Maria Nuova Reggio Emilia, Italy, 42100 Ospedale Molinette Torino, Italy, 10100 Less <<
NCT00845104 B-cell Chronic Lymphocytic Leu... More >>kemia Refractory Chronic Lymphocytic Leukemia Less << Phase 2 Withdrawn(No patients enrolled... More >>.) Less << - -
NCT00053287 Leukemia Myel... More >>odysplastic Syndromes Myelodysplastic/Myeloproliferative Diseases Less << Phase 2 Completed - United States, Ohio ... More >> Ireland Cancer Center at University Hospitals Case Medical Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States, 44106-5065 Less <<
NCT00577993 Lymphoma Phase 3 Completed - United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT02859402 T-cell Non-Hodgkin Lymphoma ... More >> Lymphoma, Extranodal NK-T-Cell Less << Phase 2 Recruiting December 2021 Korea, Republic of ... More >> Dong-A University Recruiting Busan, Korea, Republic of, 602-713 Contact: Ji Hyun Lee, MD., Ph.D.    +82-10-9397-5694    hidrleejh@dau.ac.kr    Keimyung University Dongsan Medical Center Recruiting Daegu, Korea, Republic of, 700-712 Contact: Young Rok Do, MD., Ph.D.    +82-10-3541-1160    dyr1160@dsmc.or.kr Less <<
NCT00429026 - Terminated(Slow accrual, study... More >> terminated.) Less << - -
NCT00003145 Accelerated Phase of Disease ... More >> Childhood Chronic Myelogenous Leukemia, BCR-ABL1 Positive Chronic Myelogenous Leukemia, BCR-ABL1 Positive Chronic Phase of Disease Recurrent Disease Less << Phase 2 Active, not recruiting - United States, California ... More >> City of Hope Medical Center Duarte, California, United States, 91010 Stanford University Hospitals and Clinics Stanford, California, United States, 94305 United States, Colorado University of Colorado Denver, Colorado, United States, 80217-3364 United States, Texas Baylor University Medical Center Dallas, Texas, United States, 75246 United States, Washington VA Puget Sound Health Care System Seattle, Washington, United States, 98101 Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 Germany Universitaet Leipzig Leipzig, Germany, D-04103 Italy University of Torino Torino, Italy, 10126 Less <<
NCT01283386 Lymphocytic Leukemia, Chronic Phase 4 Completed - Russian Federation ... More >> Irkutsk, Russian Federation, 664079 Kemerovo, Russian Federation, 650066 Moscow, Russian Federation, 115478 Moscow, Russian Federation, 125284 Saint-Petersburg, Russian Federation, 198205 St. Petersburg, Russian Federation, 197110 Tula, Russian Federation, 300053 UFA, Russian Federation, 450005 Less <<
NCT00577278 Graft Versus Host Disease ... More >> Leukemia Lymphoma Less << Phase 2 Active, not recruiting March 2019 United States, California ... More >> City of Hope Medical Center Duarte, California, United States, 91010-3000 Less <<
NCT00801060 Chronic Lymphocytic Leukemia Phase 2 Terminated - -
NCT00301834 - Completed - -
NCT01105273 Aplastic Anemia Phase 1 Phase 2 Completed - Korea, Republic of ... More >> Asan Medical Center Seoul, Korea, Republic of, 138-736 Less <<
NCT00125606 Acute Myeloid Leukemia Phase 3 Terminated(insufficient patien... More >>t recruitement) Less << - Germany ... More >> Department of Medicine/Hematology and Oncology Muenster, NRW, Germany, 48149 Less <<
NCT00169208 Follicular Lymphoma Phase 2 Completed - France ... More >> Service de médecine D - Maladies du Sang CHU Angers Angers, France, 49033 Service d'Hématologie Hôpital Jean Minjoz Besançon, France, 25030 Hôpital Henri Mondor Créteil, France, 94010 Hôpital A. Michallon BP 217X Grenoble, France, 38043 Service Oncologie - Centre Victor Hugo Le Mans, France, 72015 Service d'hématologie clinique - Centre Hospitalier du Dr Schaffner Lens, France, 62307 Hôpital Claude Huriez - Sce des Maladies du Sang - Place Verdun Lille, France, 59037 Centre Hospitalier Lyon-sud Lyon, France, 69310 Centre régional de lutte contre le cancer Léon Bérard Lyon, France, 69373 Service d'hématologie Institut Paoli Calmette Marseille, France, 13273 Service d'hématologie - Hôpital Necker Paris, France, 75015 Service d'Hématologie Hôpital St Louis Paris, France, 75475 Service d'hématologie clinique - Hôpital de Pontchaillou Rennes, France, 35033 Centre Henri Becquerel Rouen, France, 76038 Service Oncologie CHU Bretonneau Tours, France, 37044 Service d'hématologie Institut Gustave Roussy Villejuif, France, 94805 Less <<
NCT00118352 Acute Undifferentiated Leukemi... More >>a Adult Acute Lymphoblastic Leukemia in Remission Adult Acute Myeloid Leukemia in Remission Adult Nasal Type Extranodal NK/T-cell Lymphoma Anaplastic Large Cell Lymphoma Angioimmunoblastic T-cell Lymphoma Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative Childhood Acute Lymphoblastic Leukemia in Remission Childhood Acute Myeloid Leukemia in Remission Childhood Burkitt Lymphoma Childhood Chronic Myelogenous Leukemia Childhood Diffuse Large Cell Lymphoma Childhood Immunoblastic Large Cell Lymphoma Childhood Myelodysplastic Syndromes Childhood Nasal Type Extranodal NK/T-cell Lymphoma Chronic Myelomonocytic Leukemia Chronic Phase Chronic Myelogenous Leukemia Cutaneous B-cell Non-Hodgkin Lymphoma Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue Hepatosplenic T-cell Lymphoma Intraocular Lymphoma Juvenile Myelomonocytic Leukemia Mast Cell Leukemia Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable Nodal Marginal Zone B-cell Lymphoma Noncutaneous Extranodal Lymphoma Peripheral T-cell Lymphoma Previously Treated Myelodysplastic Syndromes Recurrent Adult Acute Lymphoblastic Leukemia Recurrent Adult Acute Myeloid Leukemia Recurrent Adult Burkitt Lymphoma Recurrent Adult Diffuse Large Cell Lymphoma Recurrent Adult Diffuse Mixed Cell Lymphoma Recurrent Adult Diffuse Small Cleaved Cell Lymphoma Recurrent Adult Grade III Lymphomatoid Granulomatosis Recurrent Adult Hodgkin Lymphoma Recurrent Adult Immunoblastic Large Cell Lymphoma Recurrent Adult Lymphoblastic Lymphoma Recurrent Adult T-cell Leukemia/Lymphoma Recurrent Childhood Acute Lymphoblastic Leukemia Recurrent Childhood Acute Myeloid Leukemia Recurrent Childhood Anaplastic Large Cell Lymphoma Recurrent Childhood Grade III Lymphomatoid Granulomatosis Recurrent Childhood Large Cell Lymphoma Recurrent Childhood Lymphoblastic Lymphoma Recurrent Childhood Small Noncleaved Cell Lymphoma Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma Recurrent Grade 1 Follicular Lymphoma Recurrent Grade 2 Follicular Lymphoma Recurrent Grade 3 Follicular Lymphoma Recurrent Mantle Cell Lymphoma Recurrent Marginal Zone Lymphoma Recurrent Mycosis Fungoides/Sezary Syndrome Recurrent Small Lymphocytic Lymphoma Recurrent/Refractory Childhood Hodgkin Lymphoma Refractory Chronic Lymphocytic Leukemia Refractory Hairy Cell Leukemia Refractory Multiple Myeloma Relapsing Chronic Myelogenous Leukemia Secondary Myelodysplastic Syndromes Small Intestine Lymphoma Splenic Marginal Zone Lymphoma Testicular Lymphoma Waldenstr?m Macroglobulinemia Less << Phase 2 Completed - United States, Washington ... More >> Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 Italy University of Torino Torino, Italy, 10126 Less <<
NCT00429026 Renal Cell Cancer Phase 2 Terminated(Slow accrual, study... More >> terminated.) Less << - United States, Texas ... More >> U.T. M.D. Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00193466 Non-Hodgkins Lymphoma Phase 2 Completed - -
NCT00086775 Leukemia Phase 2 Completed - United States, Massachusetts ... More >> Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute Boston, Massachusetts, United States, 02115 United States, Mississippi Jackson Oncology Associates, PLLC Jackson, Mississippi, United States, 39202 United States, New Jersey Cancer Institute of New Jersey at Robert Wood Johnson University Hospital New Brunswick, New Jersey, United States, 08903 United States, Pennsylvania Western Pennsylvania Cancer Institute Pittsburgh, Pennsylvania, United States, 15224 Hillman Cancer Center at University of Pittsburgh Cancer Institute Pittsburgh, Pennsylvania, United States, 15232 Less <<
NCT00005799 Accelerated Phase Chronic Myel... More >>ogenous Leukemia Adult Acute Lymphoblastic Leukemia in Remission Adult Acute Myeloid Leukemia in Remission Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities Adult Acute Myeloid Leukemia With Del(5q) Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) Adult Acute Myeloid Leukemia With t(15;17)(q22;q12) Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) Adult Acute Myeloid Leukemia With t(8;21)(q22;q22) B-cell Chronic Lymphocytic Leukemia Childhood Acute Lymphoblastic Leukemia in Remission Childhood Acute Myeloid Leukemia in Remission Childhood Chronic Myelogenous Leukemia Childhood Myelodysplastic Syndromes Childhood Renal Cell Carcinoma Chronic Phase Chronic Myelogenous Leukemia Clear Cell Renal Cell Carcinoma de Novo Myelodysplastic Syndromes Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue Nodal Marginal Zone B-cell Lymphoma Previously Treated Myelodysplastic Syndromes Recurrent Adult Acute Lymphoblastic Leukemia Recurrent Adult Acute Myeloid Leukemia Recurrent Adult Diffuse Small Cleaved Cell Lymphoma Recurrent Adult Hodgkin Lymphoma Recurrent Childhood Acute Lymphoblastic Leukemia Recurrent Childhood Acute Myeloid Leukemia Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma Recurrent Grade 1 Follicular Lymphoma Recurrent Grade 2 Follicular Lymphoma Recurrent Marginal Zone Lymphoma Recurrent Mycosis Fungoides/Sezary Syndrome Recurrent Small Lymphocytic Lymphoma Recurrent/Refractory Childhood Hodgkin Lymphoma Refractory Chronic Lymphocytic Leukemia Refractory Hairy Cell Leukemia Refractory Multiple Myeloma Relapsing Chronic Myelogenous Leukemia Splenic Marginal Zone Lymphoma Stage III Renal Cell Cancer Stage IV Renal Cell Cancer T-cell Large Granular Lymphocyte Leukemia Type 1 Papillary Renal Cell Carcinoma Type 2 Papillary Renal Cell Carcinoma Waldenstr?m Macroglobulinemia Less << Not Applicable Active, not recruiting - United States, California ... More >> City of Hope Medical Center Duarte, California, United States, 91010 Stanford University Hospitals and Clinics Stanford, California, United States, 94305 United States, Colorado University of Colorado Denver, Colorado, United States, 80217-3364 United States, Texas Baylor University Medical Center Dallas, Texas, United States, 75246 United States, Utah Huntsman Cancer Institute/University of Utah Salt Lake City, Utah, United States, 84112 United States, Washington Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 Germany Universitaet Leipzig Leipzig, Germany, D-04103 Less <<
NCT00499889 - Terminated(Support issue.) - -
NCT00118352 - Completed - -
NCT00499889 Leukemia Phase 2 Terminated(Support issue.) - United States, Texas ... More >> UT MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT01255319 - Unknown November 2014 Korea, Republic of ... More >> Asan Medical Center Recruiting Seoul, Asanbyeongwon-gil, songpa-gu, Korea, Republic of, 138-736 Contact: Yae-Eun Jang, nurse    82-2-3010-6378    redpin75@paran.com Less <<
NCT03303950 Anemia ASXL1 ... More >>Gene Mutation EZH2 Gene Mutation IDH1 Gene Mutation IDH2 Gene Mutation Plasma Cell Myeloma Primary Myelofibrosis Recurrent Plasma Cell Myeloma Secondary Myelofibrosis Thrombocytopenia Less << Phase 2 Recruiting October 2022 United States, Utah ... More >> Huntsman Cancer Institute/University of Utah Recruiting Salt Lake City, Utah, United States, 84112 Contact: Catherine Lee, MD    801-587-0231    Catherine.Lee@hci.utah.edu    Principal Investigator: Catherine Lee, MD Less <<
NCT00301834 Congenital Amegakaryocytic Thr... More >>ombocytopenia Diamond-blackfan Anemia Leukemia Myelodysplastic Syndromes Severe Congenital Neutropenia Less << Phase 2 Completed - United States, California ... More >> UCSF Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States, 94115 United States, Wisconsin University of Wisconsin Paul P. Carbone Comprehensive Cancer Center Madison, Wisconsin, United States, 53792-6164 Less <<
NCT00253513 - Completed - -
NCT00553098 Immunodeficiency Syndrome ... More >> Non-Cancer Diagnosis Less << Phase 2 Active, not recruiting - United States, California ... More >> Children's Hospital and Research Center at Oakland Oakland, California, United States, 94609-1809 United States, Ohio Cleveland Clinic Foundation Cleveland, Ohio, United States, 44195 United States, Oregon Oregon Health and Science University Portland, Oregon, United States, 97239 United States, Tennessee Vanderbilt University/Ingram Cancer Center Nashville, Tennessee, United States, 37232 United States, Washington Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 United States, Wisconsin Children's Hospital of Wisconsin Milwaukee, Wisconsin, United States, 53201 Less <<
NCT00253513 Leukemia Myel... More >>odysplastic Syndromes Less << Phase 1 Phase 2 Completed - United States, Oregon ... More >> OHSU Knight Cancer Institute Portland, Oregon, United States, 97239-3098 United States, Washington Seattle Cancer Care Alliance Seattle, Washington, United States, 98109-1023 Fred Hutchinson Cancer Research Center Seattle, Washington, United States, 98109 Less <<
NCT00075478 Acute Lymphoblastic Leukemia i... More >>n Remission Acute Myeloid Leukemia in Remission Aggressive Non-Hodgkin Lymphoma Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive Diffuse Large B-Cell Lymphoma Hematopoietic and Lymphoid Cell Neoplasm Indolent Non-Hodgkin Lymphoma Mantle Cell Lymphoma Myelodysplastic/Myeloproliferative Neoplasm Plasma Cell Myeloma Refractory Chronic Lymphocytic Leukemia Refractory Hodgkin Lymphoma Waldenstrom Macroglobulinemia Less << Phase 3 Completed - United States, Oregon ... More >> OHSU Cancer Institute-Southern Region Medford, Oregon, United States, 97504 United States, Utah Huntsman Cancer Institute/University of Utah Salt Lake City, Utah, United States, 84112 LDS Hospital Salt Lake City, Utah, United States, 84143 United States, Washington VA Puget Sound Health Care System Seattle, Washington, United States, 98101 Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 United States, Wisconsin Froedtert and the Medical College of Wisconsin Milwaukee, Wisconsin, United States, 53226 Germany Medizinische Univ Klinik Koln Koln, Germany, 50924 Universitaet Leipzig Leipzig, Germany, D-04103 University of Tuebingen-Germany Tuebingen, Germany, D-72076 Italy University of Torino Torino, Italy, 10126 Less <<
NCT00887042 Acute Myeloid Leukemia Phase 1 Phase 2 Unknown May 2012 Korea, Republic of ... More >> Seoul National University Hospital Seoul, Chongno-gu, Korea, Republic of, 110-744 Less <<
NCT00553098 - Active, not recruiting - -
NCT00008177 Adult Acute Myeloid Leukemia i... More >>n Remission Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities Adult Acute Myeloid Leukemia With Del(5q) Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) Adult Acute Myeloid Leukemia With t(15;17)(q22;q12) Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) Adult Acute Myeloid Leukemia With t(8;21)(q22;q22) Chronic Myelomonocytic Leukemia de Novo Myelodysplastic Syndromes Previously Treated Myelodysplastic Syndromes Recurrent Adult Acute Myeloid Leukemia Refractory Anemia With Excess Blasts Refractory Anemia With Excess Blasts in Transformation Refractory Anemia With Ringed Sideroblasts Refractory Cytopenia With Multilineage Dysplasia Secondary Myelodysplastic Syndromes Untreated Adult Acute Myeloid Leukemia Less << Phase 1 Active, not recruiting - United States, Washington ... More >> Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 Less <<
NCT00075478 - Completed - -
NCT00416884 Leukemia Phase 2 Terminated(Low enrollment) - United States, Oregon ... More >> OHSU Knight Cancer Institute Portland, Oregon, United States, 97239-3098 Less <<
NCT00416884 - Terminated(Low enrollment) - -
NCT00860574 Accelerated Phase Chronic Myel... More >>ogenous Leukemia Adult Acute Lymphoblastic Leukemia in Remission Adult Acute Myeloid Leukemia in Remission Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities Adult Acute Myeloid Leukemia With Del(5q) Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) Adult Acute Myeloid Leukemia With t(15;17)(q22;q12) Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) Adult Acute Myeloid Leukemia With t(8;21)(q22;q22) Blastic Phase Chronic Myelogenous Leukemia Childhood Acute Lymphoblastic Leukemia in Remission Childhood Acute Myeloid Leukemia in Remission Childhood Chronic Myelogenous Leukemia Childhood Myelodysplastic Syndromes Chronic Myelomonocytic Leukemia de Novo Myelodysplastic Syndromes Previously Treated Myelodysplastic Syndromes Recurrent Adult Acute Lymphoblastic Leukemia Recurrent Adult Acute Myeloid Leukemia Recurrent Childhood Acute Lymphoblastic Leukemia Recurrent Childhood Acute Myeloid Leukemia Secondary Myelodysplastic Syndromes Untreated Adult Acute Lymphoblastic Leukemia Untreated Childhood Acute Lymphoblastic Leukemia Less << Phase 2 Completed - United States, Colorado ... More >> University of Colorado Denver, Colorado, United States, 80217-3364 United States, Oregon Oregon Health and Science University Portland, Oregon, United States, 97239 United States, Washington Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 Less <<
NCT00619645 - Completed - -
NCT00019838 Leukemia Lymp... More >>homa Less << Phase 1 Completed - United States, Maryland ... More >> Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support Bethesda, Maryland, United States, 20892-1182 NCI - Center for Cancer Research Bethesda, Maryland, United States, 20892 Less <<
NCT00014235 Acute Myeloid Leukemia/Transie... More >>nt Myeloproliferative Disorder Acute Undifferentiated Leukemia Adult Acute Lymphoblastic Leukemia in Remission Adult Acute Myeloid Leukemia in Remission Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities Adult Acute Myeloid Leukemia With Del(5q) Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) Adult Acute Myeloid Leukemia With t(15;17)(q22;q12) Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) Adult Acute Myeloid Leukemia With t(8;21)(q22;q22) Adult Nasal Type Extranodal NK/T-cell Lymphoma Anaplastic Large Cell Lymphoma Angioimmunoblastic T-cell Lymphoma Blastic Plasmacytoid Dendritic Cell Neoplasm Childhood Acute Lymphoblastic Leukemia in Remission Childhood Acute Myeloid Leukemia in Remission Childhood Burkitt Lymphoma Childhood Diffuse Large Cell Lymphoma Childhood Immunoblastic Large Cell Lymphoma Childhood Myelodysplastic Syndromes Childhood Nasal Type Extranodal NK/T-cell Lymphoma Chronic Myelomonocytic Leukemia Cutaneous B-cell Non-Hodgkin Lymphoma de Novo Myelodysplastic Syndromes Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue Hepatosplenic T-cell Lymphoma Intraocular Lymphoma Juvenile Myelomonocytic Leukemia Mast Cell Leukemia Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable Nodal Marginal Zone B-cell Lymphoma Noncutaneous Extranodal Lymphoma Peripheral T-cell Lymphoma Post-transplant Lymphoproliferative Disorder Previously Treated Myelodysplastic Syndromes Primary Systemic Amyloidosis Recurrent Adult Acute Lymphoblastic Leukemia Recurrent Adult Acute Myeloid Leukemia Recurrent Adult Burkitt Lymphoma Recurrent Adult Diffuse Large Cell Lymphoma Recurrent Adult Diffuse Mixed Cell Lymphoma Recurrent Adult Diffuse Small Cleaved Cell Lymphoma Recurrent Adult Grade III Lymphomatoid Granulomatosis Recurrent Adult Hodgkin Lymphoma Recurrent Adult Immunoblastic Large Cell Lymphoma Recurrent Adult Lymphoblastic Lymphoma Recurrent Adult T-cell Leukemia/Lymphoma Recurrent Childhood Acute Lymphoblastic Leukemia Recurrent Childhood Acute Myeloid Leukemia Recurrent Childhood Anaplastic Large Cell Lymphoma Recurrent Childhood Grade III Lymphomatoid Granulomatosis Recurrent Childhood Large Cell Lymphoma Recurrent Childhood Lymphoblastic Lymphoma Recurrent Childhood Small Noncleaved Cell Lymphoma Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma Recurrent Grade 1 Follicular Lymphoma Recurrent Grade 2 Follicular Lymphoma Recurrent Grade 3 Follicular Lymphoma Recurrent Mantle Cell Lymphoma Recurrent Marginal Zone Lymphoma Recurrent Mycosis Fungoides/Sezary Syndrome Recurrent Small Lymphocytic Lymphoma Recurrent/Refractory Childhood Hodgkin Lymphoma Refractory Chronic Lymphocytic Leukemia Refractory Hairy Cell Leukemia Refractory Multiple Myeloma Small Intestine Lymphoma Splenic Marginal Zone Lymphoma Stage II Multiple Myeloma Stage III Multiple Myeloma T-cell Large Granular Lymphocyte Leukemia Testicular Lymphoma Untreated Adult Acute Lymphoblastic Leukemia Untreated Adult Acute Myeloid Leukemia Untreated Childhood Acute Lymphoblastic Leukemia Untreated Childhood Acute Myeloid Leukemia and Other Myeloid Malignancies Waldenstr?m Macroglobulinemia Less << Not Applicable Active, not recruiting - United States, Arizona ... More >> University of Arizona Health Sciences Center Tucson, Arizona, United States, 85724 United States, California City of Hope Medical Center Duarte, California, United States, 91010 Stanford University Hospitals and Clinics Stanford, California, United States, 94305 United States, Oregon OHSU Knight Cancer Institute Portland, Oregon, United States, 97239 United States, Texas Baylor University Medical Center Dallas, Texas, United States, 75246 United States, Utah Huntsman Cancer Institute/University of Utah Salt Lake City, Utah, United States, 84112 LDS Hospital Salt Lake City, Utah, United States, 84143 United States, Washington Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 United States, Wisconsin Froedtert Hospital Milwaukee, Wisconsin, United States, 53226-3596 Germany Universitaet Leipzig Leipzig, Germany, D-04103 Italy University of Torino Torino, Italy, 10126 Less <<
NCT00619645 Leukemia Lymp... More >>homa Multiple Myeloma and Plasma Cell Neoplasm Myelodysplastic Syndromes Less << Phase 2 Completed - United States, California ... More >> University of California Davis Cancer Center Sacramento, California, United States, 95817 Less <<
NCT00281931 Prolymphocytic Leukemia Phase 2 Terminated - Germany ... More >> Helios Klinikum Erfurt Erfurt, Germany, 99012 Less <<
NCT00410163 - Completed - -
NCT00005580 Leukemia Lymp... More >>homa Less << Phase 1 Completed - United States, New York ... More >> New York Presbyterian Hospital - Cornell Campus New York, New York, United States, 10021 United States, Pennsylvania Fox Chase Cancer Center Philadelphia, Pennsylvania, United States, 19111 United States, Virginia Massey Cancer Center Richmond, Virginia, United States, 23298-0037 Less <<
NCT00228852 T-Cell Immune Deficiency Disea... More >>ses Severe Combined Immunodeficiency Less << Phase 1 Phase 2 Completed - United States, Georgia ... More >> Children's Healthcare of Atlanta Atlanta, Georgia, United States, 30322 Less <<
NCT00020800 Lymphoma Phase 2 Completed - United States, Arizona ... More >> Arizona Cancer Center Tucson, Arizona, United States, 85724 United States, California Cedars-Sinai Medical Center Los Angeles, California, United States, 90048 Jonsson Comprehensive Cancer Center, UCLA Los Angeles, California, United States, 90095-1781 United States, District of Columbia Walter Reed Army Medical Center Washington, District of Columbia, United States, 20307-5000 United States, Illinois Rush-Presbyterian-St. Luke's Medical Center Chicago, Illinois, United States, 60612 United States, Iowa Holden Comprehensive Cancer Center Iowa City, Iowa, United States, 52242-1009 United States, Maryland Marlene and Stewart Greenebaum Cancer Center, University of Maryland Baltimore, Maryland, United States, 21201 United States, Massachusetts Tuft-New England Medical Center Boston, Massachusetts, United States, 02111 Massachusetts General Hospital Cancer Center Boston, Massachusetts, United States, 02114 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 United States, New York Long Island Jewish Medical Center New Hyde Park, New York, United States, 11040 Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10021 United States, Ohio Barrett Cancer Center Cincinnati, Ohio, United States, 45267-0502 Cleveland Clinic Taussig Cancer Center Cleveland, Ohio, United States, 44195 Canada, Alberta Cross Cancer Institute Edmonton, Alberta, Canada, T6G 1Z2 Canada, Ontario Chedoke-McMaster Hospitals Hamilton, Ontario, Canada, L8N 3Z5 Sweden Huddinge University Hospital Stockholm, Sweden, SE-141 86 United Kingdom Saint Bartholomew's Hospital London, England, United Kingdom, EC1A 7BE Less <<
NCT00003829 Leukemia Phase 2 Completed - United States, Arizona ... More >> CCOP - Scottsdale Oncology Program Scottsdale, Arizona, United States, 85259-5404 United States, Illinois CCOP - Illinois Oncology Research Association Peoria, Illinois, United States, 61602 CCOP - Carle Cancer Center Urbana, Illinois, United States, 61801 United States, Iowa CCOP - Cedar Rapids Oncology Project Cedar Rapids, Iowa, United States, 52403-1206 CCOP - Iowa Oncology Research Association Des Moines, Iowa, United States, 50309-1016 Siouxland Hematology-Oncology Sioux City, Iowa, United States, 51101-1733 United States, Kansas CCOP - Wichita Wichita, Kansas, United States, 67214-3882 United States, Michigan CCOP - Ann Arbor Regional Ann Arbor, Michigan, United States, 48106 United States, Minnesota CCOP - Duluth Duluth, Minnesota, United States, 55805 Mayo Clinic Cancer Center Rochester, Minnesota, United States, 55905 CentraCare Clinic Saint Cloud, Minnesota, United States, 56303 CCOP - Metro-Minnesota Saint Louis Park, Minnesota, United States, 55416 United States, Nebraska CCOP - Missouri Valley Cancer Consortium Omaha, Nebraska, United States, 68131 United States, North Dakota Quain & Ramstad Clinic, P.C. Bismarck, North Dakota, United States, 58501 Altru Health Systems Grand Forks, North Dakota, United States, 58201 United States, South Dakota Rapid City Regional Hospital Rapid City, South Dakota, United States, 57709 CCOP - Sioux Community Cancer Consortium Sioux Falls, South Dakota, United States, 57105-1080 Less <<
NCT00809276 Lymphoma Mult... More >>iple Myeloma Leukemia Myelodysplastic Syndrome Less << Phase 1 Phase 2 Completed - United States, Maryland ... More >> The Sydney Kimmel Comprehensive Cancer center Baltimore, Maryland, United States, 21231 United States, Texas Marcos deLima, MD Houston, Texas, United States, 77030 United States, Washington Paul V. O'Donnell, M.D., Ph.D. Seattle, Washington, United States, 98109 Less <<
NCT00410163 Leukaemia, Lymphocytic, Chroni... More >>c Less << Phase 2 Completed - United States, Texas ... More >> GSK Investigational Site Houston, Texas, United States, 77030 United Kingdom GSK Investigational Site Plymouth, Devon, United Kingdom, PL68DH Less <<
NCT01503242 Plasma Cell Myeloma ... More >> Refractory Plasma Cell Myeloma Less << Phase 1 Active, not recruiting December 6, 2019 United States, Washington ... More >> Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 Less <<
NCT00880815 CD20 Positive ... More >> Chronic Lymphocytic Leukemia Follicular Lymphoma Mantle Cell Lymphoma Marginal Zone Lymphoma Recurrent Diffuse Large B-Cell Lymphoma T-Cell Non-Hodgkin Lymphoma Less << Phase 1 Active, not recruiting February 28, 2020 United States, Texas ... More >> M D Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00809276 - Completed - -
NCT00987480 Aplastic Anemia ... More >> Leukemia Myelodysplastic Syndrome Less << Phase 2 Completed - United States, Massachusetts ... More >> Children's Hospital Boston Boston, Massachusetts, United States, 02115 United States, New York Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 The Rockefeller University New York, New York, United States, 10065 United States, Ohio Cincinnati Children's Hospital Cincinnati, Ohio, United States, 45229 United States, Washington Fred Hutchinson Cancer Research Center Seattle, Washington, United States, 98109 United States, Wisconsin Children's Hospital of Wisconsin Milwaukee, Wisconsin, United States Less <<
NCT00987480 - Completed - -
NCT00789776 Acute Lymphoblastic Leukemia ... More >> Acute Myeloid Leukemia Aggressive Non-Hodgkin Lymphoma Diffuse Large B-Cell Lymphoma Previously Treated Myelodysplastic Syndrome Recurrent Chronic Lymphocytic Leukemia Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive Recurrent Indolent Adult Non-Hodgkin Lymphoma Recurrent Mantle Cell Lymphoma Recurrent Plasma Cell Myeloma Recurrent Small Lymphocytic Lymphoma Refractory Chronic Lymphocytic Leukemia Refractory Hodgkin Lymphoma Refractory Plasma Cell Myeloma Refractory Small Lymphocytic Lymphoma Waldenstrom Macroglobulinemia Less << Phase 1 Phase 2 Active, not recruiting May 18, 2021 United States, Washington ... More >> Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 United States, Wisconsin Children's Hospital of Wisconsin Milwaukee, Wisconsin, United States, 53201 Froedtert and the Medical College of Wisconsin Milwaukee, Wisconsin, United States, 53226 Less <<
NCT00096382 Melanoma (Skin) Phase 2 Completed - United States, Maryland ... More >> Warren Grant Magnuson Clinical Center - NCI Clinical Trials Referral Office Bethesda, Maryland, United States, 20892-1182 NCI - Surgery Branch Bethesda, Maryland, United States, 20892-1201 Less <<
NCT00096382 - Completed - -
NCT00453388 Acute Myeloid Leukemia in Remi... More >>ssion de Novo Myelodysplastic Syndrome Fanconi Anemia Previously Treated Myelodysplastic Syndrome Less << Phase 2 Active, not recruiting - United States, California ... More >> Children's Hospital and Research Center at Oakland Oakland, California, United States, 94609-1809 United States, Tennessee Vanderbilt University/Ingram Cancer Center Nashville, Tennessee, United States, 37232 United States, Washington Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 United States, Wisconsin Children's Hospital of Wisconsin Milwaukee, Wisconsin, United States, 53201 Brazil Universidade Federal do Paraná Curitiba, Paraná, Brazil, 80060-000 Less <<
NCT03690011 T-cell Acute Lymphoblastic Leu... More >>kemia T-cell Acute Lymphoblastic Lymphoma T-non-Hodgkin Lymphoma Less << Phase 1 Not yet recruiting May 1, 2038 United States, Texas ... More >> Houston Methodist Hospital Not yet recruiting Houston, Texas, United States, 77030 Contact: LaQuisa HIll, MD    832-824-4670    LaQuisa.Hill@bcm.edu    Contact: Jacqueline Castello    713-441-1450    jxcastel@txch.org    Texas Children's Hospital Not yet recruiting Houston, Texas, United States, 77030 Contact: Rayne Rouce, MD    832-824-4716    rhrouce@txch.org    Contact: Jacqueline Castello    832-824-4391    jxcastel@txch.org Less <<
NCT00453388 - Active, not recruiting - -
NCT00324623 Melanoma (Skin) Phase 1 Completed - Switzerland ... More >> Centre Hospitalier Universitaire Vaudois Lausanne, Switzerland, CH-1011 Less <<
NCT00603954 Hematological Malignancies Phase 2 Completed - Belgium ... More >> UZA Edeghem, Antwerpen, Belgium AZ Gasthuisberg Leuven Leuven, Flamish Brabant, Belgium, 3000 UZ Gent Gent, Flanders Oost, Belgium University Hospital Mont-Godinne Godinne, Namur, Belgium AZ St-Jan Brugge, West Flanders, Belgium UZA Stuyvenberg Antwerpen, Belgium Bordet Institute Brussels, Belgium St Luc UCL Brussels, Belgium UZ Brussels Brussels, Belgium CHU Sart Tilman Liege, Belgium, 4000 Netherlands University Hospital Maastricht Maastricht, Limburg, Netherlands, 6200 Less <<
NCT00010361 Metabolism, Inborn Errors ... More >> Granulomatous Disease, Chronic Less << Not Applicable Completed - United States, Washington ... More >> Fred Hutchinson Cancer Research Center Seattle, Washington, United States, 98109 Less <<
NCT00579137 Severe Combined Immunodeficien... More >>cy Disease Severe Primary Immunodeficiency Disorder Undefined T Cell Deficiency Disorder Wiskott-Aldrick Syndrome Less << Phase 1 Phase 2 Terminated(slow accrual) - United States, Texas ... More >> Texas Children's Hospital Houston, Texas, United States, 77030 Less <<
NCT00579137 - Terminated(slow accrual) - -
NCT02333838 Leukemia, Myeloid Phase 2 Active, not recruiting May 2019 France ... More >> Hôpital de Brabois, Hématologie Clinique et thérapie cellulaire Vandoeuvre les Nancy, France, 54511 Less <<
NCT00085449 Leukemia Lymp... More >>homa Multiple Myeloma and Plasma Cell Neoplasm Myelodysplastic Syndromes Myelodysplastic/Myeloproliferative Neoplasms Less << Phase 1 Phase 2 Completed - -
NCT03190733 Chronic Graft-versus-host-dise... More >>ase Leukemia Relapse Less << Phase 4 Not yet recruiting September 30, 2021 -
NCT00698009 Neuroblastoma Phase 2 Terminated(Slow accrual.) - United States, Texas ... More >> UT MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00698009 - Terminated(Slow accrual.) - -
NCT01390402 - Completed - -
NCT01390402 Leukemia Chro... More >>nic Myelogenous Leukemia Less << Phase 2 Completed - United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT03192397 Acute Myeloid Leukemia in Remi... More >>ssion Adult Acute Lymphoblastic Leukemia in Complete Remission Chronic Myelogenous Leukemia, BCR-ABL1 Positive in Remission Chronic Myelomonocytic Leukemia in Remission Graft Versus Host Disease Hodgkin Lymphoma Minimal Residual Disease Myelodysplastic Syndrome Myeloproliferative Neoplasm Non-Hodgkin Lymphoma Plasma Cell Myeloma Severe Aplastic Anemia Waldenstrom Macroglobulinemia Less << Phase 2 Recruiting July 1, 2022 United States, New York ... More >> Roswell Park Cancer Institute Recruiting Buffalo, New York, United States, 14263 Contact: Roswell Park    877-275-7724    ASKRPCI@roswellpark.org    Principal Investigator: Christine M. Ho Less <<
NCT03600909 Fanconi Anemia ... More >> Myelodysplastic Syndrome (MDS) Acute Myelogenous Leukemia (AML) Less << Phase 2 Recruiting May 2022 United States, New York ... More >> Memorial Sloan Kettering Cancer Center Recruiting New York, New York, United States, 10065 Contact: Farid Boulad, MD    212-639-6684       Contact: Maria Cancio, MD    212-639-2446       Principal Investigator: Faird Boulad, MD Less <<
NCT00613561 Severe Immunodeficiency Diseas... More >>es Less << Phase 2 Unknown December 2017 United States, Illinois ... More >> Children's Memorial Hospital Recruiting Chicago, Illinois, United States, 60614 Less <<
NCT01582048 Patients Receiving Mismatched ... More >>Allogeneic HCT Less << Phase 2 Terminated(slow enrollment) - Germany ... More >> Hematology/Oncology Medical Center University Hospital of Mainz Mainz, Germany, D-55101 Bone Marrow Transplantation Unit Medical Center University Hospital of Nuernberg Nuernberg, Germany, D-90419 Department of Hematology/Oncology Medical Center University Hospital of Tuebingen Tuebingen, Germany, D-72076 BMT-Unit Deutsche Klinik für Diagnostik Wiesbaden, Germany, D-65191 Less <<
NCT00006252 Leukemia Lymp... More >>homa Less << Phase 2 Completed - United States, California ... More >> Rebecca and John Moores UCSD Cancer Center La Jolla, California, United States, 92093-0658 Veterans Affairs Medical Center - San Diego San Diego, California, United States, 92161 UCSF Comprehensive Cancer Center San Francisco, California, United States, 94115 United States, Delaware Beebe Medical Center Lewes, Delaware, United States, 19958 CCOP - Christiana Care Health Services Newark, Delaware, United States, 19713 St. Francis Hospital Wilmington, Delaware, United States, 19805 United States, Iowa Holden Comprehensive Cancer Center at University of Iowa Iowa City, Iowa, United States, 52242 United States, Maryland Union Hospital Cancer Center at Union Hospital Elkton MD, Maryland, United States, 21921 United States, Massachusetts UMASS Memorial Cancer Center - University Campus Worcester, Massachusetts, United States, 01655 United States, New Jersey Cancer Institute of New Jersey at the Cooper University Hospital - Voorhees Voorhees, New Jersey, United States, 08043 United States, New York Roswell Park Cancer Institute Buffalo, New York, United States, 14263-0001 Elmhurst Hospital Center Elmhurst, New York, United States, 11373 Queens Cancer Center of Queens Hospital Jamaica, New York, United States, 11432 Mount Sinai Medical Center New York, New York, United States, 10029 United States, North Carolina Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill Chapel Hill, North Carolina, United States, 27599-7295 Wake Forest University Comprehensive Cancer Center Winston-Salem, North Carolina, United States, 27157-1096 United States, Ohio Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University Columbus, Ohio, United States, 43210-1240 United States, Pennsylvania Western Pennsylvania Cancer Institute at Western Pennsylvania Hospital Pittsburgh, Pennsylvania, United States, 15224-1791 United States, Virginia Massey Cancer Center at Virginia Commonwealth University Richmond, Virginia, United States, 23298-0037 Less <<
NCT01292135 B-cell Chronic Lymphocytic Leu... More >>kemia Small Lymphocytic Lymphoma Less << Phase 1 Completed - United States, Massachusetts ... More >> Dana Farber Cancer Center Boston, Massachusetts, United States, 02115 United States, New York CLL Research and Treatment Program New Hyde Park, New York, United States, 11042 Weill Medical College of Cornell University New York, New York, United States, 10065 University of Rochester Rochester, New York, United States, 14642 United States, Tennessee Sarah Cannon Research Institute Nashville, Tennessee, United States, 37203 United States, Texas MD Anderson Houston, Texas, United States, 77030 Less <<
NCT01292135 - Completed - -
NCT02161783 - Recruiting July 2021 United States, Minnesota ... More >> University of Minnesota Medical Center, Fairview Recruiting Minneapolis, Minnesota, United States, 55455 Contact: Timothy Krepski    612-273-2800    tkrepsk1@fairview.org    Principal Investigator: Troy C Lund, MD, PhD Less <<
NCT00078065 Multiple Myeloma Phase 2 Completed - United States, California ... More >> Oncotherapeutics Los Angeles, California, United States, 90067 University of California, San Diego San Diego, California, United States, 92093 University of California, San Francisco San Francisco, California, United States, 94143 United States, Maryland Johns Hopkins Medical Institute Baltimore, Maryland, United States, 21231 Center for Cancer & Blood Disorders Bethesda, Maryland, United States, 20817 United States, Missouri Washington University School of Medicine St. Louis, Missouri, United States, 63110 United States, New Jersey Hackensack University Medical Center Hackensack, New Jersey, United States, 07601 United States, Oregon Oregon Health Sciences University Portland, Oregon, United States, 97239 United States, South Carolina Cancer Centers of the Carolinas Greenville, South Carolina, United States, 29605 Less <<
NCT01434472 Post-Transplant Lymphoprolifer... More >>ative Disorder Recurrent Adult Diffuse Large Cell Lymphoma Recurrent B-Cell Non-Hodgkin Lymphoma Recurrent Burkitt Lymphoma Refractory B-Cell Non-Hodgkin Lymphoma Refractory Burkitt Lymphoma Refractory Diffuse Large B-Cell Lymphoma Less << Phase 2 Recruiting September 24, 2022 United States, Washington ... More >> Fred Hutch/University of Washington Cancer Consortium Recruiting Seattle, Washington, United States, 98109 Contact: Ajay K. Gopal    206-288-2037    agopal@u.washington.edu    Principal Investigator: Ajay K. Gopal Less <<
NCT00559221 Acute Myeloid Leukemia Phase 2 Unknown June 2008 Korea, Republic of ... More >> Asan Medical Center Recruiting Seoul, Korea, Republic of, 138-736 Contact: Yae-Eun , Jang    82-2-3010-7290    redpin75@paran.com    Principal Investigator: Hawk Kim, professor Less <<
NCT01110031 Leukaemia, Lymphocytic, Chroni... More >>c Less << Phase 1 Completed - United States, California ... More >> GSK Investigational Site La Jolla, California, United States, 92093 Australia, New South Wales GSK Investigational Site Randwick, New South Wales, Australia, 2031 New Zealand GSK Investigational Site Auckland, New Zealand, 1150 GSK Investigational Site Christchurch, New Zealand, 8011 Less <<
NCT00408447 Sickle Cell Disease ... More >> Beta Thalassemia Less << Phase 2 Recruiting December 2018 United States, New York ... More >> Morgan Stanley Children's Hospital, New York-Presbyterian, Columbia University Recruiting New York, New York, United States, 10032 Contact: Monica Bhatia, MD    212-305-9138    mb2476@columbia.edu    Principal Investigator: Monica Bhatia, MD Less <<
NCT02096614 Solid Tumors Phase 1 Recruiting - Japan ... More >> Mie University Hospital Recruiting Tsu, Mie, Japan Contact: Yasuyuki Ota, Ph.D.          Contact: Chisato Minamide, RN Less <<
NCT00104858 Chronic Lymphocytic Leukemia ... More >> Prolymphocytic Leukemia Recurrent Small Lymphocytic Lymphoma Refractory Chronic Lymphocytic Leukemia Stage III Chronic Lymphocytic Leukemia Stage III Small Lymphocytic Lymphoma Stage IV Chronic Lymphocytic Leukemia Stage IV Small Lymphocytic Lymphoma T-Cell Large Granular Lymphocyte Leukemia Less << Phase 2 Active, not recruiting - United States, Minnesota ... More >> Mayo Clinic Rochester, Minnesota, United States, 55905 United States, Washington VA Puget Sound Health Care System Seattle, Washington, United States, 98101 Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 Denmark Rigshospitalet University Hospital Copenhagen, Denmark, 2100 Italy University of Torino Torino, Italy, 10126 Less <<
NCT02366546 Solid Tumors Phase 1 Active, not recruiting - Japan ... More >> Mie University Hospital Tsu, Mie, Japan Less <<
NCT02145039 Acute Leukemias ... More >> Burkitt's Lymphoma Chronic Myelogenous Leukemia Less << Not Applicable Active, not recruiting June 2020 United States, Minnesota ... More >> University of Minnesota Masonic Cancer Center Minneapolis, Minnesota, United States, 55455 Less <<
NCT01471067 Blood And Marrow Transplantati... More >>on Leukemia Lymphoma Transplantation Infection Transplantation, Bone Marrow Less << Phase 1 Completed - United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00060424 B-Cell Prolymphocytic Leukemia... More >> Chronic Lymphocytic Leukemia Prolymphocytic Leukemia Recurrent Chronic Lymphocytic Leukemia Recurrent Small Lymphocytic Lymphoma Refractory Chronic Lymphocytic Leukemia T-Cell Prolymphocytic Leukemia Less << Phase 2 Completed - United States, Washington ... More >> Veterans Administration Center-Seattle Seattle, Washington, United States, 98108 Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 Italy University of Torino Torino, Italy, 10126 Less <<
NCT00902044 Sarcoma Phase 1 Recruiting July 2031 United States, Texas ... More >> Houston Methodist Hospital Recruiting Houston, Texas, United States, 77030 Contact: Nabil M Ahmed, MD    832-824-4611    nmahmed@txch.org    Contact: Catherine Robertson    832-824-4594    csrobert@txch.org    Texas Children's Hospital Recruiting Houston, Texas, United States, 77030 Contact: Nabil M Ahmed, MD    832-824-4611    nmamed@txch.org    Contact: Meenakshi Hegde, MD    832-824-4840    mghegde@txch.org Less <<
NCT00060424 - Completed - -
NCT00863330 Melanoma (Skin) Phase 2 Terminated(administrative deci... More >>sion- PI retired and treating physician left the institution) Less << - United States, Wisconsin ... More >> Aurora St. Luke's Medical Center Milwaukee, Wisconsin, United States, 53215 Less <<
NCT00796068 Acute Biphenotypic Leukemia ... More >> Adult Acute Lymphoblastic Leukemia in Remission Adult Acute Myeloid Leukemia in Remission Adult Myelodysplastic Syndrome Blasts Under 5 Percent of Bone Marrow Nucleated Cells Childhood Acute Lymphoblastic Leukemia in Remission Childhood Acute Myeloid Leukemia in Remission Childhood Chronic Myelogenous Leukemia, BCR-ABL1 Positive Childhood Myelodysplastic Syndrome Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive Myelodysplastic Syndrome With Excess Blasts-2 Less << Phase 2 Recruiting - United States, Colorado ... More >> University of Colorado Hospital Completed Aurora, Colorado, United States, 80045 United States, Oregon Oregon Health and Science University Completed Portland, Oregon, United States, 97239 United States, Washington Fred Hutch/University of Washington Cancer Consortium Recruiting Seattle, Washington, United States, 98109 Contact: Filippo Milano    206-667-5925    fmilano@fredhutch.org    Principal Investigator: Filippo Milano Less <<
NCT00863330 - Terminated(administrative deci... More >>sion- PI retired and treating physician left the institution) Less << - -
NCT00909948 Non Hodgkin's Lymphoma ... More >> Hodgkin Disease Multiple Myeloma Less << Phase 1 Terminated(Slow Accrual) - United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Less <<
NCT01168219 Acute Myeloid Leukemia ... More >> Adult Acute Megakaryoblastic Leukemia Adult Acute Monoblastic Leukemia Adult Acute Monocytic Leukemia Adult Acute Myeloid Leukemia in Remission Adult Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11 Adult Acute Myeloid Leukemia With Maturation Adult Acute Myeloid Leukemia With Minimal Differentiation Adult Acute Myeloid Leukemia With t(16;16)(p13.1;q22); CBFB-MYH11 Adult Acute Myeloid Leukemia With t(8;21); (q22; q22.1); RUNX1-RUNX1T1 Adult Acute Myeloid Leukemia With t(9;11)(p22.3;q23.3); MLLT3-KMT2A Adult Acute Myeloid Leukemia Without Maturation Adult Acute Myelomonocytic Leukemia Adult Erythroleukemia Adult Pure Erythroid Leukemia Alkylating Agent-Related Acute Myeloid Leukemia de Novo Myelodysplastic Syndrome Myelodysplastic Syndrome Myelodysplastic Syndrome With Excess Blasts Previously Treated Myelodysplastic Syndrome Recurrent Adult Acute Myeloid Leukemia Secondary Myelodysplastic Syndrome Untreated Adult Acute Myeloid Leukemia Less << Phase 2 Active, not recruiting November 15, 2018 United States, Delaware ... More >> Beebe Medical Center Lewes, Delaware, United States, 19958 Christiana Care Health System-Christiana Hospital Newark, Delaware, United States, 19718 United States, Florida Florida Hospital Orlando Orlando, Florida, United States, 32803 United States, Iowa University of Iowa/Holden Comprehensive Cancer Center Iowa City, Iowa, United States, 52242 United States, Maryland University of Maryland/Greenebaum Cancer Center Baltimore, Maryland, United States, 21201 Union Hospital of Cecil County Elkton, Maryland, United States, 21921 United States, Missouri Washington University School of Medicine Saint Louis, Missouri, United States, 63110 United States, New Hampshire Dartmouth Hitchcock Medical Center Lebanon, New Hampshire, United States, 03756 United States, New Jersey Cooper Hospital University Medical Center Camden, New Jersey, United States, 08103 United States, New York Northwell Health NCORP Lake Success, New York, United States, 11042 Mount Sinai Hospital New York, New York, United States, 10029 Weill Medical College of Cornell University New York, New York, United States, 10065 United States, North Carolina UNC Lineberger Comprehensive Cancer Center Chapel Hill, North Carolina, United States, 27599 Wake Forest University Health Sciences Winston-Salem, North Carolina, United States, 27157 United States, Ohio Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States, 43210 Less <<
NCT02118285 Ovarian Cancer ... More >> Fallopian Tube Carcinoma Primary Peritoneal Carcinoma Less << Phase 1 Completed - United States, Minnesota ... More >> University of Minnesota Masonic Cancer Center Minneapolis, Minnesota, United States, 55455 Less <<
NCT01274195 Hematopoietic Stem Cell Transp... More >>lantation Less << Phase 2 Unknown December 2013 Korea, Republic of ... More >> Seoul National University Hospital Recruiting Seoul, Daehangno, Jongno-gu, Korea, Republic of Contact: Hyoung Jin Kang, MD, PhD    82 2 2072 0177    kanghj@snu.ac.kr    Contact: Ji Won Lee, MD    82 2 2072 0177    agnesjw@hanmail.net    Principal Investigator: Hyo Seop Ahn, MD, PhD Less <<
NCT00255684 Chronic Myeloproliferative Dis... More >>orders Graft Versus Host Disease Leukemia Lymphoma Multiple Myeloma Myelodysplastic Syndromes Myelodysplastic/Myeloproliferative Neoplasms Less << Not Applicable Terminated(low accrual) - United States, New York ... More >> James P. Wilmot Cancer Center at University of Rochester Medical Center Rochester, New York, United States, 14642 Less <<
NCT02252107 Acute Myeloid Leukemia (AML) Phase 2 Active, not recruiting October 2019 Belgium ... More >> University of Liège Liège, Belgium Netherlands University Medical Center Groningen (UMCG) Groningen, Netherlands Radboud university medical center Nijmegen, Netherlands, 6500 HB Less <<
NCT01168219 - Active, not recruiting - -
NCT00156858 Hematologic Malignancy Not Applicable Unknown - Canada, Alberta ... More >> Tom Baker Cancer Centre Recruiting Calgary, Alberta, Canada, T2N 4N2 Contact: Rachel Syme, PhD       clinical_trials_tbcc@cancerboard.ab.ca    Sub-Investigator: Chris Brown          Sub-Investigator: Ron Anderson          Principal Investigator: James Russell          Sub-Investigator: Victor Lewis Less <<
NCT00255684 - Terminated(low accrual) - -
NCT00045513 Leukemia Lymp... More >>homa Less << Phase 1 Phase 2 Completed - Canada, Ontario ... More >> McMaster Children's Hospital at Hamilton Health Sciences Hamilton, Ontario, Canada, L8N 3Z5 London Health Sciences Centre London, Ontario, Canada, N6A 465 Princess Margaret Hospital at University Health Network Toronto, Ontario, Canada, M5G 2M9 Less <<
NCT00121186 Lymphoma Phase 2 Terminated(poor accrual) - United States, Illinois ... More >> Cardinal Bernardin Cancer Center at Loyola University Medical Center Maywood, Illinois, United States, 60153 United States, Indiana St. Francis Hospital and Health Centers - Beech Grove Campus Beech Grove, Indiana, United States, 46107 Reid Hospital & Health Care Services, Incorporated Richmond, Indiana, United States, 47374 United States, Kansas Cancer Center of Kansas, PA - Chanute Chanute, Kansas, United States, 66720 Cancer Center of Kansas, PA - Dodge City Dodge City, Kansas, United States, 67801 Cancer Center of Kansas, PA - El Dorado El Dorado, Kansas, United States, 67042 Cancer Center of Kansas, PA - Kingman Kingman, Kansas, United States, 67068 Southwest Medical Center Liberal, Kansas, United States, 67901 Cancer Center of Kansas, PA - Newton Newton, Kansas, United States, 67114 Cancer Center of Kansas, PA - Parsons Parsons, Kansas, United States, 67357 Cancer Center of Kansas, PA - Pratt Pratt, Kansas, United States, 67124 Cancer Center of Kansas, PA - Salina Salina, Kansas, United States, 67042 Cancer Center of Kansas, PA - Wellington Wellington, Kansas, United States, 67152 Associates in Womens Health, PA - North Review Wichita, Kansas, United States, 67203 Cancer Center of Kansas, PA - Medical Arts Tower Wichita, Kansas, United States, 67208 Cancer Center of Kansas, PA - Wichita Wichita, Kansas, United States, 67214 CCOP - Wichita Wichita, Kansas, United States, 67214 Via Christi Cancer Center at Via Christi Regional Medical Center Wichita, Kansas, United States, 67214 Cancer Center of Kansas, PA - Winfield Winfield, Kansas, United States, 67156 United States, New York Highland Hospital of Rochester Rochester, New York, United States, 14620 Interlakes Oncology/Hematology PC Rochester, New York, United States, 14623 James P. Wilmot Cancer Center at University of Rochester Medical Center Rochester, New York, United States, 14642 United States, Ohio Grandview Hospital Dayton, Ohio, United States, 45405 Good Samaritan Hospital Dayton, Ohio, United States, 45406 David L. Rike Cancer Center at Miami Valley Hospital Dayton, Ohio, United States, 45409 Veterans Affairs Medical Center - Dayton Dayton, Ohio, United States, 45428 CCOP - Dayton Dayton, Ohio, United States, 45429 Blanchard Valley Medical Associates Findlay, Ohio, United States, 45840 Charles F. Kettering Memorial Hospital Kettering, Ohio, United States, 45429 Middletown Regional Hospital Middletown, Ohio, United States, 45044 UVMC Cancer Care Center at Upper Valley Medical Center Troy, Ohio, United States, 45373-1300 United States Air Force Medical Center - Wright-Patterson Wright-Patterson Afb, Ohio, United States, 45433-5529 Ruth G. McMillan Cancer Center at Greene Memorial Hospital Xenia, Ohio, United States, 45385 Less <<
NCT03246178 Severe Aplastic Anemia Not Applicable Enrolling by invitation December 1, 2020 China ... More >> Department of Hematology, 304th Clinical Division, Chinese PLA General Hospital Beijing, China, 100048 Less <<
NCT00121186 - Terminated(poor accrual) - -
NCT01247688 Lymphoid Hematological Maligna... More >>ncies Umbilical Cord Blood Transplant Less << Not Applicable Withdrawn(This study was withd... More >>rawn due to low accrual.) Less << - -
NCT00416910 Chronic Lymphocytic Leukemia Phase 3 Terminated(low recruitment) - -
NCT01659606 Dyskeratosis Congenita ... More >> Hoyeraal Hreidarsson Syndrome Revesz Syndrome Aplastic Anemia Less << Phase 2 Recruiting December 2034 United States, California ... More >> Children's Hospital Los Angeles Recruiting Los Angeles, California, United States, 90027 Contact: Kimberly Arieli    323-361-5744    karieli@chla.usc.edu    Principal Investigator: Michael Pulsipher, MD          United States, Massachusetts Boston Children's Hospital (pediatric patients) Recruiting Boston, Massachusetts, United States, 02115 Contact: Suneet Agarwal, MD, PHD    617-919-7579    suneet.agarwal@childrens.harvard.edu    Contact: Leslie Lehmann, MD       leslie_lehmann@dfci.harvard.edu    Principal Investigator: Suneet Agarwal, MD, PHD          Sub-Investigator: Leslie Lehmann, MD          Dana-Farber Cancer Institute (adult patients) Recruiting Boston, Massachusetts, United States, 02115 Contact: Suneet Agarwal, MD, PHD       suneet.agarwal@childrens.harvard.edu    Contact: Joseph Antin, MD       Joseph_Antin@dfci.harvard.edu    Principal Investigator: Suneet Agarwal, MD, PHD          Sub-Investigator: Joseph Antin, MD          United States, New York Memorial Sloan Kettering Cancer Center Recruiting New York, New York, United States, 10065 Contact: Farid Boulad, MD    212-639-6684    bouladf@mskcc.org    Principal Investigator: Farid Boulad, MD          United States, Ohio Cincinnati Children's Hospital Medical Center Recruiting Cincinnati, Ohio, United States, 45229 Contact: Kasiani Myers, MD       Kasiani.Myers@cchmc.org    Principal Investigator: Kasiani Myers, MD          United States, Pennsylvania Children's Hospital of Philadelphia Recruiting Philadelphia, Pennsylvania, United States, 19104 Contact: Barb McGlynn    215-590-1303    MCGLYNN@email.chop.edu    Principal Investigator: Tim Olson, MD, PHD          United States, Texas Baylor College of Medicine Recruiting Houston, Texas, United States, 77030 Contact: Ghadir Sasa, MD    832-824-4524    gssasa@txch.org    Principal Investigator: Ghadir Sasa, MD          United States, Washington Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Recruiting Seattle, Washington, United States, 98109 Contact: Lauri Burroughs, MD    206-667-2396    lburroug@fhcrc.org    Principal Investigator: Lauri Burroughs, MD          United States, Wisconsin University of Wisconsin Hospital and Clinics, American Family Children's Hospital Recruiting Madison, Wisconsin, United States, 53792 Contact: Jenny Weiland    608-890-8070    jlweiland@pediatrics.wisc.edu    Contact: Peds Hem Onc Main Office    608-263-6200    PedsHemOncResearch@lists.wisc.edu    Principal Investigator: Inga Hoffman, MD          Sweden Karolinska University Hospital Recruiting Stockholm, Sweden Contact: Mikael Sundin, MD, PHD    +46 8 585 848 43    mikael.c.sundin@sll.se    Principal Investigator: Mikael Sundin, MD, PHD Less <<
NCT00427336 Aplastic Anemia Not Applicable Completed - United States, Texas ... More >> U.T.M.D. Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00427336 - Completed - -
NCT00937625 Melanoma Phase 1 Phase 2 Completed - Denmark ... More >> Department of Oncology, Copenhagen University Hospital, Herlev Herlev, Denmark, 2730 Less <<
NCT00134004 - Completed - -
NCT00134004 Chronic Myeloproliferative Dis... More >>orders Leukemia Lymphoma Multiple Myeloma and Plasma Cell Neoplasm Myelodysplastic Syndromes Less << Phase 2 Completed - United States, Georgia ... More >> Blood and Marrow Transplant Program at Northside Hospital Atlanta, Georgia, United States, 30342 United States, Maryland Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States, 21231-2410 United States, Pennsylvania Hahnemann University Hospital Philadelphia, Pennsylvania, United States, 19102-1192 Less <<
NCT01807182 Stage III Skin Melanoma ... More >> Stage IIIA Skin Melanoma Stage IIIB Skin Melanoma Stage IIIC Skin Melanoma Stage IV Skin Melanoma Less << Phase 2 Active, not recruiting June 30, 2019 United States, Washington ... More >> Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 Less <<
NCT00309842 Acute Myeloid Leukemia ... More >> Acute Lymphocytic Leukemia Chronic Myelogenous Leukemia Myelofibrosis MDS Refractory Anemia Chronic Lymphocytic Leukemia Prolymphocytic Leukemia Non-Hodgkin's Lymphoma Leukemia Lymphoma Multiple Myeloma Myelodysplastic Syndromes Less << Phase 2 Completed - United States, Minnesota ... More >> Masonic Cancer Center at University of Minnesota Minneapolis, Minnesota, United States, 55455 United States, Washington Fred Hutchinson Cancer Research Center Seattle, Washington, United States, 98109 Less <<
NCT03648697 Nasopharyngeal Carcinoma Phase 2 Not yet recruiting October 10, 2020 China, Fujian ... More >> Fujian Cancer Hospital Not yet recruiting Fuzhou, Fujian, China, 350014 Contact: Jianji Pan    0591-83660063    panjianji@126.com Less <<
NCT00937300 Squamous Cell Carcinoma ... More >> Head and Neck Cancer Less << Phase 1 Withdrawn(The patients eligibl... More >>e for this trial do not exist anymore due to change in procedures.) Less << - Denmark ... More >> Department of Oncology, Copenhagen University Hospital, Herlev Herlev, Denmark, 2730 Less <<
NCT02461316 - Completed - Serbia ... More >> Belgrade, Serbia, 11000 Kragujevac, Serbia, 34000 Novi Sad, Serbia, 21000 Less <<
NCT02412475 Leukemia, Acute Myeloid Phase 1 Active, not recruiting February 2019 United States, Minnesota ... More >> Children's Hospitals and Clinics of Minnesota Minneapolis, Minnesota, United States, 55404 United States, Wisconsin Children's Hospital of Wisconsin Milwaukee, Wisconsin, United States, 53226 Less <<
NCT00919503 Hematopoietic Cell Transplanta... More >>tion Recipient Non-Malignant Less << Phase 2 Recruiting - United States, Colorado ... More >> Children's Hospital Colorado Active, not recruiting Aurora, Colorado, United States, 80045 United States, Oregon Oregon Health and Science University Completed Portland, Oregon, United States, 97239 United States, Tennessee Vanderbilt University/Ingram Cancer Center Active, not recruiting Nashville, Tennessee, United States, 37232 United States, Washington Seattle Children's Hospital Recruiting Seattle, Washington, United States, 98105 Contact: Lauri M. Burroughs    206-667-2396    lburroug@fhcrc.org    Principal Investigator: Lauri M. Burroughs          Fred Hutch/University of Washington Cancer Consortium Recruiting Seattle, Washington, United States, 98109 Contact: Lauri M. Burroughs    206-667-2396    lburroug@fhcrc.org    Principal Investigator: Lauri M. Burroughs          United States, Wisconsin Children's Hospital of Wisconsin Suspended Milwaukee, Wisconsin, United States, 53226 Less <<
NCT01005576 - Completed - -
NCT03513328 Bone Marrow Failure Syndrome ... More >> Thalassemia Sickle Cell Disease Diamond Blackfan Anemia Acquired Neutropenia in Newborn Acquired Anemia Hemolytic Acquired Thrombocytopenia Hemophagocytic Lymphohistiocytoses Wiskott-Aldrich Syndrome Chronic Granulomatous Disease Common Variable Immunodeficiency X-linked Lymphoproliferative Disease Severe Combined Immunodeficiency Hurler Syndrome Mannosidosis Adrenoleukodystrophy Less << Phase 1 Phase 2 Recruiting June 2022 United States, Florida ... More >> UF Health Shands Children's Hospital Recruiting Gainesville, Florida, United States, 32608 Less <<
NCT00789776 - Active, not recruiting - -
NCT00506129 Lymphoma Bone... More >> Marrow Transplantation Less << Phase 2 Completed - United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT01005576 Severe Thalassemia Phase 2 Completed - United States, California ... More >> Regents of University of California- UCLA Los Angeles, California, United States, 90095 Children's Hospital and Research Center at Oakland Oakland, California, United States, 94609 United States, District of Columbia Children's National Medical Center Washington, District of Columbia, United States, 20010 United States, Florida University of Miami Miami, Florida, United States, 33136 All Children's Research Institute, Inc. Saint Petersburg, Florida, United States, 33701 United States, Georgia Emory University Atlanta, Georgia, United States, 30322 United States, Illinois Children's Memorial Hospital Chicago, Illinois, United States, 60614 United States, Massachusetts Dana Farber Cancer Institute Boston, Massachusetts, United States, 02115 United States, Michigan University of Michigan Ann Arbor, Michigan, United States, 48109 United States, Missouri Washington University Saint Louis, Missouri, United States, 63110 United States, North Carolina The University of North Carolina at Chapel Hill Chapel Hill, North Carolina, United States, 27599 Duke University Durham, North Carolina, United States, 27710 United States, Ohio The Research Institute at Nationwide Children's Hospital Columbus, Ohio, United States, 43205 United States, Oregon Oregon Health and Science University Portland, Oregon, United States, 97239 United States, Pennsylvania The Children's Hospital of Philadelphia Philadelphia, Pennsylvania, United States, 19104 United States, Tennessee Vanderbilt University Nashville, Tennessee, United States, 37232 United States, Texas UT Southwestern Medical Center Dallas, Texas, United States, 75390 Methodist Healthcare System of San Antonio San Antonio, Texas, United States, 78229 Less <<
NCT00963872 Leukemia Lymp... More >>homa Multiple Myeloma Myelodysplastic Syndromes Less << Phase 1 Phase 2 Terminated(Lack of efficacy af... More >>ter interim analysis) Less << - United States, Minnesota ... More >> University of Minnesota Medical Center - Fairview Minneapolis, Minnesota, United States, 55455 Less <<
NCT03337568 - Recruiting March 30, 2021 Korea, Republic of ... More >> Asan Medical Center Recruiting Seoul, Korea, Republic of Contact: Kyoo-Hyung Lee, MD    82-2-3010-3213    khlee2@amc.seoul.kr    Contact: Inpyo Choi, PhD    82-42-860-4223    ipchoi@kribb.re.kr Less <<
NCT00004862 Leukemia Phase 1 Completed - United States, Ohio ... More >> Arthur G. James Cancer Hospital - Ohio State University Columbus, Ohio, United States, 43210-1240 Less <<
NCT00510887 Lymphoma, Follicular Phase 2 Terminated(Low accrual.) - United States, North Carolina ... More >> Duke University Medical Center Durham, North Carolina, United States, 27710 Less <<
NCT02143830 Fanconi Anemia ... More >> Severe Marrow Failure Myelodysplastic Syndrome (MDS) Acute Myelogenous Leukemia (AML) Less << Phase 2 Recruiting May 2020 United States, New York ... More >> Memorial Sloan Kettering Cancer Center Recruiting New York, New York, United States, 10174 Contact: Jessica Chaisson    646-888-5718    chaissoj@mskcc.org    Principal Investigator: Farid Boulad, MD          United States, Ohio Cincinnati Children's Hospital Medical Center Recruiting Cincinnati, Ohio, United States, 45229 Principal Investigator: Parinda Mehta, MD          United States, Washington Fred Hutchinson Cancer Research Center Recruiting Seattle, Washington, United States, 98109 Contact: Sheri Ballard    206-667-4222    sballard@fredhutch.org    Principal Investigator: K. Scott Baker, MD Less <<
NCT00963872 - Terminated(Lack of efficacy af... More >>ter interim analysis) Less << - -
NCT00001586 - Completed - -
NCT03530085 Acute Myeloid Leukemia ... More >> Allogeneic Hematopoietic Stem Cell Transplantation Conditioning Elderly Less << Phase 2 Phase 3 Recruiting April 2022 China, Guangdong ... More >> Department of Hematology,Nanfang Hospital, Southern Medical University Recruiting Guangzhou, Guangdong, China, 510515 Contact: Li Xuan    +86-020-62787883    356135708@qq.com    Principal Investigator: Qifa Liu Less <<
NCT00510887 - Terminated(Low accrual.) - -
NCT00391066 Chronic Lymphocytic Leukemia Phase 2 Terminated - -
NCT00001586 Chronic Lymphocytic Leukemia Phase 2 Completed - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT00525876 Lymphoma Not Applicable Completed - United States, Texas ... More >> UT MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00373594 Cold Agglutinin Disease Phase 2 Completed - Norway ... More >> Haukeland University Hospital Bergen, Norway Haugesund Hospital Haugesund, Norway Ullevaal University Hospital Oslo, Norway, 0407 Rikshospitalet-Radiumhospitalet University Hospital Oslo, Norway Sykehuset i Vestfold Tonsberg, Norway Russian Federation BMT Clinic, St Petersburg Pavlov State Medical University St Petersburg, Russian Federation, 197089 Less <<
NCT01592981 Waldenstrom's Macroglobulinaem... More >>ia Less << Phase 2 Active, not recruiting July 2021 United Kingdom ... More >> Basingstoke & North Hampshire Hospital Basingstoke, United Kingdom Royal United Hospital Bath, United Kingdom Birmingham Heartlands Hospital Birmingham, United Kingdom, B9 5SS City Hospital Birmingham, United Kingdom Pilgrim Hospital Boston, United Kingdom Colchester General Hospital Colchester, United Kingdom Darent Valley Hospital Dartford, United Kingdom Derriford Hospital Derriford, United Kingdom Dewsbury and District Hospital Dewsbury, United Kingdom Royal Devon and Exeter Hospital Exeter, United Kingdom Grantham and District Hospital Grantham, United Kingdom St James University Hospital Leeds, United Kingdom, LS9 7TF Leicester Royal Infirmary Leicester, United Kingdom Lincoln County Hospital Lincoln, United Kingdom Royal Liverpool University Hospital Liverpool, United Kingdom St Bartolomew's Hospital London, United Kingdom, EC1A 7BE University College Hospital London, United Kingdom, NW1 2BU King's College Hospital London, United Kingdom Northwick Park Hospital London, United Kingdom Royal Free Hospital London, United Kingdom Maidstone Hospital Maidstone, United Kingdom Pontefract Hospital Pontefract, United Kingdom Queen's Hospital Romford, United Kingdom Salisbury District Hospital Salisbury, United Kingdom Musgrove Park Hospital Taunton, United Kingdom Torbay Hospital Torbay, United Kingdom Tunbridge Wells Hospital Tunbridge Wells, United Kingdom Pinderfields Hospital Wakefield, United Kingdom Sandwell Hospital West Bromwich, United Kingdom Royal Hampshire County Hospital Winchester, United Kingdom Less <<
NCT00402558 Myelodysplastic Syndrome ... More >> Leukemia Less << Phase 1 Completed - United States, Texas ... More >> UT MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00812669 Leukemia Phase 2 Active, not recruiting September 2022 Ireland ... More >> St. James's Hospital Dublin, Ireland, 8 University College Hospital Galway, Ireland Mid-Western Cancer Centre at Mid-Western Regional Hospital Limerick, Ireland, 0009 Midland Regional Hospital at Tullamore Tullamore, Ireland Waterford Regional Hospital Waterford, Ireland United Kingdom St. George's Hospital London, England, United Kingdom, SW17 ORE Less <<
NCT01203722 Hematologic Malignancies Phase 1 Phase 2 Recruiting December 2023 United States, Maryland ... More >> Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Recruiting Baltimore, Maryland, United States, 21231-2410 Contact: Clinical Trials Office - Sidney Kimmel Comprehensive Cancer Ce    410-955-8804    jhcccro@jhmi.edu Less <<
NCT00525876 - Completed - -
NCT00112593 Accelerated Phase Chronic Myel... More >>ogenous Leukemia Acute Undifferentiated Leukemia Adult Acute Lymphoblastic Leukemia in Remission Adult Acute Myeloid Leukemia in Remission Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities Adult Acute Myeloid Leukemia With Del(5q) Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) Adult Acute Myeloid Leukemia With t(15;17)(q22;q12) Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) Adult Acute Myeloid Leukemia With t(8;21)(q22;q22) Adult Grade III Lymphomatoid Granulomatosis Adult Nasal Type Extranodal NK/T-cell Lymphoma Aggressive NK-cell Leukemia AIDS-related Diffuse Large Cell Lymphoma AIDS-related Diffuse Mixed Cell Lymphoma AIDS-related Diffuse Small Cleaved Cell Lymphoma AIDS-related Immunoblastic Large Cell Lymphoma AIDS-related Lymphoblastic Lymphoma AIDS-related Peripheral/Systemic Lymphoma AIDS-related Primary CNS Lymphoma AIDS-related Small Noncleaved Cell Lymphoma Anaplastic Large Cell Lymphoma Angioimmunoblastic T-cell Lymphoma Blastic Phase Chronic Myelogenous Leukemia Childhood Acute Lymphoblastic Leukemia in Remission Childhood Acute Myeloid Leukemia in Remission Childhood Burkitt Lymphoma Childhood Chronic Myelogenous Leukemia Childhood Diffuse Large Cell Lymphoma Childhood Grade III Lymphomatoid Granulomatosis Childhood Immunoblastic Large Cell Lymphoma Childhood Myelodysplastic Syndromes Childhood Nasal Type Extranodal NK/T-cell Lymphoma Chronic Eosinophilic Leukemia Chronic Myelomonocytic Leukemia Chronic Neutrophilic Leukemia Chronic Phase Chronic Myelogenous Leukemia Contiguous Stage II Adult Burkitt Lymphoma Contiguous Stage II Adult Diffuse Large Cell Lymphoma Contiguous Stage II Adult Diffuse Mixed Cell Lymphoma Contiguous Stage II Adult Diffuse Small Cleaved Cell Lymphoma Contiguous Stage II Adult Immunoblastic Large Cell Lymphoma Contiguous Stage II Adult Lymphoblastic Lymphoma Contiguous Stage II Grade 1 Follicular Lymphoma Contiguous Stage II Grade 2 Follicular Lymphoma Contiguous Stage II Grade 3 Follicular Lymphoma Contiguous Stage II Mantle Cell Lymphoma Contiguous Stage II Marginal Zone Lymphoma Contiguous Stage II Small Lymphocytic Lymphoma Cutaneous B-cell Non-Hodgkin Lymphoma Essential Thrombocythemia Extramedullary Plasmacytoma Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue Hepatosplenic T-cell Lymphoma HIV Infection HIV-associated Hodgkin Lymphoma Intraocular Lymphoma Isolated Plasmacytoma of Bone Juvenile Myelomonocytic Leukemia Mast Cell Leukemia Meningeal Chronic Myelogenous Leukemia Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable Myeloid/NK-cell Acute Leukemia Nodal Marginal Zone B-cell Lymphoma Noncontiguous Stage II Adult Burkitt Lymphoma Noncontiguous Stage II Adult Diffuse Large Cell Lymphoma Noncontiguous Stage II Adult Diffuse Mixed Cell Lymphoma Noncontiguous Stage II Adult Diffuse Small Cleaved Cell Lymphoma Noncontiguous Stage II Adult Immunoblastic Large Cell Lymphoma Noncontiguous Stage II Adult Lymphoblastic Lymphoma Noncontiguous Stage II Grade 1 Follicular Lymphoma Noncontiguous Stage II Grade 2 Follicular Lymphoma Noncontiguous Stage II Grade 3 Follicular Lymphoma Noncontiguous Stage II Mantle Cell Lymphoma Noncontiguous Stage II Marginal Zone Lymphoma Noncontiguous Stage II Small Lymphocytic Lymphoma Noncutaneous Extranodal Lymphoma Peripheral T-cell Lymphoma Polycythemia Vera Post-transplant Lymphoproliferative Disorder Previously Treated Myelodysplastic Syndromes Primary Central Nervous System Lymphoma Primary Myelofibrosis Primary Systemic Amyloidosis Progressive Hairy Cell Leukemia, Initial Treatment Prolymphocytic Leukemia Secondary Acute Myeloid Leukemia Secondary Myelodysplastic Syndromes Small Intestine Lymphoma Splenic Marginal Zone Lymphoma Stage 0 Chronic Lymphocytic Leukemia Stage I Adult Burkitt Lymphoma Stage I Adult Diffuse Large Cell Lymphoma Stage I Adult Diffuse Mixed Cell Lymphoma Stage I Adult Diffuse Small Cleaved Cell Lymphoma Stage I Adult Hodgkin Lymphoma Stage I Adult Immunoblastic Large Cell Lymphoma Stage I Adult Lymphoblastic Lymphoma Stage I Adult T-cell Leukemia/Lymphoma Stage I Childhood Anaplastic Large Cell Lymphoma Stage I Childhood Hodgkin Lymphoma Stage I Childhood Large Cell Lymphoma Stage I Childhood Lymphoblastic Lymphoma Stage I Childhood Small Noncleaved Cell Lymphoma Stage I Chronic Lymphocytic Leukemia Stage I Cutaneous T-cell Non-Hodgkin Lymphoma Stage I Grade 1 Follicular Lymphoma Stage I Grade 2 Follicular Lymphoma Stage I Grade 3 Follicular Lymphoma Stage I Mantle Cell Lymphoma Stage I Marginal Zone Lymphoma Stage I Multiple Myeloma Stage I Small Lymphocytic Lymphoma Stage IA Mycosis Fungoides/Sezary Syndrome Stage IB Mycosis Fungoides/Sezary Syndrome Stage II Adult Hodgkin Lymphoma Stage II Adult T-cell Leukemia/Lymphoma Stage II Childhood Anaplastic Large Cell Lymphoma Stage II Childhood Hodgkin Lymphoma Stage II Childhood Large Cell Lymphoma Stage II Childhood Lymphoblastic Lymphoma Stage II Childhood Small Noncleaved Cell Lymphoma Stage II Chronic Lymphocytic Leukemia Stage II Cutaneous T-cell Non-Hodgkin Lymphoma Stage II Multiple Myeloma Stage IIA Mycosis Fungoides/Sezary Syndrome Stage IIB Mycosis Fungoides/Sezary Syndrome Stage III Adult Burkitt Lymphoma Stage III Adult Diffuse Large Cell Lymphoma Stage III Adult Diffuse Mixed Cell Lymphoma Stage III Adult Diffuse Small Cleaved Cell Lymphoma Stage III Adult Hodgkin Lymphoma Stage III Adult Immunoblastic Large Cell Lymphoma Stage III Adult Lymphoblastic Lymphoma Stage III Adult T-cell Leukemia/Lymphoma Stage III Childhood Anaplastic Large Cell Lymphoma Stage III Childhood Hodgkin Lymphoma Stage III Childhood Large Cell Lymphoma Stage III Childhood Lymphoblastic Lymphoma Stage III Childhood Small Noncleaved Cell Lymphoma Stage III Chronic Lymphocytic Leukemia Stage III Cutaneous T-cell Non-Hodgkin Lymphoma Stage III Grade 1 Follicular Lymphoma Stage III Grade 2 Follicular Lymphoma Stage III Grade 3 Follicular Lymphoma Stage III Mantle Cell Lymphoma Stage III Marginal Zone Lymphoma Stage III Multiple Myeloma Stage III Small Lymphocytic Lymphoma Stage IIIA Mycosis Fungoides/Sezary Syndrome Stage IIIB Mycosis Fungoides/Sezary Syndrome Stage IV Adult Burkitt Lymphoma Stage IV Adult Diffuse Large Cell Lymphoma Stage IV Adult Diffuse Mixed Cell Lymphoma Stage IV Adult Diffuse Small Cleaved Cell Lymphoma Stage IV Adult Hodgkin Lymphoma Stage IV Adult Immunoblastic Large Cell Lymphoma Stage IV Adult Lymphoblastic Lymphoma Stage IV Adult T-cell Leukemia/Lymphoma Stage IV Childhood Anaplastic Large Cell Lymphoma Stage IV Childhood Hodgkin Lymphoma Stage IV Childhood Large Cell Lymphoma Stage IV Childhood Lymphoblastic Lymphoma Stage IV Childhood Small Noncleaved Cell Lymphoma Stage IV Chronic Lymphocytic Leukemia Stage IV Cutaneous T-cell Non-Hodgkin Lymphoma Stage IV Grade 1 Follicular Lymphoma Stage IV Grade 2 Follicular Lymphoma Stage IV Grade 3 Follicular Lymphoma Stage IV Mantle Cell Lymphoma Stage IV Marginal Zone Lymphoma Stage IV Small Lymphocytic Lymphoma Stage IVA Mycosis Fungoides/Sezary Syndrome Stage IVB Mycosis Fungoides/Sezary Syndrome T-cell Large Granular Lymphocyte Leukemia Testicular Lymphoma Unspecified Adult Solid Tumor, Protocol Specific Unspecified Childhood Solid Tumor, Protocol Specific Waldenstr?m Macroglobulinemia Less << Not Applicable Completed - United States, Washington ... More >> Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 Less <<
NCT01186640 T-cell-prolymphocytic Leukemia Phase 2 Completed - Germany ... More >> University Hospital Cologne Cologne, Germany, 50924 Less <<
NCT00521859 Hematologic Malignancies Phase 1 Completed - United States, Texas ... More >> UT MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00150878 Acute Myeloid Leukemia Phase 3 Terminated(Insurance coverage ... More >>reached) Less << - Germany ... More >> Medizinische Klinik und Poliklinik I Dresden, Germany, 01307 Less <<
NCT00597519 Cancer Leukem... More >>ia Myelodysplastic Syndrome Non-Hodgkin's Lymphoma Less << Phase 2 Completed - United States, New York ... More >> Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 Less <<
NCT00309881 Chronic Lymphocytic Leukemia Phase 2 Completed - Germany ... More >> Kreiskrankenhaus Bad Hersfeld, Germany, 36251 DIAKO Ev. Diakonie Krankenhaus gGmbH Bremen, Germany, 28239 Medizinische Universitaetsklinik I at the University of Cologne Cologne, Germany, D-50924 Universitaetsklinikum Essen Essen, Germany, D-45122 Gemeinschaftspraxis Fuer Innere Medizin, Hematologie Und Onkologie Giessen, Germany, 35392 St. Marien Hospital - Katholisches Krankenhaus Hagen gGmbH Hagen, Germany, 58095 Allgemeines Krankenhaus Hagen Hagen, Germany, D-58095 Praxis fur Innere Medizin - Hamburg Hamburg, Germany, 22457 Asklepios Klinik St. Georg Hamburg, Germany, D-20099 Marienhospital at Ruhr University Bochum Herne, Germany, D-44625 Clinic for Bone Marrow Transplantation and Hematology and Oncology Idar-Oberstein, Germany, D-55743 Internistische Gemeinschaftspraxis - Kassel Kassel, Germany, 34117 Internistische Onkologische Praxis - Kronach Kronach, Germany, 96317 Klinikum der Universitaet Muenchen - Grosshadern Campus Munich, Germany, D-81377 Klinikum Oldenburg Oldenburg, Germany, D-26133 Marienhospital Stuttgart Stuttgart, Germany, 70199 Haematologische Praxis Weiden, Germany, D-92637 Medizinische Poliklinik, Universitaet Wuerzburg Wuerzburg, Germany, D-97070 Less <<
NCT02776202 Sickle Cell Disease Phase 2 Recruiting December 2019 Saudi Arabia ... More >> King Abdul Aziz Medical City for National Guard Recruiting Riyadh, Saudi Arabia Contact: Nagham RZ Sheblaq    009668011111 ext 53352    sheblaqn@ngha.med.sa    Contact    009668011111 ext 53352    sheblaqn@ngha.med.sa    Principal Investigator: Nagham RZ Sheblaq, BS.c Less <<
NCT00112593 - Completed - -
NCT03056339 B-Lymphoid Malignancies ... More >> Acute Lymphocytic Leukemia Chronic Lymphocytic Leukemia Non-hodgkin Lymphoma Less << Phase 1 Phase 2 Recruiting June 2022 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact: Clinical Research Operations       krezvani@mdanderson.org Less <<
NCT02932956 Solid Tumors Phase 1 Not yet recruiting February 2037 United States, Texas ... More >> Texas Children's Hospital Not yet recruiting Houston, Texas, United States, 77030 Contact: Andras A Heczey, M.D.       axheczey@txch.org Less <<
NCT00597519 - Completed - -
NCT00587054 - Completed - -
NCT00787761 - Completed - -
NCT00787761 Myeloproliferative Disorders ... More >> Kidney Cancer Leukemia Lymphoma Multiple Myeloma and Plasma Cell Neoplasm Myelodysplastic Syndromes Myelodysplastic/Myeloproliferative Diseases Less << Phase 2 Completed - United States, Georgia ... More >> Blood and Marrow Transplant Group of Georgia Atlanta, Georgia, United States, 30342 Less <<
NCT00289549 Leukemia, Lymphocytic, Chronic Phase 2 Completed - United States, Texas ... More >> MD Anderson Cancer Center, University of Texas Houston, Texas, United States, 77030 Less <<
NCT01664910 Lymphoma Leuk... More >>emia Less << Phase 1 Phase 2 Recruiting October 2019 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Less <<
NCT00091143 Melanoma (Skin) Phase 1 Completed - United States, Oregon ... More >> Providence Cancer Center at Providence Portland Medical Center Portland, Oregon, United States, 97213-2967 Less <<
NCT03434769 Non-Hodgkin Lymphoma Phase 1 Recruiting July 2021 United States, Ohio ... More >> University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center Recruiting Cleveland, Ohio, United States, 44106-5065 Contact: Paolo F. Caimi, MD    800-241-6422    paolo.caimi@case.edu    Principal Investigator: Paolo F. Caimi, MD Less <<
NCT00802113 Non-Hodgkin's Lymphoma ... More >> Hodgkins Disease Less << Phase 1 Phase 2 Completed - United States, New York ... More >> Columbia University Medical Center New York, New York, United States, 10032 Less <<
NCT02275663 Acute Myeloid Leukemia Phase 2 Unknown October 2018 Saudi Arabia ... More >> King Fahad Medical City Recruiting Riyadh, Saudi Arabia, 11525 Contact: Ibraheem Motabi, MD    +966112889999 ext 11998    imotabi@kfmc.med.sa Less <<
NCT00587054 Allogeneic Stem Cell Transplan... More >>t Leukemia Non-Hodgkins Lymphoblastic Lymphoma Myelodysplastic Syndrome Paroxysmal Nocturnal Hemoglobinuria (PNH) Less << Phase 2 Completed - United States, New York ... More >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10065 Less <<
NCT00167180 Leukemia, Myeloid, Chronic ... More >> Lymphomas Multiple Myeloma Myelodysplastic Syndrome Leukemia, Lymphocytic, Acute Leukemia, Lymphocytic, Chronic AML Less << Phase 2 Completed - United States, Minnesota ... More >> Masonic Cancer Center, University of Minnesota Minneapolis, Minnesota, United States, 55455 Less <<
NCT00859001 Follicular Lymphoma Phase 2 Completed - Italy ... More >> Istituto di Ematologia e Oncologia Medica Seràgnoli Bologna, BO, Italy, 40138 Less <<
NCT00167180 - Completed - -
NCT03294954 Neuroblastoma Phase 1 Recruiting August 10, 2034 United States, Texas ... More >> Texas Children's Hospital Recruiting Houston, Texas, United States, 77030 Contact: Andras Heczey, MD    832-824-4233    axheczey@txch.org Less <<
NCT01370772 B-cell Chronic Lymphocytic Leu... More >>kemia CLL Less << Phase 2 Completed - France ... More >> Stephane LEPRETRE Rouen, CLCC Henri Becquerel, France, 76038 Guillaume CARTRON Montpellier, Regional university Hospital, France, 34295 Less <<
NCT00008151 Leukemia Myel... More >>odysplastic Syndromes Less << Phase 2 Completed - United States, Washington ... More >> Fred Hutchinson Cancer Research Center Seattle, Washington, United States, 98109-1024 Less <<
NCT00731328 Leukemia Myel... More >>odysplastic Syndromes Nonmalignant Neoplasm Paroxysmal Nocturnal Hemoglobinuria Less << Phase 2 Completed - Korea, Republic of ... More >> Asan Medical Center - University of Ulsan College of Medicine Seoul, Korea, Republic of, 138-736 Less <<
NCT00082940 Leukemia Phase 2 Completed - United States, California ... More >> St. Joseph Hospital Regional Cancer Center - Orange Orange, California, United States, 92868-3849 United States, Illinois Robert H. Lurie Comprehensive Cancer Center at Northwestern University Chicago, Illinois, United States, 60611 United States, Indiana Medical Center Vincennes Vincennes, Indiana, United States, 47591 United States, Louisiana Cancer Care Specialists Houma, Louisiana, United States, 70360 Feist-Weiller Cancer Center at Louisiana State University Health Sciences Shreveport, Louisiana, United States, 71130-3932 United States, Michigan Josephine Ford Cancer Center at Henry Ford Health System Detroit, Michigan, United States, 48202 United States, North Carolina Southeastern Medical Oncology Center Goldsboro, North Carolina, United States, 27534 Comprehensive Cancer Center at Wake Forest University Winston-Salem, North Carolina, United States, 27157-1082 United States, South Carolina Gibbs Regional Cancer Center at Spartanburg Regional Medical Center Spartanburg, South Carolina, United States, 29303 United States, Tennessee Chattanooga Oncology and Hematology Associates Chattanooga, Tennessee, United States, 37404 United States, Texas Southwest Regional Cancer Center - Central Austin, Texas, United States, 78705 Less <<
NCT01894477 Acute Myeloid Leukemia in Remi... More >>ssion Chronic Myelomonocytic Leukemia Minimal Residual Disease Myelodysplastic Syndrome Myelodysplastic/Myeloproliferative Neoplasm Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable Less << Phase 2 Active, not recruiting January 2022 United States, Washington ... More >> Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 Less <<
NCT00607854 Diffuse Large B-Cell Lymphoma ... More >> Mantle Cell Lymphoma Less << Phase 2 Completed - France ... More >> Service d'hématologie - CHU de Besançon Besançon, France, 25030 Service des maladies du sang - Hôpital Haut-Lévêque - avenue de magellan Bordeaux - Pessac, France, 33600 Service d'hématologie - CHU Hôtel Dieu Clermont-Ferrand Clermont-Ferrand, France, 63000 Service de médecine nucléaire - Centre de Lutte contre le Cancer de la Région Auvergne Jean Perrin Clermont-Ferrand, France, 63011 Hôpital Edouard Herriot Lyon, France, 69437 Service d'Oncologie Hématologie, Institut Paoli Calmettes - 232 Bd Ste Marguerite Marseille, France, 13009 Hématologie et Oncologie médicale - CHU Lapeyronie Montpellier, France, 34295 Service d'Hématologie, Hôpital Hôtel Dieu, CHU Nantes - 1 Place Alexis Ricordeau Nantes, France, 44093 Service d'hématologie clinique - Hôpital l'Archet 1 Nice, France, 06202 Service d'Hématologie Adultes - Hôpital Necker-Enfants Malade Paris, France, 75015 Pôle hématologie et immunologie clinique - Hôpital Saint-Louis Paris, France, 75475 Département d'hématologie et d'Oncologie - CHRU Hautepierre Strasbourg, France, 67098 Less <<
NCT01894477 - Active, not recruiting - -
NCT02498912 Solid Tumors Phase 1 Recruiting August 2019 United States, New York ... More >> Memorial Sloan Kettering Cancer Center Recruiting New York, New York, United States, 10065 Contact: Roisin O'Cearbhaill, MD    646-888-4227       Contact: Jae Park, MD    212-639-4048       Principal Investigator: Roisin O'Cearbhaill, MD Less <<
NCT00005851 Recurrent Renal Cell Cancer ... More >> Stage IV Renal Cell Cancer Less << Phase 1 Phase 2 Active, not recruiting - United States, Arizona ... More >> University of Arizona Health Sciences Center Tucson, Arizona, United States, 85724 United States, Colorado Rocky Mountain Cancer Centers-Aurora Aurora, Colorado, United States, 80012 United States, Texas Baylor University Medical Center Dallas, Texas, United States, 75246 United States, Washington VA Puget Sound Health Care System Seattle, Washington, United States, 98101 Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 United States, Wisconsin Froedtert and the Medical College of Wisconsin Milwaukee, Wisconsin, United States, 53226 Less <<
NCT01410344 Leukemia Lymp... More >>homa HIV Less << Phase 2 Active, not recruiting December 2018 United States, Arizona ... More >> Mayo Clinic - Phoenix Phoenix, Arizona, United States, 85054 United States, California City of Hope National Medical Center Duarte, California, United States, 91010 University of CA, SF San Francisco, California, United States, 94143-0324 United States, Florida H. Lee Moffitt Cancer Center Tampa, Florida, United States, 33624 United States, Georgia Blood & Marrow Transplant Program at Northside Hospital Atlanta, Georgia, United States, 30342 United States, Maryland Johns Hopkins Baltimore, Maryland, United States, 21231 United States, Minnesota Mayo Clinic - Rochester Rochester, Minnesota, United States, 55905 United States, Pennsylvania University of Pennsylvania Cancer Center Philadelphia, Pennsylvania, United States, 19104 United States, Texas University of Texas/MD Anderson CRC Houston, Texas, United States, 77030 Texas Transplant Institute San Antonio, Texas, United States, 78229 United States, Wisconsin Medical College of Wisconsin Milwaukee, Wisconsin, United States, 53211 Less <<
NCT00005898 Fanconi's Anemia Phase 1 Phase 2 Completed - United States, Minnesota ... More >> University of Minnesota Cancer Center Minneapolis, Minnesota, United States, 55455 Less <<
NCT00328861 - Completed - -
NCT00328861 Metastatic Melanoma ... More >> Metastatic Kidney Cancer Less << Phase 2 Completed - United States, Maryland ... More >> National Cancer Institute (NCI) Bethesda, Maryland, United States, 20892 Less <<
NCT03448978 Multiple Myeloma Phase 1 Recruiting March 1, 2020 United States, District of Col... More >>umbia Georgetown University Lombardi Comprehensive Cancer Center Recruiting Washington, District of Columbia, United States, 20007 United States, Maryland The Center for Cancer and Blood Disorders Recruiting Bethesda, Maryland, United States, 20817 United States, Virginia Virgina Cancer Specialists Recruiting Fairfax, Virginia, United States, 22031 Less <<
NCT01410344 - Active, not recruiting - -
NCT00025038 Juvenile Myelomonocytic Leukem... More >>ia Less << Phase 2 Completed - United States, California ... More >> Children's Oncology Group Arcadia, California, United States, 91006-3776 Less <<
NCT01666080 Hematologic Disorders ... More >> Hemoglobinopathies Immunodeficiencies Less << Not Applicable Recruiting June 2019 United States, Minnesota ... More >> Masonic Cancer Center, University of Minnesota Recruiting Minneapolis, Minnesota, United States, 55455 Contact: Weston P. Miller, M.D.    612-626-2778    mill4991@umn.eud    Principal Investigator: Weston P. Miller, M.D. Less <<
NCT00578643 - Completed - -
NCT00618540 - Terminated(Slow accrual) - -
NCT00618540 Histiocytosis, Langerhans-cell Phase 2 Terminated(Slow accrual) - United States, Minnesota ... More >> Masonic Cancer Center at University of Minnesota Minneapolis, Minnesota, United States, 55455 Less <<
NCT00959231 Hematopoietic/Lymphoid Cancer Phase 2 Unknown - United Kingdom ... More >> Bristol Royal Hospital for Children Recruiting Bristol, England, United Kingdom, BS2 8BJ Contact: Contact Person    44-117-342-8044       Cancer Research UK Clinical Centre at St. James's University Hospital Recruiting Leeds, England, United Kingdom, LS16 6QB Contact: Contact Person    44-113-206-6020       University College of London Hospitals Recruiting London, England, United Kingdom, NW1 2PQ Contact: Rachael Hough, MD    44-845-155-5000 ext. 5239       UCL Cancer Institute Recruiting London, England, United Kingdom, WC1E 6DD Contact: Contact Person    44-207-830-2301       Great Ormond Street Hospital for Children Recruiting London, England, United Kingdom, WC1N 3JH Contact: Contact Person    44-207-813-8335       University of Newcastle-Upon-Tyne Northern Institute for Cancer Research Recruiting Newcastle-Upon-Tyne, England, United Kingdom, NE2 4HH Contact: Contact Person    44-191-222-7785 Less <<
NCT00578643 Chronic Granulomatous Disease Phase 2 Completed - United States, Texas ... More >> Texas Children's Hospital Houston, Texas, United States, 77030 Less <<
NCT00615589 - Terminated(Low accrual) - -
NCT02581007 Chronic Myelogenous Leukemia ... More >> Acute Myelogenous Leukemia Myelodysplastic Syndrome Acute Lymphocytic Leukemia Chronic Lymphocytic Leukemia Hodgkin's Lymphoma Non-Hodgkin's Lymphoma Myelofibrosis CMML Multiple Myeloma Less << Phase 2 Active, not recruiting October 2019 United States, Georgia ... More >> Northside Hospital Atlanta, Georgia, United States, 30342 Less <<
NCT02065362 EBV-positive Nasopharyngeal Ca... More >>rcinoma Less << Phase 1 Active, not recruiting February 2033 United States, Texas ... More >> Houston Methodist Hospital Houston, Texas, United States, 77030 Texas Children's Hospital Houston, Texas, United States, 77030 Less <<
NCT00615589 Multiple Myeloma ... More >> Plasma Cell Leukemia Less << Phase 2 Terminated(Low accrual) - United States, Michigan ... More >> University of Michigan,Department of Internal Med. Hematology- Oncology Ann Arbor, Michigan, United States, 48109 Less <<
NCT02784561 Leukemia Phase 4 Not yet recruiting July 2020 -
NCT00627666 Leukemia Myel... More >>odysplastic Syndromes Myelodysplastic/Myeloproliferative Neoplasms Less << Phase 2 Completed - Korea, Republic of ... More >> Asan Medical Center - University of Ulsan College of Medicine Seoul, Korea, Republic of, 138-736 Less <<
NCT02171104 Mucopolysaccharidosis Disorder... More >>s Hurler Syndrome Hunter Syndrome Maroteaux Lamy Syndrome Sly Syndrome Alpha-Mannosidosis Fucosidosis Aspartylglucosaminuria Glycoprotein Metabolic Disorders Sphingolipidoses Recessive Leukodystrophies Globoid Cell Leukodystrophy Metachromatic Leukodystrophy Niemann-Pick B Niemann-Pick C Subtype 2 Sphingomyelin Deficiency Peroxisomal Disorders Adrenoleukodystrophy With Cerebral Involvement Zellweger Syndrome Neonatal Adrenoleukodystrophy Infantile Refsum Disease Acyl-CoA Oxidase Deficiency D-Bifunctional Enzyme Deficiency Multifunctional Enzyme Deficiency Alpha-methylacyl-CoA Racmase Deficiency Mitochondrial Neurogastrointestingal Encephalopathy Severe Osteopetrosis Hereditary Leukoencephalopathy With Axonal Spheroids (HDLS; CSF1R Mutation) Inherited Metabolic Disorders Less << Phase 2 Recruiting September 2019 United States, Minnesota ... More >> Masonic Cancer Center, University of Minnesota Recruiting Minneapolis, Minnesota, United States, 55455 Contact: Kim Nelson    612-273-2925    knelso62@fairview.org Less <<
NCT00623935 - Completed - -
NCT01051115 Chronic Lymphocytic Leukemia Phase 2 Unknown January 2016 Netherlands ... More >> Maastricht university medical center Not yet recruiting Maastricht, Limburg, Netherlands, 6229 HX Contact: Michel van Gelder, MD, PhD    +31-43 - 387 6543    m.van.gelder@mumc.nl    Academic Medical Center Recruiting Amsterdam, NH, Netherlands, 1105 AZ Contact: Marjolein Spiering, Ms    +31-20-5669111    m.spiering@amc.nl    Contact: Arnon P Kater, MD, PhD    +31-20-5669111    a.p.kater@amc.nl    Erasmus MC-Daniel den Hoed Cancer Center Recruiting Rotterdam, ZH, Netherlands, 3015 CE Contact: Jeanette K Doorduijn, MD, PhD    +31-10 7040704    j.doorduijn@erasmusmc.nl    University Medical Center Groningen Recruiting Groningen, Netherlands, 9713 GZ Contact: Simon MG Daenen, MD, PhD    +31-50 3616161    s.m.g.j.daenen@int.umcg.nl Less <<
NCT00623935 Acute Myelogenous Leukemia Phase 2 Completed - United States, Michigan ... More >> University of Michigan Cancer Center Ann Arbor, Michigan, United States, 48109 Less <<
NCT03173417 Leukemia Phase 1 Phase 2 Recruiting December 1, 2020 China ... More >> Hebei Yanda Ludaopei Hospital Recruiting Beijing, China Contact: Xinan lu, Dr       luxinan@immunochina.com    Contact    86-189-1157-6946 Less <<
NCT01955460 Melanoma Phase 1 Recruiting October 2019 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Less <<
NCT03287674 Metastatic Ovarian Cancer Phase 1 Phase 2 Active, not recruiting October 2020 Denmark ... More >> Center for Cancer Immune Therapy Dept. of Hematology/oncology Copenhagen, Denmark, 2730 Less <<
NCT03579888 Acute Lymphoblastic Leukemia ... More >> Blasts More Than 5 Percent of Bone Marrow Nucleated Cells Blasts More Than 5 Percent of Peripheral Blood White Cells CD19 Positive Chronic Lymphocytic Leukemia Minimal Residual Disease Non-Hodgkin Lymphoma Small Lymphocytic Lymphoma Less << Phase 1 Not yet recruiting December 2021 United States, Texas ... More >> M D Anderson Cancer Center Not yet recruiting Houston, Texas, United States, 77030 Contact       pkebriae@mdanderson.org Less <<
NCT01653717 Advanced Cancers ... More >> Leukemia Less << Phase 1 Completed - United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT02287311 Hodgkin Disease ... More >> Non-Hodgkin Lymphoma Severe Chronic Active Epstein Barr Virus T/NK-lymphoproliferative Disease Less << Phase 1 Recruiting March 2023 United States, Texas ... More >> Houston Methodist Hospital Recruiting Houston, Texas, United States, 77030 Contact: Helen E Heslop    832-824-4662    hheslop@bcm.edu    Texas Children's Hospital Recruiting Houston, Texas, United States, 77030 Contact: Rayne H Rouce, MD    832-824-4716    rouce@bcm.edu Less <<
NCT01082133 Fanconi Anemia Phase 2 Completed - United States, Ohio ... More >> Cincinnati Children's Hospital Medical Center Cincinnati, Ohio, United States, 45229 Less <<
NCT00693927 Hematologic Malignancies Phase 2 Completed - Belgium ... More >> CHU Sart Tilman Liege, Belgium, B4000 Less <<
NCT01350232 - Terminated(Poor accrual) - -
NCT00636155 Lymphoma, Small Lymphocytic ... More >> Leukemia, Lymphocytic, Chronic Less << Phase 2 Terminated(funding) - United States, North Carolina ... More >> Duke University Medical Center Durham, North Carolina, United States, 27710 Less <<
NCT00841724 Hematological Malignancies Phase 2 Completed - France ... More >> Institut Paoli Calmettes Marseille, France, 13273 CHU de Nantes Nantes, France, 44093 CHU de Bordeaux Pessac, France, 33604 Less <<
NCT00636155 - Terminated(funding) - -
NCT00074269 Breast Cancer Phase 2 Terminated(Terminated early du... More >>e to poor enrollment) Less << - United States, California ... More >> Rebecca and John Moores UCSD Cancer Center La Jolla, California, United States, 92093-0658 Less <<
NCT01019876 Bone Marrow Failure ... More >> Osteopetrosis Fanconi Anemia Severe Combined Immunodeficiency Less << Phase 2 Phase 3 Unknown May 2013 United States, New York ... More >> Columbia University Medical Center Recruiting New York, New York, United States, 10032 Contact: James Garvin, MD, PhD    212-305-5872    jhg1@columbia.edu    Contact: William A Kim, PhD    212-305-7213    billkim@columbia.edu    Principal Investigator: James Garvin, MD, PhD Less <<
NCT00523809 Breast Cancer ... More >> Ovarian Cancer Less << Phase 2 Terminated(Slow accrual.) - United States, Texas ... More >> U.T.M.D. Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00523809 - Terminated(Slow accrual.) - -
NCT00739141 Leukemia Myel... More >>odysplastic Syndrome Non-Hodgkins Lymphoma Chronic Myelogenous Leukemia Hodgkins Lymphoma Less << Phase 2 Active, not recruiting August 2019 United States, New York ... More >> Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 Less <<
NCT00090051 - Completed - -
NCT01350232 Sickle Cell Anemia ... More >> Sickle Cell-hemoglobin C Disease Sickle Cell-β0-thalassemia Less << Not Applicable Terminated(Poor accrual) - United States, Pennsylvania ... More >> Thomas Jefferson University Philadelphia, Pennsylvania, United States, 19107 Less <<
NCT00907036 Lymphoma Phase 2 Unknown - -
NCT00074269 - Terminated(Terminated early du... More >>e to poor enrollment) Less << - -
NCT00090051 Chronic Lymphocytic Leukemia Phase 3 Completed - -
NCT03208556 Relapsed or Refractory B-cell ... More >>Lymphoma Less << Phase 1 Recruiting June 1, 2020 China ... More >> Beijing Cancer Hosptical Recruiting Beijing, China Contact: Zhitao Ying, MD       yingzhitao001@163.com    Principal Investigator: Jun Zhu, MD          Sub-Investigator: Zhitao Ying, MD          Sub-Investigator: Xiaoyu Xiang, PhD Less <<
NCT03658785 Recurrence Tumor ... More >> Metastatic Cancer Solid Tumor Less << Phase 1 Phase 2 Not yet recruiting December 31, 2024 China, Hubei ... More >> Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology Recruiting Wuhan, Hubei, China, 430000 Contact: Wang Less <<
NCT00091104 Melanoma (Skin) Phase 1 Completed - United States, Maryland ... More >> Warren Grant Magnuson Clinical Center - NCI Clinical Trials Referral Office Bethesda, Maryland, United States, 20892-1182 NCI - Surgery Branch Bethesda, Maryland, United States, 20892-1201 Less <<
NCT02482090 Metastatic Ovarian Cancer Phase 1 Completed - Denmark ... More >> Center for Cancer Immune Therapy Dept. of Hematology/oncology Copenhagen, Herlev, Denmark, 2730 Less <<
NCT00354172 - Terminated(Competing study was... More >> started.) Less << - -
NCT01271907 Metastatic Cutaneous Melanoma Phase 2 Terminated(Study was terminate... More >>d due to withdrawal of CRADA partner.) Less << - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT00354172 Leukemia Myel... More >>odysplastic Syndromes Less << Phase 2 Terminated(Competing study was... More >> started.) Less << - United States, Minnesota ... More >> Masonic Cancer Center at University of Minnesota Minneapolis, Minnesota, United States, 55455 Less <<
NCT00301951 Leukemia Lymp... More >>homa Multiple Myeloma and Plasma Cell Neoplasm Myelodysplastic Syndromes Less << Phase 1 Completed - United States, California ... More >> UCSF Comprehensive Cancer Center San Francisco, California, United States, 94143-0324 Less <<
NCT00043810 Acute Myelogenous Leukemia ... More >> Myelodysplastic Syndrome Less << Phase 1 Phase 2 Terminated - United States, Texas ... More >> UT MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT01292603 Lymphocytic Leukemia, Chronic Phase 1 Completed - -
NCT03126864 Hematopoietic/Lymphoid Cancer ... More >> Acute Myeloid Leukemia Less << Phase 1 Recruiting August 2021 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact       wwierda@mdanderson.org Less <<
NCT02274506 Blood And Marrow Transplantati... More >>on Leukemia Lymphoma Less << Phase 1 Withdrawn - -
NCT01292603 - Completed - -
NCT00036738 - Active, not recruiting - -
NCT01271907 - Terminated(Study was terminate... More >>d due to withdrawal of CRADA partner.) Less << - -
NCT00036738 Adult Acute Lymphoblastic Leuk... More >>emia in Remission Adult B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1 Blastic Phase Childhood Acute Lymphoblastic Leukemia in Remission Childhood B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1 Chronic Myelogenous Leukemia, BCR-ABL1 Positive Chronic Phase of Disease Recurrent Adult Acute Lymphoblastic Leukemia Recurrent Childhood Acute Lymphoblastic Leukemia Recurrent Disease Less << Phase 2 Active, not recruiting September 2018 United States, Colorado ... More >> Presbyterian - Saint Lukes Medical Center - Health One Denver, Colorado, United States, 80218 United States, Washington VA Puget Sound Health Care System Seattle, Washington, United States, 98101 Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 Less <<
NCT02049580 Lymphoma Phase 2 Unknown November 2016 Italy ... More >> Istituto Clinico Humanitas Recruiting Rozzano, MI, Italy, 20089 Contact: Luca Castagna, MD    +39028224 ext 4587    luca.castagna@humanitas.it    Principal Investigator: Luca Castagna, MD Less <<
NCT00062036 Melanoma (Skin) Phase 1 Phase 2 Completed - United States, Maryland ... More >> Warren Grant Magnuson Clinical Center - NCI Clinical Trials Referral Office Bethesda, Maryland, United States, 20892-1182 NCI - Center for Cancer Research Bethesda, Maryland, United States, 20892 Less <<
NCT02844062 Glioblastoma Multiforme Phase 1 Recruiting July 2019 China ... More >> Sanbo Brain Hospital Capital Medical University Recruiting Beijing, China, 100093 Contact: Zhixiong Lin, MD    +86-10-13905918963    lzx1967@sina.com Less <<
NCT00305708 Congenital Amegakaryocytic Thr... More >>ombocytopenia Diamond-blackfan Anemia Fanconi Anemia Leukemia Severe Congenital Neutropenia Thrombocytopenia Less << Phase 1 Phase 2 Completed - United States, California ... More >> UCSF Comprehensive Cancer Center San Francisco, California, United States, 94115 Less <<
NCT00827099 Myeloproliferative Disorders ... More >> Leukemia Lymphoma Multiple Myeloma and Plasma Cell Neoplasm Myelodysplastic Syndromes Less << Phase 2 Terminated(Unacceptable morbid... More >>ity & mortality) Less << - United States, Georgia ... More >> Blood and Marrow Transplant Group of Georgia Atlanta, Georgia, United States, 30342 Less <<
NCT01359254 - Terminated(did not accrue enou... More >>gh patients.) Less << - -
NCT01359254 Hematological Disease Phase 2 Terminated(did not accrue enou... More >>gh patients.) Less << - United States, Illinois ... More >> University of Chicago Chicago, Illinois, United States, 60637 Less <<
NCT00589316 Acute Myeloid Leukemia Arising... More >> From Previous Myelodysplastic Syndrome Adult Acute Lymphoblastic Leukemia in Remission Adult Acute Myeloid Leukemia in Remission CD45-Positive Neoplastic Cells Present Chronic Myelomonocytic Leukemia Previously Treated Myelodysplastic Syndrome Refractory Anemia With Excess Blasts Refractory Anemia With Ring Sideroblasts Refractory Cytopenia With Multilineage Dysplasia Refractory Cytopenia With Multilineage Dysplasia and Ring Sideroblasts Less << Phase 1 Active, not recruiting October 1, 2024 United States, Washington ... More >> Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 Less <<
NCT00562640 Fallopian Tube Cancer ... More >> Ovarian Cancer Primary Peritoneal Cavity Cancer Less << Phase 1 Active, not recruiting December 2019 United States, New York ... More >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10065 Less <<
NCT00167206 Fanconi Anemia Phase 1 Phase 2 Terminated(Treatment with thym... More >>ic shielding found safe, another study started.) Less << - United States, Minnesota ... More >> Masonic Cancer Center, University of Minnesota Minneapolis, Minnesota, United States, 55455 Less <<
NCT00827099 - Terminated(Unacceptable morbid... More >>ity & mortality) Less << - -
NCT03096782 Hematopoietic/Lymphoid Cancer Phase 2 Recruiting October 2020 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact: Clinical Research Operations       alolson@mdanderson.org Less <<
NCT00034528 Hemoglobinopathies ... More >> Anemia, Sickle Cell Hemoglobin SC Disease Thalassemia Thalassemia Major Less << Phase 2 Terminated(Due to slow recruit... More >>ment) Less << - United States, Massachusetts ... More >> Dana-Farber Cancer Institute/Harvard Cancer Center, Brigham and Women's Hospital and Massachusetts General Hospital Boston, Massachusetts, United States, 02115 Less <<
NCT00167206 - Terminated(Treatment with thym... More >>ic shielding found safe, another study started.) Less << - -
NCT00337246 Leukemia Phase 2 Completed - United Kingdom ... More >> Birmingham Heartlands Hospital Birmingham, England, United Kingdom, B9 5SS Blackpool Victoria Hospital Blackpool, England, United Kingdom, FY3 8NR Kent and Canterbury Hospital Canterbury, England, United Kingdom, CT2 7NR St Helier Hospital Carshalton, England, United Kingdom, SM5 1AA Darent Valley Hospital Dartford Kent, England, United Kingdom, DA2 8DA Medway Maritime Hospital Gillingham Kent, England, United Kingdom, ME7 5NY Leeds General Infirmary at Leeds Teaching Hospital NHS Trust Leeds, England, United Kingdom, LS1 3EX Leicester Royal Infirmary Leicester, England, United Kingdom, LE1 5WW Royal Liverpool and Broadgreen Hospitals NHS Trust Liverpool, England, United Kingdom, L7 8XP Maidstone Hospital Maidstone, England, United Kingdom, ME16 9QQ Christie Hospital NHS Trust Manchester, England, United Kingdom, M20 4BX Royal Cornwall Hospital Truro, Cornwall, England, United Kingdom, TR1 3LJ Kent and Sussex Hospital Tunbridge Wells, Kent, England, United Kingdom, TN4 8AT Wishaw General Hospital Wishaw, England, United Kingdom, ML2 0DP Monklands General Hospital Airdrie, Scotland, United Kingdom, ML6 0JF University Hospital of Wales Cardiff, Wales, United Kingdom, CF14 4XW Less <<
NCT02917083 Hodgkin's Lymphoma ... More >> Non-Hodgkin Lymphoma Less << Phase 1 Recruiting February 2035 United States, Texas ... More >> Houston Methodist Hospital Recruiting Houston, Texas, United States, 77030 Contact: Carlos A Ramos, MD    832-824-4817    caramos@bcm.edu    Contact: Munu Bilgi, MS    832-824-1518    mxbilgi@txch.org    Texas Children's Hospital Recruiting Houston, Texas, United States, 77030 Contact: Carlos A Ramos, MD    832-824-4817    caramos@bcm.edu    Contact: Munu Bilgi, MS    832-824-1518    mxbilgi@txch.org Less <<
NCT00448201 - Completed - -
NCT00448201 Chronic Myeloproliferative Dis... More >>orders Leukemia Lymphoma Multiple Myeloma and Plasma Cell Neoplasm Myelodysplastic Syndromes Less << Phase 2 Completed - United States, North Carolina ... More >> Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill Chapel Hill, North Carolina, United States, 27599-7295 Less <<
NCT01071239 Fanconi Anemia Phase 2 Completed - United States, Wisconsin ... More >> Medical College of Wisconsin Milwaukee, Wisconsin, United States, 53226 Less <<
NCT00582894 Hematological Neoplasms ... More >> Hematopoietic Stem Cell Transplantation Less << Not Applicable Completed - United States, Oklahoma ... More >> University of Oklahoma Health Sciences Center Oklahoma City, Oklahoma, United States, 73104 Less <<
NCT00582894 - Completed - -
NCT02156726 - Unknown July 2015 Czech Republic ... More >> Department of Hematology - Oncology, University Hospital Brno, Czech Republic, 60500 Department of Hemato-Oncology, University Hospital Olomouc, Czech Republic, 77520 Department of Hematology, University Hospital Plzen, Czech Republic, 30599 Department of Medicine - Hematology, University Hospital Kralovske Vinohrady Praha, Czech Republic, 10034 1st Department of Medicine - Hematology, University General Hospital Praha, Czech Republic, 12808 Institute for Hematology and Blood Transfusion Praha, Czech Republic, 12820 4th Department of Medicine - Hematology, University Hospital Hradec Kralove, ČR, Czech Republic, 50005 Less <<
NCT01435343 Acute Myeloblastic Leukemia Phase 1 Phase 2 Completed - Spain ... More >> Hospital Universitari Germans Trials i Pujol Badalona, Spain Hospital Clínic de Barcelona Barcelona, Spain Hospital de la Santa Creu i Sant Pau. Barcelona, Spain Hospital Duran i Reynals - ICO L'Hospitalet Barcelona, Spain Hospital Universitario Vall d'Hebron Barcelona, Spain Hospital Universitario Reina Sofía Córdoba, Spain Hospital Clínico San Carlos Madrid, Spain Hospital Universitario 12 de Octubre Madrid, Spain Hospital Clínico Universitario de Salamanca Salamanca, Spain Hospital Universitari La Fe Valencia, Spain Less <<
NCT01247701 Myeloid Hematological Malignan... More >>cies Less << Not Applicable Recruiting November 2027 United States, Texas ... More >> Texas Children's Hospital Recruiting Houston, Texas, United States, 77030 Contact: Caridad A Martinez, MD    832-824-4692    camartin@txch.org    Contact: Marlen Dinu    832-824-4881    mxdinu@txch.org Less <<
NCT00243009 Kidney Cancer Phase 2 Terminated(Due to a lack of a ... More >>referal base, study was terminated.) Less << - United States, Oregon ... More >> OHSU Knight Cancer Institute Portland, Oregon, United States, 97239-3098 Less <<
NCT02809092 Acute Myeloid Leukemia Phase 1 Phase 2 Recruiting September 2020 Brazil ... More >> Centro Terapia e Tecnologia Celular Recruiting Porto Alegre, Rio Grande Do Sul, Brazil, 90035-903 Contact: Lucia Silla, PhD    55 51 33597516    dralucia.silla@gmail.com    Contact: Vanessa Valim, Msc    55 51 33598850    vanessavalim@gmail.com Less <<
NCT03384225 High Risk Acute Myeloid Leukem... More >>ia Allogeneic Hematopoeitic Stem Cell Transplantation Less << Phase 3 Recruiting July 31, 2020 China, Shanghai ... More >> Shanghai general hospital, Shanghai Jiaotong university school of medicine Recruiting Shanghai, Shanghai, China, 200080 Contact: Xingpeng Wang, M.D.,Ph. D.    86-21-63069298    sfph_edu2@163.com    Contact: Yanhong Zhu    86-21-63240090 ext 6213    sfph_edu2@shumu.edu.cn    Sub-Investigator: Jieling Jiang, M.D.          Principal Investigator: Xiaoxia Hu, M.D.          Principal Investigator: Qiang Liu, M.D.          Principal Investigator: Yajing Xu, M.D.          Principal Investigator: Ting Yang, M.D.          Principal Investigator: Huangfang Wang, M.D.          Sub-Investigator: Yang Cao, M.D. Less <<
NCT03384212 High Risk Acute Myeloid Leukem... More >>ia Allogeneic Hematopoeitic Stem Cell Transplantation Less << Phase 3 Recruiting July 31, 2020 China, Shanghai ... More >> Shanghai general hospital, Shanghai Jiaotong university school of medicine Recruiting Shanghai, Shanghai, China, 200080 Contact: Xingpeng Wang, M.D.,Ph. D.    86-21-63069298    sfph_edu2@163.com    Contact: Yanhong Zhu    86-21-63240090 ext 6213    sfph_edu2@shumu.edu.cn    Sub-Investigator: Jieling Jiang, M.D.          Principal Investigator: Xiaoxia Hu, M.D.          Principal Investigator: Qiang Liu, M.D.          Principal Investigator: Yajing Xu, M.D.          Principal Investigator: Ting Yang, M.D.          Principal Investigator: Huangfang Wang, M.D.          Sub-Investigator: Yang Cao, M.D. Less <<
NCT00242931 Prostate Cancer Phase 2 Withdrawn(Unable to successful... More >>ly recruit subjects to this study.) Less << - -
NCT03635632 Relapsed Neuroblastoma ... More >> Refractory Neuroblastoma Less << Phase 1 Not yet recruiting December 2037 United States, Texas ... More >> Texas Children's Hospital Not yet recruiting Houston, Texas, United States, 77030 Contact: Bilal Omer, MD    832-824-6855    bomer@bcm.edu    Contact: Jacqueline Castello    832-824-4391    jxcastel@texaschildrens.org Less <<
NCT00056979 Inherited Metabolic Storage Di... More >>seases Less << Phase 1 Phase 2 Terminated - United States, Texas ... More >> Texas Children's Hospital Houston, Texas, United States The Methodist Hospital Houston, Texas, United States Less <<
NCT00920972 Metabolic Disorders ... More >> Hematologic, Immune, or Bone Marrow Disorders Hemoglobinopathies Non-malignant Disorders Less << Phase 1 Phase 2 Recruiting December 2021 United States, Arizona ... More >> Phoenix Children's Hospital Recruiting Phoenix, Arizona, United States, 85016 Principal Investigator: Roberta Adams, MD          United States, California University of California Recruiting San Diego, California, United States, 92123 Principal Investigator: Eric Anderson, MD          United States, District of Columbia George Washington University School of Medicine Recruiting Washington, District of Columbia, United States, 20010 Principal Investigator: David Jacobsohn, MD          United States, Florida University of Miami Recruiting Miami, Florida, United States, 33136 Principal Investigator: Martin Andreansky, MD          Miami Children's Hospital Recruiting Miami, Florida, United States, 33155 Principal Investigator: Kamar Godder, MD          All Children's Hospital Recruiting Saint Petersburg, Florida, United States, 33701 Principal Investigator: Gregory Hale, MD          United States, Illinois Children's Memorial Hospital Recruiting Chicago, Illinois, United States, 60614 Principal Investigator: Sonali Chaudhury, MD          United States, Indiana Indiana University School of Medicine Recruiting Indianapolis, Indiana, United States, 46202 Principal Investigator: Paul Haut, MD          United States, Louisiana Louisiana State University Recruiting New Orleans, Louisiana, United States, 70112 Principal Investigator: Lolie Yu, MD          United States, Missouri Children's Mercy Hospitals and Clinics Recruiting Kansas City, Missouri, United States, 64108 Principal Investigator: Jignesh Dalal, MD          St. Louis University Recruiting Saint Louis, Missouri, United States, 63104 Contact: Deepika Bhatla, MD          Principal Investigator: Deepika Bhatla, MD          Washington University School of Medicine (in St. Louis) Recruiting Saint Louis, Missouri, United States, 63110 Contact: Shalini Shenoy, MD    314-454-6018    shenoy@wustl.edu    Contact: Lisa Murray, MA, CCRP    3144544240    Murray_L@kids.wustl.edu    United States, New Jersey Hackensack University Medical Center Recruiting Hackensack, New Jersey, United States, 07601 Principal Investigator: Alfred Gillio, MD          United States, New York Columbia University Medical Center Recruiting New York, New York, United States, 10032 Contact: Monica Bhatia, MD          Principal Investigator: Monica Bhatia, MD          United States, North Carolina Carolinas Medical Center Recruiting Charlotte, North Carolina, United States, 28232 Principal Investigator: Michael Eckrich, MD          Duke University Medical Center Recruiting Durham, North Carolina, United States, 27705 Principal Investigator: Suhag Parikh, MD          United States, Texas Texas Transplant Institute Recruiting San Antonio, Texas, United States, 78229 Principal Investigator: Troy Quigg, MD          Canada, Manitoba University of Manitoba Active, not recruiting Winnipeg, Manitoba, Canada, R3E 0W3 Canada University of Calgary Recruiting Calgary, Canada Contact: Gregory Guilcher, MD          Principal Investigator: Gregory Guilcher, MD Less <<
NCT03766126 Acute Myeloid Leukemia, in Rel... More >>apse Acute Myeloid Leukemia, Adult Acute Myeloid Leukemia, Refractory Less << Phase 1 Recruiting December 3, 2033 United States, Pennsylvania ... More >> University of Pennsylvania Recruiting Philadelphia, Pennsylvania, United States, 19104 Contact: EmergingMed    855-216-0098    PennCancerTrials@emergingmed.com    Contact: Saar Gill, MD, PhD       Saar.Gill@pennmedicine.upenn.edu Less <<
NCT00073879 Kidney Cancer Not Applicable Completed - United States, Texas ... More >> Baylor College of Medicine Houston, Texas, United States, 77030 Less <<
NCT00579111 Myelodysplastic and Myeloproli... More >>ferative Disorders Acute Myelogenous Leukemia Acute Lymphoblastic Leukemia Chronic Myelogenous Leukemia Multiple Myeloma Plasma Cell Dyscrasia Lymphoproliferative Disorders Hematologic Diseases Less << Phase 1 Phase 2 Terminated(slow accrual) - United States, Texas ... More >> Texas Children's Hospital Houston, Texas, United States, 77030 The Methodist Hospital Houston, Texas, United States, 77030 Less <<
NCT00579111 - Terminated(slow accrual) - -
NCT00968461 Leukemia Lymp... More >>hoproliferative Disorders Less << Phase 1 Withdrawn - -
NCT00802568 Multiple Myeloma and Plasma Ce... More >>ll Neoplasm Less << Phase 2 Completed - France ... More >> Marseille Institute of Cancer - Institut J. Paoli and I. Calmettes Marseille, France, 13273 Less <<
NCT01212887 Breast Cancer ... More >> Colorectal Cancer Gastric Cancer Lung Cancer Ovarian Cancer Pancreatic Cancer Unspecified Adult Solid Tumor, Protocol Specific Less << Phase 1 Terminated(due to safety conce... More >>rns and lack of efficacy) Less << - United Kingdom ... More >> Christie Hospital Manchester, England, United Kingdom, M20 4BX Less <<
NCT00651781 Acute Myeloid Leukemia Phase 1 Phase 2 Completed - Spain ... More >> Hospital Germans Trias I Pujol Badalona, Spain Hospital Clinic y Provincial de Barcelona Barcelona, Spain Hospital Santa Creu y Sant Pau.Barcelona Barcelona, Spain Hospital Vall d´hebron Barcelona, Spain Hospital Juan Canalejo La Coruña, Spain Hospital 12 de Octubre Madrid, Spain Hospital Clínico San Carlos. Madrid, Spain Hospital Ramón y Cajal. Madrid Madrid, Spain Hospital Morales Messeguer Murcia, Spain Hospital Central de Asturias Oviedo, Spain Hospital Universitario de Salamanca Salamanca, Spain Hospital La Fe de Valencia Valencia, Spain Hospital Lozano Blesa Zaragoza, Spain Less <<
NCT00644371 Non-Hodgkin Lymphoma Phase 2 Completed - Spain ... More >> H. Santa Creu i Sant Pau. Barcelona, Barcelona., Spain Clinica Universitaria de Navarra Pamplona, Navarra, Spain H.U. 12 de Octubre Madrid, Spain H.U. Gregorio Marañón Madrid, Spain H.U. La Princesa Madrid, Spain H.U. Ramón y Cajal. Madrid, Spain H. Morales Meseguer. Murcia, Spain H. Virgen de la Arrixaca Murcia, Spain H. Central de Asturias Oviedo, Spain H. Clinico de Salamanca Salamanca, Spain H. U. Marqués de Valdecilla. Santander, Spain H. Clínico Valencia Valencia, Spain H. La Fe Valencia, Spain H.U. Miguel Servet Zaragoza., Spain Less <<
NCT01135329 - Terminated(The stopping rule w... More >>as met and hence the study was closed) Less << - -
NCT00806767 Chronic Myeloproliferative Dis... More >>orders Leukemia Lymphoma Multiple Myeloma and Plasma Cell Neoplasm Myelodysplastic Syndromes Myelodysplastic/Myeloproliferative Neoplasms Less << Phase 2 Completed - France ... More >> Marseille Institute of Cancer - Institut J. Paoli and I. Calmettes Marseille, France, 13273 Less <<
NCT00427661 - Completed - -
NCT01135329 Lymphoma Leuk... More >>emia Myelodysplastic Syndrome Less << Phase 2 Terminated(The stopping rule w... More >>as met and hence the study was closed) Less << - United States, Maryland ... More >> The Sydney Kimmel Comprehensive Cancer Center Baltimore, Maryland, United States, 21231 Less <<
NCT00750126 Solid Tumors ... More >>Hematologic Neoplasms Less << Phase 2 Unknown April 2009 France ... More >> Paillard Catherine Recruiting Clermont-Ferrand, France, 63003 Contact: Paillard Catherine, Dr       cpaillard@chu-clermontferrand.fr Less <<
NCT00462332 - Completed - -
NCT00462332 Leukemia Phase 2 Completed - Italy ... More >> S.O.C. di Ematologia - Azienda Ospedaliera - SS. Antonio e Biagio e Cesare Arrigo Alessandria, Italy Universita Degli Studi di Bari Bari, Italy, 70124 Universita Cattolica del Sacro Cuore - Campobasso Campobasso, Italy, 86100 Università di Catania - Cattedra di Ematologia - Ospedale "Ferrarotto" Catania, Italy, 95124 Ospedale Regionale A. Pugliese Catanzaro, Italy, 88100 Ospedale Civile Cosenza Cosenza, Italy, 87100 Universita di Ferrara Ferrara, Italy, 44100 Azienda Ospedaliera di Firenze Firenze, Italy, 50011 Ospedale San Martino Genova, Italy, 16132 ASL Le/1 P.O. Vito Fazzi - U.O. di Ematologia ed UTIE Lecce, Italy Azienda Ospedaliera Papardo Messina, Italy Azienda Ospedaliera Universitaria - Policlinico G. Martino Dipartimento di Medicina Interna - U.O. Messina Messina, Italy Ospedale Maggiore Policlinico Milano, Italy, 20122 Azienda Ospedaliera - Universitaria di Modena Modena, Italy, 41100 U.O. Ematologia Clinica - Azienda USL di Pescara Pescara, Italy Azienda Ospedaliera Bianchi Melacrino Morelli Reggio Calabria, Italy, 89100 Azienda Ospedaliera Universitaria Policlinico Tor Vergata Rome, Italy, 00133 Ospedale Sant' Eugenio Rome, Italy, 00144 Università Degli Studi "La Sapienza" Rome, Italy, 00161 Policlinico A. Gemelli - Universita Cattolica del Sacro Cuore Rome, Italy, 00168 U.O.C. Ematologia e Trapianti - A.O. Senese - Policlinico " Le Scotte" Siena, Italy Azienda Sanitaria Ospedale San Giovanni Battista Molinette di Torino Turin, Italy, 10126 Policlinico Universitario Udine Udine, Italy, 33100 Less <<
NCT00385788 - Completed - -
NCT00427661 Sickle Cell Disease ... More >> Thalassemia Hemoglobinopathies Less << Not Applicable Completed - United States, Pennsylvania ... More >> Children's Hospital of Pittsburgh Pittsburgh, Pennsylvania, United States, 15213 Less <<
NCT00385788 Hodgkin's Disease Phase 2 Completed - United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT03774654 Refractory B-Cell Non-Hodgkin ... More >>Lymphoma Refractory B-Cell Small Lymphocytic Lymphoma Relapsed Adult ALL Relapsed CLL Relapsed Non Hodgkin Lymphoma Less << Phase 1 Not yet recruiting March 2034 United States, Texas ... More >> Houston Methodist Hospital Not yet recruiting Houston, Texas, United States, 77030 Contact: Carlos Ramos, MD    832-824-4817    caramos@bcm.edu    Texas Children's Hospital Not yet recruiting Houston, Texas, United States, 77030 Contact: Carlos Ramos, MD    832-824-4817    caramos@bcm.edu Less <<
NCT00138229 Melanoma (Skin) Phase 2 Terminated - United States, Maryland ... More >> Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support Bethesda, Maryland, United States, 20892-1182 NCI - Surgery Branch Bethesda, Maryland, United States, 20892-1201 Less <<
NCT02483325 Hematological Diseases Phase 2 Recruiting September 2018 France ... More >> Institut Paoli Calmettes Recruiting Marseille, France, 13009 Principal Investigator: FURST Sabine, MD Less <<
NCT02905188 Hepatocellular Carcinoma Phase 1 Not yet recruiting October 2036 United States, Texas ... More >> Houston Methodist Hospital Not yet recruiting Houston, Texas, United States, 77030 Contact: Andras Heczey, MD       axheczey@txch.org Less <<
NCT00053092 Lymphoma Phase 2 Completed - Australia, Victoria ... More >> Peter MacCallum Cancer Centre East Melbourne, Victoria, Australia, 3002 United Kingdom Derriford Hospital Plymouth, England, United Kingdom, PL6 8DH Less <<
NCT03081910 T-cell Acute Lymphoblastic Lym... More >>phoma T-non-Hodgkin Lymphoma T-cell Acute Lymphoblastic Leukemia Less << Phase 1 Recruiting June 1, 2036 United States, Texas ... More >> Houston Methodist Hospital Recruiting Houston, Texas, United States, 77030 Contact: Rayne Rouce, MD    832-824-4716    rhrouce@txch.org    Texas Children's Hospital Recruiting Houston, Texas, United States, 77030 Contact: Rayne Rouce, MD    832-824-4716    rhrouce@txch.org Less <<
NCT00093522 Kidney Cancer Phase 2 Unknown - United States, Wisconsin ... More >> Midwest Heart Surgery Institute, Limited Milwaukee, Wisconsin, United States, 53215 Vince Lombardi Cancer Clinic at Aurora St. Luke's Medical Center Milwaukee, Wisconsin, United States, 53215 Less <<
NCT03142646 Leukemia Phase 1 Phase 2 Recruiting October 1, 2018 China ... More >> Beijing hospital Recruiting Beijing, China Contact: hui liu, md    15801390058    espinas@163.com    Peking University People's Hospital (PKUPH) Recruiting Peking, China Contact: Xiaojun Huang, MD          Principal Investigator: Xiaojun Huang, MD Less <<
NCT00769522 Chronic Lymphocytic Leukemia Phase 3 Completed - Germany ... More >> Medizinische Universitaetsklinik I at the University of Cologne Cologne, Germany, D-50924 Less <<
NCT01300247 - Completed - -
NCT00397813 - Active, not recruiting - -
NCT00397813 Atypical Chronic Myeloid Leuke... More >>mia, BCR-ABL1 Negative Chronic Myelomonocytic Leukemia de Novo Myelodysplastic Syndrome Essential Thrombocythemia Myeloproliferative Neoplasm Paroxysmal Nocturnal Hemoglobinuria Polycythemia Vera Polycythemia Vera, Post-Polycythemic Myelofibrosis Phase Primary Myelofibrosis Refractory Anemia Refractory Anemia With Excess Blasts Refractory Anemia With Ring Sideroblasts Refractory Cytopenia With Multilineage Dysplasia Refractory Cytopenia With Multilineage Dysplasia and Ring Sideroblasts Less << Phase 2 Active, not recruiting September 2022 United States, Utah ... More >> LDS Hospital Salt Lake City, Utah, United States, 84143 United States, Washington Veterans Administration Center-Seattle Seattle, Washington, United States, 98108 Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 Less <<
NCT01300247 Lymphocytic Leukemia, Chronic Phase 1 Completed - United States, Alabama ... More >> Huntsville, Alabama, United States, 35805 United States, California Duarte, California, United States, 91010 La Jolla, California, United States, 92093 Los Angeles, California, United States, 90095 United States, Connecticut Southington, Connecticut, United States, 06489 United States, Florida Tampa, Florida, United States, 33612-9497 United States, Georgia Atlanta, Georgia, United States, 30322 Marietta, Georgia, United States, 30060 United States, Illinois Chicago, Illinois, United States, 60637 United States, Maryland Boston, Maryland, United States, 02115 United States, Massachusetts Boston, Massachusetts, United States, 02114 United States, Minnesota St. Louis Park, Minnesota, United States, 55426 United States, Missouri Springfield, Missouri, United States, 65807 United States, New York Rochester, New York, United States, 14642 United States, Texas Houston, Texas, United States, 77030 United States, Washington Seattle, Washington, United States, 98109 Tacoma, Washington, United States, 98405 United States, Wisconsin Madison, Wisconsin, United States, 53705 Less <<
NCT00429572 Breast Cancer Phase 2 Completed - United States, Texas ... More >> U.T.M.D. Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00429572 - Completed - -
NCT01787474 Recurrent Adult Acute Myeloid ... More >>Leukemia Refractory Acute Myeloid Leukemia Less << Phase 1 Phase 2 Recruiting May 30, 2020 United States, Texas ... More >> M D Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact: Stefan O. Ciurea    713-792-8750       Principal Investigator: Stefan O. Ciurea Less <<
NCT01679041 Multiple Sclerosis Phase 2 Terminated(Insufficient accrua... More >>ls; PI leaving site) Less << - United States, Texas ... More >> Amarillo Diagnostic Clinic Amarillo, Texas, United States, 79106 Dr Ruby Saulog Amarillo, Texas, United States, 79106 Texas Oncology Amarillo, Texas, United States, 79106 Less <<
NCT00006184 Multiple Myeloma Phase 2 Completed - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT02379520 Human Papillomavirus-Related C... More >>arcinoma Human Papillomavirus Positive Oropharyngeal Carcinoma Human Papillomavirus Positive Cervical Carcinoma Human Papillomavirus Positive Anal Carcinoma Human Papillomavirus Positive Vulvar Carcinoma Human Papillomavirus Positive Penile Carcinoma Less << Phase 1 Recruiting October 2033 United States, Texas ... More >> Houston Methodist Hospital Recruiting Houston, Texas, United States, 77030 Contact: Carlos A Ramos, MD    832-824-4817    caramos@bcm.edu    Contact: Vicky Torrano    832-824-7821    vtorrano@bcm.edu Less <<
NCT00006184 - Completed - -
NCT02933775 CD19 Positive Malignant B-cell... More >> Leukemia and Lymphoma Less << Phase 1 Not yet recruiting January 2020 China, Shanghai ... More >> Renji Hospital, Shanghai Jiaotong University School of Medicine Not yet recruiting Shanghai, Shanghai, China, 200127 Contact: Honghui Huang, MD       honghui_huang@163.com    Principal Investigator: Fangyuan Chen, MD          Sub-Investigator: Honghui Huang, MD Less <<
NCT02937844 Glioblastoma Multiforme Phase 1 Recruiting July 2019 China ... More >> Sanbo Brain Hospital Capital Medical University Recruiting Beijing, China, 100093 Contact: Zhixiong Lin, MD    +86-10-13905918963    lzx1967@sina.com Less <<
NCT02456350 Chronic Lymphocytic Leukemia ... More >> Acute Lymphocytic Leukemia Lymphoma Less << Phase 1 Recruiting December 2019 China, Guangdong ... More >> Shenzhen Second People's Hospital, The First Affiliated Hospital of Shenzhen University Recruiting Shenzhen, Guangdong, China, 518035 Contact: Mingjun Wang, M.D., Ph.D.    15814723218    mingjunw429@163.com    Contact: Weihong Chen, M.D., Ph.D.    13923871697    whitney-cindy@hotmail.com    Principal Investigator: Xin Du, M.D., Ph.D.          Principal Investigator: Mingjun Wang, M.D., Ph.D.          Principal Investigator: Geng Tian, M.D., Ph.D.          Principal Investigator: Weihong Chen, M.D., Ph.D. Less <<
NCT00467961 - Completed - -
NCT02601313 Relapsed/Refractory Mantle Cel... More >>l Lymphoma Less << Phase 2 Recruiting March 2034 -
NCT03076437 Acute Lymphocytic Leukemia ... More >> Chronic Lymphocytic Leukemia Lymphoma Less << Phase 1 Phase 2 Recruiting December 31, 2019 China, Guangdong ... More >> Department of Hematology, Dongguan People's Hospital Recruiting Dongguan, Guangdong, China, 523059 Contact: Yirong Jiang, MD    13688967985    dgjyr0769@163.com    Contact: Mingjun Wang, MD, PhD    15814723218    mingjunw429@163.com    Principal Investigator: Yirong Jiang, MD Less <<
NCT00467961 CML (Chronic Myelogenous Leuke... More >>mia) CLL (Chronic Lymphocytic Leukemia) AML (Acute Myelogenous Leukemia) Acute Lymphocytic Leukemia MDS (Myelodysplastic Syndrome) Less << Phase 2 Completed - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT02390739 Metastatic Thyroid Cancer Phase 1 Phase 2 Withdrawn - -
NCT03412877 Glioblastoma ... More >>Non-Small Cell Lung Cancer Ovarian Cancer Breast Cancer Gastrointestinal/Genitourinary Cancer Less << Phase 2 Recruiting March 23, 2028 United States, Maryland ... More >> National Institutes of Health Clinical Center Recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact NCI/Surgery Branch Recruitment Center    866-820-4505    irc@nih.gov Less <<
NCT01455051 Chronic Lymphocytic Leukemia Phase 2 Unknown October 2017 Spain ... More >> Hospital Germans Trias i Pujol Recruiting Badalona, Spain Contact: Christelle Ferra, MD       CHRISTELLE.FERRA@telefonica.net    Principal Investigator: Christelle Ferra, MD, PhD          Hospital de la Santa Creu Sant Pau Recruiting Barcelona, Spain, 08025 Contact: Carolina Moreno, MD, PhD       cmorenoa@santpau.cat    Principal Investigator: Carolina Moreno, MD, PhD          Hospital Vall d'Hebron Recruiting Barcelona, Spain Contact: Francesc Bosch, MD, PhD       fbosch@vhebron.net    Principal Investigator: Francesc Bosch, MD, PhD          Institut Catala d'Oncologia Recruiting Hospitalet de Llobregat, Spain Contact: Rafael Duarte, MD, PhD       rduarte@iconcologia.net    Principal Investigator: Rafael Duarte, MD, PhD          Hospital La Princesa Recruiting Madrid, Spain Contact: Javier Loscertales, MD       javlos@yahoo.com    Principal Investigator: Javier Loscertales, MD          Hospital Puerta de Hierro Recruiting Madrid, Spain Contact: Jose Angel Garcia-Marco, MD, PhD       jagarciam@medynet.com    Principal Investigator: Jose Angel Garcia-Marco, MD, PhD          Hospital Central de Asturias Recruiting Oviedo, Spain Contact: Carlos Vallejo, MD          Principal Investigator: Carlos Vallejo          Hospital Clinico Recruiting Valencia, Spain Contact: Maria Jose Terol       terol39@ono.com    Principal Investigator: Maria Jose Terol, MD, PhD          Hospital La Fe Recruiting Valencia, Spain Contact: Jaime Sanz          Principal Investigator: Jaime Sanz Less <<
NCT02447055 Multiple Myeloma ... More >> Myeloma-Multiple Less << Early Phase 1 Withdrawn - -
NCT02771197 Acute Myeloid Leukemia Phase 2 Recruiting June 30, 2021 United States, Georgia ... More >> Blood and Marrow Transplant Group of Georgia Recruiting Atlanta, Georgia, United States, 30342 Contact: Scott R. Solomon, MD    404-255-1930       Northside Hospital Recruiting Atlanta, Georgia, United States, 30342 Contact: Scott Solomon, MD    404-255-1930    ssolomon@bmtga.com    Contact: Stacey Brown, BA    404-851-8238    stacey.brown@northside.com    Principal Investigator: Scott Solomon, MD          Sub-Investigator: H. Kent Holland, MD          Sub-Investigator: Asad Bashey, MD, PHD          Sub-Investigator: Lawrence E Morris, MD Less <<
NCT03322735 Multiple Myeloma Phase 1 Phase 2 Recruiting December 2019 China, Henan ... More >> Cancer Hospital Affiliate to Zhengzhou University & Henan Cancer Hospital Recruiting Zhengzhou, Henan, China Contact: Yongping Song    +86-13521186987    ph200811@163.com    Principal Investigator: Yongping Song Less <<
NCT02489266 Metastatic Melanoma Phase 1 Withdrawn - -
NCT00176865 Hemophagocytic Lymphohistiocyt... More >>osis X-Linked Lymphoproliferative Disorders Chediak-Higashi Syndrome Griscelli Syndrome Immunologic Deficiency Syndromes Langerhans-Cell Histiocytosis Less << Phase 2 Completed - United States, Minnesota ... More >> Masonic Cancer Center University of Minnesota Minneapolis, Minnesota, United States, 55455 Less <<
NCT00426517 Inherited Immune Deficiencies Early Phase 1 Recruiting January 8, 2026 United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact Office of Patient Recruitment (OPR)    800-411-1222 ext TTY8664111010    prpl@cc.nih.gov Less <<
NCT00475384 Acute Myelogenous Leukemia ... More >> Acute Lymphocytic Leukemia Myelodysplastic Syndrome Leukemia Less << Phase 1 Completed - United States, California ... More >> Childrens Hospital Los Angeles Los Angeles, California, United States, 90027 United States, Florida University of Florida Shands Hospital Gainesville, Florida, United States, 32610-0278 United States, Massachusetts Dana Farber Cancer Institute Boston, Massachusetts, United States, 02115 United States, Texas University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00176865 - Completed - -
NCT00602693 Leukemia Lymp... More >>homa Multiple Myeloma Plasma Cell Neoplasm Myelodysplastic Syndromes Less << Phase 1 Completed - United States, Minnesota ... More >> Masonic Cancer Center at University of Minnesota Minneapolis, Minnesota, United States, 55455 Less <<
NCT01853631 Non-Hodgkin Lymphoma ... More >> Chronic Lymphocytic Leukemia Acute Lymphocytic Leukemia Less << Phase 1 Recruiting February 2033 United States, Texas ... More >> Houston Methodist Hospital Recruiting Houston, Texas, United States, 77030 Contact: Carlos A. Ramos, MD    832-824-4817    caramos@bcm.edu    Contact: Catherine Robertson    832-824-4594    csrobert@txch.org    Texas Children's Hospital Recruiting Houston, Texas, United States, 77030 Contact: Carlos A. Ramos, MD    832-824-4817    caramos@bcm.edu    Contact: Catherine Robertson    832-824-4594    csrobert@txch.org Less <<
NCT01145209 Small Lymphocytic Lymphoma ... More >> CLL (Chronic Lymphocytic Leukemia) Less << Phase 2 Active, not recruiting December 31, 2019 United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT03049449 Lymphoma, Large-Cell, Anaplasi... More >>tc Hodgkin Disease Lymphoma, Hodgkins Enteropathy-Associated T-Cell Lymphoma Lymphoma, Extranodal NK-T-Cell Less << Phase 1 Recruiting June 30, 2022 United States, Maryland ... More >> National Institutes of Health Clinical Center Recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact National Cancer Institute Referral Office    888-624-1937 Less <<
NCT02614066 Acute Lymphoblastic Leukemia Phase 1 Phase 2 Recruiting March 2034 -
NCT01251575 Adult Acute Lymphoblastic Leuk... More >>emia Adult Acute Myeloid Leukemia Adult Diffuse Large B-Cell Lymphoma Adult Myelodysplastic Syndrome Adult Non-Hodgkin Lymphoma Aggressive Non-Hodgkin Lymphoma Childhood Acute Lymphoblastic Leukemia Childhood Acute Myeloid Leukemia Childhood Diffuse Large B-Cell Lymphoma Childhood Myelodysplastic Syndrome Childhood Non-Hodgkin Lymphoma Chronic Lymphocytic Leukemia Chronic Lymphocytic Leukemia in Remission Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive Hematopoietic and Lymphoid Cell Neoplasm Mantle Cell Lymphoma Plasma Cell Myeloma Prolymphocytic Leukemia Recurrent Chronic Lymphocytic Leukemia Refractory Chronic Lymphocytic Leukemia T-Cell Prolymphocytic Leukemia Waldenstrom Macroglobulinemia Recurrent Diffuse Large B-Cell Lymphoma Recurrent Hodgkin Lymphoma Less << Phase 2 Recruiting - United States, Colorado ... More >> Presbyterian - Saint Lukes Medical Center - Health One Recruiting Denver, Colorado, United States, 80218 Contact: Michael B. Maris    720-754-4800    Michael.Maris@healthonecares.com    Principal Investigator: Michael B. Maris          United States, Utah Huntsman Cancer Institute/University of Utah Completed Salt Lake City, Utah, United States, 84112 United States, Washington VA Puget Sound Health Care System Recruiting Seattle, Washington, United States, 98101 Contact: Thomas R. Chauncey    206-762-1010    thomas.chauncey@va.gov    Principal Investigator: Thomas R. Chauncey          Fred Hutch/University of Washington Cancer Consortium Recruiting Seattle, Washington, United States, 98109 Contact: Brenda M. Sandmaier    206-667-4961    bsandmai@fredhutch.org    Principal Investigator: Brenda M. Sandmaier          Denmark Rigshospitalet University Hospital Recruiting Copenhagen, Denmark, 2100 Contact: Niels Anderson    45 35 45 1134    niels.smedegaard.andersen@rh.regionh.dk    Principal Investigator: Niels Anderson Less <<
NCT01823198 Leukemia Phase 1 Phase 2 Recruiting June 2021 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Less <<
NCT01273181 Metastatic Cancer ... More >> Metastatic Renal Cancer Metastatic Melanoma Less << Phase 1 Phase 2 Terminated - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT01273181 - Terminated - -
NCT03393611 Myelodysplastic Syndromes ... More >> Leukemia, Myeloid, Acute Leukemia, Relapsed Adult Acute Myeloid Myelodysplastic Syndromes, Previously Treated Less << Phase 1 Recruiting November 30, 2021 United States, New York ... More >> Weill Cornell Medical College Recruiting New York, New York, United States, 10021 Contact: Jennifer Bourke, RN    212-746-2844    jeb9097@med.cornell.edi    Contact: Usama Gergis, MD    646-962-7950    usg2001@med.cornell.edu    Principal Investigator: Usama Gergis, MD          Sub-Investigator: Koen van Besien, MD          Sub-Investigator: Tsiporah Shore, MD          Sub-Investigator: Sebastian Mayer, MD Less <<
NCT02431988 Diffuse Large B-Cell Lymphoma Phase 1 Recruiting December 2020 United Kingdom ... More >> University College London Hospital Recruiting London, United Kingdom Contact: Karl Peggs    +44 2076796236    k.peggs@ucl.ac.uk    Principal Investigator: Karl Peggs Less <<
NCT02625480 Acute Lymphoblastic Leukemia Phase 1 Phase 2 Recruiting October 2034 -
NCT00813124 Stem Cell Transplantation ... More >> Leukemia Less << Phase 2 Completed - United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT03706547 Multiple Myeloma in Relapse ... More >> Multiple Myeloma Progression Less << Phase 1 Not yet recruiting December 2021 China ... More >> Department of Hematology ,Fudan University Zhongshan Hospital Active, not recruiting Shanghai, China, 200032 Less <<
NCT01063647 Hematological Malignancies Phase 1 Phase 2 Completed - Finland ... More >> Helsinki University Central Hospital Helsinki, Finland, FIN-00290 Germany Charité University Hospital Berlin Berlin, Germany, 12203 University Hospital Hamburg Eppendorf Hamburg, Germany, 20246 5th Medical Clinic, Clinic North Nuremberg, Germany, 90340 University Hospital Rostock Rostock, Germany, 18057 Poland Silesian Medical University Katowice, Poland, 40-029 Sweden Karolinska University Hospital & Karolinska Institute Stockholm, Sweden, 141 86 Less <<
NCT03191773 Acute Lymphocytic Leukemia ... More >> Chronic Lymphocytic Leukemia Lymphoma Less << Phase 1 Phase 2 Recruiting December 31, 2020 China, Guangdong ... More >> Department of Hematology, Dongguan People's Hospital Recruiting Dongguan, Guangdong, China Contact: Yirong Jiang, MD    0086 13688967985    dgjyr0769@163.com    Principal Investigator: Yirong Jiang, MD          Department of Hematology, the First People's Hospital of Foshan Recruiting Foshan, Guangdong, China Contact: Zhuowen Chen, MD    0086 18928617712    czwen@fsyyy.com    Contact: Wei Luo, MD    0086 18038865996    luowei_421@163.com    Principal Investigator: Zhuowen Chen, MD          Department of Hematology, Guangzhou First People's Hospital Recruiting Guangzhou, Guangdong, China Contact: Shunqing Wang    0086 13437801998    drwangshq@medmail.com.cn    Principal Investigator: Shunqing Wang, MD          Department of Hematology, The First Affiliated Hospital of Guangdong Pharmaceutical University Recruiting Guangzhou, Guangdong, China Contact: Xueyi Pan    0086 13922217835    xypan88@163.com    Principal Investigator: Xueyi Pan, MD          Department of Hematology,the Second Affiliated Hospital of Guangzhou Medical University Recruiting Guangzhou, Guangdong, China Contact: Ying Feng, MD    0086 13602723030    fyzlply@163.com    Principal Investigator: Ying Feng, MD Less <<
NCT00455312 - Completed - -
NCT03602612 Myeloma-Multiple ... More >> Myeloma, Plasma-Cell Less << Phase 1 Recruiting January 1, 2024 United States, Maryland ... More >> National Institutes of Health Clinical Center Recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact National Cancer Institute Referral Office    888-624-1937 Less <<
NCT01496547 Acute Leukemia Phase 2 Unknown June 2018 China ... More >> Blood & Marrow Transplantation Center, RuiJin Hospital Recruiting Shanghai, China, 200025 Contact: Jiong HU, M.D.          Principal Investigator: Ling Wang, M.D. Less <<
NCT02348216 Refractory Diffuse Large B Cel... More >>l Lymphoma (DLBCL) Relapsed Diffuse Large B-Cell Lymphoma Transformed Follicular Lymphoma (TFL) Primary Mediastinal B-cell Lymphoma (PMBCL) High Grade B-cell Lymphoma (HGBCL) Less << Phase 1 Phase 2 Recruiting October 2034 -
NCT00048399 Graft Failure Phase 1 Phase 2 Terminated - United States, Texas ... More >> Texas Children's Hospital Houston, Texas, United States, 77030 The Methodist Hospital Houston, Texas, United States, 77030 Less <<
NCT00455312 Dyskeratosis Congenita ... More >> Aplastic Anemia Less << Phase 2 Phase 3 Completed - United States, Minnesota ... More >> Masonic Cancer Center, University of Minnesota Minneapolis, Minnesota, United States, 55455 Less <<
NCT00049504 - Completed - -
NCT00049504 Accelerated Phase Chronic Myel... More >>ogenous Leukemia Adult Acute Lymphoblastic Leukemia in Remission Adult Acute Myeloid Leukemia in Remission Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities Adult Acute Myeloid Leukemia With Del(5q) Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) Adult Acute Myeloid Leukemia With t(15;17)(q22;q12) Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) Adult Acute Myeloid Leukemia With t(8;21)(q22;q22) Adult Nasal Type Extranodal NK/T-cell Lymphoma Anaplastic Large Cell Lymphoma Angioimmunoblastic T-cell Lymphoma Childhood Acute Lymphoblastic Leukemia in Remission Childhood Acute Myeloid Leukemia in Remission Childhood Burkitt Lymphoma Childhood Chronic Myelogenous Leukemia Childhood Myelodysplastic Syndromes Childhood Nasal Type Extranodal NK/T-cell Lymphoma Cutaneous B-cell Non-Hodgkin Lymphoma de Novo Myelodysplastic Syndromes Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue Hematopoietic/Lymphoid Cancer Hepatosplenic T-cell Lymphoma Intraocular Lymphoma Nodal Marginal Zone B-cell Lymphoma Peripheral T-cell Lymphoma Post-transplant Lymphoproliferative Disorder Previously Treated Myelodysplastic Syndromes Recurrent Adult Burkitt Lymphoma Recurrent Adult Diffuse Large Cell Lymphoma Recurrent Adult Diffuse Mixed Cell Lymphoma Recurrent Adult Diffuse Small Cleaved Cell Lymphoma Recurrent Adult Grade III Lymphomatoid Granulomatosis Recurrent Adult Hodgkin Lymphoma Recurrent Adult Immunoblastic Large Cell Lymphoma Recurrent Adult Lymphoblastic Lymphoma Recurrent Adult T-cell Leukemia/Lymphoma Recurrent Childhood Anaplastic Large Cell Lymphoma Recurrent Childhood Grade III Lymphomatoid Granulomatosis Recurrent Childhood Large Cell Lymphoma Recurrent Childhood Lymphoblastic Lymphoma Recurrent Childhood Small Noncleaved Cell Lymphoma Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma Recurrent Grade 1 Follicular Lymphoma Recurrent Grade 2 Follicular Lymphoma Recurrent Grade 3 Follicular Lymphoma Recurrent Mantle Cell Lymphoma Recurrent Marginal Zone Lymphoma Recurrent Mycosis Fungoides/Sezary Syndrome Recurrent Small Lymphocytic Lymphoma Recurrent/Refractory Childhood Hodgkin Lymphoma Refractory Chronic Lymphocytic Leukemia Refractory Multiple Myeloma Relapsing Chronic Myelogenous Leukemia Secondary Myelodysplastic Syndromes Small Intestine Lymphoma Splenic Marginal Zone Lymphoma Stage II Multiple Myeloma Stage III Adult Burkitt Lymphoma Stage III Adult Diffuse Large Cell Lymphoma Stage III Adult Diffuse Mixed Cell Lymphoma Stage III Adult Diffuse Small Cleaved Cell Lymphoma Stage III Adult Hodgkin Lymphoma Stage III Adult Immunoblastic Large Cell Lymphoma Stage III Adult Lymphoblastic Lymphoma Stage III Adult T-cell Leukemia/Lymphoma Stage III Childhood Hodgkin Lymphoma Stage III Chronic Lymphocytic Leukemia Stage III Cutaneous T-cell Non-Hodgkin Lymphoma Stage III Grade 1 Follicular Lymphoma Stage III Grade 2 Follicular Lymphoma Stage III Grade 3 Follicular Lymphoma Stage III Mantle Cell Lymphoma Stage III Marginal Zone Lymphoma Stage III Multiple Myeloma Stage III Mycosis Fungoides/Sezary Syndrome Stage III Small Lymphocytic Lymphoma Stage IV Adult Burkitt Lymphoma Stage IV Adult Diffuse Large Cell Lymphoma Stage IV Adult Diffuse Mixed Cell Lymphoma Stage IV Adult Diffuse Small Cleaved Cell Lymphoma Stage IV Adult Hodgkin Lymphoma Stage IV Adult Immunoblastic Large Cell Lymphoma Stage IV Adult Lymphoblastic Lymphoma Stage IV Adult T-cell Leukemia/Lymphoma Stage IV Childhood Hodgkin Lymphoma Stage IV Chronic Lymphocytic Leukemia Stage IV Cutaneous T-cell Non-Hodgkin Lymphoma Stage IV Grade 1 Follicular Lymphoma Stage IV Grade 2 Follicular Lymphoma Stage IV Grade 3 Follicular Lymphoma Stage IV Mantle Cell Lymphoma Stage IV Marginal Zone Lymphoma Stage IV Mycosis Fungoides/Sezary Syndrome Stage IV Small Lymphocytic Lymphoma Testicular Lymphoma Waldenstr?m Macroglobulinemia Less << Phase 2 Completed - United States, Washington ... More >> Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 Less <<
NCT00076752 Lupus Erythematosus, Systemic Phase 2 Completed - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT02724904 Lymphoma Phase 1 Phase 2 Withdrawn(Drug logistics) December 2021 United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02115 Dana Farber Cancer Institute Boston, Massachusetts, United States, 02215 Less <<
NCT00045435 Acute Myeloid Leukemia With Mu... More >>ltilineage Dysplasia Following Myelodysplastic Syndrome Adult Acute Megakaryoblastic Leukemia (M7) Adult Acute Minimally Differentiated Myeloid Leukemia (M0) Adult Acute Monoblastic Leukemia (M5a) Adult Acute Monocytic Leukemia (M5b) Adult Acute Myeloblastic Leukemia With Maturation (M2) Adult Acute Myeloblastic Leukemia Without Maturation (M1) Adult Acute Myeloid Leukemia in Remission Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities Adult Acute Myeloid Leukemia With Del(5q) Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) Adult Acute Myeloid Leukemia With t(8;21)(q22;q22) Adult Acute Myelomonocytic Leukemia (M4) Adult Erythroleukemia (M6a) Adult Pure Erythroid Leukemia (M6b) Secondary Acute Myeloid Leukemia Less << Phase 2 Active, not recruiting - United States, Oregon ... More >> OHSU Cancer Institute Portland, Oregon, United States, 97210 United States, Washington Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 Less <<
NCT03016377 Acute Lymphoblastic Leukemia ... More >> Immune System Diseases Immunoproliferative Disorders Less << Phase 1 Recruiting October 2036 United States, North Carolina ... More >> Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill Recruiting Chapel Hill, North Carolina, United States, 27599 Contact: Catherine Cheng    919-445-4208    catherine_cheng@med.unc.edu    Contact: Spencer Laing    (919) 445-4208    spencer.laing@med.unc.edu    Principal Investigator: Matthew Foster, MD Less <<
NCT00045435 - Active, not recruiting - -
NCT03624036 Relapsed/Refractory Chronic Ly... More >>mphocytic Leukemia Less << Phase 1 Phase 2 Recruiting September 2035 United States, Tennessee ... More >> Sarah Cannon Research Center Recruiting Nashville, Tennessee, United States, 37203 Contact: Renee Thompson       Renee.Thompson@sarahcannon.com    Principal Investigator: Ian Flinn Less <<
NCT03761056 B-cell Lymphoma Phase 2 Recruiting December 2034 United States, Texas ... More >> MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact: Liliana Vallejo       LNVallejo@mdanderson.org    Contact: Yiming Chen       Yichen@mdanderson.org    Principal Investigator: Sattva Neelapu Less <<
NCT00357565 Leukemia Myel... More >>odysplastic Syndromes Childhood Acute Myeloid Leukemia in Remission Recurrent Childhood Acute Myeloid Leukemia Secondary Acute Myeloid Leukemia Childhood Acute Lymphoblastic Leukemia in Remission Previously Treated Myelodysplastic Syndrome Secondary Myelodysplastic Syndrome Refractory Anemia With Excess Blasts in Transformation Refractory Anemia With Excess Blasts Refractory Anemia De Novo Myelodysplastic Syndrome Childhood Myelodysplastic Syndrome Less << Phase 2 Recruiting February 2019 United States, Minnesota ... More >> Masonic Cancer Center, University of Minnesota Recruiting Minneapolis, Minnesota, United States, 55455 Contact: Christen Ebens, MD    612-624-0123    ebens012@umn.edu Less <<
NCT03743246 Precursor Cell Lymphoblastic L... More >>eukemia-Lymphoma Lymphoma, Non-Hodgkin Less << Phase 1 Phase 2 Recruiting December 1, 2023 Spain ... More >> Hospital Infantil Universitario Niño Jesús Recruiting Madrid, Spain, 28009 Less <<
NCT01141959 - Completed - United States, Washington ... More >> Fred Hutchinson Cancer Research Center Seattle, Washington, United States, 98109 Less <<
NCT02678143 Sickle Cell Disease Phase 1 Recruiting May 31, 2020 United States, Missouri ... More >> Washington University School of Medicine Recruiting Saint Louis, Missouri, United States, 63110 Contact: Mark A Schroeder, M.D.    314-454-8304    markschroeder@wustl.edu    Principal Investigator: Mark A Schroeder, M.D.          Sub-Investigator: Bader Alahmari, M.D.          Sub-Investigator: Morey Blinder, M.D.          Sub-Investigator: Allison King, M.D. Less <<
NCT00343798 Accelerated Phase Chronic Myel... More >>ogenous Leukemia Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome Adult Acute Lymphoblastic Leukemia in Remission Adult Acute Myeloid Leukemia in Remission Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities Adult Acute Myeloid Leukemia With Del(5q) Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) Adult Acute Myeloid Leukemia With t(15;17)(q22;q12) Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) Adult Acute Myeloid Leukemia With t(8;21)(q22;q22) Adult Nasal Type Extranodal NK/T-cell Lymphoma Anaplastic Large Cell Lymphoma Childhood Acute Lymphoblastic Leukemia in Remission Childhood Acute Myeloid Leukemia in Remission Childhood Burkitt Lymphoma Childhood Chronic Myelogenous Leukemia Childhood Diffuse Large Cell Lymphoma Childhood Immunoblastic Large Cell Lymphoma Childhood Myelodysplastic Syndromes Childhood Nasal Type Extranodal NK/T-cell Lymphoma Chronic Phase Chronic Myelogenous Leukemia Contiguous Stage II Adult Burkitt Lymphoma Contiguous Stage II Adult Diffuse Large Cell Lymphoma Contiguous Stage II Adult Diffuse Mixed Cell Lymphoma Contiguous Stage II Adult Immunoblastic Large Cell Lymphoma Contiguous Stage II Adult Lymphoblastic Lymphoma Contiguous Stage II Grade 3 Follicular Lymphoma Contiguous Stage II Mantle Cell Lymphoma de Novo Myelodysplastic Syndromes Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue Nodal Marginal Zone B-cell Lymphoma Noncontiguous Stage II Adult Burkitt Lymphoma Noncontiguous Stage II Adult Diffuse Large Cell Lymphoma Noncontiguous Stage II Adult Diffuse Mixed Cell Lymphoma Noncontiguous Stage II Adult Immunoblastic Large Cell Lymphoma Noncontiguous Stage II Adult Lymphoblastic Lymphoma Noncontiguous Stage II Grade 3 Follicular Lymphoma Noncontiguous Stage II Mantle Cell Lymphoma Previously Treated Myelodysplastic Syndromes Prolymphocytic Leukemia Recurrent Adult Burkitt Lymphoma Recurrent Adult Diffuse Large Cell Lymphoma Recurrent Adult Diffuse Mixed Cell Lymphoma Recurrent Adult Grade III Lymphomatoid Granulomatosis Recurrent Adult Immunoblastic Large Cell Lymphoma Recurrent Adult Lymphoblastic Lymphoma Recurrent Childhood Anaplastic Large Cell Lymphoma Recurrent Childhood Grade III Lymphomatoid Granulomatosis Recurrent Childhood Large Cell Lymphoma Recurrent Childhood Lymphoblastic Lymphoma Recurrent Grade 1 Follicular Lymphoma Recurrent Grade 2 Follicular Lymphoma Recurrent Grade 3 Follicular Lymphoma Recurrent Mantle Cell Lymphoma Recurrent Marginal Zone Lymphoma Recurrent Small Lymphocytic Lymphoma Refractory Anemia Refractory Anemia With Excess Blasts Refractory Anemia With Excess Blasts in Transformation Refractory Chronic Lymphocytic Leukemia Refractory Multiple Myeloma Secondary Acute Myeloid Leukemia Secondary Myelodysplastic Syndromes Splenic Marginal Zone Lymphoma Stage I Adult Burkitt Lymphoma Stage I Adult Diffuse Large Cell Lymphoma Stage I Adult Diffuse Mixed Cell Lymphoma Stage I Adult Immunoblastic Large Cell Lymphoma Stage I Adult Lymphoblastic Lymphoma Stage I Childhood Lymphoblastic Lymphoma Stage I Grade 3 Follicular Lymphoma Stage I Mantle Cell Lymphoma Stage II Childhood Lymphoblastic Lymphoma Stage III Adult Burkitt Lymphoma Stage III Adult Diffuse Large Cell Lymphoma Stage III Adult Diffuse Mixed Cell Lymphoma Stage III Adult Immunoblastic Large Cell Lymphoma Stage III Adult Lymphoblastic Lymphoma Stage III Childhood Lymphoblastic Lymphoma Stage III Grade 3 Follicular Lymphoma Stage III Mantle Cell Lymphoma Stage IV Adult Burkitt Lymphoma Stage IV Adult Diffuse Large Cell Lymphoma Stage IV Adult Diffuse Mixed Cell Lymphoma Stage IV Adult Immunoblastic Large Cell Lymphoma Stage IV Adult Lymphoblastic Lymphoma Stage IV Childhood Lymphoblastic Lymphoma Stage IV Grade 3 Follicular Lymphoma Stage IV Mantle Cell Lymphoma Less << Phase 1 Completed - United States, California ... More >> City of Hope Medical Center Duarte, California, United States, 91010 United States, Colorado University of Colorado Cancer Center - Anschutz Cancer Pavilion Aurora, Colorado, United States, 80045 University of Colorado Denver, Colorado, United States, 80217-3364 United States, Washington Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 Less <<
NCT02194374 Leukemia Phase 1 Withdrawn(Study closed with no... More >> enrollment due to unavailability of reagent.) Less << - -
NCT02400281 Acute Myeloid Leukemia Phase 1 Phase 2 Active, not recruiting April 2020 United States, Texas ... More >> MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00076752 - Completed - -
NCT03573700 Acute Lymphoblastic Leukemia, ... More >>in Relapse Acute Lymphoblastic Leukemia, Refractory Less << Phase 1 Phase 2 Recruiting July 1, 2024 United States, Tennessee ... More >> St. Jude Children's Research Hospital Recruiting Memphis, Tennessee, United States, 38105 Contact: Aimee C. Talleur, MD    866-278-5833    referralinfo@stjude.org    Principal Investigator: Aimee C. Talleur, MD Less <<
NCT00946023 - Terminated(Funding was unavail... More >>able to complete the study as originally planned.) Less << - -
NCT01175785 Accelerated Phase Chronic Myel... More >>ogenous Leukemia Adult Acute Myeloid Leukemia in Remission Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities Adult Acute Myeloid Leukemia With Del(5q) Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) Adult Acute Myeloid Leukemia With t(15;17)(q22;q12) Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) Adult Acute Myeloid Leukemia With t(8;21)(q22;q22) Childhood Acute Lymphoblastic Leukemia in Remission Childhood Acute Myeloid Leukemia in Remission Childhood Chronic Myelogenous Leukemia Childhood Myelodysplastic Syndromes Chronic Phase Chronic Myelogenous Leukemia de Novo Myelodysplastic Syndromes Previously Treated Myelodysplastic Syndromes Refractory Anemia Refractory Anemia With Excess Blasts Refractory Anemia With Excess Blasts in Transformation Relapsing Chronic Myelogenous Leukemia Secondary Myelodysplastic Syndromes Less << Phase 2 Completed - United States, Washington ... More >> Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 Less <<
NCT02320383 Chronic Lymphocytic Leucemia Phase 2 Active, not recruiting September 2022 Germany ... More >> German CLL Study Group Cologne, Germany, 50923 Less <<
NCT00028418 Hematologic Neoplasms ... More >> Lymphoproliferative Disorders Leukemia Leukemia, Lymphocytic, Chronic Less << Phase 1 Completed - United States, Texas ... More >> University of Texas M. D. Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00946023 Lymphoma B-ce... More >>ll Lymphoma Non Hodgkin Lymphoma Chronic Lymphocytic Leukemia Less << Phase 2 Terminated(Funding was unavail... More >>able to complete the study as originally planned.) Less << - United States, Maryland ... More >> Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States, 21231 Less <<
NCT00048737 Lymphoma Leuk... More >>emia Less << Phase 1 Phase 2 Completed - United States, Texas ... More >> MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00303719 Kidney Cancer ... More >> Leukemia Lymphoma Multiple Myeloma Plasma Cell Neoplasm Myelodysplastic Syndromes Less << Phase 2 Active, not recruiting December 2021 United States, Minnesota ... More >> Masonic Cancer Center, University of Minnesota Minneapolis, Minnesota, United States, 55455 Less <<
NCT00988715 Chronic Myelomonocytic Leukemi... More >>a Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable Previously Treated Myelodysplastic Syndrome Recurrent Adult Acute Lymphoblastic Leukemia Recurrent Adult Acute Myeloid Leukemia Refractory Anemia With Excess Blasts Refractory Cytopenia With Multilineage Dysplasia Refractory Cytopenia With Multilineage Dysplasia and Ringed Sideroblasts Secondary Acute Myeloid Leukemia Less << Phase 1 Completed - United States, Washington ... More >> Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 Less <<
NCT00048737 - Completed - -
NCT00392782 - Terminated - -
NCT03615144 Non-Malignant Hematologic Diso... More >>rders Less << Phase 2 Recruiting July 2021 United States, New York ... More >> Memorial SloanKettering Cancer Center Recruiting New York, New York, United States, 10065 Contact: Maria Cancio, MD    212-639-2446       Contact: Farid Boulad, MD    212-639-6684       Principal Investigator: Maria Cancio, MD Less <<
NCT03399773 Acute Biphenotypic Leukemia ... More >> Acute Lymphoblastic Leukemia Acute Myeloid Leukemia Chronic Myelogenous Leukemia Myelodysplastic Syndromes Less << Phase 2 Recruiting August 2021 United States, New York ... More >> Memorial Sloan Kettering Cancer Center Not yet recruiting New York, New York, United States, 10065 United States, Washington Fred Hutch/University of Washington Cancer Consortium Recruiting Seattle, Washington, United States, 98109 Less <<
NCT00392782 Leukemia Myel... More >>odysplastic Syndromes Less << Phase 2 Terminated - United States, Florida ... More >> Moffitt Cancer Center Tampa, Florida, United States, 33612 United States, Georgia Winship Cancer Institute of Emory University Atlanta, Georgia, United States, 30322 United States, Indiana Indiana University Melvin and Bren Simon Cancer Center Indianapolis, Indiana, United States, 46202-5289 United States, Minnesota Masonic Cancer Center at University of Minnesota Minneapolis, Minnesota, United States, 55455 United States, Missouri Siteman Cancer Center at Barnes-Jewish Hospital - Saint Louis Saint Louis, Missouri, United States, 63110 United States, Ohio Arthur G. James Cancer Hospital and Richard J. Solove Research Institute at Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States, 43210-1240 United States, Pennsylvania Abramson Cancer Center of the University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104-4283 United States, Wisconsin Medical College of Wisconsin Cancer Center Milwaukee, Wisconsin, United States, 53226 Midwest Children's Cancer Center at Children's Hospital of Wisconsin Milwaukee, Wisconsin, United States, 53226 Less <<
NCT01369875 Metastatic Melanoma ... More >> Skin Cancer Less << Phase 2 Completed - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT01369875 - Completed - -
NCT02423915 Leukemia Lymp... More >>homa Less << Phase 1 Phase 2 Active, not recruiting July 2019 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00622895 - Completed - -
NCT00303667 - Completed - -
NCT00670410 Neuroblastoma Phase 1 Terminated(Poor accrual) - United States, New York ... More >> Columbia Presbyterian Medical Center, Morgan Stanley Children's Hospital New York Presbyterian New York, New York, United States, 10032 Less <<
NCT03585764 Ovarian Cancer ... More >> Fallopian Tube Cancer Primary Peritoneal Carcinoma Less << Phase 1 Recruiting October 2035 United States, Pennsylvania ... More >> University of Pennsylvania Health System Recruiting Philadelphia, Pennsylvania, United States, 19104 Contact: Payal D Shah, MD    855-216-0098    PennCancerTrials@emergingmed.com Less <<
NCT00622895 Systemic Scleroderma ... More >> Severe Systemic Sclerosis Less << Phase 1 Phase 2 Completed - United States, Colorado ... More >> Colorado Blood Cancer Institute Denver, Colorado, United States, 80218 United States, Washington Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 Less <<
NCT02774291 HLA-A2 Positive Cells Present ... More >> Metastatic Malignant Neoplasm Metastatic Malignant Neoplasm in the Brain Less << Not Applicable Recruiting February 2020 United States, New York ... More >> Albert Einstein College of Medicine Recruiting Bronx, New York, United States, 10461 Contact: Ira Braunschweig    718-920-4826    aecc@aecom.yu.edu    Principal Investigator: Ira Braunschweig Less <<
NCT02354690 Metastatic Melanoma Phase 1 Phase 2 Active, not recruiting August 2020 Denmark ... More >> Center for Cancer Immune Therapy, Dept. of Haematology/Oncology Copenhagen, Herlev, Denmark, 2730 Less <<
NCT00303667 Acute Myelogenous Leukemia Phase 1 Phase 2 Completed - United States, Minnesota ... More >> Masonic Cancer Center, University of Minnesota Minneapolis, Minnesota, United States, 55455 Less <<
NCT00764829 - Completed - United States, Washington ... More >> Fred Hutchinson Cancer Research Center Seattle, Washington, United States, 98109 Less <<
NCT02707393 Chronic Myeloid Leukemia Phase 2 Phase 3 Recruiting January 2024 Austria ... More >> Universitätsklinik für Kinder- und Jugendheilkunde Not yet recruiting Graz, Austria, 8036 Contact: Christian Urban, Prof., MD    0043-316-385 ext 3485    christian.urban@medunigraz.at    Principal Investigator: Christian Urban, Prof., MD          St. Anna Kinderspital Recruiting Wien, Austria, 1050 Contact: Susanne Matthes, MD    0043-1-40170 ext 3100    susanne.matthes@stanna.at    Contact: Christina Peters, Prof., MD    0043-1-40170 ext 3100    christina.peters@stanna.at    Principal Investigator: Susanne Matthes, MD          Czechia Hospital Motol, Department of Pediatric Hematology and Oncology, BMT Unit Recruiting Praha, Czechia, 15006 Contact: Petr Sedlacek, MD    00420-22443 ext 6552    Petr.Sedlacek@fnmotol.cz    Principal Investigator: Petr Sedlacek, MD          Italy Clinica Pediatrica Recruiting Monza, Italy, 20052 Contact: Adriana Balduzzi, MD       abalduzzi@fondazionembbm.it Less <<
NCT00427557 Multiple Myeloma ... More >> Leukemia Lymphoma Less << Phase 2 Completed - United States, Texas ... More >> UT MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00427557 - Completed - -
NCT01946373 Melanoma Phase 1 Recruiting December 2018 Sweden ... More >> Karolinska University Hospital Recruiting Stockholm, Sweden, SE-171 76 Contact: Roger Tell, MD, PhD    +46760293911    roger.tell@ki.se    Principal Investigator: Roger Tell, MD, PhD Less <<
NCT02661035 Acute Myelogenous Leukemia ... More >> Acute Lymphocytic Leukemia Chronic Myelogenous Leukemia Plasma Cell Leukemia Myelodysplastic Syndromes Chronic Lymphocytic Leukemia Small Lymphocytic Lymphoma B-Cell Lymphoma Follicular Lymphoma Lymphoplasmacytic Lymphoma Mantle-Cell Lymphoma Prolymphocytic Leukemia Lymphoblastic Lymphoma Burkitt's Lymphoma Non-Hodgkin's Lymphoma Multiple Myeloma Myeloproliferative Syndromes Hematological Diseases Less << Phase 2 Recruiting March 2023 United States, Minnesota ... More >> Masonic Cancer Center at University of Minnesota Recruiting Minneapolis, Minnesota, United States, 55455 Contact: Tim Krepski    612-273-2800    tkrepsk1@fairview.org    Principal Investigator: Erica Warlick, MD Less <<
NCT01339910 Leukemia, Myelocytic, Acute Phase 3 Terminated(Accrual terminated ... More >>as recommended by the data and safety monitoring board.) Less << - -
NCT01010217 Blood Stem Cell Transplant Fai... More >>lure Leukemia Hematologic Malignancies Less << Phase 2 Completed - United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00027924 Leukemia Myel... More >>odysplastic Syndromes Less << Phase 2 Completed - United States, Washington ... More >> Fred Hutchinson Cancer Research Center Seattle, Washington, United States, 98109-1024 Less <<
NCT02666898 Leukemia, Lymphocytic, Chronic... More >>, B-Cell Less << Phase 2 Completed - France ... More >> Sponsor FILO Tours, France, 37054 Less <<
NCT00652899 Fallopian Tube Cancer ... More >> Ovarian Cancer Peritoneal Cavity Cancer Less << Phase 2 Terminated(Withdrawn due to to... More >>xicity) Less << - United States, Minnesota ... More >> Masonic Cancer Center at University of Minnesota Minneapolis, Minnesota, United States, 55455 Less <<
NCT00652899 - Terminated(Withdrawn due to to... More >>xicity) Less << - -
NCT01339910 - Terminated(Accrual terminated ... More >>as recommended by the data and safety monitoring board.) Less << - -
NCT00645606 Leukemia Phase 3 Completed - France ... More >> French Innovative leukemia Organization TOURS Cedex, France, 37044 Less <<
NCT03696784 Lymphoma Lymp... More >>homa, B-Cell Immune System Diseases Immunoproliferative Disorders Lymphatic Diseases Less << Phase 1 Not yet recruiting October 30, 2033 United States, North Carolina ... More >> Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill Not yet recruiting Chapel Hill, North Carolina, United States, 27599 Contact: Catherine Cheng    919-445-4208    catherine_cheng@med.unc.edu    Contact: Spencer Laing    919-962-8618    ssblaing@email.unc.edu    Principal Investigator: Grover Natalie, MD Less <<
NCT02385955 Hematologic Malignancy Phase 2 Not yet recruiting April 2019 -
NCT03549442 Multiple Myeloma Phase 1 Recruiting May 2021 United States, Pennsylvania ... More >> Univ. of Pennsylvania Recruiting Philadelphia, Pennsylvania, United States, 19104 Contact: Alfred Garfall, MD Less <<
NCT00489281 Sickle Cell Disease Phase 2 Active, not recruiting December 2018 United States, Maryland ... More >> Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States, 21231-2410 Less <<
NCT01319565 Metastatic Melanoma ... More >> Skin Cancer Less << Phase 2 Active, not recruiting June 1, 2020 United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT01875237 Leukemia Myel... More >>oma Myeloproliferative Diseases Less << Phase 1 Phase 2 Terminated - United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00038844 Lymphoma Leuk... More >>emia Less << Not Applicable Completed - United States, Texas ... More >> U.T.M.D. Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00924001 Melanoma Mali... More >>gnant Melanoma Melanoma, Experimental Less << Phase 1 Phase 2 Terminated(study was stopped d... More >>ue to low accrual) Less << - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT02867800 Sickle Cell Disease ... More >> Graft Versus Host Disease Less << Phase 1 Recruiting December 2019 United States, District of Col... More >>umbia Children's National Medical Center Recruiting Washington, District of Columbia, United States, 20010 Contact: Shahleen Ahmed, CRC    202-476-6850    szahmed@childrensnational.org    Principal Investigator: Allistair Abraham, MD          United States, Georgia Children's Healthcare of Atlanta Recruiting Atlanta, Georgia, United States, 30322 Contact: Kelsey Rogowski, MPH    404-785-7749    Kelsey.Rogowski@choa.org    Principal Investigator: Ann Haight, MD          United States, Illinois Ann & Robert H. Lurie Children's Hospital of Chicago Recruiting Chicago, Illinois, United States, 60611 Contact: Nicole Fisher, CRC    312-227-4871    nfisher@luriechildrens.org    Principal Investigator: Sonali Chaudhury, MD          United States, New York Columbia University Medical Center Recruiting New York, New York, United States, 10032 Contact: Danielle Dietzen, NP    212-305-8443    dad9025@nyp.org    Contact: Jean Sosna, RN MS    212-305-2050    js4403@cumc.columbia.edu    Principal Investigator: Monica Bhatia, MD          United States, North Carolina North Carolina Cancer Hospital Not yet recruiting Chapel Hill, North Carolina, United States, 27514 Contact: Juanita Cuffee    919-962-8733    cuffee@med.unc.edu    Principal Investigator: Kimberly Kasow, MD          United States, Ohio Nationwide Children's Hospital Recruiting Columbus, Ohio, United States, 43205 Contact: Mary Beth Scholz, RN    614-722-3654    Mary.Scholz@nationwidechildrens.org    Principal Investigator: Hemalatha Rangarajan, MD Less <<
NCT00924001 - Terminated(study was stopped d... More >>ue to low accrual) Less << - -
NCT00376519 Graft Versus Host Disease ... More >> Leukemia Lymphoma Multiple Myeloma and Plasma Cell Neoplasm Myelodysplastic Syndromes Secondary Myelofibrosis Less << Phase 1 Terminated(Slow accrual) - United States, Minnesota ... More >> Masonic Cancer Center at University of Minnesota Minneapolis, Minnesota, United States, 55455 Less <<
NCT01995344 Metastatic Melanoma Phase 2 Unknown December 2018 United Kingdom ... More >> The Christie NHS Foundation Trust Manchester, Greater Manchester, United Kingdom, M20 4BX Less <<
NCT00988013 Acute Myeloid Leukemia ... More >> Lymphoblastic Leukemia Acute Leukemia Non Hodgkins Lymphoma Chronic Myeloid Leukemia Less << Phase 1 Unknown September 2017 United States, Illinois ... More >> University of Illinois at Chicago Chicago, Illinois, United States, 60612 Less <<
NCT00006090 Leukemia Phase 2 Withdrawn(No enrollment.) - -
NCT00304720 Multiple Myeloma ... More >> Lymphoma Acute Myelogenous Leukemia Acute Lymphocytic Leukemia Myelodysplastic Syndrome Less << Phase 2 Unknown - United States, Colorado ... More >> Rocky Mountain Blood and Marrow Transplant Program Recruiting Denver, Colorado, United States, 80218 Contact: Peter A McSweeney, MD    303-336-2184    Peter.McSweeney@usoncology.com    Contact: Juli B Murphy    303-285-5087    Juli.Murphy@usoncology.com    Sub-Investigator: Robert M Rifkin, MD          Principal Investigator: Peter A McSweeney, MD          Sub-Investigator: Jeffrey V Matous, MD          Sub-Investigator: Scott I Bearman, MD          Sub-Investigator: Mark W Brunvand, MD          Sub-Investigator: Michael B Maris, MD Less <<
NCT00448357 Chronic Myeloproliferative Dis... More >>orders Leukemia Lymphoma Multiple Myeloma and Plasma Cell Neoplasm Myelodysplastic Syndromes Less << Phase 1 Phase 2 Completed - United States, North Carolina ... More >> Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill Chapel Hill, North Carolina, United States, 27599-7295 Less <<
NCT01821781 Immune Deficiency Disorders ... More >> Severe Combined Immunodeficiency Chronic Granulomatous Disease X-linked Agammaglobulinemia Wiskott-Aldrich Syndrome Hyper-IgM DiGeorge Syndrome Chediak-Higashi Syndrome Common Variable Immune Deficiency Immune Dysregulatory Disorders Hemophagocytic Lymphohistiocytosis IPEX Autoimmune Lymphoproliferative Syndrome X-linked Lymphoproliferative Syndrome Less << Phase 2 Recruiting March 2021 United States, Missouri ... More >> Washington University Recruiting Saint Louis, Missouri, United States, 63110 Contact: Jeffrey Bednarski, MD    314-454-6018    Bednarski_J@kids.wustl.edu    Contact: Lisa Murray, CCRP    314-454-4240    Murray_L@kids.wustl.edu    Principal Investigator: Jeffrey Bednarski, MD          United States, Texas Methodist Heathcare Recruiting San Antonio, Texas, United States, 78229 Contact: Troy Quigg, DO, MS       Troy.Quigg@mhshealth.com Less <<
NCT01585428 - Completed - -
NCT02766868 Lymphoblastic Leukemia, Acute,... More >> Adult Less << Phase 2 Recruiting July 2019 China ... More >> Blood & Marrow Transplantation Center, RuiJin Hospital Recruiting Shanghai, China, 200025 Contact: Ling Wang    86-21-64370045 ext 601818    cclingjar@163.com Less <<
NCT00448357 - Completed - -
NCT01585428 Cervical Cancer ... More >> Oropharyngeal Cancer Vaginal Cancer Anal Cancer Penile Cancer Less << Phase 2 Completed - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT02441803 Leukemia Phase 2 Active, not recruiting September 2023 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00875667 Mantle Cell Lymphoma ... More >> Lymphoma, Mantle-Cell Less << Phase 2 Active, not recruiting July 5, 2019 -
NCT02507479 Non Hodgkin Lymphoma ... More >> Hodgkin Lymphoma Chronic Lymphocytic Leukemia Multiple Myeloma Less << Phase 2 Recruiting July 2019 Israel ... More >> Chaim Sheba Medical Center Recruiting Tel-Hashomer, Israel, 52621 Contact: Arnon Nagler, MD    972 3 530 5830    a.nagler@sheba.health.gov.il    Contact: Avichai Shimoni, MD    972 3 530 5303    ashimoni@sheba.health.gov.il    Sub-Investigator: Avichai Shimoni, MD          Chaim Sheba Medical Center Recruiting Tel-Hashomer, Israel Principal Investigator: Arnon Nagler, MD Less <<
NCT03687463 - Enrolling by invitation April 10, 2020 -
NCT03171220 Advanced Malignant Solid Tumor Phase 1 Phase 2 Recruiting December 31, 2020 China, Jiangsu ... More >> The Comprehensive Cancer Centre of Drum Tower Hospital, Medical School of Nanjing University and Clinical Cancer Institute of Nanjing University Recruiting Nanjing, Jiangsu, China, 210008 Contact: Baorui Liu, M.D. & Ph.D    +86-25-83304616 ext 61331    baoruiliu@nju.edu.cn    Contact: Zhengyun Zou, M.D. & Ph.D    +86-25-83304616 ext 61331    zouzhengyun@medmail.com.cn Less <<
NCT01079013 Non Hodgkin Lymphoma ... More >> Hodgkin Lymphoma Less << Phase 2 Unknown April 2018 Israel ... More >> Chaim Sheba Medical Center Tel-Hashomer, Israel, 52621 Less <<
NCT03509961 B-cell Acute Lymphoblastic Leu... More >>kemia Less << Phase 2 Recruiting April 1, 2022 United States, California ... More >> Children's Hospital Los Angeles Recruiting Los Angeles, California, United States, 90027 Contact: Aunsha Williamson    323-361-7551    awilliamson@chla.usc.edu    Principal Investigator: Hisham Abdel-Azim, MD          United States, Texas Methodist Healthcare System Recruiting San Antonio, Texas, United States, 78229 Contact: Candace Taylor    210-575-7379    Candace.taylor@mhshealth.com    Principal Investigator: Troy Quigg, DO Less <<
NCT00091611 Kidney Neoplasms Phase 1 Terminated(This study was term... More >>inated due to low accrual.) Less << - United States, Maryland ... More >> National Cancer Institute (NCI) Bethesda, Maryland, United States, 20892 Less <<
NCT01534143 - Terminated(Data was not collec... More >>ted, because funding was unavailable to continue study.) Less << - -
NCT02626338 Relapsed/Refractory Acute Myel... More >>oid Leukemia (AML) Less << Phase 1 Phase 2 Completed - United States, Arkansas ... More >> University of Arkansas Little Rock, Arkansas, United States, 72205 United States, California City of Hope Medical Center Duarte, California, United States, 91010 United States, Texas University of Texas Southwestern Medical Center Dallas, Texas, United States, 75390 Houston Methodist Houston, Texas, United States, 77030 Less <<
NCT02833805 Severe Aplastic Anemia ... More >> Aplastic Anemia Bone Marrow Failure Immunosuppression Less << Phase 2 Recruiting August 2020 United States, Maryland ... More >> Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Recruiting Baltimore, Maryland, United States, 21287 Contact: Amy E DeZern, MD    410-502-7208    adezern1@jhmi.edu Less <<
NCT00509288 Melanoma Skin... More >> Cancer Less << Phase 2 Completed - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT00473551 Leukemia Lymp... More >>homa Myeloma Less << Phase 1 Terminated(Terminated due to s... More >>low accrual.) Less << - United States, Texas ... More >> U.T.M.D. Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT01534143 Refractory Multiple Myeloma ... More >> Stage I Multiple Myeloma Stage II Multiple Myeloma Stage III Multiple Myeloma Less << Phase 2 Terminated(Data was not collec... More >>ted, because funding was unavailable to continue study.) Less << - United States, Michigan ... More >> Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States, 48201 Less <<
NCT02614560 Acute Myeloid Leukemia Phase 1 Phase 2 Terminated - United States, California ... More >> City of Hope National Medical Center Duarte, California, United States, 91010-3000 United States, Colorado Colorado Blood Cancer Institute Denver, Colorado, United States, 80218 United States, Florida H. Lee Moffitt Cancer Center & Research Institute Tampa, Florida, United States, 33612 United States, Illinois University of Chicago Chicago, Illinois, United States, 60637-1470 United States, Kansas University of Kansas Cancer Center Westwood, Kansas, United States, United States United States, Massachusetts Dana Farber Cancer Institute Boston, Massachusetts, United States, 02215 United States, New York Memorial Sloan Kettering Cancer Center New York, New York, United States, 10021 Weill Cornell Medical College New York, New York, United States, 10065 United States, Ohio Case Western Reserve University / University Hospitals Case Medical Center Cleveland, Ohio, United States, 44106 United States, Texas MD Anderson Cancer Center / University of Texas Houston, Texas, United States, 77030-4095 United States, Washington Fred Hutchinson Cancer Research Center Seattle, Washington, United States, 98109-1024 Less <<
NCT00314106 - Completed - -
NCT00509288 - Completed - -
NCT00001832 - Completed - -
NCT00314106 Metastatic Melanoma Phase 2 Completed - United States, Maryland ... More >> National Cancer Institute (NCI) Bethesda, Maryland, United States, 20892 Less <<
NCT00946374 Mantle-Cell Lymphoma Phase 2 Unknown June 2011 Germany ... More >> University Hospital Recruiting Heidelberg, Germany, 69120 Contact: Markus Munder, MD Less <<
NCT00001832 Melanoma Neop... More >>lasm Metastasis Less << Phase 2 Completed - United States, Maryland ... More >> National Cancer Institute (NCI) Bethesda, Maryland, United States, 20892 Less <<
NCT00871689 - Terminated(Due to graft failur... More >>e.) Less << - -
NCT00871689 Leukemia Phase 2 Terminated(Due to graft failur... More >>e.) Less << - United States, Minnesota ... More >> University of Minnesota Children's Hospital - Fairview Minneapolis, Minnesota, United States, 55455 Less <<
NCT02529839 Multiple Sclerosis Not Applicable Unknown October 2017 -
NCT00625729 - Terminated(No patients exhibit... More >>ed natural killer cell expansion (primary endpoint).) Less << - -
NCT02556931 Myelodysplastic Syndrome ... More >> Chronic Myelomonocytic Leukemia Small Lymphocytic Lymphoma Chronic Lymphocytic Leukemia Prolymphocytic Leukemia Chronic Myeloid Leukemia Chronic Myeloproliferative Disorders Multiple Myeloma Plasma Cell Neoplasm Plasma Cell Dyscrasia Myelofibrosis Polycythemia Vera Essential Thrombocythemia Plasma Cell Leukemia Less << Phase 2 Active, not recruiting December 2019 United States, Maryland ... More >> Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States, 21287 Less <<
NCT00423709 Hodgkin's Disease Not Applicable Completed - United States, Texas ... More >> U.T. M.D. Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT01119066 Acute Lymphoblastic Leukemia ... More >> Acute Myelogenous Leukemia Myelodysplastic Syndrome Multiple Myeloma Less << Phase 2 Recruiting May 2019 United States, New York ... More >> Memorial Sloan Kettering Cancer Center Recruiting New York, New York, United States, 10065 Contact: Richard O'Reilly, MD    212-639-5957       Contact: Sergio Giralt, MD    212-639-3859       Principal Investigator: Richard O'Reilly, MD Less <<
NCT00625729 Leukemia Lymp... More >>homa Less << Phase 1 Phase 2 Terminated(No patients exhibit... More >>ed natural killer cell expansion (primary endpoint).) Less << - United States, Minnesota ... More >> Masonic Cancer Center, University of Minnesota Minneapolis, Minnesota, United States, 55455 Less <<
NCT00176852 Sickle Cell Disease ... More >> Thalassemia Severe Congenital Neutropenia Diamond-Blackfan Anemia Shwachman-Diamond Syndrome Less << Phase 2 Phase 3 Active, not recruiting January 2019 United States, Minnesota ... More >> Masonic Cancer Center, University of Minnesota Minneapolis, Minnesota, United States, 55455 Less <<
NCT00943293 Preleukemia M... More >>yeloproliferative Disorders Lymphoma Myeloma Graft Versus Host Disease Less << Phase 1 Terminated(Poor accrual; did n... More >>ot enter phase 2) Less << - United States, Illinois ... More >> The Uniiversity of Chicago Chicago, Illinois, United States, 60637 Less <<
NCT03710421 Recurrent Plasma Cell Myeloma ... More >> Refractory Plasma Cell Myeloma Less << Phase 1 Not yet recruiting December 10, 2021 United States, California ... More >> City of Hope Medical Center Not yet recruiting Duarte, California, United States, 91010 Contact: Myo Htut, MD    626-218-2405    htut@coh.org    Principal Investigator: Myo Htut, MD Less <<
NCT00176852 - Active, not recruiting - -
NCT01701323 Acute Leukemia of Ambiguous Li... More >>neage Acute Myeloid Leukemia Less << Phase 1 Terminated - United States, Georgia ... More >> Emory University/Winship Cancer Institute Atlanta, Georgia, United States, 30322 United States, Washington Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 Less <<
NCT02053545 Leukemia Lymp... More >>homa MDS Less << Phase 1 Phase 2 Unknown December 2018 United States, Illinois ... More >> Ann & Robert H. Lurie Children's Hospital of Chicago Recruiting Chicago, Illinois, United States, 60611 Contact: Joseph Laskowski       jlaskowski@luriechildrens.org    Principal Investigator: Reggie Duerst Less <<
NCT00006261 Breast Cancer Phase 2 Withdrawn - United States, Ohio ... More >> Ireland Cancer Center at University Hospitals Case Medical Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States, 44106-5065 Less <<
NCT01828619 - Unknown - China ... More >> Peking University People's Hospital Beijing, China, 100044 Less <<
NCT01312376 Ovarian Carcinoma ... More >> Fallopian Tube Cancer Primary Peritoneal Cancer Less << Phase 1 Unknown - United States, Pennsylvania ... More >> Abramson Cancer Center of the University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104 Less <<
NCT00603460 Ovarian Cancer ... More >> Primary Peritoneal Cancer Less << Phase 1 Phase 2 Withdrawn March 2013 United States, Pennsylvania ... More >> University of Pennsylania Philadelphia, Pennsylvania, United States, 19104 Less <<
NCT03467256 B-cell Acute Lymphoblastic Leu... More >>kemia Acute Lymphocytic Leukemia, Pediatric Less << Phase 1 Phase 2 Recruiting March 2023 Russian Federation ... More >> Dmitry Rogachev National Research Center of Pediatric Hematology, Oncology and Immunology Recruiting Moscow, Russian Federation, 117198 Contact: Zhanna Shekhovtsova    4956647078    zhanna.shekhovtsova@fccho-moscow.ru    Contact: Eugene Pashanov, Prof. PhD    +79262205578    e.pashanov@gmail.com    Sub-Investigator: Olga Molostvova Less <<
NCT00894049 Allograft All... More >>ogeneic Cell Transplantaion Hematological Malignancy Solid Tumor Less << Phase 2 Completed - France ... More >> CHU Bordeaux Pessac, France CHU Clermont Ferrand, France CHU Lyon, France Institut Paoli-Calmettes Marseille, France CHU Montpellier, France Less <<
NCT01068301 Acute Lymphoblastic Leukemia ... More >> Acute Myeloid Leukemia Chronic Myeloid Leukemia Myelodysplastic Syndrome Non-Hodgkin's Lymphoma Less << Phase 1 Completed - United States, Tennessee ... More >> St. Jude Children's Research Hospital Memphis, Tennessee, United States, 38105 Less <<
NCT00526292 Leukemia Myel... More >>odysplastic Syndromes Less << Phase 2 Completed - United States, New York ... More >> Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 Less <<
NCT00526292 - Completed - -
NCT03434704 Transplant-Related Hematologic... More >> Malignancy Leukemia, Acute Myelodysplastic Syndromes Graft Vs Host Disease Fungal Infection Less << Phase 2 Recruiting September 15, 2022 Italy ... More >> Ospedale San Raffaele Recruiting Milano, Lombardia, Italy, 20132 Contact: Fabio Ciceri, MD    0039022643 ext 4289    ciceri.clinicaltrials@hsr.it    Sub-Investigator: Raffaella Greco, MD          Sub-Investigator: Jacopo Peccatori, MD          Sub-Investigator: Maria Teresa Lupo Stanghellini, MD          Sub-Investigator: Andrea Assanelli, MD          Sub-Investigator: Consuelo Corti, MD Less <<
NCT01622556 Hematologic Malignancies Phase 2 Terminated January 2017 United States, Virginia ... More >> University of Virginia Charlottesville, Virginia, United States, 22908 Less <<
NCT03318861 Multiple Myeloma Phase 1 Recruiting October 2032 United States, California ... More >> University of California Los Angeles Recruiting Los Angeles, California, United States, 90024 Contact: Bruck Habtemariam       bhabtemariam@mednet.ucla.edu    Contact: Cynthia Courtney       clcourtney@mednet.ucla.edu    United States, Florida H Lee Moffitt Cancer Center Recruiting Tampa, Florida, United States, 33612 Contact: Matthew Scott       matthew.scott@moffitt.org    United States, Georgia Winship Cancer Institute of Emory University Recruiting Atlanta, Georgia, United States, 30322 Contact: Tolu Adewuya       tolu.adewuya@emory.edu    United States, Illinois University of Chicago Medicine Recruiting Chicago, Illinois, United States, 60637 Contact: Becky Malloy       rmalloy@medicine.bsd.uchicago.edu    Contact: Linda Schroeder       lschroed@medicine.bsd.uchicago.edu    United States, Maryland Johns Hopkins Hospital Recruiting Baltimore, Maryland, United States, 21231 United States, Massachusetts Massachusetts General Hospital Recruiting Boston, Massachusetts, United States, 02114 Contact: Noopur Raje, MD    617-724-4000    NRAJE@mgh.harvard.edu    Dana Farber Cancer Institute Recruiting Boston, Massachusetts, United States, 02115 Beth Israel Deaconess Medical Center Recruiting Boston, Massachusetts, United States, 02215 Contact: David Avigan, MD       davigan@bidmc.harvard.edu    United States, Minnesota Mayo Clinic Recruiting Rochester, Minnesota, United States, 55905 Contact: Tracee Shevlin       shevlin.tracee@mayo.edu    United States, New York Memorial Sloan Kettering Cancer Center Recruiting New York, New York, United States, 10065 Contact: Sergio Giralt, MD       GiraltS@mskcc.org    United States, Tennessee Vanderbilt University Medical Center Recruiting Nashville, Tennessee, United States, 37232 Contact: Cancer Trials Information Program    800-811-8480       Contact: CAR-T Cell Line    615-936-2102       United States, Texas The University of Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact: Ashley Morphey       alandry1@mdanderson.org Less <<
NCT02724163 Acute Myeloid Leukaemia Phase 3 Recruiting December 2032 United Kingdom ... More >> Royal Aberdeen Children's Hospital Recruiting Aberdeen, United Kingdom, AB25 2ZG Aberdeen Royal Infirmary, NHS Grampian Recruiting Aberdeen, United Kingdom, AB25 2ZN Belfast City Hospital, Belfast Health and Social Care Trust Not yet recruiting Belfast, United Kingdom, BT9 7AB Birmingham Children's Hospital NHS Foundation Trust Recruiting Birmingham, United Kingdom, B4 6NH University Hospitals Bristol NHS Foundation Trust Recruiting Bristol, United Kingdom, BS1 3NU Addenbrookes Hospital, Cambridge University Hospitals NHS Foundation Trust Recruiting Cambridge, United Kingdom, CB2 0QQ Cardiff and Vale University Health Board, Noah's Ark Children's Hospital for Wales Recruiting Cardiff, United Kingdom, CF14 4XW NHS Lothian, Royal Hospital for Sick Children Recruiting Edinburgh, United Kingdom, EH9 1LF NHS Greater Glasgow and Clyde, The Royal Hospital for Children Recruiting Glasgow, United Kingdom, G51 4TF Leeds General Infirmary, Leeds Teaching Hospitals NHS Trust Recruiting Leeds, United Kingdom, LS9 7TF Alder Hey Children's NHS Foundation Trust Recruiting Liverpool, United Kingdom, L12 2AP University College London Hospitals NHS Foundation Trust Recruiting London, United Kingdom, NW1 2PG The Royal Marsden NHS Foundation Trust Recruiting London, United Kingdom, SW3 6JJ Great Ormond Street Hospital For Children NHS Trust Recruiting London, United Kingdom, WC1N 3JH Royal Manchester Childrens' Hospital , Central Manchester University Hospitals NHS Foundation Trust Recruiting Manchester, United Kingdom, M13 9WL The Christie NHS Foundation Not yet recruiting Manchester, United Kingdom, M20 4BX The Newcastle Upon Tyne Hospitals NHS Foundation Trust Recruiting Newcastle, United Kingdom, NE7 7DN Nottingham University Hospitals NHS Trust Recruiting Nottingham, United Kingdom, NG7 2UH John Radcliffe Hospital, Oxford Radcliffe Hospitals NHS Trust Recruiting Oxford, United Kingdom, OX3 9DU Sheffield Children's NHS Foundation Trust Recruiting Sheffield, United Kingdom, S10 2TH Southampton University Hospitals NHS Trust Recruiting Southampton, United Kingdom, SO16 6YD Less <<
NCT01962415 Primary Immunodeficiency (PID)... More >> Congenital Bone Marrow Failure Syndromes Inherited Metabolic Disorders (IMD) Hereditary Anemias Inflammatory Conditions Less << Phase 2 Recruiting November 2020 United States, Pennsylvania ... More >> Children's Hospital of Pittsburgh of UPMC Recruiting Pittsburgh, Pennsylvania, United States, 15224 Contact: Jason Rowan, RN    412-692-6195    jason.rowan@chp.edu    Sub-Investigator: Maria Escolar, MD          Sub-Investigator: Randy Windreich, MD          Sub-Investigator: Jessie Barnum, MD          Sub-Investigator: Craig Byersdorfer, MD          Sub-Investigator: Beth Carella, DO Less <<
NCT01328496 Hematologic Malignancies ... More >> Disorder Related to Transplantation Hematopoietic Malignancy Less << Phase 2 Completed - United States, Tennessee ... More >> St. Jude Children's Research Hospital Memphis, Tennessee, United States, 38105 Less <<
NCT02457650 Bladder Carcinoma ... More >> Breast Cancer Esophagus Carcinoma Lung Cancer Melanoma Multiple Myeloma Neuroblastoma Ovarian Cancer Synovial Sarcoma Other Metastatic Solid Cancers Less << Phase 1 Recruiting December 2019 China, Guangdong ... More >> Shenzhen Second People's Hospital, The First Affiliated Hospital of Shenzhen University Recruiting Shenzhen, Guangdong, China, 518035 Contact: Mingjun Wang, M.D., Ph.D.    15814723218    mingjunw429@163.com    Contact: Geng Tian, M.D., Ph.D.    13724395569    tiangeng666@aliyun.com    Principal Investigator: Geng Tian, M.D., Ph.D.          Principal Investigator: Mingjun Wang, M.D., Ph.D. Less <<
NCT01338675 Chronic Granulomatous Disease Phase 1 Phase 2 Unknown December 2013 Korea, Republic of ... More >> Seoul National University Hospital Recruiting Seoul, Daehangno, Jongno-gu, Korea, Republic of Contact: Hyoung Jin Kang, MD, PhD    82 2 2072 3304    kanghj@snu.ac.kr    Contact: Ji Won Lee, MD    82 2 2072 0177    agnesjw@hanmail.net Less <<
NCT01328496 - Completed - -
NCT03105336 Follicular Lymphoma ... More >> Marginal Zone Lymphoma Indolent Non-Hodgkin Lymphoma Less << Phase 2 Recruiting March 2034 United States, Arizona ... More >> Banner MD Anderson Cancer Center Recruiting Gilbert, Arizona, United States, 85234 Contact: Andrea Winkle    480-256-3421    andrea.winkle@bannerhealth.com    Principal Investigator: Javier Munoz, MD          United States, California USC Norris Comprehensive Cancer Center Recruiting Los Angeles, California, United States, 90033 Contact: Kevin Kelly, MD    323-865-3828    kevin.kelly@med.usc.edu    Principal Investigator: Kevin Kelly, MD          University of California Los Angeles Recruiting Los Angeles, California, United States, 90095 Contact: Sven de Vos, MD, PhD    310-267-2756    devos@mednet.ucla.edu    Principal Investigator: Sven de Vos, MD, PhD          United States, District of Columbia Georgetown Lombardi Comprehensive Cancer Center Recruiting Washington, District of Columbia, United States, 20057 Contact: Pashna Munshi, MD    202-444-1212    pashna.n.munshi@gunet.georgetown.edu    Principal Investigator: Pashna Munshi, MD          United States, Florida University of Miami Hospital and Clinics Recruiting Miami, Florida, United States, 33136 Contact: Nathalie Luis    305-243-7648    nluis@med.miami.edu    Principal Investigator: Joseph Rosenblatt, MD          H Lee Moffitt Cancer Center Recruiting Tampa, Florida, United States, 33612 Contact: Matthew Scott    813-745-7227    matthew.scott@moffitt.org    Principal Investigator: Julio Chavez, MD          United States, Massachusetts Dana Farber Cancer Institute Recruiting Boston, Massachusetts, United States, 02215 Contact: Krystle Benedict    617-582-8713    Krystle_Benedict@dfci.harvard.edu    Principal Investigator: Caron Jacobson, MD          United States, New Jersey Hackensack University Medical Center - John Theurer Cancer Center Recruiting Hackensack, New Jersey, United States, 07601 Contact: Kara Yannotti    551-996-5168    kara.yannotti@hackensackmeridian.org    Principal Investigator: Lori Leslie, MD          United States, New York Columbia University Medical Center Recruiting New York, New York, United States, 10037 Contact: Julia Gould    212-342-3849    jg3686@cumc.columbia.edu    Principal Investigator: Ran Reshef, MD          University of Rochester Medical Center (URMC) Recruiting Rochester, New York, United States, 14642 Contact: Erin Enfield    585-276-4404    erin_enfield@urmc.rochester.edu    Principal Investigator: Carla Casulo, MD          United States, Ohio Ohio State University Medical Center Recruiting Columbus, Ohio, United States, 43210 Contact: Nicole Szuminski    614-688-9796    nicole.szuminski@osumc.edu    Principal Investigator: Basem William, MD          United States, Pennsylvania Fox Chase Cancer Center Recruiting Philadelphia, Pennsylvania, United States, 19111-2497 Contact: Elisabeth Giraud       Elisabeth.Giraud@fccc.edu    Contact: Laura McIntyre       Laura.McIntyre@fccc.edu    Principal Investigator: Henry Fung, MD          UPMC Hillman Cancer Center Recruiting Pittsburgh, Pennsylvania, United States, 15213 Contact: Linda Fukas    412-623-6037    fukaslj@upmc.edu    Principal Investigator: Alison Sehgal, MD          United States, Tennessee Sarah Cannon Research Institute Recruiting Nashville, Tennessee, United States, 37203 Contact: Ask Sarah    615-339-4214    asksarah@sarahcannon.com    Principal Investigator: Ian Flinn, MD, PhD          Vanderbilt University Medical Center Recruiting Nashville, Tennessee, United States, 37232 Contact: Delia Darst    615-343-7190    delia.h.darst@vumc.org    Principal Investigator: Olalekan Oluwole, MD          United States, Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact: Liliana Vallejo    713-563-4167    lnvallejo@mdanderson.org    Contact: Sherry Adkins    713-745-3035    sadkins@mdanderson.org    Principal Investigator: Sattva Neelapu, MD          United States, Washington Fred Hutchinson Cancer Research Center Recruiting Seattle, Washington, United States, 98109 Contact: Immunotherapy Trials Intake    206-606-4668    immunotherapy@seattlecca.org    Principal Investigator: David Maloney, MD, PhD          France Centre Hospitalier Régional Universitaire de Lille Recruiting Lille, France, 59037 Principal Investigator: Ibrahim Yakoub-Agha, MD          Centre Hospitalier Lyon Sud Recruiting Pierre-Bénite, France, 69495 Principal Investigator: Gilles Salles, MD Less <<
NCT03348033 Chronic Myeloid Leukemia Phase 1 Phase 2 Enrolling by invitation March 2020 -
NCT00344825 - Completed - Italy ... More >> Many locations, Italy Less <<
NCT03110640 B-cell Adult Acute Lymphoblast... More >>ic Leukemia B-cell Chronic Lymphocytic Leukemia Adult Acute Lymphoblastic Leukemia in Remission Hematopoietic/Lymphoid Cancer Refractory Chronic Lymphocytic Leukemia Less << Phase 1 Not yet recruiting September 2020 -
NCT02959905 Metastatic Melanoma Phase 1 Unknown March 2018 China, Guangdong ... More >> Sun Yat-Sen University Cancer Center Recruiting Guangzhou, Guangdong, China, 510030 Contact: Ye Cao, Doctor    86-20-87343826    contact@sysucc.org.cn    Principal Investigator: Xiao Sh Zhang, Doctor Less <<
NCT02680951 Acute Myeloid Leukemia Phase 1 Withdrawn(Withdrawn due to lac... More >>k of participants.) Less << - -
NCT03128359 Acute Leukemia ... More >> Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma Chronic Myelogenous Leukemia, BCR-ABL1 Positive Diffuse Large B-Cell Lymphoma Follicular Lymphoma Graft Versus Host Disease Hodgkin Lymphoma Mantle Cell Lymphoma Marginal Zone Lymphoma Myelodysplastic Syndrome Myeloproliferative Neoplasm Recurrent Acute Myeloid Leukemia With Myelodysplasia-Related Changes Recurrent Plasma Cell Myeloma Refractory Plasma Cell Myeloma Secondary Myelodysplastic Syndrome Less << Phase 2 Recruiting June 2019 United States, California ... More >> City of Hope Medical Center Recruiting Duarte, California, United States, 91010 Contact: Monzr M. Al Malki, MD    626-256-4673    malmalki@coh.org    Principal Investigator: Monzr M. Al Malki, MD Less <<
NCT00941928 - Terminated(Slow accrual) - -
NCT03166397 Malignant Melanoma Stage IV Phase 2 Recruiting June 1, 2021 Israel ... More >> Sheba Medical Center Recruiting Ramat Gan, Israel, 5262100 Contact: Meital Bar    972-3-5305201    meital.bar@sheba.health.gov.il    Principal Investigator: Jacob Schachter, MD Less <<
NCT02310997 Leukaemia Lym... More >>phoma Other Haematological Diseases Less << Phase 2 Terminated(Trial closed early ... More >>due to poor recruitment) Less << - United Kingdom ... More >> University College London Hospital London, Greater London, United Kingdom, W1T 4TJ University Hospital Birmingham Birmingham, United Kingdom, B15 2TH Bristol Haematology & Oncology Centre Bristol, United Kingdom, BS2 8ED Addenbrooke's Hospital Cambridge, United Kingdom, CB2 0QQ St James' University Hospital Leeds, United Kingdom, LS9 7TF St Bartholomew's Hospital London, United Kingdom, EC1A 7BE Great Ormond Street Hospital for Children London, United Kingdom, WC1N 3JH Manchester Royal Infirmary Manchester, United Kingdom, M13 9WL Christie Hospital NHS Foundation Trust Manchester, United Kingdom, M20 4BX Nottingham City Hospital Nottingham, United Kingdom, NG5 1PB Royal Hallamshire Hospital Sheffield, United Kingdom, S10 2JF Royal Marsden Hospital Sutton, United Kingdom, SM2 5PT Less <<
NCT03704298 Refractory Large B-cell Lympho... More >>ma Less << Phase 1 Phase 2 Recruiting June 2035 United States, Florida ... More >> Moffitt Cancer Center Recruiting Tampa, Florida, United States, 33612 Less <<
NCT03412526 Metastatic Ovarian Cancer Phase 2 Not yet recruiting February 1, 2022 Israel ... More >> Sheba medical Center Not yet recruiting Ramat Gan, Israel, 5262100 Contact: Jacob Schachter, Prof.    972-3-5304907    jacob.scachter@sheba.health.gov.il    Contact: Meital Bar    972-3-5305201    meital.bar@sheba.health.gov.il Less <<
NCT00182650 Lymphoma Phase 1 Completed - United States, California ... More >> City of Hope Comprehensive Cancer Center Duarte, California, United States, 91010-3000 Less <<
NCT01583686 Cervical Cancer ... More >> Pancreatic Cancer Ovarian Cancer Mesothelioma Lung Cancer Less << Phase 1 Phase 2 Recruiting December 31, 2029 United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact NCI/Surgery Branch Recruitment Center    866-820-4505    irc@nih.gov Less <<
NCT00941928 Leukemia Pedi... More >>atric Cancer Less << Phase 2 Terminated(Slow accrual) - United States, Texas ... More >> UT MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT02153905 Breast Cancer ... More >> Cervical Cancer Renal Cancer Melanoma Bladder Cancer Less << Phase 1 Phase 2 Terminated - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT03139370 Solid Tumor Phase 1 Recruiting November 2034 United States, California ... More >> University of California Los Angeles (UCLA) Recruiting Los Angeles, California, United States, 90095 Contact: Anna Crosetti       ACrosetti@mednet.ucla.edu    Principal Investigator: Alexandra Drakaki, MD          United States, Florida University of Miami Health System Recruiting Miami, Florida, United States, 33136 Contact: Nathalie Luis    301-243-7648    nluis@med.miami.edu    Principal Investigator: Peter Hosein, MD          Moffitt Cancer Center Recruiting Tampa, Florida, United States, 12902 Contact: Jeffrey Edelman       jeffrey.edelman@moffitt.org    Principal Investigator: Benjamin Creelan, MD          United States, Massachusetts Massachusetts General Hospital Recruiting Boston, Massachusetts, United States, 02114 Contact: Jami Brown    617-724-9190    jbrown56@mgh.harvard.edu    Principal Investigator: Marcela Maus, MD, PhD          United States, New York Icahn School of Medicine at Mount Sinai Recruiting New York, New York, United States, 10029 Contact: Cynthia Knauer, RN    212-241-9955    Cynthia.knauer@mountsinai.org    Contact: Ash Tewari, MD    1-212-241-9955    Ash.tewari@mountsinai.org    Principal Investigator: Ash Tewari, MD          Memorial Sloan Kettering Cancer Center Recruiting New York, New York, United States, 10065 Contact: Geoffrey Noah    646-888-4593       Contact: Shanette Bourne    646-888-4593       Principal Investigator: Chris Klebanoff, MD          United States, Texas Baylor Scott and White Health Recruiting Dallas, Texas, United States, 75246 Contact: Carlos Becerra, MD    214-370-1254    carlos.becerra@usoncology.com    Contact: Delia Graham    1-214-820-5424    delia.graham@bswhealth.com    Principal Investigator: Carlos Becerra, MD          MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact: Ly Nguyen    713-563-2169    lmnguyen1@mdanderson.org    Principal Investigator: Partow Kebriaei, MD Less <<
NCT00923364 MDS Immunodef... More >>iciency GATA2 Less << Phase 2 Completed - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT00923364 - Completed - -
NCT02105116 - Terminated(No patients were el... More >>igible to receive the experimental component of the protocol therapy.) Less << - -
NCT01300572 Acute Myeloid Leukemia Arising... More >> From Previous Myelodysplastic Syndrome Chronic Myelomonocytic Leukemia Previously Treated Myelodysplastic Syndrome Recurrent Adult Acute Lymphoblastic Leukemia Recurrent Adult Acute Myeloid Leukemia Refractory Anemia With Excess Blasts Secondary Acute Myeloid Leukemia Less << Phase 1 Active, not recruiting July 2022 United States, Washington ... More >> Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 Less <<
NCT03190941 Pancreatic Cancer ... More >> Gastric Cancer Gastrointestinal Cancer Colon Cancer Rectal Cancer Less << Phase 1 Phase 2 Recruiting June 29, 2028 United States, Maryland ... More >> National Institutes of Health Clinical Center Recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact NCI/Surgery Branch Recruitment Center    866-820-4505    irc@nih.gov Less <<
NCT02133196 Advanced Non-Small Cell Lung C... More >>ancer Squamous Cell Carcinoma Advanced NSCLC Adenosquamous Carcinoma Adenocarcinomas Less << Phase 2 Recruiting October 23, 2025 United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact NCI/Surgery Branch Recruitment Center    866-820-4505    irc@nih.gov Less <<
NCT00640796 Leukemia, Myeloid, Acute ... More >> Leukemia, Lymphocytic, Acute, T-Cell Juvenile Myelomonocytic Leukemia Lymphoblastic T-cell Lymphoblastic Lymphoma Myelodysplastic Syndrome Less << Phase 1 Completed - United States, Tennessee ... More >> St. Jude Children's Research Hospital Memphis, Tennessee, United States, 38105 Less <<
NCT01810926 Graft Versus Host Disease Phase 2 Unknown October 2016 Italy ... More >> University of Cagliari Active, not recruiting Cagliari, Italy, 09126 San Raffaele Scientific Institute Active, not recruiting Milano, Italy, 20132 University of Milano-Bicocca San Gerardo Hospital Active, not recruiting Monza, Italy, 20052 Bambino Gesù Hospital and Research Institute Recruiting Rome, Italy, 00165 Contact: Maria Ester Bernardo, MD       mebernardo@gmail.com    Principal Investigator: Franco Locatelli Less <<
NCT01454596 Malignant Glioma ... More >> Glioblastoma Brain Cancer Gliosarcoma Less << Phase 1 Phase 2 Recruiting December 28, 2029 United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact NCI/Surgery Branch Recruitment Center    866-820-4505    irc@nih.gov Less <<
NCT00948922 Multiple Myeloma Phase 2 Active, not recruiting December 2019 United States, Florida ... More >> H. Lee Moffitt Cancer Center Tampa, Florida, United States, 33612 Less <<
NCT02105116 Adult Acute Megakaryoblastic L... More >>eukemia (M7) Adult Acute Minimally Differentiated Myeloid Leukemia (M0) Adult Acute Monoblastic Leukemia (M5a) Adult Acute Monocytic Leukemia (M5b) Adult Acute Myeloblastic Leukemia With Maturation (M2) Adult Acute Myeloblastic Leukemia Without Maturation (M1) Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities Adult Acute Myeloid Leukemia With Del(5q) Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) Adult Acute Myeloid Leukemia With t(8;21)(q22;q22) Adult Acute Myelomonocytic Leukemia (M4) Adult Erythroleukemia (M6a) Adult Pure Erythroid Leukemia (M6b) Recurrent Adult Acute Myeloid Leukemia Untreated Adult Acute Myeloid Leukemia Less << Not Applicable Terminated(No patients were el... More >>igible to receive the experimental component of the protocol therapy.) Less << - United States, New Jersey ... More >> Rutgers Cancer Institute of New Jersey New Brunswick, New Jersey, United States, 08903 Less <<
NCT03745326 Gastrointestinal Cancer ... More >> Pancreatic Cancer Gastric Cancer Colon Cancer Rectal Cancer Less << Phase 1 Phase 2 Recruiting December 1, 2028 United States, Maryland ... More >> National Institutes of Health Clinical Center Recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact NCI/Surgery Branch Recruitment Center    866-820-4505    irc@nih.gov Less <<
NCT00948922 - Active, not recruiting - -
NCT02062359 Metastatic Cancer ... More >> Metastatic Melanoma Less << Phase 2 Terminated(Study was closed du... More >>e to poor accrual.) Less << - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT00782379 Leukemia Lymp... More >>homa Myelodysplastic Syndromes Less << Phase 2 Completed - United States, Georgia ... More >> Blood and Marrow Transplant Group of Georgia Atlanta, Georgia, United States, 30342 Less <<
NCT00782379 - Completed - -
NCT01028716 Acute Biphenotypic Leukemia ... More >> Acute Erythroid Leukemia in Remission Acute Leukemia in Remission Acute Megakaryoblastic Leukemia Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome Acute Myeloid Leukemia in Remission Acute Myeloid Leukemia With FLT3/ITD Mutation Acute Myeloid Leukemia With Inv(3) (q21.3;q26.2) or t(3;3) (q21.3;q26.2); GATA2, MECOM Acute Myeloid Leukemia With Inv(3) (q21.3;q26.2); GATA2, MECOM Acute Myeloid Leukemia With Multilineage Dysplasia Acute Myeloid Leukemia With t(6;9) (p23;q34.1); DEK-NUP214 Acute Undifferentiated Leukemia Adult Acute Lymphoblastic Leukemia in Complete Remission B Acute Lymphoblastic Leukemia With t(1;19)(q23;p13.3); E2A-PBX1 (TCF3-PBX1) B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1 Burkitt Lymphoma Childhood Acute Lymphoblastic Leukemia in Complete Remission DS Stage II Plasma Cell Myeloma DS Stage III Plasma Cell Myeloma Myelodysplastic Syndrome Recurrent Anaplastic Large Cell Lymphoma Recurrent Diffuse Large B-Cell Lymphoma Recurrent Follicular Lymphoma Recurrent Hodgkin Lymphoma Recurrent Mantle Cell Lymphoma Recurrent Marginal Zone Lymphoma Recurrent Plasma Cell Myeloma Refractory Plasma Cell Myeloma Secondary Acute Myeloid Leukemia T Lymphoblastic Lymphoma Less << Phase 2 Recruiting - United States, Washington ... More >> VA Puget Sound Health Care System Not yet recruiting Seattle, Washington, United States, 98101 Contact: Thomas Chauncey    206-764-2969    thomas.chauncey@va.gov    Principal Investigator: Thomas Chauncey          Fred Hutch/University of Washington Cancer Consortium Recruiting Seattle, Washington, United States, 98109 Contact: Rachel B. Salit    206-667-1317    rsalit@fredhutch.org    Principal Investigator: Rachel B. Salit Less <<
NCT02062359 - Terminated(Study was closed du... More >>e to poor accrual.) Less << - -
NCT01814046 Metastatic Ocular Melanoma ... More >> Metastatic Uveal Melanoma Less << Phase 2 Terminated(Investigator left t... More >>he National Institutes of Health (NIH)) Less << - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT00897260 Hematological Malignancy ... More >> Bone Marrow Failure Syndrome Less << Not Applicable Completed - Canada, British Columbia ... More >> Vancouver General Hospital, Leukemia/BMT Program of BC Vancouver, British Columbia, Canada, V5Z 1M9 Less <<
NCT03121001 Sickle Cell Disease Phase 2 Recruiting October 28, 2026 United States, Illinois ... More >> University of Illinois at Chicago Recruiting Chicago, Illinois, United States, 60612 Contact: Damiano Rondelli, MD    312-413-3547    drond@uic.edu Less <<
NCT00305682 Myeloproliferative Disorders ... More >> Leukemia Lymphoma Myelodysplastic Syndromes Less << Phase 2 Active, not recruiting June 2019 United States, Minnesota ... More >> Masonic Cancer Center at University of Minnesota Minneapolis, Minnesota, United States, 55455 Less <<
NCT02410551 Myeloproliferative Diseases Phase 2 Terminated - United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT02410551 - Terminated - -
NCT01814046 - Terminated(Investigator left t... More >>he National Institutes of Health (NIH)) Less << - -
NCT00322101 Acute Myeloid Leukemia With Mu... More >>ltilineage Dysplasia Following Myelodysplastic Syndrome Acute Myeloid Leukemia/Transient Myeloproliferative Disorder Adult Acute Myeloid Leukemia in Remission Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities Adult Acute Myeloid Leukemia With Del(5q) Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) Adult Acute Myeloid Leukemia With t(15;17)(q22;q12) Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) Adult Acute Myeloid Leukemia With t(8;21)(q22;q22) Childhood Acute Myeloid Leukemia in Remission Childhood Myelodysplastic Syndromes de Novo Myelodysplastic Syndromes Myelodysplastic Syndrome With Isolated Del(5q) Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable Previously Treated Myelodysplastic Syndromes Recurrent Adult Acute Myeloid Leukemia Recurrent Childhood Acute Myeloid Leukemia Secondary Acute Myeloid Leukemia Secondary Myelodysplastic Syndromes Less << Phase 3 Completed - United States, Colorado ... More >> HealthOne Presbyterian St. Lukes Medical Center Denver, Colorado, United States United States, Georgia Emory University Altanta, Georgia, United States, 30322 United States, New York Weill Cornell University New York, New York, United States, 10021 United States, Utah University of Utah Salt Lake City, Utah, United States, 84112 United States, Washington Veterans Administration Center-Seattle Seattle, Washington, United States, 98108 Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 United States, Wisconsin Medical College Wisconsin Milwaukee, Wisconsin, United States Germany Technical University Dresden Dresden, Saxony, Germany, 01307 Less <<
NCT01468818 - Terminated(Study was closed pr... More >>ematurely due to slow and insufficient accrual.) Less << - -
NCT02917096 Primary Myelofibrosis ... More >> Secondary Myelofibrosis Less << Not Applicable Recruiting October 2019 United States, California ... More >> City of Hope Medical Center Recruiting Duarte, California, United States, 91010 Contact: Haris Ali    626-256-4673       Principal Investigator: Haris Ali Less <<
NCT03448393 Acute Lymphoid Leukemia ... More >> B-Cell Leukemia Leukemia, Lymphocytic, B Cell B-Cell Lymphoma Lymphoma, Non-Hodgkin Less << Phase 1 Recruiting December 1, 2032 United States, Maryland ... More >> National Institutes of Health Clinical Center Recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact National Cancer Institute Referral Office    888-624-1937 Less <<
NCT03412409 Acute Leukemia ... More >> Myelodysplastic Syndromes Less << Phase 2 Recruiting March 1, 2020 China ... More >> Peking University, Institute of Hematolgoy Recruiting Beijing, China Contact: Xiao-Dong Mo Less <<
NCT03466320 AML MDS Phase 1 Recruiting August 2021 United States, Colorado ... More >> University of Colorado Recruiting Aurora, Colorado, United States, 80045 United States, New York New York School of Medicine Recruiting New York, New York, United States, 10016 Belgium Institute Jules Bordet Recruiting Brussels, Belgium UZ Gent Recruiting Gent, Belgium Less <<
NCT03412266 Myelodysplastic Syndromes Phase 2 Recruiting March 1, 2020 China, Beijing ... More >> Peking University Institute of Hematology,Beijing Recruiting Beijing, Beijing, China, 100044 Contact: Xiao-Dong Mo       mxd453@163.com    Principal Investigator: Xiao-Jun Huang, MD Less <<
NCT00509496 Skin Cancer M... More >>elanoma Less << Phase 2 Terminated(Low accrual) - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT00322101 - Completed - -
NCT01468818 Metastatic Melanoma ... More >> Skin Cancer Less << Phase 2 Terminated(Study was closed pr... More >>ematurely due to slow and insufficient accrual.) Less << - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT00509496 - Terminated(Low accrual) - -
NCT02830724 Pancreatic Cancer ... More >> Renal Cell Cancer Breast Cancer Melanoma Ovarian Cancer Less << Phase 1 Phase 2 Recruiting January 1, 2028 United States, Maryland ... More >> National Institutes of Health Clinical Center Recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact NCI/Surgery Branch Recruitment Center    866-820-4505    irc@nih.gov Less <<
NCT02497404 Leukemia, Erythroblastic, Acut... More >>e Myelodysplastic Syndromes Less << Phase 2 Recruiting July 2021 United States, New York ... More >> Weill Cornell Medical College Recruiting New York, New York, United States, 10021 Contact: Jennifer Bourke, RN    212-746-2844    jeb9097@med.cornell.edu    Principal Investigator: Sebastian Mayer, MD          Sub-Investigator: Koen van Besien, MD          Sub-Investigator: Tsiporah Shore, MD          Sub-Investigator: Usama Gergis, MD          Sub-Investigator: Adrienne Phillips, MD          Sub-Investigator: Jingmei Hsu, MD          Sub-Investigator: Joseph Scandura, MD Less <<
NCT00038857 Leukemia Lymp... More >>homa Less << Phase 2 Completed - United States, Texas ... More >> MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00781170 Multiple Myeloma ... More >> Stem Cell Transplantation Less << Phase 2 Completed - -
NCT03538613 Gastrointestinal Epithelial Ca... More >>ncer Gastrointestinal Neoplasm Cancer of Gastrointestinal Tract Cancer, Gastrointestinal Less << Phase 1 Phase 2 Withdrawn(NCI not moving forwa... More >>rd with study execution.) Less << - -
NCT00188136 Acute Myeloid Leukemia Phase 2 Completed - Germany ... More >> University hospital Carl Gustav Carus Dresden, Germany, 01307 Less <<
NCT03084380 Hepatocellular Carcinoma Phase 1 Phase 2 Not yet recruiting May 31, 2020 China, Chongqing ... More >> Department of Oncology, Xinqiao Hospital ChongQing, Chongqing, China, 400037 Less <<
NCT00054353 - Completed - -
NCT02111850 Cervical Cancer ... More >> Renal Cancer Urothelial Cancer Melanoma Breast Cancer Less << Phase 1 Phase 2 Recruiting December 27, 2024 United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact NCI/Surgery Branch Recruitment Center    866-820-4505    irc@nih.gov Less <<
NCT00054353 Refractory Multiple Myeloma Phase 1 Phase 2 Completed - United States, Washington ... More >> Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 Italy University of Torino Torino, Italy, 10126 Less <<
NCT00038857 - Completed - -
NCT02446964 Adult Acute Lymphoblastic Leuk... More >>emia in Complete Remission Acute Myeloid Leukemia in Remission Previously Treated Myelodysplastic Syndrome Recurrent Adult Acute Lymphoblastic Leukemia Recurrent Adult Acute Myeloid Leukemia Recurrent Childhood Acute Lymphoblastic Leukemia Recurrent Childhood Acute Myeloid Leukemia Childhood Acute Lymphoblastic Leukemia in Complete Remission Less << Phase 1 Active, not recruiting November 2019 United States, California ... More >> City of Hope Comprehensive Cancer Center Duarte, California, United States, 91010 Less <<
NCT02443831 Acute Lymphoblastic Leukemia ... More >> Burkitt Lymphoma Less << Phase 1 Recruiting December 2030 United Kingdom ... More >> Great Ormond Street Hospital Recruiting London, United Kingdom Contact: Prof. Persis Amrolia          University College Hospital Recruiting London, United Kingdom Contact: Dr Rachael Hough          Royal Manchester Infirmary Not yet recruiting Manchester, United Kingdom Contact: Eleni Tholouli          Royal Manchester Royal Children's Hopsital (part of MRI) Recruiting Manchester, United Kingdom Contact: Dr Rob Wynn Less <<
NCT02876978 Lung Squamous Cell Carcinoma Phase 1 Recruiting April 2019 China, Shanghai ... More >> Shanghai Chest Hospital,Shanghai Jiaotong University Recruiting Shanghai, Shanghai, China, 200030 Less <<
NCT00790413 Neuroblastoma Early Phase 1 Active, not recruiting - Sweden ... More >> Lund University Hospital, Department of Pediatric Oncology and Bone Marrow Transplantation Lund, Sweden, 221 85 Less <<
NCT01967823 Melanoma Meni... More >>ngioma Breast Cancer Non-Small Cell Lung Cancer Hepatocellular Cancer Less << Phase 2 Recruiting July 28, 2028 United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact NCI/Surgery Branch Recruitment Center    866-820-4505    irc@nih.gov Less <<
NCT00990496 Glioblastoma Multiforme Phase 1 Terminated(Accrual goals not m... More >>et) Less << - -
NCT02472392 EWINGS SARCOMA Phase 1 Completed - United States, Kentucky ... More >> University of Louisville Louisville, Kentucky, United States, 40202 Less <<
NCT03396575 Diffuse Intrinsic Pontine Glio... More >>ma (DIPG) Less << Phase 1 Recruiting June 2022 United States, Florida ... More >> UF Health Shands Children's Hospital Recruiting Gainesville, Florida, United States, 32610 Contact: Marcia Hodik, RN    352-273-6971    marcia.hodik@neurosurgery.ufl.edu    Principal Investigator: Sridharan Gururangan, FRCP          University of Florida Not yet recruiting Gainesville, Florida, United States, 32610 Less <<
NCT01640301 Recurrent Adult Acute Myeloid ... More >>Leukemia Recurrent Childhood Acute Myeloid Leukemia Secondary Acute Myeloid Leukemia Therapy-Related Acute Myeloid Leukemia Less << Phase 1 Phase 2 Recruiting October 1, 2030 United States, Washington ... More >> Fred Hutch/University of Washington Cancer Consortium Recruiting Seattle, Washington, United States, 98109 Contact: Daniel Egan    206-667-4971    degan@fredhutch.org    Principal Investigator: Daniel Egan Less <<
NCT02215967 Myeloma, Plasma-Cell ... More >> Myeloma-Multiple Less << Phase 1 Active, not recruiting October 31, 2019 United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT01457131 Metastatic Cancer ... More >> Metastatic Melanoma Metastatic Renal Cancer Less << Phase 1 Terminated - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT01163201 Hematologic Malignancy ... More >> Acute Myeloid Leukemia Acute Lymphocytic Leukemia Chronic Myelogenous Leukemia in Blast Crisis Anemia, Refractory, With Excess of Blasts Chronic Myeloproliferative Disease Chronic Lymphocytic Leukemia Small Lymphocytic Lymphoma Marginal Zone B-cell Lymphoma Follicular Lymphoma Lymphoplasmacytic Lymphoma Mantle-Cell Lymphoma Prolymphocytic Lymphoma Large Cell Non-Hodgkin's Lymphoma Lymphoblastic Lymphoma Burkitt's Lymphoma High Grade Non-Hodgkin's Lymphoma Less << Phase 1 Phase 2 Withdrawn(Replaced by a new st... More >>udy) Less << January 2015 United States, Minnesota ... More >> Masonic Cancer Center, University of Minnesota Minneapolis, Minnesota, United States, 55445 Less <<
NCT00282412 Rheumatoid Arthritis Phase 1 Terminated(No participant enro... More >>lled for three years. No plan to continue study.) Less << - United States, Illinois ... More >> Northwestern University, Feinberg School of Medicine Chicago, Illinois, United States, 60611 Less <<
NCT00282412 - Terminated(No participant enro... More >>lled for three years. No plan to continue study.) Less << - -
NCT00593554 Acute Myeloid Leukemia ... More >> Acute Lymphoblastic Leukemia Myelodysplasia Chronic Myeloid Leukemia Less << Phase 2 Terminated(Slow accrual) - United States, Indiana ... More >> Indiana University Cancer Center Indianapolis, Indiana, United States, 46202 Less <<
NCT02659943 Lymphoma, B-Cell ... More >> Lymphoma, Non-hodgkins Less << Phase 1 Active, not recruiting December 1, 2021 United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT02988466 Hematologic Malignancies Phase 2 Recruiting January 2021 United States, Minnesota ... More >> Masonic Cancer Center at University of Minnesota Recruiting Minneapolis, Minnesota, United States, 55455 Contact: Tim Krepski    612-273-2800    tkrepsk1@fairview.org Less <<
NCT00593554 - Terminated(Slow accrual) - -
NCT03093168 Multiple Myeloma Phase 1 Recruiting February 2020 China, Henan ... More >> Henan Province of TCM Recruiting Zhengzhou, Henan, China Contact: Zhi Cheng, M.D.    +(86)-139-3852-6995    clinicaltrials.chengzhi@outlook.com Less <<
NCT02181478 Acute Lymphoblastic Leukemia ... More >> Acute Myelogenous Leukemia Myelodysplastic Syndromes Myelofibrosis Relapsed Non-Hodgkin Lymphoma Refractory Non-Hodgkin Lymphoma Hodgkin Lymphoma Refractory Hodgkin Lymphoma Relapsed Chronic Lymphocytic Leukemia Refractory Chronic Lymphocytic Leukemia Lymphoid Malignancies Chronic Myelogenous Leukemia Less << Early Phase 1 Recruiting November 2018 United States, Ohio ... More >> Case Comprehensive Cancer Center Recruiting Cleveland, Ohio, United States, 44106-5065 Contact: Leland Metheny, MD    216-983-4946    Leland.Metheny@uhhospitals.org    Contact: Marcos de Lima, MD    216-286-6869    Marcos.deLima@uhhospitals.org    Principal Investigator: Leland Metheny Less <<
NCT02685670 Hematopoietic/Lymphoid Cancer ... More >> Adult Acute Lymphoblastic Leukemia in Remission B-cell Adult Acute Lymphoblastic Leukemia B-cell Chronic Lymphocytic Leukemia Recurrent Adult Diffuse Large Cell Lymphoma Recurrent Grade 1 Follicular Lymphoma Recurrent Grade 2 Follicular Lymphoma Recurrent Grade 3 Follicular Lymphoma Recurrent Mantle Cell Lymphoma Refractory Chronic Lymphocytic Leukemia Stage III Adult Diffuse Large Cell Lymphoma Stage III Chronic Lymphocytic Leukemia Stage III Grade 1 Follicular Lymphoma Stage III Grade 2 Follicular Lymphoma Stage III Grade 3 Follicular Lymphoma Stage III Mantle Cell Lymphoma Stage IV Adult Diffuse Large Cell Lymphoma Stage IV Chronic Lymphocytic Leukemia Stage IV Grade 1 Follicular Lymphoma Stage IV Grade 2 Follicular Lymphoma Stage IV Grade 3 Follicular Lymphoma Stage IV Mantle Cell Lymphoma Less << Phase 1 Phase 2 Recruiting December 2019 China, Henan ... More >> Henan Province of TCM Recruiting Zhengzhou, Henan, China Contact: Zhi Cheng, M.D. Less <<
NCT02621021 Melanoma Phase 2 Recruiting June 16, 2026 United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact NCI/Surgery Branch Recruitment Center    866-820-4505    irc@nih.gov Less <<
NCT01020539 Acute Myelogenous Leukemia ... More >> Myelodysplastic Syndrome Juvenile Myelomonocytic Leukemia Less << Phase 1 Active, not recruiting March 2018 United States, New York ... More >> Columbia University Medical Center New York, New York, United States, 10032 Less <<
NCT03721068 Neuroblastoma Phase 1 Not yet recruiting April 1, 2036 United States, North Carolina ... More >> Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill Chapel Hill, North Carolina, United States, 27599-7295 Less <<
NCT02653196 Neuroepithelial Tumor ... More >> Solid Tumor Allogeneic Hematopoietic Stem Cell Transplantation Less << Early Phase 1 Terminated(The Principal Inves... More >>tigator left the institution.) Less << - United States, New York ... More >> The Children's Hospital at Montefiore The Bronx, New York, United States, 10467 Less <<
NCT00187096 Acute Myeloid Leukemia Not Applicable Completed - United States, Tennessee ... More >> St. Jude Children's Research Hospital Memphis, Tennessee, United States, 38105 Less <<
NCT00338377 Melanoma Phase 2 Recruiting February 2019 United States, Texas ... More >> The University of Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact: Patrick Hwu, MD    713-792-2921    phwu@mdanderson.org    Principal Investigator: Patrick Hwu, MD Less <<
NCT01045382 Leukemia, Myeloid, Acute ... More >> Leukemia, Lymphoblastic, Acute Leukemia, Myelocytic, Chronic Myeloproliferative Disorders Myelodysplastic Syndromes Multiple Myeloma Leukemia, Lymphocytic, Chronic Hodgkin's Disease Lymphoma, Non-Hodgkin Less << Phase 2 Recruiting July 2023 Belgium ... More >> UZA Recruiting Edeghem, Antwerpen, Belgium, 2650 Contact: Wilfried Schroyens, MD, PhD    32 382 204111    wilfried.schroyens@uza.be    Principal Investigator: Wilfried Schroyens, MD, PhD          St-Luc UCL Recruiting Brussels, Brabant, Belgium, 1200 Contact: Augustin Ferrant, MD, PhD    32 27641880    ferrant@sang.ul.ac.be    Principal Investigator: Augustin Ferrant, MD, PhD          AZ Gasthuisberg Leuven Recruiting Leuven, Flamish Brabant, Belgium, 3000 Contact: Johan Maertens, MD    32- 16 33 22 11    johan.maertens@uz.kuleuven.ac.be    Principal Investigator: Johan Maertens, MD          UZ Gent Recruiting Gent, Flanders Ost, Belgium, 9000 Contact: Lucien Noens, MD, PhD    32(09) 332 21 31    Lucien.Noens@Ugent.be    Principal Investigator: Lucien Noens, MD, PhD          Sub-Investigator: Tessa Kerre, MD, PhD          AZ St-Jan Recruiting Brugge, Flanders West, Belgium, 8000 Contact: Dominik Selleslag, MD    00/32/50 453060    dominik.selleslag@azbrugge.be    Principal Investigator: Dominik Selleslag, MD          Cliniques Universitaires Mont-Godinne Recruiting Yvoir, Namur, Belgium, 5530 Contact: Carlos Graux, MD    32(081)423831    carlos.graux@uclouvain.be    Contact: Chantal Doyen, MD    32(081)423831    chantal.doyen@sang.ucl.ac.be    Principal Investigator: Chantal Doyen, MD, PhD          Sub-Investigator: Carlos Graux, MD, PhD          Hôpital Stuyvenberg Recruiting Antwerpen, Belgium, 2060 Contact: Pierre Zachée, MD, PhD    32(03)2177111    pierre.zachee@zna.be    Principal Investigator: Pierre Zachée, MD, PhD          Bordet Institute Recruiting Brussels, Belgium, 1000 Contact: Philippe Lewalle, MD, PhD    00/32/2 5417208    plewalle@ulb.ac.be    Contact: Dominique Bron, MD, PhD    00/32/ 2 5417208    bron@ulb.ac.be    Principal Investigator: Philippe Lewalle, MD, PhD          Sub-Investigator: Dominique Bron, MD, PhD          Vrije Universiteit Brussel Recruiting Brussels, Belgium, 1050 Contact: Rik Schots, MD    00/32/2 4763105    Rik.Schots@uzbrussel.be    Principal Investigator: Rik Schots, MD          CHU-ULg Recruiting Liège, Belgium, 4000 Contact: Yves Beguin, MD, PhD    00/32/4 3667201    yves.beguin@chu.ulg.ac.be    Contact: Frédéric Baron, MD, PhD    00/32/4 3667201    F.Baron@chu.ulg.ac.be    Principal Investigator: Yves Beguin, MD, PhD          Sub-Investigator: Frédéric Baron, MD, PhD          Sub-Investigator: Chantal Lechanteur, PhD          Sub-Investigator: Etienne Baudoux, MD          Sub-Investigator: Evelyne Willems, MD Less <<
NCT03633773 Intrahepatic Cholangiocarcinom... More >>a Less << Phase 1 Phase 2 Recruiting December 31, 2024 China, Zhejiang ... More >> The second affiliated hospital of Zhejiang University Recruiting Hangzhou, Zhejiang, China, 310009 Contact: Qi Zhang, MD    8613819137113 Less <<
NCT00187096 - Completed - -
NCT00520130 - Active, not recruiting - -
NCT00909168 Acute Myeloid Leukemia Phase 2 Phase 3 Completed - Italy ... More >> University Hospital, Udine Udine, Italy, 33100 Less <<
NCT00043979 Sarcoma Phase 2 Completed - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT01063660 Acute Myeloid Leukaemia Phase 2 Completed - Germany ... More >> University of Rostock Rostock, Germany, 18057 Less <<
NCT02761915 Relapsed or Refractory Neurobl... More >>astoma Less << Phase 1 Recruiting February 2023 United Kingdom ... More >> University College London (UCL), Not yet recruiting London, United Kingdom, WC1E 6BT Contact: Person       rachael.hough@uclh.nhs.uk;    Principal Investigator: Rachel Hough, Dr          Great Ormond Street Hospital for Children NHS Foundation Trust (GOSH) Recruiting London, United Kingdom, WC1N 3JH Contact: Person       j.anderson@ucl.ac.uk    Principal Investigator: John Anderson, Prof Less <<
NCT00004135 Kidney Cancer ... More >> Melanoma (Skin) Less << Phase 2 Completed - United States, Illinois ... More >> University of Chicago Cancer Research Center Chicago, Illinois, United States, 60637-1470 Less <<
NCT02757885 Sickle Cell Disease Phase 2 Recruiting December 2020 United States, Georgia ... More >> Children's Healthcare of Atlanta Recruiting Atlanta, Georgia, United States, 30033 Contact: Lakshmanan Krishnamurti, MD    404-785-1441    lakshmanan.krishnamurti@emory.edu Less <<
NCT00520130 Myelodysplastic Syndrome ... More >> Hodgkin's Lymphoma Non-Hodgkin's Disease Acute Leukemia Multiple Myeloma Less << Phase 1 Phase 2 Active, not recruiting December 2018 United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT00002833 Graft Versus Host Disease ... More >> Leukemia Myelodysplastic Syndromes Less << Phase 2 Completed - United States, Texas ... More >> University of Texas - MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00043979 - Completed - -
NCT01598025 Acute Leukemia ... More >> Chronic Leukemia Myelodysplastic Syndrome Non-Hodgkins Lymphoma Less << Not Applicable Terminated(Closed due to poor ... More >>accrual) Less << - United States, New York ... More >> Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065-0009 Less <<
NCT00002838 Leukemia Phase 1 Phase 2 Completed - United States, Texas ... More >> University of Texas - MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT02918292 Severe Aplastic Anemia Phase 2 Recruiting February 2022 -
NCT03367546 Sickle Cell Disease ... More >> Thalassemia High Risk Hematologic Disorders Cerebral Adrenoleukodystrophy Inherited Metabolic Disorders Less << Phase 2 Recruiting November 2025 United States, Minnesota ... More >> Masonic Caner Center at University of Minnesota Recruiting Minneapolis, Minnesota, United States, 55455 Contact: Kim Nelson    612-273-2925    knelso62@fairview.org Less <<
NCT00478244 Epidermolysis Bullosa Not Applicable Terminated(Competing studies) - United States, Minnesota ... More >> Masonic Cancer Center, University of Minnesota Minneapolis, Minnesota, United States, 55455 Less <<
NCT01176006 DOCK8 Deficiency Phase 2 Recruiting December 31, 2022 United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact National Cancer Institute Referral Office    (888) NCI-1937 Less <<
NCT00160355 Wiskott-Aldrich Syndrome Phase 1 Completed - United States, Tennessee ... More >> St. Jude Children's Research Hospital Memphis, Tennessee, United States, 38105 Less <<
NCT01598025 - Terminated(Closed due to poor ... More >>accrual) Less << - -
NCT03263559 Sickle Cell Disease Phase 2 Recruiting December 2024 United States, Alabama ... More >> University of Alabama at Birmingham Recruiting Birmingham, Alabama, United States, 35294 Contact: Hilary Haines, MD       hhaines@peds.uab.edu    United States, California UCSF Benioff Children's Hospital Oakland Recruiting Oakland, California, United States, 94609 Contact: Mark C. Walters, MD    925-783-5070    mwalters@mail.cho.org    United States, Florida University of Florida College of Medicine Recruiting Gainesville, Florida, United States, 32610 Contact: Lucien Black       vblack@ufl.edu    Nicklaus Children's Hospital/University of Miami Children's Hospital Recruiting Miami, Florida, United States, 33155 Contact: Kamar Godder       kamar.godder@nicklaushealth.org    H. Lee Moffitt Cancer Center Recruiting Tampa, Florida, United States, 33612 Contact: Michael L. Nieder, MD    813-745-2191    michael.nieder@moffitt.org    United States, Georgia Northside Hospital Recruiting Atlanta, Georgia, United States, 30342 Contact: Melhem Solh, MD    404-255-1930    msolh@bmtga.com    United States, Missouri Washington University, St. Louis Recruiting Saint Louis, Missouri, United States, 63110 Contact: Shalini Shenoy       shalinishenoy@wustl.edu    United States, New Jersey Hackensack University Medical Center Recruiting Hackensack, New Jersey, United States, 07601 Contact: Jennifer Krajewski       jennifer.krajewski@hackensackmeridian.org    United States, New York Northwell Health/Monter Cancer Center Recruiting Lake Success, New York, United States, 11042 Contact: Ruthee-Lu Bayer       rbayer@northwell.edu    United States, Texas Texas Transplant Institute Recruiting San Antonio, Texas, United States, 78229 Contact: Paul J. Shaughnessy, MD    210-575-6904    Paul.Shaughnessy@MHShealth.com Less <<
NCT00914940 Graft Versus Host Disease ... More >> Leukemia Myelodysplastic Syndromes Less << Phase 2 Active, not recruiting December 2019 United States, Connecticut ... More >> Yale University School of Medicine/Yale New Haven Hospital New Haven, Connecticut, United States, 06520 United States, Washington Fred Hutchinson Cancer Research Center Seattle, Washington, United States, 98109-1024 Less <<
NCT02880293 Hematologic Malignancy Not Applicable Recruiting August 2019 United States, New York ... More >> Memorial Sloan Kettering Cancer Center Recruiting New York, New York, United States, 10065 Contact: Brian Shaffer, MD    212-639-2212       Principal Investigator: Brian Shaffer, MD Less <<
NCT01993719 Metastatic Melanoma Phase 2 Recruiting September 28, 2029 United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact NCI/Surgery Branch Recruitment Center    866-820-4505    irc@nih.gov Less <<
NCT00478244 - Terminated(Competing studies) - -
NCT02159495 Adult Acute Myeloid Leukemia i... More >>n Remission Acute Biphenotypic Leukemia Early Relapse of Acute Myeloid Leukemia Late Relapse of Acute Myeloid Leukemia Recurrent Adult Acute Myeloid Leukemia Secondary Acute Myeloid Leukemia Blastic Plasmacytoid Dendritic Cell Neoplasm Acute Myeloid Leukemia Adult Acute Lymphoblastic Leukemia Interleukin-3 Receptor Subunit Alpha Positive Minimal Residual Disease Refractory Acute Myeloid Leukemia Untreated Adult Acute Myeloid Leukemia Less << Phase 1 Recruiting December 2019 United States, California ... More >> City of Hope Medical Center Recruiting Duarte, California, United States, 91010 Contact: Lihua E. Budde    800-826-4673    ebudde@coh.org    Principal Investigator: Lihua E. Budde Less <<
NCT01532700 Chronic Lymphocytic Leukemia (... More >>CLL) Less << Phase 2 Completed - Canada, Ontario ... More >> University Health Network-Princess Margaret Hospital Toronto, Ontario, Canada, M5G 2M9 Less <<
NCT03338972 Recurrent Plasma Cell Myeloma ... More >> Refractory Plasma Cell Myeloma TNFRSF17 Positive Less << Phase 1 Recruiting December 15, 2022 United States, Washington ... More >> Fred Hutch/University of Washington Cancer Consortium Recruiting Seattle, Washington, United States, 98109 Contact: Immunotherapy Trials Intake, SCCA    206-606-4668    immunotherapy@seattlecca.org    Principal Investigator: Damian J. Green Less <<
NCT00003553 Kidney Cancer Phase 2 Unknown - United States, Maryland ... More >> NIH - Warren Grant Magnuson Clinical Center Recruiting Bethesda, Maryland, United States, 20892-1182 Contact: Patient Recruitment    800-411-1222 Less <<
NCT00536978 - Completed - -
NCT00874315 Neuroblastoma Phase 2 Withdrawn(lack of accrual) - United States, Illinois ... More >> Children's Memorial Hospital Chicago, Illinois, United States United States, New York Morgan Stanley Children's Hospital of NY New York, New York, United States United States, Ohio Nationwide Children's Hospital Columbus, Ohio, United States, 43205 United States, Wisconsin Children's Hopsital of Wisconsin Milwaukee, Wisconsin, United States Less <<
NCT02057770 Leukemia, Myeloid, Acute Phase 1 Terminated(Low accrual rate) - United States, Missouri ... More >> Washington University School of Medicine Saint Louis, Missouri, United States, 63110 Less <<
NCT03302403 B Cell Lymphoma ... More >> B Cell Leukemia Myeloma Hepatocellular Carcinoma Pancreatic Carcinoma Adenocarcinoma of Esophagogastric Junction Less << Not Applicable Not yet recruiting December 2020 China, Zhejiang ... More >> First Affiliated Hospital of Wenzhou Medical University Not yet recruiting Wenzhou, Zhejiang, China, 325000 Contact: Kang Yu, MD    +86-13806681379    yukang62@126.com    Principal Investigator: Mengtao Zhou, MD          Principal Investigator: Kang Yu, MD          Principal Investigator: Songfu Jiang, MD Less <<
NCT03277729 CD20 Positive ... More >> Recurrent B-Cell Non-Hodgkin Lymphoma Recurrent Chronic Lymphocytic Leukemia Recurrent Diffuse Large B-Cell Lymphoma Recurrent Follicular Lymphoma Recurrent Lymphoplasmacytic Lymphoma Recurrent Mantle Cell Lymphoma Recurrent Marginal Zone Lymphoma Refractory B-Cell Non-Hodgkin Lymphoma Refractory Diffuse Large B-Cell Lymphoma Refractory Follicular Lymphoma Refractory Lymphoplasmacytic Lymphoma Refractory Mantle Cell Lymphoma Refractory Transformed Indolent Non-Hodgkin Lymphoma Less << Phase 1 Phase 2 Recruiting November 16, 2037 United States, Washington ... More >> Fred Hutch/University of Washington Cancer Consortium Recruiting Seattle, Washington, United States, 98109 Contact: Mazyar Shadman    206-667-5467    mshadman@uw.edu    Principal Investigator: Mazyar Shadman Less <<
NCT02828592 Severe Aplastic Anemia Phase 2 Recruiting April 2022 United States, Georgia ... More >> Blood and Marrow Transplant Group of Georgia Recruiting Atlanta, Georgia, United States, 30342 Contact: Melhem Solh, MD    404-255-1930    msolh@bmtga.com    Northside Hospital Recruiting Atlanta, Georgia, United States, 30342 Contact: Melhem Solh, MD    404-255-1930    msolh@bmtga.com    Contact: Stacey Brown    404-851-8238    stacey.brown@northside.com    Sub-Investigator: Scott Solomon, MD          Sub-Investigator: H. Kent Holland, MD          Sub-Investigator: Asad Bashey, MD, PhD          Sub-Investigator: Lawrence Morris, MD          Principal Investigator: Melhem Solh, MD Less <<
NCT01144403 - Terminated - -
NCT01144403 Diffuse Large B-Cell Lymphoma Phase 2 Terminated - Romania ... More >> Brasov, Romania, 500326 Bucharest, Romania, 005098 Bucharest, Romania, 022328 Bucuresti, Romania, 030171 Cluj-Napoca, Romania, 400015 Iasi, Romania, 700111 Targu-mures, Romania, 540136 Timisoara, Romania, 300079 Less <<
NCT00923390 Renal Cancer ... More >>Kidney Cancer Less << Phase 1 Terminated - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT01905943 Chronic Lymphocytic Leukemia Phase 3 Completed - -
NCT03711864 Multiple Myeloma Phase 1 Recruiting December 20, 2020 China, Beijing ... More >> Peking Union Medical College Hospital Recruiting Beijing, Beijing, China, 100005 Contact: Jian Li, M.D.    +86-18610852525    lijian@pumch.cn    Contact: Lu Zhang, M.D.    +86-18610728815    pumczhanglu@163.com Less <<
NCT03765177 Acute Lymphoblastic Leukemia ... More >> Non-Hodgkin's Lymphoma Less << Phase 1 Phase 2 Not yet recruiting March 31, 2022 -
NCT01905943 - Completed - -
NCT00536978 Lymphoma Leuk... More >>emia Less << Phase 2 Completed - United States, Texas ... More >> UT MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT01758328 Multiple Myeloma Phase 1 Active, not recruiting December 2019 United States, New York ... More >> Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 Less <<
NCT03019666 Multiple Myeloma ... More >> Non-Hodgkin Lymphoma Diffuse Large B Cell Lymphoma Mantle-Cell Lymphoma Follicular Lymphoma Indolent B Cell Lymphoma Primary Mediastinal Lymphoma Lymphoplasmacytic Lymphoma Less << Phase 1 Recruiting March 31, 2020 United States, Minnesota ... More >> Masonic Cancer Center, University of Minnesota Recruiting Minneapolis, Minnesota, United States, 55455 Contact: Timothy Krepski, RN    612-273-2800    tkrepsk1@fairview.org    Principal Investigator: Veronika Bachanova, MD, PhD Less <<
NCT00058825 Hematologic Malignancies Phase 1 Phase 2 Terminated(Slow accrual due to... More >> practice changes meant study would take too long to finish) Less << - United States, Texas ... More >> Texas Children's Hospital Houston, Texas, United States, 77030 The Methodist Hospital Houston, Texas, United States, 77030 Less <<
NCT02845999 Gastrointestinal Metastatic Ca... More >>ncer Less << Phase 1 Completed - France ... More >> University hospital of Besançon Besançon, France, 25000 Less <<
NCT00067002 Leukemia, Lymphocytic, Acute ... More >> Leukemia, Myelocytic, Acute Leukemia, Myeloid, Chronic Lymphoma, Non-Hodgkin Less << Phase 2 Completed - United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 770030 Less <<
NCT00058825 - Terminated(Slow accrual due to... More >> practice changes meant study would take too long to finish) Less << - -
NCT00053989 Chronic Myeloproliferative Dis... More >>orders Leukemia Lymphoma Multiple Myeloma and Plasma Cell Neoplasm Myelodysplastic Syndromes Myelodysplastic/Myeloproliferative Diseases Less << Phase 2 Completed - United States, New York ... More >> Roswell Park Cancer Institute Buffalo, New York, United States, 14263-0001 Less <<
NCT01369888 Metastatic Melanoma ... More >> Skin Cancer Less << Phase 1 Phase 2 Terminated(Closed this protoco... More >>l due to autoimmune toxicity.) Less << - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT01369888 - Terminated(Closed this protoco... More >>l due to autoimmune toxicity.) Less << - -
NCT00634881 Chronic Lymphocytic Leukemia Phase 1 Phase 2 Completed - Germany ... More >> Medizinische Universitaetsklinik I at the University of Cologne Cologne, Germany, D-50924 Klinikum Barnim GmbH, Werner Forssmann Krankenhaus Eberswalde, Germany, 16225 Universitatsklinikum Heidelberg Heidelberg, Germany, D-69115 Klinikum Lippe - Lemgo Lemgo, Germany, D-32657 III Medizinische Klinik Mannheim Mannheim, Germany, D-68305 Krankenhaus Barmherzige Brueder Regensburg Regensburg, Germany, D-93049 Less <<
NCT01759732 Acquired Aplastic Anemia Phase 2 Unknown December 2015 Korea, Republic of ... More >> Asan Medical Center Recruiting Seoul, Korea, Republic of, 138-736 Contact: Ho Joon Im, MD, PhD    82-2-3010-3371    hojim@amc.seoul.kr    Sub-Investigator: Kyung Nam Koh, MD, PhD Less <<
NCT00108108 Chronic Lymphocytic Leukemia Phase 1 Terminated(Slow enrollment and... More >> minimal preliminary biological and clinical efficacy.) Less << - United States, California ... More >> University of California San Diego StudyCoordinator:CHCD122A2101 La Jolla, California, United States, 92093-0658 United States, Indiana St. Francis Cancer Research Foundation Beech Grove, Indiana, United States, 46107 United States, Maryland The Sidney Kimmel Cancer Center at Johns Hopkins Hospital Div Of HematologicMalignancies Baltimore, Maryland, United States, 21231 United States, Ohio OSU Medical Center/Arthur G. James Cancer Hospital StudyCoordinator:CHCD122A2101 Columbus, Ohio, United States, 43210 United States, Texas MD Anderson Cancer Center/University of Texas Dept of MD Anderson CancerCent Houston, Texas, United States, 77030-4009 Less <<
NCT00608517 - Terminated(slow accrual) - -
NCT00825149 Non-Hodgkin's Lymphoma Phase 1 Completed - -
NCT00513604 Melanoma Mali... More >>gnant Melanoma Melanoma, Experimental Experimental Melanomas Less << Phase 2 Completed - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT01181258 Non-Hodgkin Lymphoma ... More >> Chronic Lymphocytic Leukemia Less << Phase 2 Completed - United States, Minnesota ... More >> Masonic Cancer Center, University of Minnesota Minneapolis, Minnesota, United States, 55455 Less <<
NCT01181258 - Completed - -
NCT02644655 Recurrent B-Cell Tumor ... More >> Refractory B-Cell Tumor Less << Phase 1 Phase 2 Unknown September 2017 China ... More >> Eastern Hepatobiliary Surgery Hospital Recruiting Shanghai, China, 200438 Contact: Huajun Jin, PHD    +86-21-81875372    hj-jin@hotmail.com    Principal Investigator: Qijun Qian, PHD          Principal Investigator: Huajun Jin, PHD          Principal Investigator: Zhengang Yuan, PHD          Sub-Investigator: Yao Huang, MD          Sub-Investigator: Fuping Zhou, MD          Sub-Investigator: Yongmei Ding, MD Less <<
NCT02722668 Acute Leukemia ... More >> Acute Myeloid Leukemia Acute Lymphoblastic Leukemia/Lymphoma Burkitt's Lymphoma Natural Killer Cell Malignancies Chronic Myelogenous Leukemia Myelodysplastic Syndrome Large-cell Lymphoma Hodgkin Lymphoma Multiple Myeloma Relapsed Chronic Lymphocytic Leukemia Relapsed Small Lymphocytic Lymphoma Marginal Zone B-cell Lymphoma Follicular Lymphoma Lymphoplasmacytic Lymphoma Mantle-cell Lymphoma Prolymphocytic Leukemia Bone Marrow Failure Syndromes Myeloproliferative Neoplasms/Myelofibrosis Biphenotypic/Undifferentiated/Prolymphocytic Leukemias MRD Positive Leukemia Leukemia or MDS in Aplasia Relapsed T-Cell Lymphoma Relapsed Multiple Myeloma Plasma Cell Leukemia Less << Phase 2 Recruiting December 2029 United States, Minnesota ... More >> Masonic Cancer Center at University of Minnesota Recruiting Minneapolis, Minnesota, United States, 55455 Contact: Claudio Brunstein, MD    612-625-3918    bruns072@umn.edu Less <<
NCT00608517 Graft Versus Host Disease ... More >> Leukemia Lymphoma Multiple Myeloma and Plasma Cell Neoplasm Myelodysplastic Syndromes Less << Not Applicable Terminated(slow accrual) - United States, Tennessee ... More >> Vanderbilt-Ingram Cancer Center - Cool Springs Nashville, Tennessee, United States, 37067-1631 Vanderbilt-Ingram Cancer Center at Franklin Nashville, Tennessee, United States, 37067-5615 Veterans Affairs Medical Center - Nashville Nashville, Tennessee, United States, 37212 Vanderbilt-Ingram Cancer Center Nashville, Tennessee, United States, 37232-6838 Less <<
NCT00513604 - Completed - -
NCT03594162 - - - United States, North Carolina ... More >> Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill Chapel Hill, North Carolina, United States, 27599 Less <<
NCT00186966 Acute Myeloid Leukemia Phase 3 Completed - United States, Tennessee ... More >> St. Jude Children's Research Hospital Memphis, Tennessee, United States, 38105 Less <<
NCT00589563 Chronic Myeloproliferative Dis... More >>orders Graft Versus Host Disease Infection Leukemia Lymphoma Multiple Myeloma and Plasma Cell Neoplasm Myelodysplastic Syndromes Myelodysplastic/Myeloproliferative Neoplasms Precancerous Condition Secondary Myelofibrosis Small Intestine Cancer Less << Phase 2 Completed - United States, Arizona ... More >> Banner Good Samaritan Medical Center Phoenix, Arizona, United States, 85006 United States, California City of Hope Comprehensive Cancer Center Duarte, California, United States, 91010-3000 Less <<
NCT01585415 Metastatic Cancer ... More >> Melanoma Less << Phase 1 Terminated - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT00708721 Cancer Chroni... More >>c Myelomonocytic Leukemia Less << Phase 1 Phase 2 Terminated(Data analysis revea... More >>led sufficient data for safety and efficacy) Less << - United States, Utah ... More >> Huntsman Cancer Institute Salt Lake City, Utah, United States, 84112 Less <<
NCT00589563 - Completed - -
NCT02722135 Leukemia, Myeloid, Acute Phase 1 Withdrawn September 2018 Belgium ... More >> Boehringer Ingelheim Investigational Site Gent, Belgium Less <<
NCT00708721 - Terminated(Data analysis revea... More >>led sufficient data for safety and efficacy) Less << - -
NCT02167958 Leukemia MDS ... More >> Myelofibrosis Lymphoma Less << Phase 1 Recruiting July 2020 United States, Pennsylvania ... More >> UPMC Hillman Cancer Center Recruiting Pittsburgh, Pennsylvania, United States, 15232 Contact: Rita Johnson, RN    412-647-8571    Johnsonr1@upmc.edu    Sub-Investigator: Annie P Im, MD          Sub-Investigator: Alison R Sehgal, MD          Sub-Investigator: Mounzer E Agha, MD          Sub-Investigator: Jing-Zhou Hou, MD          Sub-Investigator: Mounzer Agha, MD          Sub-Investigator: Kathleen Dorritie, MD          Sub-Investigator: Anastasios Raptis, MD Less <<
NCT02375984 Metastatic Melanoma Phase 2 Terminated(PI changed institut... More >>ions) Less << - United States, California ... More >> John Wayne Cancer Institute Santa Monica, California, United States, 90404 Less <<
NCT00491634 Acute Myeloid Leukemia ... More >> Myelodysplastic Syndrome Less << Phase 2 Completed - Israel ... More >> Chaim Sheba Medical Center Tel-Hashomer, Israel Less <<
NCT03330834 Advanced Lung Cancer Phase 1 Not yet recruiting September 30, 2019 -
NCT00487448 Myelodysplastic Syndrome ... More >> Acute Myeloblastic Leukemia Less << Phase 4 Completed - Spain ... More >> Hospital de la Ribera Alzira, Spain Hospital Germans Trias i Pujol Badalona, Spain Hospital del Mar Barcelona, Spain Hospital Vall d'Hebron Barcelona, Spain Hospital Puerta del Mar Cadiz, Spain Hospital del SAS Jerez de la Frontera, Spain Hospital de Leon Leon, Spain Hospital Clínico San Carlos Madrid, Spain Hospital Universitario La Paz Madrid, Spain Hospital Morales Messeguer Murcia, Spain Hospital Central de Asturias Oviedo, Spain Hospital Clínico de Salamanca Salamanca, Spain Hospital Arnau de Vilanova Valencia, Spain Hospital Dr. Pesset Valencia, Spain Hospital Universitario La Fe Valencia, Spain Less <<
NCT01904136 Leukemia Myel... More >>oproliferative Diseases Less << Phase 1 Phase 2 Recruiting April 2020 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Less <<
NCT01495572 Metastatic Melanoma ... More >> Skin Cancer Less << Phase 2 Terminated(Due to slow accrual... More >>, the investigator decided to close the study.) Less << - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT01495572 - Terminated(Due to slow accrual... More >>, the investigator decided to close the study.) Less << - -
NCT00021151 Leukemia Not Applicable Completed - United States, Ohio ... More >> Ireland Cancer Center Cleveland, Ohio, United States, 44106-5065 Less <<
NCT00849745 Systemic Lupus Erythematosus ... More >> Systemic Sclerosis Less << Phase 1 Terminated(low accrual) - United States, North Carolina ... More >> Duke University Health System Durham, North Carolina, United States, 27705 Less <<
NCT00004145 Leukemia Lymp... More >>homa Multiple Myeloma and Plasma Cell Neoplasm Myelodysplastic Syndromes Less << Phase 2 Completed - United States, Illinois ... More >> University of Chicago Cancer Research Center Chicago, Illinois, United States, 60637-1470 Less <<
NCT00352976 Fanconi Anemia Phase 2 Phase 3 Recruiting December 2018 United States, Minnesota ... More >> University of Minnesota Medical Center Recruiting Minneapolis, Minnesota, United States, 55455 Contact: Margaret L MacMillan, M.D.    612-626-2778    macmi002@umn.edu Less <<
NCT01153971 Non-Hodgkin's Lymphoma Phase 2 Completed - Italy ... More >> Ospedale Civile Dello Spirito Santo; Divisione Di Ematologia Pescara, Abruzzo, Italy, 65100 Ospedale Civile; Divisione Di Oncologia Pescara, Abruzzo, Italy, 65124 Ospedale Oncologico Regionale; U.O. Oncologia Medica Ed Ematologia Rionero in Vulture, Basilicata, Italy, 85028 Ospedale Riuniti; Divisione Di Ematologia Reggio Calabria, Calabria, Italy, 89100 A.O.U. Policlinico di Modena-Dipartimento di Medicina Diagnostica, Clinica e di Sanità pubblica Modena, Emilia-Romagna, Italy, 41100 Az. Osp. Arcispedale S. Maria Nuova; U.O. Di Ematologia Reggio Emilia, Emilia-Romagna, Italy, 42100 Universita' Degli Studi La Sapienza-Ist.Di Ematologia;Dip. Biotecnologie Cel CELLULARI ED EMATOLOGIA Roma, Lazio, Italy, 00161 A.O. Spedali Civili Di Brescia-P.O. Spedali Civili;U.O. Ematologia Brescia, Lombardia, Italy, 25123 Ospedale Maggiore Di Milano; U.O. Ematologia I - Padiglione Marcora Milano, Lombardia, Italy, 20122 Asst Grande Ospedale Metropolitano Niguarda; Dipartimento Di Ematologia Ed Oncologia Milano, Lombardia, Italy, 20162 Ospedale Civile SS. Antonio E Biagio DI Alessandria; Ematologia Alessandria, Piemonte, Italy, 15121 Az. Osp. S. Croce Ospedale Generale; Sezione Di Ematologia Cuneo, Piemonte, Italy, 12100 A.O. Universitaria S. Giovanni Battista-Molinette Di Torino; Ematologia 1 Torino, Piemonte, Italy, 10126 Az. Osp. Papardo; Struttura Complessa Di Ematologia Messina, Sicilia, Italy, 98165 Az. Osp. Di Careggi; Divisione Di Ematologia Firenze, Toscana, Italy, 50135 Less <<
NCT01153971 - Completed - -
NCT00412360 Acute Myelogenous Leukemia ... More >> Acute Lymphocytic Leukemia Chronic Myelogenous Leukemia Myelodysplastic Syndrome Natural Killer Cell Lymphoblastic Leukemia/Lymphoma Less << Phase 3 Completed - -
NCT00179790 Leukemia Canc... More >>er Less << Phase 1 Phase 2 Completed - United States, Illinois ... More >> Ann & Robert H Lurie Children's Hospital of Chicago Chicago, Illinois, United States, 60625 Less <<
NCT00412360 - Completed - -
NCT03215810 Non-Small Cell Lung Cancer ... More >> Metastatic Non-small Cell Lung Cancer Squamous Cell Carcinoma Advanced NSCLC Adenosquamous Carcinoma Adenocarcinomas Less << Phase 1 Recruiting March 2021 United States, Florida ... More >> University of Florida Health Cancer Center. Not yet recruiting Gainesville, Florida, United States, 32608 H. Lee Moffitt Cancer Center and Research Institute Recruiting Tampa, Florida, United States, 33612 Contact: Ben Creelan, M.D.    813-745-3050    thoraciccro@moffitt.org    Principal Investigator: Ben Creelan, M.D.          Sub-Investigator: Scott Antonia, M.D., Ph.D.          Sub-Investigator: Alberto Chiappori, M.D.          Sub-Investigator: Jhanelle Gray, M.D.          Sub-Investigator: Eric Haura, M.D.          Sub-Investigator: Amod Sarnaik, M.D.          Sub-Investigator: Tawee Tanvetyanon, M.D. Less <<
NCT00278213 Prolymphocytic Leukemia Phase 2 Completed - Austria ... More >> Allgemeines Krankenhaus - Universitatskliniken Vienna, Austria, A-1090 Hanuschkrankenhaus Vienna, Austria, A-1140 Germany Allgemeinen Krankenhaus Celle Kinderklinik Celle, Germany, 29223 St. Johannes Hospital - Medical Klinik II Duisburg, Germany, D-47166 Helios Klinikum Erfurt Erfurt, Germany, D-99089 Universitaetsklinikum Essen Essen, Germany, D-45147 Klinikum Garmisch - Partenkirchen GmbH Garmisch-Partenkirchen, Germany, N 82467 Sana Klinikum Hof Hof, Germany, 95032 University Hospital Schleswig-Holstein - Kiel Campus Kiel, Germany, D-24116 Internistische Praxis - Ludwigsburg Ludwigsburg, Germany, 71638 Sana Kliniken Luebeck Luebeck, Germany, D-23560 Haematologische Praxis - Moenchengladbach Moenchengladbach, Germany, 41239 Gemeinschaftliche Schwerpunktpraxis - Osnabrueck Osnabrueck, Germany, 49074 Caritasklinik St. Theresia Saarbrucken, Germany, D-66113 Schwerpunktpraxis fuer Haematologie und Onkologie Saarbruecken, Germany, 66113 Southwest German Cancer Center at Eberhard-Karls-University Tuebingen, Germany, D-72076 Dr. Horst-Schmidt-Kliniken Wiesbaden, Germany, D-65199 Hamatologisch - Onkologische Praxis Wurzburg Wurzburg, Germany, 97070 Klinikum des Landkreises Loebau-Zittau GmbH Zittau, Germany, 02763 Less <<
NCT02440464 Multiple Myeloma Phase 2 Active, not recruiting March 2023 United States, Alabama ... More >> University of Alabama Birmingham, Alabama, United States, 35294 United States, California City of Hope National Medical Center Duarte, California, United States, 91010 United States, Florida H. Lee Moffitt Cancer Center Tampa, Florida, United States, 33624 United States, Georgia Emory University Atlanta, Georgia, United States, 30322 BMT Northside Atlanta, Georgia, United States, 30342 United States, Illinois Loyola University Medical Center Maywood, Illinois, United States, 60153 United States, Kentucky University of Kentucky Lexington, Kentucky, United States, 40536 United States, Minnesota University of Minnesota Minneapolis, Minnesota, United States, 55455 United States, New York Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10065 United States, North Carolina Duke University Medical Center Durham, North Carolina, United States, 27705 United States, Ohio Ohio State/Arthur G. James Cancer Hospital Columbus, Ohio, United States, 43210 United States, Texas University of Texas /MD Anderson CRC Houston, Texas, United States, 77030 United States, West Virginia West Virginia University Morgantown, West Virginia, United States, 26506 United States, Wisconsin University of Wisconsin Hospital & Clinics Madison, Wisconsin, United States, 53792 Medical College of Wisconsin Milwaukee, Wisconsin, United States, 53211 Less <<
NCT03475134 Metastatic Melanoma Phase 1 Recruiting June 1, 2024 Switzerland ... More >> CHUV Oncology Department Recruiting Lausanne, Vaud, Switzerland, 1011 Contact: George Coukos    +41213140627    george.coukos@chuv.ch Less <<
NCT02799147 Leukemia, Acute Lymphoblastic ... More >> Acute Myeloid Leukemia Mixed-Lineage Acute Leukemias Less << Phase 1 Phase 2 Recruiting June 2020 Russian Federation ... More >> First Pavlov State Medical University of St. Petersburg Recruiting Saint-Petersburg, Russian Federation, 197089 Contact: Ivan S. Moiseev, PhD    +79217961951    moisiv@mail.ru    Contact: Olga A. Slesarchuk, PhD    +79111910003    olga.slesarchuk@gmail.com    Sub-Investigator: Olga V. Pirogova, M.S. Less <<
NCT02548468 Cutaneous T-Cell Non-Hodgkin L... More >>ymphoma Recurrent Mycosis Fungoides and Sezary Syndrome Stage IIB Mycosis Fungoides and Sezary Syndrome Stage IIIA Mycosis Fungoides and Sezary Syndrome Stage IIIB Mycosis Fungoides and Sezary Syndrome Stage IVA Mycosis Fungoides and Sezary Syndrome Stage IVB Mycosis Fungoides and Sezary Syndrome Less << Phase 1 Withdrawn(Slow accrual) - -
NCT00186797 Aplastic Anemia Not Applicable Completed - United States, Tennessee ... More >> St. Jude Children's Research Hospital Memphis, Tennessee, United States, 38105 Less <<
NCT00578292 Thalassemia Not Applicable Terminated(Over the course of ... More >>this study stem cell transplant was determined to be standard of care for this disease and as such the study is no longer relevant.) Less << - United States, Texas ... More >> Texas Children's Hospital Houston, Texas, United States, 77030 Less <<
NCT02435901 Sickle Cell Disease ... More >> Beta Thalassemia-Major Less << Phase 1 Phase 2 Completed - United States, New York ... More >> Cohen Children's Medical Center of New York New Hyde Park, New York, United States, 11040 Less <<
NCT00931645 Chronic Lymphocytic Leukemia Phase 3 Completed - France ... More >> DBIM Hopital Saint Louis Paris, France, 75000 Less <<
NCT01564784 Acute Lymphoblastic Leukemia Phase 3 Completed - -
NCT01564784 - Completed - -
NCT00301860 Leukemia Lymp... More >>homa Less << Not Applicable Terminated(lack of efficacy) - United States, California ... More >> UCSF Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States, 94115 Less <<
NCT00017108 Leukemia Phase 3 Unknown - Belgium ... More >> Hopital Universitaire Erasme Brussels, Belgium, 1070 Cliniques Universitaires Saint-Luc Brussels, Belgium, 1200 Hopital de Jolimont Haine Saint Paul, Belgium, 7100 Czech Republic University Hospital - Olomouc Olomouc, Czech Republic, 775 20 Hungary County Hospital Kaposvar, Hungary, H-7400 Italy Azienda Ospedaliera Papardo Messina, Italy Ospedale Sant' Eugenio Rome, Italy, 00144 Macedonia, The Former Yugoslav Republic of Clinical Center Skopje Skopje, Macedonia, The Former Yugoslav Republic of, 91000 Netherlands Leyenburg Ziekenhuis 's-Gravenhage, Netherlands, 2545 CH Onze Lieve Vrouwe Gasthuis Amsterdam, Netherlands, 1091 HA Leiden University Medical Center Leiden, Netherlands, 2300 CA University Medical Center Nijmegen Nijmegen, Netherlands, NL-6500 HB Portugal Hospital Escolar San Joao Porto, Portugal, 4200 Less <<
NCT03622788 Acute Lymphoblastic Leukemia ... More >> Acute Myeloid Leukemia Acute Myeloid Leukemia in Remission Aplastic Anemia Bone Marrow Failure Chronic Lymphocytic Leukemia Chronic Myelogenous Leukemia, BCR-ABL1 Positive Donor Follicular Lymphoma Hematopoietic Cell Transplantation Recipient Hodgkin Lymphoma Mantle Cell Lymphoma Myelodysplastic Syndrome Myeloproliferative Neoplasm Near Complete Response of Multiple Myeloma or Plasma Cell Leukemia Non-Hodgkin Lymphoma Partial Response of Multiple Myeloma or Plasma Cell Leukemia Plasma Cell Myeloma Less << Phase 1 Phase 2 Not yet recruiting April 1, 2020 United States, Texas ... More >> M D Anderson Cancer Center Not yet recruiting Houston, Texas, United States, 77030 Contact: Richard E. Champlin    713-792-8750       Principal Investigator: Richard E. Champlin Less <<
NCT01773395 Myelodysplastic Syndrome ... More >> Acute Myeloid Leukemia Chronic Myelomonocytic Leukemia Less << Phase 2 Recruiting January 2033 United States, Massachusetts ... More >> Massachusetts General Hospital Recruiting Boston, Massachusetts, United States, 02114 Contact: Yi-Bin Chen, MD    617-726-5765    YCHEN6@partners.org    Principal Investigator: Yi-Bin Chen, MD          Brigham and Women's Hospital Recruiting Boston, Massachusetts, United States, 02115 Contact: Vincent Ho, MD    617-632-5938    vtho@partners.org    Principal Investigator: Vincent Ho, MD          Dana-Farber Cancer Institute Recruiting Boston, Massachusetts, United States, 02115 Contact: Vincent Ho, MD    617-632-5938    vtho@partners.org    Principal Investigator: Vincent Ho, MD          Beth Israel Deaconess Medical Center Recruiting Boston, Massachusetts, United States, 02215 Contact: Jacalyn Rosenblatt, MD    617-667-9920    jrosenb1@bidmc.harvard.edu    Principal Investigator: Jacalyn Rosenblatt, MD Less <<
NCT00053196 Leukemia Lymp... More >>homa Multiple Myeloma Plasma Cell Neoplasm Myelodysplastic Syndromes Myeloproliferative Neoplasms Less << Phase 2 Completed - United States, California ... More >> Rebecca and John Moores UCSD Cancer Center La Jolla, California, United States, 92093-0658 United States, Delaware Beebe Medical Center Lewes, Delaware, United States, 19958 CCOP - Christiana Care Health Services Newark, Delaware, United States, 19713 St. Francis Hospital Wilmington, Delaware, United States, 19805 United States, Maryland Union Hospital Cancer Center at Union Hospital Elkton MD, Maryland, United States, 21921 United States, Missouri Siteman Cancer Center at Barnes-Jewish Hospital St Louis, Missouri, United States, 63110 United States, New Jersey Cancer Institute of New Jersey at the Cooper University Hospital - Voorhees Voorhees, New Jersey, United States, 08043 United States, New York Roswell Park Cancer Institute Buffalo, New York, United States, 14263-0001 United States, North Carolina Wake Forest University Comprehensive Cancer Center Winston-Salem, North Carolina, United States, 27157-1096 United States, Ohio Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University Columbus, Ohio, United States, 43210-1240 United States, Pennsylvania Western Pennsylvania Cancer Institute at Western Pennsylvania Hospital Pittsburgh, Pennsylvania, United States, 15224-1791 United States, Virginia Massey Cancer Center at Virginia Commonwealth University Richmond, Virginia, United States, 23298-0037 Less <<
NCT01597219 Hodgkin's Lymphoma ... More >> Non-Hodgkin's Lymphoma Acute Myeloid Leukaemia Acute Lymphoblastic Leukaemia Myelodysplastic Syndrome Chronic Myeloid Leukaemia Chronic Lymphocytic Leukaemia Acquired Bone Marrow Failure Syndromes Other Haematological Malignancies; Unrelated HSCT Indicated Less << Phase 2 Recruiting March 2020 United Kingdom ... More >> Birmingham Heartlands Recruiting Birmingham, United Kingdom Contact: Dr Shankara Paneesha          Bristol Royal Infirmary Recruiting Bristol, United Kingdom Principal Investigator: Dr Rachel Protheroe          Addenbrooke's Hospital Recruiting Cambridge, United Kingdom Principal Investigator: Dr Ben Uttenthal          Beatson Hospital Recruiting Glasgow, United Kingdom Principal Investigator: Dr Dave Irvine          St James' University Hospital Recruiting Leeds, United Kingdom Principal Investigator: Dr Maria Gilleece          Royal Liverpool Hospital Recruiting Liverpool, United Kingdom Principal Investigator: Dr Rahuman Salim          King's College Hospital Recruiting London, United Kingdom Principal Investigator: Dr Kavita Raj          St Bartholomew's Hospital Active, not recruiting London, United Kingdom University College Hospital Recruiting London, United Kingdom Principal Investigator: Dr Panagiotis Kottaridis          Manchester Royal Infirmary Recruiting Manchester, United Kingdom Principal Investigator: Dr Eleni Tholouli          Freeman Hospital Recruiting Newcastle, United Kingdom Principal Investigator: Prof Matthew Colin          Royal Hallamshire, Sheffield & Weston Park Recruiting Sheffield, United Kingdom Principal Investigator: Prof John Snowden Less <<
NCT03171831 Thalassemia Major Phase 4 Recruiting April 1, 2022 China, Guangxi ... More >> First Affiliated Hospital of Guangxi Medical University Recruiting Nanning, Guangxi, China, 510515 Contact: Yongrong Lai, MD    +86（0771）5356510    laiyongrong@hotmail.com Less <<
NCT03591510 FLT3-mutated Acute Myeloid Leu... More >>kemia Less << Phase 2 Not yet recruiting April 21, 2025 Korea, Republic of ... More >> Novartis Investigative Site Seoul, Korea, Republic of, 03080 Less <<
NCT01707004 Acute Myeloid Leukemia With Mu... More >>ltilineage Dysplasia Following Myelodysplastic Syndrome Adult Acute Myeloid Leukemia in Remission Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities Adult Acute Myeloid Leukemia With Del(5q) Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) Adult Acute Myeloid Leukemia With t(15;17)(q22;q12) Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) Adult Acute Myeloid Leukemia With t(8;21)(q22;q22) de Novo Myelodysplastic Syndromes Previously Treated Myelodysplastic Syndromes Recurrent Adult Acute Myeloid Leukemia Secondary Acute Myeloid Leukemia Less << Phase 2 Completed - United States, Wisconsin ... More >> University of Wisconsin Hospital and Clinics Madison, Wisconsin, United States, 53792 Less <<
NCT03500731 Idiopathic Pulmonary Fibrosis ... More >> Emphysema or COPD Less << Phase 1 Phase 2 Recruiting December 2026 United States, Pennsylvania ... More >> UPMC Presbyterian Recruiting Pittsburgh, Pennsylvania, United States, 15214 Contact: John McDyer, MD    412-648-6161    mcdyerjf@upmc.edu    Children's Hospital of Pittsburgh of UPMC Recruiting Pittsburgh, Pennsylvania, United States, 15224 Contact: Jason Rowan, RN    412-692-6195    jason.rowan@chp.edu    Principal Investigator: Paul Szabolcs, MD Less <<
NCT02127892 - Terminated(Closed due to slow ... More >>accrual. Nine subjects enrolled over 7 years.) Less << - -
NCT03152526 Acute Myelogenous Leukemia Not Applicable Recruiting June 2022 United States, Illinois ... More >> Universtiy of Chicago Recruiting Chicago, Illinois, United States, 60637 Contact: Preeti Karmali    773-702-9440    pkarmali@medicine.bsd.uchicago.edu    Principal Investigator: Satyajit Kosuri, MD          United States, Minnesota University of Minnesota Recruiting Minneapolis, Minnesota, United States, 55455 Contact: Erica Orcholski    612-626-5174    eorchols@umn.edu    Principal Investigator: Sarah Cooley, MD Less <<
NCT02127892 Severe Combined Immunodeficien... More >>cy Less << Phase 1 Phase 2 Terminated(Closed due to slow ... More >>accrual. Nine subjects enrolled over 7 years.) Less << - United States, California ... More >> Children's Hospital Los Angeles Los Angeles, California, United States, 90027 Less <<
NCT02349906 Primary Immunodeficiencies ... More >> Inborn Errors of Metabolism Haemoglobinopathies Bone Marrow Failure Syndromes Less << Phase 2 Recruiting December 2019 Austria ... More >> St. Anna Children's Hospital Withdrawn Vienna, Austria, 1090 Czechia University Hospital Motol, Dep. of Paediatric Haematology and Oncology Recruiting Prague, Czechia Contact: Petr Sedlacek, MD, Prof.    +42060672 ext 6550       Germany Department of Pediatric Oncology & Hematology, Charite Berlin Not yet recruiting Berlin, Germany, 13353 Contact: Johannes Schulte, MD, Prof.          Duesseldorf University Hospital Withdrawn Duesseldorf, Germany, 40225 University Children's Hospital Essen Pediatric stem cell transplantation Not yet recruiting Essen, Germany, 45122 Contact: Rita Beier, MD          University Hospital Frankfurt Recruiting Frankfurt am Main, Germany, 60590 Contact: Peter Bader, MD, Prof.          University Medical Center Hamburg-Eppendorf Withdrawn Hamburg, Germany, 20246 Hannover Medical University, Dep. of Paediatrics, Paediatric Haematology and Oncology Recruiting Hannover, Germany Contact: Karl-Walter Sykora, MD, Prof.    +49(0)511532 ext 5830       Heidelberg University Hospital Recruiting Heidelberg, Germany, 69120 Contact: Johann Greil, MD, Prof.          University of Jena, Department of Pediatrics Not yet recruiting Jena, Germany, 07747 Contact: Bernd Gruhn, MD, Prof.          University Hospital Regensburg Withdrawn Regensburg, Germany, 93053 Ulm, University Hospital, Clinic for Children and Adolescents Recruiting Ulm, Germany, 89075 Contact: Ansgar Schulz, MD, Prof.    +49(0)731500 ext 57154       University Hospital of Wuerzburg Withdrawn Wuerzburg, Germany, 97080 Italy SC Oncoematologia Pediatrica Ospedale Pediatrico Microcitemico "Antonio Cao" A.O. Brotzu Not yet recruiting Cagliari, Italy, 09121 Contact: Maria Grazia Orofino, MD          UOC Ematologia ed Oncologia Pediatrica con TMO AOU Policlinico Vittorio Emanuele Not yet recruiting Catania, Italy, 95123 Contact: Giovanna Russo, MD          Reparto Trapianti Midollo Osseo Clinica Pediatrica Universitaria Fondazione MBBM-Ospedale San Gerardo Not yet recruiting Monza, Italy, 20900 Contact: Sonia Bonanomi, MD          S.C. Oncoematologia Pediatrica Fondazione IRCCS Policlinico San Matteo Not yet recruiting Pavia, Italy, 27100 Contact: Marco Zecca, MD          Oncoematologia Pediatrica A.O. di Perugia Ospedale S. Maria della Misericordia Not yet recruiting Perugia, Italy, 06156 Contact: Maurizio Caniglia, MD          U.O. Oncoematologia Pediatrica Azienda Ospedaliero Universitaria Pisana Ospedale S. Chiara Not yet recruiting Pisa, Italy, 56100 Contact: Mariacristina Menconi, MD          Ospedale Bambino Gesu Roma Recruiting Rome, Italy, 00165 Contact: Franco Locatelli, MD, Prof.          Ospedale Infantile Regina Margherita Torino Recruiting Turin, Italy, 10126 Contact: Franca Fagioli, MD, Prof.          U.O.C. Oncoematologia Pediatrica Policlinico "G.B. Rossi" - AOUI Verona Recruiting Verona, Italy, 37134 Contact: Simone Cesaro, MD          Poland Szpital Uniwersytecki im. dr Antoniego Jurasza Recruiting Bydgoszcz, Poland, 85-094 Contact: Jan Styczynski, MD, Prof          Uniwersytecki Szpital Dzieciecy w Krakowie Recruiting Krakow, Poland, 30-663 Contact: Jolanta Gozdzik, MD          Dzieciecy Szpital Kliniczny im. A. Gebali w Lublinie Not yet recruiting Lublin, Poland, 20-093 Contact: Katarzyna Drabko, MD          Wroclaw Medical University, Department of Pediatric Hematology/Oncology and BMT Recruiting Wroclaw, Poland, 50-368 Contact: Krzysztof Kałwak, MD, PhD, Prof.    (48)-71 ext 7703170 Less <<
NCT02858310 Papillomavirus Infections ... More >> Cervical Intraepithelial Neoplasia Carcinoma In Situ Vulvar Neoplasms Vulvar Diseases Less << Phase 1 Phase 2 Recruiting January 1, 2026 United States, Maryland ... More >> National Institutes of Health Clinical Center Recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact National Cancer Institute Referral Office    888-624-1937 Less <<
NCT01370213 Acute Myeloid Leukemia ... More >> Myelodysplastic Syndrome Less << Phase 2 Active, not recruiting January 2019 United States, Georgia ... More >> Emory University Atlanta, Georgia, United States, 30322 United States, Minnesota University of Minnesota, Masonic Cancer Center Minneapolis, Minnesota, United States, 55455 United States, Missouri Washington University St. Louis, Missouri, United States, 63110 United States, Ohio Ohio State University Columbus, Ohio, United States, 43210 Less <<
NCT00393029 - Completed - -
NCT00598624 Leukemia Chro... More >>nic Myeloid Leukemia Myelodysplastic Syndrome Diffuse Large Cell Lymphoma Hodgkin Lymphoma Chronic Lymphocytic Leukemia Multiple Myeloma Less << Phase 2 Unknown December 2010 Italy ... More >> Ematologia, Ospedale Casa Sollievo della Sofferenza Recruiting San Giovanni Rotondo, Foggia, Italy Contact: Angelo Michele Carella, MD       am.carella@operapadrepio.it    Contact: Marzia Tricarico, DM       m.tricarico@operapadrepio.it    Principal Investigator: Nicola Cascavilla, MD          IRCCS San Raffaele; Unità Operativa di Ematologia Recruiting Milano, MI, Italy, 20100 Contact: Alessandro Crotta, MD    +39 0226433903    a.crotta@hsr.it    Contact: Stefania Trinca    +39 0226434289    stefania.trinca@hsr.it    Principal Investigator: Jacopo Peccatori, MD          USC Ematologia, Ospedali Riuniti Recruiting Bergamo, Italy Contact: Anna Grassi, MD       agrassi@ospedaliriuniti.bergamo.it    Contact: Maria Luisa Ferrari, DM       mlferrari@ospedaliriuniti.bergamo.it    Principal Investigator: Alessandro Rambaldi, MD          Ospedale centrale di Bolzano - Reparto di Ematologia Recruiting Bolzano, Italy Contact: Enrico Morello, MD    +390471908807    enrico.morello@asbz.it    Principal Investigator: Enrico Morello, MD          PO "R.Binaghi" - CTMO Recruiting Cagliari, Italy Contact: Adriana Vacca, MD    +393285452813    vaadriana@tiscali.it    Principal Investigator: Giorgio La Nasa, MD          AO "Santa Croce" e Carle - Reparto di Ematologia Recruiting Cuneo, Italy Contact: Laura Bertolotti, Data Manager    +390171642229    laura.bertolotti@libero.it    Principal Investigator: Andrea Gallamini, MD          Istituto Europeo di Oncologia - Divisione di Ematologia Recruiting Milano, Italy Contact: Liliana Calabrese, Data Manager    +390257489536    liliana.calabrese@ieo.it    Principal Investigator: Giovanni Martinelli, MD          Ospedale Civile - UTI ematologia per il trapianto emopoietico Recruiting Pescara, Italy Contact: Paolo Di Bartolomei, MD       pescaratmo@virgilio.it    Principal Investigator: Paolo Di Bartolomei, MD          Arcispedale Santa Maria Nuova - SC di Ematologia Recruiting Reggio Emilia, Italy Contact: Alessandro Bonini, MD       bonini.alessandro@asmn.re.it    Principal Investigator: Luigi Gugliotta, MD          Dipartimento Biotecnologie Cellulari ed Ematologia; Azienda Policlinico Umberto I Recruiting Roma, Italy, 00100 Contact: Emilia Iannella, MD    +39 3202233365    emiliaiannella@libero.it    Contact: Roberto Ricci    +39 3477578735    r.ricci@bce.uniroma1.it    Principal Investigator: Roberto Foa, MD          AO San Camillo Forlanini - UOC ematologia e trapianto Recruiting Roma, Italy Contact: Beatrice Pinazzi, MD       mpinazzi@scamilloforlanini.rm.it    Principal Investigator: Ignazio Majolino, MD          AOU Santa Maria della Misericordia - Clinica Ematologica Recruiting Udine, Italy Contact: Francesca Patriarca, MD       patriarca.francesca@aoud.sanita.fvg.it    Principal Investigator: Michela Cerno, MD Less <<
NCT00003620 B-cell Chronic Lymphocytic Leu... More >>kemia Refractory Chronic Lymphocytic Leukemia Stage I Chronic Lymphocytic Leukemia Stage II Chronic Lymphocytic Leukemia Stage III Chronic Lymphocytic Leukemia Stage IV Chronic Lymphocytic Leukemia Less << Phase 2 Completed - United States, Illinois ... More >> Cancer and Leukemia Group B Chicago, Illinois, United States, 60606 Less <<
NCT03653338 Sickle Cell Anemia ... More >> Beta-thalassemia Major Diamond-blackfan Anemia Less << Phase 1 Phase 2 Recruiting August 1, 2025 United States, Pennsylvania ... More >> Children's Hosptial of Pittsburgh of UPMC Recruiting Pittsburgh, Pennsylvania, United States, 15224 Principal Investigator: Beth Carella, DO Less <<
NCT02278887 Metastatic Melanoma Phase 3 Recruiting September 2020 Denmark ... More >> CCIT Department of Oncology and Haematology Herlev Hospital Recruiting Copenhagen, Denmark Contact: Inge Marie Svane, Prof.       Inge.Marie.Svane@regionh.dk    Contact: Troels H. Borch       troels.holz.borch@regionh.dk    Principal Investigator: Inge Marie Svane, Prof.          Netherlands Netherlands Cancer Institute Recruiting Amsterdam, NH, Netherlands, 1066CX Contact: Maartje Rohaan    +31205126186    m.rohaan@nki.nl    Principal Investigator: John B.A.G. Haanen, Prof. Less <<
NCT01062490 Myelodysplastic Syndrome Phase 2 Completed - Finland ... More >> Helsinki University Central Hospital Helsinki, Finland, 00029 Less <<
NCT02461121 Acute Myeloid Leukemia Phase 3 Completed - China, Beijing ... More >> Affiliated Hospital of Academy of Military Medical Sciences , Beijing, Beijing, China, 100071 Less <<
NCT00393029 Anti-p53 TCR-Gene Phase 2 Completed - United States, Maryland ... More >> National Institutes of Health Bethesda, Maryland, United States, 20892 Less <<
NCT01050439 Leukemia Lymp... More >>homa Bone Marrow Failure Syndromes Immunodeficiencies Histiocytosis Less << Phase 2 Terminated(PI left the institu... More >>tion) Less << - United States, New York ... More >> Columbia University Medical Center New York, New York, United States, 10032 Less <<
NCT00704938 Kidney Cancer ... More >> Melanoma (Skin) Unspecified Adult Solid Tumor, Protocol Specific Less << Phase 2 Terminated(Terminated due to w... More >>ithdrawal of support from our collaborator.) Less << - United States, Maryland ... More >> Warren Grant Magnuson Clinical Center - NCI Clinical Trials Referral Office Bethesda, Maryland, United States, 20892-1182 Less <<
NCT00704938 - Terminated(Terminated due to w... More >>ithdrawal of support from our collaborator.) Less << - -
NCT00001830 Chronic Lymphocytic Leukemia ... More >> Graft vs Host Disease Hodgkin's Disease Multiple Myeloma Non Hodgkin's Lymphoma Less << Phase 1 Completed - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT01719341 - Unknown - Singapore ... More >> National University Hospital Recruiting Singapore, Singapore, 119074 Contact: Zi Yi Lim, MB ChB    65 6779 5555    Zi_Yi_Lim@nuhs.edu.sg    Principal Investigator: Zi Yi Lim, MB ChB Less <<
NCT00006413 Mastocytosis Phase 2 Completed - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT00686556 Acute Lymphoblastic Leukemia ... More >> Myelodysplastic Syndrome Multiple Myeloma Less << Phase 1 Completed - United States, Minnesota ... More >> Masonic Cancer Center at University of Minnesota Minneapolis, Minnesota, United States, 55455 Less <<
NCT00006379 Chronic Myeloproliferative Dis... More >>orders Leukemia Lymphoma Multiple Myeloma and Plasma Cell Neoplasm Myelodysplastic Syndromes Myelodysplastic/Myeloproliferative Diseases Precancerous/Nonmalignant Condition Small Intestine Cancer Less << Phase 2 Completed - United States, Ohio ... More >> Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States, 44106-5065 Less <<
NCT03455517 Chronic Myeloid Leukemia Phase 2 Not yet recruiting March 2021 -
NCT03642626 Acute Lymphoblastic Leukemia ... More >> Large B-cell Lymphoma Less << Phase 2 Not yet recruiting July 2028 -
NCT03257241 Acute Myeloid Leukemia Phase 3 Recruiting December 31, 2020 Poland ... More >> Medical University of Bialystok Clinical Hospital Recruiting Białystok, Poland, 15-276 Contact: Jarosław Piszcz, Dr          Markiewicz Memorial Oncology Center Brzozow Recruiting Brzozów, Poland, 36-200 Contact: Andrzej Pluta, Dr          University Clinical Centre in Gdansk Recruiting Gdańsk, Poland, 80-210 Contact: Maria Bieniaszewska, Dr          Holycross Cancer Center Recruiting Kielce, Poland, 25-001 Contact: Marzena Wątek, Dr          Ludwik Rydygier Memorial Specialized Hospital Recruiting Kraków, Poland, 30-001 Contact: Małgorzata Raźny, Dr          Regional Specialised Hospital in Legnica Recruiting Legnica, Poland, 59-220 Contact: Jadwiga Hołojda          Independent Public University Hospital No. 1 in Lublin Recruiting Lublin, Poland, 20-001 Contact: Marek Hus, Prof.          Clinical Hospital at the Karol Marcinkowski Medical University in Poznan Recruiting Poznań, Poland, 60-355 Contact: MAciej Kaźmierczak, Dr          Copernicus Memorial Hospital in Lodz Comprehensive Cancer Center and Traumatology Recruiting Łódź, Poland, 93-513 Contact: Agnieszka Wierzbowska, Prof.    +48426895191    agawierzbowska@wp.pl Less <<
NCT00001765 Chronic Granulomatous Disease Phase 1 Completed - United States, Maryland ... More >> National Institute of Allergy and Infectious Diseases (NIAID) Bethesda, Maryland, United States, 20892 Less <<
NCT02660281 Hematological Disease ... More >> Immune Deficiencies Solid Tumors Myelofibrosis Multiple Myeloma Lymphoma Less << Phase 1 Recruiting October 2026 United States, New York ... More >> Wilmot Cancer Institute Recruiting Rochester, New York, United States, 14642 Contact: Jeffrey Andolina, MD    585-275-2981    jeffrey_andolina@urmc.rochester.edu    Contact: Jessica Mavor    585-275-9680    jessica_mavor@urmc.rochester.edu Less <<
NCT00005785 Hematologic Neoplasm ... More >> HIV Infection Less << Phase 1 Completed - United States, Maryland ... More >> National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Bethesda, Maryland, United States, 20892 Less <<
NCT00003552 Stage IV Melanoma ... More >> Recurrent Melanoma Less << Phase 1 Phase 2 Terminated - United States, Maryland ... More >> National Heart, Lung, and Blood Institute Bethesda, Maryland, United States, 20892 Less <<
NCT00281879 Chronic Myeloproliferative Dis... More >>orders Leukemia Lymphoma Multiple Myeloma and Plasma Cell Neoplasm Myelodysplastic Syndromes Myelodysplastic/Myeloproliferative Neoplasms Unusual Cancers of Childhood Less << Phase 2 Terminated - United States, Oregon ... More >> OHSU Knight Cancer Institute Portland, Oregon, United States, 97239-3098 Less <<
NCT00031005 Leukocyte-Adhesion Deficiency ... More >>Syndrome Less << Phase 2 Completed - United States, Maryland ... More >> National Institute of Allergy and Infectious Diseases (NIAID) Bethesda, Maryland, United States, 20892 Less <<
NCT00353860 Immunosuppression ... More >> Leukemia Less << Phase 2 Completed - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT03720457 CD19-positive ... More >> Diffuse Large B-cell Lymphoma Follicular Lymphoma Less << Phase 1 Recruiting October 2023 China, Shanghai ... More >> Fudan University Zhongshan Hospital Recruiting Shanghai, Shanghai, China, 200000 Contact: Peng Liu, Professor    021-60267405    Liu.peng@zs-hospital.sh.cn Less <<
NCT00006417 Chronic Granulomatous Disease Phase 2 Completed - United States, Maryland ... More >> National Institute of Allergy and Infectious Diseases (NIAID) Bethesda, Maryland, United States, 20892 Less <<
NCT01244451 Patients With CLL Relapsing Af... More >>ter an Initial Response (CR, PR ≥ 6 Months) Following no More Than Two Prior Treatment Lines; or Patients With CLL Refractory (SD, PD or CR/PR < 6 Months) Following no More Than Two Prior Treatment Lines Less << Phase 2 Completed - Italy ... More >> Dipartimento Area Medica - Presidio Ospedaliero "C. e G.Mazzoni" Ascoli, Italy Unità Operativa Ematologia 1 - Università degli Studi di Bari Bari, Italy, 70010 Ist.Ematologia e Oncologia Medica L.e A. Seragnoli Bologna, Italy Azienda Sanitaria di Bolzano - Ospedale Centrale - Ematologia e Centro TMO Bolzano, Italy Azienda ASL di Cagliari Cagliari, Italy, 9121 U.O.C. di Onco-Ematologia - Centro di Ricerca e Formazione ad Alta tecnologia nelle Scienze Biomediche Campobasso, Italy Ospedale Ferrarotto Catania, Italy, 95124 Azienda Ospedaliera Pugliese Ciaccio Catanzaro, Italy, 88100 U.O. Ematologia - P.O. Annunziata - A.O. di Cosenza Cosenza, Italy Sez.Ematologia e Dip. scienze Biomediche Arcispedale S. Anna Ferrara, Italy, 44100 Policlinico di Careggi, Università delgi studi di Firenze Firenze, Italy Clinica Ematologica - Università degli Studi Genova, Italy ASL Le1 P.O. Vito Fazzi - U.O. di Ematologia Lecce, Italy, 73100 Azienda Ospedaliera Universitaria - Policlinico G. Martino Dipartimento di Medicina Interna - U.O. Messina Messina, Italy Messina Divisione di Ematologia - Azienda Ospedaliera Ospedali Riuniti "Papardo Piemonte" Messina, Italy Centro Trapianti di Midollo - IRCCS Ospedale Maggiore Policlinico Milano, Italy Unità Trapianto di Midollo Ist. Nazionale Tumori Milano, Italy Sez. di medicina Interna Oncologia ed Ematologia Modena, Italy Ospedale San Gennaro - ASL Napoli 1 Napoli, Italy, 80143 U.O. Ematologia Clinica - Azienda USL di Pescara Pescara, Italy Dipartimento Emato-Oncologia A.O. "Bianchi-Melacrino-Morelli" Reggio Calabria, Italy S.C. di Ematologia e Trapianti - I.F.O. Istituto Nazionale Tumori Regina Elena Roma, Italy Università degli Studi "Sapienza" - Dip Biotecnologie Cellulari ed Ematologia - Divisione di Ematologia Roma, Italy Università degli Studi - Policlinico di Tor Vergata Roma, Italy Università degli studi di Roma La Cattolica Roma, Italy Ospedale S.Eugenio Rome, Italy, 00144 Ospedale Casa Sollievo della sofferenza San Giovanni Rotondo, Italy U.O. Ematologia, Azienda Ospedaliera Universitaria Senese Siena, Italy, 53100 SS.C. di Oncoematologia - Dipartimento di Medicina Clinica e Sperimentale - Azienda Ospedaliera - S. Maria Di Terni Terni, Italy Div. di Ematologia "Molinette" Osp. Maggiore S. G. Battista Torino, Italy Clinica Ematologica - Policlinico Universitario Udine, Italy Policlinico G.B. Rossi Verona, Italy, 37134 Less <<
NCT00763490 Hematological Malignancies Phase 2 Completed - United States, Michigan ... More >> University of Michigan Cancer Center Ann Arbor, Michigan, United States, 48109 Less <<
NCT00079391 Hematologic Malignancies ... More >> Bone Marrow Transplant Rejection Less << Phase 2 Completed - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT00763490 - Completed - -
NCT00079391 - Completed - -
NCT01174121 Metastatic Colorectal Cancer ... More >> Metastatic Gastric Cancer Metastatic Pancreatic Cancer Metastatic Hepatocellular Carcinoma Progressive Glioblastoma Metastatic Ovarian Cancer Metastatic Breast Cancer Less << Phase 2 Recruiting December 27, 2024 United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact NCI/Surgery Branch Recruitment Center    866-820-4505    irc@nih.gov Less <<
NCT00086203 Chronic Lymphocytic Leukemia Phase 2 Completed - United States, Arkansas ... More >> University of Arkansas for Medical Science Little Rock, Arkansas, United States, 72205 United States, Florida Ocala Oncology Center Ocala, Florida, United States, 34474 Gulfcoast Oncology Associates St. Petersburg, Florida, United States, 33705 United States, Indiana Indiana Oncology/Hematology Consultants Indianapolis, Indiana, United States, 46202 United States, Massachusetts Dana Farber Cancer Institute Boston, Massachusetts, United States, 02115 United States, Montana Hematology/Oncology Centers of the Northern Rockies Billings, Montana, United States, 59101 United States, Nevada Nevada Cancer Institute Las Vegas, Nevada, United States, 89135 United States, New York Queens Medical Associates, PC Fresh Meadows, New York, United States, 11365 Long Island Jewish Medical Center New Hyde Park, New York, United States, 11040 NYU Medical Center New York, New York, United States, 10016 James P. Wilmot Cancer Center/University of Rochester Rochester, New York, United States, 14642 United States, North Carolina Raleigh Hematology/Oncology Clinic Cary, North Carolina, United States, 27511 Wake Forest University Health Sciences Winston-Salem, North Carolina, United States, 27157 United States, Oklahoma Cancer Care Associates/Oklahoma City Oklahoma City, Oklahoma, United States, 73112 Cancer Care Associates--Tulsa Tulsa, Oklahoma, United States, 74136 United States, South Carolina Cancer Centers of the Carolinas Seneca, South Carolina, United States, 29672 United States, Texas Texas Cancer Center/Abilene Abilene, Texas, United States, 79606-5208 MD Anderson Cancer Center Houston, Texas, United States, 77030 United States, Virginia Virginia Oncology Associates-Lake Wright Cancer Center Norfolk, Virginia, United States, 23502 Less <<
NCT00040651 Scleroderma S... More >>ystemic Sclerosis Less << Phase 1 Terminated - United States, Pennsylvania ... More >> UPMC Hillman Cancer Center Pittsburgh, Pennsylvania, United States, 15232 Less <<
NCT01098188 Chronic Lymphocytic Leukemia Phase 1 Completed - France ... More >> Clinique Victor Hugo Le Mans, France, 72000 Hôpital Hurriez Lille, France, 59037 Institut Paoli Calmettes Marseille, France, 13273 Hôpital Saint Eloi Montpellier, France, 34295 CH Lyon Sud Pierre Bénite, France, 69495 Hôpital Pontchaillou Rennes, France, 35033 Centre Henri Becquerel Rouen, France, 76038 Hôpital de Brabois Vandoeuvre Les Nancy, France, 54511 Institut Gustave Roussy Villejuif, France, 94800 Less <<
NCT01459211 Chronic Lymphocytic Leukemia Phase 2 Completed - United Kingdom ... More >> Royal Liverpool University Hospital Liverpool, United Kingdom University College London London, United Kingdom, W1T 4TJ Less <<
NCT02277392 Ovarian, Fallopian Tube and Pe... More >>ritoneal Cancer Less << Phase 1 Withdrawn - United States, Pennsylvania ... More >> Abramson Cancer Center of the University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104 Less <<
NCT00413478 Chronic Lymphocytic Leukemia ... More >> Leukemia Less << Phase 2 Terminated(Slow accrual.) - United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00562965 Lymphoma, Follicular Phase 3 Terminated(See termination rea... More >>son in detailed description.) Less << - -
NCT00562965 - Terminated(See termination rea... More >>son in detailed description.) Less << - -
NCT01580228 Chronic Lymphocytic Leukemia (... More >>CLL) Less << Phase 3 Completed - -
NCT00413478 - Terminated(Slow accrual.) - -
NCT00061581 Acute Lymphocytic Leukemia ... More >> Chronic Myeloid Leukemia Acute Myelocytic Leukemia Myelodysplastic Syndromes Myeloproliferative Disorders Less << Phase 2 Completed - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT03314974 Acute Leukemia ... More >> Acute Myeloid Leukemia Acute Lymphoblastic Leukemia Lymphoma Chronic Myelogenous Leukemia Plasma Cell Leukemia Myeloproliferative Neoplasms Myelofibrosis Myelodysplasia Refractory Anemia High Risk Anemia Chronic Lymphocytic Leukemia Small Lymphocytic Lymphoma Marginal Zone B-Cell Lymphoma Follicular Lymphoma Lymphoplasmacytic Lymphoma Mantle-Cell Lymphoma Prolymphocytic Leukemia Diffuse Large Cell Non Hodgkins Lymphoma Lymphoblastic Lymphoma Burkitt Lymphoma High Grade Non-Hodgkin's Lymphoma, Adult Multiple Myeloma Juvenile Myelomonocytic Leukemia Biphenotypic/Undifferentiated/Prolymphocytic Leukemias MRD Positive Leukemia Natural Killer Cell Malignancies Acquired Bone Marrow Failure Syndromes Less << Phase 2 Recruiting November 10, 2023 United States, Minnesota ... More >> Masonic Cancer Center at University of Minnesota Recruiting Minneapolis, Minnesota, United States, 55337 Contact: Timothy Krepski, RN    612-273-2800    tkrepsk1@Fairview.org Less <<
NCT00927797 Immunocytoma/Morbus Waldenstr?... More >>m B-Cell Non-Hodgkin's Lymphoma B-Cell Chronic Lymphocytic Leukemia Less << Phase 2 Unknown January 2012 -
NCT00382759 Hematological Malignancies Phase 2 Phase 3 Completed - Italy ... More >> Ospedale San Giovanni Battista Torino, Italy, 10126 Less <<
NCT01678430 Chronic Lymphocytic Leukaemia Phase 3 Unknown December 2017 United Kingdom ... More >> Countess of Chester Hospital Recruiting Chester, Cheshire, United Kingdom Principal Investigator: Salaheddin Tueger          Derriford Hospital Recruiting Plymouth, Devon, United Kingdom Principal Investigator: Simon Rule          Torbay Hospital Recruiting Torquay, Devon, United Kingdom Principal Investigator: Deborah Turner          Royal Bournemouth Hospital Recruiting Bournemouth, Dorset, United Kingdom Principal Investigator: Helen McCarthy          Dorset County Hospital Recruiting Dorchester, Dorset, United Kingdom Principal Investigator: Akeel Moosa          Colchester General Hospital Recruiting Colchester, Essex, United Kingdom Principal Investigator: Mike Hamblin          Basingstoke and North Hampshire Hospital Recruiting Basingstoke, Hampshire, United Kingdom Principal Investigator: Sylwia Simpson          Southampton General Hospital Recruiting Southampton, Hampshire, United Kingdom Principal Investigator: Andrew Duncombe          Barnet and Chase Farm Hospitals Recruiting Enfield, Hertfordshire, United Kingdom Principal Investigator: Andres Virchis          Kent and Canterbury Hospital Recruiting Canterbury, Kent, United Kingdom Principal Investigator: Christopher Pocock          Maidstone Hospital Recruiting Maidstone, Kent, United Kingdom Principal Investigator: Saad Rassam          Princess Royal Hospital Recruiting Orpington, Kent, United Kingdom Principal Investigator: Corrine De Lord          Queen Elizabeth Hospital Recruiting Woolwich, London, United Kingdom Principal Investigator: Corrine De Lord          West Middlesex University Hospital Recruiting Isleworth, Middlesex, United Kingdom Principal Investigator: Magda Alobaidi          Ealing Hospital Recruiting Southall, Middlesex, United Kingdom Principal Investigator: Richard Kaczmarski          Hillingdon Hospital Recruiting Uxbridge, Middlesex, United Kingdom Principal Investigator: Richard Kaczmarski          Belfast City Hospital Recruiting Belfast, Northern Ireland, United Kingdom Principal Investigator: Paul Kettle          Royal United Hospital Recruiting Bath, Somerset, United Kingdom Principal Investigator: Christopher Knechtli          Weston General Hospital Recruiting Weston-super-Mare, Somerset, United Kingdom Principal Investigator: Philip Robson          Queens Hospital Recruiting Burton-upon-Trent, Staffordshire, United Kingdom Principal Investigator: Humayun Ahmad          Queen Elizabeth Hospital Recruiting Gateshead, Tyne and Wear, United Kingdom Principal Investigator: Scott Marshall          Queen Elizabeth Hospital Recruiting Birmingham, West Midlands, United Kingdom Principal Investigator: Paul Moss          Bradford Royal Infirmary Recruiting Bradford, West Yorkshire, United Kingdom Principal Investigator: Adrian Williams          Airdale General Hospital Recruiting Keighley, West Yorkshire, United Kingdom Principal Investigator: Chetan Patalappa          St James University Hospital Recruiting Leeds, West Yorkshire, United Kingdom Principal Investigator: Peter Hillmen          Salisbury District Hospital Recruiting Salisbury, Wiltshire, United Kingdom Principal Investigator: Jonathan Cullis          Arrowe Park Hospital Recruiting Upton, Wirral, United Kingdom Principal Investigator: Ranjit Dasgupta          Royal Liverpool Hospital Recruiting Liverpool, United Kingdom Principal Investigator: Andrew Pettitt Less <<
NCT00281879 - Terminated - -
NCT01393366 Chronic Lymphocytic Leukemia Not Applicable Completed - France ... More >> Centre Hospitalier de la côte basque Bayonne, France, 64109 CH Saint Jean Perpignan, France, 66046 CHU Purpan Toulouse, France, 31059 Less <<
NCT03240861 HLA-A*0201 Positive Cells Pres... More >>ent Locally Advanced Malignant Neoplasm NY-ESO-1 Positive Unresectable Malignant Neoplasm Less << Phase 1 Recruiting September 1, 2022 United States, California ... More >> UCLA / Jonsson Comprehensive Cancer Center Recruiting Los Angeles, California, United States, 90095 Contact: Antoni Ribas    310-206-3928    aribas@mednet.ucla.edu    Principal Investigator: Antoni Ribas Less <<
NCT00822393 Acute Myeloid Leukemia ... More >> Myelodysplastic Syndrome Less << Phase 3 Completed - Finland ... More >> Helsinki University Central Hospital, Dept. of Medicine Helsinki, Finland, 00290 France Centre Hospitalier Lyon Sud Lyon, France, 69495 Hopital Saint-Louis Paris, France, 75475 Germany Universitätsklinikum Carl Gustav Carus Dresden, Med. Klinik I Dresden, Germany, 01307 Klinik für Knochenmarktransplantation Essen, Germany, 45122 Malteser Krankenhaus St. Franziskus-Hospital Flensburg, Germany, 24939 Universitätsklinikum Freiburg Freiburg, Germany, 79106 Universitätsmedizin Goettingen, Haematolgie und Onkologie Göttingen, Germany, 37075 Asklepios Kliniken Hamburg GmbH Hamburg, Germany, 20099 Universitätsklinikum Heidelberg Heidelberg, Germany, 69120 Friedrich-Schiller-Universität Jena Jena, Germany, 07747 Universitätsklinikum Koeln, Stammzelltransplantation Koeln, Germany, 50937 Universitätsklinikum Leipzig, Haematologie, internistische Onkologie Leipzig, Germany, 04109 Johannes-Gutenberg-Universität Mainz, III. Medizinische Klinik Mainz, Germany, 55131 Klinikum Rechts der Isar der TU München, III. Med. Klinik Muenchen, Germany, 81675 Universitätsklinikum Münster Münster, Germany, 48129 Klinikum Nürnberg, 5. Medizinische Klinik Nürnberg, Germany, 90419 Klinikum Oldenburg gGmbH Oldenburg, Germany, 26133 Klinikum der Universität Regensburg Regensburg, Germany, 93053 Universität Rostock Rostock, Germany, 18057 Universität Tübingen Tübingen, Germany, 72076 Stiftung Deutsche Klinik für Diagnostik Wiesbaden, Germany, 65191 Klinikum der Universität Würzburg Würzburg, Germany, 97070 Hungary St. Istvan and St. Laszlo Hospital of Budapest Budapest, Hungary, 1097 Italy Azienda Ospedaliera Papa Giovanni XXIII Bergamo, Italy, 24127 Hematology University of Brescia Brescia, Italy, 1-25123 Scientific Institute H. San Raffaele Milan, Italy, 20132 Ospedale Civile Pescara Pescara, Italy, 65123 Policlinico Umberto I Univ. La Sapienza Rome, Italy, 00161 Clinica Ematologica ed Unita di Terapie Cellulari 'Carlo Melzi' Udine, Italy, 33100 Policlinico GB Rossi (Borgo Roma), Div. di Ematologia Verona, Italy, 37134 Poland Medical University of Gdansk Gdansk, Poland, 80-952 Silesian Medical University Katowice, Poland, 40-032 Less <<
NCT00006100 Lymphoma Phase 1 Unknown - United States, Pennsylvania ... More >> Penn State Cancer Institute at Milton S. Hershey Medical Center Hershey, Pennsylvania, United States, 17033-0850 Less <<
NCT00027573 Kidney Cancer Phase 2 Completed - United States, Arizona ... More >> CCOP - Mayo Clinic Scottsdale Oncology Program Scottsdale, Arizona, United States, 85259-5404 United States, Indiana Indiana University Cancer Center Indianapolis, Indiana, United States, 46202-5289 United States, Massachusetts Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02215 United States, Minnesota Mayo Clinic Cancer Center Rochester, Minnesota, United States, 55905 United States, New Jersey CCOP - Northern New Jersey Hackensack, New Jersey, United States, 07601 United States, Oklahoma CCOP - Oklahoma Tulsa, Oklahoma, United States, 74136 Less <<
NCT00282425 Scleroderma Phase 1 Terminated(No subject enrolled... More >> since 2009) Less << - United States, Illinois ... More >> Northwestern University, Feinberg School of Medicine Chicago, Illinois, United States, 60611 Less <<
NCT01754870 Chronic Lymphocytic Leukemia (... More >>CLL) Small Lymphocytic Lymphoma (SLL) Less << Phase 2 Withdrawn(slow accrual) - United States, Wisconsin ... More >> University of Wisconsin Carbone Cancer Center Madison, Wisconsin, United States, 53792 Less <<
NCT00801931 Leukemia Lymp... More >>homa Neuroblastoma Immunodeficiencies Anemia Less << Phase 1 Phase 2 Terminated(Poor accrual) - United States, New York ... More >> Columbia Presbyterian Medical Center New York, New York, United States, 10032 Less <<
NCT01220544 Acute Myeloid Leukemias ... More >> Advanced Hematological Malignancies Indication for Allogeneic Stem Cell Transplantation no HLA-identical Donor Available Less << Phase 1 Phase 2 Unknown October 2011 Germany ... More >> Charite Campus Benjamin FRanklin, Medical Clinic III, Department of Hematology/Oncology Recruiting Berlin, Germany, 12200 Contact: Lutz Uharek, Prof.    +49308445 ext 4550    lutz.uharek@charite.de    Contact: Birte Friedrichs, Dr.    +49308445 ext 4574    birte.friedrichs@charite.de    Medical Clinic II, Department of Hematology/Oncology, University of Leipzig Recruiting Leipzig, Germany, 04103 Contact: Dietger Niederwieser, Prof.    +4934197 ext 13050    dietger@medizin.uni-leipzig.de    Contact: Nadezda Basara, Dr.       Nadezda.Basara@medizin.uni-leipzig.de Less <<
NCT01350258 Hematologic Malignancies ... More >> Acute Leukemia Myelodysplastic Syndromes (MDS) Other Than RA or RARS Subtypes Hodgkin's Lymphoma Non-Hodgkin's Lymphoma Myeloma Chronic Myelogenous (or Myeloid) Leukemia (CML) Resistant to STI Therapy Less << Phase 1 Phase 2 Terminated(Poor accrual) - United States, Pennsylvania ... More >> Thomas Jefferson University Philadelphia, Pennsylvania, United States, 19107 Less <<
NCT00393185 Primary Biliary Cirrhosis Phase 1 Withdrawn - -
NCT01350258 - Terminated(Poor accrual) - -
NCT00863148 MDS AML ... More >> ALL BAL Less << Phase 2 Completed - France ... More >> Hôpital Edouard Herriot Lyon, France, 69437 Institut Paoli Calmettes Marseille, France, 13273 Nantes University hospital Nantes, France, 44093 Hôpital Saint Louis Paris, France, 75475 CHU Haut-Lévêque Pessac, France, 33604 CHRU Hautepierre Strasbourg, France, 67098 Less <<
NCT00303836 Recurrent Melanoma ... More >> Stage IV Melanoma Less << Phase 2 Terminated - United States, Maryland ... More >> National Cancer Institute Surgery Branch Bethesda, Maryland, United States, 20892-1201 Less <<
NCT03182244 Acute Myeloid Leukemia With FM... More >>S-like Tyrosine Kinase (FLT3) Mutation Less << Phase 3 Recruiting June 2020 -
NCT00466674 Myeloma Phase 2 Completed - France ... More >> Mohamad Sobh Lyon, France, 69437 Less <<
NCT00274846 Leukemia Phase 2 Completed - United States, Minnesota ... More >> Masonic Cancer Center Minneapolis, Minnesota, United States, 55455 Less <<
NCT01105650 Ovarian Cancer ... More >> Fallopian Tube Cancer Primary Peritoneal Cancer Breast Cancer Less << Phase 2 Completed - United States, Minnesota ... More >> Masonic Cancer Center, University of Minnesota Minneapolis, Minnesota, United States, 55455 Less <<
NCT01105650 - Completed - -
NCT00274846 - Completed - -
NCT02782546 Acute Myeloid Leukemia Phase 2 Recruiting February 28, 2022 United States, Missouri ... More >> Washington University School of Medicine Recruiting Saint Louis, Missouri, United States, 63110 Contact: Amanda Cashen, M.D.    314-454-8323    acashen@wustl.edu    Principal Investigator: Amanda Cashen, M.D.          Sub-Investigator: Todd Fehniger, M.D., Ph.D.          Sub-Investigator: John DiPersio, M.D., Ph.D.          Sub-Investigator: Peter Westervelt, M.D., Ph.D.          Sub-Investigator: Geoffrey Uy, M.D.          Sub-Investigator: Ravi Vij, M.D.          Sub-Investigator: Camille Abboud, M.D.          Sub-Investigator: Meagan Jacoby, M.D., Ph.D.          Sub-Investigator: Iskra Pusic, M.D.          Sub-Investigator: Armin Ghobadi, M.D.          Sub-Investigator: Mark Schroeder, M.D.          Sub-Investigator: Keith Stockerl-Goldstein, M.D. Less <<
NCT00943800 Leukemia Myel... More >>odysplastic Syndrome Multiple Myeloma Lymphoma Less << Not Applicable Active, not recruiting September 2018 United States, Illinois ... More >> The University of Chicago Chicago, Illinois, United States, 60637 Less <<
NCT01701674 Metastatic Melanoma Not Applicable Active, not recruiting February 2019 United States, Florida ... More >> H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States, 33612 Less <<
NCT03118492 Secondary Myelofibrosis Phase 1 Recruiting October 2020 United States, California ... More >> City of Hope Medical Center Recruiting Duarte, California, United States, 91010 Contact: Monzr M. Al Malki, MD    626-256-4673 ext 62405    malmalki@coh.org    Principal Investigator: Monzr M. Al Malki, MD Less <<
NCT01701674 - Active, not recruiting - -
NCT02690545 Lymphoma Lymp... More >>homa, Non-Hodgkin Immune System Diseases Immunoproliferative Disorders Lymphatic Diseases Lymphoproliferative Disorders Neoplasms Neoplasms by Histologic Type Less << Phase 1 Phase 2 Recruiting October 2034 United States, North Carolina ... More >> Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill Recruiting Chapel Hill, North Carolina, United States, 27599 Contact: Catherine Cheng    919-445-4208    catherine_cheng@med.unc.edu    Contact: Spencer Laing    919-962-8618    ssblaing@email.unc.edu    Principal Investigator: Anne Beaven, MD Less <<
NCT01540812 - Recruiting December 2019 Spain ... More >> Hospital Germans Trias i Pujol Recruiting Badalona, Barcelona, Spain Contact: Jose Mª Ribera, Dr       jmribera@iconcologia.com Less <<
NCT00048412 Myelodysplastic Disorders ... More >> Leukemia Multiple Myeloma Plasma Cell Dyscrasia Lymphoproliferative Disorders Less << Phase 1 Phase 2 Completed - United States, Texas ... More >> Texas Children's Hospital Houston, Texas, United States, 77030 The Methodist Hospital Houston, Texas, United States, 77030 Less <<
NCT01118091 Skin Cancer M... More >>elanoma Metastatic Melanoma Less << Phase 2 Completed - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT01118091 - Completed - -
NCT00564200 Multiple Myeloma Phase 2 Completed - Spain ... More >> H. Clinic I Provincial Barcelona, Spain H. de la Santa Creu I Sant Pau Barcelona, Spain Instituto Catalán de Oncología Barcelona, Spain H. de Jerez Jerez de la Frontera, Spain H. 12 de Octubre Madrid, Spain H. Univ. Gregorio Marañón Madrid, Spain H. Univ. La Princesa Madrid, Spain H. Univ. Morales Meseguer Murcia, Spain H. Univ. Son Dureta Palma de Mallorca, Spain H. Univ. de Salamanca Salamanca, Spain Less <<
NCT00723099 Acute Lymphoblastic Leukemia ... More >> Acute Myeloid Leukemia Aggressive Non-Hodgkin Lymphoma Chronic Myelogenous Leukemia, BCR-ABL1 Positive Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive Indolent Non-Hodgkin Lymphoma Lymphoma Mixed Phenotype Acute Leukemia Myelodysplastic Syndrome Myeloproliferative Neoplasm Recurrent Chronic Lymphocytic Leukemia Recurrent Follicular Lymphoma Recurrent Lymphoplasmacytic Lymphoma Recurrent Mantle Cell Lymphoma Recurrent Marginal Zone Lymphoma Recurrent Plasma Cell Myeloma Recurrent Small Lymphocytic Lymphoma Recurrent T-Cell Non-Hodgkin Lymphoma Refractory Chronic Lymphocytic Leukemia Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive Refractory Follicular Lymphoma Refractory Hodgkin Lymphoma Refractory Lymphoplasmacytic Lymphoma Refractory Mantle Cell Lymphoma Refractory Small Lymphocytic Lymphoma T-Cell Non-Hodgkin Lymphoma Less << Phase 2 Active, not recruiting November 13, 2019 United States, Colorado ... More >> University of Colorado Hospital Aurora, Colorado, United States, 80045 Colorado Blood Cancer Institute Denver, Colorado, United States, 80218 United States, Utah LDS Hospital Salt Lake City, Utah, United States, 84143 United States, Washington VA Puget Sound Health Care System Seattle, Washington, United States, 98101 Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 United States, Wisconsin Froedtert and the Medical College of Wisconsin Milwaukee, Wisconsin, United States, 53226 Less <<
NCT02775292 Adult Solid Neoplasm ... More >> Childhood Solid Neoplasm Metastatic Neoplasm Less << Phase 1 Recruiting June 2019 United States, California ... More >> UCLA / Jonsson Comprehensive Cancer Center Recruiting Los Angeles, California, United States, 90095 Contact: Siwen Hu-Lieskovan    310-794-4955       Principal Investigator: Antoni Ribas Less <<
NCT02528877 Acute Myeloid Leukemia in Remi... More >>ssion Primary Myelofibrosis Primary Myelofibrosis, Prefibrotic Stage Secondary Acute Myeloid Leukemia Secondary Myelofibrosis Less << Phase 1 Withdrawn(The study design was... More >> revised so a new protocol will be opened.) Less << - United States, California ... More >> City of Hope Medical Center Duarte, California, United States, 91010 Less <<
NCT00013533 Hodgkin Lymphoma ... More >> Lymphocytic Leukemia Mixed Cell Leukemia Myelodysplastic Syndrome Non Hodgkin's Lymphoma CML ALL AML Lymphoma Less << Early Phase 1 Completed - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT01047072 Systemic Scleroderma Phase 2 Withdrawn - United States, Washington ... More >> Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 Less <<
NCT01565616 - Completed - -
NCT01570348 Crohn Disease Phase 2 Active, not recruiting February 2022 United States, Washington ... More >> Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 Less <<
NCT00610311 Metastatic Melanoma ... More >> Skin Cancer Less << Phase 2 Terminated(The study was termi... More >>nated due to low accrual.) Less << - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT01850108 Sickle Cell Disease ... More >> Hemoglobinopathies Less << Not Applicable Recruiting November 2020 United States, Tennessee ... More >> Vanderbilt-Ingram Cancer Center Recruiting Nashville, Tennessee, United States, 37232 Contact: Clinical Trials Information Program    800-811-8480       Principal Investigator: Adetola A Kassim, MD Less <<
NCT03399448 Multiple Myeloma ... More >> Melanoma Synovial Sarcoma Myxoid/Round Cell Liposarcoma Less << Phase 1 Recruiting January 2033 United States, Pennsylvania ... More >> University of Pennsylvania Recruiting Philadelphia, Pennsylvania, United States, 19104 Contact: EmergingMed    855-216-0098    PennCancerTrials@emergingmed.com Less <<
NCT02638428 Relapsed Pediatric Solid Tumor... More >> Refractory Pediatric Solid Tumor Relapsed Pediatric AML Refractory Pediatric AML Less << Phase 2 Recruiting December 2023 Korea, Republic of ... More >> Samsung Medical Center Recruiting Seoul, Korea, Republic of Contact: Ki Woong Sung    82-2-3410-3529    kwsped@skku.edu    Principal Investigator: Ki Woong Sung Less <<
NCT00610311 - Terminated(The study was termi... More >>nated due to low accrual.) Less << - -
NCT01565616 Sickle Cell Disease Phase 2 Completed - United States, California ... More >> Children's Hospital of Oakland Oakland, California, United States, 94609 United States, District of Columbia Children's National Medical Center Washington, D.C., District of Columbia, United States, 20010 United States, Florida University of Miami Miami, Florida, United States, 33136 United States, Georgia Children's Healthcare of Atlanta Atlanta, Georgia, United States, 30322 Emory University Atlanta, Georgia, United States, 30322 United States, North Carolina Duke University Medical Center Durham, North Carolina, United States, 27710 United States, Pennsylvania Chidren's Hospital of Pittsburgh Pittsburgh, Pennsylvania, United States, 15224 United States, Virginia Virginia Commonwealth University Richmond, Virginia, United States, 23298 Less <<
NCT01858740 Accelerated Phase Chronic Myel... More >>ogenous Leukemia, BCR-ABL1 Positive Acute Biphenotypic Leukemia Acute Leukemia of Ambiguous Lineage Acute Undifferentiated Leukemia Adult Acute Lymphoblastic Leukemia in Remission Adult Acute Myeloid Leukemia in Remission Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive Childhood Acute Lymphoblastic Leukemia in Remission Childhood Acute Myeloid Leukemia in Remission Chronic Myelogenous Leukemia, BCR-ABL1 Positive Myelodysplastic Syndrome With Excess Blasts-1 Myelodysplastic Syndrome With Excess Blasts-2 Recurrent Adult Acute Lymphoblastic Leukemia Recurrent Adult Acute Myeloid Leukemia Recurrent Childhood Acute Lymphoblastic Leukemia Recurrent Childhood Acute Myeloid Leukemia Refractory Adult Acute Lymphoblastic Leukemia Refractory Childhood Acute Lymphoblastic Leukemia Less << Phase 2 Active, not recruiting January 30, 2022 United States, Washington ... More >> Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 Less <<
NCT00586274 FANCONI ANEMIA Phase 1 Terminated(Poor accrual) - United States, Texas ... More >> Texas Children's Hospital Houston, Texas, United States, 77030 The Methodist Hospital Houston, Texas, United States, 77030 Less <<
NCT02845596 Severe Aplastic Anemia Not Applicable Recruiting May 2020 United States, California ... More >> Children's Hospital Los Angeles Recruiting Los Angeles, California, United States, 90027 Contact: Nini Huynh    323-361-5286    huhuynh@chla.usc.edu    Principal Investigator: Michael Pulsipher, MD          United States, Colorado Children's Hospital Colorado Recruiting Aurora, Colorado, United States, 80045 Contact: Wendy Moore    720-777-6353    Wendy.moore2@childrenscolorado.org    Principal Investigator: Taizo Nakano, MD          United States, Massachusetts Boston Children's Hospital Recruiting Boston, Massachusetts, United States, 02115 Contact: Maggie Malsch, MSN       maggie.malsch@childrens.harvard.edu    Contact: Leah Cheng       leah.cheng@childrens.harvard.edu    Principal Investigator: David A Williams, MD          United States, New Jersey Hackensack University Medical Center Recruiting Hackensack, New Jersey, United States, 07601 Contact: Jeanette Haugh    551-996-3457    jeanette.haugh@hackensackmeridian.org    Principal Investigator: Alfred Gillio, MD          United States, Pennsylvania Children's Hospital of Philadelphia Recruiting Philadelphia, Pennsylvania, United States, 19104 Contact: Barbara McGlynn    215-590-1303    mcglynn@email.chop.edu    Principal Investigator: Timothy Olson, MD          United States, Texas Texas Children's Hospital Recruiting Houston, Texas, United States, 77030 Contact: Margaret Nagel    832-824-1538    menagel@texaschildrens.org    Principal Investigator: Alison Bertuch, MD          United States, Washington Fred Hutchinson Cancer Research Center Recruiting Seattle, Washington, United States, 98109 Contact: Bernie McLaughlin    206-667-4916    bmclaugh@fredhutch.org    Principal Investigator: Lauri Burroughs, MD Less <<
NCT01462396 Neuroblastoma Phase 1 Completed - United States, Missouri ... More >> Children's Mercy Hospital Kansas City, Missouri, United States, 64108 Less <<
NCT01303887 Follicular Lymphoma Phase 3 Unknown September 2016 -
NCT00143845 - Completed - -
NCT01044745 Accelerated Phase Chronic Myel... More >>ogenous Leukemia Adult Acute Lymphoblastic Leukemia in Remission Adult Acute Myeloid Leukemia in Remission Adult Nasal Type Extranodal NK/T-cell Lymphoma Blastic Phase Chronic Myelogenous Leukemia Contiguous Stage II Adult Burkitt Lymphoma Contiguous Stage II Adult Diffuse Large Cell Lymphoma Contiguous Stage II Adult Diffuse Mixed Cell Lymphoma Contiguous Stage II Adult Diffuse Small Cleaved Cell Lymphoma Contiguous Stage II Adult Immunoblastic Large Cell Lymphoma Contiguous Stage II Adult Lymphoblastic Lymphoma Contiguous Stage II Grade 1 Follicular Lymphoma Contiguous Stage II Grade 2 Follicular Lymphoma Contiguous Stage II Grade 3 Follicular Lymphoma Contiguous Stage II Mantle Cell Lymphoma Contiguous Stage II Marginal Zone Lymphoma Contiguous Stage II Small Lymphocytic Lymphoma de Novo Myelodysplastic Syndromes Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue Graft Versus Host Disease Nodal Marginal Zone B-cell Lymphoma Noncontiguous Stage II Adult Burkitt Lymphoma Noncontiguous Stage II Adult Diffuse Large Cell Lymphoma Noncontiguous Stage II Adult Diffuse Mixed Cell Lymphoma Noncontiguous Stage II Adult Diffuse Small Cleaved Cell Lymphoma Noncontiguous Stage II Adult Immunoblastic Large Cell Lymphoma Noncontiguous Stage II Adult Lymphoblastic Lymphoma Noncontiguous Stage II Grade 1 Follicular Lymphoma Noncontiguous Stage II Grade 2 Follicular Lymphoma Noncontiguous Stage II Grade 3 Follicular Lymphoma Noncontiguous Stage II Mantle Cell Lymphoma Noncontiguous Stage II Marginal Zone Lymphoma Noncontiguous Stage II Small Lymphocytic Lymphoma Previously Treated Myelodysplastic Syndromes Recurrent Adult Acute Lymphoblastic Leukemia Recurrent Adult Acute Myeloid Leukemia Recurrent Adult Burkitt Lymphoma Recurrent Adult Diffuse Large Cell Lymphoma Recurrent Adult Diffuse Mixed Cell Lymphoma Recurrent Adult Diffuse Small Cleaved Cell Lymphoma Recurrent Adult Grade III Lymphomatoid Granulomatosis Recurrent Adult Immunoblastic Large Cell Lymphoma Recurrent Adult Lymphoblastic Lymphoma Recurrent Adult T-cell Leukemia/Lymphoma Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma Recurrent Grade 1 Follicular Lymphoma Recurrent Grade 2 Follicular Lymphoma Recurrent Grade 3 Follicular Lymphoma Recurrent Mantle Cell Lymphoma Recurrent Marginal Zone Lymphoma Recurrent Mycosis Fungoides/Sezary Syndrome Recurrent Small Lymphocytic Lymphoma Refractory Chronic Lymphocytic Leukemia Relapsing Chronic Myelogenous Leukemia Secondary Myelodysplastic Syndromes Splenic Marginal Zone Lymphoma Stage I Adult Burkitt Lymphoma Stage I Adult Diffuse Large Cell Lymphoma Stage I Adult Diffuse Mixed Cell Lymphoma Stage I Adult Diffuse Small Cleaved Cell Lymphoma Stage I Adult Immunoblastic Large Cell Lymphoma Stage I Adult Lymphoblastic Lymphoma Stage I Adult T-cell Leukemia/Lymphoma Stage I Chronic Lymphocytic Leukemia Stage I Cutaneous T-cell Non-Hodgkin Lymphoma Stage I Grade 1 Follicular Lymphoma Stage I Grade 2 Follicular Lymphoma Stage I Grade 3 Follicular Lymphoma Stage I Mantle Cell Lymphoma Stage I Marginal Zone Lymphoma Stage I Mycosis Fungoides/Sezary Syndrome Stage I Small Lymphocytic Lymphoma Stage II Adult T-cell Leukemia/Lymphoma Stage II Chronic Lymphocytic Leukemia Stage II Cutaneous T-cell Non-Hodgkin Lymphoma Stage II Mycosis Fungoides/Sezary Syndrome Stage III Adult Burkitt Lymphoma Stage III Adult Diffuse Large Cell Lymphoma Stage III Adult Diffuse Mixed Cell Lymphoma Stage III Adult Diffuse Small Cleaved Cell Lymphoma Stage III Adult Immunoblastic Large Cell Lymphoma Stage III Adult Lymphoblastic Lymphoma Stage III Adult T-cell Leukemia/Lymphoma Stage III Chronic Lymphocytic Leukemia Stage III Cutaneous T-cell Non-Hodgkin Lymphoma Stage III Grade 1 Follicular Lymphoma Stage III Grade 2 Follicular Lymphoma Stage III Grade 3 Follicular Lymphoma Stage III Mantle Cell Lymphoma Stage III Marginal Zone Lymphoma Stage III Mycosis Fungoides/Sezary Syndrome Stage III Small Lymphocytic Lymphoma Stage IV Adult Burkitt Lymphoma Stage IV Adult Diffuse Large Cell Lymphoma Stage IV Adult Diffuse Mixed Cell Lymphoma Stage IV Adult Diffuse Small Cleaved Cell Lymphoma Stage IV Adult Immunoblastic Large Cell Lymphoma Stage IV Adult Lymphoblastic Lymphoma Stage IV Adult T-cell Leukemia/Lymphoma Stage IV Chronic Lymphocytic Leukemia Stage IV Cutaneous T-cell Non-Hodgkin Lymphoma Stage IV Grade 1 Follicular Lymphoma Stage IV Grade 2 Follicular Lymphoma Stage IV Grade 3 Follicular Lymphoma Stage IV Mantle Cell Lymphoma Stage IV Marginal Zone Lymphoma Stage IV Mycosis Fungoides/Sezary Syndrome Stage IV Small Lymphocytic Lymphoma Untreated Adult Acute Lymphoblastic Leukemia Untreated Adult Acute Myeloid Leukemia Waldenstr?m Macroglobulinemia Less << Phase 2 Active, not recruiting March 2018 United States, Nebraska ... More >> University of Nebraska Medical Center Omaha, Nebraska, United States, 68198-7830 Less <<
NCT03615105 Acute Lymphoid Leukemia (ALL) ... More >> Acute Myeloid Leukemia (AML) Chronic Myeloid Leukemia (CML) Hodgkin Lymphoma Non-Hodgkin Lymphoma Chronic Lymphocytic Leukemia Less << Phase 2 Recruiting July 2021 United States, New York ... More >> Memorial Sloan Kettering Cancer Center Recruiting New York, New York, United States, 10065 Contact: Brian Shaffer, MD    212-639-2212       Contact: Miguel-Angel Perales, MD    212-639-8682       Principal Investigator: Brian Shaffer, MD Less <<
NCT02702960 Fibrolamellar Hepatocellular C... More >>arcinoma Hepatocellular Carcinoma (Fibrolamellar Variant) Hepatocellular Carcinoma Less << Phase 2 Withdrawn(This study was withd... More >>rawn due to lack of necessary resources from the liver transplant surgical group.) Less << - United States, Maryland ... More >> Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States, 21205 Less <<
NCT00143845 Multiple Myeloma ... More >> Lymphocytic Leukemia, Chronic Lymphoma, Low-Grade Less << Phase 2 Completed - United States, Michigan ... More >> The University of Michigan Ann Arbor, Michigan, United States, 48109 Less <<
NCT02061800 Chronic Myeloid Leukemia (CML)... More >> Acute Myelogenous Leukemia (AML) Myelodysplastic Syndrome (MDS) Juvenile Myelomonocytic Leukemia (JMML) Acute Lymphoblastic Leukemia (ALL) Lymphoma (Hodgkin's and Non-Hodgkin's) Less << Phase 1 Phase 2 Recruiting December 2018 United States, New York ... More >> Columbia University Medical Center Recruiting New York, New York, United States, 10032 Contact: Jean Sosna, RN    212-305-2050       Principal Investigator: Diane George, MD Less <<
NCT02793544 Myelodysplastic Syndrome (MDS)... More >> Chronic Lymphocytic Leukemia (CLL) Chemotherapy-sensitive Lymphoma Acute Lymphoblastic Leukemia (ALL)/T Lymphoblastic Lymphoma Acute Myelogenous Leukemia (AML) Acute Biphenotypic Leukemia (ABL) Acute Undifferentiated Leukemia (AUL) Less << Phase 2 Recruiting December 2019 United States, Florida ... More >> Shands HealthCare & University of Florida Recruiting Gainesville, Florida, United States, 32610 Contact: Maxim Norkin, MD       Maxim.Norkin@medicine.ufl.edu    Contact: Meghan Vazquez       meghan.vazquez@medicine.ufl.edu    Principal Investigator: Maxim Norkin, MD          University of Miami Recruiting Miami, Florida, United States, 33136 Contact: Antonio Jimenez, MD       amjimenez@miami.edu    Contact: Kirenia Correa       k.correa@med.miami.edu    Principal Investigator: Antonio Jimenez, MD          H. Lee Moffitt Cancer Center and Research Institute Recruiting Tampa, Florida, United States, 33612 Contact: Farhad Khimani, MD       Farhad.Khimani@moffitt.org    Contact: Carmen Patton       Carmen.Patton@moffitt.org    Principal Investigator: Farhad Khimani, MD          United States, Maryland University of Maryland Greenebaum Cancer Center Recruiting Baltimore, Maryland, United States, 21201 Contact: Nancy Hardy, MD       nhardy1@umm.edu    Contact: Sherri Bauman       sphilip1@umm.edu    Principal Investigator: Nancy Hardy, MD          The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Recruiting Baltimore, Maryland, United States, 21287 Contact: Javier Bolanos Meade, MD       fbolano2@jhmi.edu    Contact: Leo Luznik, MD       luznile@jhmi.edu    Principal Investigator: Javier Bolanos Meade, MD          Principal Investigator: Leo Luznik, MD          United States, Michigan Karmanos Cancer Institute Recruiting Detroit, Michigan, United States, 48201 Contact: Asif Alavi, MD       alavia@karmanos.org    Contact: Charlotte Brown       brownc@karmanos.org    Principal Investigator: Asif Alavi, MD          United States, New York Memorial Sloan Kettering Cancer Center - Adults Recruiting New York, New York, United States, 10065 Contact: Brian Shaffer, MD       shaffeb1@mskcc.org    Contact: Stephanie Chinapen       chinapes@mskcc.org    Principal Investigator: Brian Shaffer, MD          United States, North Carolina University of North Carolina Hospitals Recruiting Chapel Hill, North Carolina, United States, 27599 Contact: Katarzyna Jamieson, MD       katarzyna_jamieson@med.unc.edu    Contact: Mary Owen       mary_owen@med.unc.edu    Principal Investigator: Katarzyna Jamieson, MD          United States, Ohio Ohio State Medical Center, James Cancer Center Recruiting Columbus, Ohio, United States, 43210 Contact: Hannah Choe, MD          Contact: Nicole Szuminski       Nicole.Szuminski@osumc.edu    Principal Investigator: Hannah Choe, MD          United States, Virginia Virginia Commonwealth University Massey Cancer Center Bone Marrow Transplant Program Recruiting Richmond, Virginia, United States, 23298 Contact: John McCarty, MD       john.mccarty@vcuhealth.org    Contact: Kathy Candler       kcandler@mcvh-vcu.edu    Principal Investigator: John McCarty, MD          United States, Wisconsin Froedtert Memorial Lutheran Hospital Recruiting Milwaukee, Wisconsin, United States, 53226 Contact: Bronwen Shaw, MD, PhD       beshaw@mcw.edu    Contact: Sharon Yim       syim@mcw.edu    Principal Investigator: Bronwen Shaw, MD, PhD Less <<
NCT02029638 - Terminated(Slow accrual) - -
NCT02029638 Kidney Transplantation Phase 2 Terminated(Slow accrual) - United States, Maryland ... More >> Johns Hopkins University Baltimore, Maryland, United States, 21205 Less <<
NCT03128034 Acute Lymphoblastic Leukemia i... More >>n Remission Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome Acute Myeloid Leukemia in Remission CD45-Positive Neoplastic Cells Present Chronic Myelomonocytic Leukemia Myelodysplastic Syndrome With Excess Blasts Recurrent Adult Acute Myeloid Leukemia Refractory Adult Acute Lymphoblastic Leukemia Less << Phase 1 Phase 2 Recruiting April 19, 2026 United States, Washington ... More >> Fred Hutch/University of Washington Cancer Consortium Recruiting Seattle, Washington, United States, 98109 Contact: Brenda M. Sandmaier    206-667-4961    bsandmai@fredhutch.org    Principal Investigator: Brenda M. Sandmaier Less <<
NCT02652468 Lymphoma Not Applicable Active, not recruiting March 15, 2020 United States, Wisconsin ... More >> University of Wisconsin Carbone Cancer Center Madison, Wisconsin, United States, 53705 Less <<
NCT01427881 Accelerated Phase Chronic Myel... More >>ogenous Leukemia Adult Acute Lymphoblastic Leukemia in Remission Adult Acute Megakaryoblastic Leukemia (M7) Adult Acute Myeloid Leukemia in Remission Adult Erythroleukemia (M6a) Adult Nasal Type Extranodal NK/T-cell Lymphoma Adult Pure Erythroid Leukemia (M6b) Anaplastic Large Cell Lymphoma Angioimmunoblastic T-cell Lymphoma Blastic Phase Chronic Myelogenous Leukemia Childhood Acute Erythroleukemia (M6) Childhood Acute Lymphoblastic Leukemia in Remission Childhood Acute Megakaryocytic Leukemia (M7) Childhood Acute Myeloid Leukemia in Remission Childhood Burkitt Lymphoma Childhood Chronic Myelogenous Leukemia Childhood Diffuse Large Cell Lymphoma Childhood Immunoblastic Large Cell Lymphoma Childhood Myelodysplastic Syndromes Childhood Nasal Type Extranodal NK/T-cell Lymphoma Chronic Myelomonocytic Leukemia Chronic Phase Chronic Myelogenous Leukemia Cutaneous B-cell Non-Hodgkin Lymphoma de Novo Myelodysplastic Syndromes Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue Hepatosplenic T-cell Lymphoma Intraocular Lymphoma Nodal Marginal Zone B-cell Lymphoma Noncutaneous Extranodal Lymphoma Peripheral T-cell Lymphoma Philadelphia Chromosome Negative Chronic Myelogenous Leukemia Post-transplant Lymphoproliferative Disorder Previously Treated Myelodysplastic Syndromes Recurrent Adult Acute Lymphoblastic Leukemia Recurrent Adult Acute Myeloid Leukemia Recurrent Adult Burkitt Lymphoma Recurrent Adult Diffuse Large Cell Lymphoma Recurrent Adult Diffuse Mixed Cell Lymphoma Recurrent Adult Diffuse Small Cleaved Cell Lymphoma Recurrent Adult Grade III Lymphomatoid Granulomatosis Recurrent Adult Hodgkin Lymphoma Recurrent Adult Immunoblastic Large Cell Lymphoma Recurrent Adult Lymphoblastic Lymphoma Recurrent Adult T-cell Leukemia/Lymphoma Recurrent Childhood Acute Lymphoblastic Leukemia Recurrent Childhood Acute Myeloid Leukemia Recurrent Childhood Anaplastic Large Cell Lymphoma Recurrent Childhood Grade III Lymphomatoid Granulomatosis Recurrent Childhood Large Cell Lymphoma Recurrent Childhood Lymphoblastic Lymphoma Recurrent Childhood Small Noncleaved Cell Lymphoma Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma Recurrent Grade 1 Follicular Lymphoma Recurrent Grade 2 Follicular Lymphoma Recurrent Grade 3 Follicular Lymphoma Recurrent Mantle Cell Lymphoma Recurrent Marginal Zone Lymphoma Recurrent Mycosis Fungoides/Sezary Syndrome Recurrent Small Lymphocytic Lymphoma Recurrent/Refractory Childhood Hodgkin Lymphoma Relapsing Chronic Myelogenous Leukemia Secondary Acute Myeloid Leukemia Secondary Myelodysplastic Syndromes Small Intestine Lymphoma Splenic Marginal Zone Lymphoma Stage III Multiple Myeloma Testicular Lymphoma Waldenstr?m Macroglobulinemia Less << Phase 2 Completed - United States, Washington ... More >> Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 Less <<
NCT00387959 - Completed - -
NCT01427881 - Completed - -
NCT00008307 Leukemia Lymp... More >>homa Multiple Myeloma and Plasma Cell Neoplasm Myelodysplastic Syndromes Less << Phase 2 Unknown - United States, New York ... More >> Herbert Irving Comprehensive Cancer Center at Columbia University New York, New York, United States, 10032 Less <<
NCT01118013 Leukemia Lymp... More >>homa Lymphoproliferative Disorder Multiple Myeloma and Plasma Cell Neoplasm Myelodysplastic Syndromes Myelodysplastic/Myeloproliferative Neoplasms Less << Phase 2 Terminated - United States, Delaware ... More >> Tunnell Cancer Center at Beebe Medical Center Lewes, Delaware, United States, 19958 CCOP - Christiana Care Health Services Newark, Delaware, United States, 19713 United States, Florida Florida Hospital Cancer Institute at Florida Hospital Orlando Orlando, Florida, United States, 32803-1273 United States, Maryland Greenebaum Cancer Center at University of Maryland Medical Center Baltimore, Maryland, United States, 21201 Union Hospital of Cecil County Elkton MD, Maryland, United States, 21921 United States, Missouri Siteman Cancer Center at Barnes-Jewish Hospital - Saint Louis Saint Louis, Missouri, United States, 63110 United States, New Jersey Cancer Institute of New Jersey at Cooper - Voorhees Voorhees, New Jersey, United States, 08043 United States, New York New York Weill Cornell Cancer Center at Cornell University New York, New York, United States, 10021 United States, North Carolina Wake Forest University Comprehensive Cancer Center Winston-Salem, North Carolina, United States, 27157-1096 United States, Ohio Arthur G. James Cancer Hospital and Richard J. Solove Research Institute at Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States, 43210-1240 Less <<
NCT01118013 - Terminated - -
NCT00376480 Leukemia Myel... More >>odysplastic Syndromes Less << Phase 1 Unknown - United States, California ... More >> Childrens Hospital Los Angeles Recruiting Los Angeles, California, United States, 90027-0700 Contact: Neena Kapoor, MD    323-669-2434    nkapoor@chla.usc.edu    United States, Massachusetts Massachusetts General Hospital Recruiting Boston, Massachusetts, United States, 02114 Contact: Clinical Trials Office - Massachusetts General Hospital    877-726-5130       Children's Hospital Boston Recruiting Boston, Massachusetts, United States, 02115 Contact: Eva Guinan, MD    617-632-4932       Dana-Farber/Harvard Cancer Center at Dana Farber Cancer Institute Recruiting Boston, Massachusetts, United States, 02115 Contact: Eva Guinan, MD    617-632-4932       United States, Texas M. D. Anderson Cancer Center at University of Texas Recruiting Houston, Texas, United States, 77030-4009 Contact: Clinical Trials Office - M. D. Anderson Cancer Center at the U    713-792-3245 Less <<
NCT00176878 - Completed - -
NCT00304018 Leukemia Lymp... More >>homa Multiple Myeloma and Plasma Cell Neoplasm Myelodysplastic Syndromes Less << Phase 1 Completed - United States, California ... More >> UCSF Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States, 94115 Less <<
NCT00740467 Graft Versus Host Disease ... More >> Leukemia Lymphoma Multiple Myeloma and Plasma Cell Neoplasm Precancerous Condition Less << Phase 2 Unknown - France ... More >> Marseille Institute of Cancer - Institut J. Paoli and I. Calmettes Recruiting Marseille, France, 13273 Contact: Contact Person    33-4-91-22-37-54 Less <<
NCT02508038 Acute Myeloid Leukemia ... More >> Acute Lymphoblastic Leukemia Hodgkin Lymphoma Non-Hodgkin Lymphoma Myelodysplastic Syndrome Myeloproliferative Syndrome Rhabdomyosarcoma Ewing Sarcoma Primitive Neuroectodermal Tumor Osteosarcoma Neuroblastoma Less << Phase 1 Recruiting November 2023 United States, Wisconsin ... More >> University of Wisconsin Carbone Cancer Center Recruiting Madison, Wisconsin, United States, 53705 Contact: Pediatric HemOnc Main Line    608-263-6200    PEDSHemOncResearch@lists.wisc.edu    Contact: Research Office    608-890-8070    PEDSHemOncResearch@lists.wisc.edu    Principal Investigator: Mario Otto, MD, PhD Less <<
NCT00176878 Diamond-Blackfan Anemia ... More >> Kostmann's Neutropenia Shwachman-Diamond Syndrome Less << Phase 2 Phase 3 Completed - United States, Minnesota ... More >> University of Minnesota Medical Center Minneapolis, Minnesota, United States, 55455 Less <<
NCT01697527 Malignant Neoplasm Phase 2 Recruiting November 2, 2019 United States, California ... More >> University of California at Los Angeles (UCLA ) Recruiting Los Angeles, California, United States, 90095 Contact: Arun Singh    310-829-5471    asingh@mednet.ucla.edu    Principal Investigator: Arun Singh Less <<
NCT00079144 Melanoma (Skin) Phase 2 Completed - United States, Maryland ... More >> Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support Bethesda, Maryland, United States, 20892-1182 NCI - Center for Cancer Research Bethesda, Maryland, United States, 20892 Less <<
NCT00829647 Chronic Lymphocytic Leukemia ... More >> Leukemia Less << Phase 1 Phase 2 Withdrawn(Unable to enroll) - -
NCT00209209 Lymphoma, Mantle-Cell Phase 3 Active, not recruiting December 2018 Czech Republic ... More >> General University Hospital, 1St Department of Medicine Praha, Czech Republic, CZ-12808 Denmark Nordic Lymphoma Group Copenhagen, Denmark, DK-2100 France Groupe D´Etudes des Lymphomes De l´Adulte (GELA) Paris, France, F-75743 Germany German Low Grade Study Group (Glsg) Munich, Germany, D-81377 Italy Ospedale Ferratotto, Divisione Di Ematologia Catania, Italy, I-95124 Netherlands HOVON - Dutch Haemato-Oncology Association (HOVON-Datacenter) Rotterdam, Netherlands, NL-3008 AE Poland The Maria Sklodowska Memorial, Cancer Center - Inst. of Oncology Warszawa, Poland, PL-02-781 Less <<
NCT01954784 Refractory Multiple Myeloma ... More >> Stage I Multiple Myeloma Stage II Multiple Myeloma Stage III Multiple Myeloma Less << Phase 1 Terminated(Funding unavailable... More >>) Less << - United States, Ohio ... More >> Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center Cleveland, Ohio, United States, 44195 Less <<
NCT00387959 Leukemia Lymp... More >>homa Less << Phase 2 Completed - United States, New York ... More >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10065 Less <<
NCT02070406 Unspecified Adult Solid Tumor,... More >> Protocol Specific Less << Phase 1 Recruiting July 17, 2020 United States, California ... More >> Jonsson Comprehensive Cancer Center Recruiting Los Angeles, California, United States, 90095 Contact: Antoni Ribas    310-206-3928    aribas@mednet.ucla.edu    Principal Investigator: Antoni Ribas Less <<
NCT01652014 Accelerated Phase Chronic Myel... More >>ogenous Leukemia Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome Adult Acute Lymphoblastic Leukemia in Remission Adult Acute Myeloid Leukemia in Remission Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) Adult Acute Myeloid Leukemia With t(15;17)(q22;q12) Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) Adult Acute Myeloid Leukemia With t(8;21)(q22;q22) Adult Nasal Type Extranodal NK/T-cell Lymphoma Anaplastic Large Cell Lymphoma Angioimmunoblastic T-cell Lymphoma Blastic Phase Chronic Myelogenous Leukemia Cutaneous B-cell Non-Hodgkin Lymphoma de Novo Myelodysplastic Syndromes Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue Hepatosplenic T-cell Lymphoma Intraocular Lymphoma Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable Nodal Marginal Zone B-cell Lymphoma Noncutaneous Extranodal Lymphoma Peripheral T-cell Lymphoma Post-transplant Lymphoproliferative Disorder Previously Treated Myelodysplastic Syndromes Recurrent Adult Acute Lymphoblastic Leukemia Recurrent Adult Acute Myeloid Leukemia Recurrent Adult Burkitt Lymphoma Recurrent Adult Diffuse Large Cell Lymphoma Recurrent Adult Diffuse Mixed Cell Lymphoma Recurrent Adult Diffuse Small Cleaved Cell Lymphoma Recurrent Adult Grade III Lymphomatoid Granulomatosis Recurrent Adult Hodgkin Lymphoma Recurrent Adult Immunoblastic Large Cell Lymphoma Recurrent Adult Lymphoblastic Lymphoma Recurrent Adult T-cell Leukemia/Lymphoma Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma Recurrent Grade 1 Follicular Lymphoma Recurrent Grade 2 Follicular Lymphoma Recurrent Grade 3 Follicular Lymphoma Recurrent Mantle Cell Lymphoma Recurrent Marginal Zone Lymphoma Recurrent Mycosis Fungoides/Sezary Syndrome Recurrent Small Lymphocytic Lymphoma Refractory Chronic Lymphocytic Leukemia Refractory Hairy Cell Leukemia Refractory Multiple Myeloma Relapsing Chronic Myelogenous Leukemia Secondary Acute Myeloid Leukemia Secondary Myelodysplastic Syndromes Small Intestine Lymphoma Splenic Marginal Zone Lymphoma T-cell Large Granular Lymphocyte Leukemia Testicular Lymphoma Waldenstr?m Macroglobulinemia Less << Phase 2 Withdrawn(Funding unavailable) January 2017 United States, New Jersey ... More >> Cancer Institute of New Jersey New Brunswick, New Jersey, United States, 08903 Less <<
NCT00296023 Chronic Myeloproliferative Dis... More >>orders Leukemia Lymphoma Multiple Myeloma and Plasma Cell Neoplasm Myelodysplastic Syndromes Less << Not Applicable Completed - United States, California ... More >> Alta Bates Comprehensive Cancer Center Berkeley, California, United States, 94704 UCSF Comprehensive Cancer Center San Francisco, California, United States, 94143-0324 Less <<
NCT00498316 Myelodysplastic Syndrome ... More >> Leukemia Less << Phase 1 Completed - United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00612222 - Terminated(The study was termi... More >>nated due to low accrual.) Less << - -
NCT02926833 Refractory Diffuse Large B Cel... More >>l Lymphoma Less << Phase 1 Phase 2 Recruiting June 2023 United States, California ... More >> City of Hope Recruiting Duarte, California, United States, 91010 Contact: Hormoz Mirshkarlo       hmirshkarlo@coh.org    Stanford Cancer Center Recruiting Stanford, California, United States, 94305 Contact: Juliana K Craig       jkcraig@stanford.edu    United States, Florida H Lee Moffitt Cancer Center Recruiting Tampa, Florida, United States, 33612 Contact: Matthew Scott       matthew.scott@moffitt.org    United States, Massachusetts Dana Farber Cancer Institute Recruiting Boston, Massachusetts, United States, 02215 Contact: Guadalupe De Maeyer       gdemaeyer@partners.org    United States, Texas University of Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact: Sherry Adkins       sadkins@mdanderson.org Less <<
NCT01203228 Myelodysplastic Syndromes ... More >> Secondary Acute Myeloid Leukemia Less << Phase 3 Terminated - Germany ... More >> University Hospital Düsseldorf, Germany Martin-Luther-Universität Halle-Wittenberg Halle, Germany University Hospital Eppendorf Hamburg, Germany University Hospital Heidelberg, Germany UKSH Campus Kiel Kiel, Germany University Hospital Köln, Germany University Hospital Leipzig, Germany Universitätsklinikum Munster Munster, Germany University Hospital Tübingen, Germany Italy Santi Antonio e Biagio Alessandria, Italy Ospedale di Careggi Firenze, Italy Ospedale Maggiore di Milano Milano, Italy Netherlands Radboud University MC Nijmegen, Netherlands Russian Federation SPb State I. Pavlov Medical University St. Petersburg, Russian Federation Less <<
NCT01663766 GVHD (Acute or Chronic) ... More >> Acute Myeloid or Lymphoblastic Leukemia (AML or ALL) Myelodysplastic Syndrome Chronic Myelogenous Leukemia (CML) Multiple Myeloma (MM) Non-Hodgekin Lymphoma (NHL-both Follicular & Diffuse Large Cell) Chronic Lymphocytic Leukemia or Small Lymphocytic Leukemia (CLL or SLL) Less << Phase 1 Unknown January 2017 United States, Ohio ... More >> Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States, 43210 Less <<
NCT00023192 Chronic Granulomatous Disease Phase 3 Completed - United States, Maryland ... More >> National Institute of Allergy and Infectious Diseases (NIAID) Bethesda, Maryland, United States, 20892 Less <<
NCT02169791 Acute Leukemia ... More >> Chronic Leukemia Myelodysplastic Syndrome Lymphomas Multiple Myeloma Less << Phase 2 Active, not recruiting August 30, 2020 United States, Georgia ... More >> Northside Hospital Atlanta, Georgia, United States, 30342 Less <<
NCT00612222 Metastatic Melanoma ... More >> Skin Cancer Less << Phase 2 Terminated(The study was termi... More >>nated due to low accrual.) Less << - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT03520647 Severe Aplastic Anemia (SAA) ... More >> Hypo-Plastic Myelodysplastic Syndrome (MDS) Less << Phase 2 Recruiting June 1, 2028 United States, Maryland ... More >> National Institutes of Health Clinical Center Recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact Office of Patient Recruitment (OPR)    800-411-1222 ext TTY8664111010    prpl@cc.nih.gov Less <<
NCT00004114 Leukemia Lymp... More >>homa Myelodysplastic Syndromes Less << Phase 1 Withdrawn(Study never opened) - -
NCT00047060 Mycosis Fungoides ... More >> Sezary Syndrome Less << Phase 1 Active, not recruiting July 1, 2021 United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT02806375 Primary Myelofibrosis ... More >> Myeloproliferative Disorders Less << Phase 1 Phase 2 Active, not recruiting June 2019 Russian Federation ... More >> First Pavlov State Medical University of St. Petersburg Saint-Petersburg, Russian Federation, 197089 Less <<
NCT03236129 Hematological Malignancies ... More >> Regulatory T Cell Depletion Relapse Less << Phase 3 Not yet recruiting September 2021 France ... More >> Henri Mondor Hospital Not yet recruiting Creteil, France, 94010 Contact: Damien VANHOYE, PhD    (0)1 44 84 17 93 ext +33    damien.vanhoye@drc.aphp.fr    Contact: Laetitia GREGOIRE, M. Sc    (0)1 49 81 41 64 ext +33    Laetitia.gregoire@aphp.fr Less <<
NCT00080353 Melanoma Phase 2 Completed - United States, Maryland ... More >> National Cancer Institute (NCI) Bethesda, Maryland, United States, 20892 Less <<
NCT01659151 Metastatic Melanoma Phase 2 Active, not recruiting December 2019 United States, Florida ... More >> H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States, 33612 Less <<
NCT01050946 Leukemia, Lymphocytic, Acute ... More >> Leukemia, Lymphocytic, Chronic Leukemia, Myelocytic, Acute Leukemia, Myeloid, Chronic Lymphoma, Non-Hodgkin Lymphoma, Hodgkins Less << Phase 2 Terminated(Only one patient wa... More >>s enrolled. Due to low accrual study was terminated) Less << - -
NCT03287817 Diffuse Large B Cell Lymphoma ... More >> Relapsed Diffuse Large B-Cell Lymphoma Refractory Diffuse Large B-Cell Lymphoma DLBCL Less << Phase 1 Phase 2 Recruiting March 2021 United Kingdom ... More >> University College London Hospitals NHS Foundation Trust Recruiting London, United Kingdom Principal Investigator: Dr Kirit Ardeshna          The Christie NHS Foundation Trust Not yet recruiting Manchester, United Kingdom Principal Investigator: Dr Adrian Bloor          Freeman Hospital, The Newcastle upon Tyne Hospitals NHS Foundation Trust Recruiting Newcastle upon Tyne, United Kingdom Principal Investigator: Dr Wendy Osborne Less <<
NCT01050946 - Terminated(Only one patient wa... More >>s enrolled. Due to low accrual study was terminated) Less << - -
NCT00002798 Childhood Acute Erythroleukemi... More >>a (M6) Childhood Acute Megakaryocytic Leukemia (M7) Childhood Acute Monoblastic Leukemia (M5a) Childhood Acute Monocytic Leukemia (M5b) Childhood Acute Myeloblastic Leukemia With Maturation (M2) Childhood Acute Myeloblastic Leukemia Without Maturation (M1) Childhood Acute Myelomonocytic Leukemia (M4) Childhood Myelodysplastic Syndromes Chronic Myelomonocytic Leukemia de Novo Myelodysplastic Syndromes Refractory Anemia Refractory Anemia With Excess Blasts Refractory Anemia With Excess Blasts in Transformation Refractory Anemia With Ringed Sideroblasts Secondary Myelodysplastic Syndromes Untreated Childhood Acute Myeloid Leukemia and Other Myeloid Malignancies Less << Phase 3 Completed - United States, California ... More >> Children's Oncology Group Arcadia, California, United States, 91006-3776 Less <<
NCT03585517 AML Phase 1 Recruiting November 1, 2020 China ... More >> Xian Lu Recruiting Beijing, China Contact: xian lu    86 ext 86    luxinan@immunochina.com Less <<
NCT00780988 Colorectal Neoplasms ... More >> Anal, Colon, and Rectal Cancers Less << Phase 1 Withdrawn - United States, California ... More >> Stanford University School of Medicine Stanford, California, United States, 94305 Less <<
NCT03430011 Multiple Myeloma Phase 1 Phase 2 Recruiting March 2021 United States, Alabama ... More >> University of Alabama Recruiting Birmingham, Alabama, United States, 35294 Contact: Tiffany D Hill, RN, BSN    205-996-8023    tiffanydhill@uabmc.edu    Principal Investigator: Luciano Costa, MD, PhD          United States, California City of Hope Comprehensive Cancer Center Recruiting Duarte, California, United States, 91010 Contact: Myo Htut, MD    626-218-2405 ext 82405    mhtut@coh.org    Principal Investigator: Myo Htut, MD          University of California Recruiting San Francisco, California, United States, 94143 Contact: Helen Diller Family Comprehensive Cancer Center       HDFCCC.CIP@ucsf.edu    Principal Investigator: Sandy Wong, MD          United States, Georgia Winship Cancer Institute at Emory University Not yet recruiting Atlanta, Georgia, United States, 30322 Contact: Jonathan Kaufman, MD    404-778-1900    jlkaufm@emory.edu    Principal Investigator: Jonathan Kaufman, MD          United States, Illinois The University of Chicago Medicine Recruiting Chicago, Illinois, United States, 60637 Contact: Rebecca Malloy    773-834-1475    rmalloy@medicine.bsd.uchicago.edu    Principal Investigator: Andrzej Jakubowiak, MD, PhD          United States, New Jersey Hackensack University Medical Center Recruiting Hackensack, New Jersey, United States, 07601 Contact: Leah Cappadona, RN    551-996-5078    Leah.Cappadona@hackensackmeridian.org    Principal Investigator: David Siegel, MD, PhD          United States, New York Roswell Park Cancer Institute Recruiting Buffalo, New York, United States, 14203 Contact: Lisa Martin    716-845-4892    Lisa.Martin@RoswellPark.org    Contact: Aaron Pry    716-845-2910    Aaron.Pry@RoswellPark.org    Principal Investigator: Kelvin Lee, MD          Memorial Sloan Kettering Cancer Center Recruiting New York, New York, United States, 10065 Contact: Claudia Diamonte, RN    212-639-5317    diamontc@mskcc.org    Principal Investigator: Sham Mailankody, MD          United States, Washington Swedish Cancer Institute Recruiting Seattle, Washington, United States, 98104 Contact: Tenzin Tsomo    206-386-2831    Tenzin.Tsomo@swedish.org    Principal Investigator: William Bensinger, MD Less <<
NCT00852163 Leukemia Myel... More >>odysplastic Syndrome Less << Phase 2 Completed - United States, Texas ... More >> Baylor University Medical Center Dallas, Texas, United States, 75246 Less <<
NCT00333190 Hematologic Malignancy ... More >> AML ALL CML Multiple Myeloma NHL Hodgkin's Lymphoma Less << Not Applicable Completed - United States, Massachusetts ... More >> Brigham and Women's Hospital Boston, Massachusetts, United States, 02115 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 Less <<
NCT02421939 Leukemia, Acute Myeloid (AML) Phase 3 Active, not recruiting December 2020 -
NCT00001144 Chronic Myeloid Leukemia ... More >> Graft vs Host Disease Less << Phase 2 Completed - United States, Maryland ... More >> National Heart, Lung and Blood Institute (NHLBI) Bethesda, Maryland, United States, 20892 Less <<
NCT01947322 Acute Myeloid Leukemia Phase 1 Phase 2 Completed - France ... More >> Service d'Hématologie Clinique du Pr. Leblond- Hôpital Pitié salpêtrière Paris, France, 75013 Service d'Hématologie adultes du Pr. Hermine - Hôpital Necker Enfants Malades Paris, France, 75015 Service d'Hématologie oncologie du Pr. Mohty -Hôpital Saint Antoine Paris, France, 75571 Service d'Hématologie Clinique du Pr. Cordonnier-Hôpital Henri Mondor Paris, France, 94010 Less <<
NCT03153462 - - - United States, California ... More >> City of Hope Duarte, California, United States, 91010 Contact: Elizabeth Budde, MD       ebudde@coh.org    Stanford Cancer Institute Stanford, California, United States, 94305 Contact: Julianna Craig       jkcraig@stanford.edu    United States, Florida H. Lee Moffitt Cancer and Research Institute Tampa, Florida, United States, 33612 Contact: Matthew Scott       matthew.scott@moffitt.org    United States, Illinois University of Chicago Medical Center Chicago, Illinois, United States, 60637 Contact: Linda Schroeder       lschroed@medicine.bsd.uchicago.edu    Principal Investigator: Peter Reidell, MD          United States, Kansas The University of Kansas Hospital Investigational Drug Services Westwood, Kansas, United States, 66205 Contact: Renee Sol       rsol@kumc.edu    United States, Massachusetts Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02215 Contact: Michael Rocchio       michaelj_rocchio@dfci.harvard.edu    United States, Minnesota Mayo Clinic Rochester, Minnesota, United States, 55905 Contact: Kristin Arends       arends.kristen@mayo.edu    United States, Nebraska University of Nebraska Medical Center Omaha, Nebraska, United States, 68198-6840 Contact: Susan Blumel    402-559-9183    sblumel@unmc.edu    United States, New York Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 Contact: Miguel-Angel Perales, MD       peralesm@MSKCC.ORG    United States, Ohio James Cancer Hospital and Solove Research Institute at The Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States, 43210 Contact: Nicole Szuminski       nicole.szuminski@osumc.edu    United States, Texas The University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Contact: Sherry Adkins       sadkins@mdanderson.org    Contact: Liliana Vallejo       lnvallejo@mdanderson.org Less <<
NCT03616470 Acute Myeloid Leukemia Phase 3 Recruiting December 2023 United States, Massachusetts ... More >> Dana Farber Cancer Institute Recruiting Boston, Massachusetts, United States, 02215 Contact: Daniel J DeAngelo, MD, PhD    617-632-2645    Daniel_Deangelo@dfci.harvard.edu    Principal Investigator: Daniel DeAngelo, MD, PhD          United States, New York University of Rochester Medical Center Recruiting Rochester, New York, United States, 14642 Contact: Brandon DeLorme    585-275-5295    Brandon_Delorme@URMC.Rochester.edu    Principal Investigator: Jane Liesveld, MD          United States, Ohio The Ohio State University Wexner Medical Center and James Cancer Hospital Recruiting Columbus, Ohio, United States, 43210 Contact: Jennifer Dienno    614-293-0752    Jennifer.Dienno@osumc.edu    Principal Investigator: Alice Mims, MD          United States, Texas The University of Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact: Naval Daver, MD    713-794-4392    NDaver@mdanderson.org    Principal Investigator: Naval Daver, MD          United States, Washington Seattle Cancer Care Alliance Recruiting Seattle, Washington, United States, 98109 Contact: Niall Curley    206-606-1231    Ncurley8@seattlecca.org    Principal Investigator: Pamela Becker, MD, PhD Less <<
NCT01453062 - Completed - -
NCT03497533 Non-hodgkin Lymphoma,B Cell Phase 1 Phase 2 Recruiting December 31, 2020 China, Hunan ... More >> Hunan Provincial People's Hospital Recruiting Changsha, Hunan, China, 410005 Contact: Jianjun Chen    +86 0731 83928147       Contact: Ming Zhou    +86 0731 83928145    zhouming_0321@163.com Less <<
NCT00077922 - Completed - -
NCT03289455 B Acute Lymphoblastic Leukemia... More >> Recurrent Childhood Acute Lymphoblastic Leukemia Refractory Childhood Acute Lymphoblastic Leukemia B-cell Acute Lymphoblastic Leukemia Less << Phase 1 Phase 2 Recruiting December 2021 United Kingdom ... More >> Great Ormond Street Hospital for Children NHS Foundation Trust Recruiting London, United Kingdom Principal Investigator: Professor Persis Amrolia          University College London Hospitals NHS Foundation Trust Recruiting London, United Kingdom Principal Investigator: Dr Rachael Hough          Royal Manchester Children's Hospital Recruiting Manchester, United Kingdom Principal Investigator: Professor Robert Wynn Less <<
NCT00423826 - - - United States, Michigan ... More >> Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States, 48201-1379 Less <<
NCT00077922 Leukemia Lymp... More >>hocytic Chronic Less << Phase 2 Completed - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT00334074 Acute Myelogenous Leukemia ... More >> Myelodysplastic Syndromes Chronic Myelogenous Leukemia Less << Phase 2 Completed - United States, Texas ... More >> Baylor University Medical Center Dallas, Texas, United States, 75246 Less <<
NCT00818961 Leukemia Lymp... More >>homa Myelodysplastic Syndromes Myelodysplastic/Myeloproliferative Diseases Less << Phase 2 Terminated(terminated early du... More >>e to meeting end point with fewer patients than anticipated) Less << - United States, Georgia ... More >> Blood and Marrow Transplant Group of Georgia Atlanta, Georgia, United States, 30342 Less <<
NCT03720496 Non-hodgkin Lymphoma,B Cell Phase 1 Recruiting December 1, 2021 China, Hainan ... More >> The Second Affiliated Hospital of Hainan Medical University Recruiting Haikou, Hainan, China, 570100 Contact: Haifeng Lin    +86 13322060949    13322060949@163.com    Contact: Yasong Wu    +86 18020091931    yasong.wu@timmune.com Less <<
NCT03638206 B-cell Acute Lymphoblastic Leu... More >>kemia Lymphoma Myeloid Leukemia Multiple Myeloma Hepatoma Gastric Cancer Pancreatic Cancer Mesothelioma Colorectal Cancer Esophagus Cancer Lung Cancer Glioma Melanoma Synovial Sarcoma Ovarian Cancer Renal Carcinoma Less << Phase 1 Phase 2 Recruiting March 1, 2023 China, Henan ... More >> The First Affiliated Hospital of Zhengzhou University Recruiting Zhengzhou, Henan, China, 450052 Contact: Yi Zhang, MD, PhD    86-15138928971    yizhang@zzu.edu.cn Less <<
NCT01174108 Severe Aplastic Anemia ... More >> MDS (Myelodysplastic Syndrome) Less << Phase 2 Recruiting June 30, 2020 United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact Office of Patient Recruitment (OPR)    800-411-1222 ext TTY8664111010    prpl@cc.nih.gov    University of Maryland at Baltimore/MPRC Recruiting Catonsville, Maryland, United States, 21228 Contact: Nancy Hardy, M.D.    410-328-1230    nhardy12@umm.edu Less <<
NCT00366418 Refractory Chronic Lymphocytic... More >> Leukemia Less << Phase 1 Completed - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT00334074 - Completed - -
NCT01013441 Chronic Lymphocytic Leukemia Phase 1 Phase 2 Active, not recruiting December 2018 United States, Pennsylvania ... More >> Abramson Cancer Center, University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104 United States, Texas MD Anderson Cancer Center, University of Texas Houston, Texas, United States, 77030 Less <<
NCT00818961 - Terminated(terminated early du... More >>e to meeting end point with fewer patients than anticipated) Less << - -
NCT00383448 Adrenoleukodystrophy ... More >> Metachromatic Leukodystrophy Globoid Cell Leukodystrophy Tay Sachs Disease Sandhoffs Disease Wolman Disease I-Cell Disease Sanfilippo Syndrome GM1 Gangliosidosis Less << Phase 2 Completed - United States, Minnesota ... More >> Masonic Cancer Center, University of Minnesota Minneapolis, Minnesota, United States, 55455 Less <<
NCT03290664 Acute Myelogenous Leukemia Phase 2 Terminated(Slow accrual) - United States, Minnesota ... More >> University of Minnesota, Masonic Cancer Center Minneapolis, Minnesota, United States, 55455 Less <<
NCT00130754 Stem Cell Transplantation ... More >> Graft Vs Host Disease Less << Phase 3 Completed - Israel ... More >> Hadassah Medical Organization Jerusalem, Israel, 91120 Less <<
NCT01534702 Acute Myeloid Leukemia Phase 1 Phase 2 Unknown September 2015 Germany ... More >> Universitätsklinikum Düsseldorf Not yet recruiting Düsseldorf, Germany, 40225 Contact: Andrea Kuendgen, MD       andrea.kuendgen@med.uni-duesseldorf.de    Principal Investigator: Andrea Kuendgen, MD          Klinikum Essen-Werden Recruiting Essen, Germany, 45239 Contact: Mohammad Wattad, MD       m.wattad@kliniken-essen-sued.de    Principal Investigator: Mohammad Wattad, MD          Universitätsklinikum Freiburg Recruiting Freiburg, Germany, D-79106 Contact: Michael Luebbert, MD       luebbert@mm11.ukl.uni-freiburg.de    Principal Investigator: Michael Luebbert, MD          Universitätsklinikum Hamburg-Eppendorf Not yet recruiting Hamburg, Germany, 20246 Contact: Walter Fiedler, MD       fiedler@uke.uni-hamburg.de    Principal Investigator: Walter Fiedler, MD          Hannover Medical School Recruiting Hannover, Germany, D-30625 Contact: Juergen Krauter, MD    +49-511-532-3720    Krauter.Juergen@MH-Hannover.de    Principal Investigator: Juergen Krauter, MD          Klinikum Rechts der Isar Not yet recruiting Muenchen, Germany, 81675 Contact: Justus Duyster       justus.duyster@lrz.tum.de    Principal Investigator: Justus Duyster, MD          Universitätsklinikum Ulm Not yet recruiting Ulm, Germany, 89081 Contact: Richard Schlenk, MD       Richard.Schlenk@uniklinik-ulm.de    Principal Investigator: Richard Schlenk, MD Less <<
NCT03229876 Acute Lymphoblastic Leukemia (... More >>ALL) Non Hodgkin Lymphoma (NHL) Less << Not Applicable Recruiting December 30, 2020 China, Henan ... More >> First Affliated Hospital of Zhengzhou University Recruiting Zhengzhou, Henan, China, 450052 Contact: Xinfeng Chen, PhD          Principal Investigator: Yi Zhang, Professor          China, Hunan Second Xiangya Hospital of Central South University Recruiting Changsha, Hunan, China, 410011 Contact: Yajuan Cui, PhD          Principal Investigator: Yunxiao Xu, Professor Less <<
NCT00604201 Myelodysplastic Syndrome (MDS)... More >> Severe Aplastic Anemia (SAA) Less << Phase 2 Recruiting December 31, 2019 United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact Office of Patient Recruitment (OPR)    800-411-1222 ext TTY8664111010    prpl@cc.nih.gov Less <<
NCT00859586 Leukemia, Myeloid, Acute ... More >> Leukemia, Lymphoblastic, Acute Leukemia, Myelocytic, Chronic Less << Phase 2 Completed - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT03752541 Multiple Myeloma Not Applicable Recruiting November 20, 2020 China, Hunan ... More >> Second Xiangya Hospital of Central South University Recruiting Changsha, Hunan, China, 410011 Contact: Yajuan Cui, PhD          Principal Investigator: Yunxiao Xu, Professor Less <<
NCT01295593 Chronic Lymphocytic Leukemia Phase 1 Phase 2 Unknown April 2013 Belgium ... More >> Clinique Sud Luxembourg Recruiting Arlon, Belgium, 6700 Contact: Pascal Pierre, MD          Institut Jules Bordet Recruiting Brussels, Belgium, 1000 Contact: Dominique Bron, MD, PhD          ULB Erasme Recruiting Brussels, Belgium, 1070 Contact: Alain Kentos, MD          Cliniques universitaires Saint Luc Recruiting Brussels, Belgium, 1200 Principal Investigator: Eric Van Den Neste, MD, PhD          Grand Hôpital de Charleori - Site notre Dame Recruiting Charleroi, Belgium, 6000 Contact: Marc André, MD          Clinique Notre-Dame de Grâce Recruiting Gosselies, Belgium, 6041 Contact: Marie Maerevoet, MD          Hôpital de Jolimont Recruiting Haine-St-Paul, Belgium, 7100 Contact: Valérie Delrieu, MD          CHU ULg Recruiting Liège, Belgium, 4000 Contact: Bernard De Prijck, MD          Clinique Saint Pierre Recruiting Ottignies, Belgium, 1340 Contact: Thierry Connerotte, MD, PhD          Heilig-Hartziekenhuis Recruiting Roeselaere, Belgium, 8800 Contact: Hilde Demuynck, MD          Cliniques de Mont Godinne Recruiting Yvoir, Belgium, 5530 Contact: Christian Chatelain, MD, PhD Less <<
NCT02701517 Unrecognized Condition: Mature... More >> B or T-cell Neoplasm Less << Phase 2 Terminated(The trial was stopp... More >>ed before the targeted number of patients was reached due to lack of support.) Less << - Poland ... More >> Department of Propedeutic Oncology, Medical University of Gdansk Gdansk, Poland Spain Clinical Hematology Department. ICO-Hospital Germans Trias i Pujol. Jose Carreras Research Institute Badalona, Barcelona, Spain Hospital Clinic I Provincial Barcelona, Spain Santa Creu I Sant Pau Hospital Barcelona, Spain Hospital Universitario de Salamanca Salamanca, Spain Less <<
NCT00859586 - Completed - -
NCT00202917 Hematologic Malignancies Phase 1 Phase 2 Completed - Germany ... More >> University of Dresden Medical Center Dresden, Germany, D-01307 Center for Marrow Transplantation Essen, Germany, 45122 Medical Center University of Hamburg Hamburg, Germany, 20246 Medical Center University of Muenster Muenster, Germany, 48129 South West German Cancer Center, University of Tuebingen Medical Center Tuebingen, Germany, 72076 Deutsche Klinik für Diagnostik Wiesbaden, Germany, 65191 University of Wuerzburg Medical Center Wuerzburg, Germany, D-97070 Less <<
NCT02165007 Sickle Cell-thalassemia Diseas... More >>e Thalassemia Less << Phase 1 Recruiting April 2023 United States, District of Col... More >>umbia Childrens National Medical Center Recruiting Washington, District of Columbia, United States, 20010 Less <<
NCT01521689 Chronic Lymphocytic Leukemia Phase 2 Unknown June 2015 France ... More >> Institut Paoli Calmettes Marseille, France, 13009 Less <<
NCT00337519 Chronic Lymphocytic Leukemia Phase 2 Unknown April 2009 Germany ... More >> Klinikum Chemnitz gGmbH Chemnitz, Germany, 09113 Uniklinikum Carl Gustav Carus Dresden, Germany, 01307 Deutsche Klinik für Diagnostik GmbH Wiesbaden, Germany, 65191 Less <<
NCT00074490 Lymphoma Leuk... More >>emia Myeloproliferative Disorders Multiple Myleoma Myelodysplastic Syndrome Less << Phase 2 Completed - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 United States, New Jersey Hackensack University Medical Center Hackensack, New Jersey, United States Less <<
NCT02592577 Non-Small Cell Lung Cancer ... More >> Carcinoma Less << Phase 1 Recruiting April 2019 United States, California ... More >> City of Hope Recruiting Duarte, California, United States, 91010 Contact: Cara Nolan    626-256-4673 ext 32341    canolan@coh.org    Principal Investigator: Karen Reckamp, MD          Stanford Cancer Center Recruiting Palo Alto, California, United States, 94304 Contact: Jordan S Preiss, BA    650-723-1002    jpreiss2@stanford.edu    Contact: Melanie G San Pedro-Salcedo          Principal Investigator: Joel W Neal, MD PhD          United States, Florida University of Miami Sylvester Comprehensive Cancer Center Recruiting Miami, Florida, United States, 33136 Contact: Michelle Liendo    305-243-0864    mliendo@med.miami.edu    Principal Investigator: Raja Mudad, M.D.          H. Lee Moffitt Cancer Center Recruiting Tampa, Florida, United States, 33612 Contact: Jeff L Edelman, MS    813-745-1040    Jeffrey.Edelman@moffitt.org    Contact: Matt Taddeo       Matt.Taddeo@moffitt.org    Principal Investigator: Ben Creelan, MD, MS          United States, Georgia Winship Cancer Institute of Emory University Recruiting Atlanta, Georgia, United States, 30322 Contact: Shantina N Walls, BS    404-778-4995    shantina.n.walls@emory.edu    Contact: Ellie C Butler          Principal Investigator: Taofeek K Owonikoko, MD, PhD          United States, Indiana Indiana University Simon Cancer Center Recruiting Indianapolis, Indiana, United States, 46033 Contact: Margaret M Uhrich, RN    317-274-4505    muhrich@iu.edu    Contact: Namratha Kolur    317-278-2356    nkolur@iu.edu    Principal Investigator: Shadia I Jalal, MD          United States, Maryland University of Maryland, Greenebaum Cancer Center Recruiting Baltimore, Maryland, United States, 21157 Contact: Brett Goldberger, MS    410-328-1160    brett.goldberger@umm.edu    Contact: Maha Khalil          Principal Investigator: Nancy Hardy, MD          United States, Massachusetts Massachusetts General Hospital Recruiting Boston, Massachusetts, United States, 02114 Contact: Justin F Gainor, M.D.    617-724-4000    jgainor@partners.org    Principal Investigator: Justin F Gainor, M.D.          United States, Missouri Washington University, School of Medicine Recruiting Saint Louis, Missouri, United States, 63110 Contact: Usha Rawat    314-286-2098    rawat@wustl.edu    Principal Investigator: Ramaswamy Govindan, MD          United States, North Carolina Duke University Medical Center, Duke Cancer Institute Recruiting Durham, North Carolina, United States, 27710 Contact: Shawna Savage, RN, BSN    919-668-1462    shawna.savage@duke.edu    Principal Investigator: Jeffrey M Clarke, MD          United States, Ohio Ohio State University Wexner Medical Center Recruiting Columbus, Ohio, United States, 43210 Contact: Catherine Schweitzer    614-685-5414    catherine.schweitzer@osumc.edu    Principal Investigator: Kai He, MD          United States, Pennsylvania Fox Chase Cancer Center Recruiting Philadelphia, Pennsylvania, United States, 19111 Contact: Patti Kelly    215-728-2195    patricia.murphy@fccc.edu    Principal Investigator: Martin Edelman, MD          United States, Tennessee Tennessee Oncology- Sarah Cannon Research Institute Recruiting Nashville, Tennessee, United States, 37203 Contact    615-329-7400    asksarah@sarahcannon.com    Principal Investigator: Melissa Johnson, MD          United States, Texas The University of Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact: Matthew Parker, RN    713-745-6767    mrparker@mdanderson.org    Contact: Sara Nasser       SNasser@mdanderson.org    Principal Investigator: Vincent K Lam, MD          Canada, Ontario Princess Margaret Cancer Centre Recruiting Toronto, Ontario, Canada, M5G1X6 Contact: Penelope Bradbury, MD    416-946-4501 ext 3544    TIP@uhn.ca    Contact: Ausmeema Hossain    416-946-4501 ext 8084    Ausmeema.Hossain@uhn.ca    Principal Investigator: Penelope Bradbury, MD          Spain Hospital Universitario Fundación Jiménez Díaz Recruiting Madrid, Spain, 28040 Contact: Adriana Armellini    91 550 48 00 ext 2486    adriana.armellini@start.stoh.com    Contact: Raquel Martinez       raquel.garcia@startmadrid.com    Principal Investigator: Victor Moreno, MD          Hospital Universitario 12 Octubre Avda. de Córdoba s/n Recruiting Madrid, Spain, 28041 Contact: Sara Gomez    +34 91 4692313    abecia@@h12o.es    Contact: Carlos Gonzalez          Principal Investigator: Luis Paz-Ares Rodríguez, MD          United Kingdom University College Hospital Macmillan Cancer Centre Recruiting London, United Kingdom, WC1E 6AG Contact: Gemma Hector    07852219920    Gemma.Hector@uclh.nhs.uk    Contact: Krishna Patel       krishna.patel@uclh.nhs.uk    Principal Investigator: Martin D Forster, MBBS, FRCP, PhD          The Christie NHS Foundation Trust Recruiting Manchester, United Kingdom, M20 4BX Contact: Shweta Vyas    +44 (0) 161 918 2323    Shweta.vyas@christie.nhs.uk    Contact: Kate Armitage    +44 (0) 161 918 7887    Kate.Armitage@christie.nhs.uk    Principal Investigator: Fiona Thistlethwaite, MD Less <<
NCT00547196 Leukemia Lymp... More >>homa Myelodysplastic Syndromes Less << Not Applicable Active, not recruiting September 2019 United States, Arizona ... More >> Banner Good Samaritan Medical Center Phoenix, Arizona, United States, 85006 United States, California City of Hope Comprehensive Cancer Center Duarte, California, United States, 91010-3000 Less <<
NCT02577094 Lymphocyte B CD22 Positive Acu... More >>te Lymphoblastic Leukemia Less << Phase 1 Phase 2 Withdrawn - -
NCT01457885 Acute Myeloblastic Leukemia Phase 2 Completed - United States, Alabama ... More >> University of Alabama, Birmingham Birmingham, Alabama, United States, 35233 United States, California City of Hope National Medical Center Duarte, California, United States, 91010 United States, Kansas University of Kansas Medical Center Kansas City, Kansas, United States, 66160 United States, Michigan University of Michigan Cancer Center Ann Arbor, Michigan, United States, 48109 United States, Missouri Washington University at St Louis Saint Louis, Missouri, United States, 63110 United States, New Jersey Hackensack University Medical Center Hackensack, New Jersey, United States, 07601 United States, Pennsylvania University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104 United States, Tennessee Vanderbuilt University Nashville, Tennessee, United States, 37232 United States, Washington University of Washington Seattle, Washington, United States, 98109 United States, Wisconsin Medical College of Wisconsin Milwaukee, Wisconsin, United States, 53226 Canada, Ontario Hospital for Sick Children Toronto, Ontario, Canada, M5G 1X8 Princess Margaret Hospital Toronto, Ontario, Canada, M5G 2M9 Less <<
NCT00855452 Metastatic Breast Cancer ... More >> Malignant Melanoma Renal Cell Cancer Gastrointestinal Cancer Less << Phase 2 Completed - Israel ... More >> Hadassah University Hospital Jerusalem, Israel, 91120 Less <<
NCT00799799 Myeloblastic Leukemia Phase 1 Unknown December 2009 Italy ... More >> Institute of Hematology "L. & A. Seragnoli" Recruiting Bologna, Bo, Italy, 40138 Less <<
NCT02989064 Urinary Bladder Cancer ... More >> Head and Neck Cancer Melanoma Less << Phase 1 Recruiting May 2020 United States, Massachusetts ... More >> Massachusetts General Hospital Recruiting Boston, Massachusetts, United States, 02114 Contact: Ryan Sullivan, MD    617-724-4000    rsullivan7@partners.org    Principal Investigator: Ryan Sullivan, MD          United States, Pennsylvania Fox Chase Cancer Center Recruiting Philadelphia, Pennsylvania, United States, 19111 Contact: Patti Kelly    215-728-2195    patriciamurphy@fccc.edu    Principal Investigator: Anthony Olszanski, MD, RPh          United States, Tennessee Tennessee Oncology - Sarah Cannon Research Institute Recruiting Nashville, Tennessee, United States, 37203 Contact    615-339-4214    asksarah@sarahcannon.com    Principal Investigator: Melissa Johnson, MD          United States, Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact: Danxia Ke    713-792-4384    dke@mdanderson.org    Contact: Ly M Nguyen          Principal Investigator: David S Hong, MD          Canada, Ontario Princess Margaret Cancer Centre Recruiting Toronto, Ontario, Canada, M5G1X6 Contact: Marcus Butler, MD    416-946-4501    TIP@uhn.ca    Contact: Anna Spreafico          Principal Investigator: Marcus Butler, MD Less <<
NCT01457885 - Completed - -
NCT02935257 Leukemia, Lymphoblastic, Acute Phase 1 Recruiting November 2024 United Kingdom ... More >> University College London Hospital Recruiting London, United Kingdom Contact: Prof. Karl Peggs          Principal Investigator: Prof. Karl Peggs Less <<
NCT00453206 - Completed - -
NCT00453206 Chronic Myeloproliferative Dis... More >>orders Leukemia Lymphoma Multiple Myeloma and Plasma Cell Neoplasm Myelodysplastic Syndromes Less << Not Applicable Completed - United States, North Carolina ... More >> Wake Forest University Comprehensive Cancer Center Winston-Salem, North Carolina, United States, 27157-1096 Less <<
NCT03164057 Acute Myeloid Leukemia ... More >> Myelodysplastic Syndromes Less << Phase 2 Recruiting June 2027 United States, California ... More >> City of Hope Comprehensive Cancer Center Recruiting Duarte, California, United States, 91010 Contact: Weili Sun, MD,PhD    800-826-4673    weilisun@coh.org    Principal Investigator: Weili Sun, MD,PhD          Children's Hospital of Central California Recruiting Madera, California, United States, 93636 Contact: Faisal Razzaqi, MD    866-353-5437    frazzaqi@valleychildrens.org    Principal Investigator: Faisal Razzaqi, MD          Children's Hospital of Orange County Recruiting Orange, California, United States, 92968 Contact: Jamie Frediani, MD    714-509-4348    jfrediani@choc.org    Principal Investigator: Jamie Frediani, MD          Lucile Packard Children's Hospital Stanford University Recruiting Palo Alto, California, United States, 94304 Contact: Norman J. Lacayo, MD    650-497-8953    lacayon@stanford.edu    Principal Investigator: Norman J. Lacayo, MD          Rady Children's Hospital and Health Center Recruiting San Diego, California, United States, 92123 Contact: Deborah Schiff, MD    858-966-5983    dschiff@chsd.org    Principal Investigator: Deborah Schiff, MD          United States, Tennessee St. Jude Children's Research Hospital Recruiting Memphis, Tennessee, United States, 38105 Contact: Tanja A. Gruber, MD, PhD    866-278-5833    tanja.gruber@stjude.org    Contact: Referral Office    866-278-5833    referralinfo@stjude.org    Principal Investigator: Tanja A. Gruber, MD, PhD          United States, Texas Cook Children's Medical Center Recruiting Fort Worth, Texas, United States, 76104 Contact: Kenneth M. Heym, MD    682-885-4007    kenneth.heym@cookchildrens.org    Principal Investigator: Kenneth M. Heym, MD Less <<
NCT03053206 Acute Myeloid Leukemia, in Rel... More >>apse Less << Phase 2 Not yet recruiting December 31, 2019 -
NCT01966510 Patients With Advanced Lymphoi... More >>d Malignancies in the Absence of an HLA Identical or Mismatch Donor Less << Phase 2 Completed - France ... More >> Saint Louis hospital Paris, France, 75010 Less <<
NCT00282282 Graft Versus Host Disease ... More >> GVHD Less << Phase 2 Completed - United States, Massachusetts ... More >> Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 Less <<
NCT00282282 - Completed - -
NCT00676806 Leukemia Lymp... More >>homa Multiple Myeloma Aplastic Anemia Less << Phase 2 Terminated(Slow accrual) - United States, Massachusetts ... More >> Tufts Medical Center Boston, Massachusetts, United States, 02111 Less <<
NCT00986518 Colorectal Cancer Phase 1 Phase 2 Completed - France ... More >> Service hépato-gastro-enterologie, Pitié-Salpêtrière Hospital Paris, France, 75013 Less <<
NCT01428973 Graft-Versus-Host Disease ... More >> Hematological Malignancies Less << Phase 2 Recruiting September 2020 Belgium ... More >> Ziekenhuis Netwerk Antwerpen (ZNA) Recruiting Antwerpen,, Antwerpen, Belgium, 2060 Contact: Pierre Zachee, MD; PhD    32-3-2177111    pierre.zachee@zna.be    University Hospital, Antwerp Recruiting Edegem, Antwerp, Belgium, 2650 Contact: Wilfried Schroyens, MD; PhD    32-03-2204111    wilfried.schroyens@uza.be    Jules Bordet Institute Recruiting Brussels, Brabant, Belgium, 1000 Contact: Philippe Lewalle, MD; PhD    32-02-5417208    plewalle@ulb.ac.be    Cliniques universitaires Saint-Luc- Université Catholique de Louvain Recruiting Brussels,, Brussels Region Capital, Belgium, 1200 Contact: Xavier Poiré, MD; PhD    32-02-7641880    xavier.poire@uclouvain.be    AZ VUB Jette Recruiting Brussels, Brussels Region Capital, Belgium, 1090 Contact: Rik Schots, MD; PhD    32-02-4763105    Rik.Schots@uzbrussel.be    Queen Fabiola Children's University Hospital Recruiting Brussels, Brussels, Region Capital, Belgium, 1020 Contact: Alice Fester, MD    32-02-4772678    afester@ulb.ac.be    University Hospital, Gasthuisberg Recruiting Leuven, Flamish Brabant, Belgium, 3000 Contact: Johan Maertens, MD    32-16-33 22 11    johan.maertens@uz.kuleuven.ac.be    UZ Gent Recruiting Gent, Flanders Ost, Belgium, 9000 Contact: Lucien Noens, MD; PhD    32-09-332 21 31    Lucien.Noens@Ugent.be    Contact: Tessa Kerre, MD; PhD    32-09-3323464    Tessa.Kerre@Ugent.be    Jolimont Hospital Haine Saint Paul Recruiting Haine St-Paul, Hainaut, Belgium, 7100 Contact: Nicole Straetmans, MD    32-64-233989    nicole.straetmans@scarlet.be    Cliniques Universitaires de Mont-Godinne Recruiting Yvoir, Namur, Belgium, 5530 Contact: Carlos Graux, MD; PhD    32-081-423831    carlos.graux@uclouvain.be    AZ Sint-Jan AV Recruiting Brugge, West Flanders, Belgium, 8000 Contact: Dominik Selleslag, MD    32-50-453060    dominik.selleslag@azbrugge.be    H.-Hart Hospital Roeselare-Menen Recruiting Roeselare, Western Flanders, Belgium, 8800 Contact: Dries Deeren, MD    32-51-237437    ddeeren@hhr.be    CHU Sart Tilman Recruiting Liège, Belgium, 4000 Principal Investigator: Frédéric Baron, MD; PhD          Sub-Investigator: Yves Beguin, MD; PhD          Sub-Investigator: Evelyne Willems, MD; PhD Less <<
NCT00129155 Hematological Malignancies ... More >> Allogeneic Transplantation Less << Phase 2 Unknown - France ... More >> Hôpital Edouard Herriot Recruiting Lyon, France, 69437 Contact: Mauricette MICHALLET, MD    33 472 117 329    mauricette.michallet@chu-lyon.fr    Principal Investigator: Mauricette Michallet, MD Less <<
NCT00676806 - Terminated(Slow accrual) - -
NCT00429416 - Completed - -
NCT01240525 Graft Versus Host Disease ... More >> Leukemia Lymphoma Myeloma Myelodysplastic Syndrome Less << Phase 2 Recruiting June 2020 United Kingdom ... More >> Birmingham Heartlands Hospital Recruiting Birmingham, United Kingdom Principal Investigator: Richard Lovell, Dr          Bristol Royal Hospital for Children Recruiting Bristol, United Kingdom Principal Investigator: Stephen Robinson, Dr          Addenbrooke's Hospital Recruiting Cambridge, United Kingdom Principal Investigator: Ben Uttenthal, Dr          Beatson West of Scotland Cancer Centre Recruiting Glasgow, United Kingdom Principal Investigator: Andrew Clark, Dr          St James's University Hospital Recruiting Leeds, United Kingdom Principal Investigator: Maria Gilleece, Dr          Leicester Royal Infirmary Recruiting Leicester, United Kingdom Principal Investigator: Ann Hunter, Dr          University College Hospital London (UCLH) Recruiting London, United Kingdom Contact       r.chakraverty@ucl.ac.uk    Principal Investigator: Ronjon Chakraverty, Prof          Christie Hospital Recruiting Manchester, United Kingdom Principal Investigator: Adrian Bloor, Dr          Nottingham City Hospital Recruiting Nottingham, United Kingdom Principal Investigator: Nigel Russell, Prof          Royal Hallamshire Hospital Recruiting Sheffield, United Kingdom Principal Investigator: John Snowden, Professor          University Hospitals Southampton Recruiting Southampton, United Kingdom Principal Investigator: Debbie Richardson, Dr Less <<
NCT03295058 Severe Aplastic Anemia Phase 2 Phase 3 Not yet recruiting June 2020 -
NCT00429416 Hematologic Malignancies Phase 1 Phase 2 Completed - United States, Pennsylvania ... More >> Thomas Jefferson University` Philadelphia, Pennsylvania, United States, 19107 Less <<
NCT00145626 - Completed - -
NCT00535912 Leukemia, Lymphocytic, Chronic Phase 3 Completed - -
NCT00145626 Acute Myeloid Leukemia ... More >> Acute Lymphocytic Leukemia Myelodysplasia Chronic Myeloid Leukemia Histiocytosis Less << Phase 2 Completed - United States, Tennessee ... More >> St. Jude Children's Research Hospital Memphis, Tennessee, United States, 38105 Less <<
NCT00342316 Acute Myeloid Leukemia Phase 3 Unknown December 2017 -
NCT00006250 Lymphoma Phase 3 Unknown - -
NCT02920008 Acute Myeloid Leukemia Phase 3 Active, not recruiting December 2019 -
NCT03016806 Acute Leukemia ... More >> Immune Deficiency Disorder Congenital Hematological Disorder Metabolism Disorder Aplastic Anemia Myelodysplastic Syndromes Chronic Leukemia Lymphoma Multiple Myeloma Solid Tumor Less << Phase 1 Recruiting June 2026 United States, New York ... More >> Wilmot Cancer Institute Recruiting Rochester, New York, United States, 14642 Contact: Jane L Liesveld, MD    585-275-4099    jane_liesveld@urmc.rochester.edu    Contact: Michael W Becker, MD    585-275-4099    michael_becker@urmc.rochester.edu Less <<
NCT03349502 Acute Myeloid Leukemia Phase 2 Recruiting January 1, 2020 Korea, Republic of ... More >> Seoul National University Hospital Recruiting Seoul, Korea, Republic of, 03080 Contact: Sang-A Kim, MD    +82 10 3026 0621    sanga0906@naver.com    Principal Investigator: Youngil Koh, MD          Sub-Investigator: Sung soo Yoon, MD, PhD          Sub-Investigator: In ho Kim, MD          Sub-Investigator: Dong-Yeop Shin, MD Less <<
NCT00636909 AML ALL ... More >> CML Chronic Phase, Accelerated Phase, or Blast Crisis CLL MDS RELAPSED NON-HODGKIN'S OR HODGKIN'S LYMPHOMA APLASTIC ANEMIA MULTIPLE MYELOMA MYELOPROLIFERATIVE DISORDER (P Vera, CMML, ET) Less << Phase 2 Completed - -
NCT01362452 Leukemia Lymp... More >>homa Less << Phase 1 Completed - United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00149006 Tumors Phase 2 Unknown - Israel ... More >> Hadassah Medical Organization Recruiting Jerusalem, Israel, 91120 Contact: Shimon Slavin, MD    +972-2-6776561    slavin@hadassah.org.il Less <<
NCT00886522 Hematological Malignancies Phase 2 Completed - Italy ... More >> Hematology Institute "L. and A. Seràgnoli", S. Orsola-Malpighi University Hospital Bologna, Italy, 40138 Less <<
NCT00338494 B-Cell Lymphoma Phase 1 Completed - United States, Connecticut ... More >> Yale Comprehensive Cancer Center at Yale University School of Medicine New Haven, Connecticut, United States, 06520 Less <<
NCT03198195 - Enrolling by invitation July 10, 2020 -
NCT01690520 Acute Biphenotypic Leukemia ... More >> Acute Lymphoblastic Leukemia in Remission Acute Myeloid Leukemia in Remission Chronic Myelogenous Leukemia Myelodysplastic Syndrome Less << Phase 2 Active, not recruiting - United States, California ... More >> City of Hope Comprehensive Cancer Center Duarte, California, United States, 91010 Stanford Cancer Institute Palo Alto Palo Alto, California, United States, 94304 United States, Colorado University of Colorado Denver, Colorado, United States, 80217-3364 United States, Massachusetts Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02215 United States, New York Mount Sinai Hospital New York, New York, United States, 10029 United States, North Carolina Duke University Medical Center Durham, North Carolina, United States, 27710 United States, Ohio Cleveland Clinic Foundation Cleveland, Ohio, United States, 44195 United States, Washington Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 Less <<
NCT01828489 Pediatric Acute Myeloblastic L... More >>eukemia Less << Phase 3 Recruiting March 2023 Belgium ... More >> HUDERF, L'Hôpital des Enfants Hématologie / Oncologie Recruiting Brussel, Belgium, 1020 Contact: Laurence Dedeken, MD, PhD    +32 2 4773311    laurence.dedeken@huderf.be    UZ Brussel, Pediatrische Hemato-Oncologie F930 Recruiting Brussel, Belgium, 1090 Contact: Jutte Van der Werff ten Bosch, MD, PhD    +32 2 4774111    JVDWerff@uzbrussel.be    UCL, Cliniques Universitaires Saint-Luc Recruiting Brussel, Belgium, 1200 Contact: Sophie Dupont, MD, PhD    +32 2 7641111    sophie.dupont@uclouvain.be    Ghent University Hospital, Children´s Hospital, Princess Elisabeth, Department of Pediatric Hematology-Oncology Recruiting Ghent, Belgium, 9000 Contact: Barbara de Moerloose, MD, PhD       barbara.demoerloose@uzgent.be    UZ Leuven, Kinder Hemato-Oncologie Recruiting Leuven, Belgium, 3000 Contact: Anne Uyttebroeck, MD, PhD    +32 16 33 22 11    anne.uyttebroeck@uzleuven.be    CHR Citadelle Recruiting Liège, Belgium Contact: Marie-Françoise Dresse, MD, PhD    +32 42238980    marie.francoise.dresse@chrcitadelle.be    CHC Espérance Recruiting Montegnée, Belgium Contact: Pierre Philippet, MD, PhD    +32 42249111    pierre.philippet@chc.be    Denmark Department of Pediatrics, Aarhus University Hospital Skejby Recruiting Aarhus, Denmark, 8200 Contact: Henrik Hasle, MD, PhD       hasle@dadlnet.dk    Dept of Pediatrics and Adolescent Medicine, Rigshospitalet, University of Copenhagen Recruiting Copenhagen, Denmark Contact: Birgitte Lausen, MD, PhD       birgitte.lausen@rh.regionh.dk    Estonia Tallinn Children's Hospital, Dep. Hematology oncology Not yet recruiting Tallinn, Estonia, 13419 Contact: Kadri Saks, MD, PhD       kadri.saks@lastehaigla.ee    Finland Division of Hematology-Oncology and Stem Cell Transplantation, Children's Hospital, Helsinki University Central Hospital Recruiting Helsinki, Finland, 00029 Contact: Kirsi Jahnukainen, MD, PhD       kirsi.jahnukainen@ki.se    Department of Pediatrics, Kuopio University Hospital Recruiting Kuopio, Finland, 70211 Contact: Pekka Riikonen    +358 447172392    pekka.riikonen@kuh.fi    Principal Investigator: Pekka Riikonen          Department of Pediatrics, Oulu University Hospital Recruiting Oulu, Finland, 90029 Contact: Merja Möttönen    +358 83155251    merja.mottonen@ppshp.fi    Principal Investigator: Merja Möttönen          Department of Pediatrics, Tampere University Central Hospital Recruiting Tampere, Finland, 33521 Contact: Mikko Arola    +358 3 31164386    mikko.arola@pshp.fi    Principal Investigator: Mikko Arola          Department of Pediatrics, Turku University Central Hospital Recruiting Turku, Finland, 20520 Contact: Minna Koskenvuo, MD, PhD    +358 50 3624430    minna.koskenvuo@utu.fi    Principal Investigator: Minna Koskenvuo          Hong Kong Dept of Paediatrics & Adolescent Medicine, Queen Mary Hospital, The University of Hong Kong Recruiting Hong Kong, Hong Kong Contact: Shau-Yin Ha, MD, PhD       syha@hku.hk    Iceland Children´s Hospital, Landspitali University Hospital Not yet recruiting Reykjavik, Iceland Contact: Olafur Jonsson, MD, PhD       olafurgi@landspitali.is    Netherlands VU University Medical Center Department of Pediatric Oncology/Hematology Recruiting Amsterdam, Netherlands, 1007 Contact: Gertjan Kaspers, MD, PhD       GJL.Kaspers@vumc.nl    Emma Children's Hospital/ Amsterdam Medical Center Department of Pediatric Oncology Recruiting Amsterdam, Netherlands, 1100 DD Contact: Huib Caron, MD, PhD       h.n.caron@amc.uva.nl    Department of Pediatric Oncology/Hematology Beatrix childrens hospital / University Medical Center Groningen Recruiting Groningen, Netherlands, 9700 RB Contact: Eveline de Bont, MD, PhD       e.de.bont@bkk.umcg.nl    University Medical Center Nijmegen Department of Pediatric Oncology/Hematolog Recruiting Nijmegen, Netherlands, 6500 HB Contact: Dunja te Loo, MD, PhD       m.teloo@cukz.umcn.nl    Erasmus MC - Sophia Childrens Hospital University Medical Center Rotterdam Recruiting Rotterdam, Netherlands, 3000 CB Contact: Marry van den Heuvel-Eibrink, MD, PhD       m.vandenheuvel@erasmusmc.nl    Norway Department of Pediatrics, Haukeland University Hospital, Bergen Recruiting Bergen, Norway, 5021 Contact: Dorota , Wojcik    +47 55 97 50 00    dorota.malgorzata.wojcik@helse-bergen.no    Principal Investigator: Dorota Wojcik          Pediatric Dept, Women and Children's Division, Oslo University Hospital Rikshospitalet Recruiting Oslo, Norway, N-0424 Contact: Bernward Zeller, MD, PhD       bernward.zeller@ous-hf.no    Department of Pediatrics, University Hospital of North Norway, Tromsoe Recruiting Tromsoe, Norway, N-9038 Contact: Trond Flaegstad    +47 91507766    Trond.Flaegstad@unn.no    Principal Investigator: Trond Flaegstad          Department of Cancer and Haemathology, St Olavs Hospital, Trondheim University Hospital Recruiting Trondheim, Norway, N-7006 Contact: Svein Kolmannskog    +47 815 55 850    svein.kolmannskog@ntnu.no    Principal Investigator: Svein Kolmannskog          Sweden Queen Silvias Childrens and Adolescents Hospital Recruiting Gothenburg, Sweden, 41685 Contact: Jonas Abrahamsson, MD, PhD       jonas.abrahamsson@vgregion.se    Principal Investigator: Jonas Abrahamsson          Dept of Pediatrics, Linköpings University Hospital Recruiting Linköping, Sweden, 58185 Contact: Mikael Behrendtz, MD, PhD          Principal Investigator: Mikael Behrendtz          Dept of Pediatrics, Skåne University Hospital Recruiting Lund, Sweden, 22241 Contact: Cornelis Pronk, MD, PhD       kees-jan.pronk@med.lu.se    Astrid Lindgrens Barnsjukhus, Karolinska University Hospital Recruiting Stockholm, Sweden, 17176 Contact: Karin Belander-Strålin, MD       karin.belander-stralin@karolinska.se    Dept of Pediatrics, Norrlands University Hospital Recruiting Umeå, Sweden, 90185 Contact: Ulrika Norén-Nyström, MD, PhD       Ulrika.norennystrom@pediatri.umu.se    Dept of Pediatrics, Akademiska barnsjukhuset Recruiting Uppsala, Sweden, 751 85 Contact: Josefine Palle, MD, PhD       josefine.palle@akademiska.se Less <<
NCT01252667 Acute Myeloid Leukemia Phase 2 Active, not recruiting - United States, Colorado ... More >> University of Colorado Hospital Aurora, Colorado, United States, 80045 United States, Louisiana Ochsner Medical Center Jefferson New Orleans, Louisiana, United States, 70121 United States, Washington VA Puget Sound Health Care System Seattle, Washington, United States, 98101 Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 Less <<
NCT01790295 Primary Myelofibrosis ... More >> Post Polycythemia Vera Myelofibrosis Post Essential Thrombocythemia Myelofibrosis Less << Phase 2 Active, not recruiting February 2021 United States, Georgia ... More >> Emory Hospital Atlanta, Georgia, United States, 30322 United States, Illinois Northwestern University, Robert h. Lurie Comprehensive Cancer Center Chicago, Illinois, United States, 60611 United States, Kansas University of Kansas Cancer Center Westwood, Kansas, United States, 66205 United States, New York Icahn School of Medicine at Mount Sinai New York, New York, United States, 10029 United States, North Carolina Wake Forest Baptist Medical Center Winston-Salem, North Carolina, United States, 27103 United States, Ohio Ohio State University Columbus, Ohio, United States, 43210 Canada Princess Margaret Cancer Centre, University of Toronto Toronto, Canada, M5G 2M9 United Kingdom University of Oxford Oxford, United Kingdom, OX3 9DS Less <<
NCT00179764 Tumors Malign... More >>ant Melanoma Hematological Malignancies Myelogenous Leukemia, Chronic Leukemia, Lymphoblastic, Acute Less << Phase 2 Unknown December 2016 United States, Illinois ... More >> Children's Memorial Hospital Recruiting Chicago, Illinois, United States, 60614 Principal Investigator: Morris Kletzel, M.D. Less <<
NCT01745913 Acute Myelogenous Leukemia ... More >> Myelodysplastic Syndrome Acute Lymphocytic Leukemia Hodgkin's Lymphoma Non-Hodgkin's Lymphoma Less << Phase 2 Terminated(Slow accrual) - United States, New York ... More >> Weill Cornell Medical College New York, New York, United States, 10026 Less <<
NCT00040417 Sickle Cell Anemia ... More >> Hemoglobinopathy Thalassemia Less << Phase 2 Terminated - United States, Texas ... More >> Texas Children's Hospital Houston, Texas, United States, 77030 The Methodist Hospital Houston, Texas, United States, 77030 Less <<
NCT02950051 Chronic Lymphocytic Leukemia Phase 3 Recruiting January 2024 -
NCT01745913 - Terminated(Slow accrual) - -
NCT00051311 Hematologic Neoplasms Phase 2 Completed - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT00972101 Stem Cell Transplantation ... More >> Leukemia Lymphoma Pediatric Disorders Less << Phase 1 Withdrawn(Development of other... More >> studies led to termination without recruitment.) Less << - -
NCT03361748 Multiple Myeloma Phase 2 Active, not recruiting November 1, 2023 United States, California ... More >> University of California - San Francisco San Francisco, California, United States, 94143 United States, Georgia Emory University Atlanta, Georgia, United States, 30322 United States, Massachusetts Dana Farber Cancer Institute Boston, Massachusetts, United States, 02115 Massachusetts General Hospital Boston, Massachusetts, United States, 02214 United States, Minnesota Mayo Clinic Rochester, Minnesota, United States, 55905 United States, New Jersey Hackensack University Medical Center Hackensack, New Jersey, United States, 07601 United States, New York Mt. Sinai Medical Center New York, New York, United States, 10029 United States, Tennessee Sarah Cannon Research Institute Nashville, Tennessee, United States, 37203 United States, Texas University of Texas Southwestern Medical Center Dallas, Texas, United States, 75390 Belgium Universitaire Ziekenhuizen Leuven Leuven, Flemish Brabant, Belgium, 3000 Canada Princess Margaret Cancer Centre Toronto, Canada, M5G 2M9 France Centre Hospitalier Regional Universitaire de Lille-Hopital Calude Huriez Service des Maladies du Sang Lille, Hauts-de-France, France, 59037 Centre Hospitalier Universitaire de Nantes - Hotel Dieu Nantes, Pays De La Loire, France, 44093 Germany Universitatsklinikum Heidelberg Medizinische Klinik Krehl-Klinik Haematologie, Onkologie, Rheumato Heidelberg, Baden-Württemberg, Germany, 69120 University of Tübingen Tübingen, Baden-Württemberg, Germany, 72076 Universitatsklinikum Würzburg Würzburg, Bavaria, Germany, 97080 Italy Azienda Ospedaliero Universitaria Di Bologna Policlinico Bologna, Emilia-Romagna, Italy, 40138 Ospedali Riuniti di Bergamo Bergamo, Italy, 24128 Spain Hospital Universitari Germans Trias i Pujol Can Ruti Badalona, Barcelona, Spain, 08916 Clinica Universidad de Navarra Pamplona, Navarre, Spain, 31008 Less <<
NCT02220985 Accelerated Phase Chronic Myel... More >>ogenous Leukemia, BCR-ABL1 Positive Acute Biphenotypic Leukemia Acute Leukemia of Ambiguous Lineage Acute Undifferentiated Leukemia Adult Acute Lymphoblastic Leukemia in Remission Adult Acute Myeloid Leukemia in Remission Allogeneic Hematopoietic Stem Cell Transplantation Recipient Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive Blastic Plasmacytoid Dendritic Cell Neoplasm Childhood Acute Lymphoblastic Leukemia in Remission Childhood Acute Myeloid Leukemia in Remission Donor Lymphoblastic Lymphoma Myelodysplastic Syndrome With Excess Blasts Myelodysplastic Syndrome With Excess Blasts-1 Myelodysplastic Syndrome With Excess Blasts-2 Recurrent Adult Acute Lymphoblastic Leukemia Recurrent Adult Acute Myeloid Leukemia Recurrent Childhood Acute Lymphoblastic Leukemia Recurrent Childhood Acute Myeloid Leukemia Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive Refractory Acute Lymphoblastic Leukemia Refractory Acute Myeloid Leukemia Less << Phase 2 Recruiting - United States, Pennsylvania ... More >> University of Pittsburgh Cancer Institute (UPCI) Recruiting Pittsburgh, Pennsylvania, United States, 15232 Contact: Alison Sehgal    412-864-7764    sehgalar@upmc.edu    Principal Investigator: Alison Sehgal          United States, Washington Fred Hutch/University of Washington Cancer Consortium Recruiting Seattle, Washington, United States, 98109 Contact: Marie Bleakley    206-667-6572    mbleakle@fredhutch.org    Principal Investigator: Marie Bleakley Less <<
NCT01005745 Metastatic Melanoma Not Applicable Active, not recruiting December 2019 United States, Florida ... More >> H. Lee Moffitt Cancer Center & Research Institute Tampa, Florida, United States, 33612 Less <<
NCT00004485 Sickle Cell Anemia Phase 1 Phase 2 Completed - United States, California ... More >> Children's Hospital of Oakland Oakland, California, United States, 94609 United States, Washington Fred Hutchinson Cancer Research Center Seattle, Washington, United States, 98109 Less <<
NCT02153580 Post-transplant Lymphoprolifer... More >>ative Disorder B-Cell Prolymphocytic Leukemia Recurrent Adult Burkitt Lymphoma Recurrent Adult Diffuse Large Cell Lymphoma Recurrent Grade 1 Follicular Lymphoma Recurrent Grade 2 Follicular Lymphoma Recurrent Grade 3 Follicular Lymphoma Recurrent Mantle Cell Lymphoma Recurrent Marginal Zone Lymphoma Recurrent Small Lymphocytic Lymphoma Refractory Chronic Lymphocytic Leukemia Refractory Hairy Cell Leukemia B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between Diffuse Large B-Cell Lymphoma and Burkitt Lymphoma B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between Diffuse Large B-Cell Lymphoma and Classical Hodgkin Lymphoma Recurrent Lymphoplasmacytic Lymphoma Less << Phase 1 Recruiting December 2021 United States, California ... More >> City of Hope Medical Center Recruiting Duarte, California, United States, 91010 Contact: Tanya Siddiqi    800-826-4673       Principal Investigator: Tanya Siddiqi Less <<
NCT03670966 Acute Lymphoblastic Leukemia i... More >>n Remission Acute Myeloid Leukemia in Remission Chronic Myelomonocytic Leukemia Myeloproliferative Neoplasm, Unclassifiable Less << Phase 1 Phase 2 Not yet recruiting September 1, 2024 United States, Washington ... More >> Fred Hutch/University of Washington Cancer Consortium Not yet recruiting Seattle, Washington, United States, 98109 Contact: Phuong Vo          Principal Investigator: Phuong Vo Less <<
NCT00053014 Leukemia Phase 2 Terminated(Poor accrual) - -
NCT00053014 - Terminated(Poor accrual) - -
NCT01005745 - Active, not recruiting - -
NCT01342289 Hodgkin's Lymphoma ... More >> Leukemia Myelodysplastic Syndrome(MDS) Multiple Myeloma Non Hodgkin's Lymphoma Less << Phase 1 Completed - United States, Maryland ... More >> Sidney Kimmel Comprehensive Cancer Center Baltimore, Maryland, United States, 21231 Less <<
NCT00079625 Breast Neoplasms Phase 1 Completed - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT03480360 Acute Myeloid Leukemia ... More >> Chronic Lymphocytic Leukemia Chronic Myeloid Leukemia Myelodysplasia Myeloproliferative Disorder Myelofibrosis Lymphoma Lymphoma, Non-Hodgkin Plasma Cell Disorder Less << Phase 3 Recruiting December 31, 2022 United States, New Hampshire ... More >> Dartmouth Hitchcock Medical Center, Norris Cotton Cancer Center Recruiting Lebanon, New Hampshire, United States, 03756 Contact: Research Nurse    800-639-6918    cancer.research.nurse@dartmouth.edu    Contact: Michael Sainz    603-650-5153    michael.sainz@hitchcock.org Less <<
NCT00566696 - Active, not recruiting - -
NCT00566696 Leukemia, Acute Lymphocytic (A... More >>LL) Leukemia, Myeloid, Acute(AML) Leukemia, Myeloid, Chronic(CML) Juvenile Myelomonocytic Leukemia (JMML) Hemoglobinuria, Paroxysmal Nocturnal (PNH) Hodgkin Lymphoma Lymphoma, Non-Hodgkin (NHL) Myelodysplastic Syndrome (MDS) Less << Phase 2 Active, not recruiting December 2018 United States, Tennessee ... More >> St. Jude Children's Research Hospital Memphis, Tennessee, United States, 38105 Less <<
NCT01500161 Acute Myelogenous Leukemia ... More >> Acute Lymphocytic Leukemia Chronic Lymphocytic Leukemia Chronic Myelogenous Leukemia Hodgkins Disease Non-Hodgkins Lymphoma Aplastic Anemia Multiple Myeloma Myelodysplastic Syndrome Less << Phase 2 Terminated(Insufficient accrua... More >>ls) Less << - United States, Texas ... More >> Texas Oncology Amarillo, Texas, United States, 79106 Less <<
NCT01682226 Leukemia Myel... More >>odysplastic Syndrome Lymphoma Less << Phase 2 Active, not recruiting September 2019 United States, New York ... More >> Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 Less <<
NCT02652455 Melanoma (Skin) ... More >> Skin Cancer Less << Early Phase 1 Active, not recruiting August 2020 United States, Florida ... More >> H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States, 33612 Less <<
NCT02406092 Non-Hodgkin Lymphoma Phase 3 Active, not recruiting July 16, 2019 Algeria ... More >> Hôpital Dorban CHU Annaba, Service d'Hématologie Annaba, Algeria, 23000 EHS CAC Hospital FRANTZ FANON ZABANA BLIDA; Hematology ward Blida, Algeria, 09000 EHU Oran, Service d'Hématologie et de Thérapie Cellulaire Oran, Algeria, 31000 Centre hospitalo-univerisitaire de Tizi Ouzou - Nedir Mohamed;Service d'hématologie Tizi Ouzou, Algeria, 15000 Morocco CHU 20 Aout Service D'Onco-Hematologie Pediatrique Casablanca, Morocco, 20100 Clinique AlMadina; Service hematologie Casablanca, Morocco, 20340 Centre Hospitalier Uni Ire de Marrakech; Oncologie-Hématologie Marrakech, Morocco, 40000 CHU Ibn Sina Rabat Service de medecine interne Rabat, Morocco, 10090 Tunisia CHU Fattouma Bourguiba, Monastir; Service d'hématologie Monastir, Tunisia, 5000 CHU Hédi Chacker; Service d'hématologie Sfax, Tunisia, 3025 CHU Farhat Hached; Service d'hématologie Sousse, Tunisia, 4000 Aziza Othmana Hospital; Clinical Haematology Tunis, Tunisia, 1008 Hopital Militaire d'instruction de Tunis; Service d'hématologie Tunis, Tunisia, 1008 Less <<
NCT00923351 Neuroblastoma ... More >> Sarcoma Rhabdomyosarcoma-Embryonal Rhabdomyosarcoma- Alveolar Neuroectodermal Tumors, Primitive, Peripheral Less << Phase 1 Phase 2 Completed - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT01652092 SCID Omenn's ... More >>Syndrome Reticular Dysgenesis Wiskott-Aldrich Syndrome Bare Lymphocyte Syndrome Common Variable Immunodeficiency Chronic Granulomatous Disease CD40 Ligand Deficiency Hyper IgM Syndrome X-linked Lymphoproliferative Disease Hemophagocytic Lymphohistiocytosis Griscelli Syndrome Chediak-Higashi Syndrome Langerhan's Cell Histiocytosis Less << Not Applicable Recruiting December 2020 United States, Minnesota ... More >> Masonic Cancer Center, University of Minnesota Recruiting Minneapolis, Minnesota, United States, 55455 Contact: Angela R. Smith, M.D.    612-626-2778    smith719@umn.edu    Principal Investigator: Angela R. Smith, M.D. Less <<
NCT00923195 Melanoma Skin... More >> Cancer Less << Phase 2 Completed - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT00923351 - Completed - -
NCT00923195 - Completed - -
NCT01810588 Hematologic Malignancies Not Applicable Recruiting December 2019 United States, Illinois ... More >> University of Chicago Medical Center Recruiting Chicago, Illinois, United States, 60637 Contact: Linda Schroeder, MS, RN    773-834-0982    lschroed@medicine.bsd.uchicago.edu    Principal Investigator: Andrew Artz,, MD, PhD          United States, New York Weill Cornell Medical College Recruiting New York, New York, United States, 10065 Contact: June Greenberg, RN    212-746-2651    jdg2002@med.cornell.edu Less <<
NCT00258427 Fanconi Anemia Phase 2 Recruiting January 2020 United States, Minnesota ... More >> Masonic Cancer Center, University of Minnesota Recruiting Minneapolis, Minnesota, United States, 55455 Contact: Timothy Krepski    612-273-2800    tkrepsk1@fairview.org    Principal Investigator: Margaret MacMillan, M.D. Less <<
NCT02294552 Acute Myeloid Leukemia ... More >> Acute Lymphoid Leukemia Lymphoma Myelodysplastic Syndromes Chronic Lymphocytic Leukemia Immune System Diseases Less << Phase 2 Completed - Russian Federation ... More >> First Pavlov State Medical University of St. Petersburg Saint-Petersburg, Russian Federation, 197089 Less <<
NCT01384513 Adult Acute Lymphoblastic Leuk... More >>emia in Remission Adult Acute Myeloid Leukemia in Remission Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities Adult Acute Myeloid Leukemia With Del(5q) Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) Adult Acute Myeloid Leukemia With t(15;17)(q22;q12) Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) Adult Acute Myeloid Leukemia With t(8;21)(q22;q22) Adult Nasal Type Extranodal NK/T-cell Lymphoma Aplastic Anemia Childhood Acute Lymphoblastic Leukemia in Remission Childhood Acute Myeloid Leukemia in Remission Childhood Myelodysplastic Syndromes Chronic Eosinophilic Leukemia Chronic Myelomonocytic Leukemia Chronic Neutrophilic Leukemia Essential Thrombocythemia Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue Juvenile Myelomonocytic Leukemia Mastocytosis Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable Nodal Marginal Zone B-cell Lymphoma Polycythemia Vera Previously Treated Myelodysplastic Syndromes Primary Myelofibrosis Recurrent Adult Acute Lymphoblastic Leukemia Recurrent Adult Acute Myeloid Leukemia Recurrent Adult Diffuse Small Cleaved Cell Lymphoma Recurrent Adult Grade III Lymphomatoid Granulomatosis Recurrent Adult Hodgkin Lymphoma Recurrent Childhood Acute Lymphoblastic Leukemia Recurrent Childhood Acute Myeloid Leukemia Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma Recurrent Grade 1 Follicular Lymphoma Recurrent Grade 2 Follicular Lymphoma Recurrent Marginal Zone Lymphoma Recurrent Mycosis Fungoides/Sezary Syndrome Recurrent Small Lymphocytic Lymphoma Recurrent/Refractory Childhood Hodgkin Lymphoma Refractory Anemia Refractory Anemia With Ringed Sideroblasts Refractory Hairy Cell Leukemia Refractory Multiple Myeloma Secondary Myelodysplastic Syndromes Splenic Marginal Zone Lymphoma T-cell Large Granular Lymphocyte Leukemia Waldenstr?m Macroglobulinemia Less << Phase 2 Recruiting July 2020 United States, Pennsylvania ... More >> Thomas Jefferson University Recruiting Philadelphia, Pennsylvania, United States, 19107 Contact: Dolores Grosso, DNP, CRNP    215-955-8874       Principal Investigator: Dolores Grosso, DNP, CRNP          Principal Investigator: Neal Flomenberg, MD          Sub-Investigator: S. Onder Alpdogan, MD          Sub-Investigator: Matthew Carabasi, MD          Sub-Investigator: Joanne Filicko-O'Hara, MD          Sub-Investigator: Margaret Kasner, MD          Sub-Investigator: Ubaldo Martinez-Outschoorn, MD          Sub-Investigator: John L Wagner, MD          Sub-Investigator: Mark Weiss, MD          Sub-Investigator: Maria Werner-Wasik, MD          Sub-Investigator: Wenyin Shi, MD, PhD          Sub-Investigator: William O'Hara, PharmD          Sub-Investigator: Thomas Klumpp, MD          Sub-Investigator: Manish Sharma, MD Less <<
NCT01087398 Osteopetrosis Phase 2 Phase 3 Unknown December 2012 Iran, Islamic Republic of ... More >> Hematology-Oncology & SCT Research Center Recruiting Tehran, Iran, Islamic Republic of, 14114 Contact: Amir Ali Hamidieh, MD    84902645 ext +98-21    aahamidieh@sina.tums.ac.ir    Sub-Investigator: Ardeshir Ghavamzadeh, MD          Sub-Investigator: Mahdi Jalili, MD Less <<
NCT01807611 Leukemia Lymp... More >>homa Less << Phase 2 Recruiting July 2020 United States, Tennessee ... More >> St. Jude Children's Research Hospital Recruiting Memphis, Tennessee, United States, 38105 Contact: Brandon M. Triplett, MD    866-278-5833    referralinfo@stjude.org    Principal Investigator: Brandon M. Triplett, MD Less <<
NCT00031655 Adult Acute Lymphoblastic Leuk... More >>emia in Remission Childhood Acute Lymphoblastic Leukemia in Remission Recurrent Adult Acute Lymphoblastic Leukemia Recurrent Childhood Acute Lymphoblastic Leukemia Less << Phase 2 Completed - United States, Oregon ... More >> Oregon Health and Sciences University Portland, Oregon, United States United States, Washington Veterans Affairs Puget Sound Healthcare System Seattle, Washington, United States, 98108 Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 Less <<
NCT03449108 Malignant Neoplasms of Bone an... More >>d Articular Cartilage Malignant Neoplasms of Female Genital Organs Less << Phase 2 Recruiting December 2020 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact: Clinical Research Operations       CR_Study_Registration@mdanderson.org Less <<
NCT00795132 Acute Leukaemia ... More >> Chronic Disease Leukemia Myelodysplasia Lymphoma Less << Phase 2 Completed - United States, Utah ... More >> Primary Children's Medical Center Salt Lake City, Utah, United States, 84112 Less <<
NCT01181271 - Completed - -
NCT02790515 Acute Lymphoblastic Leukemia (... More >>ALL) Acute Myeloid Leukemia (AML) Myeloid Sarcoma Chronic Myeloid Leukemia (CML) Juvenile Myelomonocytic Leukemia (JMML) Myelodysplastic Syndrome (MDS) Non-Hodgkin Lymphoma (NHL) Less << Phase 2 Recruiting June 2020 United States, Tennessee ... More >> St. Jude Children's Research Hospital Recruiting Memphis, Tennessee, United States, 38105 Contact: Brandon Triplett, MD    866-278-5833    referralinfo@stjude.org    Principal Investigator: Brandon Triplett, MD Less <<
NCT00795132 - Completed - -
NCT01088048 Indolent Non-Hodgkin's Lymphom... More >>a Chronic Lymphocytic Leukemia Mantle Cell Lymphoma Less << Phase 1 Completed - United States, Alabama ... More >> Clearview Cancer Institute Huntsville, Alabama, United States, 35805 United States, California UCLA Los Angeles, California, United States, 90024 Stanford Cancer Center Palo Alto, California, United States, 94304-5548 United States, Maryland Center for Cancer and Blood Disorders Bethesda, Maryland, United States, 20817 United States, Missouri Washington University School of Medicine Saint Louis, Missouri, United States, 63110 United States, New York Long Island Jewish Medical Center New Hyde Park, New York, United States, 11040 Weill Medical College of Cornell New York, New York, United States, 10021 United States, Oregon Willamette Valley Cancer Institute and Research Center Springfield, Oregon, United States, 97477 United States, Tennessee Sarah Cannon Research Institute Nashville, Tennessee, United States, 37203 United States, Texas MD Anderson Cancer Houston, Texas, United States, 77030 United States, Washington North Star Lodge Cancer Center Yakima, Washington, United States, 98902 Less <<
NCT00295971 Congenital Amegakaryocytic Thr... More >>ombocytopenia Leukemia Myelodysplastic Syndromes Severe Congenital Neutropenia Less << Phase 1 Completed - United States, California ... More >> UCSF Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States, 94115 United States, North Carolina Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill Chapel Hill, North Carolina, United States, 27599-7295 Less <<
NCT01760655 Accelerated Phase Chronic Myel... More >>ogenous Leukemia Adult Acute Lymphoblastic Leukemia in Remission Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities Adult Acute Myeloid Leukemia With Del(5q) Adult Nasal Type Extranodal NK/T-cell Lymphoma Anaplastic Large Cell Lymphoma Angioimmunoblastic T-cell Lymphoma Blastic Phase Chronic Myelogenous Leukemia Childhood Acute Lymphoblastic Leukemia in Remission Childhood Burkitt Lymphoma Childhood Chronic Myelogenous Leukemia Childhood Diffuse Large Cell Lymphoma Childhood Immunoblastic Large Cell Lymphoma Childhood Myelodysplastic Syndromes Childhood Nasal Type Extranodal NK/T-cell Lymphoma Chronic Myelomonocytic Leukemia Chronic Phase Chronic Myelogenous Leukemia Cutaneous B-cell Non-Hodgkin Lymphoma de Novo Myelodysplastic Syndromes Essential Thrombocythemia Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue Hepatosplenic T-cell Lymphoma Intraocular Lymphoma Juvenile Myelomonocytic Leukemia Nodal Marginal Zone B-cell Lymphoma Noncutaneous Extranodal Lymphoma Peripheral T-cell Lymphoma Polycythemia Vera Post-transplant Lymphoproliferative Disorder Previously Treated Myelodysplastic Syndromes Primary Myelofibrosis Recurrent Adult Acute Myeloid Leukemia Recurrent Adult Burkitt Lymphoma Recurrent Adult Diffuse Large Cell Lymphoma Recurrent Adult Diffuse Mixed Cell Lymphoma Recurrent Adult Diffuse Small Cleaved Cell Lymphoma Recurrent Adult Grade III Lymphomatoid Granulomatosis Recurrent Adult Hodgkin Lymphoma Recurrent Adult Immunoblastic Large Cell Lymphoma Recurrent Adult Lymphoblastic Lymphoma Recurrent Adult T-cell Leukemia/Lymphoma Recurrent Childhood Acute Myeloid Leukemia Recurrent Childhood Anaplastic Large Cell Lymphoma Recurrent Childhood Grade III Lymphomatoid Granulomatosis Recurrent Childhood Large Cell Lymphoma Recurrent Childhood Lymphoblastic Lymphoma Recurrent Childhood Small Noncleaved Cell Lymphoma Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma Recurrent Grade 1 Follicular Lymphoma Recurrent Grade 2 Follicular Lymphoma Recurrent Grade 3 Follicular Lymphoma Recurrent Mantle Cell Lymphoma Recurrent Marginal Zone Lymphoma Recurrent Mycosis Fungoides/Sezary Syndrome Recurrent Small Lymphocytic Lymphoma Recurrent/Refractory Childhood Hodgkin Lymphoma Refractory Anemia With Excess Blasts Refractory Anemia With Excess Blasts in Transformation Refractory Cytopenia With Multilineage Dysplasia Refractory Hairy Cell Leukemia Refractory Multiple Myeloma Relapsing Chronic Myelogenous Leukemia Secondary Acute Myeloid Leukemia Small Intestine Lymphoma Splenic Marginal Zone Lymphoma T-cell Large Granular Lymphocyte Leukemia Testicular Lymphoma Waldenstr?m Macroglobulinemia Less << Phase 2 Recruiting January 2020 United States, Pennsylvania ... More >> Thomas Jefferson University Recruiting Philadelphia, Pennsylvania, United States, 19107 Contact: Dolores Grosso, RN, CRNP, DNP    215-955-8874       Principal Investigator: Dolores Grosso, RN, CRNP, DNP          Principal Investigator: Neal Flomenberg, MD          Sub-Investigator: S. Onder Alpdogan, MD          Sub-Investigator: Matthew Carabasi, MD          Sub-Investigator: Joanne Filicko-O'Hara, MD          Sub-Investigator: Margaret Kasner, MD          Sub-Investigator: William O'Hara, PharmD          Sub-Investigator: Ubaldo Outschoorn Martinez, MD          Sub-Investigator: John Wagner, MD          Sub-Investigator: Mark Weiss, MD Less <<
NCT03128996 Severe Sickle Cell Disease ... More >> Bone Marrow Failure Syndromes Metabolic Disorders Immunologic Disorders Hemoglobinopathies Non-malignant Disorders Less << Phase 1 Phase 2 Recruiting April 2024 United States, Missouri ... More >> Washington University School of Medicine Recruiting Saint Louis, Missouri, United States, 63110 Contact: Shalini Shenoy, MD    314-454-6018    shalinishenoy@wustl.edu    Contact: Lisa Murray, MA, CCRP    314-454-4240    murraylm@wustl.edu    Principal Investigator: Shalini Shenoy, MD Less <<
NCT00925821 Multiple Myeloma Phase 2 Completed - Germany ... More >> Charité University Hospital - Virchow Klinikum Berlin, Germany Dresden University Hospital Dresden, Germany, 01307 Erlangen University Hospital Erlangen, Germany, 91054 Freiburg University Hospital Freiburg, Germany, 79106 Jena University Hospital Jena, Germany Kiel University Hospital Kiel, Germany, 24105 Munich Grosshadern University Hospital Munich, Germany, 81377 University Hospital of Munich Technical University Munich, Germany, 81675 Klinikum Nuremberg Nuremberg, Germany, 90419 Regensburg University Hospital Regensburg, Germany, 93053 Rostock University Hospital Rostock, Germany, 18057 Ulm University Hospital Ulm, Germany, 89081 Less <<
NCT03247309 Solid Tumor C... More >>ancer Head and Neck Squamous Cell Carcinoma Non-small Cell Lung Cancer Less << Phase 1 Recruiting December 2033 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Less <<
NCT02229266 Acute Myeloid Leukemia Phase 2 Recruiting September 2020 Germany ... More >> Klinikum Bayreuth Not yet recruiting Bayreuth, Germany Contact: Alexander Kiani, Prof. Dr. med.       alexander.kiani@klinikum-bayreuth.de    Principal Investigator: Alexander Kiani, Prof. Dr. med.          Klinikum Chemnitz Not yet recruiting Chemitz, Germany Contact: Regina Herbst, Dr. med.       r.herbst@skc.de    Principal Investigator: Mathias Hänel, PD Dr. med.          Universitätsklinikum Dresden Recruiting Dresden, Germany Contact: Malte von Bonin, Dr. med.       Malte.Bonin@uniklinikum-dresden.de    Principal Investigator: Malte von Bonin, Dr. med. Less <<
NCT01181271 Diffuse, Large B-Cell, Lymphom... More >>a Lymphoma, Low-Grade T-Cell Lymphoma Mantle-Cell Lymphoma Hodgkin's Lymphoma Chronic Lymphocytic Leukemia Lymphoma, Small Lymphocytic Less << Phase 2 Completed - United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Dana Farber Cancer Institute Boston, Massachusetts, United States, 02115 Less <<
NCT01969942 Ewing Sarcoma Phase 1 Withdrawn(No subjects meeting ... More >>study inclusion were enrolled.) Less << - United States, Kentucky ... More >> Pediatric Hematology/Oncology University of Louisville Louisville, Kentucky, United States, 40202 Less <<
NCT00916045 Leukemia, Myeloid, Acute ... More >> Myelodysplastic Syndromes Leukemia, Lymphoblastic, Acute Lymphoma, Non-Hodgkin Hodgkin Disease Chronic Lymphocytic Leukemia Less << Phase 2 Terminated(Recruitment issues) - United Kingdom ... More >> King's College Hosptial NHS Foundation Trust London, United Kingdom, SE5 9RS Less <<
NCT00003816 Chronic Myeloproliferative Dis... More >>orders Leukemia Lymphoma Myelodysplastic Syndromes Myelodysplastic/Myeloproliferative Diseases Nonmalignant Neoplasm Unspecified Adult Solid Tumor, Protocol Specific Unspecified Childhood Solid Tumor, Protocol Specific Less << Phase 2 Phase 3 Active, not recruiting December 1, 2019 United States, New York ... More >> Roswell Park Cancer Institute Buffalo, New York, United States, 14263-0001 Less <<
NCT00113646 Lymphoma Leuk... More >>emia Multiple Myeloma Myelodysplastic Syndrome Less << Phase 2 Terminated(Expiration of MEDI-... More >>507) Less << - United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02116 Less <<
NCT00910650 Metastatic Melanoma Phase 2 Recruiting December 2019 United States, California ... More >> University of California Los Angeles, David Geffen School of Medicine Recruiting Los Angeles, California, United States, 90095 Less <<
NCT02013167 Relapsed/Refractory B-precurso... More >>r Acute Lymphoblastic Leukemia Less << Phase 3 Terminated - -
NCT03643276 Acute Lymphoblastic Leukemia, ... More >>Pediatric Less << Phase 3 Recruiting July 14, 2028 -
NCT02013167 - Terminated - -
NCT03240731 Sickle Cell Disease Phase 2 Recruiting September 2020 France ... More >> CHU Henri-Mondor Recruiting Créteil, France, 94000 Contact: Sébastien Maury          intercommunal hospital of Créteil Recruiting Créteil, France, 94000 Contact: Corinne Pondarre          Contact: Françoise Bernaudin          CHU La Timone Not yet recruiting Marseille, France Contact: Claire Galambrun          Hospital Necker Recruiting Paris, France Contact: Felipe Suarez          Hospital Robert-Debré Recruiting Paris, France Contact: Jean-Hugue Dalle          Saint-Louis hospital Recruiting Paris, France Contact: Nathalie Dhédin, MD, PhD          Contact: Gérard Socie          CHU Strasbourg Recruiting Strasbourg, France Contact: Catherine Paillard Less <<
NCT00594308 Acute Myelogenous Leukemia ... More >> Acute Lymphocytic Leukemia Chronic Myelogenous Leukemia Chronic Lymphocytic Leukemia Myelodysplasia Lymphoma, Non-Hodgkin's Mantle-Cell Lymphoma Hodgkin's Disease Multiple Myeloma Myelofibrosis Less << Not Applicable Terminated(Treatment ineffecti... More >>ve) Less << - United States, Indiana ... More >> Indiana Universtiy Simon Cancer Center Indianapolis, Indiana, United States, 46202 Less <<
NCT00048893 Breast Neoplasms ... More >> Metastases, Neoplasm Less << Phase 1 Phase 2 Terminated(The study was close... More >>d to accrual due to very poor enrollment.) Less << - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 United States, New Jersey Hackensack University Medical Center Hackensack, New Jersey, United States, 07601 Less <<
NCT00048893 - Terminated(The study was close... More >>d to accrual due to very poor enrollment.) Less << - -
NCT00745420 Sickle Cell Disease Phase 2 Completed - -
NCT01050764 Leukemia, Acute ... More >> Chronic Myelogenous Leukemia (CML) Myelodysplastic Syndrome (MDS) Non-Hodgkin Lymphoma (NHL) Chronic Lymphocytic Leukemia (CLL) Acute Myelogenous Leukemia (AML) Acute Lymphoblastic Leukemia (ALL) Less << Phase 1 Phase 2 Terminated(Safety) - United States, California ... More >> Stanford University School of Medicine Stanford, California, United States, 94305 Less <<
NCT00594308 - Terminated(Treatment ineffecti... More >>ve) Less << - -
NCT01050764 - Terminated(Safety) - -
NCT00745420 - Completed - -
NCT00912223 Lymphoma, Non-Hodgkin Phase 2 Completed - United States, California ... More >> City of Hope National Medical Center Duarte, California, United States, 91010-3000 University of California, San Diego (UCSD) Medical Center La Jolla, California, United States, 92093 University of California, Davis Medical Center Sacramento, California, United States, 95817 Stanford Hospital and Clinics Stanford, California, United States, 94305 United States, Florida University of Florida College of Medicine Gainesville, Florida, United States, 32610-0277 H. Lee Moffitt Cancer Center Tampa, Florida, United States, 33624 United States, Illinois Rush University Medical Center Chicago, Illinois, United States, 60612 United States, Massachusetts Dana-Farber Cancer Institute (DFCI)/Brigham & Women's Hospital Boston, Massachusetts, United States, 02114 Dana-Farber Cancer Institute (DFCI)/Massachusetts General Hospital Boston, Massachusetts, United States, 02114 United States, Minnesota University of Minnesota Minneapolis, Minnesota, United States, 55455 United States, Nebraska University of Nebraska Medical Center Omaha, Nebraska, United States, 68198-7680 United States, North Carolina University of North Carolina Hospital at Chapel Hill Chapel Hill, North Carolina, United States, 27599-7305 Wake Forest University Health Sciences Winston-Salem, North Carolina, United States, 27157 United States, Ohio University Hospitals of Cleveland/Case Western Cleveland, Ohio, United States, 44106-5061 Ohio State/Arthur G. James Cancer Hospital Columbus, Ohio, United States, 43210 United States, Oklahoma University of Oklahoma Medical Center Oklahoma City, Oklahoma, United States, 73104 United States, Tennessee Vanderbilt University Medical Center Nashville, Tennessee, United States, 37232-8210 United States, Texas University of Texas, MD Anderson Cancer Research Center Houston, Texas, United States, 77030 United States, West Virginia West Virginia University Morgantown, West Virginia, United States, 26506-9162 United States, Wisconsin University of Wisconsin Hospital and Clinics Madison, Wisconsin, United States, 53792-5156 Medical College of Wisconsin Milwaukee, Wisconsin, United States, 53211 Less <<
NCT01593696 ALL B Cell Ly... More >>mphoma Leukemia Large Cell Lymphoma Non-Hodgkin Lymphoma Less << Phase 1 Completed - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT03462316 Bone Sarcoma ... More >>Soft Tissue Sarcoma Less << Phase 1 Recruiting February 15, 2020 China, Guangdong ... More >> Sun Yat-Sen Univerisity Recruiting Guangzhou, Guangdong, China, 510000 Contact: Xing Zhang, PhD,MD    86-020-87343192    zhangxing@sysucc.org.cn    Principal Investigator: Xing Zhang Less <<
NCT00912223 - Completed - -
NCT02759822 - Recruiting - Brazil ... More >> Instituto Nacional de Cancer Recruiting Rio de Janeiro, Brazil, 20230-130 Contact: Leonardo J Arcuri, MD    +55(21)3207-1304    leonardojavier@gmail.com    Contact: Simone Lermontov    +55(21)3207-1261    simonelermontov@globo.com Less <<
NCT01121029 Type 1 Diabetes Mellitus Phase 1 Phase 2 Completed - Mexico ... More >> Hospital Universitario Dr. José Eleuterio González Monterrey, Nuevo Leon, Mexico, 64460 Less <<
NCT01037764 Acute Lymphoid Leukemia Phase 2 Terminated(The PI resigned the... More >> institute, and the rest investigators at the institute decided to terminate the study.) Less << - Korea, Republic of ... More >> Inje University Haeundae Paik Hospital Pusan, Korea, Republic of Asan Medical Center Seoul, Korea, Republic of, 138-736 Less <<
NCT00604136 Metastatic Melanoma Phase 2 Recruiting July 2020 Israel ... More >> Hadassah Medical Organization, Jerusalem, Israel Recruiting Jerusalem, Israel, 91120 Contact: Hadas Lemberg, PhD    00 972 2 6777572    lhadas@hadassah.org.il    Sub-Investigator: Shoshana Frankenburg, PhD          Principal Investigator: Michal Lotem, MD Less <<
NCT03321123 Precursor B-Lymphoblastic Lymp... More >>homa/Leukaemia Refractory Less << Phase 2 Not yet recruiting December 31, 2019 -
NCT00793351 Neuroblastoma Phase 2 Completed - Korea, Republic of ... More >> Samsung Medical Center Seoul, Korea, Republic of Less <<
NCT00881920 Lymphoma Myel... More >>oma Leukemia Less << Phase 1 Recruiting July 2034 United States, Texas ... More >> Houston Methodist Hospital Recruiting Houston, Texas, United States, 77030 Contact: Carlos Ramos, MD    832-824-4817    caramos@bcm.edu    Contact: Vicky Torrano    832-824-7821    vxtorran@txch.org    Texas Children's Hospital Recruiting Houston, Texas, United States, 77030 Contact: Carlos A Ramos, MD    832-824-4817    caramos@bcm.edu    Contact: Vicky Torrano    832-824-7821    vxtorran@txch.org Less <<
NCT01814488 Acute Leukemia Phase 2 Completed - Italy ... More >> Azienda Ospedaliera SS Antonio e Biagio Alessandria, Italy Policlinico Bari, Italy Divisione di Ematologia - Ospedali Papa Giovanni XXIII Bergamo, Italy Ospedale San Orsola Bologna, Italy Ospedale Regionale Generale- Divisione Ematologia Bolzano, Italy Ospedale Binaghi Cagliari, Italy Ospedale Oncologico Businco Cagliari, Italy Ospedale Ferrarotto - Ematologia Catania, Italy S.C. Ematologia - Azienda Ospedaliera S. Croce e Carle Cuneo, Italy Cattedra di Ematologia - Azienda Ospedaliera di Careggi Firenze, Italy Ospedale Policlinico San Martino - IST Genova, Italy Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico Milano, Italy Ospedale Niguarda Ca' Grande Milano, Italy Ospedale San Raffaele Milano, Italy Divisione Ematologia - Azienda Ospedaliera Universitaria - Policlinico - Modena, Italy Cattedra di Medicina Interna ed Ematologia - Ospedale S. Gerardo de' i Tintori - Università degli Studi di Milano Monza, Italy AO Ospedali Riuniti Villa Sofia - Cervello Palermo, Italy Dipartimento Oncologico La Maddalena Palermo, Italy Fondazione IRCCS San Matteo Pavia, Italy, 27100 Dip. di Ematologia - Unità di Terapia Intensiva Ematologica per il Trapianto Emopoietico - Ospedale Civile di Pescara Pescara, Italy Ospedale G. Da Saliceto di Piacenza Piacenza, Italy Cattedra di Ematologia - Policlinico Roma, Italy Policlinico A. Gemelli Roma, Italy Policlinico Universitario Tor Vergata Roma, Italy U.O. di Ematologia e Trapianti di Midollo Osseo - Azienda Osp. S. Camillo-Forlanini / Padiglione Morgagni Roma, Italy Ematologia e Centro Trapianti Midollo Osseo - Ospedale IRCCS Casa Sollievo della Sofferenza S. Giovanni Rotondo (FG), Italy Ospedale San Giuseppe Moscato Taranto, Italy Azienda ospedaliera Città della Salute e della Scienza Torino, Italy Centro Trapianti Metropolitano Torino, Italy A.O. Santa Maria della Misericordia Udine, Italy Less <<
NCT03213964 Epithelial Ovarian Cancer ... More >> Fallopian Tube Cancer Primary Peritoneal Cancer Less << Phase 1 Recruiting April 1, 2020 United States, Minnesota ... More >> Masonic Cancer Center, University of Minnesota Recruiting Minneapolis, Minnesota, United States, 55455 Contact: Melissa Geller, MD    612-624-0123    gelle005@umn.edu    Principal Investigator: Melissa Geller, MD Less <<
NCT01966367 Bone Marrow Failure Syndrome ... More >> Severe Aplastic Anemia Severe Congenital Neutropenia Amegakaryocytic Thrombocytopenia Diamond-Blackfan Anemia Schwachman Diamond Syndrome Primary Immunodeficiency Syndromes Acquired Immunodeficiency Syndromes Histiocytic Syndrome Familial Hemophagocytic Lymphocytosis Lymphohistiocytosis Macrophage Activation Syndrome Langerhans Cell Histiocytosis (LCH) Hemoglobinopathies Sickle Cell Disease Sickle Cell-beta-thalassemia Less << Early Phase 1 Recruiting December 2019 United States, New York ... More >> Morgan Stanley Children's Hospital, New York-Presbyterian, Columbia University Recruiting New York, New York, United States, 10032 Contact: Jean Sosna, RN       js4403@columbia.edu    Contact: Danielle Dietzen, CPNP    212-305-8443    dad9025@nyp.org    Principal Investigator: Diane George, MD Less <<
NCT02014506 Haploidentical Hematopoietic S... More >>tem Cell Transplantation Malignant Disease Non-malignant Disease Less << Phase 1 Phase 2 Recruiting December 2018 Korea, Republic of ... More >> Asan Medical Center Recruiting Seoul, Korea, Republic of, 138-736 Contact: Ho Joon Im, MD & PhD    82-2-3010-3371    hojim@amc.seoul.kr    Principal Investigator: Ho Joon Im, MD & PhD Less <<
NCT01998633 Hemophagocytic Lymphohistiocyt... More >>osis Chronic Active Epstein-Barr Virus Infection Chronic Granulomatous Disease HIGM-1 Leukocyte Adhesion Deficiency IPEX Less << Phase 2 Completed - -
NCT01484470 Hematologic Malignancies Phase 2 Active, not recruiting September 2018 United States, Illinois ... More >> Loyola University Medical Center Maywood, Illinois, United States, 60153 Less <<
NCT03672318 Multiple Myeloma ... More >> Immune System Diseases Less << Phase 1 Recruiting October 2032 United States, North Carolina ... More >> Lineberger Comprehensive Cancer Center at University of North Carolina Recruiting Chapel Hill, North Carolina, United States, 27599 Contact: Catherine Cheng    919-445-4208    catherine_cheng@med.unc.edu    Contact: Spencer Laing    919-962-8618    ssblaing@email.unc.edu    Principal Investigator: Sacha Tuchman, MD, MPS Less <<
NCT03263767 Graft Versus Host Disease Phase 2 Not yet recruiting February 2022 -
NCT01861106 GATA2 Immunod... More >>eficiency MDS Less << Phase 2 Recruiting December 31, 2021 United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact National Cancer Institute Referral Office    888-624-1937 Less <<
NCT01464359 Acute Myelogenous Leukemia ... More >> Refractory Acute Myelogenous Leukemia Less << Phase 2 Terminated(Slow accrual) - United States, Minnesota ... More >> Masonic Cancer Center, University of Minnesota Minneapolis, Minnesota, United States, 55455 Less <<
NCT01464359 - Terminated(Slow accrual) - -
NCT01033552 Epidermolysis Bullosa Phase 2 Recruiting October 2019 United States, Minnesota ... More >> University of Minnesota Masonic Cancer Center and Medical Center Recruiting Minneapolis, Minnesota, United States, 55455 Contact: Kim Nelson, RN    612-273-2925    knelso62@fairview.org    Principal Investigator: Jakub Tolar, MD, PhD Less <<
NCT00997529 Metastatic Solid Tumor Not Applicable Completed - United States, Massachusetts ... More >> Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02115 Less <<
NCT01065545 Acute Myeloid Leukemia Phase 1 Withdrawn(Due to funding issue... More >>s.) Less << - -
NCT01751997 Acute Myeloid Leukemia Phase 2 Phase 3 Recruiting December 2019 Korea, Republic of ... More >> Catholic Blood and Marrow Transplantation Center, Seoul St. Mary's Hospital Recruiting Seoul, Korea, Republic of, 137-701 Less <<
NCT00054236 Chronic Myeloproliferative Dis... More >>orders Leukemia Lymphoma Multiple Myeloma and Plasma Cell Neoplasm Myelodysplastic Syndromes Myelodysplastic/Myeloproliferative Diseases Less << Phase 1 Completed - United States, Ohio ... More >> Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States, 44106-5065 Less <<
NCT02737384 Combined Immunodeficiencies Phase 2 Terminated - France ... More >> Hôpital Necker-Enfants Malades Paris, France, 75015 Less <<
NCT00278512 Vasculitis Phase 1 Terminated(No participant enro... More >>lled over five years. No plan to continue the study.) Less << - United States, Illinois ... More >> Northwestern University, Feinberg School of Medicine Chicago, Illinois, United States, 60611 Less <<
NCT03615313 Advanced Solid Tumor Phase 1 Phase 2 Recruiting December 3, 2020 China, Shanghai ... More >> China Recruiting Shanghai, Shanghai, China, 200072 Contact: Xue Yang    0086-021-66301147    shsyiec@126.com    Contact: Juemin Fang    0086-021-39590256 Less <<
NCT00278512 - Terminated(No participant enro... More >>lled over five years. No plan to continue the study.) Less << - -
NCT01974479 B-cell Acute Lymphoblastic Leu... More >>kemia Less << Phase 1 Suspended(Suspended for 12 mon... More >>ths - an interim review of (CAR) CD19 research strategy for the treatment of CD19 positive ALL.) Less << February 2018 Singapore ... More >> Department of Paediatrics, National University Health System Singapore, Singapore, 119228 Department of Haematology, NCIS, National University Health System Singapore, Singapore Department of Hematology, Singapore General Hospital Singapore, Singapore Less <<
NCT03560908 Relapsed AML ... More >>T(8;21) C-KIT Mutation Less << Phase 1 Recruiting December 31, 2020 China, Tianjin ... More >> HBDH Recruiting Tianjin, Tianjin, China, 300020 Contact: Hui Wei Less <<
NCT02409576 Ewing Sarcoma ... More >> Osteosarcoma Rhabdomyosarcoma Less << Phase 1 Phase 2 Unknown September 2018 Singapore ... More >> National University Hospital Recruiting Singapore, Singapore, 119228 Contact: Chetan Dhamne    (65) 6772 3361    chetan_dhamne@nuhs.edu.sg    Contact: Clarice Chan    (65) 67726586    chan_zi_ying_clarice@nuhs.edu.sg    Principal Investigator: Chetan Dhamne          Sub-Investigator: Dario Campana          KK Women's and Children's Hospital Not yet recruiting Singapore, Singapore Contact: Tan Ah Moy       tan.ah.moy@kkh.com.sg    Contact: Jillian Teo    +65 6394-5025    Jillian.Teo.CL@kkh.com.sg Less <<
NCT00597714 Hodgkin's Disease ... More >> Non Hodgkin's Lymphoma Myeloma Leukemia Myelodysplasia Less << Phase 2 Completed - United States, North Carolina ... More >> Duke University Health System Durham, North Carolina, United States, 27710 Less <<
NCT03441958 Multiple Myeloma Phase 1 Phase 2 Recruiting March 1, 2024 Canada, Quebec ... More >> CIUSSS de l'Est-de-l'île-de-Montréal, Installation Hôpital Maisonneuve Rosemond Recruiting Montréal, Quebec, Canada, H1T2M4 Contact: Séverine Landais, PhD    514-252-3400 ext 3609    slandais.hmr@ssss.gouv.qc.ca    Contact: Jean Roy, MD    514-252-3400    jroy.hmr@ssss.gouv.qc.ca Less <<
NCT01998633 - Completed - -
NCT02991898 Acute Lymphoblastic Leukemia ... More >> Burkitt Lymphoma Natural Killer Cell Malignancies Chronic Myelogenous Leukemia Myelodysplastic Syndromes Large-cell Lymphoma Chronic Lymphocytic Leukemia Small Lymphocytic Lymphoma Marginal Zone B-Cell Lymphoma Follicular Lymphoma Lymphoplasmacytic Lymphoma Mantle-Cell Lymphoma Prolymphocytic Leukemia Hodgkin Lymphoma Multiple Myeloma Acute Myelogenous Leukemia Biphenotypic Leukemia Undifferentiated Leukemia Less << Phase 2 Suspended(Considering new tech... More >>nology for product.) Less << January 2025 United States, Minnesota ... More >> Masonic Cancer Center at University of Minnesota Minneapolis, Minnesota, United States, 55455 Less <<
NCT00597714 - Completed - -
NCT00544115 Chronic Myeloproliferative Dis... More >>orders Graft Versus Host Disease Leukemia Lymphoma Multiple Myeloma and Plasma Cell Neoplasm Myelodysplastic Syndromes Myelodysplastic/Myeloproliferative Diseases Precancerous/Nonmalignant Condition Less << Phase 2 Active, not recruiting - -
NCT02535364 Acute Lymphoblastic Leukemia Phase 2 Terminated(Safety reasons) - United States, Alabama ... More >> University of Alabama Birmingham Comprehensive Cancer Center Birmingham, Alabama, United States, 35295 United States, California City of Hope Duarte, California, United States, 91010 University of California San Francisco, California, United States, 94143 United States, Colorado University of Colorado Denver -- Anschutz Medical Campus Aurora, Colorado, United States, 80045 United States, Florida Sylvester Comprehensive Cancer Center/UMHC Miami, Florida, United States, 33136 United States, Georgia The Blood and Marrow Transplant Program at Northside Hospital Atlanta, Georgia, United States, 30342 United States, Illinois Northwestern University Robert H Lurie Comprehensive Cancer Center Chicago, Illinois, United States, 60611 University of Chicago Medical Center Chicago, Illinois, United States, 60637 United States, Maryland Sidney Kimmel Comprehensive Cancer Center @ Johns Hopkins Baltimore, Maryland, United States, 21287 United States, Massachusetts Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02215 United States, Missouri Washington University School of Medicine Saint Louis, Missouri, United States, 63110 United States, Nebraska University of Nebraska Medical Center Omaha, Nebraska, United States, 68198 United States, New York Roswell Park Cancer Institute Buffalo, New York, United States, 14263 Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 United States, Ohio Cleveland Clinic Cleveland, Ohio, United States, 44195 United States, Tennessee Vanderbilt University Medical Center Nashville, Tennessee, United States, 37232 United States, Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT03146234 Hepatocellular Carcinoma Not Applicable Recruiting June 15, 2020 China, Shanghai ... More >> Renji Hospital, Shanghai Jiaotong University School of Medicine Recruiting Shanghai, Shanghai, China, 20001 Contact: Bo Zhai, MD    +86-021-68383134    zhaiboshi@sina.com    Principal Investigator: Bo Zhai, MD          Sub-Investigator: Donghua Shi, MD Less <<
NCT00244010 Anemia, Aplastic ... More >> Amegakaryocytic Thrombocytopenia Diamond-Blackfan Anemia Kostmann Syndrome Less << Not Applicable Completed - United States, Tennessee ... More >> St. Jude Children's Research Hospital Memphis, Tennessee, United States, 38105 Less <<
NCT00244010 - Completed - -
NCT02535364 - Terminated(Safety reasons) - -
NCT00890500 Hematologic Malignancies ... More >> Allogeneic Stem Cell Transplantation Less << Phase 1 Completed - United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 Less <<
NCT01597778 Acute Lymphocytic Leukemia ... More >> Acute Myelogenous Leukemia Burkitt's Lymphoma Follicular Lymphoma Hodgkin Lymphoma Mantle Cell Lymphoma Non-Hodgkin Lymphoma Less << Phase 3 Active, not recruiting June 2020 -
NCT03441100 Solid Tumor, Adult ... More >> Cancer Hepatocellular Carcinoma Hepatocellular Cancer Nonsmall Cell Lung Cancer Liver Cancer Lung Cancer Less << Phase 1 Recruiting June 2033 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Less <<
NCT03540303 Relapsed Non Hodgkin Lymphoma Phase 1 Recruiting April 30, 2020 China, Henan ... More >> Henan Cancer Hospital Recruiting Zhengzhou, Henan, China, 450000 Contact: Quanli Gao, M.D    +86-15038171966    gaoquanli2015@126.com    Contact: Lu Han, M.D    +86-13838583031    luhan0377@163.com Less <<
NCT00966810 Philadelphia Chromosome-positi... More >>ve Chronic Myelocytic Leukemia Less << Phase 2 Phase 3 Unknown January 2011 Israel ... More >> Rambam Health Care Campus Haifa, Israel, 31096 Less <<
NCT02706392 Estrogen Receptor Negative ... More >> HER2/Neu Negative Progesterone Receptor Negative Recurrent Adult Acute Lymphoblastic Leukemia Recurrent Mantle Cell Lymphoma Refractory Chronic Lymphocytic Leukemia Stage IV Breast Cancer AJCC v6 and v7 Stage IV Non-Small Cell Lung Cancer AJCC v7 Triple-Negative Breast Carcinoma Less << Phase 1 Recruiting - United States, Washington ... More >> Fred Hutch/University of Washington Cancer Consortium Recruiting Seattle, Washington, United States, 98109 Contact: Immunotherapy Trials Intake, SCCA    206-606-4668    immunotherapy@seattlecca.org    Principal Investigator: David G. Maloney Less <<
NCT03259516 Myelodysplastic Syndromes Phase 1 Phase 2 Recruiting December 25, 2021 Russian Federation ... More >> First Pavlov State Medical University of St. Petersburg Recruiting Saint-Petersburg, Russian Federation, 197089 Contact: Ivan S. Moiseev, MD, PhD    +79217961951    moisiv@mail.ru    Contact: Elena V Morozova, MD, PhD    +79119278229    dr_morozova@mail.ru    Principal Investigator: Boris V Afanasyev, MD, Prof          Sub-Investigator: Elena V Morozova, MD, PhD          Sub-Investigator: Yulia V Rudnizkaya, MD, PhD          Sub-Investigator: Ivan S Moiseev, MD, PhD          Sub-Investigator: Nikolai Yu Tcvetkov, MD Less <<
NCT03270748 Myeloid Malignancies Phase 2 Not yet recruiting January 1, 2021 Italy ... More >> Ospedale San Orsola Bologna, Italy AOU-IRCCS San Martino-IST Genova, Italy A.O.U. Citta della Salute e della Scienza Not yet recruiting Torino, Italy Principal Investigator: Benedetto Bruno Less <<
NCT01804634 Refractory and/or Relapsed Met... More >>astatic Solid Tumors Less << Phase 2 Recruiting December 2020 United States, Maryland ... More >> The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Recruiting Baltimore, Maryland, United States, 21231 Contact: Heather Symons, MD, MHS    410-502-4997    hsymons2@jhmi.edu    Principal Investigator: Heather Symons, MD, MHS Less <<
NCT03664661 Relapsed/Refractory Myeloma Phase 1 Recruiting April 30, 2020 China, Henan ... More >> Cancer Hospital Affiliate to Zhengzhou University & Henan Cancer Hospital Recruiting Zhengzhou, Henan, China, 450000 Contact: Yongping Song    +86-13521186987    ph200811@163.com    Principal Investigator: Yongping Song Less <<
NCT03686124 Refractory Cancer ... More >> Recurrent Cancer Solid Tumor, Adult Cancer Less << Phase 1 Not yet recruiting January 2035 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Not yet recruiting Houston, Texas, United States, 77030 Contact: Apostolia Tsimberidou, M.D., Ph.D. Less <<
NCT03539406 Recurrent Ovarian Carcinoma ... More >> Recurrent Fallopian Tube Carcinoma Recurrent Primary Peritoneal Carcinoma Less << Phase 1 Not yet recruiting May 2020 -
NCT03355859 Non Hodgkin Lymphoma Phase 1 Recruiting March 2022 China, Shanghai ... More >> Ruijin hospital Recruiting Shanghai, Shanghai, China, 200025 Contact: Weili ZHAO, MD, PhD    86-21-64370045 ext 610707    zhao.weili@yahoo.com    Contact: Shu CHENG, MD, PhD    86-21-64370045 ext 665251    orenge@medmail.com.cn    Principal Investigator: Weili ZHAO, MD, PhD          Sub-Investigator: Shu CHENG, MD, PhD Less <<
NCT03344367 Non Hodgkin Lymphoma Phase 1 Recruiting March 2022 China ... More >> Beijing Cancer Hospital Recruiting Beijing, China, 100142 Contact: Jun Zhu, MD    +86-10-88196596    zj@bjcancer.org    Contact: Zhitao Ying, MD    +86-10-88196109    yingzhitao001@163.com    Principal Investigator: Jun Zhu, MD          Sub-Investigator: Zhitao Ying, MD Less <<
NCT03081780 Refractory Acute Myelogenous L... More >>eukemia Relapsed Acute Myelogenous Leukemia Less << Phase 1 Recruiting January 1, 2021 United States, Minnesota ... More >> University of Minnesota, Masonic Cancer Center Recruiting Minneapolis, Minnesota, United States, 55455 Contact: Timothy Krepski, RN    612-273-2800    tkrepsk1@fairview.org    Principal Investigator: Sarah Cooley, MD Less <<
NCT03393936 Renal Cell Carcinoma Phase 1 Phase 2 Recruiting March 30, 2035 China, Shanghai ... More >> Shanghai Public Health Clinical Center Recruiting Shanghai, Shanghai, China, 200000 Contact: Tongyu Zhu    13816002121    tyzhu@fudan.edu.cn    Contact: Hongliang Zong    +8613817903385    zonghl@PerHum.com    Principal Investigator: Tongyu Zhu Less <<
NCT03068819 Acute Myeloid Leukemia in Chil... More >>dren Less << Phase 1 Recruiting November 30, 2024 United States, Missouri ... More >> Washington University School of Medicine Recruiting Saint Louis, Missouri, United States, 63110 Contact: Amanda Cashen, M.D.    314-454-8323    acashen@wustl.edu    Principal Investigator: Amanda Cashen, M.D.          Sub-Investigator: Jeffrey Bednarski, M.D., Ph.D.          Sub-Investigator: Todd Fehniger, M.D., Ph.D.          Sub-Investigator: Shalini Shenoy, M.D.          Sub-Investigator: Robert Hayashi, M.D.          Sub-Investigator: Andrew Cluster, M.D.          Sub-Investigator: John DiPersio, M.D., Ph.D.          Sub-Investigator: Peter Westervelt, M.D., Ph.D.          Sub-Investigator: Geoffrey Uy, M.D.          Sub-Investigator: Ravi Vij, M.D.          Sub-Investigator: Camille Abboud, M.D.          Sub-Investigator: Rizwan Romee, M.D.          Sub-Investigator: Meagan Jacoby, M.D., Ph.D.          Sub-Investigator: Iskra Pusic, M.D.          Sub-Investigator: Armin Ghobadi, M.D.          Sub-Investigator: Mark Schroeder, M.D.          Sub-Investigator: Keith Stockerl-Goldstein, M.D. Less <<
NCT02360111 Leukemia Myel... More >>odysplastic Syndrome Non-Hodgkin's Lymphoma Less << Not Applicable Terminated(Lack of accrual) - United States, New York ... More >> Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 Less <<
NCT02582775 Epidermolysis Bullosa Phase 2 Recruiting September 2022 United States, Minnesota ... More >> University of Minnesota Masonic Cancer Center and Medical Center Recruiting Minneapolis, Minnesota, United States, 55455 Contact: Kim Nelson, RN    612-273-2925    knelso62@fairview.org    Principal Investigator: Jakub Tolar, MD, PhD Less <<
NCT02842138 B-cell Lymphoma Phase 1 Recruiting June 2019 China ... More >> Peking University Cancer Hospital Recruiting Beijing, China, 100142 Contact: Jun Zhu, MD    +86-10-88196596    zj@bjcancer.org Less <<
NCT02360111 - Terminated(Lack of accrual) - -
NCT00578942 Lymphoma Myel... More >>oma Leukemia Myelodysplasia Solid Tumors Less << Phase 2 Completed - United States, North Carolina ... More >> Duke University Health Systems Durham, North Carolina, United States, 27710 Less <<
NCT00318110 Metastatic Renal Cell Carcinom... More >>a Less << Phase 2 Terminated(Unable to meet subj... More >>ect enrollment goal.) Less << - United States, California ... More >> University of California - Los Angeles Los Angeles, California, United States, 90095 United States, Florida Shands - University of Florida Gainesville, Florida, United States, 32610 United States, Minnesota University of Minnesota Minneapolis, Minnesota, United States, 55455 United States, Pennsylvania University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104 United States, Texas M.D. Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00578942 - Completed - -
NCT03298828 Acute Lymphoblastic Leukemia ... More >> Burkitt Lymphoma Less << Phase 1 Not yet recruiting October 2022 -
NCT01349101 Hematological Malignancies Phase 2 Recruiting February 2020 United States, Pennsylvania ... More >> Thomas Jefferson University Recruiting Philadelphia, Pennsylvania, United States, 19107 Contact: John L Wagner, MD    215-955-8874       Contact: Donna Zuccarello    215-955-6612       Principal Investigator: John L Wagner, MD          Sub-Investigator: Neal Flomenberg, MD          Sub-Investigator: Seyfettin Onder Alpdogan, MD          Sub-Investigator: Matthew Carabasi, MD          Sub-Investigator: Beth Colombe, PhD          Sub-Investigator: Joanne Filicko-O'Hara, MD          Sub-Investigator: Dolores Grosso, DNP, CRNP          Sub-Investigator: Margaret Kasner, MD          Sub-Investigator: Lisa Kearns, CRNP          Sub-Investigator: William O'Hara, PharmD          Sub-Investigator: Mark Weiss, MD          Sub-Investigator: Maria Werner-Wasik, MD          Sub-Investigator: Ubaldo Martinez-Outschoorn, MD          Sub-Investigator: Manish Sharma, MD          Sub-Investigator: Thomas Klumpp, MD          Sub-Investigator: Sameh Gaballa, MD Less <<
NCT02996773 Acute Lymphoblastic Leukemia ... More >> Acute Myelogenous Leukemia Myelodysplastic Syndromes Chronic Myelogenous Leukemia Juvenile Myelomonocytic Leukemia Lymphoma,Non-Hodgkin Lymphoma, Hodgkin Lymphoma, Follicular Marginal Zone Lymphoma Large Cell Lymphoma Mantle-Cell Lymphoma Gray Zone Lymphoma Burkitt Lymphoma Less << Phase 1 Phase 2 Recruiting April 2022 United States, Arizona ... More >> The University of Arizona Cancer Center Recruiting Tucson, Arizona, United States, 85724 Contact: Olga Ambriz    (520) 694-4767    oambriz@email.arizona.edu    Principal Investigator: Emmanuel Katsanis, MD          Sub-Investigator: Faiz Anwer, MD          Sub-Investigator: Daniel Persky, MD          Sub-Investigator: Soham Puvvada, MD          Sub-Investigator: Ali McBride, PharmD, MS, BCPS          Sub-Investigator: Denise J. Roe, DrPH          Sub-Investigator: Murali Kodali, MD          Sub-Investigator: Lisa Kopp, DO          Sub-Investigator: Ravitharan Krishnadasan, MD          Sub-Investigator: Sandra Kurtin, NPC          Sub-Investigator: Laura McPheeters, NP          Sub-Investigator: Jana Montez, NP          Sub-Investigator: Lauren Nichols, MD          Sub-Investigator: Luz Pelayo-Katsanis, RN, PNP          Sub-Investigator: Lauren Sapp, NP          Sub-Investigator: Katherine Whitney, NP          Sub-Investigator: Andrew Yeager, MD          Sub-Investigator: Yi Zeng, MD Less <<
NCT00113828 Lymphoma Leuk... More >>emia Multiple Myeloma Myelodysplastic Syndrome Less << Phase 2 Terminated(Insufficient accrua... More >>l) Less << - United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Less <<
NCT01208896 Lymphoma, Follicular ... More >> Stem Cell Transplantation Less << Phase 2 Completed - France ... More >> University Hospital Angers Angers Cedex 01, Angers, France, 49033 Service Hématologie, Hôpital Minjoz Besançon, France, 25030 Service Hématologie, Hôpital Augustin Morvan Brest, France, 29609 University Hospital, Caen Caen, France Service Hématologie et Thérapie cellulaire, Pavillon Villemin Pasteur, CHU Clermont-Ferrand Clermont-Ferrand, France, 63000 CHU Grenoble Grenoble, France, 38043 CHRU Lille Lille, France, 59037 CHU Limoges Limoges, France, 87042 Hôpital Edouard Herriot Lyon, France, 69374 Service Hématologie Oncologie, Hôpital Lapeyronie, CHU de Montpellier Montpellier, France, 34295 CHU Nancy Nancy, France, 54511 Service Hématologie Clinique, CHU -Hôtel Dieu Nantes, France, 44093 Service Hématologie Clinique, Hôpital Archet 1 Nice, France, 06202 APHP Hôpital Necker-Enfants malades Paris, France, 75015 APHP Hôpital Saint Louis Paris, France, 75475 APHP Hôpital Pitié-Salpêtrière Paris, France, 75651 APHP Hôpital Henri-Mondor Paris, France, 94010 Service des maladies du sang - Hôpital Haut-Lévêque - avenue de magellan Pessac, France, 33600 CHU Poitiers - La Milétrie Poitiers, France, 86000 Service Hématologie Clinique, Hôpital Pontchaillou Rennes, France, 35033 Centre Henri Becquerel Rouen, France Institut de Cancérologie de la Loire Saint Etienne, France, 60008 Département d'Hématologie et d'Oncologie, Hôpital CHRU de Hautepierre Strasbourg, France, 67098 Service Hématologie, Hôpital Purpan Toulouse, France, 31059 CHRU Tours Tours, France, 37000 Institut Gustave Roussy Villejuif, France, 94805 Less <<
NCT02273856 - Terminated(The study was termi... More >>nated due to insufficient subject enrollment and very slow enrollment.) Less << - Jordan ... More >> Site JO96201 King Abdullah University Hospital Irbid, Jordan, 22110 Kuwait Site KW96501 Kuwait Cancer Control Center Shuwaikh, Kuwait, 70653 Lebanon Site Hammoud Hospital University Medical Center Beirut, Lebanon, 1600 Site Hotel Dieu De France Beirut, Lebanon, 166830 Oman Site OM96801 Sultan Qaboos University Hospital Muscat, Oman, 123 Qatar Site Hamad Medical Coorporation, National Center for Cancer Care and Research, Al Amal Hospital Doha, Qatar, 3050 Saudi Arabia Site SA96601 Aseer Central Hospital Abha, Aseer, Saudi Arabia, 61421 United Arab Emirates Site AE97101 Sheikh Khalifa Medical City Abu Dhabi, United Arab Emirates, 51900 Less <<
NCT02504047 Hematologic Neoplasms Not Applicable Recruiting July 2019 Canada, Alberta ... More >> Foothills Medical Center / Tom Baker Cancer Center Recruiting Calgary, Alberta, Canada, T2N 4N2 Contact: Andrew Daly, MD    4035213706    andrew.daly@albertahealthservices.ca    Contact: Mamta Kantharia       mamta.kantharia@albertahealthservices.ca    Principal Investigator: Andrew Daly, MD          Canada, Manitoba Health Sciences Center Recruiting Winnipeg, Manitoba, Canada, R3A 1R9 Contact: Kristjan Paulson, MD       kpaulson@cancercare.mb.ca    Principal Investigator: Kristjan Paulson, MD          Sub-Investigator: Donna Wall, MD          Sub-Investigator: David Szwajcer, MD          Canada, Ontario Ottawa General Hospital Not yet recruiting Ottawa, Ontario, Canada, K1H 8L6 Contact: Christopher Bredeson, MD       cbredeson@toh.on.ca    Principal Investigator: Christopher Bredeson, MD          Canada, Quebec McGill University Health Centre Not yet recruiting Montreal, Quebec, Canada, H4A 3J1 Contact: Gizelle Popradi, MD       gizelle.popradi@mcgill.ca    Principal Investigator: Gizelle Popradi, MD          Canada, Saskatchewan Royal University Hospital Not yet recruiting Saskatoon, Saskatchewan, Canada, S7N 0W8 Contact: Mark Bosch, MD       Mark.Bosch@saskcancer.ca    Principal Investigator: Mark Bosch Less <<
NCT02386332 - Not yet recruiting March 2020 -
NCT03467516 Uveal Neoplasms ... More >> Melanoma, Uveal Less << Phase 2 Recruiting August 1, 2021 United States, Pennsylvania ... More >> UPMC Hillman Cancer Center Recruiting Pittsburgh, Pennsylvania, United States, 15232 Contact: Krystle L Eaton, BSN    412-623-7957    mientkiewiczk@upmc.edu Less <<
NCT03047811 Advanced Malignant Solid Tumor... More >>s Less << Not Applicable Recruiting December 31, 2017 China, Shanghai ... More >> Cancer hospital Fudan University Recruiting Shanghai, Shanghai, China, 200032 Contact: Wu X hua, doctor    13482888167    xhwu2011@yahoo.com Less <<
NCT00084695 Childhood Langerhans Cell Hist... More >>iocytosis Fanconi Anemia Leukemia Lymphoma Myelodysplastic Syndromes Neuroblastoma Sarcoma Unspecified Childhood Solid Tumor, Protocol Specific Less << Phase 2 Unknown - United States, Pennsylvania ... More >> Penn State Hershey Cancer Institute at Milton S. Hershey Medical Center Recruiting Hershey, Pennsylvania, United States, 17033-0850 Contact: Kenneth G. Lucas, MD    717-531-6012    klucas@psu.edu Less <<
NCT00807196 Non-Hodgkins Lymphoma Phase 1 Phase 2 Unknown December 2012 Canada, Quebec ... More >> Hopital Maisonneuve-Rosemont Recruiting Montreal, Quebec, Canada, H2V 1W7 Contact: Thomas Kiss, MD    (514)252-3404    thomas.kiss@umontreal.ca    Contact: Dominique Beaupré, BSc nursing    (514)252-3400 ext 5605    dbeaupré.hmr@ssss.gouv.qc.ca    Principal Investigator: Thomas Kiss, M.D. Less <<
NCT03590574 T Cell Non-Hodgkin Lymphoma ... More >> Peripheral T-Cell Lymphoma, Not Otherwise Specified Angioimmunoblastic T-cell Lymphoma Anaplastic Large Cell Lymphoma Less << Phase 1 Phase 2 Recruiting December 2022 United Kingdom ... More >> University College London Hospitals NHS Foundation Trust Recruiting London, United Kingdom Contact: Dr Kate Cwynarski          The Christie NHS Foundation Trust Not yet recruiting Manchester, United Kingdom Contact: Professor John Radford          Freeman Hospital, The Newcastle upon Tyne Hospitals NHS Foundation Trust Not yet recruiting Newcastle Upon Tyne, United Kingdom Contact: Dr Tobias Menne Less <<
NCT03373071 CD19-ALL CD19... More >>-LNH Less << Phase 1 Phase 2 Recruiting December 2027 Italy ... More >> Ospedale Pediatrico Bambino Gesù Recruiting Roma, Italy Contact: Franco Locatelli, MD, PhD    066859 ext 2678    franco.locatelli@opbg.net    Principal Investigator: Franco Locatelli, MD, PhD Less <<
NCT02706405 BCL2 Gene Rearrangement ... More >> BCL6 Gene Rearrangement CD19 Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified High-Grade B-Cell Lymphoma With MYC, BCL2, and BCL6 Rearrangements MYC Gene Rearrangement Recurrent Diffuse Large B-Cell Lymphoma Recurrent Mediastinal (Thymic) Large B-Cell Cell Lymphoma Refractory Diffuse Large B-Cell Lymphoma Refractory Mediastinal (Thymic) Large B-Cell Cell Lymphoma Less << Phase 1 Recruiting December 1, 2033 United States, Washington ... More >> Fred Hutch/University of Washington Cancer Consortium Recruiting Seattle, Washington, United States, 98109 Contact: Immunotherapy Trials Intake, SCCA    206-606-4668    immunotherapy@seattlecca.org    Principal Investigator: Cameron J. Turtle Less <<
NCT03287804 Multiple Myeloma Phase 1 Phase 2 Recruiting October 2020 Netherlands ... More >> VU University Medical Centre Amsterdam Recruiting Amsterdam, Netherlands Principal Investigator: Professor Sonja Zweegman          United Kingdom University College London Hospitals NHS Foundation Trust Recruiting London, United Kingdom Principal Investigator: Dr Rakesh Popat          The Christie NHS Foundation Trust Recruiting Manchester, United Kingdom, M20 4BX Principal Investigator: Dr James Cavet          Freeman Hospital, The Newcastle upon Tyne Hospitals NHS Foundation Trust Recruiting Newcastle upon Tyne, United Kingdom Principal Investigator: Dr Tobias Menne Less <<
NCT03672851 Acute Leukemia ... More >> Acute Leukemia in Relapse Acute Myeloid Leukemia Relapsed or Refractory Acute Leukemia Less << Phase 1 Recruiting December 31, 2020 China, Shaanxi ... More >> Second Affiliated Hospital of Xi'an Jiaotong University Recruiting Xi'an, Shaanxi, China, 710000 Contact: Aili He, MD, PhD    86-29-87679459    heaili@mail.xjtu.edu.cn    Contact: Jian-Li Wang, MD, PhD    86-29-87679457    wangjianli73@sina.cn    Principal Investigator: Aili He, MD, PhD Less <<
NCT02665065 Acute Myeloid Leukemia ... More >> Leukemia, Acute Myeloid Myeloid Leukemia, Acute Leukemia, Myeloid, Acute Acute Myelogenous Leukemia Leukemia, Acute Myelogenous Myelogenous Leukemia, Acute Less << Phase 3 Recruiting June 2020 United States, Arizona ... More >> Banner MD Anderson Cancer Center Recruiting Gilbert, Arizona, United States United States, Connecticut Yale Cancer Center Recruiting New Haven, Connecticut, United States United States, Florida Mayo Clinic Recruiting Jacksonville, Florida, United States United States, Illinois Loyola University Medical Center Recruiting Maywood, Illinois, United States United States, Kansas The University of Kansas Cancer Center Recruiting Westwood, Kansas, United States United States, Minnesota Mayo Clinic Recruiting Rochester, Minnesota, United States United States, Missouri Washington University School of Medicine Recruiting Saint Louis, Missouri, United States United States, Nebraska University of Nebraska Medical Center Recruiting Omaha, Nebraska, United States United States, New York Roswell Park Cancer Institute Recruiting Buffalo, New York, United States Memorial Sloan Kettering Cancer Center Recruiting New York, New York, United States Stony Brook University Recruiting Stony Brook, New York, United States United States, Ohio University Hospital of Cleveland Seidman Cancer Center Recruiting Cleveland, Ohio, United States The Ohio State University Comprehensive Cancer Center Recruiting Columbus, Ohio, United States United States, Texas Baylor Charles A. Sammons Cancer Center Recruiting Dallas, Texas, United States MD Anderson Cancer Center Recruiting Houston, Texas, United States United States, Washington Fred Hutchinson Cancer Research Center Recruiting Seattle, Washington, United States United States, Wisconsin Medical College of Wisconsin Recruiting Milwaukee, Wisconsin, United States Canada, Ontario University of Ottawa Recruiting Ottawa, Ontario, Canada Less <<
NCT02199301 End Stage Renal Disease Not Applicable Unknown December 2017 Korea, Republic of ... More >> Samsung Medical Center, Organ Transplant Center Recruiting Seoul, Korea, Republic of, 135-710 Contact: Sung Joo Kim, MD, PhD    82-2-3410-3476    kmhyj.kim@samsung.com    Contact: Jae Berm Park, MD, PhD    82-2-3410-3647    jbparkmd@gmail.com    Principal Investigator: Sung Joo Kim, MD, PhD          Sub-Investigator: Jae Berm Park, MD, PhD Less <<
NCT00275678 Blood Stem Cell Transplant Phase 3 Completed - United States, Minnesota ... More >> Mayo Clinic Rochester, Minnesota, United States, 55905 Less <<
NCT01067300 Leukemia Phase 3 Unknown January 2016 France ... More >> Assistance Publique - Hôpitaux de Marseille Marseille, France Less <<
NCT01461837 Sickle Cell Disease Phase 2 Recruiting April 2019 United States, California ... More >> University of California Los Angeles (UCLA) Recruiting Los Angeles, California, United States, 90095 Contact: Theodore Moore, MD    310-825-6708    tbmoore@mednet.ucla.edu    Contact: LaMarr Taylor, CCRP    310-794-8929    LaMarrTaylor@mednet.ucla.edu    Principal Investigator: Theodore Moore, MD          Children's Hospital and Research Center Oakland Completed Oakland, California, United States, 94609 United States, Illinois Lurie Children's Hospital Completed Chicago, Illinois, United States, 60611-2605 United States, Missouri Washington University/St. Louis Children's Hospital Recruiting Saint Louis, Missouri, United States, 63110 Contact: Shalini Shenoy, MD    314-454-6018    Shenoy@kids.wustl.edu    Contact: Megan Holtmann    314-454-6018       Principal Investigator: Shalini Shenoy, MD          United States, New York New York Medical College Recruiting Valhalla, New York, United States, 10595 Contact: Mitchell S Cairo, MD    914-594-2150    mitchell_cairo@nymc.edu    Contact: Sandi Fabricatore, RN, PNP    914-594-2152    Fabricatores@wcmc.com    Principal Investigator: Mitchell S Cairo, MD          United States, Ohio Cincinnati Children's Hospital Withdrawn Cincinnati, Ohio, United States, 45229 United States, Wisconsin Medical College of Wisconsin/Children's Hospital of Wisconsin Recruiting Milwaukee, Wisconsin, United States, 53226 Contact: Julie Talano, MD    414-955-4185    jtalano@mcw.edu    Contact: Kathy Jodarski    414-266-2681    kjodarski@chw.org    Principal Investigator: Julie Talano, MD Less <<
NCT02672501 Leukemia, B-Cell Phase 1 Phase 2 Recruiting December 2019 China, Shanghai ... More >> Shanghai Changhai Hospital，The Second Military Medical University Recruiting Shanghai, Shanghai, China, 200090 Contact: Jianmin Yang, Doctor    18317172636    yangjianmin@csco.org.cn Less <<
NCT00775931 Severe Osteopetrosis Phase 2 Phase 3 Unknown October 2015 United States, Minnesota ... More >> University of MInnesota, Fairview Minneapolis, Minnesota, United States, 55455 Less <<
NCT01218867 - Completed - -
NCT02013817 Lymphocytic Leukemia, Chronic Phase 2 Completed - Austria ... More >> Tiroler Landeskrankenanstalten Ges.M.B.H.; Innere Medizin Abt. Für Hämatologie & Onkologie Innsbruck, Austria, 6020 LKH Hochsteiermark; Abt. für Innere Medizin Leoben, Austria, 8700 Kh Der Barmherzigen Schwestern; Interne I X Linz, Austria, 4010 A.Ö. Krankenhaus Der Elisabethinen Linz; I. Interne Abt. Linz, Austria, 4020 Kepler Universitätskliniken GmbH - Med Campus III; I. Medizinische Abteilung Linz, Austria, 4020 Landeskrankenhaus Rankweil; Interne E Rankweil, Austria, 6830 Lkh Salzburg - Univ. Klinikum Salzburg; Iii. Medizinische Abt. Salzburg, Austria, 5020 Klinikum Kreuzschwestern Wels; Iii. Interne Abt. Wels, Austria, 4600 Less <<
NCT01218867 Metastatic Cancer ... More >> Metastatic Melanoma Renal Cancer Less << Phase 1 Phase 2 Completed - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT02199041 Hematological Malignancies Phase 2 Terminated(The study was halte... More >>d early due to slow accrual.) Less << - United States, Tennessee ... More >> St. Jude Children's Research Hospital Memphis, Tennessee, United States, 38105 Less <<
NCT02013817 - Completed - -
NCT00255710 Chronic Myeloproliferative Dis... More >>orders Graft Versus Host Disease Leukemia Lymphoma Multiple Myeloma and Plasma Cell Neoplasm Myelodysplastic Syndromes Myelodysplastic/Myeloproliferative Diseases Less << Phase 1 Completed - United States, Maryland ... More >> Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States, 21231-2410 Less <<
NCT00078858 Accelerated Phase Chronic Myel... More >>ogenous Leukemia Adult Acute Lymphoblastic Leukemia in Remission Adult Acute Myeloid Leukemia in Remission Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities Adult Acute Myeloid Leukemia With Del(5q) Adult Acute Myeloid Leukemia With Inv(16)(p13;q22) Adult Acute Myeloid Leukemia With t(15;17)(q22;q12) Adult Acute Myeloid Leukemia With t(16;16)(p13;q22) Adult Acute Myeloid Leukemia With t(8;21)(q22;q22) Adult Grade III Lymphomatoid Granulomatosis Adult Nasal Type Extranodal NK/T-cell Lymphoma Anaplastic Large Cell Lymphoma Angioimmunoblastic T-cell Lymphoma Childhood Acute Lymphoblastic Leukemia in Remission Childhood Acute Myeloid Leukemia in Remission Childhood Burkitt Lymphoma Childhood Chronic Myelogenous Leukemia Childhood Diffuse Large Cell Lymphoma Childhood Grade III Lymphomatoid Granulomatosis Childhood Immunoblastic Large Cell Lymphoma Childhood Myelodysplastic Syndromes Childhood Nasal Type Extranodal NK/T-cell Lymphoma Childhood Renal Cell Carcinoma Chronic Myelomonocytic Leukemia Chronic Phase Chronic Myelogenous Leukemia Clear Cell Renal Cell Carcinoma Contiguous Stage II Adult Burkitt Lymphoma Contiguous Stage II Adult Diffuse Large Cell Lymphoma Contiguous Stage II Adult Diffuse Mixed Cell Lymphoma Contiguous Stage II Adult Immunoblastic Large Cell Lymphoma Contiguous Stage II Adult Lymphoblastic Lymphoma Contiguous Stage II Grade 3 Follicular Lymphoma Contiguous Stage II Mantle Cell Lymphoma de Novo Myelodysplastic Syndromes Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue Hepatosplenic T-cell Lymphoma Juvenile Myelomonocytic Leukemia Myelodysplastic/Myeloproliferative Neoplasm, Unclassifiable Nodal Marginal Zone B-cell Lymphoma Noncontiguous Stage II Adult Burkitt Lymphoma Noncontiguous Stage II Adult Diffuse Large Cell Lymphoma Noncontiguous Stage II Adult Diffuse Mixed Cell Lymphoma Noncontiguous Stage II Adult Immunoblastic Large Cell Lymphoma Noncontiguous Stage II Adult Lymphoblastic Lymphoma Noncontiguous Stage II Grade 3 Follicular Lymphoma Noncontiguous Stage II Mantle Cell Lymphoma Noncutaneous Extranodal Lymphoma Peripheral T-cell Lymphoma Post-transplant Lymphoproliferative Disorder Previously Treated Myelodysplastic Syndromes Recurrent Adult Acute Lymphoblastic Leukemia Recurrent Adult Acute Myeloid Leukemia Recurrent Adult Burkitt Lymphoma Recurrent Adult Diffuse Large Cell Lymphoma Recurrent Adult Diffuse Mixed Cell Lymphoma Recurrent Adult Diffuse Small Cleaved Cell Lymphoma Recurrent Adult Grade III Lymphomatoid Granulomatosis Recurrent Adult Hodgkin Lymphoma Recurrent Adult Immunoblastic Large Cell Lymphoma Recurrent Adult Lymphoblastic Lymphoma Recurrent Adult T-cell Leukemia/Lymphoma Recurrent Childhood Acute Lymphoblastic Leukemia Recurrent Childhood Acute Myeloid Leukemia Recurrent Childhood Anaplastic Large Cell Lymphoma Recurrent Childhood Grade III Lymphomatoid Granulomatosis Recurrent Childhood Large Cell Lymphoma Recurrent Childhood Lymphoblastic Lymphoma Recurrent Childhood Small Noncleaved Cell Lymphoma Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma Recurrent Grade 1 Follicular Lymphoma Recurrent Grade 2 Follicular Lymphoma Recurrent Grade 3 Follicular Lymphoma Recurrent Mantle Cell Lymphoma Recurrent Marginal Zone Lymphoma Recurrent Mycosis Fungoides/Sezary Syndrome Recurrent Renal Cell Cancer Recurrent Small Lymphocytic Lymphoma Recurrent/Refractory Childhood Hodgkin Lymphoma Refractory Anemia Refractory Anemia With Ringed Sideroblasts Refractory Chronic Lymphocytic Leukemia Refractory Hairy Cell Leukemia Refractory Multiple Myeloma Relapsing Chronic Myelogenous Leukemia Splenic Marginal Zone Lymphoma Stage I Adult Burkitt Lymphoma Stage I Adult Diffuse Large Cell Lymphoma Stage I Adult Diffuse Mixed Cell Lymphoma Stage I Adult Immunoblastic Large Cell Lymphoma Stage I Adult Lymphoblastic Lymphoma Stage I Adult T-cell Leukemia/Lymphoma Stage I Childhood Anaplastic Large Cell Lymphoma Stage I Childhood Large Cell Lymphoma Stage I Childhood Lymphoblastic Lymphoma Stage I Childhood Small Noncleaved Cell Lymphoma Stage I Grade 3 Follicular Lymphoma Stage I Mantle Cell Lymphoma Stage II Adult T-cell Leukemia/Lymphoma Stage II Childhood Anaplastic Large Cell Lymphoma Stage II Childhood Large Cell Lymphoma Stage II Childhood Lymphoblastic Lymphoma Stage II Childhood Small Noncleaved Cell Lymphoma Stage III Adult Burkitt Lymphoma Stage III Adult Diffuse Large Cell Lymphoma Stage III Adult Diffuse Mixed Cell Lymphoma Stage III Adult Immunoblastic Large Cell Lymphoma Stage III Adult Lymphoblastic Lymphoma Stage III Adult T-cell Leukemia/Lymphoma Stage III Childhood Anaplastic Large Cell Lymphoma Stage III Childhood Large Cell Lymphoma Stage III Childhood Lymphoblastic Lymphoma Stage III Childhood Small Noncleaved Cell Lymphoma Stage III Grade 3 Follicular Lymphoma Stage III Mantle Cell Lymphoma Stage IV Adult Burkitt Lymphoma Stage IV Adult Diffuse Large Cell Lymphoma Stage IV Adult Diffuse Mixed Cell Lymphoma Stage IV Adult Immunoblastic Large Cell Lymphoma Stage IV Adult Lymphoblastic Lymphoma Stage IV Adult T-cell Leukemia/Lymphoma Stage IV Childhood Anaplastic Large Cell Lymphoma Stage IV Childhood Large Cell Lymphoma Stage IV Childhood Lymphoblastic Lymphoma Stage IV Childhood Small Noncleaved Cell Lymphoma Stage IV Grade 3 Follicular Lymphoma Stage IV Mantle Cell Lymphoma Stage IV Renal Cell Cancer T-cell Large Granular Lymphocyte Leukemia Type 1 Papillary Renal Cell Carcinoma Type 2 Papillary Renal Cell Carcinoma Untreated Adult Acute Lymphoblastic Leukemia Untreated Adult Acute Myeloid Leukemia Untreated Childhood Acute Lymphoblastic Leukemia Untreated Childhood Acute Myeloid Leukemia and Other Myeloid Malignancies Waldenstr?m Macroglobulinemia Less << Phase 1 Phase 2 Active, not recruiting - United States, California ... More >> Stanford University Hospitals and Clinics Stanford, California, United States, 94305 United States, Colorado Rocky Mountain Cancer Centers-Midtown Denver, Colorado, United States, 80218 United States, Georgia Emory University/Winship Cancer Institute Atlanta, Georgia, United States, 30322 United States, Oregon OHSU Knight Cancer Institute Portland, Oregon, United States, 97239 United States, Utah Huntsman Cancer Institute/University of Utah Salt Lake City, Utah, United States, 84112 United States, Washington Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 United States, Wisconsin Froedtert Memorial Lutheran Hospital, Medical College of Wisconsin Milwaukee, Wisconsin, United States, 53226 Germany Universitaet Leipzig Leipzig, Germany, D-04103 University of Tuebingen-Germany Tuebingen, Germany, D-72076 Italy University of Torino Torino, Italy, 10126 Less <<
NCT03767725 Multiple Myeloma in Relapse Phase 1 Recruiting September 1, 2021 China, Guangdong ... More >> Shenzhen Second People's Hospital,The first affiliated hospital of Shenzhen University Recruiting Shenzhen, Guangdong, China, 518035 Contact: Weihong Chen    86-755-83366388 ext 8199    whitney-cindy@hotmail.com    Contact: Xin Du    86-755-83366388 ext 8197    duxingz@medmail.com.cn Less <<
NCT02199041 - Terminated(The study was halte... More >>d early due to slow accrual.) Less << - -
NCT00670748 - Terminated(A more highly selec... More >>ted protocol with ESO TCR opened for pts with melanoma) Less << - -
NCT02395822 Acute Myelogenous Leukemia Phase 2 Completed - United States, Minnesota ... More >> Masonic Cancer Center at University of Minnesota Minneapolis, Minnesota, United States, 55455 Less <<
NCT00670748 Metastatic Melanoma ... More >> Metastatic Renal Cell Cancer Metastatic Cancer Less << Phase 2 Terminated(A more highly selec... More >>ted protocol with ESO TCR opened for pts with melanoma) Less << - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT01231412 - Completed - -
NCT01385423 Acute Myelogenous Leukemia ... More >> Myelodysplastic Syndrome Less << Phase 1 Completed - United States, Minnesota ... More >> Masonic Cancer Center, University of Minnesota Minneapolis, Minnesota, United States, 55455 Less <<
NCT03531736 Myeloid Diseases Phase 1 Recruiting May 2020 United States, New York ... More >> Memorial Sloan Kettering Cancer Center Recruiting New York, New York, United States, 10065 Contact: Roni Tamari, MD    212-639-5987       Contact: Miguel-Angel Perales, MD    212-639-8682       Principal Investigator: Roni Tamari, MD Less <<
NCT02395822 - Completed - -
NCT01231412 Acute Lymphoblastic Leukemia ... More >> Acute Myeloid Leukemia Aggressive Non-Hodgkin Lymphoma Chronic Lymphocytic Leukemia Diffuse Large B-Cell Lymphoma Hematopoietic and Lymphoid Cell Neoplasm Indolent Non-Hodgkin Lymphoma Mantle Cell Lymphoma Myelodysplastic Syndrome Myeloproliferative Neoplasm Prolymphocytic Leukemia Recurrent Chronic Lymphocytic Leukemia Recurrent Plasma Cell Myeloma Refractory Chronic Lymphocytic Leukemia Refractory Chronic Myelogenous Leukemia, BCR-ABL1 Positive Refractory Hodgkin Lymphoma Small Lymphocytic Lymphoma T-Cell Chronic Lymphocytic Leukemia Waldenstrom Macroglobulinemia Less << Phase 3 Completed - United States, Colorado ... More >> University of Colorado Denver, Colorado, United States, 80217-3364 Presbyterian - Saint Lukes Medical Center - Health One Denver, Colorado, United States, 80218 United States, Georgia Emory University/Winship Cancer Institute Atlanta, Georgia, United States, 30322 United States, Utah Huntsman Cancer Institute/University of Utah Salt Lake City, Utah, United States, 84112 United States, Washington VA Puget Sound Health Care System Seattle, Washington, United States, 98101 Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 Denmark Aarhus University Hospital Arhus, Denmark, 8200 Rigshospitalet University Hospital Copenhagen, Denmark, 2100 Germany Medizinische Univ Klinik Koln Koln, Germany, 50924 Universitaet Leipzig Leipzig, Germany, D-04103 University of Tuebingen-Germany Tuebingen, Germany, D-72076 Less <<
NCT03593902 Systemic Sclerosis ... More >> Scleroderma Less << Phase 2 Phase 3 Recruiting January 2026 United States, Illinois ... More >> Northwestern University, Feinberg School of Medicine Recruiting Chicago, Illinois, United States, 60611 Contact: Kathleen Quigley    312-695-4960    k-quigley@northwestern.edu    Principal Investigator: Richard Burt, MD          Northwestern University Recruiting Chicago, Illinois, United States, 60611 Contact: Kathleen Quigley, RN    312-695-8192    kathleen.quigley@nm.org    Principal Investigator: Richard Burt, MD Less <<
NCT01898793 Leukemia, Myeloid, Acute Phase 1 Phase 2 Recruiting December 31, 2020 United States, Missouri ... More >> Washington University School of Medicine Recruiting Saint Louis, Missouri, United States, 63110 Contact: Amanda Cashen, M.D.    314-434-8323    acashen@wustl.edu    Principal Investigator: Amanda Cashen, M.D.          Sub-Investigator: Camille Abboud, M.D.          Sub-Investigator: Todd Fehniger, M.D., Ph.D.          Sub-Investigator: John DiPersio, M.D., Ph.D.          Sub-Investigator: Meagan Jacoby, M.D., Ph.D.          Sub-Investigator: Iskra Pusic, M.D.          Sub-Investigator: Mark Schroeder, M.D.          Sub-Investigator: Keith Stockerl-Goldstein, M.D.          Sub-Investigator: Geoffrey Uy, M.D.          Sub-Investigator: Ravi Vij, M.D.          Sub-Investigator: Lukas Wartman, M.D.          Sub-Investigator: John Welch, M.D.,Ph.D.          Sub-Investigator: Peter Westervelt, M.D., Ph.D.          Sub-Investigator: Armin Ghobadi, M.D.          Sub-Investigator: Michael Tomasson, M.D.          Sub-Investigator: Matthew Walter, M.D.          Sub-Investigator: Tanya Wildes, M.D.          Sub-Investigator: Brad Kahl, M.D.          Sub-Investigator: Terrence Wong, M.D. Ph.D.          Sub-Investigator: Jeffery Bednarski, M.D., Ph.D.          Sub-Investigator: Shalini Shenoy, M.D.          Sub-Investigator: Robert Hayashi, M.D.          Sub-Investigator: Sima Bhatt, M.D. Less <<
NCT00691015 Chronic Myeloproliferative Dis... More >>orders Leukemia Lymphoma Multiple Myeloma and Plasma Cell Neoplasm Myelodysplastic Syndromes Myelodysplastic/Myeloproliferative Neoplasms Less << Phase 2 Completed - United States, Michigan ... More >> Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States, 48201-1379 Less <<
NCT03050216 Acute Myeloid Leukemia Phase 2 Suspended(Interim Analysis) September 2020 United States, Minnesota ... More >> Masonic Cancer Center at University of Minnesota Minneapolis, Minnesota, United States, 55455 Less <<
NCT00691015 - Completed - -
NCT00505921 Lymphoma Phase 2 Terminated(Slow Accrual.) - United States, Texas ... More >> UT MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT03610490 High Grade Ovarian Serous Aden... More >>ocarcinoma Oligometastasis Ovarian Carcinosarcoma Pancreatic Ductal Adenocarcinoma Recurrent Osteosarcoma Recurrent Ovarian Carcinoma Refractory Osteosarcoma Refractory Ovarian Carcinoma Less << Phase 2 Recruiting September 30, 2021 United States, Texas ... More >> M D Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact: Ljiljana Milojevic    713-792-8578    lmilojev@mdanderson.org    Principal Investigator: Amir A. Jazaeri Less <<
NCT02080195 - Terminated(Study was unable to... More >> accrue subjects) Less << - -
NCT02080195 Lupus Erythematosus ... More >> Graft-versus-host Disease Less << Phase 1 Phase 2 Terminated(Study was unable to... More >> accrue subjects) Less << - United States, Maryland ... More >> Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States, 21205 Less <<
NCT03597594 Severe Combined Immunodeficien... More >>cy Less << Phase 1 Phase 2 Recruiting July 1, 2028 United States, Tennessee ... More >> St. Jude Children's Research Hospital Recruiting Memphis, Tennessee, United States, 38105 Contact: Ewelina Mamcarz, MD    866-278-5833    referralinfo@stjude.org Less <<
NCT02259348 Acute Lymphoblastic Leukemia (... More >>ALL) Acute Myeloid Leukemia (AML) Myeloid Sarcoma Chronic Myelogenous Leukemia (CML) Juvenile Myelomonocytic Leukemia (JMML) Myelodysplastic Syndrome (MDS) Non-Hodgkin Lymphoma (NHL) Less << Phase 2 Terminated(Investigator's deci... More >>sion.) Less << - United States, Tennessee ... More >> St. Jude Children's Research Hospital Memphis, Tennessee, United States, 38105 Less <<
NCT00505921 - Terminated(Slow Accrual.) - -
NCT00741455 Hematologic Malignancies Not Applicable Active, not recruiting December 2023 United States, New Hampshire ... More >> Dartmouth-Hitchcock Medical Center Lebanon, New Hampshire, United States, 03756 Less <<
NCT01527045 Aggressive Non-Hodgkin Lymphom... More >>a Blasts Under 5 Percent of Bone Marrow Nucleated Cells Chronic Lymphocytic Leukemia Loss of Chromosome 17p Myelodysplastic/Myeloproliferative Neoplasm Non-Hodgkin Lymphoma Prolymphocytic Leukemia Recurrent Adult Acute Lymphoblastic Leukemia Recurrent Adult Acute Myeloid Leukemia Recurrent Aggressive Adult Non-Hodgkin Lymphoma Recurrent Childhood Acute Lymphoblastic Leukemia Recurrent Childhood Acute Myeloid Leukemia Recurrent Chronic Lymphocytic Leukemia Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive Recurrent Diffuse Large B-Cell Lymphoma Recurrent Hodgkin Lymphoma Recurrent Mantle Cell Lymphoma Recurrent Non-Hodgkin Lymphoma Recurrent Plasma Cell Myeloma Recurrent Small Lymphocytic Lymphoma Waldenstrom Macroglobulinemia Less << Phase 2 Recruiting - United States, Colorado ... More >> Presbyterian - Saint Lukes Medical Center - Health One Completed Denver, Colorado, United States, 80218 United States, Washington Fred Hutch/University of Washington Cancer Consortium Recruiting Seattle, Washington, United States, 98109 Contact: Marco Mielcarek    206-667-2827    mmielcar@fhcrc.org    Principal Investigator: Marco Mielcarek Less <<
NCT02259348 - Terminated(Investigator's deci... More >>sion.) Less << - -
NCT00924287 - Terminated(This study was term... More >>inated after the first patient treated on study died as a result of the treatment.) Less << - -
NCT01050855 Non Malignant Diseases ... More >> Immunodeficiencies Hemoglobinopathies Less << Phase 2 Recruiting December 2018 United States, Pennsylvania ... More >> The Children's Hospital of Philadelphia Recruiting Philadelphia, Pennsylvania, United States, 19104 Contact: Barbara McGlynn    215-590-1303    mcglynn@email.chop.edu    Contact: Patricia Hankins, RN    215 590-5168    hankinsp@email.chop.edu    Principal Investigator: Nancy J Bunin, MD Less <<
NCT03526185 Metastatic Melanoma Early Phase 1 Recruiting December 1, 2019 United States, Connecticut ... More >> Yale New Haven Hospital Recruiting New Haven, Connecticut, United States, 06510 Contact: Michael E Hurwitz, MD, PhD Less <<
NCT00924287 Metastatic Cancer Phase 1 Phase 2 Terminated(This study was term... More >>inated after the first patient treated on study died as a result of the treatment.) Less << - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT02888301 Malignant Neoplasm Not Applicable Recruiting June 12, 2021 United States, California ... More >> UCLA / Jonsson Comprehensive Cancer Center Recruiting Los Angeles, California, United States, 90095 Contact: Martin Allen-Auerbach    310-983-1444       Principal Investigator: Martin Allen-Auerbach Less <<
NCT02925351 Autoimmune Disease ... More >> Crohn Disease Inflammatory Disorder Rheumatoid Arthritis Systemic Lupus Erythematosus Takayasu Arteritis Less << Not Applicable Recruiting January 25, 2022 United States, California ... More >> UCLA / Jonsson Comprehensive Cancer Center Recruiting Los Angeles, California, United States, 90095 Contact: Martin Allen-Auerbach    310-983-1444       Principal Investigator: Martin Allen-Auerbach Less <<
NCT00189488 Graft Versus Host Disease ... More >> Hematologic Malignancies Less << Phase 2 Completed - -
NCT03296137 Cancer Phase 1 Phase 2 Recruiting March 13, 2020 Denmark ... More >> Center for Cancer immune Therapy (CCIT), Dept. of Hematology and dept. of Oncology Recruiting Copenhagen, Denmark, 2730 Contact: Anders H Kverneland, MD       anders.kverneland@regionh.dk Less <<
NCT00328237 Acute Myeloid Leukemia ... More >> Acute Lymphoblastic Leukemia Chronic Myeloid Leukemia Non-Hodgkin Lymphoma Myelodysplastic Syndromes Less << Phase 2 Unknown - United States, Colorado ... More >> Rocky Mountain Blood and Marrow Transplant Program Recruiting Denver, Colorado, United States, 80218 Sub-Investigator: Scott Bearman, MD          Sub-Investigator: Robert Rifkin, MD          Sub-Investigator: Mark Brunvand, MD          Sub-Investigator: Jeffrey Matous, MD          Sub-Investigator: Michael Maris, MD Less <<
NCT02765243 Neuroblastoma ... More >> Effects of Immunotherapy Less << Phase 2 Recruiting December 30, 2019 China, Guangdong ... More >> Zhujiang Hospital of Southern Medical University Recruiting Guangzhou, Guangdong, China, 510282 Contact: Wu xiaoxiao    +86-13826084545    zjllwyh@sina.com    Contact: Wang liqing, MD    +86-15918421985    wliqing2014@163.com Less <<
NCT00189488 - Completed - -
NCT00317096 Lymphoma, Follicular ... More >> Lymphoma, Low-Grade Lymphoma, Intermediate-Grade Less << Phase 3 Active, not recruiting June 2021 Germany ... More >> German Low Grade Study Group (Glsg) Munich, Germany, D-81377 Less <<
NCT00117598 Lymphoma Phase 3 Completed - -
NCT02282904 Chronic Granulomatous Disease Early Phase 1 Active, not recruiting March 1, 2023 United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT00810602 Hematologic Malignancies ... More >> Graft vs Host Disease Less << Phase 1 Phase 2 Completed - United States, Michigan ... More >> University of Michigan Cancer Center Ann Arbor, Michigan, United States, 48109 United States, Missouri Washington University School of Medicine St. Louis, Missouri, United States, 63110 Less <<
NCT00810602 - Completed - -
NCT01497002 Acute Myeloid Leukaemia Phase 3 Unknown December 2013 Germany ... More >> University of Leipzig, Hematology Recruiting Leipzig, Germany, 04103 Principal Investigator: Dietger Niederwieser Less <<
NCT00145587 Osteopetrosis Not Applicable Terminated(Due to the principa... More >>l investigator having left the institution.) Less << - United States, Tennessee ... More >> St. Jude Children's Research Hospital Memphis, Tennessee, United States, 38105 Less <<
NCT00117598 - Completed - -
NCT01238328 Mucopolysaccharidosis Phase 2 Phase 3 Unknown December 2012 Iran, Islamic Republic of ... More >> Hematology-Oncology & SCT Research Center Recruiting Teharn, Tehran, Iran, Islamic Republic of, 14114 Contact: Amir Ali Hamidieh, MD    84902645 ext +9821    aahamidieh@sina.tums.ac.ir    Principal Investigator: Amir Ali Hmidieh, MD          Sub-Investigator: Ardeshir Ghavamzadeh, MD          Sub-Investigator: Kamran Alimoghaddam, MD          Sub-Investigator: Mahdi Jalili, MD Less <<
NCT00145613 Acute Lymphoblastic Leukemia (... More >>ALL) Acute Myeloid Leukemia (AML) Secondary AML Myelodysplastic Syndrome (MDS) Secondary MDS Chronic Myeloid Leukemia Juvenile Myelomonocytic Leukemia (JMML) Paroxysmal Nocturnal Hemoglobinuria (PNH) Lymphoma, Non-Hodgkin Hodgkin Disease Less << Phase 2 Completed - United States, Tennessee ... More >> St. Jude Children's Research Hospital Memphis, Tennessee, United States, 38105 Less <<
NCT00145587 - Terminated(Due to the principa... More >>l investigator having left the institution.) Less << - -
NCT00198991 Adult Acute Lymphocytic Leukem... More >>ia Less << Phase 4 Unknown - Germany ... More >> University of Frankfurt, Medical Dept. II Recruiting Frankfurt, Germany, 60590 Contact: Dieter Hoelzer, MD,PhD    ++49(0)69 6301 5194    hoelzer@em.uni-frankfurt.de    Contact: Nicola Goekbuget, MD    ++49(0)69 6301 6365    goekbuget@em.uni-frankfurt.de    Principal Investigator: Dieter Hoelzer, MD,PhD          Sub-Investigator: Nicola Goekbuget, MD Less <<
NCT00133367 Multiple Myeloma ... More >> Non-Hodgkin's Lymphoma Hodgkin's Disease Myelogenous Leukemia Lymphoblastic Leukemia Less << Phase 2 Completed - United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 Less <<
NCT00199056 Adult Acute Lymphocytic Leukem... More >>ia Less << Phase 4 Completed - Germany ... More >> University Hospital, Medical Dept. II Frankfurt, Germany, 60590 Less <<
NCT00143559 Leukemia Acut... More >>e Lymphoblastic Leukemia Acute Myeloid Leukemia Chronic Myeloid Leukemia Juvenile Myelomonocytic Leukemia Myelodysplastic Syndrome Paroxysmal Nocturnal Hemoglobinuria Hodgkin's Lymphoma Non-Hodgkin Lymphoma Less << Phase 2 Completed - United States, Tennessee ... More >> St. Jude Children's Research Hospital Memphis, Tennessee, United States, 38105 Less <<
NCT03579875 Fanconi Anemia ... More >> Severe Aplastic Anemia Myelodysplastic Syndromes Less << Phase 2 Recruiting February 2029 United States, Minnesota ... More >> Masonic Cancer Center at University of Minnesota Recruiting Minneapolis, Minnesota, United States, 55455 Contact: Kim Nelson, RN    612-273-2925    knelso62@fairview.org Less <<
NCT01117441 Leukemia Phase 3 Active, not recruiting December 2021 -
NCT03674411 Acute Myeloid Leukemia ... More >> Acute Lymphocytic Leukemia Biphenotypic/Undifferentiated Leukemia Chronic Myelogenous Leukemia Myelodysplasia Relapsed Large Cell Lymphoma Mantle Cell Lymphoma Hodgkin Lymphoma Burkitt Lymphoma Relapsed T-Cell Lymphoma Lymphoplasmacytic Lymphoma Less << Phase 2 Not yet recruiting July 2023 -
NCT02894645 Acute Lymphoblastic Leukemia (... More >>ALL) Less << Phase 4 Unknown - Malaysia ... More >> University of Malaya Medical Centre Recruiting Kuala Lumpur, Malaysia, 59100 Contact: Hany Arrifin, MBBS    +603 7949 6785    hany@ummc.edu.my    Subang Jaya Medical Centre Recruiting Subang Jaya, Malaysia, 47500 Contact: Hai Peng Lin, MBBS       flslhp@gmail.com    Contact: Lee Lee Chan, MBBS       drchanleelee@gmail.com    Singapore National University Hospital Recruiting Singapore, Singapore, 119074 Contact: Allen Yeoh, MBBS    (+65) 6772 4406    allen_yeoh@nuhs.edu.sg    KK Women's and Children's Hospital Recruiting Singapore, Singapore, 229899 Contact: Ah Moy Tan, MBBS    (+65) 63941039    tan.ah.moy01@singhealth.com.sg Less <<
NCT00080925 Chronic Myeloproliferative Dis... More >>orders Leukemia Lymphoma Multiple Myeloma and Plasma Cell Neoplasm Myelodysplastic Syndromes Myelodysplastic/Myeloproliferative Neoplasms Less << Phase 1 Completed - United States, Maryland ... More >> Warren Grant Magnuson Clinical Center - NCI Clinical Trials Referral Office Bethesda, Maryland, United States, 20892-1182 Less <<
NCT00778882 Chronic Granulomatous Disease Phase 1 Phase 2 Active, not recruiting October 2022 Korea, Republic of ... More >> Seoul National University Hospital Seoul, Korea, Republic of, 110-744 Less <<
NCT00005802 Leukemia Phase 1 Phase 2 Completed - United States, Washington ... More >> Fred Hutchinson Cancer Research Center Seattle, Washington, United States, 98109-1024 Less <<
NCT00055653 Leukemia Lymp... More >>homa Myelodysplastic Syndromes Myelodysplastic-Myeloproliferative Diseases Less << Phase 2 Completed - -
NCT00027547 Leukemia Phase 1 Phase 2 Completed - United States, Oregon ... More >> Cancer Institute at Oregon Health and Science University Portland, Oregon, United States, 97239 United States, Washington Fred Hutchinson Cancer Research Center Seattle, Washington, United States, 98109-1024 Germany Universitaet Leipzig Leipzig, Germany, D-04103 Less <<
NCT00004255 Graft Versus Host Disease ... More >> Leukemia Myelodysplastic Syndromes Less << Phase 2 Phase 3 Completed - United States, California ... More >> University of California San Diego Cancer Center La Jolla, California, United States, 92093-0658 United States, Colorado Presbyterian-St Luke's Medical Center Denver, Colorado, United States, 80218 United States, District of Columbia Lombardi Cancer Center Washington, District of Columbia, United States, 20007 United States, Florida Shands Hospital and Clinics, University of Florida Gainesville, Florida, United States, 32610-100277 United States, Indiana Indiana Blood and Marrow Transplantation Indianapolis, Indiana, United States, 46202 United States, Kentucky James Graham Brown Cancer Center Louisville, Kentucky, United States, 40202 United States, Michigan Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States, 48201-1379 United States, New York University of Rochester Cancer Center Rochester, New York, United States, 14642 New York Medical College Valhalla, New York, United States, 10595 United States, Oklahoma University of Oklahoma Health Sciences Center Oklahoma City, Oklahoma, United States, 73190 United States, Oregon Oregon Cancer Center Portland, Oregon, United States, 97201-3098 United States, Pennsylvania Hahnemann University Hospital Philadelphia, Pennsylvania, United States, 19102-1192 United States, Texas University of Texas - MD Anderson Cancer Center Houston, Texas, United States, 77030-4009 South Texas Cancer Institute San Antonio, Texas, United States, 78229 United States, Virginia Massey Cancer Center Richmond, Virginia, United States, 23298-0037 Less <<
NCT00295997 Chronic Myeloproliferative Dis... More >>orders Kidney Cancer Leukemia Lymphoma Multiple Myeloma and Plasma Cell Neoplasm Myelodysplastic Syndromes Myelodysplastic/Myeloproliferative Neoplasms Less << Not Applicable Unknown - United States, California ... More >> UCSF Comprehensive Cancer Center San Francisco, California, United States, 94115 United States, North Carolina Wake Forest University Comprehensive Cancer Center Winston-Salem, North Carolina, United States, 27157-1096 Less <<
NCT00276809 Chronic Lymphocytic Leukemia Phase 2 Completed - Germany ... More >> Charite - Universitaetsmedizin Berlin - Campus Benjamin Franklin Berlin, Germany, D-12200 Universitaetsklinikum Essen Essen, Germany, D-45122 Asklepios Klinik St. Georg Hamburg, Germany, D-20099 Medizinische Hochschule Hannover Hannover, Germany, D-30625 Universitatsklinikum Heidelberg Heidelberg, Germany, D-69120 Staedtisches Klinikum Karlsruhe gGmbH Karlsruhe, Germany, 76133 University Hospital Schleswig-Holstein - Kiel Campus Kiel, Germany, D-24105 Universitaetsklinkum Magdeburg der Otto-von-Guericke-Universitaet Magdeburg Magdeburg, Germany, D-39120 Universitatsklinik Mainz Mainz, Germany, 55101 Klinikum der Universitaet Muenchen - Grosshadern Campus Munich, Germany, D-81377 Klinikum Rechts Der Isar - Technische Universitaet Muenchen Munich, Germany, D-81675 Comprehensive Cancer Center Ulm at Universitaetsklinikum Ulm Ulm, Germany, D-89081 Less <<
NCT00089453 Multiple Myeloma Phase 1 Completed - United States, Arkansas ... More >> University of Arkansas for Medical Sciences/MIRT Little Rock, Arkansas, United States, 72205 Less <<
NCT00425802 Leukemia Lymp... More >>homa Less << Phase 2 Completed - United States, New York ... More >> Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 Less <<
NCT00066417 Chronic Myeloproliferative Dis... More >>orders Leukemia Myelodysplastic/Myeloproliferative Diseases Less << Phase 2 Terminated(Trial was withdrawn... More >> for drug availability issues.) Less << - United States, Maryland ... More >> NIH - Warren Grant Magnuson Clinical Center Bethesda, Maryland, United States, 20892-1182 Less <<
NCT01085617 Leukemia Muco... More >>sitis Oral Complications Less << Phase 3 Recruiting July 2023 United Kingdom ... More >> UCL Cancer Institute Recruiting London, England, United Kingdom, WC1E 6DD Contact: Contact Person    44-207-830-2833 Less <<
NCT00454480 Leukemia Myel... More >>odysplastic Syndromes Less << Phase 2 Phase 3 Completed - -
NCT00425802 - Completed - -
NCT01020734 Leukemia Phase 2 Completed - Korea, Republic of ... More >> Inje University - Haeundae Paik Hospital Busan, Korea, Republic of, 612-030 Asan Medical Center - University of Ulsan College of Medicine Seoul, Korea, Republic of, 138-736 Less <<
NCT00187083 Acute Lymphoblastic Leukemia Phase 3 Completed - United States, Tennessee ... More >> St. Jude Children's Research Hospital Memphis, Tennessee, United States, 38105 Less <<
NCT00521430 Leukemia Lymp... More >>homa Multiple Myeloma and Plasma Cell Neoplasm Myelodysplastic Syndromes Nonmalignant Neoplasm Unspecified Adult Solid Tumor, Protocol Specific Less << Not Applicable Completed - Korea, Republic of ... More >> Asan Medical Center - University of Ulsan College of Medicine Seoul, Korea, Republic of, 138-736 Less <<
NCT00365287 Breast Cancer ... More >> Kidney Cancer Leukemia Lymphoma Multiple Myeloma and Plasma Cell Neoplasm Myelodysplastic Syndromes Less << Phase 1 Phase 2 Completed - -
NCT01027000 Leukemia Lymp... More >>homa Less << Phase 2 Active, not recruiting - -
NCT01279616 Sickle Cell Disease Phase 2 Terminated(PI moving to a diff... More >>erent institution.) Less << - United States, Ohio ... More >> Nationwide Children's Hospital Columbus, Ohio, United States, 43205 Less <<
NCT00275015 Chronic Lymphocytic Leukemia Phase 2 Completed - -
NCT00574496 Lymphoma Phase 2 Active, not recruiting November 2019 United States, New York ... More >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10065 Less <<
NCT02098512 Hodgkin Lymphoma Phase 1 Phase 2 Recruiting December 2019 United States, New York ... More >> New York Medical College Recruiting Valhalla, New York, United States, 10595 Contact: Mitchell Cairo    914-594-2150    mitchell_cairo@nymc.edu    Contact: Jessica Hochberg, MD    914-594-2132    jessica_hochberg@nymc.edu Less <<
NCT03070327 Multiple Myeloma Phase 1 Recruiting February 2020 United States, New York ... More >> Memorial Sloan Kettering Cancer Center Recruiting New York, New York, United States, 10065 Contact: Sham Mailankody, MD    212-639-2131       Contact: Craig Sauter, MD    212-639-3460       Principal Investigator: Sham Mailankody, MD Less <<
NCT00582816 Leukemia Soli... More >>d Tumors Less << Phase 1 Phase 2 Terminated(toxicity) - United States, Wisconsin ... More >> Kenneth DeSantes., MD Madison, Wisconsin, United States, 53972 Less <<
NCT00028600 Multiple Myeloma ... More >> Plasma Cell Neoplasm Less << Phase 2 Completed - United States, California ... More >> UCSF Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States, 94115 United States, Delaware Tunnell Cancer Center at Beebe Medical Center Lewes, Delaware, United States, 19958 CCOP - Christiana Care Health Services Newark, Delaware, United States, 19713 United States, District of Columbia Lombardi Comprehensive Cancer Center at Georgetown University Medical Center Washington, District of Columbia, United States, 20007 United States, Illinois University of Chicago Cancer Research Center Chicago, Illinois, United States, 60637-1470 United States, Iowa Holden Comprehensive Cancer Center at University of Iowa Iowa City, Iowa, United States, 52242-1002 United States, Maryland Union Hospital Cancer Program at Union Hospital Elkton MD, Maryland, United States, 21921 United States, Missouri Siteman Cancer Center at Barnes-Jewish St. Peters Hospital - Saint Louis St Louis, Missouri, United States, 63110 United States, New Jersey Cancer Institute of New Jersey at Cooper - Voorhees Voorhees, New Jersey, United States, 08043 United States, New York Roswell Park Cancer Institute Buffalo, New York, United States, 14263-0001 Mount Sinai Medical Center New York, New York, United States, 10029 United States, North Carolina Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill Chapel Hill, North Carolina, United States, 27599-7295 Wake Forest University Comprehensive Cancer Center Winston-Salem, North Carolina, United States, 27157-1096 United States, Ohio Arthur G. James Cancer Hospital and Solove Research Institute at Ohio State University Medical Center Columbus, Ohio, United States, 43210-1240 United States, Pennsylvania Western Pennsylvania Cancer Institute at Western Pennsylvania Hospital Pittsburgh, Pennsylvania, United States, 15224-1791 Less <<
NCT02876679 Graft vs Host Disease Phase 2 Recruiting February 2020 France ... More >> Saint Antoine Hospital - Hematology Department Recruiting Paris, France, 75012 Contact: Mohamad MOHTY, PU-PH    01.49.28.26.20 ext +33    mohamad.mohty@inserm.fr    Contact: Florent MALARD, CCU-AH    01.49.28.26.20 ext +33    malardf@yahoo.fr Less <<
NCT01027000 - Active, not recruiting - -
NCT00582816 - Terminated(toxicity) - -
NCT00262886 Kidney Cancer Phase 2 Completed - United States, New York ... More >> James P. Wilmot Cancer Center at University of Rochester Medical Center Rochester, New York, United States, 14642 Less <<
NCT00004878 Graft Versus Host Disease ... More >> Leukemia Less << Phase 2 Withdrawn(study never opened) - -
NCT00744692 Non Malignant Disorders ... More >> Immunodeficiencies Congenital Marrow Failures Hemoglobinopathies Inborn Errors of Metabolism Sickle Cell Thalassemia Lysosomal Storage Disease Less << Phase 1 Completed - United States, North Carolina ... More >> Duke University Medical Center Pediatric Blood and Marrow Transplant Program Durham, North Carolina, United States, 27705 Less <<
NCT00744692 - Completed - -
NCT00104975 Chronic Myeloproliferative Dis... More >>orders Leukemia Lymphoma Myelodysplastic Syndromes Myelodysplastic/Myeloproliferative Neoplasms Less << Phase 1 Completed - United States, Connecticut ... More >> Yale Cancer Center New Haven, Connecticut, United States, 06520-8028 Less <<
NCT02512679 Stem Cell Transplantation ... More >> Bone Marrow Transplantation Peripheral Blood Stem Cell Transplantation Allogeneic Transplantation Genetic Diseases Thalassemia Pediatrics Diamond-Blackfan Anemia Combined Immune Deficiency Wiskott-Aldrich Syndrome Chronic Granulomatous Disease X-linked Lymphoproliferative Disease Metabolic Diseases Less << Phase 2 Terminated(Optimal dose obtain... More >>ed for engraftment and minimizing toxicity) Less << - -
NCT01252784 - Unknown October 2014 Korea, Republic of ... More >> Asan Medical Center Recruiting Seoul, Asanbyeongwon-gil, songpa-gu, Korea, Republic of, 138-736 Contact: Yae-Eun Jang, nurse    82-2-3010-6378    redpin75@paran.com Less <<
NCT02512679 - Terminated(Optimal dose obtain... More >>ed for engraftment and minimizing toxicity) Less << - -
NCT00005863 Leukemia Myel... More >>odysplastic Syndromes Myelodysplastic/Myeloproliferative Neoplasms Less << Phase 3 Completed - United Kingdom ... More >> Birmingham Heartlands Hospital Birmingham, England, United Kingdom, B9 5SS Less <<
NCT03250338 Relapsed/Refractory Acute Myel... More >>oid Leukemia With FLT3 Activating Mutations Less << Phase 3 Recruiting October 2021 United States, California ... More >> UC Davis Comprehensive Cancer Center Recruiting Sacramento, California, United States, 95817 Contact: Brian Jonas, MD    916-734-5959       United States, Kansas Kansas University Recruiting Kansas City, Kansas, United States, 666160 Contact: Sunil Abhyankar, MD          Principal Investigator: Sunil Abhyankar, MD          United States, Michigan Karmanos Cancer Center Recruiting Detroit, Michigan, United States, 48201 Contact: Jay Yang, MD       yangj@karmanos.org    Henry Ford Health System Recruiting Detroit, Michigan, United States, 48202 Contact: Yue Guo, MD          Principal Investigator: Yue Guo, MD          United States, New York Roswell Park Cancer Institute Recruiting Buffalo, New York, United States, 14263 Contact: Eunice Wang, MD          Principal Investigator: Eunice Wang, MD Less <<
NCT00005803 Prolymphocytic Leukemia ... More >> Recurrent Adult Hodgkin Lymphoma Recurrent Childhood Hodgkin Lymphoma Recurrent Childhood Non-Hodgkin Lymphoma Recurrent Chronic Lymphocytic Leukemia Recurrent Non-Hodgkin Lymphoma Recurrent Small Lymphocytic Lymphoma Refractory Childhood Hodgkin Lymphoma Refractory Chronic Lymphocytic Leukemia Refractory Hodgkin Lymphoma Refractory Non-Hodgkin Lymphoma Refractory Small Lymphocytic Lymphoma T-Cell Chronic Lymphocytic Leukemia T-Cell Prolymphocytic Leukemia Less << Phase 1 Phase 2 Active, not recruiting September 1, 2018 United States, Utah ... More >> Huntsman Cancer Institute/University of Utah Salt Lake City, Utah, United States, 84112 LDS Hospital Salt Lake City, Utah, United States, 84143 United States, Washington VA Puget Sound Health Care System Seattle, Washington, United States, 98101 Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 Germany Universitaet Leipzig Leipzig, Germany, D-04103 Less <<
NCT02428517 - Terminated(The PI resigned the... More >> institute, and the rest investigators at the institute decided to terminate the study.) Less << - Korea, Republic of ... More >> Inje University Busan Paik Hospital Busan, Korea, Republic of Inje University Haeundae Paik Hospital Busan, Korea, Republic of Asan Medical Center, University of Ulsan College of Medicine Seoul, Korea, Republic of Ulsan University Hospital, University of Ulsan College of Medicine Ulsan, Korea, Republic of Less <<
NCT00005803 - Active, not recruiting - -
NCT01343043 Synovial Sarcoma Phase 1 Recruiting May 31, 2020 United States, Florida ... More >> GSK Investigational Site Recruiting Tampa, Florida, United States, 33612 Contact: US GSK Clinical Trials Call Center    877-379-3718    GSKClinicalSupportHD@gsk.com    Contact: EU GSK Clinical Trials Call Center    +44 (0) 20 8990 4466    GSKClinicalSupportHD@gsk.com    United States, Maryland GSK Investigational Site Recruiting Bethesda, Maryland, United States, 20892 Contact: US GSK Clinical Trials Call Center    877-379-3718    GSKClinicalSupportHD@gsk.com    Contact: EU GSK Clinical Trials Call Center    +44 (0) 20 8990 4466    GSKClinicalSupportHD@gsk.com    United States, Massachusetts GSK Investigational Site Recruiting Boston, Massachusetts, United States, 02114 Contact: US GSK Clinical Trials Call Center    877-379-3718    GSKClinicalSupportHD@gsk.com    Contact: EU GSK Clinical Trials Call Center    +44 (0) 20 8990 4466    GSKClinicalSupportHD@gsk.com    United States, Missouri GSK Investigational Site Recruiting Saint Louis, Missouri, United States, 63110 Contact: US GSK Clinical Trials Call Center    877-379-3718    GSKClinicalSupportHD@gsk.com    Contact: EU GSK Clinical Trials Call Center    +44 (0) 20 8990 4466    GSKClinicalSupportHD@gsk.com    United States, New York GSK Investigational Site Recruiting New York, New York, United States, 10065 Contact: US GSK Clinical Trials Call Center    877-379-3718    GSKClinicalSupportHD@gsk.com    Contact: EU GSK Clinical Trials Call Center    +44 (0) 20 8990 4466    GSKClinicalSupportHD@gsk.com    United States, Texas GSK Investigational Site Recruiting Houston, Texas, United States, 77030 Contact: US GSK Clinical Trials Call Center    877-379-3718    GSKClinicalSupportHD@gsk.com    Contact: EU GSK Clinical Trials Call Center    +44 (0) 20 8990 4466    GSKClinicalSupportHD@gsk.com Less <<
NCT00028730 Leukemia Lymp... More >>homa Myelodysplastic Syndromes Myelodysplastic/Myeloproliferative Neoplasms Less << Phase 2 Completed - United States, New York ... More >> Memorial Sloan-Kettering Cancer Center New York, New York, United States, 10021 Less <<
NCT00085462 Melanoma (Skin) Phase 1 Completed - United States, Maryland ... More >> Warren Grant Magnuson Clinical Center - NCI Clinical Trials Referral Office Bethesda, Maryland, United States, 20892-1182 NCI - Surgery Branch Bethesda, Maryland, United States, 20892-1201 Less <<
NCT01786018 B-cell Lymphoma Refractory Phase 2 Unknown February 2015 Italy ... More >> Città della Salute e della Scienza di Torino Recruiting Torino, Italy, 10126 Contact: Benedetto Bruno, MD    +390116336728    benedetto.bruno@unito.it Less <<
NCT00006042 Leukemia Lymp... More >>homa Multiple Myeloma and Plasma Cell Neoplasm Myelodysplastic Syndromes Myelodysplastic/Myeloproliferative Diseases Less << Phase 1 Completed - United States, Maryland ... More >> Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States, 21231-2410 Less <<
NCT00793572 Refractory Plasma Cell Myeloma Phase 2 Active, not recruiting - United States, Washington ... More >> Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 Less <<
NCT02844530 CD22+ Relapsed/Refractory B-AL... More >>L Less << Phase 2 Withdrawn - France ... More >> CHU de Clermont-Ferrand Clermont-Ferrand, France, 63000 Less <<
NCT00096460 - Terminated(lower than anticipa... More >>ted accrual) Less << - -
NCT00014508 Multiple Myeloma and Plasma Ce... More >>ll Neoplasm Less << Phase 2 Completed - United States, Florida ... More >> Baptist Cancer Institute - Jacksonville Jacksonville, Florida, United States, 32207-8554 Mayo Clinic - Jacksonville Jacksonville, Florida, United States, 32224 United States, Massachusetts Cancer Center at Tufts - New England Medical Center Boston, Massachusetts, United States, 02111 Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02215 United States, Minnesota Mayo Clinic Cancer Center Rochester, Minnesota, United States, 55905 United States, New Jersey CCOP - Northern New Jersey Hackensack, New Jersey, United States, 07601 Cancer Institute of New Jersey at UMDNJ - Robert Wood Johnson Medical School New Brunswick, New Jersey, United States, 08903 United States, New York MBCCOP-Our Lady of Mercy Cancer Center Bronx, New York, United States, 10466 United States, Ohio Ireland Cancer Center at University Hospitals of Cleveland and Case Western Reserve University Cleveland, Ohio, United States, 44106-5065 MetroHealth's Cancer Care Center at MetroHealth Medical Center Cleveland, Ohio, United States, 44109 United States, Pennsylvania Penn State Cancer Institute at Milton S. Hershey Medical Center Hershey, Pennsylvania, United States, 17033-0850 Abramson Cancer Center at the University of Pennsylvania Philadelphia, Pennsylvania, United States, 19104 Less <<
NCT00793572 - Active, not recruiting - -
NCT00025519 Kidney Cancer Phase 2 Withdrawn - -
NCT00849147 - Completed - -
NCT00096460 Recurrent Grade 1 Follicular L... More >>ymphoma Recurrent Grade 2 Follicular Lymphoma Recurrent Grade 3 Follicular Lymphoma Follicular Lymphoma Less << Phase 2 Phase 3 Terminated(lower than anticipa... More >>ted accrual) Less << - -
NCT01008462 B-Cell Prolymphocytic Leukemia... More >> Hypodiploidy Loss of Chromosome 17p Plasma Cell Leukemia Progression of Multiple Myeloma or Plasma Cell Leukemia Recurrent Adult Hodgkin Lymphoma Recurrent Adult Non-Hodgkin Lymphoma Recurrent Childhood Hodgkin Lymphoma Recurrent Childhood Non-Hodgkin Lymphoma Recurrent Chronic Lymphocytic Leukemia Recurrent Plasma Cell Myeloma Recurrent Small Lymphocytic Lymphoma Refractory Childhood Hodgkin Lymphoma Refractory Chronic Lymphocytic Leukemia Refractory Non-Hodgkin Lymphoma Refractory Plasma Cell Myeloma Refractory Small Lymphocytic Lymphoma t(14;16) t(4;14) T-Cell Prolymphocytic Leukemia Waldenstrom Macroglobulinemia Less << Phase 2 Recruiting - United States, Washington ... More >> Fred Hutch/University of Washington Cancer Consortium Recruiting Seattle, Washington, United States, 98109 Contact: Mohamed L. Sorror    206-667-6298    msorror@fhcrc.org    Principal Investigator: Mohamed L. Sorror          United States, Wisconsin Froedtert and the Medical College of Wisconsin Completed Milwaukee, Wisconsin, United States, 53226 Less <<
NCT01158118 Leukemia, Myeloid, Acute ... More >> Myelodysplastic Syndromes Lymphoma, Non-Hodgkin Hodgkin Disease Leukemia, Lymphocytic, Chronic, B-Cell Multiple Myeloma Less << Phase 2 Completed - United States, Missouri ... More >> Washington University School of Medicine Saint Louis, Missouri, United States, 63110 Less <<
NCT03456817 Graft-versus-host-disease ... More >> Relapse Less << Phase 2 Not yet recruiting September 2023 -
NCT02520908 - Recruiting December 2024 France ... More >> Saint Louis hospital Recruiting Paris, France, 75010 Contact: Adèle de Masson, MD       adele.de-masson@inserm.fr Less <<
NCT01256398 Acute Lymphoblastic Leukemia ... More >> Adult B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1 Untreated Adult Acute Lymphoblastic Leukemia Less << Phase 2 Active, not recruiting - -
NCT01158118 - Completed - -
NCT02251821 Primary Myelofibrosis ... More >> Secondary Myelofibrosis Less << Phase 2 Recruiting - United States, Washington ... More >> Fred Hutch/University of Washington Cancer Consortium Recruiting Seattle, Washington, United States, 98109 Contact: Rachel B. Salit    206-667-1317    rsalit@fredhutch.org    Principal Investigator: Rachel B. Salit Less <<
NCT00864227 - Completed - -
NCT00209833 De Novo Akute Myeloid Leukemia... More >> (AML) Secondary Acute Myeloid Leukemia (AML) Refractory Anemia With Excess of Blasts in Transformation Less << Phase 2 Phase 3 Unknown - Germany ... More >> Hannover Medical School Hannover, Germany, 30625 Less <<
NCT00849147 Precursor B-Cell Lymphoblastic... More >> Leukemia-Lymphoma Leukemia, Myeloid, Acute Burkitt Lymphoma Lymphoma, B-Cell Lymphoma, Follicular Lymphoma, Large B-Cell, Diffuse Less << Phase 2 Completed - United States, California ... More >> City of Hope National Medical Center Duarte, California, United States, 91010-3000 University of California San Diego Medical Center La Jolla, California, United States, 92093 United States, Florida University of Florida College of Medicine (Shands) Gainesville, Florida, United States, 32610-0277 United States, Georgia Bone Marrow Transplant Group of Georgia, Northside Hospital Atlanta, Georgia, United States, 30342 United States, Hawaii Kapi'olani Medical Center for Women and Children, University of Hawaii Honolulu, Hawaii, United States, 96826 United States, Maryland University of Maryland, Greenbaum Cancer Center Baltimore, Maryland, United States, 21201 Johns Hopkins University/Sidney Kimmel Comprehensive Cancer Center (SKCCC) Baltimore, Maryland, United States, 21231 United States, Massachusetts DFCI, Massachusetts General Hospital Boston, Massachusetts, United States, 02114 United States, Michigan Karmanos Cancer Institute, Children's Hospital of Michigan Detroit, Michigan, United States, 48201 United States, Missouri Washington University, Barnes Jewish Hospital Saint Louis, Missouri, United States, 63110 United States, Oregon Oregon Health & Science University Portland, Oregon, United States, 97239-3098 United States, Pennsylvania Fox Chase, Temple University Philadelphia, Pennsylvania, United States, 19111-2442 United States, South Carolina Medical University of South Carolina Charleston, South Carolina, United States, 29425 United States, Tennessee Vanderbilt University Medical Center Nashville, Tennessee, United States, 37232-8210 United States, Texas Baylor University Medical Center Dallas, Texas, United States, 75246 Texas Transplant Institute San Antonio, Texas, United States, 78229 United States, Washington Fred Hutchinson Cancer Research Center Seattle, Washington, United States, 98109-1024 Less <<
NCT03602898 Acute Lymphoblastic Leukemia i... More >>n Remission Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome Acute Myeloid Leukemia in Remission Blasts 5 Percent or Less of Bone Marrow Nucleated Cells Chronic Myelomonocytic Leukemia Chronic Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive Donor Minimal Residual Disease Myelodysplastic Syndrome Myelofibrosis Myeloproliferative Neoplasm Recurrent Acute Myeloid Leukemia Recurrent Hodgkin Lymphoma Recurrent Non-Hodgkin Lymphoma Refractory Acute Myeloid Leukemia Therapy-Related Acute Myeloid Leukemia Less << Phase 2 Not yet recruiting September 17, 2023 United States, Washington ... More >> Fred Hutch/University of Washington Cancer Consortium Not yet recruiting Seattle, Washington, United States, 98109 Contact: Masumi Ueda    206-667-4546       Principal Investigator: Masumi Ueda Less <<
NCT02756572 Blasts 10 Percent or More of B... More >>one Marrow Nucleated Cells Chronic Myelomonocytic Leukemia-2 High Grade Malignant Neoplasm Myelodysplastic Syndrome Myelodysplastic Syndrome With Excess Blasts-2 Myeloid Neoplasm Previously Treated Myelodysplastic Syndrome Recurrent Adult Acute Myeloid Leukemia Recurrent Childhood Acute Myeloid Leukemia Refractory Acute Myeloid Leukemia Less << Not Applicable Recruiting - United States, Washington ... More >> Fred Hutch/University of Washington Cancer Consortium Recruiting Seattle, Washington, United States, 98109 Contact: Mary-Elizabeth M. Percival    206-606-1320    mperciva@seattlecca.org    Principal Investigator: Mary-Elizabeth M. Percival Less <<
NCT00199147 Acute Myeloid Leukemia Phase 4 Unknown - Germany ... More >> University Hospital, Medical Department II Recruiting Frankfurt, Germany, 60590 Contact: Oliver G Ottmann, MD    ++49-69-6301-4802    ottmann@em.uni-frankfurt.de    Contact: Gesine Bug, MD    ++49-69-6301-4802    g.bug@em.uni-frankfurt.de    Principal Investigator: Oliver G Ottmann, MD          Sub-Investigator: Gesine Bug, MD Less <<
NCT00914849 - Completed - -
NCT00998270 Multiple Myeloma Phase 2 Phase 3 Unknown October 2017 Iran, Islamic Republic of ... More >> Hematology-Oncology & SCT Research Center Recruiting Tehran, Iran, Islamic Republic of Contact: Ardeshir Ghavamzadeh, MD    84902635 ext +98-21    ghavamza@sina.tums.ac.ir    Principal Investigator: Ardeshir Ghavamzadeh, MD          Sub-Investigator: Kamran Alimoghaddam, MD          Sub-Investigator: Mahdi Jalili, MD Less <<
NCT00864227 Precursor B-Cell Lymphoblastic... More >> Leukemia-Lymphoma Leukemia, Myeloid, Acute Burkitt Lymphoma Lymphoma, B-Cell Lymphoma, Follicular Lymphoma, Large B-Cell, Diffuse Less << Phase 2 Completed - United States, California ... More >> City of Hope National Medical Center Duarte, California, United States, 91010 United States, Florida University of Florida College of Medicine, Shands Gainesville, Florida, United States, 32610-3633 H. Lee Moffitt Cancer Center Tampa, Florida, United States, 33624 United States, Iowa University of Iowa Hospitals and Clinics Iowa City, Iowa, United States, 52242-1009 United States, Kansas University of Kansas Hospital Kansas City, Kansas, United States, 66160 United States, Massachusetts Dana-Farber Cancer Institute (DFCI), Brigham & Women's Hospital Boston, Massachusetts, United States, 02114 Dana-Farber Cancer Institute (DFCI), Massachusetts General Hospital Boston, Massachusetts, United States, 02114 United States, Minnesota University of Minnesota Minneapolis, Minnesota, United States, 55455 United States, Missouri Washington University, Barnes Jewish Hospital Saint Louis, Missouri, United States, 63110 United States, New York Weill Cornell Medical College, NY Presbyterian Hospital New York, New York, United States, 10065 United States, Ohio Ohio State, Arthur G. James Cancer Hospital Columbus, Ohio, United States, 43210 United States, Pennsylvania University of Pennsylvania Cancer Center Philadelphia, Pennsylvania, United States, 19104 United States, South Carolina Medical University of South Carolina Charleston, South Carolina, United States, 29425 United States, Texas Texas Transplant Institute San Antonio, Texas, United States, 78229 United States, Virginia Virginia Commonwealth University, Medical College of Virginia (MCV) Hospital Richmond, Virginia, United States, 23298 United States, Wisconsin University of Wisconsin Hospital and Clinics Madison, Wisconsin, United States, 53792-5156 Less <<
NCT00020176 Breast Cancer Phase 2 Completed - United States, Maryland ... More >> Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support Bethesda, Maryland, United States, 20892-1182 NCI - Center for Cancer Research Bethesda, Maryland, United States, 20892 Less <<
NCT00580034 Lymphoma Myel... More >>oma Leukemia Myelodysplasia Solid Tumors Less << Phase 2 Completed - United States, North Carolina ... More >> Duke University Health Systems Durham, North Carolina, United States, 27710 Less <<
NCT00580034 - Completed - -
NCT00914849 Hematologic Neoplasms Phase 2 Completed - United States, Missouri ... More >> Washington University School of Medicine St. Louis, Missouri, United States, 63110 Less <<
NCT01949129 Acute Lymphoblastic Leukaemia Phase 2 Phase 3 Recruiting April 2023 -
NCT00056095 Kidney Cancer Phase 2 Unknown - France ... More >> Centre Hospitalier Regional et Universitaire d'Angers Recruiting Angers, France, 49033 Contact: Norbert Ifrah, MD    33-2-41-35-4472       Centre Paul Papin Recruiting Angers, France, 49100 Contact: Remy Delva    33-49-800-918-507       Centre Hospitalier Regional de Besancon - Hopital Jean Minjoz Recruiting Besancon, France, 25030 Contact: Contact Person    33-81-668-240       Hopital Saint Andre Recruiting Bordeaux, France, 33075 Contact: Alain Ravaud, MD, PhD    33-5-5679-5808    alain.ravaud@chu-bordeaux.fr    Chu-Hopital Gabriel Montpied Recruiting Clermont-Ferrand, France, 63003 Contact: Laurent Guy, MD    33-0473-750-750    lguy@chu-clermontferrand.fr    Centre Jean Perrin Recruiting Clermont-Ferrand, France, 63011 Contact: Jean Olivier    33-73-278-080       CHU de Grenoble - Hopital Michallon Recruiting Grenoble, France, 38043 Contact: Frederic Garban, MD, PhD    33-4-7676-5028       Centre Oscar Lambret Recruiting Lille, France, 59020 Contact: Armelle Caty, MD    33-32-029-5959    acaty@o-lambret.fr    Centre Hospital Universitaire Hop Huriez Recruiting Lille, France, 59037 Contact: J.P. Jouet, MD    33 3 20 444197    jpjouet@chru-lille.fr    Centre Hospital Regional Universitaire de Limoges Recruiting Limoges, France, 87042 Contact: Dominique Bordessoule, MD, PhD    33-5-5505-6642    bordessoule@unilim.fr    Centre Leon Berard Recruiting Lyon, France, 69373 Contact: Sylvie Negrier, MD    33-4-7878-2751    negrier@lyon.fnclcc.fr    Hopital Edouard Herriot - Lyon Recruiting Lyon, France, 69437 Contact: Mauricette Michallet, MD    33-472117401       Marseille Institute of Cancer - Institut J. Paoli and I. Calmettes Recruiting Marseille, France, 13273 Contact: Didier Blaise, MD    33-4-91-22-37-54    blaised@marseille.fnclcc.fr    Hopital Lapeyronie-CHU Montpellier Recruiting Montpellier, France, 34295 Contact: Eric Legouffe, MD    33-4-67-33-80-79    e-legouffe@chu-montpellier.fr    Centre Regional de Lutte Contre le Cancer - Centre Val d'Aurelle Recruiting Montpellier, France, 34298 Contact: Stephane Culine, MD    33-4-6761-3755    stculine@valdorel.fnclcc.fr    Centre Antoine Lacassagne Recruiting Nice, France, 06189 Contact: Antoine Thyss, MD    33-04-9203-1538    antoine.thyss@cal.nice.fnclcc.fr    Hopital de l'Archet CHU de Nice Recruiting Nice, France, F-06202 Contact: Contact Person    33-49-203-9267       Institut Curie Hopital Recruiting Paris, France, 75248 Contact: Pierre T. Dorval, MD    33-1-44-324-679    thierry.dorval@curie.net    Hopital Haut Leveque Recruiting Pessac, France, 33604 Contact: Reza Tabrizi, MD    33-57-656-511       Hopital Jean Bernard Recruiting Poitiers, France, 86021 Contact: Jean-Marc Tourani, MD    33-549-444-534    jm.tourani@chu.poitiers.frs.fr    Centre Hospitalier Universitaire de Rennes Recruiting Rennes, France, 35033 Contact: Thiery Lamy, MD, PhD    33-2-99-28-42-91    thierry.lamy@univ-rennes1.fr    Centre Eugene Marquis Recruiting Rennes, France, 35042 Contact: Brigitte Laguerre    33-2-9925-3000       Centre Henri Becquerel Recruiting Rouen, France, 76038 Contact: Nathalie Contentin    33-2-3208-2222       Centre Alexis Vautrin Recruiting Vandoeuvre-les-Nancy, France, 54511 Contact: Lionnel Geoffrois, MD    33-3-8359-8400       Hopitaux de Brabois Recruiting Vandoeuvre-Les-Nancy, France, 54511 Contact: Pierre Bordigoni    Not Available       Institut Gustave Roussy Recruiting Villejuif, France, F-94805 Contact: Jean-Henri Bourhis, MD, PhD    33-1-42-11-4507    jhb@igr.fr Less <<
NCT00006126 Breast Cancer ... More >> Kidney Cancer Lung Cancer Melanoma (Skin) Testicular Germ Cell Tumor Less << Phase 1 Withdrawn(Unable to accrue sub... More >>jects.) Less << - -
NCT03570892 Non-Hodgkin Lymphoma Phase 3 Not yet recruiting May 26, 2025 -
NCT01860170 - Active, not recruiting - -
NCT00068523 Chronic Myeloproliferative Dis... More >>orders Leukemia Lymphoma Multiple Myeloma and Plasma Cell Neoplasm Myelodysplastic Syndromes Myelodysplastic/Myeloproliferative Diseases Less << Not Applicable Completed - United States, Ohio ... More >> Ireland Cancer Center at University Hospitals Case Medical Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States, 44106 Less <<
NCT01423500 Lymphoblastic Leukemia, Acute,... More >> Childhood; Less << Phase 3 Unknown September 2016 Austria ... More >> Universitätsklinik für Kinder- und Jugendheilkunde, Klin. Abt. f. Hämato-Onkologie Graz, Austria, 8036 Universitätsklinik für Kinder- und Jugendheilkunde Innsbruck, Austria, 6020 St. Anna Children's Hospital Vienna, Austria, A-1090 Czech Republic Department of Paediatric Haematology and Oncology HSCT-Unit Prague, Czech Republic, 15006 Denmark Pediatric Clinic II, Rigshospitalet Copenhagen, Denmark, 4074 France Pediatric Immuno-Hematology Unit Robert Debré Hospital Paris, France, 75935 Israel Rambam Medical Center Haifa, Israel, 31096 Schneider Children`s Medical Center of Israel Petach-Tikva, Israel, 49202 Italy Clinica Pediatrica dell`Universita di Milano Bicocca, Hospitale San Gerardo Monza, Italy, 20052 Netherlands Leiden University Hospital Leiden, Netherlands, 2300 Radboud University - Nijmegen Medical Centre Nijmegen, Netherlands, 6500 Department of Paediatric Haematology and Oncology, Wilhelmina Children's Hospital Utrecht, Netherlands, 3584 Poland University Hospital, Collegium Medicum UMK, Pediatric Hematology and Oncology Bydgoszcz, Poland, 85-094 Department of Transplantation, University Children's Hospital Cracow, Poland, 30-663 Children`s University Hospital - Hematology - Oncology Lublin, Poland, 20-093 Department of Pediadric Oncology, Hematology and Transplantology, University of Medical Sciences Poznan, Poland, 60-572 Wroclaw Medical University, Dept. of Children Hematology and Oncology Wroclaw, Poland, 50-345 Slovakia Department of Pediatric Bone Marrow Transplantation Unit, University Childrens´ Hospital Bratislava, Slovakia, 833 40 Sweden Department of Pediatric Oncology, Lund University Hospital Lund, Sweden, 221-85 Turkey Department of Pediatrics, Gülhane Military Medical Academy Ankara, Turkey, 06018 Dept. of Paediatrics - BMT Unit, School of Medicine, University of Ankara Ankara, Turkey, 06100 Department of Pediatric Hematology-Oncology and Pediatric Stem Cell Transplantation, Akdeniz University School of Medicine Antalya, Turkey, 07070 Department of Pediatric Hematology, Oncology and BMT, Istanbul School of Medicine Istanbul, Turkey, 343990 Pediatric BMT Centre, Ege University Izmir, Turkey, 35100 Less <<
NCT01338987 Myelodysplastic Syndrome RAEB ... More >>2 Acute Lymphocytic Leukemia Acute Myelogenous Leukemia Myelodysplastic Syndrome RAEB 1 Less << Phase 2 Active, not recruiting November 19, 2020 United States, District of Col... More >>umbia Childrens National Medical Center Washington, District of Columbia, United States United States, Maryland National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 United States, Oklahoma University of Oklahoma Oklahoma City, Oklahoma, United States, 73104 Less <<
NCT01860170 Hematological Malignancy Phase 1 Phase 2 Active, not recruiting March 2018 United States, Michigan ... More >> Spectrum Health Grand Rapids, Michigan, United States, 49503 Less <<
NCT01423747 Lymphoblastic Leukemia, Acute,... More >> Childhood; Less << Phase 3 Unknown September 2016 Austria ... More >> Universitätsklinik für Kinder- und Jugendheilkunde, Klin. Abt. f. Hämato-Onkologie Graz, Austria, 8036 Universitätsklinik für Kinder- und Jugendheilkunde Innsbruck, Austria, 6020 St. Anna Kinderspital Vienna, Austria, 1090 Germany Charité Campus Virchow- Klinikum, Klinikum der Pädiatrie, Onkologie/Hämatologie/KMT Berlin, Germany, 13353 Klinik und Poliklinik für Kinderheilkunde, Hämatologie, Onkologie Dresden, Germany, 01307 Universitätsklinikum Düsseldorf, Klinik f. Kinderonkologie, Hämatologie u. Immunologie Düsseldorf, Germany, 40001 Klinik für Kinder und Jugendliche der Universität Erlangen-Nürnberg Erlangen, Germany, 91054 Universitätsklinikum Essen, Zentrum für Kinderheilkunde, Abt. für Hämatologie/Onkologie Essen, Germany, 45122 Klinik für Kinderheilkunde III, Hämatologie und Onkologie, Johann Wolfgang Goethe Universität Frankfurt am Main, Germany, 60590 Universitätsklinikum Freiburg, Zentrum für Kinderheilkunde und Jugendmedizin, Klinik IV: Päd. Hämatologie und Onkologie Freiburg, Germany, 79106 Zentrum für Kinderheilkunde, Abt. Hämatologie und Onkologie Giessen, Germany, 35385 Klinkum der Med. Fakultät der Martin-Luther-Universität Halle-Wittenberg, Uni. Klinik un Poliklinik für Kinder- und Jugendmedizin Halle, Germany, 06097 Universitätsklinikum Hamburg-Eppendorf, Kinderklinik, Abt. für Hämatologie und Onkologie Hamburg, Germany, 20246 Med. Hochschule Hannover, Päd. Hämatologie und Onkologie Hannover, Germany, 30625 Universitätskinderklinik, Päd. Hämatologie, Onkologie und Immunologie Heidelberg, Germany, 69120 Klinik für Knochenmarktransplantation Idar-Oberstein, Germany, 55743 Klinik für Kinder- und Jugendmedizin Jena, Germany, 07724 Universitätsklinikum Kiel, Klinik für Allgemeine Pädiatrie Kiel, Germany, 24105 Klinikum der Universität München, Dr. von Haunersches Kinderspital, Abt. für Hämatologie / Onkologie München, Germany, 80337 Städt. Krankenhaus München-Schwabing, Universitätskinderklinik der TU München, Germany, 80804 Universitätsklinikum Münster, Klinik und Poliklinik für Kinderheilkunde, päd. Hämatologie / Onkologie Münster, Germany, 48149 Univ.-Klinik für Kinderheilkunde und Jugendmedizin Tübingen, Germany, 72076 Universitätskinderklinik Ulm, Germany, 89075 Universitätsklinik, päd. Onkologie/Stammzelltransplantation Würzburg, Germany, 97080 Less <<
NCT02788201 Urothelial Carcinoma ... More >> Bladder Cancer Urinary Bladder Neoplasms Less << Phase 2 Recruiting July 1, 2020 United States, Maryland ... More >> National Institutes of Health Clinical Center Recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact National Cancer Institute Referral Office    888-624-1937 Less <<
NCT00513474 - Completed - -
NCT02881086 Acute Lymphoblastic Leukemia ... More >> Lymphoblastic Lymphoma Less << Phase 3 Recruiting June 2025 Germany ... More >> University Hospital of Frankfurt (Main) Recruiting Frankfurt (Main), Germany, 60590 Less <<
NCT00513474 Chronic Myeloproliferative Dis... More >>orders Graft Versus Host Disease Leukemia Lymphoma Multiple Myeloma and Plasma Cell Neoplasm Myelodysplastic Syndromes Myelodysplastic/Myeloproliferative Neoplasms Less << Phase 1 Completed - United States, Massachusetts ... More >> Massachusetts General Hospital Boston, Massachusetts, United States, 02114-2617 Less <<
NCT02039726 AML Phase 3 Active, not recruiting July 2019 -
NCT02179359 Sickle Cell Disease ... More >> Transfusion Dependent Alpha- or Beta- Thalassemia Diamond Blackfan Anemia Paroxysmal Nocturnal Hemoglobinuria Glanzmann Thrombasthenia Severe Congenital Neutropenia Shwachman-Diamond Syndrome Non-Malignant Hematologic Disorders Less << Not Applicable Recruiting August 2021 United States, Minnesota ... More >> University of Minnesota Medical Center, Fairview Recruiting Minneapolis, Minnesota, United States, 55455 Contact: Kim Nelson    612-273-2925    knelso62@fairview.org Less <<
NCT01422603 Acute Myeloid Leukaemia ... More >> Myelodysplasia Less << Phase 1 Phase 2 Completed - United Kingdom ... More >> Wessex Blood and Marrow Transplant Unit, Southampton University Hospitals NHS Trust Southampton, Hampshire, United Kingdom, SO16 6YD Less <<
NCT03575351 Lymphoma, Non-Hodgkin Phase 3 Recruiting January 13, 2023 -
NCT02627573 Leukemia, Chronic Myeloid ... More >> Myelodysplastic Syndromes Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative Less << Phase 2 Suspended July 2020 Russian Federation ... More >> First Pavlov State Medical University of St. Petersburg Saint-Petersburg, Russian Federation, 197089 Less <<
NCT02766465 Sickle Cell Disease Phase 2 Recruiting March 2023 -
NCT01049854 Leukemia Lymp... More >>homa Bone Marrow Failure Immunodeficiencies Histiocytosis Sickle Cell Disease Beta Thalassemia Inborn Errors of Metabolism Less << Phase 2 Completed - United States, New York ... More >> New York Medical College Valhalla, New York, United States, 10595 Less <<
NCT01244906 Hematologic Neoplasms Phase 2 Completed - United States, Georgia ... More >> Northside Hospital Atlanta, Georgia, United States, 30342 Less <<
NCT01625351 Ewing Sarcoma ... More >> Gastrointestinal Tumor Germ Cell Tumor Hepatic Tumor Lymphoma Wilms Tumor Rhabdoid Tumor Clear Cell Carcinoma Renal Cell Carcinoma Melanoma Neuroblastoma Rhabdomyosarcoma Non-rhabdomyosarcoma Less << Phase 1 Active, not recruiting August 19, 2019 United States, Tennessee ... More >> St. Jude Children's Research Hospital Memphis, Tennessee, United States, 38105 Less <<
NCT00101140 Adult Acute Erythroid Leukemia... More >> Adult Acute Monoblastic and Acute Monocytic Leukemia Adult Acute Myeloid Leukemia Less << Phase 2 Withdrawn - -
NCT02248597 Graft Versus Host Disease ... More >> Hematopoietic/Lymphoid Cancer Less << Phase 2 Recruiting January 2019 United States, North Carolina ... More >> Comprehensive Cancer Center of Wake Forest University Recruiting Winston-Salem, North Carolina, United States, 27157 Contact: Zachariah A. McIver    336-713-5440    zmciver@wakehealth.edu    Principal Investigator: Zachariah A. McIver Less <<
NCT01244906 - Completed - -
NCT00003204 Stage III Grade 1 Follicular L... More >>ymphoma Stage III Grade 2 Follicular Lymphoma Stage III Grade 3 Follicular Lymphoma Stage III Small Lymphocytic Lymphoma Stage IV Grade 1 Follicular Lymphoma Stage IV Grade 2 Follicular Lymphoma Stage IV Grade 3 Follicular Lymphoma Stage IV Small Lymphocytic Lymphoma Less << Phase 3 Completed - United States, Massachusetts ... More >> Eastern Cooperative Oncology Group Boston, Massachusetts, United States, 02215 Less <<
NCT00719849 Leukemia Lymp... More >>homa Multiple Myeloma and Plasma Cell Neoplasm Myelodysplastic Syndromes Myelodysplastic/Myeloproliferative Diseases Less << Phase 2 Terminated(A new protocol was ... More >>developed to replace this protocol in 2008, with removal of ATG and extension of MMF duration.) Less << - United States, Washington ... More >> Fred Hutchinson Cancer Research Center Seattle, Washington, United States, 98109 Less <<
NCT01451515 Lymphoblastic Lymphoma Phase 2 Active, not recruiting June 30, 2021 United States, California ... More >> Rady Children's Hospital San Diego San Diego, California, United States, 92123 United States, Tennessee St. Jude Children's Research Hospital Memphis, Tennessee, United States, 38105 Less <<
NCT03018223 Non-Hodgkin's Lymphoma ... More >> Acute Leukemia in Remission Chronic Myeloid Leukemia Primary Myelofibrosis Chronic Myelomonocytic Leukemia Myelodysplastic Syndromes Hodgkin Lymphoma Multiple Myeloma Less << Phase 2 Active, not recruiting January 2021 United States, Florida ... More >> H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States, 33612 Less <<
NCT01621477 - Terminated(Study was terminate... More >>d in August 2016 due to replacement by a new study.) Less << - -
NCT01621477 Acute Lymphoblastic Leukemia ... More >> Acute Myelocytic Leukemia Chronic Myelocytic Leukemia Juvenile Myelomonocytic Leukemia Myelodysplastic Syndrome Hodgkin or Non-Hodgkin Lymphoma Sarcoma, Myeloid Less << Phase 2 Terminated(Study was terminate... More >>d in August 2016 due to replacement by a new study.) Less << - United States, Tennessee ... More >> St. Jude Children's Research Hospital Memphis, Tennessee, United States, 38105 Less <<
NCT00372619 - Completed - -
NCT02224872 Severe Aplastic Anemia ... More >> Bone Marrow Failure Syndromes Less << Phase 2 Recruiting - United States, Maryland ... More >> The Sidney Kimmel Comprehensive Cancer Center Recruiting Baltimore, Maryland, United States, 21287 Contact: Amy DeZern, MD    410-502-7208    adezern1@jhmi.edu    Contact: Clinical Trials Office- SKCCC    410-955-8804    jhcccro@jhmi.edu    Principal Investigator: Amy DeZern, MD          United States, Wisconsin Medical College of Wisconsin/Children's Hospital of Wisconsin Not yet recruiting Milwaukee, Wisconsin, United States, 53226 Contact: David Margolis, MD    414-337-7066    dmargoli@mcw.edu    Contact: Monica Thakar, MD    414-955-7546    mthakar@mcw.edu Less <<
NCT01178086 - Completed - Germany ... More >> PIOH PD Dr. R. Schnell - Dr. H. Schulz - Dr. M. Hellmann Frechen, Germany, 50226 Less <<
NCT02084563 Acute Myeloid Leukemia ... More >> Myeloproliferative Neoplasms Myelodysplastic Syndromes Myeloproliferative/Myelodysplastic Neoplasm Less << Phase 2 Completed - Brazil ... More >> Hospital Israelita Albert Einstein Sao Paulo, SP, Brazil, 05651901 Less <<
NCT00372619 Leukemia Phase 1 Phase 2 Completed - -
NCT00989664 Lymphoma, Non-Hodgkin Phase 2 Completed - -
NCT02316613 - Completed - France ... More >> Neuilly-sur-seine, France, 92521 Less <<
NCT01178086 - Completed - -
NCT03446638 Myelodysplastic Syndromes Not Applicable Not yet recruiting September 2022 United States, Florida ... More >> University of Florida Not yet recruiting Gainesville, Florida, United States, 32608 Less <<
NCT00989664 - Completed - -
NCT01364363 Severe Aplastic Anemia ... More >> Paroxysmal Nocturnal Hemoglobinuria Acute Myelogenous Leukemia Acute Lymphoblastic Leukemia Myelodysplastic Syndromes Myeloproliferative Syndromes Chronic Myelogenous Leukemia Hodgkin's Lymphoma Non-Hodgkin's Lymphoma Multiple Myeloma Chronic Lymphocytic Leukemia Small Lymphocytic Lymphoma Large Granulocytic Leukemia Less << Not Applicable Recruiting January 2023 United States, California ... More >> Scripps Green Hospital Recruiting La Jolla, California, United States, 92037 Contact: Carol Burian    858-554-2845    Burian.Carol@scrippshealth.org    Principal Investigator: Jeffrey W. Andrey, MD Less <<
NCT02316613 - Completed - -
NCT02520895 - Completed - France ... More >> Service d'Hématologie Clinique, Centre Hospitalier Lyon Sud Pierre-Bénite, France, 69310 Less <<
NCT03035422 Refractory Acute Myeloid Leuke... More >>mia Less << Not Applicable Recruiting January 2021 France ... More >> Service d'hématologie Clinique Hôpital Saint Antoine Recruiting Paris, France, 75012 Contact: Rémy DULERY, PH    01.49.28.26.20    remy.dulery@aphp.fr    Contact: Mohamad MOHTY, PUPH    01.49.28.26.20    mohamad.mohty@inserm.fr Less <<
NCT02272478 Acute Myeloid Leukaemia ... More >> Myelodysplastic Syndrome Less << Phase 2 Phase 3 Recruiting October 2020 United Kingdom ... More >> UHW Recruiting Cardiff, United Kingdom, CF14 4XN Principal Investigator: Steve Knapper          Nottingham University Hospital Recruiting Nottingham, United Kingdom Contact: Nigel Russell, MD Less <<
NCT00560053 Multiple Myeloma Phase 3 Completed - -
NCT02356159 Myelodysplastic Syndrome ... More >> Hodgkin's Lymphoma Non-Hodgkin's Lymphoma Acute Leukemia Multiple Myeloma Less << Phase 1 Phase 2 Recruiting January 1, 2023 United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Recruiting Bethesda, Maryland, United States, 20892 Contact: For more information at the NIH Clinical Center contact National Cancer Institute Referral Office    888-624-1937 Less <<
NCT02551718 Acute Leukemia of Ambiguous Li... More >>neage Recurrent Adult Acute Lymphoblastic Leukemia Recurrent Adult Acute Myeloid Leukemia Recurrent Childhood Acute Lymphoblastic Leukemia Recurrent Childhood Acute Myeloid Leukemia Refractory Acute Myeloid Leukemia Refractory Adult Acute Lymphoblastic Leukemia Refractory Childhood Acute Lymphoblastic Leukemia Less << Not Applicable Recruiting - United States, Washington ... More >> Fred Hutch/University of Washington Cancer Consortium Recruiting Seattle, Washington, United States, 98109 Contact: Pamela S. Becker    206-616-1589    pbecker@u.washington.edu    Principal Investigator: Pamela S. Becker Less <<
NCT03079089 Refractory or Relapsed Lymphoi... More >>d Haemopathy Less << Not Applicable Recruiting June 15, 2022 France ... More >> Service d'hématologie clinique Hôpital Saint Antoine Recruiting Paris, France Contact: Rémy DULERY, PH    01.49.28.26.20    remy.dulery@aphp.fr    Contact: Mohamad MOHTY, PUPH    01.49.28.26.20    mohamad.mohty@inserm.fr Less <<
NCT00001637 Chronic Lymphocytic Leukemia ... More >> Graft vs Host Disease Leukemia Myelodysplastic Syndrome Myeloid Leukemia Less << Phase 2 Completed - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT00025662 Graft vs Host Disease ... More >> Myelodysplastic Syndromes Leukemia Leukemia, Myeloid Leukemia, Myelomonocytic, Chronic Leukemia, Lymphocytic Lymphoma Lymphoma, Mantle-cell Lymphoma, Non-Hodgkin Hodgkin Disease Less << Phase 2 Completed - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT03114670 Adult Acute Myeloid Leukemia Phase 1 Recruiting March 18, 2021 China ... More >> Fengtai District Recruiting Beijing Shi, China Contact: Hu Chen, M.D., Ph.D.    +86-010-6694-7108    chenhu217@aliyun.com Less <<
NCT00025662 - Completed - -
NCT00419250 Chronic Lymphocytic Leukemia ... More >> Leukemia, B-Cell, Chronic Less << Phase 1 Completed - -
NCT00003838 Myeloproliferative Disorders ... More >> Acute Myelogenous Leukemia Chronic Myelogenous Leukemia Myelodysplastic Syndrome Less << Phase 2 Active, not recruiting December 31, 2020 United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT00122005 Prostate Cancer Phase 1 Phase 2 Unknown July 2005 United States, Oregon ... More >> Providence Portland Medical Center Portland, Oregon, United States, 97213 Less <<
NCT02670564 Acute Lymphoblastic Leukemia Phase 4 Recruiting April 2023 Switzerland ... More >> Hôpital Cantonal de Genève, Département de Pédiatrie Recruiting Geneva, Cansearch Laboratory, Switzerland, 1211 Contact: Marc Ansari, MD, PD    +41 22 382 47 31    Marc.Ansari@hcuge.ch    Universitäts-Kinderspital beider Basel (UKBB), Onkologie/Hämatologie Recruiting Basel, Switzerland, 4056 Contact: Nicolas Von der Weid    + 41 61 704 12 12    nicolas.vonderweid@ukbb.ch    HUG Hôpitaux Universitaire de Genève, Unité d'onco-hématologie pédiatrique Recruiting Geneva, Switzerland, 1211 Contact: Marc Ansari    +41 22 372 47 31    Marc.Ansari@hcuge.ch    Universitäts-Kinderspital Recruiting Zurich, Switzerland, 8032 Contact: Güngör Tayfun    +41 44 266 74 92    tayfun.guengoer@kispi.uzh.ch Less <<
NCT03103971 Adult B Acute Lymphoblastic Le... More >>ukemia BCL2 Gene Rearrangement BCL6 Gene Rearrangement CD19 Positive Diffuse Large B-Cell Lymphoma, Not Otherwise Specified MYC Gene Rearrangement Recurrent Adult Acute Lymphoblastic Leukemia Recurrent B-Cell Non-Hodgkin Lymphoma Recurrent Diffuse Large B-Cell Lymphoma Recurrent Mediastinal (Thymic) Large B-Cell Cell Lymphoma Refractory Adult Acute Lymphoblastic Leukemia Refractory B-Cell Non-Hodgkin Lymphoma Refractory Diffuse Large B-Cell Lymphoma Refractory Mediastinal (Thymic) Large B-Cell Cell Lymphoma Transformed Recurrent Non-Hodgkin Lymphoma Less << Phase 1 Recruiting July 17, 2033 United States, Washington ... More >> Fred Hutch/University of Washington Cancer Consortium Recruiting Seattle, Washington, United States, 98109 Contact: Cameron J. Turtle    206-667-7073    cturtle@fredhutch.org    Principal Investigator: Cameron J. Turtle Less <<
NCT03391466 Relapsed/Refractory Diffuse La... More >>rge B-Cell Lymphoma (DLBCL) Less << Phase 3 Recruiting January 15, 2035 -
NCT00105001 Myelodysplastic/Myeloprolifera... More >>tive Neoplasm, Unclassifiable Previously Treated Myelodysplastic Syndrome Refractory Chronic Lymphocytic Leukemia Refractory Plasma Cell Myeloma Waldenstrom Macroglobulinemia Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive Adult Acute Lymphoblastic Leukemia in Remission Adult Acute Myeloid Leukemia in Remission Adult Acute Myeloid Leukemia With t(9;11)(p22;q23); MLLT3-MLL Adult Acute Myeloid Leukemia With Inv(16)(p13.1q22); CBFB-MYH11 Adult Acute Promyelocytic Leukemia With t(15;17)(q22;q12); PML-RARA Adult Acute Myeloid Leukemia With t(8;21)(q22;q22); RUNX1-RUNX1T1 Atypical Chronic Myeloid Leukemia, BCR-ABL1 Negative Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive Childhood Acute Lymphoblastic Leukemia in Remission Childhood Acute Myeloid Leukemia in Remission Childhood Burkitt Lymphoma Childhood Chronic Myelogenous Leukemia, BCR-ABL1 Positive Childhood Diffuse Large Cell Lymphoma Childhood Immunoblastic Lymphoma Childhood Myelodysplastic Syndrome Stage II Contiguous Adult Burkitt Lymphoma Stage II Contiguous Adult Diffuse Large Cell Lymphoma Stage II Contiguous Adult Diffuse Mixed Cell Lymphoma Stage II Contiguous Adult Diffuse Small Cleaved Cell Lymphoma Stage II Adult Contiguous Immunoblastic Lymphoma Stage II Contiguous Adult Lymphoblastic Lymphoma Stage II Grade 1 Contiguous Follicular Lymphoma Stage II Grade 2 Contiguous Follicular Lymphoma Stage II Grade 3 Contiguous Follicular Lymphoma Stage II Contiguous Mantle Cell Lymphoma Stage II Non-Contiguous Adult Burkitt Lymphoma Stage II Non-Contiguous Adult Diffuse Large Cell Lymphoma Stage II Non-Contiguous Adult Diffuse Mixed Cell Lymphoma Stage II Non-Contiguous Adult Diffuse Small Cleaved Cell Lymphoma Stage II Adult Non-Contiguous Immunoblastic Lymphoma Stage II Non-Contiguous Adult Lymphoblastic Lymphoma Stage II Grade 1 Non-Contiguous Follicular Lymphoma Stage II Grade 2 Non-Contiguous Follicular Lymphoma Stage II Grade 3 Non-Contiguous Follicular Lymphoma Stage II Non-Contiguous Mantle Cell Lymphoma Stage II Small Lymphocytic Lymphoma Recurrent Adult Acute Lymphoblastic Leukemia Recurrent Adult Acute Myeloid Leukemia Recurrent Adult Burkitt Lymphoma Recurrent Adult Diffuse Large Cell Lymphoma Recurrent Adult Diffuse Mixed Cell Lymphoma Recurrent Adult Diffuse Small Cleaved Cell Lymphoma Recurrent Adult Hodgkin Lymphoma Recurrent Adult Immunoblastic Lymphoma Recurrent Adult Lymphoblastic Lymphoma Recurrent Childhood Acute Lymphoblastic Leukemia Recurrent Childhood Acute Myeloid Leukemia Recurrent Childhood Anaplastic Large Cell Lymphoma Recurrent Childhood Large Cell Lymphoma Recurrent Childhood Lymphoblastic Lymphoma Recurrent Childhood Burkitt Lymphoma Recurrent Grade 1 Follicular Lymphoma Recurrent Grade 2 Follicular Lymphoma Recurrent Grade 3 Follicular Lymphoma Recurrent Mantle Cell Lymphoma Recurrent Marginal Zone Lymphoma Recurrent Small Lymphocytic Lymphoma Recurrent Childhood Hodgkin Lymphoma Recurrent Chronic Myelogenous Leukemia, BCR-ABL1 Positive Secondary Myelodysplastic Syndrome Stage I Adult Burkitt Lymphoma Stage I Adult Diffuse Large Cell Lymphoma Stage I Adult Diffuse Mixed Cell Lymphoma Stage I Adult Immunoblastic Lymphoma Stage I Adult Lymphoblastic Lymphoma Stage I Childhood Anaplastic Large Cell Lymphoma Stage I Childhood Large Cell Lymphoma Stage I Childhood Lymphoblastic Lymphoma Stage I Childhood Burkitt Lymphoma Stage I Grade 1 Follicular Lymphoma Stage I Grade 2 Follicular Lymphoma Stage I Grade 3 Follicular Lymphoma Stage I Mantle Cell Lymphoma Stage I Marginal Zone Lymphoma Stage I Small Lymphocytic Lymphoma Stage II Childhood Anaplastic Large Cell Lymphoma Stage II Childhood Lymphoblastic Lymphoma Stage II Childhood Burkitt Lymphoma Stage III Adult Burkitt Lymphoma Stage III Adult Diffuse Large Cell Lymphoma Stage III Adult Diffuse Mixed Cell Lymphoma Stage III Adult Diffuse Small Cleaved Cell Lymphoma Stage III Adult Immunoblastic Lymphoma Stage III Adult Lymphoblastic Lymphoma Stage III Childhood Anaplastic Large Cell Lymphoma Stage III Childhood Large Cell Lymphoma Stage III Childhood Lymphoblastic Lymphoma Stage III Childhood Burkitt Lymphoma Stage III Grade 1 Follicular Lymphoma Stage III Grade 2 Follicular Lymphoma Stage III Grade 3 Follicular Lymphoma Stage III Mantle Cell Lymphoma Stage III Marginal Zone Lymphoma Stage III Small Lymphocytic Lymphoma Stage IV Adult Burkitt Lymphoma Stage IV Adult Diffuse Large Cell Lymphoma Stage IV Adult Diffuse Mixed Cell Lymphoma Stage IV Adult Diffuse Small Cleaved Cell Lymphoma Stage IV Adult Immunoblastic Lymphoma Stage IV Adult Lymphoblastic Lymphoma Stage IV Childhood Anaplastic Large Cell Lymphoma Stage IV Childhood Large Cell Lymphoma Stage IV Childhood Lymphoblastic Lymphoma Stage IV Childhood Burkitt Lymphoma Stage IV Grade 1 Follicular Lymphoma Stage IV Grade 2 Follicular Lymphoma Stage IV Grade 3 Follicular Lymphoma Stage IV Mantle Cell Lymphoma Stage IV Marginal Zone Lymphoma Stage IV Small Lymphocytic Lymphoma Less << Phase 2 Completed - United States, Colorado ... More >> Presbyterian - Saint Lukes Medical Center - Health One Denver, Colorado, United States, 80218 United States, Georgia Emory University/Winship Cancer Institute Atlanta, Georgia, United States, 30322 United States, Utah Huntsman Cancer Institute/University of Utah Salt Lake City, Utah, United States, 84112 LDS Hospital Salt Lake City, Utah, United States, 84143 United States, Washington Veterans Administration Center-Seattle Seattle, Washington, United States, 98108 Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States, 98109 United States, Wisconsin Froedtert and the Medical College of Wisconsin Milwaukee, Wisconsin, United States, 53226 Denmark Rigshospitalet University Hospital Copenhagen, Denmark, 2100 Germany Medizinische Univ Klinik Koln Koln, Germany, 50924 Universitaet Leipzig Leipzig, Germany, D-04103 University of Tuebingen-Germany Tuebingen, Germany, D-72076 Less <<
NCT02750254 Acute Myeloid Leukemia ... More >> Myelodysplastic Syndrome Acute Lymphocytic Leukemia Less << Phase 1 Active, not recruiting October 14, 2020 United States, Missouri ... More >> Washington University School of Medicine Saint Louis, Missouri, United States, 63110 Less <<
NCT03602157 Lymphoma Lymp... More >>homa, Non-Hodgkin Immune System Diseases Immunoproliferative Disorders Lymphatic Diseases Lymphoproliferative Disorders Neoplasms Less << Phase 1 Recruiting May 30, 2036 United States, North Carolina ... More >> Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill Recruiting Chapel Hill, North Carolina, United States, 27599 Contact: Catherine Cheng    919-445-4208    catherine_cheng@med.unc.edu    Contact: Spencer Laing    919-962-8618    spencer.laing@med.unc.edu Less <<
NCT00719849 - Terminated(A new protocol was ... More >>developed to replace this protocol in 2008, with removal of ATG and extension of MMF duration.) Less << - -
NCT00105001 - Completed - -
NCT02588612 Neoplasms Phase 1 Active, not recruiting September 19, 2019 United States, Florida ... More >> GSK Investigational Site Tampa, Florida, United States, 33612 United States, Texas GSK Investigational Site Houston, Texas, United States, 77030 Less <<
NCT02727803 Leukemia Lymp... More >>homa Myeloma Myeloproliferative Diseases Less << Phase 2 Recruiting May 2021 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Less <<
NCT03326921 HLA-A*0201 HA-1 Positive Cells... More >> Present Juvenile Myelomonocytic Leukemia Recurrent Acute Biphenotypic Leukemia Recurrent Acute Undifferentiated Leukemia Recurrent Adult Acute Lymphoblastic Leukemia Recurrent Adult Acute Myeloid Leukemia Recurrent Childhood Acute Lymphoblastic Leukemia Recurrent Childhood Acute Myeloid Leukemia Refractory Acute Myeloid Leukemia Refractory Adult Acute Lymphoblastic Leukemia Refractory Childhood Acute Lymphoblastic Leukemia Allogeneic Hematopoietic Stem Cell Transplantation Recipient Blast Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive Chronic Myelomonocytic Leukemia Donor Recurrent Blastic Plasmacytoid Dendritic Cell Neoplasm Recurrent Myelodysplastic Syndrome Refractory Blastic Plasmacytoid Dendritic Cell Neoplasm Refractory Myelodysplastic Syndrome Less << Phase 1 Recruiting October 16, 2020 United States, Washington ... More >> Fred Hutch/University of Washington Cancer Consortium Recruiting Seattle, Washington, United States, 98109 Contact: Marie Bleakley    206-667-6572    mbleakle@fredhutch.org    Principal Investigator: Marie Bleakley Less <<
NCT02876510 Cancer Solid ... More >>Tumor Less << Phase 1 Recruiting September 2019 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact: Apostolia M. Tsimberidou, M.D., Ph.D. Less <<
NCT00533923 AML ALL ... More >> CLL Myelodysplastic Syndrome Non-Hodgkin's Lymphoma Hodgkin's Lymphoma Multiple Myeloma Aplastic Anemia Myeloproliferative Disorder Less << Phase 2 Completed - United States, Massachusetts ... More >> Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02215 Less <<
NCT00103558 Chronic Lymphocytic Leukemia Phase 1 Phase 2 Completed - United States, Alabama ... More >> Research Site Birmingham, Alabama, United States United States, California Research Site San Diego, California, United States United States, Maryland Research Site Baltimore, Maryland, United States United States, Ohio Research Site Columbus, Ohio, United States United States, Texas Research Site Houston, Texas, United States Less <<
NCT03380039 Refractory or Relapsed Multipl... More >>e Myeloma Less << Not Applicable Recruiting September 30, 2020 China, Shanghai ... More >> Xin Hua Hospital of Shanghai Jiao Tong University of Medicine Recruiting Shanghai, Shanghai, China, 200092 Contact: Siguo Hao, MD    +86-021-25077600    haosghj88@hotmail.com    Principal Investigator: Siguo Hao, MD Less <<
NCT02861417 Other Diseases of Blood and Bl... More >>ood-forming Organs Acute Myeloid Leukemia Acute Lymphocytic Leukemia Chronic Myeloid Leukemia Chronic Lymphocytic Leukemia Myelodysplastic Syndrome Myeloproliferative Syndrome Non-Hodgkins Lymphoma Hodgkins Lymphoma Multiple Myeloma Less << Phase 2 Recruiting August 2022 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Less <<
NCT03666000 Non-Hodgkin Lymphoma ... More >> B-cell Acute Lymphoblastic Leukemia Less << Phase 1 Phase 2 Not yet recruiting August 2021 United States, Florida ... More >> H. Lee Moffitt Cancer Center Not yet recruiting Tampa, Florida, United States, 33612 Less <<
NCT03716856 Refractory or Relapsed Multipl... More >>e Myeloma Less << Phase 1 Recruiting August 31, 2020 China, Zhejiang ... More >> First Affiliated Hospital of Zhejiang University Recruiting Hangzhou, Zhejiang, China, 310006, Contact: Jin Jie, MD    +86-0571-87236896    jiej0503@163.com    Contact: Haitao Meng, MD    +86-0571-87236896    menghait2004@163.com Less <<
NCT02960646 Leukemia Phase 1 Recruiting January 1, 2020 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact       sciurea@mdanderson.org Less <<
NCT00961142 Acute Myeloid Leukemia ... More >> Acute Lymphoblastic Leukemia Less << Phase 2 Terminated(slow recruitment) - Germany ... More >> University of Dresden Medical Center Dresden, Germany, D-01307 Center for Marrow Transplantation, University of Essen Essen, Germany, 45122 Medical Center University of Halle Halle, Germany, 06120 Medical Center University of Hamburg Hamburg, Germany, 20246 Medical Center University of Muenster Muenster, Germany, 48149 South West German Cancer Center, University of Tuebingen Medical Center Tuebingen, Germany, 72076 Deutsche Klinik für Diagnostik Wiesbaden, Germany, 65191 University of Wuerzburg Medical Center Wuerzburg, Germany, D-97070 Less <<
NCT00947388 Recurrent Small Lymphocytic Ly... More >>mphoma Refractory Chronic Lymphocytic Leukemia Stage III Chronic Lymphocytic Leukemia Stage III Small Lymphocytic Lymphoma Stage IV Chronic Lymphocytic Leukemia Stage IV Small Lymphocytic Lymphoma Less << Phase 1 Terminated(No more eligible pa... More >>tients) Less << - United States, Ohio ... More >> Case Medical Center, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States, 44106 Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center Cleveland, Ohio, United States, 44195 Less <<
NCT01141543 - Completed - Canada, Ontario ... More >> Princess Margaret Hospital Toronto, Ontario, Canada, M5G 2M9 Less <<
NCT02118311 Hematologic Malignancies Phase 2 Withdrawn(Changing study desig... More >>n. Will replace with a different protocol.) Less << September 2018 United States, Minnesota ... More >> University of Minnesota Masonic Cancer Center Minneapolis, Minnesota, United States, 55455 Less <<
NCT03170141 Glioblastoma Multiforme of Bra... More >>in Glioblastoma Multiforme Less << Phase 1 Enrolling by invitation December 2020 China, Guangdong ... More >> Shenzhen Geno-immune Medical Institute Shenzhen, Guangdong, China, 518000 Less <<
NCT01985061 Myelodysplastic Syndrome ... More >> Acute Myeloid Leukemia Less << Phase 2 Recruiting December 2018 France ... More >> Institut Paoli Calmettes Recruiting Marseille, France, 13009 Contact: Dominique GENRE, MD    33491223778    drci.up@ipc.unicancer.fr    Contact: Jihane PAKRADOUNI, PharmD, PhD    33491223778    drci.up@ipc.unicancer.fr    Principal Investigator: Didier BLAISE, MD PhD Less <<
NCT03233854 B Acute Lymphoblastic Leukemia... More >> CD19 Positive Diffuse Large B-Cell Lymphoma Associated With Chronic Inflammation Diffuse Large B-Cell Lymphoma, Not Otherwise Specified Epstein-Barr Virus Positive Diffuse Large B-Cell Lymphoma of the Elderly Minimal Residual Disease Philadelphia Chromosome Positive Recurrent Diffuse Large B-Cell Lymphoma Recurrent Mediastinal (Thymic) Large B-Cell Cell Lymphoma Refractory Diffuse Large B-Cell Lymphoma Refractory Mediastinal (Thymic) Large B-Cell Cell Lymphoma T-Cell/Histiocyte-Rich Large B-Cell Lymphoma Less << Phase 1 Recruiting September 1, 2035 United States, California ... More >> Stanford University, School of Medicine Recruiting Palo Alto, California, United States, 94304 Contact: Matthew Abramian    650-736-3351    abramian@stanford.edu    Principal Investigator: David B. Miklos Less <<
NCT01478074 Acute Myeloid Leukemia Phase 1 Withdrawn(The treatment planne... More >>d was determined to be of low feasibility as no subject was found eligible and able to enroll after screening over 30 subjects) Less << - United States, Texas ... More >> MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT02566304 Acute Myeloid Leukemia ... More >> Acute Myeloid Leukemia in Remission Aplastic Anemia Chronic Myelomonocytic Leukemia Hodgkin Lymphoma Indolent Non-Hodgkin Lymphoma Malignant Neoplasm Myelodysplastic Syndrome Myeloproliferative Neoplasm Plasma Cell Myeloma Refractory Anemia Refractory Anemia With Excess Blasts Refractory Anemia With Ring Sideroblasts Refractory Cytopenia With Multilineage Dysplasia Refractory Cytopenia With Multilineage Dysplasia and Ring Sideroblasts Less << Phase 2 Recruiting January 2021 United States, Pennsylvania ... More >> Thomas Jefferson University Recruiting Philadelphia, Pennsylvania, United States, 19107 Contact: Dolores Grosso, DNP, CRNP    215-955-8874       Principal Investigator: Dolores Grosso, DNP, CRNP          Principal Investigator: Neal Flomenberg, MD          Sub-Investigator: S. Onder Alpdogan, MD          Sub-Investigator: Matthew Carabasi, MD          Sub-Investigator: Joanne Filicko-O'Hara, MD          Sub-Investigator: Margaret Kasner, MD          Sub-Investigator: Thomas Klumpp, MD          Sub-Investigator: William O'Hara, PharmD          Sub-Investigator: Ubaldo Martinez Outschoorn, MD          Sub-Investigator: Manish Sharma, MD          Sub-Investigator: John Wagner, MD          Sub-Investigator: Mark Weiss, MD Less <<
NCT03241940 B Acute Lymphoblastic Leukemia... More >> CD19 Positive Minimal Residual Disease Philadelphia Chromosome Positive Recurrent Adult Acute Lymphoblastic Leukemia Recurrent Childhood Acute Lymphoblastic Leukemia Refractory Acute Lymphoblastic Leukemia Less << Phase 1 Recruiting August 1, 2035 United States, California ... More >> Lucile Packard Children's Hospital Stanford University Recruiting Palo Alto, California, United States, 94304 Contact: Christin New    650-497-8815    newc@stanford.edu    Principal Investigator: Crystal L. Mackall Less <<
NCT00924326 Primary Mediastinal B-cell Lym... More >>phoma Diffuse, Large B-cell Lymphoma Diffuse Large B-Cell Lymphoma Transformed From Follicular Lymphoma Mantle Cell Less << Phase 1 Phase 2 Active, not recruiting December 31, 2020 United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT02439788 Neuroblastoma Phase 1 Withdrawn(Based on newly avail... More >>able preclinical data we changed the CAR construct to a more effective version and will now study that product on a different protocol.) Less << October 2030 United States, Texas ... More >> Texas Children's Hospital Houston, Texas, United States, 77030 Less <<
NCT02763475 Acute Myeloid Leukemia ... More >> Leukemia Myeloid Leukemia Less << Phase 2 Recruiting February 2022 Spain ... More >> Hospital Universitario de Cruces Recruiting Barakaldo, Vizcaya, Spain, 48903 Principal Investigator: Itciar Astigarraga Aguirre, MD          Hospital Materno Infantil de Badajoz Recruiting Badajoz, Spain, 06010 Principal Investigator: Jose Manuel Vagace Valero, MD          Hospital Universitario 12 de Octubre Recruiting Madrid, Spain, 28041 Contact    0034913908868       Principal Investigator: José Luis Vivanco Martínez, MD.          Hospital Universitario La Paz Recruiting Madrid, Spain, 28046 Contact: María Posada, MSc.    0034912071466    maria.posada@idipaz.es    Contact: Alicia Herranz Estelles, MD, MSc    0034912071466    alicia.herranz@idipaz.es    Principal Investigator: Antonio Pérez Martínez, MD, PhD          Hospital de la Arrixaca Recruiting Murcia, Spain, 30120 Principal Investigator: José Luis Fuster, MD          Hospital Materno-Infantil de Málaga Recruiting Málaga, Spain, 29011 Principal Investigator: Antonia Pascual Martínez, MD Less <<
NCT01619761 Leukemia Chro... More >>nic Lymphocytic Leukemia Less << Phase 1 Recruiting May 2019 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Less <<
NCT02791919 CNS 2a CNS 2b... More >> CNS 2c CNS1 Recurrent Adult Acute Myeloid Leukemia Recurrent Childhood Acute Myeloid Leukemia Less << Phase 1 Withdrawn(Other - Protocol mov... More >>ed to Disapproved) Less << May 31, 2019 -
NCT02007863 Leukemia Myel... More >>odysplasia Acute Lymphocytic Leukemia Acute Myelogenous Leukemia Less << Not Applicable Completed - United States, Florida ... More >> Jackson Memorial Hospital Miami, Florida, United States, 33136 University of Miami Sylvester Comprehensive Cancer Center Miami, Florida, United States, 33136 Less <<
NCT03502577 Recurrent Plasma Cell Myeloma ... More >> Refractory Plasma Cell Myeloma Less << Phase 1 Recruiting July 30, 2034 United States, Washington ... More >> Fred Hutch/University of Washington Cancer Consortium Recruiting Seattle, Washington, United States, 98109 Contact: Immunotherapy Trials Intake, SCCA    206-606-4668    immunotherapy@seattlecca.org    Principal Investigator: Andrew J. Cowan Less <<
NCT02007863 - Completed - -
NCT01953900 Osteosarcoma ... More >>Neuroblastoma Less << Phase 1 Recruiting April 2036 United States, Texas ... More >> Houston Methodist Hospital Recruiting Houston, Texas, United States, 77030 Contact: Lisa L Wang, MD    832-824-4822    llwang@texaschildrens.org    Contact: Jacqueline Castello    832-824-4391    jxcastel@texaschildrens.org    Principal Investigator: Lisa L Wang, MD          Texas Children's Hospital Recruiting Houston, Texas, United States, 77030 Contact: Sarah Whittle, MD    832-824-1471    sbwhittl@txch.org    Contact: Jacqueline Castello    832-824-4391    jxcastel@texaschildrens.org    Principal Investigator: Sara Whittle, MD Less <<
NCT01493453 CD19 Positive Non-Hodgkin Lymp... More >>homa Less << Phase 1 Unknown December 2014 United Kingdom ... More >> The Christie NHS Foundation Trust Recruiting Manchester, United Kingdom, M20 3EE Contact: Ian Emerson, BA    01619187443    ian.emerson@christie.nhs.uk    Principal Investigator: Robert E Hawkins, BA, MB BS, MCRP, Phd, FRCP          Sub-Investigator: Fiona C Thistlethwaite, MB BChir, PhD, MRCP Less <<
NCT02333058 Acute Lymphoblastic Leukaemias... More >> (ALL) Acute Myeloid Leukaemias (AML) Myelodysplastic Syndromes (MDS) Juvenile Myelomonocytic Leukaemias (JMML) Less << Phase 2 Active, not recruiting September 2019 Austria ... More >> St. Anna Children Hospital Vienna, Austria, A-1090 Czechia University Hospital Motol, Charles University, Prague Prague, Czechia, 150-06 Germany University Clinic Düsseldorf Düsseldorf, Germany, 40225 University Clinic Erlangen-Nürnberg Erlangen, Germany, 91054 University Hospital Johann Wolfgang Goethe Frankfurt, Germany, 60590 University Clinic Hamburg-Eppendorf Hamburg, Germany, 20246 Medical University Hannover Hannover, Germany, 30625 University Clinic Heidelberg Heidelberg, Germany, 69120 University Clinic Jena Jena, Germany, 07740 University Clinic München München, Germany, 80804 Univercity Clinic Münster Münster, Germany, 48129 University Clinic Regensburg Regensburg, Germany, 93053 University Clinic Ulm Ulm, Germany, 89075 University Clinic Würzburg Würzburg, Germany, 97080 Italy Ospedale Bambino Gesu Roma Rome, Italy, 00165 Ospedale Infantile Regina Margherita Torino Turin, Italy, 10126 Poland Bydgoszcz Medical University Bydgoszcz, Poland, 85-094 Kraków Medical University Kraków, Poland, 30-663 Lublin Medical University Lublin, Poland, 20-093 Wroclaw Medical University Wroclaw, Poland, 50-368 United Kingdom Birmingham Children's Hospital Birmingham, United Kingdom, B4 6NH Central Manchester University Hospital Manchester, United Kingdom, M13 9WL Sheffield Children's Hospital Sheffield, United Kingdom, S10 2TH Less <<
NCT00714259 - Terminated(Accrual goals could... More >> not be met within a timely manner) Less << - -
NCT03101709 B Cell Lymphoma Phase 1 Recruiting July 2019 China, Henan ... More >> Henan Cancer Hospital Recruiting Zhengzhou, Henan, China Contact: Yongping Song    -86-13521186987    ph200811@163.com    Contact: Yongping Song          Principal Investigator: Yongping Song, MD Less <<
NCT00714259 Multiple Myeloma ... More >> CLL / SLL Non Hodgkin's Lymphoma Waldenstroms Mantle Cell Lymphoma Less << Phase 2 Phase 3 Terminated(Accrual goals could... More >> not be met within a timely manner) Less << - United States, Alabama ... More >> University of Alabama in Birmingham BMT/CT Program Outpatient Clinic Birmingham, Alabama, United States, 35249-6979 Less <<
NCT03528421 Non Hodgkin Lymphoma Phase 1 Recruiting May 2020 China, Beijing ... More >> Beijing Cancer Hospital Recruiting Beijing, Beijing, China Contact: Xinan Lu, Dr.          Principal Investigator: Jun Zhu Less <<
NCT02127905 Fanconi Anemia Not Applicable Withdrawn(Study was stopped du... More >>e to non-enrollment of subjects due to rarity of disease.) Less << - United States, California ... More >> Children's Hospital Los Angeles Los Angeles, California, United States, 90027 Less <<
NCT00376805 Breast Cancer Phase 2 Terminated(Withdrawn due to to... More >>xicity) Less << - United States, Minnesota ... More >> Masonic Cancer Center at University of Minnesota Minneapolis, Minnesota, United States, 55455 Less <<
NCT00060684 Lymphoma, Low-Grade ... More >> Lymphoma, Small Lymphocytic Lymphoma, Mixed-Cell, Follicular Lymphoma, Small Cleaved-Cell, Follicular Less << Phase 1 Completed - United States, Arizona ... More >> Arizona Clinical Research Center Tucson, Arizona, United States, 85712 United States, Maryland Greater Baltimore Medical Center Baltimore, Maryland, United States, 21204 United States, New Mexico New Mexico Onc/Hem Consultants, Inc. Albuquerque, New Mexico, United States, 87109 United States, Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT02924753 B-cell Acute Lymphoblastic Leu... More >>kemia Less << Phase 1 Recruiting December 2019 China, Henan ... More >> Henan Cancer Hospital Recruiting Zhengzhou, Henan, China Contact: Yongping Song       ph200811@163.com Less <<
NCT00376805 - Terminated(Withdrawn due to to... More >>xicity) Less << - -
NCT03044743 Stage IV Gastric Carcinoma ... More >> Stage IV Nasopharyngeal Carcinoma T-Cell Lymphoma Stage IV Stage IV Adult Hodgkin Lymphoma Stage IV Diffuse Large B-Cell Lymphoma Less << Phase 1 Phase 2 Recruiting March 2022 China, Jiangsu ... More >> The Comprehensive Cancer Center of Nanjing Drum Tower Hospital Recruiting Nanjing, Jiangsu, China, 210008 Contact: Yang Yang, MD,PhD,MSCR    0086-18602568379    wing_young7@hotmail.com    Contact: Jing Yan, MD    0086-15805182426    firefreebird@163.com    The Comprehensive Cancer Center of Nanjing Drum Tower Hospital Recruiting Nanjing, Jiangsu, China, 210008 Contact: Yang Yang    18602568379    wing_young7@hotmail.com Less <<
NCT02626715 Acute Myeloid Leukemia (AML) ... More >> Myelodysplastic Syndrome (MDS) Hematopoietic Stem Cell Transplant (HSCT) Less << Phase 2 Recruiting September 2021 United States, Pennsylvania ... More >> Children's Hospital of Pittsburgh of UPMC Recruiting Pittsburgh, Pennsylvania, United States, 15224 Contact: Randy Windreich, MD    412-692-5055 Less <<
NCT03146533 B Cell Lymphoma Phase 1 Phase 2 Recruiting October 2019 China, Guangdong ... More >> The Second People's Hospital of Shenzhen Recruiting Shenzhen, Guangdong, China Contact: geng tian    13724395569    tiangeng666@aliyun.com    Principal Investigator: geng tian Less <<
NCT03426969 Myelofibrosis Early Phase 1 Recruiting November 2020 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact       sciurea@mdanderson.org Less <<
NCT01246557 Chronic Lymphatic Leukemia Phase 1 Phase 2 Completed - Spain ... More >> Centro Médico Teknon Barcelona, Spain, 08022 Hospital de la Santa Creu i Sant Pau Barcelona, Spain, 08025 Hospital Universitari Valle Hebron Barcelona, Spain, 08035 Hospital Clinico Universitario de Barcelona Barcelona, Spain, 08036 Hospital Joan XXIII Tarragona, Spain, 43007 Hospital Clínico Universitario de Valencia Valencia, Spain, 46010 Less <<
NCT03263208 B-cell Acute Lymphocytic Leuke... More >>mia Less << Phase 1 Phase 2 Recruiting July 2019 China, Henan ... More >> The First Affiliated Hospital of Henan University of Science and Technology Not yet recruiting Luoyang, Henan, China Contact: Haiping Yang    +86 13938820189    13938820189@163.com    Henan Cancer Hospital Recruiting Zhengzhou, Henan, China Contact: Yongping Song    +86 13521186987    ph200811@163.com Less <<
NCT00524667 Chronic Lymphocytic Leukemia Phase 2 Terminated(Terminated due to p... More >>oor accrual.) Less << - Canada, Manitoba ... More >> CancerCare Manitoba Winnipeg, Manitoba, Canada, R3E 0V9 Less <<
NCT03600558 - Recruiting May 2019 China, Tianjin ... More >> Tianjin Medical University General Hospital Recruiting Tianjin, Tianjin, China, 300000 Contact: Zonghong Shao, MD Less <<
NCT03344705 Hematological Malignancies Phase 1 Recruiting December 1, 2020 China, Beijing ... More >> Peking University Third Hospital Recruiting Beijing, Beijing, China Contact: Xinan Lu, Dr    86-189-1157-6946    luxian@immunochina.com Less <<
NCT00683046 - Completed - -
NCT03214562 Other Diseases of Blood and Bl... More >>ood-forming Organs Acute Myeloid Leukemia Less << Phase 1 Phase 2 Recruiting September 2023 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Contact       cdinardo@mdanderson.org Less <<
NCT01490723 Leukemia Lymp... More >>homa Less << Phase 2 Active, not recruiting January 2019 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT01962636 Acute Myeloid Leukemia (AML) ... More >> Acute Lymphocytic Leukemia (ALL) Chronic Myelogenous Leukemia Plasma Cell Leukemia Myelofibrosis Myelodysplasia Chronic Lymphocytic Leukemia Small Lymphocytic Lymphoma Marginal Zone B-Cell Lymphoma Follicular Lymphoma Lymphoplasmacytic Lymphoma Mantle-Cell Lymphoma Prolymphocytic Leukemia Diffuse Large B Cell Lymphoma Lymphoblastic Lymphoma Burkitt's Lymphoma Non-Hodgkin Lymphoma Multiple Myeloma Less << Not Applicable Recruiting October 2023 United States, Minnesota ... More >> University of Minnesota Masonic Cancer Center Recruiting Minneapolis, Minnesota, United States, 55455 Contact: Claudio Brunstein, MD    612-625-3918    bruns072@umn.edu    Principal Investigator: Claudio Brunstein, MD Less <<
NCT01129323 Severe Aplastic Anemia Not Applicable Withdrawn(This study did not a... More >>ccrue any subjects and due to this will be closed.) Less << - -
NCT00683046 Acute Myelogenous Leukemia ... More >> Lymphoid Leukemia Chronic Myelogenous Leukemia Malignant Lymphoma Hodgkin's Disease Chronic Lymphocytic Leukemia Myeloproliferative Disorder Anemia, Aplastic Myelodysplastic Syndromes Less << Phase 2 Completed - United States, Illinois ... More >> The University of Chicago Chicago, Illinois, United States, 60637 Less <<
NCT01113632 - Completed - -
NCT00881556 Epidermolysis Bullosa Early Phase 1 Unknown July 2014 United States, Colorado ... More >> The Children's Hospital Aurora, Colorado, United States, 80045 United States, Illinois Children's Memorial Hospital Chicago, Illinois, United States, 60614 United States, New York Morgan Stanley Children's Hospital of NYP New York, New York, United States, 10032 Less <<
NCT00899431 Chronic Lymphocytic Leukemia Phase 2 Active, not recruiting May 2019 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT01113632 Chronic Lymphocytic Leukemia ... More >> Small Lymphocytic Lymphoma Less << Phase 2 Completed - United States, California ... More >> Los Robles Thousand Oaks, California, United States, 91360 United States, Florida Florida Cancer Specialists Ft. Myers, Florida, United States, 34236 Woodlands Medical Specialists Pensacola, Florida, United States, 32503 United States, Georgia Northeast Georgia Medical Center Gainesville, Georgia, United States, 30501 United States, Indiana Providence Medical Group Terre Haute, Indiana, United States, 47802 United States, Missouri St. Louis Cancer Care Chesterfield, Missouri, United States, 63017 United States, New Hampshire Portsmouth Regional Hospital Portsmouth, New Hampshire, United States, 03801 United States, New Jersey Hematology-Oncology Associates of Northern NJ Morristown, New Jersey, United States, 07960 United States, Ohio Oncology Hematology Care Cincinnati, Ohio, United States, 45242 The Ohio State University Columbus, Ohio, United States, 43210 United States, South Carolina South Carolina Oncology Associates Columbia, South Carolina, United States, 29210 United States, Tennessee Chattanooga Oncology Hematology Associates Chattanooga, Tennessee, United States, 37404 Tennessee Oncology Nashville, Tennessee, United States, 37203 Less <<
NCT00056966 Hematologic Malignancy Phase 1 Phase 2 Completed - United States, Texas ... More >> Texas Children's Hospital Houston, Texas, United States, 77030 The Methodist Hospital Houston, Texas, United States, 77030 Less <<
NCT01445821 Scleroderma, Systemic Phase 3 Recruiting September 2019 United States, Illinois ... More >> Northwestern University Recruiting Chicago, Illinois, United States, 60611 Sub-Investigator: Sanjiv Shah, MD          Sub-Investigator: Eric Ruderman, MD          Principal Investigator: Richard Burt, MD Less <<
NCT02379195 Metastatic Melanoma Phase 1 Phase 2 Active, not recruiting January 2020 Denmark ... More >> Center for Cancer Immune Therapy, Dept. of Haematology/Oncology Copenhagen, Herlev, Denmark, 2730 Less <<
NCT01156350 Neuroblastoma Phase 2 Unknown September 2014 France ... More >> CHU Clermont-Ferrand Not yet recruiting Clermont-Ferrand, France, 63003 Contact: Patrick LACARIN    04 73 75 11 95    placarin@chu-clermontferrand.fr Less <<
NCT02111863 Melanoma Skin... More >> Cancer Less << Phase 2 Terminated(Study terminated du... More >>e to low accrual and change in research focus.) Less << - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT03697824 Neoplasms Phase 2 Not yet recruiting July 17, 2022 -
NCT00950846 Congenital Pediatric Disorders Not Applicable Recruiting January 2025 United States, Texas ... More >> Texas Children's Hospital Recruiting Houston, Texas, United States, 77030 Contact: Caridad A Martinez, MD    832-824-4692    camartin@txch.org    Contact: Marlen Dinu    832-824-4881    mxdinu@txch.org Less <<
NCT02500576 Melanoma Phase 2 Recruiting August 1, 2020 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Less <<
NCT02111863 - Terminated(Study terminated du... More >>e to low accrual and change in research focus.) Less << - -
NCT00531310 Chronic Myeloid Leukemia Phase 2 Terminated(Poor accrual) - United States, New York ... More >> Morgan Stanley Children's Hospital of NYP New York, New York, United States, 10032 Less <<
NCT00140569 Follicular Lymphoma Phase 3 Completed - Belgium ... More >> Groupe d'atude des lymphome de l'adulte Yvoir, Belgium France Hôpital Henri Mondor Créteil, France, 94010 Centre Léon Bérard Lyon, France, 69008 Hôpital Saint Louis Paris, France, 75010 Service d'Hématologie - Centre Hospitalier Lyon-Sud Pierre-Bénite cedex, France, 69495 Centre Hospitalier Robert Debré Reims, France, 51092 Centre Henri Becquerel Rouen, France, 76038 Institut Gustave Roussy Villejuif, France Less <<
NCT02529813 Leukemia Lymp... More >>homa Less << Phase 1 Recruiting December 2021 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Less <<
NCT01389427 Mantle Cell Lymphoma Refractor... More >>y Less << Phase 1 Phase 2 Completed - France ... More >> CHU de Grenoble MICHALLON Grenoble Cedex 9, Hôpital Nord 217, France, 38043 Hôtel Dieu - Université de Nantes Nantes cedex, Place Alexis Ricordeau, France, 44093 Hôpital Henri Mondor Creteil, France, 94010 CHU de Dijon Dijon, France, 21000 Hôpital Saint-Eloi Montpellier, France, 34295 Hôpital Saint Louis Paris, France, 75475 Hôpital Necker Paris, France, 75743 Groupe hospitalier Sud Hôpital Haut-Lévêque Pessac, France, 33604 Centre Hospitalier Lyon Sud Pierre Benite, France, 69310 CHU Pontchaillou Rennes, France, 35003 CHU de Tours - Hôpital Bretonneau Tours, France, 37000 Less <<
NCT02280525 Leukemia Phase 1 Active, not recruiting March 2021 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00153985 Hemoglobinopathies ... More >> Sickle Cell Disease Thalassemia Less << Phase 2 Completed - United States, Georgia ... More >> Winship Cancer Institute-Emory University Atlanta, Georgia, United States, 30322 United States, Louisiana Feist-Weiller Cancer Center-LSU Shreveport, Louisiana, United States, 71130 United States, Massachusetts Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02115 Dana-Farber Cancer Institute Boston, Massachusetts, United States, 02115 Massachusetts General Hospital Boston, Massachusetts, United States, 02115 United States, Ohio Ohio State University College of Medicine Columbus, Ohio, United States, 43210 Less <<
NCT00003619 Chronic Myeloproliferative Dis... More >>orders Leukemia Myelodysplastic Syndromes Thrombocytopenia Less << Phase 1 Phase 2 Completed - United States, Pennsylvania ... More >> Medical College of Pennsylvania Hospital Philadelphia, Pennsylvania, United States, 19129 Medical College of Pennsylvania Philadelphia, Pennsylvania, United States, 19129 Less <<
NCT00153985 - Completed - -
NCT01236573 Skin Cancer M... More >>etastatic Melanoma Less << Phase 1 Phase 2 Terminated(Unexpected toxiciti... More >>es, likely due to TIL/IL-12 & low % of durable responses.) Less << - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT03661515 Acute Myeloid Leukemia Phase 1 Recruiting December 2019 Spain ... More >> Hospital Germans Tries i Pujol, Badalona Recruiting Badalona, Spain Contact: Susana Vives, Dr       svives@iconcologia.net    Hospital San Pedro de Alcántara, Recruiting Cáceres, Spain Contact: Juan Bergua, Dr       jmbergua@icloud.com    Hospital Universitario 12 de Octubre, Recruiting Madrid, Spain Contact: Pilar Martinez-Sanchez, Dr       mpmartinezsa@yahoo.es    Hospital la Fe Recruiting Valencia, Spain Contact: Pau Montesinos, Dr       montesinos_pau@gva.es Less <<
NCT03196414 Multiple Myeloma Phase 1 Phase 2 Recruiting December 2026 China, Jiangsu ... More >> First Affiliated Hospital, Soochow University Recruiting Suzhou, Jiangsu, China, 215000 Contact: Ling zhi Yan, Phd    13584821140    yanlingzhi@suda.edu.cn Less <<
NCT00918450 B-cell Chronic Lymphocytic Leu... More >>kemia Less << Phase 2 Withdrawn(Sponsor has decided ... More >>to not proceed with this study.) Less << - -
NCT01236573 - Terminated(Unexpected toxiciti... More >>es, likely due to TIL/IL-12 & low % of durable responses.) Less << - -
NCT02280811 - Completed - -
NCT00378534 - Completed - -
NCT02280811 Vaginal Cancer ... More >> Cervical Cancer Anal Cancer Penile Cancer Oropharyngeal Cancer Less << Phase 1 Phase 2 Completed - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT00590460 - Terminated(slow accrual) - -
NCT00590460 Fanconi Anemia ... More >> Severe Aplastic Anemia Less << Phase 1 Phase 2 Terminated(slow accrual) - United States, Texas ... More >> Methodist Hospital Houston, Texas, United States, 77030 Texas Children's Hospital Houston, Texas, United States, 77030 Less <<
NCT00378534 Chronic Myelogenous Leukemia ... More >> Acute Myelogenous Leukemia Chronic Lymphocytic Leukemia Acute Lymphoblastic Leukemia Myelodysplastic Syndrome Less << Phase 2 Completed - United States, Maryland ... More >> National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States, 20892 Less <<
NCT01740557 Melanoma Phase 1 Phase 2 Recruiting January 2021 United States, Texas ... More >> University of Texas MD Anderson Cancer Center Recruiting Houston, Texas, United States, 77030 Less <<
NCT01822652 Neuroblastoma Phase 1 Active, not recruiting October 2030 United States, Texas ... More >> Houston Methodist Hospital Houston, Texas, United States, 77030 Texas Children's Hospital Houston, Texas, United States, 77030 Less <<
NCT01639456 Acute Myelogenous Leukemia Phase 2 Withdrawn(study was abandoned ... More >>and a new study was written to replace this one) Less << January 2017 United States, Minnesota ... More >> Masonic Cancer Center, University of Minnesota Minneapolis, Minnesota, United States, 55455 United States, Missouri Washington University School of Medicine Saint Louis, Missouri, United States, 63110 Less <<
NCT01518153 Leukemia Lymp... More >>homa Myeloma Myeloproliferative Diseases Less << Phase 2 Terminated(Objectives not met.... More >>) Less << - United States, Texas ... More >> University of Texas MD Anderson Cancer Center Houston, Texas, United States, 77030 Less <<
NCT00684255 - Terminated(inactive) - -
NCT03158935 Advanced Ovarian Cancer ... More >> Malignant Melanoma Less << Phase 1 Recruiting June 2020 Canada, Ontario ... More >> Princess Margaret Cancer Centre Recruiting Toronto, Ontario, Canada, M5G 2M9 Contact: Marcus Butler, M.D.    416-946-4521    marcus.butler@uhn.ca    Principal Investigator: Marcus Butler, M.D. Less <<
NCT02926053 Metastatic Renal Cell Carcinom... More >>a Less << Phase 1 Recruiting December 2018 Denmark ... More >> Center for Cancer Immune Therapy Dept. of Hematology/oncology Recruiting Herlev, Denmark, 2730 Contact: Inge Marie, Prof., MD    +4538683868    inge.marie.svane@regionh.dk    Contact: Magnus Pedersen, MD    +4538683868    magnus.pedersen@regionh.dk Less <<
NCT01518153 - Terminated(Objectives not met.... More >>) Less << - -
NCT03676504 Acute Lymphoblastic Leukemia, ... More >>Adult Acute Lymphoblastic Leukemia, Pediatric Chronic Lymphocytic Leukemia Diffuse Large B Cell Lymphoma Follicular Lymphoma Mantle Cell Lymphoma Less << Phase 1 Phase 2 Recruiting October 1, 2020 Germany ... More >> University Hospital Heidelberg Recruiting Heidelberg, Germany Contact: Prof. Dr. Michael Schmitt    +49-6221-566614    michael.schmitt@med.uni-heidelberg.de    University Hospital Heidelberg Recruiting Heidelberg, Germany Contact: Prof. Dr. Michael Schmitt    +49-6221-566614    michael.schmitt@med.uni-heidelberg.de    Principal Investigator: Prof. Dr. Michael Schmitt          Principal Investigator: Prof. Dr. Andreas Kulozik Less <<
NCT01795976 Oesophageal Cancer Phase 2 Terminated(Withdrawal of fundi... More >>ng) Less << - United Kingdom ... More >> The Christie NHS Foundation Trust Manchester, United Kingdom, M20 3EE Less <<
NCT00005941 Cervical Cancer ... More >> Vaginal Cancer Less << Phase 2 Completed - United States, Washington ... More >> Fred Hutchinson Cancer Research Center Seattle, Washington, United States, 98109-1024 Less <<
NCT00684255 Systemic Lupus Erythematosus ... More >> Systemic Sclerosis Less << Phase 1 Terminated(inactive) - United States, New York ... More >> Columbia University Medical Center New York, New York, United States, 10032 Less <<
NCT00003729 Leukemia Phase 2 Terminated(low accrual) - Belgium ... More >> Algemeen Ziekenhuis Middelheim Antwerp, Belgium, 2020 Hopital Universitaire Des Enfants Reine Fabiola Brussels (Bruxelles), Belgium, 1020 Academisch Ziekenhuis der Vrije Universiteit Brussel Brussels (Bruxelles), Belgium, 1090 Universitair Ziekenhuis Gent Ghent (Gent), Belgium, B-9000 U.Z. Gasthuisberg Leuven, Belgium, B-3000 Centre Hospitalier Regional de la Citadelle Liege (Luik), Belgium, 4000 Clinique de l'Esperance Montegnee, Belgium, 4420 France Centre Hospitalier Regional et Universitaire d'Angers Angers, France, 49033 CHR de Besancon - Hopital Saint-Jacques Besancon, France, 25030 CHU de Caen Caen, France, 14033 CHR de Grenoble - La Tronche Grenoble, France, 38043 Centre Hospitalier Regional de Lille Lille, France, 59037 Hopital Debrousse Lyon, France, 69322 Hopital Arnaud de Villeneuve Montpellier, France, 34295 CHR Hotel Dieu Nantes, France, 44093 Centre Antoine Lacassagne Nice, France, 06189 Hopital Robert Debre Paris, France, 75019 Institut Curie - Section Medicale Paris, France, 75248 Hopital Jean Bernard Poitiers, France, 86021 Hopital Americain Reims, France, 51092 Hopital Universitaire Hautepierre Strasbourg, France, 67098 Hopital des Enfants (Purpan Enfants) Toulouse, France, 31026 Portugal Hospital Escolar San Joao Porto, Portugal, 4200 Less <<
NCT02781467 Leukemia, Myeloid, Acute Phase 1 Terminated(Business Decision) - United States, Massachusetts ... More >> Beth Israel Deaconess Medical Center Boston, Massachusetts, United States, 02215 United States, Minnesota University of Minnesota Minneapolis, Minnesota, United States, 55455 United States, New Jersey John Theurer Cancer Center at Hackensack University Medical Center Hackensack, New Jersey, United States, 07601 United States, New York Roswell Park Cancer Center Buffalo, New York, United States, 14263 Memorial Sloan Kettering Cancer Center New York, New York, United States, 10065 United States, Tennessee Vanderbilt Univ Medical Center Nashville, Tennessee, United States, 37232-6307 United States, Wisconsin Froedtert Hospital BMT Medical College of Wisconsin Milwaukee, Wisconsin, United States, 53226-3522 Less <<
NCT00006233 Melanoma (Skin) Phase 2 Completed - United States, Washington ... More >> Fred Hutchinson Cancer Research Center Seattle, Washington, United States, 98109-1023 Less <<
NCT02162420 Dyskeratosis Congenita ... More >> Aplastic Anemia Less << Not Applicable Recruiting July 2024 United States, Minnesota ... More >> University of Minnesota Medical Center, Fairview Recruiting Minneapolis, Minnesota, United States, 55455 Contact: Timothy Krepski    612-273-2800    tkrepsk1@fairview.org    Principal Investigator: Jakub Tolar, MD Less <<
NCT01877837 Sickle Cell Disease Phase 3 Active, not recruiting August 2019 United States, New Jersey ... More >> Hackensack University Medical Center Hackensack, New Jersey, United States, 07601 Less <<
NCT00004218 Leukemia Phase 3 Completed - -
NCT01106950 - Terminated(study drug (Ontak) ... More >>no longer available) Less << - -
NCT01749293 Hematologic Malignancies Phase 2 Terminated(The protocol design... More >> is being reconfigured in order to open a new study.) Less << June 2017 United States, Illinois ... More >> University of Illinois Cancer Center Chicago, Illinois, United States, 60612 Less <<
NCT01106950 Leukemia, Myelogenous, Acute Phase 2 Terminated(study drug (Ontak) ... More >>no longer available) Less << - United States, Minnesota ... More >> Masonic Cancer Center, University of Minnesota Minneapolis, Minnesota, United States, 55455 Less <<
NCT00041288 Leukemia Lymp... More >>homa Less << Phase 2 Unknown - -
NCT00290641 Chronic Myeloproliferative Dis... More >>orders Leukemia Lymphoma Myelodysplastic Syndromes Less << Not Applicable Completed - United States, Minnesota ... More >> University of Minnesota Cancer Center Minneapolis, Minnesota, United States, 55455 Less <<
NCT03821987 Aplastic Anemia|Stem Cell Tran... More >>splant Complications|Engraft Failure Less << UNKNOWN 2022-03-30 Peking University Institute of... More >> Hematology,People's hospital Peking University, Beijing, Beijing, 100044, China Less <<
NCT00262782 Chronic Lymphocytic Leukemia PHASE3 COMPLETED 2025-06-10 Hanuschkrankenhaus, Vienna, A-... More >>1140, Austria|Allg. Krankenhaus der Stadt Wien Universitaets-Kinderklinik, Wien, 1090, Austria|Klinikum St. Marien, Amberg, D-92224, Germany|Internistische Praxis - Arnstadt, Arnstadt, 99310, Germany|Zentralklinikum Augsburg, Augsburg, DOH-86156, Germany|Kreiskrankenhaus Aurich, Aurich, D-26603, Germany|Regional Hospital Am Plattenwald, Bad Friedrichshall, 74172, Germany|Regional Hospital Bad Hersfeld, Bad Hersfeld, 36251, Germany|Arzt fuer Innere Medizin - Bad Reichenhall, Bad Reichenhall, 83435, Germany|Humaine - Clinic, Bad Saarow, 15526, Germany|Ermstalklinik Bad Urach, Bad Urach, D-72574, Germany|Internistische Praxis - Berlin, Berlin, 10969, Germany|Internistische Gemeinschaftspraxis - Berlin, Berlin, 13347, Germany|Haematologisch-Onkologische Schwerpunktpraxis, Berlin, 13357, Germany|Internistische Praxis - Berlin, Berlin, 14052, Germany|Internistische Gemeinschaftspraxis - Berlin, Berlin, 14195, Germany|Charite - Campus Charite Mitte, Berlin, D-10117, Germany|Charite - Universitaetsmedizin Berlin - Campus Benjamin Franklin, Berlin, D-12200, Germany|Charite - Campus Virchow Klinikum, Berlin, D-13353, Germany|Gemeinschaftspraxis - Betzdorf, Betzdorf, 57518, Germany|Praxis Dres. F.& G. Doering, Bremen, 28205, Germany|Krankenhaus Burglengenfeld, Burglengenfeld, 93133, Germany|Onkologische Schwerpunktpraxis, Cottbus, D-03046, Germany|Staedtisches Klinikum Dessau, Dessau, D-06847, Germany|Onkologische Gemeinschaftspraxis - Dresden, Dresden, 01127, Germany|Universitaetsklinik Duesseldorf, Duesseldorf, D-40225, Germany|Michael Schaefers und Partner, Duisburg, D-47051, Germany|Internistische Gemeinschaftpraxis - Ehingen, Ehingen, 89584, Germany|Onkologische Schwerpunktpraxis - Erding, Erding, 85435, Germany|Internistische/Onkologische Praxis - Erfurt, Erfurt, 99084, Germany|Onkologische Schwerpunkt Praxis, Erlangen, D-91052, Germany|St. Antonius Hospital, Eschweiler, DOH-52249, Germany|Universitaetsklinikum Essen, Essen, D-45122, Germany|Staedtische Kliniken Esslingen, Esslingen, 73730, Germany|Internistische Gemeinschaftspraxis - Forchheim, Forchheim, 91301, Germany|Klinikum Garmisch - Partenkirchen, Garmisch-Partenkirchen, N 82467, Germany|Gemeinschaftspraxis - Germering, Germering, 82110, Germany|Internistische Praxisgemeinschaft, Germering, 82110, Germany|Klinik Fuer Innere Medizin, Hematology/Oncology, Ernst Moritz Armdt Universitaet, Greifswald, D-17487, Germany|Onkologische Gemeinschaftspraxis - Gross-Gerau, Gross-Gerau, 64521, Germany|St. Marien Hospital at Katholisches Krankenhaus hagen gem. GmbH, Hagen, 58095, Germany|Allgemeines Krankenhaus Hagen, Hagen, D-58095, Germany|Internistische Praxis - Halle, Halle, 06108, Germany|Internistische Gemeinschaftspraxis - Halle, Halle, 06110, Germany|Martin Luther Universitaet, Halle, D-06097, Germany|Praxis fur Innere Medizin - Hamburg, Hamburg, 22457, Germany|Allgemeines Krankenhaus St. Georg, Hamburg, D-20099, Germany|Universitaetsklinikum Hamburg-Eppendorf, Hamburg, D-20246, Germany|Schwerpunktpraxis Haematologie/Onkologie - Hannover, Hannover, 30169, Germany|Facharzt fuer Allgemeinmedizin - Hausham, Hausham, 83734, Germany|Facharzt fuer Innere Medizin - Hechingen, Hechingen, 72379, Germany|Onkologische Schwerpunktpraxis Heidelberg, Heidelberg, 69115, Germany|Universitatsklinikum Heidelberg, Heidelberg, 69120, Germany|Medizinischen Klinik Dr. R. Schindlbeck, Herrsching, 82211, Germany|Oncological Specialist Practice, Hildesheim, 31134, Germany|Universitaetsklinikum des Saarlandes, Homburg, D-66421, Germany|Clinic for Bone Marrow Transplantation and Hematology and Oncology, Idar-Oberstein, D-55743, Germany|Praxis am Evangelischen Krankenhaus Bethanien, Iserlohn, D-58644, Germany|Internistische Gemeinschaftspraxis - Jena, Jena, 07743, Germany|Westpfalz-Klinikum GmbH, Kaiserslautern, D-67653, Germany|Staedt Klinikum Karlsruhe GGMBH, Karlsruhe, 76133, Germany|Facharzt Fuer Jnnere Medizin, Karlsruhe, 76135, Germany|St. Vincentius-Kliniken, Karlsruhe, D-76137, Germany|Internistische Gemeinschaftspraxis - Kassel, Kassel, 34117, Germany|Staedtische Krankenhaus Kiel, Kiel, 23116, Germany|Praxis Fuer Haematologie Internistische Onkologie, Koeln, D-50677, Germany|Medizinische Universitaetsklinik I at the University of Cologne, Koln, D-50924, Germany|Internistische Onkologische Praxis - Kronach, Kronach, 96317, Germany|Internistische Praxis - Landshut, Landshut, 84028, Germany|Onkologische Schwerpunktpraxis Leer, Leer, D-26789, Germany|Klinikum Lippe - Lemgo, Lemgo, D-32657, Germany|Universitaetsklinkum Magdeburg der Otto-von-Guericke-Universitaet Magdeburg, Magdeburg, D-39120, Germany|Gemeinschaftspraxis, Mannheim, D-68161, Germany|Philipps-Universitaet Marburg Klinikum, Marburg, D-35033, Germany|Internistische Gemeinschaftspraxis - Memmingen, Memmingen, 87700, Germany|Klinikum Minden, Minden, D-32427, Germany|Haematologische Praxis - Moenchengladbach, Moenchengladbach, 41239, Germany|Haematologisch-onkologische Gemeinschaftspraxis - Muenster, Muenster, 48149, Germany|Klinikum Innenstadt, Munich, 80331, Germany|Krankenhaus Muenchen Schwabing, Munich, 80804, Germany|Hamatologische Schwerpunktpraxis, Munich, 81679, Germany|Munich Oncologic Practice at Elisenhof, Munich, D-80335, Germany|Klinikum der Universitaet Muenchen - Grosshadern Campus, Munich, D-81377, Germany|Staedtisches Krankenhaus Muenchen - Harlaching, Munich, D-81545, Germany|Klinikum Garmisch-Partenkirchen GmbH Abteilung fuer Innere Medizin Murnau, Murnau, 82418, Germany|Internistische Praxis - Neuenkirchen, Neuenkirchen, 48485, Germany|Onkologische Schwerpunktpraxis Dr. Schmidt, Neunkirchen, D-66538, Germany|Praxis fuer Haematologie und Interne Onkologie, Norderstedt, 22844, Germany|Sudharz-Krankenhaus Nordhausen gGmbH, Nordhausen, 99734, Germany|Klinikum Nuernberg - Klinikum Nord, Nuernberg, D-90419, Germany|Internistische Gemeinschaftspraxis - Offenbach, Offenbach, 63065, Germany|Hematologische Praxis, Oldenburg, 26121, Germany|Gemeinschaftliche Schwerpunktpraxis - Osnabrueck, Osnabrueck, 49074, Germany|Municipal Hospital Complex, Pforzheim, D-75178, Germany|Hematologische Onkologische Praxis, Regensburg, 93047, Germany|Jakobi Krankenhaus, Rheine, 48431, Germany|Klinik und Poliklinik fuer Innere Medizin - Universitaet Rostock, Rostock, D-18057, Germany|Caritasklinik St. Theresia, Saarbrucken, D-66113, Germany|Schwerpunktpraxis Fuer Haematologie Und Onkologie, Saarbruecke, N-66113, Germany|Onkologische Schwerpunktpraxis - Schrobenhausen, Schrobenhausen, 86529, Germany|Praxis - Schwenningen, Schwenningen, 78054, Germany|St. Marien - Krankenhaus Siegen GMBH, Siegen, D-57072, Germany|Evang. Jung-Stilling Hospital, Siegen, D-57074, Germany|Praxisgemeinschaft - Stade, Stade, 21680, Germany|Onkologische Schwerpunktpraxis - Straubing, Straubing, 94315, Germany|Haematologische Praxis, Stuttgart, D-70173, Germany|Diakonie Klinikum Stuttgart, Stuttgart, D-70176, Germany|Onkologische Gemeinschaftspraxis - Trier, Trier, 54290, Germany|Southwest German Cancer Center at Eberhard-Karls-University, Tuebingen, D-72076, Germany|Universitaetsklinikum Ulm, Ulm, D-89081, Germany|St. Marien Hospital, Vechta, D-49377, Germany|Gemeinschaftspraxis - Weiden, Weiden, 92637, Germany|Haematologisch-Onkologische Schwerpunktpraxis - Weilheim, Weilheim, 82362, Germany|Internistische Praxis - Wendlingen, Wendlingen, 73240, Germany|Medizinische Klinik und Poliklinik II - Universitaetsklinikum Wuerzburg, Wuerzburg, D-97070, Germany|Kliniken St. Antonius, Wuppertal 2, D-42283, Germany|Hamatologisch - Onkologische Praxis Wurzburg, Wurzburg, 97070, Germany Less <<
NCT05379569 Acute B Lymphoblastic Leukemia... More >>|Allogeneic Hematopoietic Stem Cell Transplantation Less << PHASE4 RECRUITING 2025-12-30 Shanghai General Hospital, Sha... More >>nghai, China Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

3.51mL

0.70mL

0.35mL

17.53mL

3.51mL

1.75mL

35.06mL

7.01mL

3.51mL

References

[1]White EL, Shaddix SC, et al. Comparison of the actions of 9-beta-D-arabinofuranosyl-2-fluoroadenine and 9-beta-D-arabinofuranosyladenine on target enzymes from mouse tumor cells. Cancer Res. 1982 Jun;42(6):2260-4.

[2]Frank DA, Mahajan S, et al. Fludarabine-induced immunosuppression is associated with inhibition of STAT1 signaling. Nat Med. 1999 Apr;5(4):444-7.

[3]Tseng WC, Derse D, et al. In vitro biological activity of 9-beta-D-arabinofuranosyl-2-fluoroadenine and the biochemical actions of its triphosphate on DNA polymerases and ribonucleotide reductase from HeLa cells. Mol Pharmacol. 1982 Mar;21(2):474-7.

[4]Weiss L, Abdul-Hai A, et al. Fludarabine in combination with cyclophosphamide decreases incidence of GVHD and maintains effective graft-versus-leukemia effect after allogeneic stem cell transplantation in murine lymphocytic leukemia. Bone Marrow Transplant. 2003 Jan;31(1):11-5.

[5]Pievani A, Michelozzi IM, et al. Fludarabine as a cost-effective adjuvant to enhance engraftment of human normal and malignant hematopoiesis in immunodeficient mice. Sci Rep. 2018 Jun 14;8(1):9125.

[6]Pharmacokinetics of fludarabine

 

Historical Records

Categories

Inhibitors/Agonists
Cell Cycle
DNA/RNA Synthesis
Inhibitors/Agonists
Cell Cycle
Nucleoside Antimetabolite/Analog
Inhibitors/Agonists
DNA Damage
DNA/RNA Synthesis
Inhibitors/Agonists
DNA Damage
Nucleoside Antimetabolite/Analog

Tags: Fludarabine | F-ara-A | NSC 118218 | NSC118218 | NSC 118218 | NSC-118218 | Nucleoside Antimetabolite/Analog | DNA/RNA Synthesis | STAT | Apoptosis | fluorinated | purine analogue | lymphoproliferative malignancies | STAT1 | 21679-14-1